
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-11701-12000*
  '("A+A" "A-C" "A-D" "A-GVGD" "A-allele" "A-bands" "A-loop" "A-to-I"
    "A-treated" "A1" "A14L" "A159E" "A15V" "A172F" "A18C" "A18G" "A19E" "A50V"
    "A8" "AA-NAT" "AARPs" "AAV" "AAV9-mediated" "ABM" "ABg" "ADCC-efficient"
    "ADF-H" "ADNI" "ADP-ribose-like" "AEP-macrocephaly" "AFA" "AG+GG" "AGEN"
    "AGEN-T2D" "AGITG" "AGS-Wnt1-injected" "AGS-Wnt1cells" "AHB"
    "AHHGEAGHHLPEPSSRETG" "AHR-NRF2-SLPI" "AHS" "AJAP1" "AJCC" "AJT"
    "AKAP-like" "AKAPs" "AKT8" "ALDHA1" "ALDH + " "ALK+TCL" "AML-complete"
    "AML-like" "AMPAR" "AMPKαinhibitor" "ANDV" "ANDV’s" "ANKRD13C" "ANKRD55"
    "AO-label" "AOC" "AOPPs" "AP26113" "APSPIIKFPGDVAP" "AR-V2" "AR-promoter"
    "ARE-luciferase" "ARE-mediated" "ARF6-GTP" "ARMS-PCR" "ASD-macrocephaly"
    "ASD-macrocephaly-epilepsy" "ASPC1" "ASSTT" "AT-56" "AT-D" "ATM-cDNA"
    "ATM-p53-14-3-3-σ" "ATP-competitive" "AVL" "AVO" "AVOs" "AW14,22LA" "AZD"
    "AZD-1152" "AZD-1152-HQPA" "AZD-1152-dependent" "AZD7726" "Abcam" "Abe"
    "Ablynx" "AceCS2" "Achilles" "Activator-Like" "Ad-based" "Ad-shCbl"
    "Ad-shCtrl" "AdCre" "AdCreRb" "AdHSP" "Adamson" "Addgene" "Adeno" "Adeno-X"
    "AdenoCre" "Adph" "Adr" "Aebersold" "Affibody" "Affymetrix" "Africa"
    "African" "African-American" "African-Americans" "Africans" "Ag" "Ag1.5"
    "AgeI" "Agilent" "Ahr" "Ai" "AiP" "AiP-induced" "Aiii" "Akbari" "Akt-null"
    "Akt-phosphoproteome" "Akt1" "Akt1-dependent" "Akt3" "Akt3-dependent"
    "Aktas" "Akti1" "Alabama" "Alamos" "Albor" "Albright" "Aldana"
    "Aldana-Masangkay" "Alexa" "Alexa594" "Alfonso" "Align-GVGD" "Alisertib"
    "All-atom" "Allografts" "Alpha-smooth" "AlphaScreen" "AluI" "Alzheimer"
    "Alzheimer's" "Alzheimer’s" "Amaxa" "America" "American" "Americans"
    "Americas" "Aminoactinomycin" "Amos" "AmoyDx" "Anderson" "Andes" "Angeles"
    "Angiostrongylus" "Apert" "Apte" "ArKO" "Arbes" "Area-specific" "Arg194Trp"
    "Arg399Gln" "Ari" "Arkansas" "Array-800" "Array-comparative" "Ashkenazi"
    "Asian" "Asians" "Asp-Glu-Ala-Asp" "AstraZeneca" "At-SAGMB"
    "At-astato-4-guanidino-methylbenzoate" "Atg13L" "Austin" "Australia"
    "Austria" "Auyeung" "Avella" "Avet-Loiseau" "Azami" "Azeri" "Aα" "Aβ" "A–C"
    "A–D" "B-D" "B-GFP" "B-WICH" "B-induced" "B-mediated" "B-related" "B-type"
    "B1" "B2" "B2-T1" "B2-T9" "B3" "B55β-shRNA" "B56β" "B56δ" "B6" "B7"
    "B7-type" "BALB" "BARD1-NfrGFP" "BARD1-mediated" "BCCL" "BCCLs"
    "BCL2-family" "BCL9-2" "BCR-ABL1-negative" "BCRABL" "BCRs" "BCSS" "BD"
    "BDNF-NTKR2" "BED" "BFAF" "BFDP=0.15" "BGJ398" "BGT226" "BIU" "BIU-87"
    "BIX" "BIX-02189" "BIX02188" "BJE6-106" "BM-MSC-related" "BMN" "BMP-family"
    "BRAFV600E" "BRAFcolon" "BRC5" "BRC8-like" "BRCA-associated" "BRCA-like"
    "BRCA1-C61G-CfrGFP" "BRCA1-C64R-CfrGFP" "BRCA1-Cys61Gly" "BRCA1-Cys64Arg"
    "BRCA1-D67Y" "BRCA1-competent" "BRCA1-defective" "BRCA1-mutated"
    "BRCA1-proficient" "BRCA1-wt" "BRCA1-ΔNp63-S100A2" "BRCA1–ΔNp63" "BRIM-3"
    "BS-1" "BSA-Cy5-coated" "BT-T" "BT474-shPTEN-LTT" "BT474M1" "BUB" "BV" "Ba"
    "Bachem" "Background" "BafA1" "Bai" "Balb" "BamHI" "BamHI-NotI" "Bangkok"
    "Bannayan-Riley-Ruvalcaba" "Bao" "Bao-hui" "Barbareschi" "Barford" "Barr"
    "Barrett" "Bartlett" "Base-excision" "Basel" "Bay11" "Bayer" "Bayer-Garner"
    "Bayes" "Bcl" "BeadArray" "BeadChip" "BeadChips" "Beare" "Beare-Stevenson"
    "Beclin1and" "Begg" "Begg's" "Begger" "Begger's" "Begg’s" "Bergamo"
    "Bergantinos" "Berho" "Berns" "Berridge" "Bertoli" "Bertoli-Avella"
    "Bethesda" "Bi-nucleation" "Bicatulamide" "Bickel" "Bihar" "Bilateria"
    "BioGenoMEL" "Biocoat" "Biosystems" "Bioworks" "Birmingham" "Bischof" "Bnz"
    "Bo" "Bogaert" "Bonferroni" "Bonvini" "Bordeleau" "Boskos" "Bossi"
    "BothPlk4" "Bouche" "Bouin" "Bousquet" "Boyden" "Boyle" "Brca1"
    "Break-apart" "Brenner" "Breslow" "Breslow’s" "Brinkmann" "British" "Britt"
    "Browser" "Bryant" "Btc" "Bu" "Bunyamwera" "Bunyaviridae" "Burkitt"
    "Burkitt’s" "Bushman" "Buttita" "Buttitta" "B–D" "C-A" "C-co-infected"
    "C-domain" "C-glucose" "C-labeled" "C-lobe" "C-α" "C-θ" "C1" "C1A–C1B–C2"
    "C1A–C1B–C2–kinase" "C1B–C2" "C1B–bilayer" "C1B–kinase" "C1–C7" "C2"
    "C2-like" "C2I" "C2I-C3" "C2–bilayer" "C3" "C3-glomerulopathy" "C4"
    "C4orf45" "C4–C7" "C57" "C57BL6" "C6" "C62S" "C6orf64" "C8"
    "CA-AKT-transfected" "CA19-9" "CAAT" "CAAX" "CACGTG" "CADM" "CADM1-EC-Fc"
    "CADM1-EC-Fc-coated" "CADM1-FL-YFP" "CADM1-ΔCT-YFP" "CADM1Δ4.1BM"
    "CADM1ΔCT" "CAGn" "CAP-Gly" "CBD" "CBV" "CCAAT" "CCGCCC" "CCGGAAG" "CCRT"
    "CD-associated" "CD-related" "CD1+CD2" "CD1-d" "CD14-dependent" "CD19+"
    "CD203" "CD203-PE" "CD203c" "CD25-FITC" "CD266" "CD28-mediated"
    "CD28-stimulated" "CD3ζ-EYFP" "CD3ζ-Lck-positive" "CD4-only" "CD40+IL-4"
    "CD44+" "CD45-PerCP" "CD4CreCtnnb1" "CD63-FITC" "CD69-FITC" "CD8-ζ" "CDJ"
    "CDRs" "CE81T" "CELAVIEW" "CEP10" "CEP17" "CEP7" "CEPH" "CEUr" "CFU-Mk"
    "CG-dinucleotide" "CGEMS" "CGM" "CH040" "CH5424802" "CH5425802" "CHB+JPT"
    "CHDs" "CHIP" "CHIR" "CHX-chase" "CICs" "CILC4" "CISs" "CKBBP2" "CLC-2"
    "CLIA" "CLIC" "CLINICAL-TRANSLATIONAL" "CLIP2" "CLO6A1" "CMAC" "CMF-like"
    "CMSF" "CMT1C" "CMY" "CNE" "CNGs" "CNNC" "CNQX" "CNVs" "COHRA" "COL-5"
    "COLD-PCR" "CONSORT" "CONTIN" "COSM5170" "COTL1mutant"
    "COTL1–5-lipoxygenase" "COXVIII" "COδ" "CPMG" "CR-EACs" "CRAN" "CRIFI"
    "CRL-1573" "CRL-1739" "CRL-5822" "CRL-5971" "CRL-5973" "CRPCs"
    "CS-EAC-implanted" "CS-MKP-1-bound" "CSC-like" "CSF14-3-3β" "CT-X" "CTAs"
    "CTCR" "CTCR-OV01" "CTCR–OV01" "CTEP" "CTG" "CTIIA" "CTNNA3" "CTTN-9KR"
    "CVs" "CW" "CX-4945" "CXCR4-tropic" "CYFRA21-1" "CYYYYCYYYY" "CZL"
    "Ca2+-ATPase" "Caenorhabditis" "CalcuSyn" "Calmette" "Calmette-Guerin"
    "CamKKβ-AMPK" "Cambridge" "Camelidae" "Camidge" "Canada" "Canadians"
    "Candace" "Capuzzo" "Cardiac-specific" "Caribbean" "Carlsbad" "Carma"
    "Carma1-Bcl10-Malt1" "Carma2" "Cary" "Cas3*-positive" "Casitas" "Caspase-3"
    "Castleman" "Cattoglio" "Caucasian" "Caucasians" "Cav-1-dependent"
    "Cav-1-knockout" "Caveolin-1–null" "Ccr7" "Ccr9" "Cdc42" "Cdc42-mediated"
    "Cdk2-and" "Ceccon" "Cederbaum" "Celia" "Celia-Terrassa"
    "Cell-adhesion-mediated" "CellQuest" "Cellometer" "Cellular" "Celon"
    "Cerevisciae" "CfrGFP" "CfrGFP-BRCA1-HA" "CfrGFP-Z" "Ch16.0" "ChAM" "ChIP"
    "ChIP-PCR" "ChIP-on-chip" "ChIP-qPCR" "ChIP-re-ChIP" "ChagoK1" "Chan"
    "Changzhou" "Charcot-Marie-Tooth" "Chernobyl" "Chernobyl-irradiated"
    "Chi-Square" "Chi-square" "Chiarle" "Chicago" "Child-Behavior" "Chioni"
    "Chk1" "Chk1-S345" "Chk1-induced" "Chk2-T68" "Chk2-dependent" "Chk2i"
    "ChlP-Seq" "Choi" "Chorley" "Christensen" "ChromHMM"
    "Chromatin-Association" "Chun" "Chung" "Ci" "Cip1" "Cja" "Cl" "Clara"
    "Clare" "Clark" "Clarke" "Clazpy" "Click-iT" "ClinicalTrials" "Clontech"
    "Cmax" "CoIP" "Cochran" "Cochrane" "Cochran’s" "Cohen" "Cohen-Saidon"
    "Coiled-Coil" "Colombia" "Colony-formation" "Colorado" "Colquhoun"
    "Compton" "Comptons" "Conchain" "Conclusions" "Control" "Coomassie"
    "Copper-induced" "Corcoran" "Corson" "Coupland" "Cowden" "Cox-1"
    "Coxsackie" "CpG-dinucleotides" "Crabbe" "Cre-drivers" "Crispino" "Crohn"
    "Crohn's" "Crohn’s" "Crompton" "Crouzon" "Crouzonoid" "Cruz" "Ct" "Cter"
    "Ctf18-replication" "Ctf18p" "Ctf8p" "Ct " "Cuc" "Cullin-RING" "Curcuma"
    "Cyclin-B1-Cdk1" "Cyto" "Cytoplasmic" "Cytoskeletal-associated" "Cytospin"
    "Czech" "Cα" "CγCO" "CγN" "Cδ1" "C " "C–E" "C–H" "C→G" "D-drug-associated"
    "D-glutamate" "D-loop" "D-loops" "D-transposition" "D2" "D2F" "D2FC" "D3"
    "D54-MG" "D5F3" "DAG-lactone" "DAG-lactone-activated" "DAG-lactone-induced"
    "DAG-lactone-stimulated" "DAG-lactone-treated" "DAR-Pin" "DBS" "DBeQ"
    "DD-IRES-ZsGreen1" "DD-Vpr-IRES-ECFP" "DD-Vpr-IRES-ZsGreen1"
    "DD-Vpr-expressing" "DDK-MYC-tagged" "DEVD" "DEVD-A" "DEXA" "DF2C" "DFNA49"
    "DFNA7" "DHHC" "DHHC13" "DIANA" "DIIRQ" "DISCUSSION" "DK-MG" "DKO1" "DKO3"
    "DKO4" "DKS" "DKS-8" "DKs5" "DM=2" "DMAG" "DMAP" "DMEM" "DMFS" "DMLE+2.2"
    "DNA-SCARS" "DNA-damage-induced" "DNA-image-cytometric" "DNA-protein"
    "DNAH5" "DNAzyme" "DNFB" "DNMIkappaBalpha" "DNMIκBα" "DNaseI" "DO-1" "DONG"
    "DPP2" "DPP8" "DPYL2" "DS-MCF-7" "DSBR" "DSBs" "DSCC" "DSCC1#1scr"
    "DSCC1#2" "DSCC1#2scr" "DSGNES" "DSGxxS" "DSM-IV-TR" "DU-4475" "DVF" "DXA"
    "DZ1" "Dahlhoff" "Dallavalle" "Danusertib" "Danvers" "Database-HGMD"
    "David" "Davidson" "Davis" "Dawei" "Dcc1p" "DeJesus" "DeJesus-Hernandez"
    "DeNicola" "Delgado" "Delgado-Martinez" "Deng" "Detroit" "Detroit-551" "Df"
    "Dhh" "Diabetes-induced" "Dictyostelium" "Didraga" "Diego" "DiffScore"
    "Dinkova" "Dinkova-Kostova" "Disheveled2" "Djuzenova" "DnaJb5" "Doebele"
    "Dojindo" "Doppler" "Double-immunofluorescence" "Double-membrane" "Doxo"
    "Dragestein" "Dras" "Drd1-like" "Dronc" "DsRed2" "Du" "Duell" "Dulbecco"
    "Dulbecco’s" "Dunbrack" "Dunham" "Dunham-Ems" "Duoxes1" "Dutch"
    "Dyn-treatment" "D–F" "E-MEXP-3715" "E-box" "E-cad" "E-plates" "E12"
    "E2-ERα-mediated" "E26" "E2β" "E2βfor" "E384X" "E7" "E9" "EAC-P"
    "EAC-P-transplanted" "EAC-V" "EAC-V-derived" "EB1-EGFP-bound"
    "EB1-EGFP-expressing" "EBNA-3C" "EBP2-T3A" "EBPb" "EBPβ" "EBPδ" "EBSCO"
    "EC-D" "EC-DL" "EC-DL-treated" "EC109" "EC50" "ECMs" "ED" "ED1303"
    "EED-sh3" "EEF" "EEG" "EFGR" "EGF+MF" "EGF-like" "EGFP-BAX-expressing"
    "EGFP-LC3B-expressing" "EGFPα-tubulin" "EGFR-cytoskeleton"
    "EGFR-non-amplified" "EGRF" "EGSSS" "EIA" "EJM" "EMBL-EBI" "EMBOSS" "EMFs"
    "EML4-ALK-positive" "EMT-like" "ENBA1" "EP-156" "EP1-4" "EPEC" "EPGN"
    "EPHB" "ER+" "ER+breast" "ER-ERE" "ER-negativity" "ER-positive" "ER-status"
    "ER-α36" "ER-α66" "ERBB2-expressing" "ERFFI1" "ERK-pathways" "ERKO" "ERMS"
    "ERRB3" "ERRB4" "ER + " "ER + breast" "ESEfinder" "ETGR" "EUS" "EUS-FNA"
    "EYFP-fluorescence" "EYK" "Earle" "Earle’s" "Early-onset" "Ebox" "Edlundh"
    "Edlundh-Rose" "Egger" "Egger's" "Egger’s" "Ehrlich" "Eiger" "Eiv" "Elmer"
    "Emory" "Ems" "End-Results" "Endou" "England" "English" "Enh-1"
    "Enrichment-pathway" "EpRE" "Epac" "Epacs" "Epcam" "EphA2-Positive"
    "EphA2-negative" "EphA2-positive" "Epigentek" "Epithelial-mesenchymal"
    "Epithelial-to-mesenchymal" "Epstein" "Ereg" "Eric" "Erkan" "Essen"
    "Etienne" "Etienne-Manneville" "Europe" "European" "Europeans" "Evans"
    "Exiqon" "Exp-5" "Exp-t" "Exp-t-mediated" "ExxLV" "ExxxLV" "Eμ" "F-ML-10"
    "F-actin" "F1,6BP" "F6P" "FACSCalibur" "FACSCanto" "FB-prosthesis" "FCDTC"
    "FCDTCs" "FEI" "FFB" "FFL" "FFPE" "FGFR1-3" "FGFR1-4" "FGFR1–3" "FGFR1–4"
    "FGFR1≈24" "FGFR2-BICC1" "FGFR2≈350" "FGFR2≈8" "FGFR3≈8" "FGFR4≈34" "FISH"
    "FISH-positive" "FKB" "FKB12-rapamycin" "FL17" "FLAG" "FLAG-tag"
    "FLAG-yAha1" "FLLL" "FLLL-32" "FLT3-ITD" "FLT3-ITD-dependent"
    "FLT3-ITD-disease" "FLT3-ITD-driven" "FLT3-ITD-expressing"
    "FLT3-ITD-induced" "FLT3-ITD-positive" "FLT3-ITD-targeted" "FLT3-TKD"
    "FMC7" "FNA" "FNAC" "FOL" "FOLFIRI" "FOLFOX" "FOLFOX-4" "FOP2-FGFR1"
    "FRAXA" "FRAXE" "FSC" "FUDP" "FUMP" "FUTP" "Factor-X" "Fallot"
    "Fas-mediated" "Fbxw7α" "Fc" "FcεRI" "FcεRI-PE" "FdUMP" "FdUTP" "Feb"
    "Fechner" "Fernandez" "Fernandez-Rhodes" "Fgfrs" "Fifty-five" "Fifty-nine"
    "Fifty-one" "Fifty-six" "Fifty-three" "Figure-4B" "Fine-mapping" "Flag"
    "Flag-IRES-ECFP" "Flag-IRES-SCAT3.1" "Flag-IWS1-transduced"
    "Flag-IWS1S720A" "Flag-R80A-expressing" "Flag-TXNL1-transfected"
    "Flag-Vpr-IRES-ECFP" "Flag-Vpr-IRES-SCAT3.1" "Flag-Vpr-IRES-ZsGreen1"
    "Flag-Vpr-expressing" "Flanagan" "Flip-IN" "FluPE" "Folland"
    "Follistatin-like" "Forty-eight" "Forty-one" "Foundation-7" "Foyil"
    "Framingham" "France" "Franzke" "Fraumeni" "Fremont" "French"
    "French-Canadian" "Friedl" "FuB2" "Fucci" "Fucci2" "Fudan" "Fugene6" "Ful"
    "Ful+AZD8931" "Funes" "Furukawa" "Förster" "G-CIMP" "G-L" "G-LISA"
    "G-actin" "G-quadruplex" "G-rich" "G-stimulatory" "G0" "G1" "G1-3"
    "G1-to-S" "G12D" "G2" "G47A" "G47A-HA" "G6P" "GA-affinity" "GA201" "GADPH"
    "GAGAGAGAA" "GAL4-Nef" "GANT61-treatment" "GAS" "GBq" "GCGC" "GCS" "GEEEK"
    "GEF-mediated" "GENEVA" "GEOD" "GEOD-23878" "GEP70" "GFP-H-RasG12V"
    "GFP-H-RasV12" "GFP-LC3B" "GFP-Rab11-decorated-endosomes" "GFP-fragment"
    "GFP-fusion" "GFP-positive" "GFRα" "GG17" "GGGCGG" "GGGGCC" "GGNn" "GJICs"
    "GLAUGEN" "GLAUGEN-NEIGHBOR" "GLCCl1" "GLOBOCAN" "GM7000" "GM=10"
    "GMR-eiger" "GOEAST" "GSE10358" "GSE14333" "GSE14468" "GSE21927" "GSH-P"
    "GSK-1120212" "GSK3αβ" "GSK3αβ-pathway" "GST-BRC3" "GST-CADM1-C"
    "GST-CADM1-CΔ4" "GST-Carma1-linker" "GST-DP1–carboxyl" "GST-HIV-1"
    "GST-Nef" "GST-Nef1-60" "GST-Nef55-206" "GST-NefWT" "GST-pull" "GST–Nef"
    "GUK-like" "GVGD" "GW-53" "GWA" "GWAS-Rep1" "GWAS-Rep1-Rep2"
    "GWAS-Rep1-Rep2-Rep3" "GWASs" "Ga" "Gabriel" "Gain-of-function" "Galbraith"
    "Galkin" "Gallo" "García" "Gasparini" "Gastrectomy" "Gastrocrom" "Gaulton"
    "Gaussian" "Gb" "GenBank" "GenCall" "GeneChip" "Genebank" "Genentech"
    "Genome-wide" "GenomePlex" "Georgakis" "George" "GeparQuinto" "German"
    "Germany" "Geusau" "Ghaneh" "Gi" "Giepmans" "Gillison" "GlcNAcP" "Gleason"
    "Gli" "Gli-ANTagonist" "Gliadel" "Glutathione-Sepharose" "Gn" "GnGc" "GnTs"
    "Gn’s" "Goekkurt" "GoldenGate" "Gomez-Hernandez" "Goodwin" "Google" "Gough"
    "Graham" "Gram-negative" "Grantham" "Grasemann" "Greek" "Grisham"
    "Grisham's" "Grose" "Growth-suppressive" "Gs" "Gsα" "Guerin" "Guillou"
    "Gupta" "GxE" "Gy" "Gynaecologistes" "Gynécologie" "Gα" "Gαi" "Gαi2" "Gαs"
    "Gαs-cAMP-PKA-PP2A" "GαsQL" "G " "G→C" "G→T" "H&E" "H-labeled"
    "H-palmitate" "H19-ICR" "H2009" "H2AK119" "H3" "H3K18" "H3K18Ac" "H3K18ac"
    "H3K27" "H3K27Ac-to-H3K27me3" "H3K36" "H3K37Ac-to-H3K27me3" "H3K79"
    "H3K9ac" "H3KAc" "H3S10" "H3S10-bound" "H4" "H4K16" "H9"
    "HA-KD-Nek2–transfected" "HA-Myr-Akt" "HA-OCT4-M3" "HA-PED-S104" "HA-Ub"
    "HA-WT-Nek2" "HA-positivity" "HA-ubiquitin–bound" "HAEC" "HAF" "HBEC-3KT"
    "HCAEC" "HCAECs" "HCCBR" "HCG18" "HCG27" "HDAC3·N-CoR" "HDCA2" "HDF" "HDFs"
    "HDMVEC" "HEC-265" "HECT-family" "HER-18" "HER-2-expressing" "HER2-18"
    "HER2-gene" "HER2-negative" "HER2-positive" "HERBIS-1B" "HERT" "HFF" "HFFs"
    "HFIB-1" "HFKs" "HFL-1" "HG-U219" "HGMD" "HGNC" "HICT" "HIF-2a" "HIV+"
    "HIV+ " "HIV-1-seropositive" "HIV-189.6" "HIV-1Tat" "HJ" "HK2-10" "HK5Cre"
    "HL116" "HLA-DR3" "HLA-DR4" "HLA-II" "HLF-F" "HLMVEC" "HLMVECs" "HMCL"
    "HME-1" "HNMECs" "HNSCCs" "HOMA-B" "HOMA-IR" "HPLC-ESI-MS" "HPS-like"
    "HPV16-positive-associated" "HPV16E6" "HR=0.29" "HR=0.376" "HR=0.82"
    "HR=1.90" "HR=2.7" "HR=3.13" "HR=3.199" "HR=5.02" "HSF2PB" "HSP2"
    "HSP90–client" "HSQC" "HTB-135" "HTB-27" "HTNV" "HU" "HWE-deviant"
    "HXB2-env" "HYZ" "Haggarty" "Hairy-enhancer" "Hajj" "Hamatani" "Hamburg"
    "Hamilton" "Hammamatsu" "HapMap2" "HapMap3" "Hapmap" "Hapmap3" "Harbin"
    "Hardy-Weinberg" "Hardy–Weinberg" "Harney" "Harrell" "Harrell's"
    "Hashimoto" "Hashimoto’s" "Hayden" "Hayes" "HbA1c" "Hebrok" "Hedenfalk"
    "Hefei" "Heidelberg" "Helsinki" "Hematoxylin-eosin" "HercepTest"
    "Hernandez" "Herrington" "Hexanucleotide" "Heyer" "Hezel" "High-expression"
    "High-level" "High-performance" "High-resolution" "High-risk" "Hilden"
    "Hillsboro" "Hippo" "Hippo-mediated" "Hirschsprung" "Hirschsprung’s"
    "His-Dlg-N" "His-Hsp90" "His-MPP3" "His-MPP3-N" "His127–Leu131" "Hispanic"
    "His–L-PGDS" "Hodgkin" "Hodgkins" "Hodgkin’s" "Hodis" "Hoechst" "Hoff"
    "Hoffmann" "Hoffmann-La" "Holland" "Holliday" "HomoloGene" "Honduran"
    "Honduras" "Hong" "Hopkins" "Horikawa" "Horst" "Hoshino"
    "Hospital-Affiliated" "Houston" "Hsc-70" "Hsp72-mortality" "Hsp722"
    "Hsp90ΔMEEVD" "Hsp90α" "HuMC" "HuMCs" "Huang" "Hubbert" "Huhtamieni"
    "Huntington" "Huntington's" "Huntington’s" "Huo" "Huzarski" "Hwang"
    "Hyper-proliferation" "Hz" "I-Eβ" "I-IB-Mal-D-GEEEK-Nanobody" "I-II" "I-IV"
    "I-Nanobody" "I-SGMIB" "I-SGMIB-Nanobody" "I-expressing" "I-induced"
    "I-iodobenzoate" "I-labeled" "I1-FFL-like" "I5" "I9" "I9M"
    "IAP-antagonists" "IARC" "IB-Mal-D-GEEEK" "IC50≈8" "ICI" "ICI-treatment"
    "IDC" "IE1-72" "IE72" "IEDB" "IFN-regulatory" "IFN-βtranscripts"
    "IGF-1-induced" "IGHV" "IHC0" "II-III" "II43,46SL" "IIA" "IIC" "III-IV"
    "IIIb" "IIIc" "IIβ" "II∼III" "IKBα" "IKK-like" "IKKs" "IKKβ-or"
    "IKKε-directed" "IL-1-α" "IL-2-dependence" "IL-2α" "IL-β" "IL-β-mediated"
    "IL-β-treated" "INKA4a" "INRICH" "INSIPID" "IODO-GEN" "IOP" "IPI-Human"
    "IPed" "IQ" "IRB" "IRES-ZsGreen1" "IRF-E" "IRF3-5D" "IRS-1and"
    "IRdye-labeled" "ISCCs" "ISGs" "ISRE-luciferase" "ITGA" "IU" "IVS" "IVS1"
    "IVSI" "IVa" "IWS1-DE" "IWS1-S720D" "IWS1S720A" "IZ" "IZ-VAD-FMK" "Iceland"
    "Icelanders" "Idziaszczyk" "Ig-like" "IgCAMs" "IgD" "IgG-isotype"
    "IgG-like" "IgII" "IgII-IgIII" "IgIII" "IgL" "Igλ" "Iizuka" "Ile114-Cδ"
    "Ile151-Cγ2" "Iliopoulos" "Illumina" "Illumina’s" "Image-J" "ImageJ"
    "ImmGen" "Immediate-early" "Immuno-PCR" "ImmunoResearch" "Immunoblotting"
    "In-depth" "In-vitro" "Inc" "Inhibitor-caspase" "Inhibitor-of-apoptosis"
    "InsR" "Insititute" "Internationale" "Intestinal-type" "Invitrogen"
    "Ioannidis" "Ioannidiset" "Iono" "Iowa" "Iowan" "Ires-Cx43" "Ishii"
    "Ishiwata" "Islet1" "Itoh" "IκB-family" "I–III" "J-M" "JAK-STAT1"
    "JAK-STAT3" "JAK-STAT3-SNAIL" "JARID1" "JASPA" "JDD" "JGH" "JIN" "JJL"
    "JL-P" "JM-A" "JM-G" "JMC" "JMD" "JMRdeA" "JNKKK" "JNKKs" "JPM50.6" "JPT"
    "JQ1" "JRD" "JREM" "JRJ" "JTT" "JV" "JW" "JZ" "Jackson" "Jackson-Weiss"
    "Jacobsen" "Jacotot" "Jan" "Janoueix" "Janoueix-Lerosey" "Janssen"
    "Japanese" "Jewish" "Ji" "Jiang" "Jin-su" "Johnson" "Joosse" "Jose" "Jung"
    "J–M" "K-RasG12V" "K-RasV12" "K18R" "K2756X" "K29R" "K5cre-CMVcaNrf2"
    "K5cre-caNrf2" "K6" "K63-linked-polyubiquitination" "K630" "K75E" "KAA"
    "KAM1" "KATO" "KCNQ16" "KEGG" "KFERQ" "KFERQ-like" "KG1a-PKCβII-GFP" "KHSV"
    "KIF" "KK1-Mock" "KK1-NDRG2-injected" "KPS" "Kadaba" "Kamal"
    "Kanamarlapudi" "Kaplan" "Kaplan-Meier" "Kaplan–Meier" "Kaplan–Meyer"
    "Kaposi" "Kaposi's" "Kaposis" "Kaposis's" "Kaposi’s" "Karpas299CHR"
    "Karpas299CR" "Katayama" "Katsuno" "Kaviar2" "Kd" "Keller" "Kennedy"
    "Keohavong" "Ki-67" "Ki-67-positive" "Kickstein" "Kiel" "Kim" "KinasePhos"
    "Kirschner" "Kirtikara" "Kit-8" "Klenow" "Km=8.4±1.2" "Km=8.4±1.2 "
    "Knock-down" "Knock-in" "Knudson" "Knudson’s" "Ko" "Kocher" "Kodak" "Kong"
    "Kool" "Korea" "Korean" "Kornev" "Kornmann" "Kostova" "Kostrzewska"
    "Kostrzewska-Poczekaj" "Kovacs" "Kowalczykowski" "KpnI" "Kraan" "Krebs"
    "Kruczynski" "Kruppel-like" "Kruskal-Wallis" "Kubovcakova" "Kumamoto"
    "Kusabira" "Kwong" "K→Q" "K→R" "L-1β" "L-DKO" "L-Glucose" "L-P"
    "L-PGDS–W43A" "L-type" "L5" "L5-induced" "L8A4" "LAML" "LAMP-2A" "LAMP2A"
    "LC3-I" "LC3B-I" "LC3B-II" "LC3I" "LC3II" "LCLs" "LCV110" "LDPI" "LDv"
    "LEOPARD" "LET1-1" "LET1-2" "LGSCs" "LIM1215sc5" "LIMKs" "LINC00313" "LISA"
    "LJC" "LJY" "LM-111" "LM-γ2" "LMM" "LMW" "LPS" "LPS-induced" "LRKK2" "LRR5"
    "LRR5-7" "LRRK2-IN-1" "LSCCs" "LTE" "LTEP" "LTEP-a-2" "LTNP" "LTNP1"
    "LTNP1v11" "LTNP1v4_1" "LTNP1v4_1_67" "LTNP2v14" "LTNP3" "LTNP4" "LTNP5v22"
    "LTNPs" "LTR-host" "LTRs" "LV-miR-222i" "LVEF" "LWF" "LX" "LYY" "LZJ"
    "Laar" "Laemmli" "Landa" "Lapidus" "Large-scale" "Latina" "Lauren"
    "Lauren's" "Lauren’s" "Laurén" "Lce" "Leah" "Leeds" "Lef" "Lehmann" "Leica"
    "Lerosey" "Leu3a" "Leung" "Levene" "Leydig" "Li" "Li-Fraumeni" "LiBRCA2"
    "Liao" "Liby" "Life" "LifeAct" "Lincoln" "Lindemann" "Lipofectamine"
    "Lippert" "Liu" "Live-cell" "Loi" "Loiseau" "Lombardy" "London" "Lorentz"
    "Low-expression" "Low-grade" "LoxP" "Loxp" "Lpa" "Ltd" "Lu" "Luciani"
    "Luminex" "Lymphochip" "Lys-128" "Lúcio" "Lúcio-model" "M&M" "M-or"
    "M-tropic" "M0" "M10" "M30-recognition" "MADISH" "MADISH-like" "MAGIC"
    "MAGuK-family" "MANTRA" "MAP2Δ1-158" "MAPLC3A" "MBA-MD-453" "MBq"
    "MCF-10As" "MCF10" "MCF10-A" "MCF10-p53" "MCF10APTEN" "MCF10Ap53"
    "MCF7-like" "MCF736" "MCF7V" "MCG132" "MCL1reduction" "MCN" "MCNs"
    "MD-MBA-231" "MDA-BR" "MDA-LDL" "MDA-M231" "MDA-MB-213" "MDA-MB-231LN"
    "MDA-MB-231cells" "MDA-MB361" "MDA-MBA-231" "MDA-responsive"
    "MDA5-directed" "MDC-label" "MDCK+CADM1" "MDCK+CADM1-GFP" "MDM2SNP309"
    "MDSC" "MDSCs" "MEEVD" "MEK-DD" "MEK-dependence" "MEM" "MF+EGF"
    "MF-activating-motility" "MHC-II" "MHC-presentation" "MHCII" "MHz"
    "MHz-range" "MIBC" "MID1-α4" "MIFS" "MIX3" "MJC" "MJE3" "MJL" "MK-2006"
    "MK-PT" "MKA" "MKP-1-null" "MKPO" "MKPO-1-dependence" "MLL-fusion"
    "MLL-fusions" "MLV-G-GFP" "MMCL" "MMCL+MM" "MMEJ" "MMRC" "MMRC0006"
    "MMRC0387" "MMTV-promoter" "MNK-45" "MOIs" "MP-7a" "MP-7f" "MP-7g" "MQ"
    "MRC-Holland" "MRE" "MREs" "MRE’s" "MRTFs" "MS-based" "MSC0" "MSC4" "MSC5"
    "MSCVTomato" "MSKCC" "MSigDB" "MT+WT" "MT-1expression" "MT-cluster-based"
    "MTB-cell" "MTDB" "MTF-1" "MTS" "MT–MT" "MV4" "MYND" "MYOD" "MYT"
    "MacroH2A" "Maekawa" "Mahajan" "Maher" "Malonyl-CoA" "Malpighi" "Mangla"
    "Manneville" "Marfan" "Marfan’s" "Margolin" "Margolin’s" "Markert" "Marsit"
    "Martinez" "Martinez-Delgado" "Maryland" "Marzec" "Masangkay" "MassARRAY"
    "Massachusetts" "Masson" "Masson-trichrome" "Masson’s" "Mathieu"
    "Matsuuchi" "Matsuyama" "Matthew" "Matullo" "MaxEntScan" "Mayo" "McLellan"
    "McMaster" "McNatt" "Mcl-1-κB" "Mdm2" "Mdm2-M459I" "Medline" "Meier"
    "Mel-U" "MelU" "Melnick" "Menten" "Merck" "Metabochip" "Metacore"
    "MethPrimer" "Methodology" "Methyl-Profiler" "Mexican" "Mexicans" "Meyer"
    "MiR-141" "MiR-146a" "MiR-146b" "MiR-19b" "MiR-222i" "MiR-34a-3p" "MiRcute"
    "MiaPaCa" "Michael" "Michaelis" "Michaelis–Menten" "Michigan"
    "Microprocessor" "MigR1" "Milan" "Mild" "Millipore" "Minimal" "Minnelli"
    "Mirabello" "MitoTracker" "Mitsudomi" "Mk" "Mml" "MoAbs" "MoMLV" "Moderate"
    "Moderately-differentiated" "Moffett" "Mohammadi" "Mollapour" "Moloney"
    "Monocyte-to-fibrocyte" "Montero" "Morris" "Mosse" "Mp" "Mp-7g" "Mps"
    "MseI" "Mst1" "MuTHER" "Muenke" "Mullan" "Muscle-specific" "MutationTaster"
    "Mx" "MyLa3765" "Myc-Mdm2–expressing" "Myc-Myr-PKCθ" "Myc-epitope-tagged"
    "Myr-Akt" "N-CON" "N-Control" "N-Ras-mediated" "N-Shh" "N-Shh-treated"
    "N-a-Acetyltransferase" "N-acetylglucosamine-6-phosphate" "N-con"
    "N-domain" "N-domains" "N-glutamine" "N-glycosylation" "N-linked" "N-lobe"
    "N-methyl-N-nirtosourea" "N-myristoylation" "N-protein" "N1-3" "N=11–20"
    "N=26" "NA22" "NADPH" "NAFLD" "NAM+TSA" "NAMI" "NAMI-A" "NATO" "NBDPS"
    "NCBI" "NCD80" "NCI" "NCI-10-C-0218" "NCI-H1792" "NCI-H209" "NCI-H69" "NCR"
    "NCT01457846" "NCTC" "NDGR2" "NDMA-receptors" "NDRP1" "NE3"
    "NEDD9-dependant" "NETN" "NEU-N" "NF-κB-1" "NF-κB-2" "NF-κB-like" "NF-КB"
    "NF1-null" "NFKβ" "NFΚBIA" "NFκ-B" "NGUS24i" "NGUS24i-infection" "NHBE"
    "NHBE-T" "NHF" "NHF-4" "NHF-A" "NHF-B" "NHF-C" "NHLBI" "NHSC" "NIBPL"
    "NIgG" "NKLDK" "NL43" "NMECs" "NNsplice" "NO" "NOD-SCID" "NOD-Scid-gamma"
    "NOD-like" "NOTCH" "NP1v5_1" "NP2v11_2_1" "NRCMs" "NSABP" "NSBAP" "NSs"
    "NT-siRNA" "NTCM" "NTSR3" "NVP" "NVP-BGJ398" "NY-1V" "NZ" "Naa10p" "Nagel"
    "Nagoya" "Nakahata" "Nakamura" "Nakano" "Nakatsuji" "Nanfang" "Natsch"
    "Naus" "Near-complete" "Nef55-206" "NefWT" "Neg" "Nek" "NeoALTTO"
    "Neomarkers" "Netherlands" "Netrins" "Newcastle" "Newcastle-Ottawa"
    "Nexcelom" "Ni" "Ni-NTA" "Niewidok" "Ninety-six" "Ninety-three" "NleE"
    "Noguchi" "Nombre" "Noonan" "North-European" "Notch-mediated" "Novartis"
    "Nox" "Nox1-5" "Nox1-preneoplastic" "Nox1-tv" "Nox2-dependent" "Nrf"
    "Nrf-null" "Nrf1involved" "Nrf2" "Nrf2-ARE" "Nrf2-down-stream" "Nrf2-null"
    "Nrf2ko" "Nrfs" "Nter" "Nts" "NuB2" "NuB3" "NuPAGE" "NuRD" "Nur" "Nε2" "N "
    "O-016" "O-GlcNAcylation" "O-acetyl" "O-glycosylation" "O-linked" "O4"
    "O6-position" "OC" "OCCCs" "OCT4-shRNA" "OD405S" "OH" "OH-Fl"
    "OH-flutamide" "OHdG" "OMIM" "OP-SCCs" "OPC" "OPCs" "OPSCCs" "OPUS"
    "OR=1.26" "OR=1.30" "OR=1.52" "OR=1.85" "OR=2.09" "OR=2.1" "OR=2.23"
    "OR=3.06" "OR=5.3" "ORPT" "ORS-and" "ORs" "OSBT" "OSBTs" "OSU" "OXR"
    "Obitrap" "Obstetristes" "Obstétrique" "Oct3" "Oct4-positive" "Olson"
    "Olympus" "Om" "Once-daily" "Onco-genes" "One-plus-one" "Open-field"
    "OpenBioSystems" "Opitz" "Ordonez" "Oris" "Ornitz" "Orsola-Malpighi"
    "Ottaviano" "Ottawa" "Overexpression" "Overholtzer" "Ovid" "P102C" "P2-T1"
    "P2-T5" "P2X7R" "P38-α" "P=3×10" "PAGE4-6His" "PAINT" "PAK-PBD-agarose"
    "PALB" "PAM50" "PANDA" "PAPR1" "PARPi" "PAX3-FOXO1" "PAb-1620" "PAb-240"
    "PBECs" "PBLs" "PC-3" "PCATs" "PCC" "PCDHA13" "PCR-RFLP" "PCR–Sanger" "PCT"
    "PCT-III" "PD53035" "PDA" "PDGRA" "PDKs" "PDPK-1" "PED-S104" "PED-tumor"
    "PEP-3" "PF-562,271" "PF-573,228" "PF271" "PFLT3" "PFSs" "PFT-μ" "PGAM-1"
    "PGAM-Tg" "PGAM2-4R" "PGAM2-S118A-FLAG" "PGAM2-S118D-FLAG" "PGAM2-T2"
    "PGAM2-WT-FLAG" "PGE-synthases" "PGES-1" "PGL3-WT-LGR4" "PHA-P"
    "PHA-P-activated" "PHLPP1-2" "PHLPP1α-IKKα" "PHLPP1β" "PHOSIDA" "PHYRE"
    "PI3K-Akt-mediated" "PI3KCA" "PI3KR1" "PIF-pocket" "PK-PD" "PKACα"
    "PKAFoxO1" "PKARII" "PKARIIβ" "PKC-θ" "PKCepilon" "PKCα" "PKCβI" "PKCβγ"
    "PKCδ-null" "PKCδ-selectivity" "PKCθ" "PKCι-Hh" "PKCι-SOX2-Hh" "PLAT-A"
    "PLATand" "PLCO" "PLK1-4" "PLXBN3" "PLZF-RARa" "PMA" "PMLI" "PMLII"
    "PMLIII" "PMLIV-3KR" "PMLIV3KR" "PMLIVa" "PMLV" "PMLVI" "PMLVIIb" "PMLc"
    "PMNLs" "PMSS1" "POZ" "PP2A-B55β" "PP2Acα" "PP5c" "PPxY" "PQGKRMGRGAPVEPSR"
    "PR-negative" "PR-positive" "PRAD" "PRC1-CBXs" "PREVEND" "PR + " "PSCAN"
    "PTEN-S380A" "PTEN-Ser380" "PTEN-null" "PTEN-proficient" "PTF" "PTF-μ"
    "PUUV" "PVN" "PXSP" "Pa-7a" "Pa-7c" "Pa-7f" "Pa-Sh" "Paired-label" "Pals-2"
    "PanIN" "Panteleyev" "Parker" "Parkinson" "Parkinson’s" "Parmigiani"
    "Patel" "PathScan" "Patient1" "Payne" "Pearson" "Pekowska" "Peng"
    "Pennsylvania" "Pepro" "PerCP" "Perez" "Perkin" "Pet24d-Rad51" "Pfizer"
    "Pharma" "Pharmingen" "Phase-contrast" "PhenGenI" "Philadelphia" "Philip"
    "Photoshop" "Piao" "Pierre" "Pifithrin-α" "Pifithrin-μ" "Pittsburgh"
    "PmirP" "Poczekaj" "Pol-Prim" "Policlinico" "PolyPhen" "PolyPhen-2"
    "Polyphen-2" "Polyphen2" "Polδ" "Polε" "Polη" "Polη-εGFP-complemented"
    "Polι" "Polκ" "Pomacea" "Pos" "Post" "Pouf1" "PrCSC" "Principal"
    "Principal-component" "Pro105–Gln108" "Procrustes" "Profiler" "Promega"
    "Prostaglandins" "Prostate-Cancer-Associated" "Prostate-cancer-associated"
    "ProteoIQ" "ProteoTuner" "Pt" "PtdIns-3,4" "PtdIns-3,4-P2" "Pten" "Ptr"
    "Puregene" "Puumala" "PvD" "PvuII" "PvuII-rs2234693" "PyMT" "P~0.023"
    "P = 0.005" "P = 0.018" "Q-MSP" "Q403X" "Q775X" "QH" "QIAamp" "QIAquick"
    "QMS" "QQ" "QT" "QT-PCR" "QTL" "QTc" "QW" "QY" "Qiagen" "Quantitative-PCR"
    "R-to-A" "R0" "R1441C" "R15Dfs" "R5-HIV-1" "R5P" "R73E" "RAD3-related"
    "RANKL–RANK-mediated" "RAPTA" "RAPTA-C" "RARa" "RASSF1A-associated"
    "RASSSF1A" "RB-miRNA" "RBH" "RBhi" "RC-U" "REGγproteasome" "REMARK"
    "RESULTS" "RET51MEN2A" "RETMEN2A" "RETMEN9A" "RETMENA" "RFC-1" "RFLP"
    "RFP-RASS1A" "RFP-RASSF1A–expressing" "RFP-RASSF1A–overexpressing"
    "RFP-XRCC1-transfected" "RGS10-1" "RGT" "RIG-I-like" "RII" "RING-like"
    "RIP1and" "RIPA-insoluble" "RIPA-soluble" "RKTs" "RLAF" "RMH" "RNA-protein"
    "RNA22" "RNAhybrid" "RNA–protein" "RNaseP" "RO-32-0432" "ROCK-1-inhabitor"
    "ROR-γt" "ROS-protective" "RP2v16_2_87" "RPCI" "RR-H460" "RT-qPCR" "RTV4"
    "RWPE" "RWPE-2" "Rab11-GTPase-containing" "Rab11-activity"
    "Rab11-endosomes" "Rab11-vesicles" "Rac1" "Rad3" "Rad3-related"
    "Radioactive" "Raf-CAAX" "RajagopalanK" "Ramachandran" "Ramirez" "Rampias"
    "Ran-GTP" "Rap" "Rap1-GTP" "Raptor-immunoprecipitates" "Raptor-mediated"
    "Ras-G12V" "Ras-G12V-induced" "Ras-G12V–expressing" "Ras-G12V–induced"
    "Ras-effector" "Ras-homologous" "RasN17" "Ravid" "Rawlings" "Rayleigh" "Rb"
    "RdelM" "Re-expression" "Re-probing" "Receptor-2" "Red-Blue-HIV-1"
    "Red-Green-HIV-1" "RefSeq" "RegulomeDB" "Renton" "Reverse-transcription"
    "Reynard" "Reynold" "Rheumatology" "Rho-GTP" "RhoA-GTP" "RhoC-GTP"
    "Rhodamine-Phalloidin" "Rhodes" "Rhoin" "Rhotekin-agarose" "Riegert"
    "Riegert-Johnson" "Riga" "Ro-32-0432" "Roche" "Roche-Genentech" "Rodier"
    "Rodriguez" "Rosa26" "Rosenfield" "Rossmann" "Roswell" "Rotterdam" "Rpd3S"
    "Runx" "Ruoslahti" "Rushmore" "Ruzzo" "RxRxxS" "S-1" "S-palmitoylation"
    "S-segment" "S1" "S100P" "S104" "S160" "S165D-α6-tubulin-expressing" "S1C"
    "S2-F" "S204" "S217" "S240" "S25N" "S2A" "S2B" "S2C" "S2D" "S2–S4" "S3"
    "S32A" "S33" "S36A" "S37" "S37–T42" "S380A" "S3C" "S3D" "S3I-1747"
    "S462-TY" "S462TY" "S4A" "S4B" "S4C" "S550" "S551" "S551A" "S552A" "S5A"
    "S6" "S6-kinase" "S637" "S637A" "S645" "S645A" "S6K" "S6RP" "S7" "S7–S11"
    "S8" "S8–S9" "S9" "S94A" "S9A" "SA-β-gal-positive" "SAGMB" "SAHA" "SAR"
    "SAT2D" "SAXS" "SB202129" "SB202196" "SB21673" "SB216763-pretreatment"
    "SB431452" "SCADS" "SCAT3.1" "SCHNN" "SDF-1α" "SDF1α" "SDv" "SEE" "SEER"
    "SERCA2a" "SFM " "SGC031" "SGMIB-Nanobody" "SGxx" "SIFT" "SILAC-MS" "SIRT"
    "SIRT-1" "SIRT-RNAi" "SIRT-RNAi-PANC-1" "SIRT1-RNAi" "SIRT1-RNAi-ASPC-1"
    "SIRT1-RNAi-PANC-1" "SIRTs" "SITR3" "SIVcpz" "SJRB011" "SJRB014" "SJRB016"
    "SJRB020" "SJRB024" "SJRB031" "SJRB032" "SJRB035" "SJRB039" "SJRB051"
    "SK-Lu-1" "SK-Mel-113" "SK-Mel-215" "SK-Mel-217" "SK-Mel-264" "SK-Mel-285"
    "SKCM" "SKUT" "SKUT-2" "SMAD3-dependent" "SN53,55RH" "SNAs" "SNP285"
    "SNP285C" "SNP309G" "SNPMClust" "SNPexp" "SNPinfo" "SNPs" "SNRP48" "SNU"
    "SNU-119" "SNU-620" "SNU-8" "SNU688" "SNVs" "SOC3" "SPC-A-1" "SPECT" "SPFH"
    "SPFH-domain" "SPIRITS" "SPOP-ΔBTB" "SPOPisa" "SPRR2D" "SSC" "SSc-A"
    "SSc-B" "SSc-C" "STACs" "STAT3-PKCβII" "STAT3-driven" "STAT3-mediated"
    "STAT3C" "STAT3α" "STAT3β" "STAT5A-dominant" "STAT5B-dominant" "STE20-like"
    "STIP1-PRPN" "STRAD1" "STROBE" "STTTS" "SUDHL-1" "SUMO-E3" "SUMOylatable"
    "SUMOylated" "SW-620" "SW480-DSCC1#1" "SW480-Mock#1" "SWHS" "SY" "SYBYL"
    "SYBYL-X" "SYKTEL" "SYKi" "Sabatini" "Sahai" "Sahra" "Saidon" "Sakamoto"
    "Sakaue" "Sakaue-Sawano" "Sangale" "Sanger" "Sasaki" "Saurat" "Scansite"
    "Scd3" "Sce" "Schiebel" "Schiff" "Schlieper" "Schmitz" "Schuldt" "Schwan"
    "Schwann" "Schäfer" "ScienceDirect" "SecretomeP" "Seiwert" "Self-renewal"
    "Selleckchem" "Sendai" "Sendoel" "Sentrix" "Sept" "Sequence-based"
    "Sequence-binding" "Sequencher" "Sequenom" "Sequenome" "Sequest" "Ser-165"
    "Ser-216-phosphorylated" "Ser104" "Ser165→Asn" "Ser165→Asp" "Ser380"
    "Ser550" "Ser720" "Serum" "Set-up" "Seto" "Seventy-five" "Seventy-two"
    "Severe" "Sf21" "Shahrzad" "Shakya" "Shenoy" "Shield1" "Shih" "Shih-tzus"
    "Shim" "Shinozaki" "Shiota" "Shoji" "Short-term" "Shue" "Si36"
    "Sigma-Aldrich" "Significance" "Singaporean" "Single-Molecule"
    "Single-cell" "Single-molecule" "Sir2p" "Sirtuin-3" "Six-hour"
    "Sixty-seven" "Sixty-two" "Sk-Mel-266" "Slingshot-1" "Slpi" "Smad2"
    "Small-cell" "Small-molecule" "Smallridge" "Smuf2" "Snell" "Soerensen"
    "Solomon" "Somanathan" "Sordella" "Sorg" "Sos" "Spain" "Spanish" "Spautin"
    "Spearman" "Spearman's" "Spearman’s" "Spectrometer" "Sphere-forming"
    "Sphroid" "Spielberger" "Sporn" "Springer" "Spurr" "Spurr’s" "SqCC" "Src"
    "SsNVs" "Stachowiak" "StageTip" "Stat3" "Stat3-mDNA" "Stat3-mtDNA"
    "State-Trait" "Stearoyl-LPC" "Steen" "Steiner" "StemPro" "Stevenson"
    "Stingl" "Stockholm" "Storer" "Stratagene" "Stress-induced"
    "Structure-function" "Study–Cognition" "Sub-cellular" "Super-infection"
    "Suppl" "Surflex" "Surflex-Dock" "SurflexDock" "Sutherland" "Sutter"
    "Sutton" "Sutton's" "Suzuki" "Sweden" "Swerdlow" "Switzerland" "Sydney"
    "Syndax" "T-77C" "T-Expressed" "T-S" "T-helper" "T-helper-17"
    "T-lymphoblast" "T-lymphoblasts" "T-lymphoma" "T-lymphotropic" "T-stage"
    "T1" "T1-2" "T1-T2" "T1-enhancing" "T1D" "T1D-risk" "T202" "T221" "T24"
    "T2D" "T2DM" "T2MD" "T3" "T3-4" "T3-L1" "T382A" "T383A" "T3A" "T4" "T41"
    "T41-reactive" "T41-β-catenin" "T41–reactive" "T47-d" "T51-6His" "T7"
    "T721A" "T721E" "T98GpDRGFP" "TA+TT" "TAK-779" "TAK-799" "TATA" "TAX1BP"
    "TBHQ" "TC+CC" "TCCD" "TCCTGCAA" "TCCTGCnA" "TCF-Luc" "TCGA-24-2038"
    "TCGA-25-1316" "TCR+CD28" "TCRhi" "TCRα" "TEAD-family" "TEAD-interaction"
    "TEAM" "TFBS" "TFBSs" "TFC" "TFIIIC2" "TFSEARCH" "TGF-1" "TGF-αalpha"
    "TGF-αby" "TGF-αligand" "TGF-αwas" "TGFβ-downregulatory" "TGP53-4" "TGTTCT"
    "TH-17" "TH17" "TIANGEN" "TIMP1is" "TKB" "TKD" "TKI-sensitivity-conferring"
    "TMRM" "TNBCs" "TNFα-treatment-recovery" "TOP-1" "TOP-like" "TP-α"
    "TP53R175P" "TRAF3IP2-dependent" "TRAF3IP2-mediated" "TRAF3IP2-null"
    "TRANSFAC" "TRDV3" "TRIPZ" "TRMPCIR" "TRMPVIR" "TRP2-shRNA_#2" "TRP2in"
    "TT-cyclobutane" "TTA" "TTC" "TTCCAAGAA" "TTCCAGGAA" "TTCCTAGAA"
    "TTCCTGGAA" "TTCTAAGAA" "TTCTCAGAA" "TTCTTGGAA" "TTTC" "TTTSSCGC" "TULV"
    "TUNNEL" "TY" "Tabl" "Taiwan" "Taiwanese" "Takashima" "Tam+AZD8931"
    "TamRes" "Tampa" "Taneytown" "Taqman" "Taqman-probe" "Tarassishin"
    "Target-scan" "TargetScan" "TargetScan5.2" "TargetScanHuman" "Tarui"
    "Tauchi" "Tc" "Tcf" "Tecnai" "Terrassa" "Tfn" "Th-17" "Th17" "TheO"
    "Thermo" "Thike" "Thiocolchicoside" "Thirty-eight" "Thirty-two" "Thr-127"
    "Thr-protein" "Thr-rich" "Thr202" "Thr36–Pro39" "Thr37" "Thr382" "Thr383"
    "Thr395Ala" "Thr39–Leu49" "Thr721" "Thr77Ala" "Tian" "Tiedt" "Time-course"
    "Time-lapse" "Tip60-containing" "Tissue" "Toh" "Toll-like"
    "Tomato-positive" "Tournigand" "Towne" "Tramtrak" "Transcription3"
    "Tribius" "Triple-negative" "Trojanowska" "Trp-53" "Ts" "Ts4Cre"
    "Ts4CreAPC" "Tt1" "TuRC" "Tubastatin" "Tuj1" "Tula"
    "Tumor–to–normal-tissue" "Turk" "Turkish" "Turks" "Twenty-eight"
    "Twenty-five" "Twenty-four" "Twenty-one" "Twenty-seven" "Twenty-two"
    "Two-hybrid" "Two-thirds" "Tykocinksi" "Tykocinski" "Tyr204" "U-test" "U1"
    "U1-Vpu" "U1-VpuShRNA" "U1-scrambled" "U133" "U251" "U373MG-PMLIII-3KR"
    "U46619" "U73122" "UAMS" "UAMS-70" "UAP" "UAS" "UAS-RNAi" "UC1" "UC6" "UCA"
    "UCA1-1" "UCA1-2" "UCA1-RT-3.1" "UCA1-RT-5.1" "UCA1-siRNA" "UCB-MSC" "UCLA"
    "UCSC" "UCSF" "UD" "UFA" "UM-SCC" "UM-SCC-11A" "UM-SCC-47" "UM-SCC-74B"
    "UMIN000007941" "UMUC" "UMUC-14" "UNC5B-mediated" "UPEN-RB-05" "UPEN-RB-31"
    "UPEN-RB-45" "URL" "USA" "USP2a" "UTRs" "UV" "UV-C" "UV-C-induced"
    "UV-KSHV" "UV-exposure" "UVA" "UVB" "Ub" "Ub-proteasome" "UniGene" "Utah"
    "V-akt" "V0" "V1" "V12" "V12-transduced" "V2" "V3" "V4" "V5" "V5-D-TOPO"
    "V5-His" "V5-TRIP-1" "V5-TRIP-1-expressing" "V5-TRIP-1-transfected"
    "V5-tag" "V5-tagged" "V7" "VAD-FMK-type" "VBT" "VCAUCH" "VDJ"
    "VEGF-cofactor" "VEGF-matrigels" "VEGF-treatment" "VEGF2" "VEGFAKT"
    "VEGFR1-3" "VFs" "VKS" "VMH" "VP16-eEF1A" "VR" "VSV-G" "VSV-G-mediated"
    "VSV-L" "VSV-N" "VSs" "VUS" "VUSs" "Val-Ala-Asp" "Val129" "Val762Ala"
    "Valencia" "Valenzuela" "Valenzuela-Fernandez" "Vargas" "Venn" "Venus"
    "Vermeij" "Verthelyi" "Vichai" "Vieira" "Vienna" "Vietnam" "Vinbastine"
    "Violet" "Virusys" "Vmax" "Vonlaufen" "Vorinostat" "Vos" "Vose" "VpuGFP"
    "Vulgaris" "W177–W199" "W43A" "WBCs" "WDB" "WEnCA" "WHI" "WHI-P131"
    "WHI-P154" "WI" "WJTOG3405" "WLL" "WO" "WPE" "WPE1" "WPE1-NA22" "WPE1-NB14"
    "WST-1" "WT-H" "WT-H-Ras" "WT-H-Ras-intact" "WT-N-Ras" "WT-PKCα" "WT-Rab11"
    "WT-Ras" "WT-SOX2" "WT-p53" "WT-α6-tubulin" "Waddell" "Wakabayashi" "Wald"
    "Wallis" "Warburg" "Warsaw" "Warthin-like" "Warts" "Waterman-Storer"
    "Weber-Fechner" "Webgestalt" "WeightMatrix" "Weinberg" "Weiss"
    "Well-designed" "Wengen" "Western-blot" "Whiteland" "Whitney" "Whole-cell"
    "Widschwendter" "Wiechen" "Wilcoxon" "Willems" "Williams" "Wiskott"
    "Wiskott-Aldrich" "Wnt-pathway" "Wnt-pathway-active" "Wu" "WueMel"
    "WueMel45" "Wyeth" "X-Omat" "X-Y" "X-box" "X-omat" "X-ray" "X-rays"
    "X4-HIV-1" "X5P" "XDD" "XH" "XIA1" "XL" "XL-184" "XLM" "XMY" "XPORT"
    "XR-100" "XRCC1Arg194Trp" "XTT" "XY" "XZ" "XbaI" "XbaI-rs9340799" "Xq21.2"
    "Xu" "Y-family" "Y1" "Y10" "Y1221" "Y1234" "Y204" "Y223" "Y381" "Y4N"
    "Y525" "Y526" "Y6" "Y9" "YC" "YCY" "YFY" "YI" "YJC" "YLH" "YRI" "YSC" "YSZ"
    "YX" "YXY" "YY589" "YY768" "YZ" "Yadav" "Yamada" "Yamanaka" "Yamazaki"
    "Yanez" "Yang" "Ye" "Yes" "Ying-Yang" "Yoon" "York-1" "Yorkie" "Yoruba"
    "Yoshiyuki" "Yu" "YxxM" "Y→F" "Z-CfrGFP" "Z-NfrGFP" "Z-alpha" "Z-alpha "
    "Z-score" "Z-scores" "ZC" "ZJY" "ZL" "ZR" "ZR-75" "ZR75" "ZX" "ZZ" "Zhang"
    "Zhao" "Zhao's" "Zhu" "Zimmermann" "Zou" "ZsGreen1" "aCGH" "aFos" "aHR=0.3"
    "aHR=3.34" "aHR=7.32" "aJAK2" "aa1-186" "aa186-304" "aa39-68" "aa429-441"
    "aa81-141" "aagt" "abdomino" "abdomino-retroperitoneal" "abdominoplasty"
    "absent-intermediary" "absorbance" "accumbens" "acetoacetyl-CoA"
    "acetyl-Lys" "acetyl-PDHA1" "acetyl-choline" "acetyl-lysine"
    "acetyl-mimetic" "acetylated-53" "acetylation-to-trimethylation"
    "acetylcholine" "acetylglucosamine" "acid-sensing" "acidic-dileucine"
    "acid–precipitable" "acral" "activators" "activity–3" "acute-type" "acyl"
    "adaptors" "adducts" "adenoma-carcinoma" "adenosylhomocysteinase-like"
    "adenylate" "adhesin-like" "adhesiveness" "adipose-derived" "adult-type"
    "advanced-stage" "afterDE" "agar" "age-and" "age-by-genotype"
    "age-telomere" "aggregometry" "aime" "akt" "alcoholic-fatty-liver-disease"
    "algorithm" "algorithms" "alkyl" "alkylguanine" "alkynyl" "all-time" "allP"
    "allelle" "allograft" "allostery" "alpha-helical" "alpha-helix"
    "alpha-negative" "alpha-risk" "alpha-secretase" "alphaC" "alphaherpesvirus"
    "alpha–delta" "alphoid" "alveoli" "amino-acid" "amino-terminal" "aminoacid"
    "aminoacylation-dependent" "aminobenzoylglutamate" "among-study"
    "amphotericin" "amplicon" "amplicons" "anRb" "anabolicm" "analogue-bound"
    "analyte" "analytes" "and-47" "andArf" "andFigure" "andPlk4" "andRb"
    "andp21" "androgen-dependant" "androgen-deprivation" "androgen-regulated"
    "aneuploidy" "aneurysm" "aneurysms" "aneurysms-osteoarthritis" "angiocrine"
    "angiogenesis-associated" "angiography" "anibody" "anorexia" "anoxia"
    "antago" "antago-miR" "antago-miR-1207-5p" "antago-miR-1266" "antago-miRs"
    "antagomirs" "antennapedia" "anterior-most" "anterograde" "antigen-1"
    "antigenome" "antigenome-sense" "antiglutamate" "antihistamine"
    "antiplasmin" "antiretroviral-naïve" "antithrombin" "antithrombin-III"
    "antitumour" "antropometry" "antrum" "apoB100" "apocrine"
    "apoptosis-competent" "apoptosis-defective" "app" "approx" "approx-imately"
    "arcOGEN" "arcuate" "are-unchanged" "area-specific" "arisen"
    "armamentarium" "array-comparative" "arrayCGH" "arrest-independent"
    "arrhythmia" "arteriole" "arterioles" "as-yet" "asDE" "ase" "astragaloside"
    "astrocytic-dependent" "at-risk" "ation" "atreriosus" "atria" "atrium"
    "attachment-independent" "attention-deficit" "atypia" "autacoids"
    "autocrine-activated" "autocrine-produced" "autofluoresce"
    "autophagy-defective" "autoradiography" "average+" "axilla" "axon" "aβ"
    "aβ-neurotoxicity" "a–c" "a–d" "b-catenin" "b-dependent" "b-lineage"
    "back-to-back" "backflow" "bacterium∶cell" "basal-like" "basal-type"
    "basaloid" "base-pair" "basepair" "bavacizumab" "bead-based" "beads-bound"
    "begun" "below-target" "benzo" "benzopyran" "benzyloxycarbonyl-Val-Ala-Asp"
    "betaine" "betaine-homocysteine" "between-center" "between-study"
    "between-subjects" "bi" "bi-allelic" "bi-cistronic" "bi-directional"
    "bi-phasic" "bi-transgenic" "bi-variate" "bidentate" "bifida" "binucleate"
    "bio" "biomass" "biomolecule" "biomolecules" "biotin-p63"
    "biotinylated-human" "bipyridyl" "bisindoyl" "bivariate" "blastocyst"
    "blastocysts" "blindJAK2" "blocker" "blockers" "blood-brain"
    "blood-derived" "blood–brain" "blown" "blue–positive" "body-mass"
    "bodyweight" "bolus" "boluses" "bootstrap" "borderline-significant"
    "bothPlk4" "bovis" "bp" "bpy" "branch-like" "branched-chain" "break-apart"
    "breakpoint" "breakpoints" "broad-spectrum" "broader" "bromopalmitate"
    "bronchio" "bronchio-alveolar" "bronchoscopy" "browsers" "bud-like"
    "bulk-degradation" "by-pass" "by-passed" "by-passes" "c-Fos"
    "c-Src-dependent" "c-index" "c-src" "c10A" "cBio" "cDNA" "cFN" "cIAP"
    "cIAPs" "cNap-1" "cPKC" "cPKCs" "cSNPs" "ca27" "caAhr" "caNrf2"
    "cacodylate" "caecum" "café-au-lait" "calcium-dependency"
    "calcium-permeable" "calf-intestinal" "calphoatin" "calphostin" "cal "
    "canakinumab" "canaliculata" "cancer-regulatory" "cancer-relevant"
    "cancer-susceptibility" "candidate-gene" "candidates" "caner" "cannabinoid"
    "cap-n-collar" "capacitance" "capillary-like" "capsid" "carbazole"
    "carbonyl" "carboxy-terminally" "carboxyl" "carboxyl-terminal"
    "carcinoma-like" "cardia" "cardiac-muscle" "cardiac-specific" "cardiocytes"
    "cardiomyoblasts" "cardiomyocite" "cardiomyocites" "cardiomyopathies"
    "cardioprotectant" "cargos" "carnitine" "carotid" "carrier-1" "carriers"
    "carryout" "cartilage-specific" "case-families" "case-parental"
    "case-reports" "caseum" "caspase-like" "caspsase-8" "catabolite"
    "catabolites" "catalogas" "catch-all" "caucasions" "caudate" "caveolin-1α"
    "ccRCC" "cd" "ceRNAs" "cecal" "cecum" "cell-adhesion-mediated"
    "cell-autonomous" "cell-intrinsic" "cell-like" "cell-permeable"
    "cell-stimulatory" "cell-to-cell" "cell-to-matrix" "cell-toxicity"
    "cell-type-specific" "cells" "centile" "centriole" "chain–only"
    "channel-forming" "channel-independent" "chaperokines" "chaperone–like"
    "checkpoint-transducer" "chemically-induced" "chemo" "chemo-radiation"
    "chemo-repellent" "chemo-resistance" "chemo-therapy" "chemoattractant"
    "chemokine-mediated" "chemoradiotherapy" "chemorepellents"
    "chemoresistance" "chemoresistant" "chemotherapy+lapatinib"
    "chemotherapy+trastuzumab" "chi-squared" "chloracne"
    "cholangiocarcinoma-like" "cholangiocarincomas" "cholesterol-and"
    "cholesterol-efflux" "cholesteryl-esters" "choline" "chorea" "chosen" "chr"
    "chr11" "chr16q" "chr1q" "chr2p" "chr6p" "chrl4q22.3" "chromaffin"
    "chromatid" "chromatin-based" "chromatin-remodeling" "chromene"
    "chromogranin-C" "chromosome-negative" "cinnamate"
    "cis-diamminedichloridoplatinum" "cis-regulatory" "cisapride"
    "cisplatin-chemotherapy" "cisplatin-induced" "cisternae" "cistrome"
    "cistromes" "clade" "clades" "classifer" "classifier" "classifiers"
    "claudin-low" "clearer" "clinic-pathologic" "clinic-pathological"
    "clinical-pathological" "clinical-pathology" "clinically-diagnosed"
    "clinically-resected" "clinical–pathological" "clinicians" "clinico"
    "clinico-pathological" "clonally-derived" "clone10A" "coactivate"
    "coactosin-like" "cobas" "cocaine-and-amphetamine-regulated" "cochaperone"
    "coded-for" "codominant" "codon" "codons" "cold-treatment" "coli"
    "colitis-associated" "colitis-induced" "colocalise" "colonosphere"
    "colonospheres" "colony-formation" "colony-forming" "color-coded" "comedo"
    "comet-like" "commonest" "comorbid" "compartments" "compendia" "complex-1"
    "compound-C" "compound-deficient" "condensate" "conductance" "confounder"
    "confounders" "congenita" "consensus-based" "constitutively-activate"
    "constrast" "contig" "continuously-distributed" "continuum"
    "contraction-induced" "contradistinct" "contrast-leakage"
    "contrast-to-necrosis" "control-families" "control-parent"
    "control-parental" "copper-exposure" "copper-induced" "copper-inducible"
    "copper-responsive" "copy-number" "coregulators" "coregulatory-binding"
    "corepress" "corneodesmosome" "corneum" "cortex-derived" "cosmids"
    "cost-effective" "cosubstrate" "cotrans" "counter-activity"
    "counter-regulatory" "counter-selection" "counteraction-specific"
    "covariate" "covariates" "coworkers" "cribriform" "crimson-positive"
    "cross-activation" "cross-comparing" "cross-complementation"
    "cross-complementing" "cross-connecting" "cross-induce"
    "cross-presentation" "cross-priming" "cross-reactivity" "cross-regulation"
    "cross-resistance" "cross-section" "cross-sectional" "cross-species"
    "cross-validation" "crossedPten" "crossingPten" "crossover" "cryptochrome"
    "ctin" "cucurbitacins" "cul" "cul-de-sac" "custom-capture" "cut-off"
    "cut-offs" "cyan" "cyano-7-nitroquinoxaline-2,3-dione" "cyclohezimide"
    "cyclooxigense-2" "cyotochrome" "cystein" "cystein-274" "cystein-276"
    "cystein-667" "cystein-669" "cysteine-274" "cysteine-proteases"
    "cysteine-reactive" "cysteine-to-serine" "cysteinyl" "cytoD"
    "cytochemistry" "cytohesin" "cytohesin-2" "cytology" "cytometer"
    "cytoskeletal-associated" "d-h" "d-loop" "d4T-containing" "dL70-3" "dN"
    "dS" "dasatinib-sensitivity" "dataset" "datasets" "day-3" "day-5" "dbGaP"
    "dbSNP" "dbcAMP" "ddI-associated" "ddI-containing" "de-protected"
    "de-protects" "de-regulation" "de-repression" "de-suppression"
    "de-ubiquitinase" "death-phosphorylation" "death–survival"
    "decarboxylase-1" "deconjugates" "decorin-null" "deeper" "degron"
    "delE746-A750" "delta-cell" "delta-cells" "denaturants"
    "denervation-induced" "density-dependency" "density-dependent"
    "density-gradient" "density–dependent" "deoxynucleotidyl"
    "deoxythymidylate" "deoxyuridine" "deoxyuridylate" "der" "desmoplasia"
    "destabilise" "df " "diabetes-like" "diabetes-mediated" "diabetic-induced"
    "dichlorophenyl" "dichroism" "dideoxynucleoside" "diet-induced"
    "diethynitrosamine" "diet–induced" "difficult-to-treat" "diffuse-type"
    "dihedrals" "dihydrofluorouracil" "dihydroorotate" "dileucine"
    "dimethylmitrosamine" "dimmer" "dimorphism" "dipeptidyl" "diphosphate"
    "diphosphate-ribose" "diploid" "diplopia" "dipole" "dipoles" "disbalance"
    "discoideum" "disease-free" "disease-free-survival" "disease-relevant"
    "disease-susceptibility" "diserine" "disomy" "distant-metastasis-free"
    "dnAMPK" "doi" "dominant-negative" "dopachrome" "dormancy"
    "dosage-dependent" "dose-curve" "dose-dependently" "dose-escalation"
    "dose-independent" "dose-induced" "dose-limiting" "dose-mediated"
    "dose-reduction" "dose-response" "double-immunofluorescence"
    "double-knockout" "double-membrane" "double-modulation" "double-strand"
    "double-transgenic" "doubly-labeled" "down-modulate" "down-modulation"
    "down-regulatory" "down-stream" "downregulators" "drawn" "drop-off"
    "droplets" "drug-like" "dsDNA" "dsRNAi" "dual-activation"
    "dual-agent-treated" "dual-color" "dual-electrode" "dual-energy"
    "dual-pathway" "dual-silenced" "dual-tropic" "duplexes" "dys-morphic"
    "dys-morphologies" "dyslipidemia" "dysmorphism" "dysmorphologies"
    "dysmorphology" "dyspareunia" "dysplasia" "dyspnea" "e+308" "e-QTL"
    "e.g.JAK" "eEF1A–Nef" "eGFP+ " "eIF-4E-binding" "eQTL" "eQTLs" "eRFs"
    "eSNP" "early-invasive" "early-life" "early-onset" "early-stage" "eaten"
    "ecDHFR" "ectoderm" "ectodomain" "effect=10.28%" "effecter" "effectof"
    "egfr_41_60" "egfr_481_500" "egfr_481–500" "egfr_61_80" "egfr_881_900"
    "eigenvectors" "eight-base-pair" "eightfold" "electrophysiology" "elegan"
    "embryoid" "emphasise" "empty-vector" "encephalomyocarditis" "end-binding"
    "end-diastolic" "end-feet" "end-organ" "end-product" "end-stage"
    "end-systolic" "end-to-end" "endocrine-therapy-alone" "endocytose"
    "endoderm" "endometrioid" "endometrium" "endoscopy" "endothelia"
    "endothelial-cell" "endothelial-cell-specific" "endothelial-monocyte"
    "endothelial-mononuclear" "endotoxemia" "endpoint" "endpoints"
    "energy-dependant" "energy-intensive" "enhancer" "enhancer-binding"
    "enhancer-mode" "eniluracil" "enoyl-CoA" "ensconsin" "envelope-mediated"
    "eosin" "eosinophilia" "eosinophils" "epalrestat" "epidermal-specific"
    "epidermoid" "epididymis" "epigenetic-mediated" "epigenetically-defined"
    "epigenetically-induced" "epigenome" "epipharynx" "epiphyses" "epithelia"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "epithelium" "epithelium-like"
    "epitope-tag" "eq" "eqs" "erythema" "erythrocytes" "estimations"
    "estomatitis" "estrogen-progesterone-EGF-independent" "et" "ether-a-go-go"
    "ethnic-specific" "et " "eunocoid" "eunucoid" "eural" "euthymia"
    "ever-smoker" "ever-smokers" "every-other-day" "ex" "ex-pleomorphic"
    "ex-vivo" "ex3" "exAR" "exAR " "exFOXA1" "exFOXA1 " "examinees"
    "exercisers" "exogenous-applied" "exome" "exon-3" "exon11" "exon14"
    "exon14–15" "exon15" "exon16" "exon19" "exon21" "exon9" "exons" "exosome"
    "exposed-patient" "exposure-induced" "expresser" "expressers"
    "extra-follicular" "extra-follicularly" "extra-thymic" "ey" "ey-Gal4"
    "face-to-face" "factor-1" "failsafe" "false-discovery" "families" "far-red"
    "farthest" "fast-dividing" "fatpad" "febrile-range" "feed-back"
    "feed-forward" "feedback-mediated" "ferricyanide" "fetal-type"
    "fibroblast-like" "fibrocontractile" "fibulins" "field-cell"
    "filopodia-like" "filtering
SNPs"
    "fine-mapping" "fine-needle" "fine-tune" "fine-tuning" "finger-like"
    "first-degree" "firstdegree" "five-day" "five-marker" "five-year"
    "fixed-cell" "flK" "flat-membrane" "flexure" "flora" "flow-based"
    "flowchart" "fluo3-AM" "fluoresce" "fluorescent-activated"
    "fluoride-sensitivity" "fluoro" "fluoro-methyl" "fluoromethyl"
    "fluoromethylketone" "fluorophore" "fluorophores" "fluorouracil-based"
    "fluorouridine" "flurouracil" "focal-adhesion" "folate-homocysteine"
    "fold-increase" "folic" "follicle" "follicles" "follistatin-like"
    "follow-up" "followed-up" "followup" "forF" "forJAK2" "forced-expression"
    "forebrain" "formazan" "formol" "forspi" "forty-seven" "fossa" "fossae"
    "four-colour" "four-week" "frame-shift" "frame-shifts" "frameshift"
    "frameshifts" "frequently-mutated" "fromBcl" "fromBcl-2" "fromEgfr"
    "fromPten" "frozen" "fructose-1" "fructose-6-bisphosphate"
    "fructose-6-phosphate" "fructose-kinase" "full-text" "fulminant"
    "functions-it" "fundus" "furthers" "futher" "gDNA" "gadolinium" "gain-of"
    "gain-of-function" "galactoiside" "galiximab" "gallbladder"
    "gammaherpesvirus" "gastro-enteric" "gastro-oesophageal" "gastrocnemius"
    "gatekeeper" "gc" "geder" "gel-filtration" "gel-plugs"
    "gene-by-environment" "gene-dosage" "gene-dose" "gene-enviroment"
    "gene-environment" "gene-gene" "gene-miRNA" "gene-only" "gene-signatures"
    "genesets" "genetically-engineered" "genetictests" "genic" "genitalia"
    "genitals" "genome" "genome-level" "genome-scale" "genome-sense"
    "genome-wide" "genomes" "genomewide" "genomically-imprinted"
    "genotype-phenotype" "geranylgeranylacetone" "germline" "gingiva"
    "gingivae" "given-drug" "given-drugs" "glia" "glioma-like" "globulin"
    "glucose-deprivation" "glutamate-cysteine" "glutamate-mediated"
    "glutamylcysteine" "glutathione-cytosine" "gluthatione" "glycans"
    "glyceraldheyde-3-phosphate-dehydrogenase" "glyco-proteins"
    "glycoconjugate" "glycolipoprotein" "goes" "gone" "goodness-of-fit"
    "greater" "greatest" "group1" "group3" "growth-suppressive"
    "guanidinomethyl" "guanylyl" "gynepathology" "h-treatment" "hBRCA2" "hCx43"
    "hCx43shRNA" "hDHFR" "hERG-FITC" "hES-like" "hESC" "hESCs" "hGC-1"
    "hGeminin" "hHsp90" "hHsp90α" "hHsp90α-E47A" "hHsp90α-K191R" "hNPC" "hNPCs"
    "hPBLC" "hPBMC" "hPMNL" "hTRET" "hWT" "hWT-iPSC" "hYAP" "haematobium"
    "hair-like" "half-life" "haplo" "haplo-insufficient" "haplogroups"
    "haplotype" "haplotypes" "hard-to-fold" "hard-wired" "head-to-head"
    "headgroup" "healthspan" "heat-shock" "heavy-chain–only" "helices" "helix"
    "helix-loop-helix" "helix–loop–helix" "hematocrit" "hematolymphoid"
    "hemichannels" "hepatectomy" "hepatitis-B" "hepatocarcinogens"
    "hepatocyte-specific" "heretofore-unreported" "herniations" "hetero"
    "hetero-complexes" "heteromers" "heterotrimer" "heterozygote"
    "heterozygousspi" "hexahistidine" "hexamer" "hiPSC" "hiPSCs" "hidden"
    "high-affinity" "high-and" "high-calcium" "high-confidence" "high-density"
    "high-dose" "high-energy" "high-expression" "high-fat" "high-fidelity"
    "high-frequency" "high-friction" "high-grade" "high-level"
    "high-molecular-weight" "high-order" "high-oxygen" "high-penetrance"
    "high-performance" "high-proliferative" "high-quality" "high-resolution"
    "high-risk" "high-sensitivity" "high-stemness" "high-surface"
    "high-susceptibility" "higher-energy" "higher-magnification" "higher-order"
    "higher-resolution" "higher-stage" "highly-specific" "hindlimb" "hindlimbs"
    "hinge-open" "hippocampal-dependent" "hirsutism" "histochemistry"
    "histologies" "histology" "histomorphometry" "histone-3" "histopathology"
    "histotype" "histotypes" "hnRP" "holo" "homeodomain" "homogenates"
    "homolog" "homologs" "homomers" "homozygote" "homozygotes" "host-mediated"
    "host-virus" "hot-spot" "hot-spotmutation" "hot-spotmutations" "hotspot"
    "hotspots" "hr" "htSNPs" "huAR" "hui" "humanSTAT5B" "hydride"
    "hydrolysis-incompetent" "hydroxyacyl-CoA" "hydroxyl"
    "hydroxymethylcytosine" "hydroxyprostaglandin" "hyper-IgA"
    "hyper-IgA–associated" "hyper-origin" "hyper-proliferation"
    "hyper-recombination" "hyperaldosteronism" "hyperdiploid" "hyperdiploidy"
    "hyperestrogenism" "hyperinsulinemia" "hypermetabolism" "hyperoxia"
    "hyperpolarization-activated" "hyperpolarizes" "hypocalcemia"
    "hypoglycemia" "hypopharynx" "hypothalamic-pituitary-gonadal"
    "hypothalamus-pituitary" "hypotonia" "hypotriploid" "hypoxia-reperfusion"
    "i-iv" "iFISH" "iHsp72" "iMMEC" "iMMECs" "iTRAQ" "ibula" "identifiers" "ie"
    "ifsec5" "ii" "iif" "iii" "ileum" "ill-defined" "imidazole"
    "immediate-to-early" "immortomouse" "immune-competent" "immune-compromised"
    "immune-deficient" "immune-enhancing" "immune-mediated" "immune-modulatory"
    "immune-regulating" "immune-sorbent" "immune-supershifted"
    "immune-surveillance" "immuno" "immuno-fluorescence" "immuno-fluorescent"
    "immuno-histochemistry" "immuno-localisation" "immuno-reactivity"
    "immunoassay" "immunoassays" "immunobiology" "immunochemistry"
    "immunocomplex" "immunocomplexes" "immunoconjugates" "immunocytochemistry"
    "immunofluoresces" "immunoglobulin" "immunohistochemical-microarray"
    "immunohistochemistry" "immunohistochemisty" "immunohistochemsitry"
    "immunophenotype" "immunoprecipitions" "immunotherapies" "immunotherapy"
    "impermeant" "importin-α" "in-depth" "in-frame" "in-house" "in-phase"
    "in-silico" "in-situ" "in-transit" "in-vitro" "in-vivo" "in-well"
    "in15-PGDH" "inApc" "inArf" "inEgfr" "inFigure" "inHIV-1" "inMdm2" "inNF1"
    "inPlk4" "inPten" "inStat5b" "inboth" "indel" "indels" "indepth"
    "indicator2" "indol" "indol-2-yl" "indoleylmaleimide" "infantum"
    "infectedEgfr" "infectedRb" "infertiltiy" "inflammation-associated"
    "inflammation-induced" "inflammation-mediated" "influnce" "infund"
    "infund-ibula" "infundibula" "infundibulum" "inguino" "inguino-femoral"
    "inhibitor-MLN8237" "inhibitor-Tubastatin" "initiators" "innervate"
    "inoculums" "inositol-1,4" "insulin-like" "integrinsα3" "integrinβ7"
    "integrome" "intention-to-treat" "inter-chromosomal" "inter-domain"
    "inter-group" "inter-kinetochore" "inter-observer" "inter-patient"
    "inter-study" "interactome" "interdomain" "intermediary-low"
    "intermediate-grade" "intermediate-low" "intermembrane" "interquartile"
    "interstrand" "interwoven" "intestinal-type" "intima" "intra"
    "intra-chromosomal" "intra-epidermal" "intra-patient" "intra-peritoneal"
    "intra-peritoneally" "intra-tumour" "intracardiac" "intracrine"
    "intrastrand" "intron-exon" "invaginations" "invariant" "invasion-motility"
    "iodo-moiety" "iodobenzoyl" "ion-dependency" "irinotecan-containing"
    "irradiation-induced" "ischaemia" "ischaemia-reperfusion"
    "ischemia-reperfusion" "ischemic-induced" "isoenzymes" "isoform-specific"
    "isomers" "isopeptide" "isotopomers" "isotype" "isotypes" "isozyme"
    "isozyme-specificity" "isozymes" "iv" "i–iii" "junction-mediating" "juxta"
    "kDal" "kHz" "kV" "kainate" "kappa-B" "karyotype" "kay" "kcal" "kcal "
    "kek-lacZ" "kekkon" "kekkon-1" "keratinoctyes" "kg" "kilobases" "kinase-2"
    "kinase1" "kinome" "knock-down" "knock-downs" "knock-in" "knocked-down"
    "knockin" "knocking-down" "known-down" "kymography" "labia"
    "laboratory-adapted" "lactone" "lactose" "lambda" "lambda " "lambdoid"
    "lamella" "lamellae" "laminin-111" "lamivudine-containing" "lane4"
    "lapaninib" "large-B-cell" "large-cell" "large-sample" "large-scale"
    "late-onset" "late-phase" "late-stage" "late-term" "latency-associated"
    "later-onset" "lattice-binding" "lattice-like" "lavage" "lead-in"
    "leakiness" "learning-disordered" "leave-one-out" "lectin-like"
    "left-sided" "lenght" "lengthier" "lenti" "lenti-viral" "less-than-twofold"
    "let-7a" "let-7b" "let-7c" "let-7f" "let-7g" "let-7g-3p"
    "leucine-rich-repeat" "leucopenia" "leukin" "leukin-6"
    "leukoencephalopathy" "leukoencephalopathy-immune" "lid-closed" "lifespan"
    "ligand-acceptor" "ligand-indepen-dent" "limbus" "lincRNA-RoR"
    "lineage-specific" "linitis" "linker-protein–dependent" "lipoarabinomannan"
    "lipoatrophy" "lipofuscin-like" "lipopolysaccharide" "lipopolysaccharides"
    "lipoproteins" "liposome" "littermate" "littermates" "live-cell"
    "lncRNA–protein" "lo" "loco-regional" "locus-deficient" "locus-specific"
    "locuses" "log-phase" "logFC" "logP" "logratio" "long-distance"
    "long-lasting" "long-lived" "long-range" "long-standing" "longa"
    "longer-term" "lookup" "loss-of-function" "losses" "loss–of-function"
    "lotillins" "low-abundance" "low-affinity" "low-calcium" "low-density"
    "low-dose" "low-energy" "low-expression" "low-frequency" "low-grade"
    "low-intensity" "low-level" "low-levels" "low-molecular-weight"
    "low-pH-induced" "low-penetrance" "low-potassium" "low-proliferative"
    "low-risk" "low-surface" "low-temperature" "low-trisomy" "lower-risk"
    "lower-scoring" "lox468" "lumB" "lumi" "lumi-aggregometry" "luminometry"
    "lumpectomy" "lungworm" "luteomas" "lymph-node" "lymphadenectomies"
    "lymphadenectomy" "lymphangiomata" "lymphnode" "lymphoblastoid"
    "lymphoceles" "lymphoedema" "lymphoid-enhancing" "lymphoid-tissue-1"
    "lymphoma-2" "lymphopenia" "lysis" "lysolipids" "mAKABα" "mAKAPα"
    "mCherry+ " "mCherry-LifeAct" "mCherry–end-binding" "mDNA" "mEGFP" "mEPSC"
    "mEPSCs" "mESCs" "mIR-134" "mIU" "mQTL" "mRNA" "mRNAs" "mT"
    "mTORC1-dependency" "mTORCs" "mTORpathway" "mTpower" "mVenus"
    "mVenus-hGeminin" "macroH" "macroH2A1.1-dependent" "macrocephalic-related"
    "macrocomplex" "macrodomain" "macroorchidism" "macrophage-tropic"
    "main-chain" "maintainance" "malar" "mannoside" "mannosyl"
    "mannosyl-oligosaccharide" "mansoni" "mastectomies" "mastectomy"
    "mastocytois" "materials" "maternally-derived" "matrigels" "matrixTFP60"
    "maxilla" "mcg" "mean+SD" "mean ± SD" "mean±S" "mean±SD" "mean ± SD"
    "meatus" "mechanisms" "mechanismson" "medulla" "meibum" "melanin"
    "melanocortin" "melanocortin-1" "melanocortin-5" "melanogaster" "mellitus"
    "membrane-permeable" "meninges" "meniscus" "menostasia" "menses" "meric"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchymal-to-epithelial"
    "mesoderm" "mesylate" "meta-P-value" "metabolizer" "metadata" "metal-based"
    "metal-inducible" "metallo" "metallo-intercalator" "metanodes"
    "metaphase–anaphase" "methenlytetrahydrofolate" "methyl-containing"
    "methyladenine" "methylation-specific-polymerase" "methylcytosine"
    "methylene" "methyltetrahydrofolate-homocysteine" "miR-1" "miR-1027-5p"
    "miR-1182" "miR-1207-5p" "miR-124" "miR-1266" "miR-128" "miR-128b"
    "miR-133a" "miR-134" "miR-138" "miR-138-5p" "miR-140" "miR-141" "miR-143"
    "miR-146" "miR-146a" "miR-146b" "miR-15" "miR-150" "miR-15a" "miR-16"
    "miR-17" "miR-17-3p" "miR-17-5p" "miR-17-92" "miR-17-92-dependent"
    "miR-17a" "miR-18" "miR-181b-1" "miR-182" "miR-188" "miR-188-3p" "miR-18a"
    "miR-18b" "miR-19" "miR-194" "miR-195" "miR-19a" "miR-19b" "miR-200"
    "miR-203" "miR-206" "miR-20a" "miR-21" "miR-210" "miR-214" "miR-218"
    "miR-22" "miR-22-downregulated" "miR-22-null" "miR-221" "miR-222i"
    "miR-222m" "miR-223" "miR-23" "miR-24" "miR-26" "miR-26a" "miR-26b"
    "miR-26b-binding" "miR-26b-tranfectants" "miR-26b-transfectants"
    "miR-26b-transfected" "miR-27a" "miR-29" "miR-301a" "miR-302c" "miR-30b"
    "miR-30e" "miR-31" "miR-32" "miR-34" "miR-342" "miR-342-5p" "miR-34a-3p"
    "miR-34a-5p" "miR-34b" "miR-34c" "miR-365" "miR-375" "miR-375-modified"
    "miR-409-3p" "miR-425" "miR-425-dependent" "miR-425-mediated" "miR-486"
    "miR-491" "miR-491-5p" "miR-541" "miR-541-3p" "miR-545" "miR-545-induced"
    "miR-629" "miR-663" "miR-744" "miR-9" "miR-9-5p" "miR-92b" "miR-Gli1-1863"
    "miR-Gli1-720" "miR-NC-treated" "miR203" "miR30-shCT" "miR30-shCT-infected"
    "miR30-shCT-transduced" "miR30-shRNA" "miR30-shRNAs" "miR30-shSykb1"
    "miR30-shSykb4" "miR34a" "miRCURY" "miRNA-122" "miRNA-1228" "miRNA-135a"
    "miRNA-146a" "miRNA-148a-induced" "miRNA-200" "miRNA-27" "miRNA-335"
    "miRNA-545" "miRNA-584" "miRNA-7" "miRNA-let7c" "miRNA-like" "miRNA-seq"
    "miRNAi" "miRNA–mRNA" "miRanda" "miRecords" "micro-CT"
    "micro-environmental" "micro-vessels" "microCT" "microPET" "microRNA-138"
    "microRNA-29b" "microangiopathies" "microbiota" "microcarcinomas"
    "microdomain" "microdomains" "microenvironment-induced" "microhomology"
    "micromoles" "microorchidism" "micropocket" "microsatellite" "microsecond"
    "microtube" "microtubule-binding" "microtubule-nucleating"
    "microvasculature" "microvessel" "microvessels" "mid-gestation" "mid-late"
    "mid-lower" "mid-upper" "midbrain" "midface" "midline" "midline-1"
    "migration-like" "millisecond" "mini-chromosome" "mini-organotypic"
    "mini-review" "minireview" "minora" "minus-end" "mir" "mir-146b" "mir-155"
    "mir-19a" "mir-19b" "mir-20" "mirtarget2" "mis-segregation" "misbalance"
    "missense" "mitarget" "mitoStat3-PKC" "mitoStat3-mtDNA" "mitomicyn"
    "mitoses" "ml " "mmLDL" "mock-infected" "mock-treated" "modelDE"
    "moderate-sized" "moderately-differentiated" "molecular-pathologic"
    "molecularly-directed" "moment-by-moment" "monckeberg" "mono-allelic"
    "mono-nuclear" "mono-nucleosomes" "mono-unsaturated" "monoadducts"
    "monocyte-brain" "monocyte-derived" "monocyte-endothelial"
    "monocyte-to-fibrocyte" "monolayer" "monophosphate" "monosomy"
    "monotherapy" "morbidities" "moribundPten" "most-recently" "motif-mediated"
    "motile" "motility-cytoskeleton" "motility-related" "mucosa"
    "multi-Institutional" "multi-cellular" "multi-centric" "multi-colour"
    "multi-disciplinary" "multi-drug" "multi-factorial" "multi-institution"
    "multi-kinase" "multi-nucleation" "multi-protein" "multi-scale"
    "multi-stage" "multi-subunit" "multi-system" "multicenter" "multidomain"
    "multigene" "multilineage" "multiparameter" "multipartite"
    "multiple-centrosome" "multiple-way" "multiploidy" "multiprotein"
    "multiscale" "multisubunit" "multitarget" "multivariate" "multivitamins"
    "murinep19" "muscle-invasive" "muscle-specific" "muscle-type" "musculature"
    "musculus" "mut1+2" "mut1+2+3" "mutTOP" "mutations" "myc-S165D-α6-tubulin"
    "myc-WT-α6-tubulin" "mycalolyde" "myo-fibroblastic" "myo-fibroblasts"
    "myocardium" "myofibroblasts" "myonuclei" "myotome" "myr-Akt2" "myrAKT"
    "myristate" "myxoid" "myxovirus" "n-6" "n=1" "n=10" "n=13" "n=185" "n=2"
    "n=29" "n=3" "n=5" "n=6" "n=7" "n=8" "n=94" "nAChR" "nCounter" "nGAAn"
    "nTTCn" "nasopharynx" "natural-logarithm" "naïve" "ncDNA" "ncomms4393"
    "near-baseline" "near-maximal" "near-optimal" "near-physiological"
    "nearest" "necro" "necro-inflammatory" "necropsy" "negative-control"
    "negative-sense" "negatively-charged" "neoadjuvant" "neonatalPten"
    "neoplasias" "neoplastic-like" "nephropathy" "netrin" "netrin-1and"
    "netrin-1transcripts" "neurite" "neuro-degenerative"
    "neuro-ectodermalization" "neuro-endocrine" "neuro-oncology"
    "neuroendocrine" "neuroendocrine-cell" "neuropathology" "neuroretina"
    "neurosphere" "neurospheres" "neutropaenia" "neutropenia"
    "neutrophil-to-lymphocyte" "neutrophilia" "never-smoker" "never-smokers"
    "never-used" "new-generation" "newer" "newest" "newly-adhered"
    "newly-synthesized" "nexin-1" "next-generation" "nick-end" "nigricans"
    "ninety-four" "no-metal" "no-target" "nod-like" "node-negative"
    "node-positive" "nonIG" "noncardia" "noncarriers" "noncomplete"
    "nonendometrioid" "nonfat" "nonmalignant" "nonprimates" "nonsense-mediated"
    "normal-karyotype" "normal-like" "normal-organ" "normal-sized"
    "normal-tissue" "nt" "nucelotide" "nucleate" "nucleates"
    "nucleation-promoting" "nucleo" "nucleus-to-cytoplasm" "nulligravid"
    "n = 2" "n = 3" "n = 5" "n = 6" "n = 2" "n = 3" "n = 5" "ocelli" "oculo"
    "oculo-cutaneous" "odds-ratio" "odds-ratios" "oestrogen" "ofCa" "ofER"
    "ofPGE" "ofPten" "off-target" "ofp21" "ofp27" "ofspi" "of∼0.02" "ogtt"
    "oldPten" "olf" "oligo" "oligoadenylates" "oligodeoxyribonucleotide"
    "oligomycin" "oligos" "omat" "on-going" "on-set" "on-target" "onPten"
    "oncogene-like" "oncogenes" "oncomiR" "oncomiRs" "oncomine" "oncomir-1"
    "oncorequisite" "oncosphere" "oncospheres" "one-by-one" "one-carbon"
    "one-half" "one-plus-one" "one-quarter" "one-third" "one-toone" "one-two"
    "one-way" "one-year-old" "ones" "oocytes" "oophorectomy" "open-angle"
    "oral-related" "ordinate" "organelle" "organelles" "organs" "ornithine"
    "oropharynx" "orp53" "orruboxistaurin" "ortholog" "orthologue"
    "orthologues" "osteoblasts" "osteomimicry" "out-compete" "out-of-frame"
    "ovarian-like" "ovarian-type" "over-activated" "over-activation"
    "over-damped" "over-estimate" "over-proliferation" "over-react"
    "over-representation" "over-ride" "over-ruled" "over-simplification"
    "overgrow" "overnutrition-induced" "overview" "own-regulated"
    "oxLDL-treated" "oxaliplatin+radiotherapy" "oxazolone" "oxidases" "oxoG"
    "oxoguanine" "oxoguanosine" "oxygenase-1" "oxygens" "p120ctn-3A" "p130C"
    "p150Luc" "p18BAX" "p21WAF" "p24Ag" "p24gag" "p38-α" "p38-β" "p38-γ"
    "p38-δ" "p38MAPK" "p42Luc" "p46Shc" "p4E-BP1" "p4EBP1" "p4EPBP1" "p52Shc"
    "p53-14-3-3-σ" "p53-activator" "p53-competent" "p53-defective"
    "p53-miR-34a-OCT4-p53" "p53-null" "p53-shRNA" "p53R172H" "p53indicated"
    "p63-miR-34a-OCT4-p63" "p63-shRNA" "p65-S529-phospho" "p65Nrf1-V5-His"
    "p66Shc-competent" "p66Shc-depdendent" "p72-dependant" "p85α" "p85–appear"
    "p=0" "p=0.0002" "p=0.001" "p=0.005" "p=0.010" "p=0.014" "p=0.018"
    "p=0.019" "p=0.022" "p=0.024" "p=0.03" "p=0.030" "p=0.05" "p=0·0008"
    "p=0·0068" "p=0·0085" "p=0·024" "p=1.07×10" "p=1.59×10" "p=1.89×10"
    "p=2.61×10" "p=8.03×10" "pABG" "pAKT-473" "pALK" "pAdeno" "pAdeno-X"
    "pAktT308" "pBI-CMV4-DsRed" "pBIND" "pBabepuro" "pBluescript" "pC"
    "pCCD1-mt-Luc" "pCCD1-wt-Luc" "pCDNA3-DsRed" "pCDNA3-T7" "pCMV" "pCMV5-AR"
    "pCR-predictive" "pCREB" "pCRaf" "pDRGFP" "pDSCC1+10" "pDSCC1+70"
    "pDSCC1-10" "pDSCC1-1023" "pDsRed2-N1vector" "pEFGP-C2-GSPT2-expressing"
    "pEGFP-C2" "pEGFP-C2-expressing" "pEGFP-CRIF1" "pEGFP-siEmpty"
    "pEGFP-siPKCβ" "pEGFR–ERBB2" "pERBB2" "pEZ-M02" "pEZ-M02-Tiam1" "pEphA2"
    "pErB2" "pFAK" "pFOX03a" "pFOX3A" "pFOXO3a" "pFRS2" "pGAL" "pGAL4-Nef"
    "pGCSLuc" "pGEX-KG" "pGEX-human" "pGEX-p53" "pGEX72" "pGL2-Basic"
    "pGL2-Mcl-1-κBwt" "pGL3-Basic" "pGL3-basic" "pGL4-HHAT-luc" "pGSK"
    "pGSK-Ser9" "pGSK3αβ" "pGSK3βα" "pGreenFire" "pHER2" "pIRES" "pIRES2"
    "pIRES2-hTRET" "pLGALS1" "pLenti6" "pMAPK" "pME18Neo" "pMEK" "pMIR-REPORT"
    "pN" "pNL4-3" "pPRAS40" "pPaxillin" "pQCT" "pS52CK18" "pS845GluR1"
    "pSGIE72" "pSTAT1" "pSTAT3" "pSer380" "pSer5-RNA" "pStage" "pT118" "pT2N1a"
    "pThr382" "pThr383" "pY1105" "pY705" "pYY1234-1235" "pack-year"
    "pack-years" "pair-wise" "paired-end-sequencing" "paired-label"
    "paired-pulse" "pairings" "pairwise" "palatine" "palmitoyltransferases"
    "pan-HDAC" "pan-HDAC-inhibitors" "pan-PI3K" "pan-keratinocyte"
    "pan-lymphocyte" "pancreata" "pancreatitis" "panendoscopy" "pannel"
    "papules" "paracrine" "paralog" "parchorin" "parenchyma" "parotid"
    "particulate" "particulates" "patho" "pathobiology" "pathogen-specific"
    "pathologically-relevant" "pathology-associated" "pathomechanisms"
    "pathophysiologies" "pathophysiology" "pathways" "pattern-recognition"
    "patttern" "pcDNA" "pcDNA-DEST53" "pcDNA3" "pcDNA3–L-PGDS–C65A-HA"
    "pcDNA3–L-PGDS–HA" "pectoralis" "pectoris" "peduncle" "pelage" "pelckstrin"
    "penetrance" "penetrant" "penile" "penta" "penta-peptide" "pentamer"
    "pentraxin" "peptidases" "peptide-major" "peptides" "per-allele" "perhaps"
    "peri-conceptional" "peri-nuclear" "periodontium" "periodontopathogens"
    "person-years" "pharmacophore" "pharmacophores" "phase-contrast" "phenyl"
    "phenylazo" "phopsho" "phopsho-S33" "phosphatase–2"
    "phosphatidylinositol-3-phosphate-5-kinase" "phosphatidylnositol"
    "phospho-IWS1" "phosphoactivate" "phosphodegrons"
    "phosphofructokinase-muscle" "phosphoinositide-binding" "phosphoinositides"
    "phosphopeptide" "phosphopeptides" "phosphor-acceptor" "phosphoribosyl"
    "phosphosubstrate" "photomicrographs" "phototherapy" "phs000090"
    "phs000280" "piBRCA2" "pigmentosa" "piloid" "pilot-study" "pit-and-fissure"
    "pita" "pixels" "placental-related" "planarians" "plasmacytoid" "plasmon"
    "plastica" "pleomorphism" "pleura" "plexiform" "plexuses" "ploidy"
    "pluripotent-associated" "plus-end" "plus-ends" "pmiR-cezanne" "pmirGlo"
    "point-of-view" "pole-mediated" "pole-ward" "poles" "polulations"
    "poly-ADP-ribose" "poly-U" "polyADP" "polyADP-ribose" "polychemotherapy"
    "polycistron" "polylinker" "polymerase-1" "polymorphism"
    "polymorphism(RFLP)" "polymorphisms" "polymorphysim" "polyphenol"
    "polypoid-like" "polyprotein" "polypyridyl" "polypyrimidine" "polysomy"
    "polyubi" "polη" "pons" "poor-prognosis" "poorer" "poorly-and"
    "poorly-differentiated" "population-average" "population-level"
    "pore-forming" "pore-size" "positron" "positron-emission" "post-Golgi"
    "post-MI" "post-administration" "post-chemotherapy" "post-consensus"
    "post-crizotinib" "post-germinal" "post-hoc" "post-infarction"
    "post-infection" "post-inflammatory" "post-integration" "post-irradiation"
    "post-menopausal" "post-mortem" "post-natal" "post-operative"
    "post-pazopanib" "post-radiation" "post-replication" "post-resection"
    "post-seroconversion" "post-surgery" "post-surgical" "post-synaptic"
    "post-therapy" "post-transcriptional" "post-transcriptionally"
    "post-transfection" "post-translational" "post-translationally"
    "post-transplantation" "post-trasfection" "post-treatment" "postmortem"
    "power=31" "pp" "pp130Cas" "pp60Src" "prebound" "predisone" "preimmune"
    "preload" "prenocodazole" "prexmiR" "prexmiR-218" "pri-miR-125b"
    "pri-miR-125b-1" "pri-miR-205" "pri-miR-21" "pri-miR-425" "primer-B"
    "primer-template" "priori" "pro-anabolicm" "pro-angiogenic"
    "pro-atherogeneic" "pro-autophagic" "pro-death" "pro-differentiation"
    "pro-fibrotic" "pro-hypertrophic" "pro-inflammatory" "pro-invasive"
    "pro-leukemogenic" "pro-metastasis" "pro-metastatic" "pro-migratory"
    "pro-mitotic" "pro-neuronal" "pro-proliferative" "pro-resistance"
    "pro-survival" "pro-tumor" "pro-tumorigenic" "proMMP2" "probands"
    "procoagulant" "procollagen" "product-binding" "profilin-ATP-actin"
    "progenitor-like" "progenitor–like" "progestin" "prognosticators"
    "progressionfree" "progressors" "proliferative-phase"
    "proliferator-activated" "promoter-repressive" "promoters"
    "proof-of-concept" "proof-of-principle" "propeptide" "propeptides"
    "properies" "proportional-hazards" "prostasphere" "prostaspheres"
    "prostate-cancer-associated" "protein-2" "protein-DNA" "protein-glutamine"
    "protein-mRNA" "proteins" "protein–bilayer" "protein–lipid" "proteome"
    "proteomes" "proteomics-based" "proteosome" "proto" "protomer" "protomers"
    "protooncogenes" "proven" "provid" "psPSA" "psPSA-luc"
    "pseudo-phosphorylated" "pseudo-phosphorylation" "pseudogenes"
    "pseudosubstrate–bilayer" "pseudovirus" "publically-available" "puc-lacZ"
    "pull-down" "pull-downs" "pulldown" "pulldowns" "pulse-chase" "pulse–chase"
    "punctae" "pylori" "pylorus" "pyridine" "pyridinecarbonitrile" "p " "p = 0"
    "p = 0.005" "p = 0.018" "p = 0.024" "p = 0.030" "p = 0" "p = 0.0002"
    "p = 0.001" "p = 0.001respectively" "p = 0.024" "p = 0.03" "p = 0.05"
    "q-score" "q-scores" "qRT" "quadriceps" "quadriplicate" "quadruplex"
    "quantile-quantile" "quantitative-PCR" "quantitative-real-time-PCR"
    "quantitative-trait" "quasi" "quasi-rigid" "quencher" "quick-coupled"
    "quinidine" "quintile" "quintiles" "r=0.13" "rCBR" "rCBV" "rHsp72" "rNef"
    "rPH" "rRNA" "rRNAs" "radiation-induced" "radiation-related" "radio-and"
    "radio-iodine" "radio-therapeutic" "radiochemotherapies" "radioenhancer"
    "radiohalogen" "radioimmunoassay" "radioimmunotherapy" "radioiodide"
    "radioiodine" "radiologic–pathologic" "radiometabolite" "radionuclide"
    "radionuclides" "radioresistance" "radioresistant" "raft-rich"
    "random-effect" "random-effects" "rank-sum" "rapalog" "rapalogs" "rarer"
    "re-aligning" "re-analysis" "re-assembly" "re-association" "re-attachment"
    "re-constitute" "re-contributed" "re-determined" "re-distributed"
    "re-distribution" "re-enforces" "re-epithelialization" "re-evaluate"
    "re-evaluated" "re-evaluation" "re-examine" "re-examined" "re-express"
    "re-expressed" "re-expressing" "re-expression" "re-fed" "re-grown"
    "re-implanted" "re-initiation" "re-instated" "re-introduction"
    "re-ligation" "re-localization" "re-locating" "re-nucleation"
    "re-occurrence" "re-operation" "re-plated" "re-plating" "re-plotted"
    "re-searching" "re-sensitized" "re-sensitizes" "re-suspension" "re-treated"
    "re-validate" "re-wiring" "read-out" "readout" "readouts" "reagent-only"
    "receptor-1" "receptor-homologous" "receptor-ligand" "receptor-α"
    "receptor–Nanobody" "recognition-targeting" "recombination-associated"
    "recombination-based" "reconfigures" "recptors" "red-green" "red-to-green"
    "red-to-yellow" "red-yellow" "red-yellow-ratio" "regrowth" "regulators"
    "regulatory-associated" "related-death" "related-gene" "relatedness"
    "remyelinate" "renilla" "replatings" "replication-permissive"
    "replicationin" "replicative-associated" "repopulate" "reportedthat"
    "residuals" "residues-RING" "resistance-to-apoptosis" "resistance–so"
    "resource-limited" "responder" "responders" "retest" "reticulocytes"
    "retino" "retinol" "retroviral-mediated" "retrovirus" "reuptake"
    "reverse-phase" "revertant" "revertants" "rhIL-2" "rhabdomyosarcomas"
    "rhodamine-phalloidin" "ribose" "ribose-5-phosphate" "riboside" "ribosyl"
    "ridden" "right-most" "right-sided" "rightmost" "rilonacept"
    "risk-associated" "risk-management" "rna22" "road-blocks" "rohibitins"
    "rosette-forming" "rotamer" "rotamers" "rotein" "rpm" "rs1001761"
    "rs10199388" "rs10256914" "rs10270569" "rs1034072" "rs1034072_A"
    "rs1038304" "rs1042522" "rs1059040" "rs1064524" "rs10790715" "rs10948751"
    "rs10974944" "rs10974944_G" "rs11061158" "rs11082098" "rs1128334"
    "rs113581344" "rs1136410" "rs1144393" "rs11540407" "rs11541664"
    "rs116102273" "rs1236" "rs12595334" "rs12595334-rs3743342" "rs12638862"
    "rs1268165" "rs12722486" "rs12901499" "rs12902499" "rs1317082" "rs13233731"
    "rs13266634" "rs13333308" "rs1635852" "rs17106184" "rs17124372"
    "rs17236529" "rs17588172" "rs17592371" "rs17653722" "rs17762454"
    "rs1799750" "rs1799782" "rs1801278" "rs1801320" "rs1805097"
    "rs1805097polymorphism" "rs1909509" "rs1999805" "rs2020921" "rs2075650"
    "rs2148710" "rs2187668" "rs2229882" "rs2234693" "rs2242844" "rs2249844"
    "rs2273650" "rs2278670" "rs2289046" "rs230496" "rs230525"
    "rs230525-rs230530" "rs230530" "rs25487" "rs25489" "rs2612101" "rs2721072"
    "rs273100" "rs2736098" "rs2736100" "rs2736100_C" "rs2755209" "rs28362491"
    "rs2847159" "rs2847324" "rs2847326" "rs2847607" "rs2853669" "rs2853691"
    "rs3130501" "rs3136739" "rs3138053" "rs3138055" "rs3219090" "rs33954691"
    "rs3743342" "rs3779512" "rs3786897" "rs3798305" "rs3834129" "rs4236601"
    "rs4275659" "rs4311394" "rs4325427" "rs4654438" "rs4736740" "rs475007"
    "rs477692" "rs4865796" "rs4870044" "rs494379" "rs502396" "rs514921"
    "rs572494" "rs58836765" "rs5919392" "rs5965433" "rs5967638" "rs6557786"
    "rs660895" "rs6929137" "rs696" "rs702465" "rs702634" "rs7097397"
    "rs7121800" "rs7166081" "rs7301826" "rs7554128" "rs7571842" "rs768023"
    "rs7705526" "rs7709971" "rs7739314" "rs7742367" "rs7903146" "rs8025774"
    "rs8031440" "rs8031440-rs8031627-rs2278670" "rs8031627" "rs864745"
    "rs889312" "rs9268645" "rs9340799" "rs9399599" "rs9479055" "rs9505118"
    "ruthenium-DNA" "rypT1c" "s00432-014-1589-3" "sAST" "sE-cad" "sIg" "sIgD"
    "sIgGκ" "sIgκ" "sIgλ" "saline-treated" "saline–treated" "salpingo"
    "salpingo-oophorectomy" "same-cell" "sarco" "sc-166588" "sc-28701"
    "sc-7974" "scFv-C" "scarless" "scavenger-type" "schizophreniain"
    "sclerosus" "sebum" "second-degree" "second-end" "second-generation"
    "secretome" "secretomes" "segements" "selectedJAK2" "selenite-treatment"
    "self-activates" "self-assembled" "self-association" "self-catabolic"
    "self-inactivating" "self-interaction" "self-oligomerization"
    "self-organize" "self-regulation" "self-renew" "self-renewal" "self-report"
    "self-reported" "self-similar" "self-tolerance" "semi" "semi-lethality"
    "semi-permissive" "semi-quantitative" "senesce" "senescence-like"
    "sensitizers" "seqMINER" "sequelae" "sequence-based" "sequence-dependent"
    "sequence-function" "sequence-independent" "sequence-specific" "sequene"
    "ser-9-GSK3β" "serology" "serosa" "serum-starved" "setpoint"
    "seventy-seven" "sh57224" "shADM" "shAURKA" "shCOTL1" "shCT" "shCbl"
    "shControl" "shCtrl" "shCx43" "shDSCC1" "shDSCC1#1" "shDSCC1#1scr"
    "shDSCC1#2" "shDSCC1#2scr" "shEGFP" "shFOXA1" "shFOXA1 " "shHD6" "shIWS"
    "shIWS1" "shIWS1-resistant" "shNEDD9" "shNF1#1" "shNF1#2" "shRNA#2"
    "shRNA-A" "shRNA-B" "shRNAmir" "shSC" "shSYK_4" "shSYK_5" "shSetD"
    "shSetD2-induced" "shSykb1" "shSykb4" "shTiam1" "shXRCC"
    "shXRCC1-transfected" "shmir" "short-hairpin" "short-term" "shorter-lived"
    "shot-gun" "siAR" "siBRCA2" "siCon" "siControl" "siCtr" "siCtrl" "siDlg"
    "siEGFR" "siERK5" "siEmpty" "siFGFR4" "siFOXA1" "siFyn" "siLAT" "siLck"
    "siNF2" "siNeg" "siPALB2" "siPKCβ" "siPTEN" "siREG" "siREGγ-treated"
    "siRNA-p120ctn-1A" "siSTAT3" "siScr" "siVps34" "siYAP" "siYAP#7" "siYAP1"
    "side-chain" "side-effects" "signal-competent" "signal-suppressive"
    "signal-to-noise" "signalling-suppressive" "signalome" "significantlywhen"
    "silico" "simpler" "simplest" "single-MT" "single-agent-treated"
    "single-cell" "single-cycle" "single-domain" "single-institution"
    "single-molecule" "single-nucleotide" "single-particle" "single-photon"
    "single-round" "single-strand" "sirtuin" "site-directed-mutagenesis" "situ"
    "six-nucleotide" "sixty-eight" "size-exclusion" "slgλ" "slow-down"
    "slow-release" "smFISH" "smFRET" "small-cell" "small-cell-lung"
    "small-cell-lung-carcinomas" "small-disorganized" "small-molecule"
    "small-sized" "smokers" "socio" "socio-economic" "soleus" "solute"
    "solutes" "some-what" "somite" "sorbitol" "sortolin" "sp90" "spatio"
    "spatio-temporal" "sphere-derived" "sphere-forming" "sphincter" "spina"
    "spinal-cord" "spindle-pole-mediated" "spine-like" "spinning-disk" "spitz"
    "splice-junctions" "splinkerette" "split1" "spontaneously-immortalized"
    "sporadic-like" "squamous-cell" "src-dependent" "ssDNA" "ssGSEA"
    "stable-isotope" "stably-expressing" "stage-specificity" "stage≥IB"
    "stainings" "standard-of-care" "stanniocalcin-1" "stanniocalcin-2"
    "state-of-the-art" "steady-state" "stellate" "stem-cell" "stem-cell-like"
    "stem-like" "stem-loop" "stem-loop-ssRNA" "stemness" "step-up" "stepwise"
    "stereotypies" "steriod" "stimuli" "stress-activated" "stress-associated"
    "stress-dependent" "stress-fibers" "stress-induced"
    "stress-induced-phosphoprotein" "stress-inducing" "stress-kinase"
    "stress-mediated" "stress-response" "stress-responsive" "stressful"
    "stressors" "stretch-enhancer" "striosomes" "stromal-specific"
    "structurally-related" "structure-activity" "structure-based"
    "structure-function" "study-end-points" "sub-G1" "sub-branches"
    "sub-cellular" "sub-classification" "sub-endogenous" "sub-fractionation"
    "sub-group" "sub-groups" "sub-lethal" "sub-lethally" "sub-nuclear"
    "sub-optimal" "sub-population" "sub-populations" "sub-type" "sub-types"
    "sub-unit" "sub-μM" "subG1" "subanalyses" "subclass" "subclasses"
    "subcohort" "subdiploid" "subdomain" "subgroupings" "subjectedPlk4"
    "sublines" "submucosa" "subperiods" "subphenotypes" "subproteome"
    "subsample" "subscale" "subset" "subsets" "subsite" "subsites" "substate"
    "substates" "substituents" "substitutions" "substrate-2" "subtype"
    "succinimidyl" "sulfhydryl" "sulfonamide" "sulforhadamine"
    "sulphate-polyacrylamide" "sunken" "super-family" "super-physiologic"
    "super-repressor" "super-shift" "superfamilies" "supernatant"
    "supernatants" "superoxide-dependent" "suppresser" "supra-physiological"
    "supraceliac" "supress" "surface-level" "surgically-resected"
    "survivorship" "switch-off" "switchover" "symptomatology" "symptoms"
    "synapse" "synapses" "synatophysin" "synergism" "synthesisThere"
    "synthesizer" "synthesizers" "tHMEC" "tRNA" "tRNALys" "tRNAMet" "tRNAPhe"
    "tRNATrp" "tRNAs" "tagBFP" "tagBFP " "tail-vein" "tall-cell"
    "tamoxifen-treatment" "target-gene" "tartrate" "taste-preference"
    "taxanes+trastuzumab" "temperature-sensitive" "tenofovir"
    "tert-butyl-hydroquinone" "test-retest" "testican-1" "tetra-acetic"
    "tetrabromobenzotriazole" "tetrad" "tetralogy" "tetramethyl" "tetrazole"
    "tetrazolium" "tetroxide" "thatPlk4" "the15" "the48.31%" "theArf" "theDE"
    "theEGFR" "theFGFR2" "theMdm2" "thePlk4" "theRb" "ther"
    "therapeutically-compelling" "therapy-naive" "therapy-sensitive"
    "thermomixer" "thermotolerance" "thesec5" "thespi" "thin-layer" "thinner"
    "thiocyanate" "thiolester" "thiolesters" "thioredoxin-like" "third-stage"
    "thirty-six" "this-difficult-to-fold" "threader" "three-carbon"
    "three-city" "three-day" "three-dimensional" "three-hit" "thrombocythemia"
    "thrombus" "thymine-adenine" "thymocyte-specific" "thyroidectomy" "tier-1"
    "tier-2" "tier-3" "time-course" "time-lapse" "time-of-flight" "time-point"
    "time-points" "time-response" "time-scales" "time=0" "timecourse"
    "timeframe" "timepoint" "timepoints" "time–signal" "tissues" "titer"
    "titers" "tixplaxtinin" "toPten" "toRb" "tobacco-addiction" "toll-like"
    "toluidine" "tomatins" "tomato-positive" "tonic-clonic" "tonsillectomy"
    "toone" "tooth-level" "top-down" "top-ten" "topoisomerase-1" "topology"
    "toxicities" "to−499" "trans-endothelial" "trans-ethnic" "transactivaiton"
    "transcription-3" "transcription-PCR" "transcriptome" "transcriptomes"
    "transducer" "transfectant" "transferase-1" "transferase-1β"
    "transferase-mediated" "transformation-specific-1" "transgenes"
    "translationally-regulated" "transwell" "trastuzumab-alone" "treatedPlk4"
    "treatment-naive" "treatment-naïve" "treatment-predictive"
    "triacylglycerides" "trialists" "trichocytes" "trichrome" "trigone"
    "trilineage" "trimester" "trimethyl" "trinucleotide" "triphosphate"
    "triple-negative" "trisomies" "trisomy" "trisphosphate" "troponin-I"
    "truncant" "truncus" "ts16hRh" "ts6hR0h" "ts6hR6h" "tube-like" "tubule"
    "tumg" "tumor-adjacent" "tumor-like" "tumor-regulatory" "tumor-specificity"
    "tumor-suppressive" "tumor-suppressor" "tumor-to-blood" "tumor-to-kidney"
    "tumor-to-muscle" "tumors" "tumorshphere" "tumorsphere" "tumorsphere-like"
    "tumorspheres" "tumor–to–normal-organ" "tumor–to–normal-tissue"
    "tumour-suppressive" "tuomrs" "turn-over" "tv" "twenty-four" "twenty-nine"
    "twenty-two" "twice-daily" "twinfilins" "two-center" "two-color"
    "two-domain" "two-handed" "two-hit" "two-hour" "two-hundred" "two-hybrid"
    "two-sample" "two-sided" "two-stage" "two-state" "two-tailed" "two-thirds"
    "two-times" "two-to-five" "two-way" "type-1" "tyr-705" "tzb" "tzus" "uH2A"
    "uPA-R" "ubiq" "ubiq-uitination" "ubiqui-tin-proteasome" "ubiquitin-and"
    "ubiquitinin" "ubiqutin" "ug" "ultra-high-speed" "ultra-low"
    "ultramicrotome" "ultrasonography" "ultraviolet-induced" "un" "undead"
    "under-damped" "under-powering" "undergoes" "undergone" "underpinnings"
    "undertaken" "unit-increase" "unit-type" "units" "univariables"
    "univariant" "univariate" "univariates" "unmet" "unpulsed-Raji" "untangle"
    "untreatedPlk4" "up-regulatory" "up-stream" "upreg" "uranyl" "urea"
    "urethra" "urothelia" "utant" "uteri" "utero" "utero-ovarian" "v-Raf"
    "v-erb-b2" "v-viii" "v567es" "vBCL2" "vaccinology" "vacuoles" "vacutainers"
    "values" "vanadium" "variate" "variations" "vascular-specific"
    "vector-alone" "vehicle-treated" "vehicle-treatment" "vera-like" "vermis"
    "vesicle-mediated" "videomicroscopy" "viii" "villi" "villus"
    "violin-containing" "viral-induced" "viral-mediated" "viremia" "vitro"
    "vivo" "vol" "volume-to-enclosed" "vs.12" "vulvectomy" "wa5" "waist-to-hip"
    "weakest" "web-based" "website" "weight-to-body" "weightings"
    "well-circumscribed" "well-condensed" "well-conserved" "well-defined"
    "well-designed" "well-differentiated" "well-documented" "well-expressed"
    "well-formed" "well-orchestrated" "well-plate" "well-recognized"
    "well-studied" "well-suited" "well-to-moderately" "well-tolerated"
    "western-blotting" "wg" "whereasArf" "whole-cell" "whole-exome"
    "whole-genome" "wich" "wide-range" "wide-ranging" "wide-spectrum"
    "widely-studied" "widely-used" "wildtype" "winged-helix" "withFGFR2"
    "withKG1" "withTCRδ" "within-group" "wk" "workers" "world-wide" "written"
    "wtTOP" "wtp" "wtp53pCDNA3-T7" "x-ray" "xylulose-5-phosphate" "x–40" "x–42"
    "yHsp90-D79N" "yHsp90-E33A" "yHsp90-GFP" "yHsp90-K178R"
    "yHsp90-K178R-expressing" "year-old" "years-old" "yeast-two-hybrid"
    "yellow-green" "yl" "z-scores" "z-transformed" "zVAD" "zero-sum-gain"
    "zymogens" "zymography" "×0+0.1" "×1" "×1+0.5" "×10" "×2+0.1" "×SD"
    "×YEAR+1.56" "×is" "× 10" "× 10 " "× 1" "× 10" "ç200" "Δ1-158" "Δ2–5"
    "Δ2–5–MTBD" "Δ3" "Δ4" "Δ468" "Δ5" "ΔASSTT" "ΔC" "ΔCT" "ΔCT " "ΔCt "
    "ΔEGSSS" "ΔFosB" "ΔG" "ΔHAT" "ΔLIM1-3" "ΔLIM2-3" "ΔLIM3" "ΔMEEVD" "ΔN"
    "ΔNBD" "ΔNLS" "ΔNSs" "ΔNp63-dependent" "ΔNp63siRNA" "ΔNp73" "ΔPDZBM" "ΔS45"
    "ΔSH2" "Δexon5q" "Δstem-loop" "ΔΔCt" "ΔΔCt " "ΔΨ" "Φ-π-S-S" "Ψ-K-x-D"
    "α-E-catenin" "α-ERKO" "α-MHC-MerCreMer" "α-adrenergic" "α-factor"
    "α-factor-mediated" "α-granule" "α-helical" "α-integrins"
    "α-melanocyte-stimulating" "α-particle–emitting" "α-positive" "α-primase"
    "α-secretase" "α1-adrenergic" "α1-chymotrypsin" "α2b" "α3β1" "α4-IP" "α5"
    "α6β4" "αC" "αCD40" "αE" "αF" "αSMA-1" "αV" "α–β" "β-adrenergic" "β-chain"
    "β-chains" "β-galactoside-binding" "β-herpesvirus" "β-heterodimer"
    "β-heterodimers" "β-oxidation" "β-particle" "β-secretase" "β-sheet"
    "β-sheets" "β-subunit" "β-subunits" "β-trace" "β-value" "β-values" "β1"
    "β2-M" "β2-M-induced" "β3" "β4" "βII" "βig-h3" "β–tubulin" "γ-GCS" "γ-Ray"
    "γ-TuRC" "γ-cadherin" "γ-glutamylcysteine" "γ-glutamyltransferase"
    "γ-irradiation" "γ-irradiation-induced" "γ-irridation" "γ-ray"
    "γ-ray-induced" "γ-rays" "γ-retroviral" "γ-retrovirus" "γ-retroviruses"
    "γ1" "γATP" "εPolη" "ηg" "κ-light" "λ-induced" "λ-phosphatase" "λPPase"
    "μ-δ" "μCT" "μL" "μg" "μg " "μg " "μl" "μmol" "ρ-score" "χ2" "ω-alkC16"
    "ω-alkynyl" "КB" "р " "‘b’" "‘undead’" "”G1" "−S" "∧GTGT" "△CT"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-11701-12000*
  '("Clare" "ofPGE" "polyprotein" "the viral genome" "replicationin" "effectof"
    "6-Bnz-1" "p24 Ag" "3 dpi" "Rhoin" "reportedthat" "interwoven" "Bnz" "&M"
    "Leu3a" "CMSF" "R-E-" "8E5" "the viral capsid" "p24gag" "-LTR" "p24 gag"
    "virological synapses" "VSs" "mycalolyde" "cytoD" "dbcAMP"
    "cyclooxigense-2" "a 2∶1" "3 p" "leukaemia/lymphomas" "RUNX"
    "oncorequisite" "co-ordinately" "de-repression" "co-selection" "haplo"
    "Ccr7/9" "all relevant major CISs" "Eμ-" "Ccr9" "multigene" "Endou"
    "metanodes" "Cattoglio" "Kool" "virtually all the retrievable CISs"
    "browsers" "splinkerette/454" "TCRhi" "integrome" "LTRs" "non-mutational"
    "Enhancer" "CISs" "MoMLV" "Moloney" "13/22" "Eμ" "co-exist" "CD34+"
    "= 0.56" "EMCV-" "-linked oligoadenylates" "oligoadenylates"
    "alphaherpesvirus" "PMLc" "EV-" "PML-/- MEFs" "300 international units/ml"
    "units/ml" "PMLIV-3KR" "I:C" "pseudovirus" "PMLIVa" "PMLVI" "PMLV" "PMLII"
    "PML-/-" "the first time PMLIV's" "EMCV" "encephalomyocarditis" "Mx"
    "myxovirus" "antigenome" "PMLIV" "PMLIII" "PMLVIIb" "PMLI" "Alexa 594"
    "ΔCt  " "PFU/ml" "IU/ml" "IFN-α/β" "OCs/T2D" "CLIP2" "MYND"
    "diabetic cell/animal" "overexpression/tags" "OCs" "KEGG"
    "degradation/synthesis" "OC" "tissues/organs" "p85α" "NIgG" "YXXM"
    "the largest IRS1 interactome" "A α" "O-linked" "armamentarium" "1–5 µ"
    "24-hour" "pY705" "relapsed/refractory" "#6" "2/7" "pPRAS40" "QTc" "6/18"
    "non-responders" "drug-associated toxicities" "every-other-day" "/low"
    "6 pS" "≤10" "28-day" "≤1.5" "≤2.5" "Avella" "Bertoli" "Laar" "Reynard"
    "heteromers" "homomers" "the OA associated SMAD3 SNP rs12901499"
    "RegulomeDB" "PhenGenI" "rs7166081" "arcOGEN" "rs2278670" "rs8031627"
    "rs8025774" "rs3743342" "rs12595334" "the OA associated SNP rs12901499"
    "meniscus" "A-allele" "the OA associated SNP rs12902499" "rs12902499"
    "-eQTLs" "eQTLs" "thoracic aortic aneurysms" "rs8031440"
    "a large osteoarthritis case–control dataset" "rs12901499" "P  = 0.05"
    "= 1" "= 0" "P  = 0" "P  = 0.005" "Noonan"
    "vascular development/angiogenesis" "±4%" "±0.2" "±0.6" "shCtrl" "shCbl"
    "loxP" "1-day" "±0.2-fold" "± 3%" "NRCMs" "±3%" "Casitas" "±0.07"
    "ischemia/reperfusion" "±2" "non-normal" "10 mg/kg" "toPten" "LoxP"
    "oldPten" "crossedPten" "mutTOP" "wtTOP" "TOP-like" "abdominoplasty"
    "neonatalPten" "inPten" "crossingPten" "ofPten" "Fgfrs" "fromPten"
    "the anterior mandibular ectoderm" "n =6" "p4EBP1" "juxta" "CD203" "FcεRI"
    "GNNK" "hypergranular HuMCs" "Elmer" "Perkin" "NuPAGE" "Nexcelom"
    "Cellometer" "cells/ml" "FcεRI-PE" "cytometer" "FACSCanto" "PerCP"
    "Multiparameter" "Photoshop" "Danvers" "Hammamatsu" "Hillsboro" "FEI"
    "Tecnai" "kV" "Reynold" "Austria" "ultramicrotome" "Leica" "Spurr’s"
    "Spurr" "uranyl" "cacodylate" "ferricyanide" "toluidine" "Cytospin" "Pepro"
    "StemPro" "CellQuest" "FACSCalibur" "Jose" "Sequencher" "antihistamine"
    "phototherapy" "Gastrocrom" "approximately 100 ng/ml" "predisone"
    "erythema" "pigmentosa" "HuMC" "HuMCs" "systemic mastocytois" "mastocytois"
    "WDSM" "100 ng/ml" "CNNC" "hYAP" "5SA" "VCAUCH" "approximately 55 nt" "Δ5"
    "siNF2/LATS2" "nCounter" "pri-miR-125b-1" "paralog" "Co-IPs" "S94A/5SA"
    "Renilla" "mature miRNA duplexes" "Lin28A/B" "Hu" "ΔC" "Kanamarlapudi"
    "optical aggregometry" "luminometry" "PKCα/β" "U46619"
    "the thromboxane A 2 mimetic U46619" "cytohesin-2/ARF6" "chromaffin"
    "Cytohesin-2" "aggregometry" "lumi" "cytohesin" "cytohesin-2" "5 μg "
    "× 10" "4 × 10" "untangle" "Cl" "GlialCAM" "FRAXE" "FRAXA" "stereotypies"
    "*9" "Dfs" "benign polymorphisms" "MutationTaster" "hypotonia"
    "strong genetic underpinnings" "underpinnings" "paroxysmal EEG" "subsample"
    "comorbid" "GLIALCAM" "EEG"
    "normal colonic and small intestinal epithelium" "RARa"
    "somatostatin-producing delta-cells" "delta-cells" "codominant"
    "schizophreniain" "facial dysmorphism" "dysmorphism" "Albright"
    "multipartite" "myonuclei" "denervation-induced synaptic nAChR" "MUSK"
    "nAChR" "cardiomyoblasts" "nucleo" "cargos" "·N-CoR" "Runx2-" "Runx"
    "isopeptide" "DnaJb5" "phosphatase–2" "receptor type-2A"
    "Muscle-specific miR-1" "2q37.3" "IIa" "H3K79"
    "Phosphorylation/dephosphorylation" "polulations" "polymorphysim" "rs696"
    "del/ins" "4q23-q24" "possible confounders" "allelle" "rs2273650"
    "rs3138053" "rs230525-rs230530" "rs230530" "rs230525" "rs230496"
    "rs28362491" "exercisers" "SMHS" "SWHS" "≥50 " "non-genetic" "confounder"
    "HapMap2" "British" "associated SNPs" "only three SNPs" "HDMVEC" "HAEC"
    "Three perfect proxy SNPs" "rs7739314" "eSNP"
    "the four genome-wide associated SNPs" "PREVEND" "rs7301826" "re-analysis"
    "rs2020921" "rs9399599" "6q24.3" "lookup" "rs3136739" "= 1.9" "=2.2×10"
    "=1.0×10" "=1.3×10" "8p" "=26" "Conchain" "MKPO" "timecourse" "angiocrine"
    "Hindlimb" "the ischemic hindlimb" "the ischemic hindlimbs" "pBluescript"
    "arteriole" "soleus" "gastrocnemius" "BS-1" "arterioles" "angiography"
    "microCT" "LDPI" "Doppler" "H3S10" "ischemic hindlimbs" "distal hindlimbs"
    "hindlimbs" "depletion/deletion" "the proximal hindlimb"
    "the distal hindlimb" "hindlimb" "monocyte/macrophages" "N = 3" "N = 6"
    "=11" "5F7GGC-" "125/131" "At-astato-4-guanidino-methylbenzoate" "SAGMB"
    "radiohalogen" "shorter-lived positron-emitting radionuclides" "tubule"
    "Schuldt" "catabolite" "radioiodide" "Ga" "Lu" "Tc" "plasmon" "CDRs"
    "the antiepidermal growth factor variant III (EGFRvIII) mAb L8A4" "L8A4"
    "radionuclide" "MBq" "±0.2%" "*I-IB-Mal-D-GEEEK-Nanobody" "MBq/mg"
    "3,4,6-tetrachloro-3α,6α-diphenyl-glycoluril" "IB-Mal-D-GEEEK"
    "iodobenzoyl" "-maleimido-Gly 1" "substituents" "catabolites"
    "radionuclides" "Camelidae" "Ablynx" "Affibody" "radioimmunotherapy"
    "dose/g" "*I-IB-Mal-D-GEEEK" "*I-SGMIB-Nanobody" "*I-SGMIB" "BT474M1"
    "*I-SGMIBand" "-GEEEK" "GEEEK" "IODO" "5F7GGC" "I-iodobenzoate"
    "guanidinomethyl" "-succinimidyl" "succinimidyl" "Nanobody" "Nanobodies"
    "± 0.07" "n = 6" "± 5" "IU/mL" "diabetic nephropathy" "Steen" "~2.5-fold"
    "RII" "2–3-fold" "antennapedia" "healthy African Americans"
    "healthy Caucasians" "lavage" "healthy African American" "histochemistry"
    "ILD" "~2.5" "dysmorphologies" "facial skeletal dysmorphology" "A172F"
    "IgIII" "IgII" "the MS phenotypic continuum" "lambdoid" "theFGFR2" "PCAs"
    "residuals" "andFGFR3 P250R" "theFGFR3 P250R" "theFGFR2 P253R" "theFGFR2 S"
    "Procrustes" "GENOTYPE" "maxilla" "midface" "malar" "Crouzonoid" "toone"
    "nigricans" "Stevenson" "Beare" "facial dysmorphology" "dysmorphology"
    "Crouzon (CS)" "Muenke" "Crouzon" "Apert" "3 P" "= 24" "FGFR1–3" "= 43"
    "2 P" "arrhythmias" "conductance" "cardiomyocites" "1.024-1.116" "df "
    "Wallis" "examinees" "3 possible genotypes" "≥19" "cardiomyocite"
    "cardiac electrophysiology" "electrophysiology" "χ 2  " "3 +" "× 1"
    "non-genomic" "P  = 0.010" "Methyladenine" "KHSV" "viral binding/entry"
    "plasmacytoid" "multicentric Castleman's" "multicentric Castleman"
    "Castleman" "gammaherpesvirus" "Kaposis's" "Kaposis" "20 ng/ml" "10 ng/ml"
    "9 × 10" "hyperpolarizes" "AMPAR" "antiglutamate" "properies"
    "cyano-7-nitroquinoxaline-2,3-dione" "CNQX" "8.1±2.3%" "11.5±2.1%"
    "21.0±3.7%" "48.4±9.7%" "59.1±9.7%" "66.6±12.5%" "70.5±8.7%" "mt" "siPTEN"
    "kainate" "hWT" "Islet1/2" "blown" "embryoid" "mesoderm" "ectoderm"
    "parental HDF" "karyotype" "hiPSC" "cell-like" "HDF" "HDFs" "hiPSCs"
    "the only drug proven" "GGGGCC" "Hexanucleotide"
    "-amino-3-hydroxy-5-methyl-4-isoxazole" "–4 " "10 ng/ml" "20 ng/ml" "±0.55"
    "S160/164" "subsequent autoradiography" "4x" "S9A" "ERMS" "myotome"
    "somite" "S160/164A" "X-Omat" "dsRed2" "methyladenine"
    "few autophagic vacuoles" "showed typical autophagic vacuoles"
    "autophagic vacuoles" "AVO" "The increased acidic vesicular organelles"
    "AVOs" "deoxynucleotidyl" "NE3" "EC109" "n =5" "deconjugates"
    "non-desirable" "non-smoker" "⩾70" "Anti-angiogenesis" "P =0.005"
    "P =0.014" "non-parametric" "N =10" "Non-cancerous"
    "A latently HCMV-infected neural progenitor/stem cell" "HFF" "S/G2" "omat"
    "Kodak" "urea" "vol/vol" "Pet24d-Rad51" "Coomassie" "Laemmli"
    "re-suspension" "NETN" "Addgene" "pGEX72"
    "horseradish peroxidase (HRP)-linked sheep anti-mouse" "anti-mouse"
    "ImmunoResearch" "Jackson" "tetramethyl" "Pittsburgh" "‑hemagglutinin (HA)"
    "Taneytown" "Virusys" "Birmingham" "Alabama" "Britt" "Cambridge" "Abcam"
    "Fremont" "Coverslips" "inoculums" "AgeI" "KpnI" "DsRed2" "BamHI"
    "polylinker" "pCDNA" "wtp" "pSGIE72" "Amaxa" "T98GpDRGFP" "Hamilton"
    "McMaster" "Philip" "Graham" "VR" "Towne" "Earle’s" "‑glutamine"
    "amphotericin" "MEM" "Earle" "pGEX" "I-expressing" "~11%" "‑nucleofection"
    "~16%" "~16 %" "Ag" "I-induced" "dL70-3" "NGUS24i" "pDRGFP" "Sce" "IE72"
    "HFFs" "U/mL" "~9%" "~7%" "4% to" "non-ATP-competitive" "app" "co-altered"
    "Hodis" "co-mutated" "shNF1 #2" "the lamellar actin subdomain"
    "MDA-MB-231LN" "CTTN-9KR" "shAURKA" "SIRT-1/2" "shNEDD9"
    "persistence/stability" "siCon" "LifeAct" "kymography" "9KR" "Tubastatin"
    "eural" "invasion/migration" "Re-expression" "mg/ml" "n=6" "TCF/Lef"
    "H3KAc" "histone-3" "RBhi" "submucosa" "follicle" "villi"
    "the distal ileum" "caecum" "ileum" "CD4CreCtnnb1" "villus" "exon-3" "ex3"
    "CD4Cre" "+/lox468" "Ts4Cre" "+/Δ468" "lox468" "Δ468" "+/" "ridden" "Coli"
    "AVM" "microbiota" "orphan receptor-γt" "anti-Human" "B220 +" "n=3"
    "Wnt/β-catenin" "any available α-tubulin isotype" "wildtype (WT)"
    "slower growing MTs" "estrogen-progesterone-EGF-independent" "non-motile"
    "EGFPα-tubulin" "tumg" "-indoleylmaleimide" "indoleylmaleimide" "bis"
    "-lactone" "lactone" "pCDNA3" "0.5–5" "comet-like" "penta" "DEVD"
    "sulfonamide" "AZD-1152-HQPA" "fluoromethyl" "VAD-FMK-type"
    "BEZ-235/PLX-4720" "ID/g" "AZD-1152" "AZD" "radiometabolite" "caspase-3/7"
    "logP" "IZ-VAD-FMK" "IZ" "iodo" "Surflex" "SYBYL" "SurflexDock" "PET/SPECT"
    "4-iodobenzyloxycarbonyl-Val-Ala-Asp" "benzyloxycarbonyl-Val-Ala-Asp"
    "F-ML-10" "SPECT" "BRAFcolon" "microPET"
    "4-fluorobenzylcarbonyl-Val-Ala-Asp" "-fluoromethylketone"
    "fluoromethylketone" "p = 0.030" "6-week" "mg/mL" "radiochemotherapies"
    "Americas" "VFs" "the associated SNPs" "guanylyl" "1.21–1.35" "p=1.07×10"
    "subanalyses" "rs17588172" "p=1.59×10" "Sept" "p=2.61×10" "7.7×10" "IOP"
    "rs4236601" "GLAUGEN" "a large case-control dataset" "POAG" "=31" "≥0.8"
    "HapMap3" "HapMap 3" "WDB" "HYZ" "XMY" "non-autonomous" "40% in" "miR-19a"
    "10 mg/kg" "4,5-dimethylthiazol-2-yl" "pLenti6" "phosphoinositides"
    "WeightMatrix" "targetscan" "rnahybrid" "rna22" "pita" "mitarget" "miranda"
    "Diana" "miRecords" "Exiqon" "rpm" "Kit-8" "Kumamoto" "Dojindo"
    "non-immune" "Epigentek" "Lincoln" "nonfat" "°C 10 " "TIANGEN" "MiRcute"
    "Houston" "Selleckchem" "BIX02188" "Austin" "MDA-MB361" "KATO" "Helsinki"
    "Fudan" "10 ng/ml" "μg " "anti-miRNA" "Ex" "leukoencephalopathy"
    "lipopolysaccharide" "HIV+" "autofluoresce" "HIV+ " "S2C"
    "elutriation/infection" "monocyte-endothelial co-culture" "TEER" "day-5"
    "M-tropic" "MPs cytoskeletal proteins, and CCR5 blockers" "blockers" "BBB"
    "HIVE" "auto-" "non-peptide" "non-infected" "IRB" "EYK" "mTORCs" "Montero"
    "Kaposi’s" "pGSK" "si" "H2009" "ribosomal S6 kinase1" "eIF" "n = 2" "= 7"
    "= 21" "= 107" "10.1038/ncomms4393" "doi" "human fibromyomatous uteri"
    "regulatory subunit B56β" "heterotrimer" "a markedly shorter lifespan"
    "lifespan" "tetrabromobenzotriazole" "-S380A/T382A/T383A" "FOXO1/4"
    "0.9-Mb" "14q11" "10q23" "Caribbean" "NDGR2" "Nakahata" "U -test" "μg "
    "5-aza-2" "kinase 1" "Gliadel" "prognosticators" "-alkylguanine"
    "alkylguanine" "8/36" "Lymphoblastoid" "five-day" "hydroxymethylcytosine"
    "methylcytosine" "mQTL" "TheO"
    "O  6 -methylguanine-DNA methyltransferase (MGMT)" "Group 3" "=94" "IDH1/2"
    "O  6 -methylguanine-DNA methyltransferase" "-ribose"
    "constitutively active IKKs" "radioenhancer" "the active Gαs"
    "constitutively active Gαs" "CNGs" "Epacs" "Adenylate" "GαsQL" "TUNNEL"
    "n = 6" "G αs" "Gαs" "-Tg" "Tg" "phosphopeptide"
    "p21 (Cdc42/Rac1)-activated kinase1" "solid aggressive tumors overgrow"
    "overgrow" "positron" "anti–human" "DO-1" "4 B" "∼1.7" "-Ebox" "Ebox"
    "Schiff" "Harney" "20q13" "Terrassa" "Celia" "Aktas" "Gupta" "Whiteland"
    "relatively smaller sized prostaspheres" "NA22" "WPE1" "Prostaspheres"
    "microvasculature" "WPE" "prostaspheres" "prostasphere" "Stemness" "n = 5"
    "re-plated" "≤ 0.001" "72 hrs" "β3" "NZ" "which makes miR-26b"
    "doxorubicin/daunorubicin" "anti-miR-26b-transfectants"
    "miR-26b-tranfectants" "anti-miR-26b" "miR-26b-transfectants" "NF-κB-1"
    "NF-κB-2" "miR-26b" "20 ng/ml" "Immuno" "Sangale" "4/10" "10/132"
    "Taqman® PCR" "® PCR" "®PCR" "14/51" "17/51" "AGITG" "MoAbs" "25/37"
    "37/51" "+1" "29/51" "punctae" "binucleate" "mTORC1/C1" "mTORC1/C2"
    "rightmost" "S204/244" "MCF-10As"
    "the clinically relevant pan-HDAC inhibitor SAHA/Vorinostat"
    "SAHA/Vorinostat" "CalcuSyn" "Synergism" "ER/PR−/+" "mTORC1/2" "BGT226"
    "Syndax" "HER2−/+" "ER/PR+" "MYC-driven Burkitt" "rapalog" "ER/PR"
    "MLN0128/TSA" "Non-transformed" "p4eBp1 S" "~50 %" "Non-malignant" "ER/"
    "endothelia" "arterial wall ex vivo" "acetylcholine" "dnAMPK" "mmLDL"
    "18:0-LPC" "16:0-LPC" "lipoproteins" "15LO" "anti-atherogenic"
    "Nox2/superoxide" "AOPPs" "lysolipids" "C/EBP" "anti-oxidative" "The 15"
    "lectin-like" "nucleating/anchoring" "likely release MTs" "regrowth"
    "Ran-GTP" "S25N" "μm/s" "re-assembly" "poles/centrosomes" "Tfn" "MTs"
    "elegan" "Caenorhabditis" "centriole"
    "its associated endosomes co-contribute" "co-contribute" "TuRC" "/H" "~60%"
    "~3-fold" "the subsequent activation/inactivation" "pp60Src"
    "endothelial-cell-specific microvessels" "microvessels"
    "the pathological vascular plexuses" "plexuses" "limbus" "micropocket"
    "lenti" "VEGFAKT" "siREG" "lane 4" "Microvascular Endothelial Cell-1"
    "cells/tissues" "matrigels" "ubiquitinin" "REGγproteasome"
    "inherent toxicities" "on/off" "fluorophore" "P102C" "A18C" "liposomes"
    "P-label" "γATP" "baculovirus/Sf21" "T51-6His" "PAGE4-6His" "S/T" "smFRET"
    "Förster" "strong denaturants" "denaturants" "CTAs" "cancer/testis"
    "RajagopalanK" "nuclear/cytoplasmic" "JJL" "classic subtype"
    "possible cancer initiators/promoters" "initiators/promoters" "Coxsackie"
    "Hashimoto’s" "Ct" "Hashimoto" "papillary histotype"
    "the follicular epithelium" "P  = 0" "AHS" "protein-2" "11q" "distal 11q"
    "11q13" "Overholtzer" "siYAP #7" "siYAP1" "siYAP" "SiCtr"
    "M 4-OH-tamoxifen" "#7" "4-OH-tamoxifen" "siCtr" "the luminal A subtype"
    "six previously published primary breast cancer datasets" "11q22" "PPxY"
    "1-3" "p = 0.030" "p = 0.001 respectively" "n = 3" "Non-targeting"
    "co-authors" "SAXS" "weightings" "IVa" "the inactive cPKC" "substate"
    "mature cPKC" "two diffusional
substates"
    "headgroup" "Rayleigh" "Substates" "eqs" "monolayers" "kcal/mol" "kcal"
    "C1A–C1B–C2" "/s" "/DAG" "DSLEFIASKLA" "interdomain" "multidomain"
    "catalytically competent cPKC" "C1B" "TIRFM" "bilayers" "pseudosubstrate"
    "cPKC" "cPKCs" "a 2:1" "Δ G" "Non-Radioactive" "≥90" "11p15"
    "Histopathology" "JASPA" "FluPE" "9E6/E7" "OHdG" "blastocysts" "LOI"
    "S32A/S36A" "co-repressor" "re-distributed" "strong ER-α36" "tumorshphere"
    "ER-α66" "immunofluoresces" "and 1×10" "mg/60-day" "the mammary fatpad"
    "fatpad" "bigger tumorspheres" "T47D/Si36" "MCF7/Si36" "T47D/V" "MCF7/V"
    "T47D/36" "MCF7/36" "Stem/Progenitor" "Hajj" "E2β" "stem/progenitor"
    "ER-α36" "re-distribution" "FuGene 6" "CD44 + /CD24" "p53indicated" "ATCC"
    "Promega" "Jung" "hypotriploid" "EGRF" "eEF1A/tRNAs" "eEF1A/Nef/tRNA"
    "rNef/eEF1A/tRNA" "tRNALys" "tRNATrp" "tRNAPhe" "tRNAMet" "eEF1A/Nef"
    "eEF1A/rNef" "BFA" "rNef/eEF1A" "Exp-5" "mature tRNAs" "NefWT"
    "GST-Nef55-206" "GST-Nef1-60" "pGAL" "pBIND"
    "the eukaryotic translation elongation factor-2" "elongation factor-2"
    "rNef" "PBLs" "Nef/eEF1A/tRNA" "tRNAs" "Nef/eEF1A" "ΔCt" "20/20" "=0.5"
    "N-linked" "cochaperones" "destabilise"
    "17-dimethylaminoethylamino-17-demethoxygeldanamycin" "DMAG" "Lehmann"
    "HCCBR" "ΔNp63siRNA" "ΔNp63-" "Kirschner" "ΔN-" "ΔNp63 siRNA" "HME-1"
    "non-tumourigenic" "corepress" "coactivate" "Mullan"
    "-allylamino-17-demethoxygeldanamycin" "cochaperone" "5-day" "−2 " "ΔN"
    "relatedness" "Iowan" "18q12.2" "Xq21.2" "rs17236529" "periodontopathogens"
    "rs17124372" "the integrin lymphocyte function-associated antigen-1"
    "rs1064524" "dfs" "COHRA" "GENEVA" "bacterial flora" "flora" "AJAP1" "Iowa"
    "18q" "BMN" "Haematological toxicities" "⩾70%" "3–4" "⩾5" "RTV4" "∼10%"
    "71±3%" "yl" "indol" "cd" "35±12%" "choline" "Menten" "Vmax" "Km=8.4±1.2 "
    "polymerase-1 (PARP)" "⩾50%" "PARPi" "⩽4" "n =3" "× 10 " "μ l " "+2 " "3/4"
    "CMY" "YLH" "YSC" "2–3 " "handling/detection" "neuro" "serum/CSF"
    "CSF/serum" "CSF/Serum" "diplopia" "eaten" "lungworm" "an in-house 14-3-3β"
    "canaliculata" "Pomacea" "14-3-3β" "Angiostrongylus" "± 10%" "Balb/C" "3+ "
    "2+ " "1+ " "17/22" "vanadium" "particulates" "SFM " "10 ng/ml" "±10%"
    "PBECs" "the bronchial epithelium" "ectodomain" "HBEC" "particulate" "PBEC"
    "neutrophilia" "toll-like" "TGF-α was" "= 2" "μg/ml " "= 1" "± 5" "in 1:1"
    "= 10" "EGF-like" "type 1C" "KIF" "membranous organelles" "anterograde"
    "autosomal recessive Charcot-Marie-Tooth Type 4H" "Type 4H" "rs13333308"
    "rs10199388" "haplogroups" "tenofovir" "peripheral lipoatrophy"
    "lipoatrophy" "severe toxicities" "dideoxynucleoside" "d4T/didanosine"
    "Wnt/beta-catenin" "= 1.8" "95 % CI=6" "=28" "95 % CI" "=1" "5.0×10"
    "long-term treated tumors reduced pHER2" "pHER2" "Tam+AZD8931" "ED"
    "TamRes" "ER+/HER2+" "Ful" "downregulators" "ER+ breast"
    "lymphoid-tissue-1" "London" "Barford" "threader" "PHYRE"
    "The perinuclear co-localization" "PHLPP1α"
    "extensive perinuclear co-localization" "Subsequent immunohistochemistry"
    "P=0.014" "8-week" "SAHB" "JQ1" "rag2:myr-Akt2" "heterozygotes"
    "T-lymphoblasts" "P = 0.019" "= 13" "Fugene6" "tetrazolium" "OH-flutamide"
    "alpha-negative" "a mutated oligodeoxyribonucleotide"
    "oligodeoxyribonucleotide" "p1256−/+315" "+315" "OH-Fl" "bicatulamide"
    "ZR75" "ZR" "non-metabolizable" "non-aromatizable" "effecter" "TGTTCT"
    "S1C" "ΔΔ Ct" "MDA-MB- 231 cells" "LNM" "Pairwise"
    "clinicopathologic/prognostic" "non-cancerous nasopharyngeal epithelium"
    "p = 0.05" "P = 0" "dimethylmitrosamine" "MHCII" "αSMA-1" "Retroviruses"
    "VpuGFP" "PCT" "necro" "C2I" "stromal cell-derived factor-1alpha"
    "pharmacophores" "2F01" "2F09" "M 2F09" "CTG" "TTA" "revertant" "Detroit"
    "-antiplasmin" "antiplasmin" "peptidases" "dipeptidyl" "shTiam1"
    "Spearman’s" "GNEF" "abnormal expression/function" "ISH" "Nanfang"
    "non-dividing" "ΔΔCt" "CEPH" "the gingival biopsies" "periodontium" "Arbes"
    "gingival epithelium" "41 gingival biopsies" "gingival biopsies" "p = 0"
    "= 15" "cyclin-dependent kinase inhibitor 1A" "MIX3" "RNAhybrid"
    "TargetScanHuman" "miR-133a" "Bilateria" "Cja" "Mml" "Ptr" "miR-9" "541-3p"
    "491-5p" "342-5p" "let-7g-3p" "miR-138-5p" "Non-coding" "NVP"
    "cholangiocarincomas" "orally/daily" "abdomino" "hypermetabolism"
    "synatophysin" "≈34" "≈24" "pFRS2" "developed dyspnea" "dyspnea" "salpingo"
    "year-old" "HFLT" "MIFS" "CA19-9" "U/ml" "supraceliac" "caudate" "CA 19-9"
    "CLIA" "CNV" "BICC1" "sSNVs" "chemorepellents" "chemoattractants" "α3β1"
    "Netrins" "EPHB" "Netrin" "SsNVs" "non-FGFR2" "E384X" "PLXBN3" "≈350" "≈8"
    "clear cell/poorly" "= 1" "n = 2" "mutations/tumor" "n = 3" "allostery"
    "C-labeled" "R5P" "isotopomers" "2DG" "H-labeled" "NADH/NAD +"
    "dihydroorotate" "glycoconjugate" "ribose-5-phosphate"
    "xylulose-5-phosphate" "GlcNAcP" "F6P" "G6P" "biomass"
    "fructose-6-bisphosphate" "MRM" "p52/p46Shc" "p46Shc" "p52Shc" "re-wiring"
    "re-expressing" "∼ 3-fold" "non-essential" "5P" "6P" "progenitor–like"
    "publicly available dataset" "FLLL-32" "FLLL" "GSE21927" "NTCM" "TCM"
    "siEmpty" "MDSC" "PKCβI" "MDSCs" "PKCβII" "βII" "7900HT" "MCF10" "CD34 +"
    "ANDV uniquely causes viremia" "IRF3/5/7" "EMBL" "Sendai" "nucleate"
    "encapsidates" "Gn’s" "constitutively active IRF3-5D" "ANDV-" "ANDV’s"
    "viremia" "HPS-like" "ΔNSs" "Bunyamwera" "Bunyaviridae" "NY-1V" "GnTs"
    "3/5/7" "GnGc" "Gn" "Gc" "PHV" "TULV" "Tula" "PUUV" "Puumala" "HTNV"
    "York-1" "ISG" "active interferon regulatory factor IRF3-5D" "IRF3-5D"
    "S-segment" "NSs" "New York-1" "ISRE" "Nombre" "ISGs" "HPS" "ANDV" "Andes"
    "Δ CT" "5/7" "β 3" "Anderson" "cBio" "Keohavong" "Grisham's" "Grisham"
    "quite heterogeneous and regular PCR Sanger" "= 1" "A18G" "Y4N" "Patient 1"
    "the ovarian surface epithelium" "cystadenoma/adenofibroma"
    "serous cystadenoma/adenofibroma" "recurrent LGSC" "LGSC" "OSBT" "LGSCs"
    "OSBTs" "p = 0.005" "Cary" "crude ORs" "Hilden" "QIAamp" "vacutainers" "±5"
    "Changzhou" "Rheumatology" "Bangkok" "Hefei" "Kong" "Hong" "1.03–2.16"
    "AG/GG"
    "E26 transformation-specific-1 (ETS1) rs1128334 G/A and WDFY family member 4 (WDFY4) rs7097397 A/G polymorphisms"
    "rs1128334" "anti-cyclic" "rs7097397" "transformation-specific-1"
    "non-synonymous" "= 1.56" "= 1.12" "desorption/ionization" "S637/S645"
    "Rawlings" "/substrate" "PKCβ/θ" "Raji human Burkitt’s" "JPM50.6"
    "S551A/S552A" "S637A/S645A" "Scansite" "Akti1/2" "TCR/CD28" "RxRxxS/T"
    "peptide:MHC" "Carma2" "Carma" "Gαi" "non-PKC" "monoadducts"
    "global gene de-regulation" "de-regulation" "GSE14333" "LIM1215sc5"
    "sh57224" "shmir" "95% CI:1.2–3.0" "HR:1.9" "NIBPL" "T-stage"
    "well-differentiated histology" "mucinous subtype" "P =0.03" "STACs"
    "interactome" "Sir2p" "Sirtuin" "~40%" "non-cancer cells" "co-regulation"
    "H3K18Ac" "indepth" "multiple maternal and fetal SNPs" "bifida" "spina"
    "deoxythymidylate" "deoxyuridylate" "rs2612101" "≤ 0.80"
    "the 34 maternal and fetal SNPs" "fetal (bottom panel) SNPs"
    "race/ethnicity" "either maternal or fetal SNPs" "Folic"
    "The remaining 11 fetal SNPs" "gluthatione"
    "the most significant fetal SNPs" "921 fetal SNPs"
    "The remaining 7 maternal SNPs" "betaine" "methenlytetrahydrofolate"
    "Two fetal SNPs" "the most significant maternal SNPs" "multivitamins"
    "NBDPS" "Arkansas" "running SNPMClust" "CRAN" "bivariate" "SNPMClust"
    "Illumina’s" "GenCall" "BeadArray" "BeadChips" "GenomePlex" "RNaseP"
    "Biosystems" "buccal cell samples using Puregene" "Valencia" "Qiagen"
    "Puregene" "RFC-1" "GoldenGate" "pairwise" "10-kb" "htSNPs" "nucelotide"
    "obstructive CHDs" "trisomies" "Fallot" "tetralogy" "atreriosus" "truncus"
    "CHDs" "9 fetal SNPs" "GxE" "Fetal SNPs" "the 17 fetal SNPs"
    "17 fetal SNPs" "BFDP" "maternal and fetal SNPs" "folic"
    "maternal and fetal single nucleotide polymorphisms" "non-Hispanic" "β  4"
    "β  3" "SEER" "Tampa" "Heidelberg" "the intronic PARP1 SNP rs3219090"
    "rs3219090" "Rs2249844" "Chicago" "DNAseI" "MuTHER" "rs1059040"
    "rs11541664" "SNPinfo" "ChromHMM" "rs2242844" "1.01–1.39" "Leeds" "Vienna"
    "FFPE" "Essen" "Riga" "host/tumor" "1.04–1.28" "rs2249844" "BioGenoMEL"
    "= 58" "= 98" "p  = 0" "p  = 0.03" "p  = 0.005" "Pathological classifiers"
    "α2b" "Immunotherapy" "pelvic lymphadenectomies" "lymphadenectomies"
    "spindle/epithelioid" "epithelioid"
    "the known predictive clinicopathological characteristics Breslow’s"
    "the known predictive clinicopathological characteristics Breslow"
    "7.3 dermal mitoses" "mitoses"
    "an unilateral inguino-femoral lymphadenectomy" "lymphoedema" "lymphoceles"
    "vulvectomy" "minora" "labia" "mTOR-" "mTOR" "Three basic histotypes"
    "genitals" "Margolin’s" "Margolin" "sclerosus (LS)" "caucasions"
    "Breslow’s" "inguino" "LVSI" "Breslow" "Sydney" "sclerosus" "=7"
    "Anti-human" "shNF1#2" "Titer" "shSC" "theEGFR" "their Residual Z-scores"
    "72hrs" "ug/ml" "Non-Targeting" "=29" "n=5" "re-sensitized" "10q"
    "formation/function" "non-demented" "GWA" "≥0.5" "filtering
SNPs"
    "Webgestalt" "netrin" "the Alzheimer’s" "ADNI" "Rotterdam" "−4" "1.2 × 10"
    "= 7" "5 ×
10"
    "1/10" "n = 2" "1
× 10"
    "reviewed/approved" "Ruoslahti" "Lpa" "pectoris (UAP)" "pectoris (SAP)"
    "UAP" "pectoris" "≥ 50" "KAA" "misbalance" "Microdomain" "Bayer" "Wiechen"
    "Ravid" "Bickel" "р " "univariant" "Caveolin-1α" "Spearman's" "caveolin-1α"
    "lotillins" "rohibitins" "tomatins" "SPFH-domain" "SPFH" "microdomain"
    "= 0.047" "= 5" "= 3" "1-2" "Tumorspheres" "tumorsphere-like" "Yadav"
    "Transcription3" "Transducers" "non-ALDH" "re-plating" "LISA" "non-GFP"
    "Davis" "Gallo" "Minnelli" "re-occurrence" "leukin" "oct3/4" "tumorspheres"
    "tumorsphere" "non-stem cell" "20 ng/ml" "Oct3/4" "miRNAi" "DiffScore"
    "BeadChip" "β4" "Dhh" "cell migration/invasion" "NOD-like" "Marsit"
    "co-mutations" "inFigure" "co-mutation" "BFAF" "Tabl" "andFigure"
    "a clearly identifiable histologic subtype" "mutations/rearrangements"
    "S4B" "S4A" "p  = 0.014" "22/78" ": C" "p  = 0" "p  = 0.024"
    "Basal/claudin" "Epcam" "MCF10A-p53 − PTEN −" "Iliopoulos"
    "MCF10A-p53-PTEN-" "MCG" "cyclohezimide" "translational/post"
    "BT474-shPTEN-LTT" "NMECs" "MCF10APTEN" "basal/claudin" "MCF10Ap53"
    "HNMECs" "HNMEC" "NOD/SCID" "anti-oxidation"
    "a replication competent HBV genome" "ser-9-GSK3β" "oxidation/antioxidant"
    "non-enzymatic" "d -GalN/LPS" "sAST" "IU/L" "synthesisThere"
    "lipopolysaccharides (LPS)" "co-injection" "lipopolysaccharides"
    "fulminant" "mean ± SD" "pylori-" "endoscopic biopsies" "Progressors"
    "Colombia" "Dysplasia" "endoscopic antral biopsies" "serology" "Steiner"
    "Honduras" "Biopsies" "Y1221/1222" "their respective phosphopeptides"
    "KinasePhos" "≥2–fold" "1278 unique phosphopeptides"
    "5218 unique phosphopeptides" "immortomouse" "fromEgfr" "PMSS1" "PD53035"
    "inEgfr" "oxoguanosine" "catabolizes" "pEGFR" "pERBB2" "wa5"
    "gastric biopsies" "Honduran" "-infectedEgfr" "infectedEgfr" "pylori"
    "Non-cancer" "– 4" "continuum" "D2FC" "I1-FFL-like" "FFL" "D2F"
    "transcription as well asF max /F" "/F" "Saidon" "Cohen" "smFISH" "forF"
    "CVs" "CV" "around 1 hr" "= 0.52" "RGT" "IQ" "JDD" "WO"
    "the middle cerebellar peduncle (MCP)" "vermis" "pons" "peduncle" "medulla"
    "3/14" "iFISH" "piloid"
    "The fibrillary component diffusely infiltrated adjacent parenchyma"
    "pleomorphism" "neuropathology" "fossa" "= 11" "= 16" "JGH" "YC" "YFY" "QW"
    "XLM" "MJC" "YCY" "dimmer" "supershift" "truncant" "pGL2-Mcl-1-κBwt"
    "DNMIκBα" "human esophageal carcinoma cell lines CE81T/VGH" "CE81T/VGH"
    "Thiocolchicoside" "France" "DNMIkappaBalpha" "2.5 × 10" "ZZ" "YZ"
    "mechanismson" "nmol/L" "μmol/L" "calphoatin" "monolayer" "cells/well"
    "the superficial BC BIU-87" "BIU-87" "BIU" "T/N " "netrin-1 and"
    "calphostin" "patttern" "= 24 " "= 7.4 " "high/low" "= 2" "ΔCT " "DVF"
    "LWF" "ZC" "re-implanted" "CD44+/CD24" "non-CSC" "chromene" "Trojanowska"
    "BJE6-106" "KAM1" "benzopyran" "cinnamate" "bisindoyl" "carbazole"
    "essential PKC isozymes" "SAR" "pharmacophore" "isozymes" "PrCSC" "PCSC"
    "Chemoresistance" "repopulate" "isozyme" "epithelial-like" "ALDH + "
    "≤ 0.05" "Thr202/Tyr204" "phospho-ERK1/2" "CD133 +" "CD44 +" "CD133+"
    "20 ng/mL" "phosphatidylnositol" "synthesizer" "tartrate" "Shue"
    "receptor interacting protein-1" "apoptotic signaling/induction"
    "synthesizers" "TGF-1" "ZJY" "YSZ" "LIMKs" "kinase-2" "ΔΔCt " "2^-" "^-"
    "ΔCt " "Lipofectamine" "24 hr" "4 × 10" "± SD" "AJT" "JRJ" "CDJ"
    "3p21.31-p21.1" "Non-Small" "Horikawa"
    "auto (ADP-ribosyl) ation and hetero (ADP-ribosyl) ation" "hetero" "DBS"
    "Vos" "pcDNA/GW-53/" "pcDNA/GW-53" "qRT" "Ct " "non-small" "pcDNA" "= 9"
    "= 8" "± 0.06" "p18 BAX" "microdomains" "DHHC" "p18BAX" "C62S"
    "autoradiography" "bromopalmitate" "bilayer" "segements"
    "cultured healthy cells increases BAX S-palmitoylation" "S-palmitoylation"
    "FuGENE 6" "α 5" "∼2%" "topoisomerase-1" "group D2" "shXRCC" "BGC823/DDP"
    "thioredoxin-like" "≥2" "group1" "Sos" "+Dox" "AZD7726" "intrastrand"
    "-Dox" "WT-H-Ras" "WT-H-" "Dox"
    "the isogenic colon cancer cells DLD-1 K-Ras WT/G12D" "WT/G12D" "H/N-Ras"
    "the specific FLT3-ITD-positive AML subtype" "Newer" "BCRABL" "SYKTEL"
    "co-transduction" "/Sca-1" "co-transduced" "MSCVTomato" "genesets"
    "Z-scores" "GSE10358" "GSE14468" "LAML" "ssGSEA" "miR30-shSykb1" "TRMPCIR"
    "TRMPVIR" "shCT" "shSykb4" "shSykb1" "hematocrit (HCT)" "miR30-shRNA"
    "tetrad" "ΔSH2" "Cter" "Nter" "miR30-shRNAs" "SYKi" "Merck" "TKD"
    "YY589/591AA" "kinome" "adaptors/regulators" "ITD" "non-interacting"
    "n = 5" "= 0.5" "7-times" "non-phosphorylatable"
    "possibly other lung cancer subtypes" "pT118" "Clara" "vacuoles" "LSCCs"
    "alkynyl" "Ag1.5" "progenitor/stem cells" "Metacore" "bronchio" "ALDHA1"
    "Oncosphere" "oncospheres" "ChagoK1" "oncosphere" "amplicon" "OCT3/4"
    "histologies" "LCLC" "Acyl" "LSCC" "co-amplified" "chaperokines"
    "geranylgeranylacetone" "iHsp72" "PMNLs" "ornithine" "endotoxemia"
    "acetylglucosamine" "thermotolerance" "transfer/transfection" "hyperoxia"
    "Ba" "pentamer" "rHsp72" "hPBLC" "hPMNL" "hPBMC" "18/18" "28/29" "cecal"
    "the intestinal epithelium" "bovine rHsp72" "AdHSP" "minireview"
    "Co-treatment" "ABT/PF271" "subG1" "ABT-737/PF271" "ABT-737/BEZ235"
    "/BEZ235" "CCLE" "PF271/BEZ235" "PF271" "OCCCs" "OCCC" "EC 50" "24 hr"
    "Chung" "Treg/Th17" "Verthelyi" "microangiopathies" "Herrington" "IVS1"
    "ofER-" "ofER" "IVS" "IVSI" "retino-" "retino" "TH17" "= 0.25" "P = 0.05"
    "= 0" "Th17" "co-signaling" "galiximab" "non-lymphoid" "ALK+ TCL" "ALK+TCL"
    "co-signal" "Jak1/3" "and 2A" "co-cultures" "SUDHL-1" "co-stimulatory"
    "Gaulton" "bodyweight" "necropsy" "DEXA" "absorbance" "R/R" "P/P" "ogtt"
    "rs1042522" "= 20" "= 0.04" "Gillison" "penile" "T:A" "subsites" "subsite"
    "palatine" "non-oropharyngeal" "non-disruptive" "G:C" "HNSCCs" "P = 0.03"
    "0–1" "P = 0.005" "A:T" "CRIFI" "Co-culture" "co-culture" "dormancy"
    "mesylate" "Yoshiyuki" "MRD" "= 2" "ΔCT " "co-cultured"
    "ipsilateral mastectomy" "subperiods" "survivorship"
    "a bilateral mastectomy" "a unilateral mastectomy" "pectoralis"
    "contralateral subcutaneous mastectomy"
    "a previous contralateral mastectomy" "the contralateral mastectomies"
    "contralateral (bilateral) mastectomy"
    "unilateral and bilateral mastectomies" "trialists" "bilateral mastectomy"
    "unilateral mastectomy" "contralateral mastectomy"
    "unilateral or bilateral mastectomy" "Chun"
    "the hypoxia-inducible factor-1" "Biocoat" "shADM" "12.0±4.3-fold"
    "=1.47×10" "DKs5" "7/10" "/ total" "DKO3" "co-activation" "GCN" "IHC 3+"
    "SGC031" "SNU" "GI" "FGFR2+/MET+" "FGFR2+" "MET+" "IHC3+" "MET IHC 3+"
    "HercepTest" "Lauren's" "had undergone total or
subtotal gastrectomy"
    "lymphadenectomy" "gastrectomy" "IHC 2+" "PDGCX" "non-response" "P =0"
    "χ  2" "=100" "HER2 / CEP17" "re-evaluated" "∼15%" "PanIN/PDA"
    "the mucinous epithelium" "PDA" "PanIN" "pelckstrin" "-triphosphate"
    "V-akt" "cytologic and architectural atypia" "Noninvasive MCNs"
    "low-grade dysplastic epithelium" "MCN" "akt" "MCNs" "n = 3" "the 15"
    "Avet-Loiseau" "mono-allelic" "MGUS/MM" "an exogenous enhancer" "HMCL"
    "at least four (NSMCE2/TRIB1, TXNDC5, FAM46C, FOXO3) -perhaps" "-perhaps"
    "MYC:IGK" "VDJ" "Loiseau" "EJM" "ANKRD55" "non-IG" "no obvious enhancer"
    "LINC00313/HSF2PB" "UCSC" "GEP70" "quintiles" "quintile" "UAMS"
    "hyperdiploid" "~20%" "heterozygous germline polymorphisms" "SMM" "MYC:IG"
    "33/218" "108/218" "101/238" "MMRC" "6/53" "42/53" "MMCL" "human Burkitt's"
    "a nearly invariant" "non-random" "~4%" "8q24" "1p" "P=0.005" "P=0.001"
    "P=0" "P=0.03" "Balb/c" "Carlsbad" "Colorado" "Pleural fluid cytology"
    "AmoyDx" "immunohistochemistry (IHC)" "SqCC" "cellular/tissue"
    "cell/tissue" "DPYL2" "hematological system development/function"
    "development/function" "Cellular/Tissue" "over/underexpressed"
    "quadriplicate" "INBE" "a membrane-associated subproteome" "subproteome"
    "univariables" "the most aggressive subtype" "p = 0.001" "p = 0.024"
    "p = 0.022" "p = 0" "= 62" "_3" "non–small-cell" "phosphoactivate" "HERT"
    "carryout" "α 2 M*-stimulated" "*-induced" "∼65–70%" "dsRNAi"
    "*-stimulated" "thiolesters" "thiolester" "cysteinyl" "a β" "–5 µ"
    "breast/ovarian" "the most common histological subtype" "serous histology"
    "Polyphen-2" "URL" "Willems" "MMMT" "8/18" "12/15" "4/31" "and 3/22" "6/31"
    "co-transformed" "CfrGFP" "NfrGFP" "Δexon5q" "DMLE+2.2" "Lombardy"
    "probands" "_775del5" "_69delAG" "Jewish" "Bergamo" "HBOC" "= 41" "n = 5"
    "= 0" "95% CI = 0" "= 16" "non-carriers" "a possible synergism" "synergism"
    "UCSF" "Milan" "colon cancer-1" "P = 0" "XH" "MQ"
    "cellular growth/proliferation" "o" "Abe" "apocrine" "eosin" "AN3CA/exAR"
    "siFOXA1" "exAR " "Enh-1" "siAR" "AN3CA/exFOXA1 " "exFOXA1" "exAR"
    "MFE-296/shFOXA1 " "MFE-296/shFOXA1" "AN3CA/NC" "AN3CA/exFOXA1" "shFOXA1"
    "MFE-296/NC" "normal endometrial tissue samples using immunohistochemistry"
    "split1" "uteri" "co-regulators" "1 + " "p = 0" "p = 0.005" "χ2" "= 51"
    "= 26" "= 0" "AR+" "OSCC/OPSCCs" "presence/absence" "Rampias" "Kaposi's"
    "Kaposi" "Barr" "Epstein" "followup" "normal oral mucosal epithelium"
    "BCL9-2" "proliferating normal epithelia" "multiploidy" "hyperdiploidy"
    "lymphnode" "OSCCS/OPSCCs" "trigone" "basaloid" "OSCC/OPSCC"
    "adenomatous polyposis coli (APC)" "ploidy" "OSCCs/OPSCCs" "OPSCCs"
    "five-year" "μ L" "cytoplasmic/nuclear" "Suzuki" "comedo" "parotid" "~80%"
    "CTCR" "3-year" "Obstétrique" "Gynécologie" "MSKCC" "=185" "YI"
    "classifiers" "Mps" "=22" "p =0.005" "p =0.001" "p =0.03" "mg/m 2"
    "Comptons" "cytology (FNAC)" "FNAC" "INKA4a" "Crompton" "Compton" "Kiel"
    "Hamburg" "Tribius" "southern USA" "only HPV DNA+" "24/50" "21/50" "18/21"
    "noncomplete" "approximately 3–9" "3–9" "epipharynx" "tonsillectomy"
    "panendoscopy" "hypopharynx" "oropharynx" "DNA+" "pack-years"
    "P  =   0.010" "–5 " "HPV16 E6" "P  =   0"
    "highly aggressive basal-like TNBCs" "ONCOMINE" "Fbxw7α" "B56δ" "B56β" "Cα"
    "Aα" "immunocomplexes" "grade/stage" "Cyclin E1" "B55β" "phosphodegrons"
    "PP2A-B55β" "Anti-Flag" "λPPase" "~5%" "PR −" "G 1 /S"
    "well-tolerated rapalogs" "Rapalogs" "integrinβ7" "neuroretina" "10mg/kg"
    "1uM" "S462TY" "readouts" "soft agar" "MTS" "TY" "three serial replatings"
    "replatings" "aFos" "RasN17" "plexiform" "NHSC" "developing glia" "glia"
    "Schwann" "Schwan" "Acute re-expression" "5 ×10" "=2" "mg/kg" "nu/nu" "≥ 2"
    "multitarget" "Zou" "Georgakis" "Kornev" "Bossi" "Ceccon" "Bonvini"
    "Galkin" "pALK" "PathScan" "Seto" "Sasaki" "Katayama" "Doebele" "Choi"
    "Christensen" "Camidge" "a dual ALK/EGFR inhibitor AP26113" "AP26113"
    "Schmitz" "Bartlett" "Foyil" "Jacobsen" "polychemotherapy" "Swerdlow"
    "Vose" "Marzec" "Chiarle" "Bai" "Bischof" "Kruczynski" "Mosse" "Lerosey"
    "Janoueix" "George" "Shiota" "Morris" "ALK+" "Karpas299CHR" "Karpas299CR"
    "CHR" "CH5424802" "≤ 0.001" "1 × 10" "5 × 10" "non-Hodgkin" "SJRB035"
    "SJRB020" "SJRB016" "this unique subset" "C6orf64" "HCG18" "16q"
    "relatively few (≤10 per tumor) chromosomal, regional or focal CNVs"
    "illumina" "A larger subset" "SJRB051" "SJRB031" "indel" "very few SNVs"
    "our previous whole genome" "Gb" "SJRB011" "UPEN-RB-31" "4/94" "≥10"
    "homeodomain" "chrl4q22.3" "3/94" "logratio" "6p" "chr6p" "gains/losses"
    "41/94" "12/94" "6/94" "indels" "SNVs" "SNV" "2p" "Grasemann" "6p22" "CNVs"
    "aCGH" "*2" "3/10" "– 2" "emphasise" "MANTRA" "Genomes" "HCG27" "-eQTL"
    "HOMA" "GIANT" "MAGIC" "CHB+JPT" "HLA-DR4" "HLA-DR3" "T1D" "covariate"
    "rs9505118" "CEUr" "Metabochip" "nearest" "Africa" "arisen" "Cochran’s"
    "Cochran" "2.5 million autosomal SNPs" "AGEN" "Mexicans" "Europeans" "T2D"
    "Mexican" "non-diabetic" "=1.02" "p =0.022" "=5" "9×10" "−5" "p =0.010"
    "p =0" "2.2×10" "Φ-π-S-S" "approx" "v567es" "es" "cotrans" "ΔASSTT"
    "ΔEGSSS" "LBD" "coIP" "polyubi" "pCMV" "Ub" "ΔBTB" "SPOPisa" "EGSSS"
    "ASSTT" "Ci/Gli" "MacroH2A" "MacroH" "multisubunit" "ubiq" "degron"
    "a less common mutational subset" "Google" "progressionfree" "9·5" "12·5"
    "·4" "·4–2·9" "·4–9·0" "6·2–7·0" "·56" "·30" "5·9" "·47" "·39" "1·6"
    "6·1–16·6" "8·0–14·0" "11·9–14·9" "·024" "·90" "·43" "7·6" "14·5" "·0085"
    "·75" "10·0" "·63–0·93" "·0068" "·32–0·46" "0·38" "1·6–2·1" "·46" "·38"
    "6·9" "·76" "·93" "·73" "·65" "0·70" "·0008" "·87" "·70" "·8" "9·7"
    "Sanger/454" "cobas" "Feb" "previously untreated stage IIIc" "BRIM-3" "·3"
    "Genentech" "Roche" "Hoffmann" "0·0001" "p=0" "·0001" "·1" "·2" "=0" "·9"
    "·6" "·7" "·0" "·5" "Jan" "Coprimary endpoints" "ECOG" "Dulbecco’s"
    "Inductively coupled plasma-mass spectrometer"
    "coupled plasma-mass spectrometer" "Insititute" "Roswell" "spectrometer"
    "Dulbecco" "kcal " "Pt" "bipyridyl"
    "the epidermal growth factor (EGF)-induced nuclear factor κB"
    "the triple-negative MDA-MB-231 cells" "RAPTA" "NAMI" "cal " "CONTIN"
    "holo" "Circular dichroism (CD)" "pyridine"
    "triple-negative MDA-MB-231 cells" "MDA-MB-231 cells" "polypyridyl" "bpy"
    "Clazpy" "metallo" "BLBC" "circular dichroism" "5-chloro-2-" "phenylazo"
    "bidentate" "this aggressive breast cancer subtype" "Anti-proliferative"
    "riboside" "cosubstrate" "accumbens" "reuptake" "remyelinate" "Katsuno"
    "Rhodes" "Also known as Kennedy’s" "Brinkmann" "Kennedy" "Markert" "Yanez"
    "Renton" "DeJesus" "Deng" "chorea" "clinicaltrials" "non-amyloidogenic"
    "aβ" "cryptochrome" "VTA" "innervate" "arcuate (ARC)" "PVN" "VMH" "arcuate"
    "non-SIRT1" "maintainance" "overview" "Huntington’s" "axon" "Sirtuins"
    "organelle" "acyl" "sirtuins" "Parkinson’s" "Parkinson" "sirtuin" "Aβ"
    "AstraZeneca" "Bicatulamide" "Thike" "primary/metastasis" "Sutton's"
    "Sutton" "Gasparini" "logFC" "non-TNBC" "histotype" "RPCI" "OSU" "5NP"
    "CK5/6" "ClinicalTrials" "non-basal" "PR−" "p  = 0.03" "ER/PR-positive"
    "orruboxistaurin" "A159E" "Gö" "HLMVECs" "HLMVEC" "PKCθ" "A/T"
    "ATM-p53-14-3-3-σ" "PIKK" "biomarker/sensor" "B- induced" "B-mediated"
    "transcription-3" "cucurbitacins" "Cuc" "to 14-3-3"
    "the exogenous p120ctn isoform 3A" "exogenous p120ctn isoform 3A"
    "Wnt/b-catenin" "p120ctn-3A" "exogenous p120ctn isoforms 1A and 3A"
    "Cytoplasmic/nuclear" "p120ctn-1A" "= 51" "3+ " "= 26" "2+ " "1+ "
    "MMP-1 functional polymorphic haplotypes"
    "MMP-1 promoter polymorphic haplotypes" "nearly 16 haplotypes" "Bihar"
    "additionally four other SNPs" "methylene" "Gabriel" "Haplotype" "Z-alpha "
    "pylorus" "TC+CC" "Heterozygous genotype" "AluI" "Genebank" "contig"
    "insertion/deletion" "their resultant haplotypes" "rs494379" "rs514921"
    "rs475007" "rs1144393" "rs1799750" "a 2G" "noncardia"
    "MMP-1 proximal promoter SNPs" "haplotypes" "T/A" "polymorphism (RFLP)"
    "T/C" "1G/2G" "p = 0.024" "χ 2  " "p  = 0.001" "P  = 0.024" "= 0.034"
    "= 0.021" "pmirGlo" "Targetscan" "in 15-PGDH" "aneurysms" "Hernandez"
    "Masson’s" "microsomal PGES-1" "in15-PGDH" "intima" "healthy ones"
    "histomorphometry" "EIA" "isomers" "non-dilated" "aneurysm"
    "prostaglandins" "backflow" "hydroxyprostaglandin" "LDv" "SDv"
    "an electrical dipole" "dipole" "migration-like" "ofCa"
    "The actin electric dipoles" "dipoles" "Lorentz" "bio" "mTpower" "MF+EGF"
    "/h" "1.24±0.12" "±0.32" "myristate" "100%compared" "inboth" "branch-like"
    "42.85±7.14% (EGF)" "TFC" "33.8±2.2was" "spine-like" "Maryland" "Bethesda"
    "ImageJ" "the public and 1 mT" "mT" "Hz" "EMFs" "AARPs" "mean ±SD" "±0.12"
    "mean±SD" "Taiwan" "Tournigand" "flowchart" "bavacizumab" "OPUS"
    "non-selected" "= 31" "= 0.25" "= 40" "MRTFs" "coregulators" "BIX" "BED"
    "siERK5" "siCtrl" "cistrome" "seqMINER" "cistromes" "PXSP" "co-regulator"
    "Factor-1" "WST-1" "lymphatic/venous" "photomicrographs" "Brenner"
    "Harrell's" "Harrell" "Conclusions/Significance" "P = 0.005" "parchorin"
    "EEF" "ITGA" "CLIC" "expresser" "expressers" "CILC4" "NHBE"
    "the mucinous subtype" "alveoli" "integrinsα3" "Pals-2" "ΔCT" "siDlg"
    "CADM1-" "CADM" "GST-CADM1-CΔ4" "MDCK+CADM1" "SCADS" "ΔCT-YFP" "and 1C"
    "and 1B" "significantlywhen" "9D2" "CADM1-EC-Fc-coated" "MDCK+CADM1-GFP"
    "neuronal synapses" "membrane-associated guanylate kinase homologs"
    "Ig-like" "IgCAMs" "Δ4" "and 1E" "Fechner" "situ" "centile"
    "immunohistochemsitry" "subcohort" "= 0.52" "–5" "UCB" "COL-3/-5" "COL-5"
    "fibroblast growth factor receptor-1" "LM- γ 2" "LM-γ2" "-5" "glycans"
    "-Lactose" "Lactose" "WI" "Oris" "FN/LM-5" "phosphorylation/expression"
    "smad2/3" "-lactose" "lactose" "4 × 10" "/2 s" "β 1" "κ B" "polyphenol"
    "5-amino-2-phenyl-benzoxazole" "AceCS2" "Rossmann" "SIRTs" "Sirtuin-3"
    "H3K9Ac" "pSTAT3" "SNR" "OXR" "FL17" "zVAD" "24/48 " "siFGFR4" "FGFR1-3"
    "timepoints" "sensitises" "FGFR1-4" "Switzerland" "Basel" "lymphoma-2"
    "normal colonic mucosa" "Novartis" "-4" "–4" "BGJ398"
    "IL-1 regulated glioblastoma secretome" "rilonacept" "canakinumab"
    "meninges" "procollagen" "expression/secretion" "mechanism/role"
    "non-targeted" "PHOSIDA" "AHHGEAGHHLPEPSSRETG" "APSPIIKFPGDVAP"
    "propeptides" "secretomes" "Carboxypeptidase A4" "TIMP1is" "proMMP2"
    "antithrombin" "V0/V1" "testican-1" "Marfan’s" "Marfan" "fibulins"
    "propeptide" "invasiveness/proliferation" "ECMs" "exosomes" "P-component"
    "pentraxin" "the principal chemoattractant" "stanniocalcin-2"
    "stanniocalcin-1" "ProteoIQ" "m/z" "identifiers"
    "the GO Biological Process algorithm" "Secretome" "non-classical"
    "SecretomeP" "exosome" "Tarassishin" "tumorigenesis/progression"
    "non-resectable" "non-catalytic" "Smad2/3" "~90%" "U251" "TCCD" "Tauchi"
    "caAhr" "Ahr" "Lce" "Sutter" "function/keratinization" "Vulgaris"
    "the marginal sebum" "the infundibular stratum corneum" "Iizuka"
    "Nakatsuji" "and 1B1" "Hayes" "HFKs" "SPRR2D"
    "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)" "Geusau" "pathomechanisms"
    "chloracne/MADISH" "Panteleyev" "infundibular stratum corneum" "upreg"
    "Franzke" "corneodesmosome" "ncDNA" "Pekowska" "Rushmore" "Ereg" "Btc"
    "Dahlhoff" "triacylglycerides" "Guillou" "Kraan" "melanocortin"
    "Rosenfield" "`-deoxyuridine" "ORS-and" "ORS" "one-year-old" "K5cre-caNrf2"
    "pelage" "trichocytes" "the hyperkeratotic stratum corneum" "infundibulum"
    "ibula" "infund" "ko" "Adph" "K5cre-CMVcaNrf2" "Ramirez" "caNrf2" "sebum"
    "Sorg" "Saurat" "chloracne/" "corneum" "Vermeij" "Ishii" "Liby" "Sporn"
    "Wakabayashi" "cysteine-reactive skin sensitizers" "Natsch" "DNFB"
    "oxazolone" "sensitizers" "Kostova" "Dinkova" "Piao" "Schäfer" "MADISH"
    "Slpi" "infundibula" "× 10 " "non-inflammatory" "Fig 1B" "co-activate"
    "Bryant" "Bouche" "co-transcriptional" "co-localise" "pathobiology"
    "Kocher" "Crispino" "Somanathan" "Mohammadi" "Stellate" "Furukawa" "Tian"
    "IIIC" "Ishiwata" "Yamazaki" "Kornmann" "Leung" "Yamanaka" "Chioni" "Peng"
    "Maher" "Stachowiak" "Ems" "Dunham" "Moffett" "LMW" "Corson" "Grose" "Itoh"
    "Ornitz" "Hebrok" "Xu" "Vonlaufen" "Hwang" "Bachem" "Kadaba" "Erkan" "Apte"
    "Coupland" "et " "physiomimetic organotypic co-cultures" "stellate"
    "desmoplasia" "10X" "non-histone" "and 3B" "JMC" "FFB" "Circular dichroism"
    "dichroism" "-TTTC" "TTTC" "Ev" "the active histone markers H3K9ac"
    "H3K9ac" "quadruplex" "Bi" "Ai" "Eiv" "+521" "non-BRCA1-mutated" "Aiii"
    "CO-IP" "= 0.015" "= 0.004" "P = 0.030" "P = 0.014" "= 0.006" "non-mutated"
    "factors/mechanisms" "FSC" "non-specifically" "~0.7" "PMA/Iono" "RBH-"
    "tagBFP-" "tagBFP " "mCherry+ " "the blue fluorescent protein tagBFP" "RBH"
    "tagBFP" "futher" "genic" "capsid" "refSeq" "Unigene" "Wald" "Pennsylvania"
    "Bushman" "DNaseI" "INSIPID" "amplicons" "MseI" "eGFP+ " "mCherry+"
    "alphoid" "non-productively" "HAART" "progeny" "non-productive" "5 × 10"
    "co-transfecting" "re-ligation" "S3C" "S2B" "S2A" "Only Par WT/ΔS45" "∼20%"
    "phopsho" "the parental line Par WT/ΔS45" "WT/ΔS45" "T41–reactive" "*13/14"
    "13/14" "ΔS45" "SB21673" "Nek"
    "the scaffold proteins adenomatous polyposis coli (APC)" "coli (APC)" "S37"
    "disjunction/splitting" "prexmiR" "pmiR" "pMIR" "DIANA" "scarless"
    "gingiva" "fibrocontractile" "gingivae" "Myofibroblasts" "2.5 × 10"
    "proteomic compendia" "infertiltiy" "a well-defined subset" "hoc" "MSigDB"
    "HICT" "Transcriptome" "topology" "Lymphochip" "DMAP" "ImmGen" "compendia"
    "Silico" "nulligravid" "Moderate/Severe" "cul" "IQR" "strong co-variation"
    "analytes" "Wilcoxon" "pg/mL" "multiplex immunoassay" "dyspareunia"
    "biological co-regulation" "co-variation" "symptomatology" "ASRM"
    "the secretory endometrium" "gynepathology" "endpoint"
    "multiplex immunoassays" ":C" "non-adherent" "non-human" "Pharma" "Celon"
    "Warsaw" "WK" "Sutherland" "Davidson" "Younger" "EOC" "AOC" "AEOC"
    "p = 0.024" "= 0.039" "QY" "SY" "concurrent chemoradiotherapy" "siSTAT3"
    "co-affecting" "co-regulated" "siControl" "CNE1-" "CNE" "siEGFR" "WHI"
    "STAT3β" "DZ1" "DNAzyme" "ETGR" "immunocomplex" "Burkitt’s" "Hodgkin’s"
    "Burkitt" "24 hrs" "higher-energy conformational substates" "substates"
    "αE" "dihedrals" "Cδ1" "COδ" "Nε2" "hydroxyl" "Helix" "hydride" "phenyl"
    "pABG" "-aminobenzoylglutamate" "aminobenzoylglutamate" "Gatekeeper" "αC"
    "subdomain" "quasi" "Michaelis" "Dunbrack" "rotamers" "which
slides ∼2.5"
    "∼2.5" "eq" "Rotamer" "microsecond" "CPMG" "Millisecond" "HSQC" "CγCO"
    "CγN" "rotamer" "αF" "millisecond" "hDHFR" "ecDHFR" "/ 2" "Written"
    "Malpighi" "Policlinico" "genetictests" "Knudson’s" "co-occurred" "Knudson"
    "Missense" "Johnson" "Riegert" "Mayo" "PI3KCA" "IDC" "S6RP" "UC1" "Ltd"
    "Invitrogen" "PTEN homologous aminoacid" "HomoloGene" "aminoacid" "browser"
    "HGMD" "Exome" "a multicentric Invasive Ductal Carcinoma rypT1c" "rypT1c"
    "underwent thyroidectomy" "lymphangiomata" "thyroidectomy" "cribriform"
    "mastectomy" "pT2N1a" "An Italian woman underwent lumpectomy" "lumpectomy"
    "oral papillomatous papules" "papules" "acral" "years-old" "Cowden"
    "pCDNA 3" "allP" "ins/ins:P" "Galbraith"
    "at least 474 single nucleotide polymorphisms" "dbSNP" "2q33–34" "del/del"
    "ins/ins" "ins/del" "P  = 0.018" "= 0.012" "= 0.004" "isoform 1A"
    "isoform 3A" "and 3A" "TCCTGCAA" "LTE" "5-Aza-CdR" "TCCTGCnA" "POZ" "à"
    "Tramtrak" "CBD" "JMD" "5-Aza-2" "LTEP" "Idziaszczyk" "tuomrs"
    "a distinct molecular-pathologic subclass" "subclass" "splenic flexure"
    "flexure" "cecum" "Yamada" "= 3E" "diploid" "Hotspot"
    "the codon R201 mutational hotspot" "Gsα" "G-stimulatory" "recptors"
    "intrapapillary mucinous neoplasias (IPMN)" "co-occur" "anoxia" "Shahrzad"
    "Matthew" "hepatocarcinogens" "Nakamura" "micro-environmental stressors"
    "hepatectomy" "thePlk4" "Ko" "BothPlk4" "andPlk4" "inPlk4"
    "hypoxia inducible factor 1α" "gallbladder" "ug/mL" "non-treated"
    "non-small cell lung carcinoma" "co-treated" "trimester" "ischaemia" "SNAs"
    "co-treatment" "Caspase 3/7" "Zhao's" "Zhao" "LV-miR-222i" "miRanda" "EREs"
    "nonendometrioid" "Obstetristes" "Gynaecologistes" "Internationale"
    "= 0.0003" "P = 0.0002" "BALB/C" "≥50" "100-nM" "Ari Melnick’s" "Melnick"
    "Ari" "Hodgkin" "EBNA-3C" "senesce" "Rodier" "indefinitely transformed LCL"
    "LCL" "viral BCL2 homologs" "Chk2i-treated LCLs" "caspase 3/7" "Chk2i"
    "non-proliferating" "lymphoblastoid" "lo" "non-viral" "goes" "5×10"
    "20 ng/mL" "∼50%" "Djuzenova" "Niewidok" "Stingl" "folding/area" "deeper"
    "erythrocytes" "wt" "Lúcio" "sorbitol"
    "the small organic osmolyte inositol not only completely abolished RVD"
    "solutes" "RVD" "Hoff" "Boyle" "solute" "2–3" "isotonic CGM" "CGM" "1–2"
    "videomicroscopy" "folds/microvilli" "HFIB-1" "smooth/flat" "S/cm"
    "5 different cell lines display symmetrical anti-field" "anti-field"
    "co-field" "MHz" "kHz" "Area-specific Membrane and Whole-cell Capacitance"
    "Capacitance" "DK-MG" "microphotographs" "Friedl" "chemo-" "area/folding"
    "F/cm 2" "capacitance" "chemo−" "chemo" "= 9" "TSC1/2" "non-malignant"
    "rs1805097 polymorphisms" "Alfonso" "0.72–1.25" "0.87–1.10" "0.89–1.14"
    "0.71–1.26" "0.91–1.14" "0.80–1.06" "0.73–1.13" "0.85–1.08" "NHW"
    "rs1805097 polymorphism" "Europe" "rs2289046"
    "an important IRS1 polymorphism rs1801278" "rs1801278" "T2DM" "Mathieu"
    "Chan" "RKTs" "IRS-1 and" "rs1805097polymorphism" "rs1805097" "substrate-2"
    "= 0.10" "= 0.05" "= 0.91" "Poczekaj" "Kostrzewska" "the Begg's" "Begg's"
    "Matullo" "Ramachandran" "only three common SNPs" "nasopharynx"
    "XRCC1Arg194Trp" "= 0.02" "95%CI " "rs1799782" "furthers" "IL-2α" "Aldrich"
    "Wiskott" "eosinophilia" "Zhu" "neurite" "KDs" "chr" "TTCCTAGAA"
    "TTCTCAGAA" "TTCCTGGAA" "TTCTTGGAA" "TTCTAAGAA" "TTCCAAGAA" "TTCCAGGAA"
    "TTC-" "TTC" "greatest" "Liao" "rhIL-2" "inStat5b" "humanSTAT5B"
    "dimorphism" "possible non-redundant" "co-activator" "5B" "5b"
    "co-activators" "egfr_41_ 60" "transbronchial biopsy" "alphaC" "_900"
    "_881" "egfr_481_500" "egfr_61_80" "egfr_41_60" "_61_80" "_60" "_1001–1020"
    "_841–860" "titer" "exon 21" "egfr_481–500" "_741–760" "_721–740"
    "Oncology" "commonest" "_500" "_481" "_41" "_481–500" "Luminex" "titers"
    "I-IV" "and 2-year" "P = 0.018" "= 0.020" "P = 0.001" "= 0.047" "= 0.007"
    "= 0.036" "_80" "immunobiology" "synergise" "co-stimuli" "VEM" "VKS"
    "immunophenotype" "non-IgD" "XTT" "anti-sIg" "sIgGκ" "anti-λ" "Igλ" "++"
    "+++" "sIgκ" "sIgλ" "isotype/IgL" "pairings" "anti-human" "endocytose"
    "‘b’" "−ve" "BCRs" "fluoresce" "10/10" "IgG/lambda" "+ve" "multiparameter"
    "secondary lymphoid follicles" "IGV" "specific splenic B-cell subsets"
    "orthologues" "IGHV" "sIg" "3/3" "S2 A" "2/2" "*-negative" "even more AiP"
    "kekkon" "AiP" "simpler" "afterDE" "gone" "modelDE" "Cas3*-positive"
    "*-positive" "asDE" "theDE" "ofspi" "kekkon-1" "kek"
    "p35 eye discs heterozygous forspi" "forspi" "heterozygousspi" "thespi"
    "Spi/EGFR" "Dras" "orthologs" "ED1303" "spitz" "Df" "UAS" "Enhancers"
    "enhancers" "/dying" "hR" "ts" "Bergantinos" "Pvf/PVR" "Eiger/Wengen"
    "eiger" "puc" "transgenes" "non-redundant" "JNKKs" "JNKKK" "kay" "dronc"
    "Suppl" "ocelli" "ey" "Yorkie" "Wg" "wg" "‘undead’" "non-apoptotic"
    "undead" "planarians" "zymogens" "arm 2L" "Dronc" "cIAP" "de-ubiquitinase"
    "cIAPs" "re-evaluation" "the hyper-IgA–associated Q403X" "DKO" "ΔNBD"
    "MigR1" "3T8" "Q403X" "Fugene 6" "=0.0013" "complex-1" "=0.034" "T221/Y223"
    "pLGALS1" "candidates/pathways" "-galactoiside" "galactoiside" "vs" "ccRCC"
    "=0.036" "5.0 × 10" "μ g" "failsafe" "epidermoid" "WBCs"
    "ADCC-triggering immunotherapy" "FOLFOX" "FOLFIRI" "subclasses" "isotype"
    "Fc" "GA201" "glyco" "μ g " "CD8 +" "intra-" "secretome" "hexamer"
    "shRNAmir" "TRIPZ" "DOX" "DAVID" "HBSS" "NHF" "SILAC"
    "organellar proteomes" "cyotochrome" "COXVIII" "rRNAs" "HSP2"
    "active/dimerized" "keratinoctyes" "Cyto" "Clarke" "HK5Cre"
    "approximately every 300-400 bp" "mDNA" "fl/fl" "viii" "Stat3C"
    "binding/GAS" "NCTC" "3PC" "MitoTracker" "Gough" "UVB" "mitoStat3"
    "non-canonical" "Spanish" "Turk" "Iranian Azeri Turks" "with/without"
    "4G/5G" "Turkish" "5G/5G" "-6754G/5G" "4G/4G" "homozygotes" "Crohn's"
    "Iranian Azeri Turks and -6754G/5G polymorphism" "Turks" "Azeri" "type-1"
    "Tcf" "KDal" "kDal" "transactivaiton" "sortolin" "U73122" "- 2" "5 × 10"
    "JMRdeA" "RdelM" "JRD" "QMS" "analyte" "non-expression" "Ottaviano"
    "Lapidus" "-fcDNA" "Widschwendter" "1/3" "fcDNA" "p = 0.018" "2 +"
    "the eutopic endometrium" "healthy postmenopausal endometrium" "Oestrogen"
    "derived factor-1-1" "menostasia" "FIGO" "clinico" "uterine endometrium"
    "atypia" "UniGene" "ISCCs" "supernatants" "endometrioid" "Anti-apoptotic"
    "P = 0.001" "Non-invasive" "24 hrs" "≤5" "/total"
    "This dual lipid/protein phosphatase" "spatio" "BV" "253J" "-trisphosphate"
    "begun" "non-reducing" "2-dependent" "anti-migratory" "isotypes" "pS52CK18"
    "NuB2" "tv" "factor 2B" "alpha-smooth muscle" "fibroblast-like"
    "revertants" "HPV16E6" "KGM" "condensate" "benzo" "Nox" "PKCepilon"
    "non-muscle" "non-cancer" "These EOBC-associated SNPs" "Tarui" "isoenzymes"
    "12q24" "12q22" "72 previously unpublished SNPs"
    "the 27 EOBC-associated SNPs" "QTL" "e" "CGEMS" "2.5×10" "missed SNPs"
    "1KG" "catalogas" "variate" "KG" "rs889312" "1.02×10"
    "the smallest P-value" "4×10" "Germany" "Canada" "GWASs" "=2.5–5.2" "Utah"
    "12q13.11" "genomewide" "the 82 currently known LOBC SNPs" "5q11.2"
    "rs2229882" "LOBC" "smallest P-value" "P-value" "P-values"
    "smallest P-values" "EOBC" "−2" "=0.10" "–2" "6×10" "intracrine"
    "cannabinoid" "XPORT" "W43A/G47A" "biogenesis/stability" "pcDNA3"
    "L-PGDS–W43A/G47A" "sunken" "ΔMEEVD" "eosinophils" "chemoattractant"
    "synthases" "autacoids" "Prostaglandins" "MEEVD" "6 × 10" "4B" "G α" "∼70%"
    "∼75%" "∼30%" "∼80%" "A/G" "3  P" "T-helper" "non-ERBB2-expressing" "CQ"
    "wk" "lengthier" "betweenBecn1 +" "inBecn1 +/+" "C57BL/6:FVB"
    "withBecn1 +/+" "inBecn1 +" "NCR" "BCL2-" "BCL" "BafA1"
    "apoptosis-defective iMMECs"
    "partially autophagy-deficientBecn1 +/− iMMECs" "iMMEC" "locuses" "v"
    "biomolecule" "tzb" "PyMT" "iMMECs" "andBecn1 +" "= 3" "= 5" "C57BL/6"
    "1  +" "17q" "co-deficiency" "andp21"
    "the noncancerous prostate epithelium" "littermates" "L/+"
    "immunofluorescent cytochemistry" "cytochemistry" "SI" "= 11" "Loxp/Loxp"
    "– 9" "constrast" "Nagoya" "Corcoran" "let-7c" "Snell" "Mp" "non-targeting"
    "let-7a" "let-7f" "let-7g" "g" "f" "ASPC1" "MiaPaCa" "Lin28a/Lin28b"
    "non-gemcitabine" "FOLFIRINOX" "flurouracil" "-2" "non-phosphorylated"
    "~75%" "phosphorylation/activation" "SM" "Flanagan" "Funes" "DeNicola"
    "available survival datasets" "KIRC" "SKCM" "Oncomine" "tHMEC"
    "immortal MSC4" "myrAKT" "CAAX" "MSC4" "stepwise" "= 0.02" "= 0.015"
    "NAD(P)H:quinone" "P  = 0.001" "= 6" "YJC" "ApoB100" "receptor-1" "ie"
    "+24" "TRANSFAC" "CCGCCC" "GGGCGG" "+179" "–126" "preimmune" "microtube"
    "heterotrimeric G protein Gαi2" "Gαi2" "Gi" "oxLDL-treated HCAECs"
    "anti-apoB100" "anti-MDA" "apoB100" "HCAECs" "1 × 10" "Gα"
    "re-localization" "MFI" "Vinbastine (VBT)" "VBT" "Vinbastine"
    "neonatal CNS" "OPCs" "PDGRA" "antigen-1" "cisternae" "± SD"
    "Co-localization" "#5" "= 6" "NHLBI" "retest" "metabolizer" "eQTL"
    "hippocampal synapses" "hidden" "inositol-1,4" "NTKR2" "Yes" "INRICH"
    "lambda" "lambda " "QQ" "the Angry Temperament subscale"
    "the Angry Reaction subscale" "subscale" "euthymia" "Vietnam"
    "trisphosphate" "6q21" "gc  " "ARIC" "Spielberger" "dbGaP" "= 5"
    "non-receptor" "= 8" "written" "Val762Ala" "762Ala" "the Egger's" "Greater"
    "1.07–1.55" "1.21–1.65" "1.14–1.58" "Ye" "caner"
    "at least 1287 reported single nucleotide polymorphisms" "cSNPs" "1q41-q42"
    "ation" "ribosyl" "GLOBOCAN" "Val/Val" "SNPexp" "HapMap" "rs1136410"
    "polymerase-1" "= 43" "P  = 0.030" "= 0.77" "= 1.56" "Shakya" "exon14/15"
    "exon14–15" "LCLs" "aagt" "gc" "IARC" "Bayes" "BRCA2 :c"
    "a strong co-segregation" "14/15" "BRCA2: c" "ESEfinder" ": c" "NNsplice"
    "MaxEntScan" "a pathogenic missense mutation co-occurring" "co-occurring"
    "co-occurrence" ":c" "Mirabello" "RMH" "Martinez" "Delgado" "rarer"
    "undertaken" "PLCO" "socio" "/S  " "alveolar epithelia" "pleura" "NleE"
    "enteropathogenic Escherichia coli (EPEC)" "coli (EPEC)" "EPEC" "coli"
    "GADPH" "non-significantly" "immuno" "pGSK3αβ" "GSK3αβ" "un" "YxxM"
    "extracellular signal-regulated kinase 1/2" "glycolipoprotein"
    "lipoarabinomannan" "alveolar epithelium" "anti-inflammatory" "supress"
    "Guerin" "Calmette" "bovis" "= 0.0017" "genetic polymorphisms/variations"
    "monckeberg" "lamellae" "cardioprotectant" "non-CHD" "rs1268165" "rs768023"
    "rs17592371" "rs4325427" "rs2721072" "rs2755209" "are/is" "Framingham"
    "Harbin" "Ottawa" "Newcastle" "Africans" "Wu" "Patel"
    "the nonsynonymous polymorphism" "Sequenome" "MassARRAY" "TaqMan"
    "1.01–1.14" "1.02–1.24" "Bu" "Dawei" "Duell" "ScienceDirect" "EBSCO" "Ovid"
    "Springer" "= 0.006" "= 1.02" "= 62" "P  = 0.005" "= 0.003" "rs25487"
    "group 1" "MRN" "knockin" "theMdm2" "SNP285C" "SNP285" "SNP309G"
    "MDM2 SNP309G" "MDM2 SNP309" "p53R172H" "theArf" "whereasArf" "MDM2SNP309"
    "andArf" "inArf" "anRb" "inApc" "Mdm2/4" "stressful" "Fraumeni" "GenBank"
    "HUANG" "Jin" "DONG" "JIN" "Bo" "hui" "Bao" "Ordonez" "Sordella"
    "bronchoscopy or CT-guided percutaneous lung biopsy" "whose biopsy"
    "bronchoscopy" "Shoji" "Mitsudomi" "wildtype" "≥20" "1.319–9.918" "≥5"
    "=0.046" "P =0.024" "=0.038" "P =0.05" "=0.004" "P =0.018" "Jiang" "ICGC"
    "=2.61" "=0.010" "107/159" "p=0.005" "p=0.014" "=2.63" "38/347" "12/49"
    "pancreata" "hematolymphoid" "oculo" "Hopkins/Emory" "loss/normal"
    "p=0.019" "Emory" "Hopkins" "=1.90" "p=0.022" "=0.005" "p=0.001" "=0.030"
    "anibody" "S217/221" "pMEK" "pEphA2" "pEphA2 S897" "pEphA2 S" "pPaxillin"
    "pFAK" "SKUT" "farthest" "immunoconjugates" "S240/244" "T202/Y204" "pMAPK"
    "pCRaf" "= 0.2" "deacetylation/acetylation" "Om"
    "distinct acetyl-mimetic K→Q" "OpenBioSystems" "oligomycin" "K18R" "K→Q"
    "~70%" "IEF" "K→R" "NAM+TSA" "phosphorylation/dephosphorylation" "PDKs"
    "Krebs" "meric" "OXPHOS" "Warburg" "an inactive Polη" "crossover"
    "Holliday" "DSBR" "Polκ" "both PCNA-associated DNA Polδ" "dsDNA" "polη"
    "siBRCA2" "siPALB2" "Q775X" "BRC3/4" "infantum" "Klenow" "piBRCA2" "ssDNA"
    "Polη-εGFP-complemented" "mitomicyn" "HU" "oxoG" "oxoguanine" "Pol η"
    "Polδ" "Heyer" "Kowalczykowski" "D-loops" "ChAM" "interstrand" "PALB2-"
    "PALB" "D-loop" "co-localize" "Polη" "-OH" "OH" "non-overlapping" "mcg"
    "a combination oral contraceptive containing 20–35 μg" "μg" "menses"
    "progestin" "mg/day" "female external genitalia" "Δ 4" "microorchidism"
    "macroorchidism" "mIU/ml" "radioimmunoassay" "ambigious genitalia" "meatus"
    "Leydig" "epididymis" "ERKO" "ArKO" "patho" "the primordial follicles"
    "follicles" "utero" "nonprimates" "frameshifts" "luteomas" "micromoles"
    "blastocyst" "severely masculinized external genitalia" "hirsutism"
    "eunocoid" "epiphyses" "eunucoid" "ambiguous genitalia" "genitalia" "–5 -"
    "re-initiation" "Antagomirs" "antagomirs" "DU-4475"
    "benign mammary epithelia" "epithelia" "ER+/PR + " "transcriptomes" "TNBC"
    "TNBCs" "DU" "ER + breast" "-9 " "PR + " "UD" "1-β-D-ribofuranoside"
    "anti-tumourigenic" "hypoglycemia" "non-diabetics" "PDPK-1" "Sahra"
    "Colquhoun" "PC-3" "trinucleotide" "a translational enhancer"
    "MID1-α4/PP2A" "urethra" "midline" "Opitz" "anti-tumour" "MID1-α4"
    "midline-1" "α4" "Alzheimer's" "Kickstein" "vitro" "CoIP" "Boyden" "JTT"
    "XDD" "LJY" "ZX" "CZL" "LZJ" "YXY" "WLL" "LX" "LYY" "LJC" "iTRAQ"
    "mannoside" "mansoni" "haematobium" "retinol" "Kim" "cFN" "β1" "Yoon"
    "non-smokers" "caseum" "globulin" "= 0.011" "P  = 0.024" "= 0.05" "= 35"
    "P  = 0.018" "Huntington's" "Huntington" "Solomon" "weakest" "SIRT" "FNA"
    "EUS" "ultrasonography" "endoscopy" "± 0.06" "μg/mL" "G 0 /G 1" "cosmids"
    "GeneChip" "pStage" "Noguchi" "3q26" "= 22" "= 0.038" "P = 0.022" "= 0.019"
    "= 0.76" "χ 2" "to 2+" "10-μm-thick" "BMI" "Ioannidiset" "6q25" "Egger's"
    "Begger's" "metadata" "Begger" "the polymorphic genotypes" "C/T" "STROBE"
    "Genotype" "rs9340799" "rs2234693" "pp" "Ioannidis" "XbaI" "PvuII" "= 1.39"
    "= 0.005" "= 0.019" "AdCreRb" "heterozygote" "onPten" "toRb" "lox/+"
    "theRb" "average+/−S" "andRb" "infectedRb" "AdCre" "Berns"
    "mutation/deletion" "AdenoCre" "non-neuroendocrine" "6/6" "dyslipidemia"
    "hyperinsulinemia" "transferase-1" "Evans" "hyper" "ex" "AAV" "proteosome"
    "the remote myocardium" "LEOPARD" "astragaloside" "LC3II"
    "the autophagic protein ULK1/2" "ULK1/2" "macrocomplex" "Tt1/Tel2" "FKB"
    "Michael" "homologs" "Candace" "Sabatini" "David" "Eric" "cardiomyopathies"
    "multiprotein" "/2" "Akbari" "whose VUSs" "the VUS’s" "p=0.05" "Latina"
    "OMIM" "traditional penetrance" "VUS" "Grantham" "Polyphen" "GVGD"
    "Angeles" "VUSs" "= 9" "=18" "=0.05" "p=0.03" "anti-parallel" "bp/turn"
    "+200" "+1000" "approximately 7-times" "bound p53 R273H" "TFBSs" "CCGGAAG"
    "TFBS" "statistically significant over-represented 7mer" "7mer" "RefSeq"
    "Seq" "p53 R273H" "= 10" "CSC-like" "Shenoy" "colonosphere" "colonospheres"
    "3.0±0.8%" "AGS-Wnt1 cells" "sphroid" "Sphroid" "normal gastric epithelium"
    "28.16±4.5%" "CD44+Oct4+" "CD44+" "CICs" "Group 1" "stem cell-like"
    "P =0.001" "PmirP" "UTRs" "immunotherapy" "immunochemistry" "hTRET" "pIRES"
    "antago" "N/P"
    "the widely used online target-gene prediction software program TargetScan"
    "website" "miRCURY" "CAAT" "TATA" "&D" "CHX-chase" "CHX" "T3A" "ENBA1"
    "μ g/ml" "homozygous Jak2V617F megakaryoblasts/ erythroblasts"
    "megakaryoblasts/ erythroblasts"
    "the heterozygous Jak2V617F megakaryoblasts/erythroblasts" "Kubovcakova"
    "acquired uniparental disomy" "~30%"
    "heterozygous Jak2V617F megakaryoblasts/erythroblasts"
    "heterozygous or homozygous Jak2V617F megakaryoblasts/erythroblasts"
    "Homozygous Jak2V617F-expressing megakaryoblasts/erythroblasts"
    "megakaryoblasts/erythroblasts" "trilineage" "Mk"
    "hemizygous or homozygous Jak2V617F"
    "significantly larger spleen size/weight" "size/weight" "hematocrit" "VF/+"
    "WBC" "heterozygous Jak2V617F" "reticulocytes" "Jak2V617F" "9pLOH" "9p"
    "JAK2V617F" "Philadelphia" "~50%" "H&E" "longa" "Curcuma" "PLATand"
    "co-knockdown" "nonmalignant" "approximately 90% HGPIN/cancer"
    "HGPIN/cancer" "LGPIN" "pc−/−" "L/L"
    "this generic transcriptional co-activator" "XY" "YX" "QH" "IL-1β/p38/AP-1"
    "p38/" "MMP2/9" "serosa" "КB" "SB202129" "Immunocytochemistry"
    "at least three superfamilies" "superfamilies" "activator protein-1"
    "mean ± SD" "& D" "× 10" "≥ 50" "p38 MAPKs" "QT" "MKA" "AVL" "MJL"
    "low/moderate" "arrayCGH" "Didraga" "non-BRCA1/2" "LumB" "Joosse" "7/18"
    "7/9" "the most predominant luminal subtype" "Nagel" "Waddell"
    "the previously described intrinsic molecular subtypes"
    "RNA based subgroupings" "homogeneous subsets" "Subtype" "Hedenfalk"
    "1.7e-3" "-classifer" "classifer" "-classifier" "non-methylated" "Holland"
    "sporadic-like" "PAM50" "Non- BRCA1 / 2" "PR-" "Parker" "classifier"
    "normal-like" "non- BRCA1 / 2" "sporadic/unselected" "lumB" "Vargas"
    "subgroupings" "p  = 0.024" "1.2 × 10" "= 22" "ER + " "Basal-like"
    "basal-like" "BRCA1 / 2" "lamella" "RASS1A" "prenocodazole" "ensconsin"
    "Foundation-7" "Michigan" "motile"
    "microtubule-associated protein Ras association domain family 1A"
    "family 1A" "reconfigures" "non–small cell lung carcinoma" "osteoblasts"
    "sublines" "intracardiac" "effector/target" "TRAP+" "CAGCTG" "E-box"
    "CACGTG" "turnover/resorption" "μCT" "hypocalcemia" "osteomimicry" "≥1"
    "contralateral prophylactic mastectomies" "mastectomies" "25-year"
    "Huzarski" "Goodwin" "Ashkenazi" "Bordeleau"
    "a subsequent prophylactic oophorectomy" "oophorectomy" "BCSS" "20-year"
    "1.0–3.3" "94/201" "12/20" "also younger" "CMF-like" "89/201" "34/201"
    "13/20" "eightfold" "firstdegree" "15-year" "noncarriers" "Sweden"
    "a 10-year" "= 0.02" "= 0.005" "= 0.002" "BRCA1/2" "95 % CI" "disbalance"
    "iif" "rotein" "sequene" "KFERQ-like" "apoptosis/viability" "S104/116"
    "HA-PED-S104" "DIIRQ" "NKLDK" "LAMP2A" "cystein" "LAMP-2A" "prebound"
    "the lysosome-associated protein type 2A" "KFERQ" "anti-oncogenic" "μL"
    "=1.85" "=62" "-value=0.91" "=0.91" "Iceland" "rs2736100_C" "rs1034072_A"
    "subphenotypes" "rs1034072" "rs10974944_G" "rs10974944" "_A" "_G" "=2.09"
    "=49.3%" "_C" "Diego" "Icelanders" "WGS" "=10" "=0.019" "=3" "HPV 6/11"
    "EFGR" "very strong co-localization" "TERT -based immunotherapies"
    "immunotherapies" "International Cancer Control/AJCC" "Control/AJCC"
    "cytology" "microcarcinomas" "Warthin-like" "Landa" "Liu" "GBq"
    "person-years" "±SD" "FCDTCs" "Chernobyl" "FCDTC"
    "differentiated/undifferentiated" "= 6" "= 8" "mean ± SD" "quinidine"
    "cisapride" "ether-a-go-go" "oocytes" "-5-" "Co-expression"
    "de-suppression" "robust re-expression" "NuRD" "Aminoactinomycin"
    "impermeant" "Pharmingen" "BD" "RGS10-1" "H3K18"
    "ovarian cancer chemoresistance" "1.2×10" "Sendoel" "ΔNp73" "co-workers"
    "TRP2 in" "TRP2in" "TRP2-shRNA_#2" "WueMel 45" "WueMel" "pGreenFire" "_#2"
    "WueMel45" "MelU" "homolog" "DHICA" "dopachrome" "melanin" "= 10" "= 3"
    "rhabdomyosarcomas" "co-activator 1" "clone 10A" "BCCLs" "ERE" "CTIIA"
    "clone10A" "BCCL" "ICI" "pSTAT1" "non-DNA binding protein" "Ii"
    "anti-tumor" "pIV" "ER + PR +" "ER +" "ER + breast" "solid/trabecular"
    "Hamatani" "D5F3" "The precise DNA breakpoints" "2/16" "histotypes"
    "_P13169357" "_P00351573" "_P15598291" "_P00340892" "_16" "breakpoints"
    "breakpoint" "2p22" "2p23.2" "Smallridge" "radioiodine" "10-years" "Tiedt"
    "Lippert" "mean+SD" "+2" "all the recommended diagnostic algorithms"
    "nearly one-half" "BCR-ABL1 -negative" "Pearson" "Bousquet" "Taqman"
    "55±9%" "ABg" "essential thrombocythemia (ET)" "gDNA/cDNA" "forJAK2"
    "Plasmidic gDNA" "gDNA" "essential thrombocythemia" "thrombocythemia" "−9"
    "= 100" "Shinozaki" "I/II" "10-year" "unfavorable DMFS" "DMFS"
    "histopathologic subtype" "Clark" "at least 1 mitosis/mm 2" "mitosis/mm 2"
    "LMM" "the histological subtype" "IIC" "IIA" "interquartile"
    "non-metastasized" "Edlundh" "= 3.6" "= 0.011" "= 0.038" "μg/ml" "&E"
    "carotid" "procoagulant" "non-DM" "huAR" "PFT-μ" "PTF-μ" "PTF" "epalrestat"
    "Δψ" "intermembrane" "=8" "profiler" "OMM" "ΔΨ" "TMRM" "Bcl" "nephropathy"
    "thrombus" "mellitus (DM)" "mellitus" "CBV" "Toh" "preload"
    "histopathology" "predicting EGFR genotypes" "Classical subtype"
    "the Classical subtype" "pathophysiologies" "subsets" "rCBR" "bolus"
    "Tykocinksi" "Tykocinski" "increased capillary leakiness" "gadolinium"
    "leakiness" "Mangla" "relatively higher rCBV" "microvessel"
    "Significantly higher median rCBV" "biopsy"
    "genetically unique GBM subtypes" "rPH" "rCBV" "= 0.05" "non-invasive"
    "p = 0.03" "= 0.01" "Pierre" "Takashima" "Nakano" "Yang" "Schlieper" "Amos"
    "Rodriguez" "Manneville" "Etienne" "Lindemann" "Haggarty" "Transwell"
    "Berridge" "formazan" "tetrazole" "Kirtikara" "Vichai" "sulforhadamine"
    "Dallavalle" "Sakamoto" "Masangkay" "Aldana" "Li" "Huo" "Parmigiani"
    "Kovacs" "Zhang" "Matsuyama" "Hubbert" "Fernandez" "Valenzuela"
    "Dragestein" "Schiebel" "Maekawa" "Sahai" "Olson" "Storer" "Ghaneh" "Hezel"
    "1 × 10" "macrodomain" "expression/activity" "healthspan" "gatekeeper"
    "UFA" "synthesis/transport" "palmitoyltransferases" "carnitine" "bootstrap"
    "multiscale" "metabolism/transport" "Intrahepatic lipid droplets"
    "droplets" "pink/orange" "ribose (OAADPR)" "polyADP" "O-acetyl"
    "non-alcoholic-fatty-liver-disease (NAFLD)" "macroH" "ribose" "NAFLD"
    "≤ 0.05" "Non-specific" "3-week" "PFSs" "a 3-week" "5-week" "⩾2"
    "multicenter" "1-year" "=84–99%" "SPIRITS" "anorexia" "neutropaenia"
    "=54–80%" "21-day" "S-1" "=9" "=6" "=13" "Leah" "U133" "colocalise"
    "pannel" "protein 2B" "non-homologous" "anti-proliferative" "μ l" "Rad3"
    "co-activated" "seq" "Illumina" "MiR-146b" "TCGA" "both mature miR-146b"
    "mir" "mouse mammary epithelium" "miR-146a" "STAT3C"
    "hepatocyte nuclear factor 4α" "paracrine" "subtypes" "κB" "miR-146b"
    "Anti-FLAG" "+ 10" "BRCA-like" "Adamson" "ceRNAs" "basepair" "bps" "RWPE-"
    "Du145-" "Du" "PCATs" "MMEJ" "microhomology" "Achilles" "DSBs" "DSB"
    "anabolicm" "PI3K/Akt/mTOR/p70S6K" "ubiqutin" "Spautin" "TLR2/4"
    "AMPKαinhibitor" "MAPLC3A" "STRAD1/MO25α" "STRAD1/MO25" "Akt/mTOR/p70S6K"
    "anti-autophagic" "fluorophores" "pixels" "semi" "strong co-localization"
    "competent Vps34/Beclin 1 signalome" "signalome" "fromBcl" "siScr" "LRR5"
    "co-localizes" "musculus" "parenchyma" "P-p70S6K" "co-localized"
    "Toll-like" "mTOR/p70S6K" "non-silencing" "UCLA" "miR-18a" "19b"
    "polycistron" "responder" "oncomir" "protooncogenes" "oncomiR" "oncomiRs"
    "+10" "Disheveled2" "Ser550/552" "S550/552A" "SB202196" "Chk1/2" "liposome"
    "radioresistant" "pancreatitis" "nucleates" "topology/structure"
    "radioresistance" "2 /2" "μl" "× 10" "p38 MAPK"
    "activation/phosphorylation" "mesenchymal-like" "nTTCn" "nGAAn" "TFSearch"
    "EMT-like" "MCF-7/HER2" "WB" "factor-1" "HER2 +" "Conditional Rb"
    "rapalogs" "22/23" "49/51" "13q" "conditional Rb" "non-catalytic subunit"
    "15/16" "Rb/p53" "penetrant" "Germline" "algorithms" "Williams"
    "neuroendocrine" "-9" "JW" "PvD" "JV" "QIAquick" "supernatant" "°C"
    "thermomixer" "1.5-μl" "l" "thiocyanate" "Stockholm" "NATO" "NSABP" "Perez"
    "exome" "Loi" "TEAM" "Buttita" "Barbareschi" "Buttitta" "p-p70S6K"
    "hotspots" "Sequenom" "hotspot" "≥ 10%" "clearer"
    "-dibenzylquinazoline-2,4-diamine" "DBeQ" "CRPCs" "mechanism/s" "co-IP/IB"
    "oligo" "luc" "psPSA-" "psPSA" "RWPE" "Gleason" "EpRE" "Oxidases"
    "oxidases" "CRPC" "Co-IP" "co-IP" "non-tumorigenic" "type 2A"
    "two publicly available breast cancer datasets"
    "no publicly available datasets" "datasets" "immunoglobulin" "ΔLIM2-3"
    "ther" "1/2" "7–9" "Co-transfection" "1–3" "co-precipitation"
    "co-precipitate" "ΔLIM1-3" "Hirschsprung’s" "and 2B" "MEN" "neoplasias"
    "Hirschsprung" "InsR" "TKB" "RETMENA" "RETMEN2A"
    "non-receptor tyrosine kinases" "Huang" "aneuploidy" "iv" "Shield 1"
    "ProteoTuner" "pME18Neo/Flag-IRES-SCAT3.1" "pME18Neo/Flag-Vpr-IRES-SCAT3.1"
    "Flag-IRES-SCAT3.1" "Flag-Vpr-IRES-SCAT3.1" "Venus" "30/120" "1/110"
    "SCAT 3.1" "*7" "*6" "*4" "*3" "G0/G1" "ZsGreen1" "Flag-Vpr-IRES-ZsGreen1"
    "Clontech" "Adeno" "pAdeno" "*8" "*5" "LCV110" "Olympus" "pME18Neo"
    "Alexa594" "Hoechst" "Shield1" "CELAVIEW" "SCAT3.1" "ECFP" "cyan"
    "hGeminin" "mVenus" "Sakaue" "S/G2/M" "Azami" "Kusabira" "HeLa/Fucci"
    "Fucci" "Vieira" "Jacotot" "G1/S" "herniations" "LTR" "HeLa/Fucci2"
    "Fucci2" "the fluorescent ubiquitination-based cell cycle indicator2"
    "indicator2" "anti-cleaved" "#4" "/G1" "anti-Flag" "Hoshino" "eRFs"
    "proteomes" "pEGFP-C2-" "pEGFP" "PQGKRMGRGAPVEPSR" "chosen" "GSPT2/18s"
    "Sequest" "NCBI" "Browser" "Bioworks" "Inc" "Thermo" "Spectrometer" "XL"
    "Obitrap" "AHB" "influnce"
    "eukaryotic peptide chain release factor GTP-binding subunit 3b"
    "subunit 3b" "rRNA" "WCX" "aime" "sequelae" "= 0.055"
    "Methodology/Principal" "steriod" "immunoassays" "musculature" "Auyeung"
    "and 2D:4D" "hyperestrogenism" "wich" "Huhtamieni" "lenght"
    "using less specific commercial immunoassay" "immunoassay" "Bogaert"
    "Crabbe" "setpoint" "Folland" "Janssen" "antropometry" "2D:4D" "−0.04±0.01"
    "LC-MS/MS" "Bonferroni" "rs5919392" "rs5965433" "−0.08±0.04" "±0.06"
    "quadriceps" "kg/m 2" "kg" "polymorphisms (SNP)" "AIS" "Polymorphisms" "FE"
    "pQCT" "CSA" "DXA" "GGNn" "CAGn" "= 0.01" "p = 0.0002" "p = 0.03" "PSCAN"
    "DKO1" "DKS" "Keller" "∼1.8" "pBabepuro" "5q13.3" "ase" "newest" "America"
    "DKO4" "+ 5" "1×10" "non-target" "DSCC1-" "DSCC" "McLellan" "Rb" "+5"
    "5.6±2.9%" "0.7±0.3%" "#8" "#3" "DSCC1#1" "shDSCC1#2scr" "shDSCC1#1scr"
    "shEGFP" "#2" "#1" "shDSCC1" "GEOD-23878" "E-MEXP-3715" "GEOD" "mut1+2"
    "pDSCC1-10/+109" "STTTS" "+70" "+10/+109" "TTTSSCGC" "TFSEARCH" "Genome"
    "adjacent non-cancerous colonic mucosa" "non-cancerous" "anti-apoptotic"
    "Dcc1p" "Ctf8p" "Ctf18p" "non-cancerous colonic mucosa" "CIMP"
    "microsatellite" "silico" "their matched noncancerous colonic mucosa"
    "≥9.17 µ" "≥13.20 µ" "≥15.78 µ" "≥4.4" "geder"
    "indirect bilirubin level ≥9.17 µmol/L" "U/L" "mol/L" "mg/L" "mmol/L"
    "Whitney" "only homozygous GG" "Weinberg" "kilobases" "chromatid"
    "Homozygous GG" "P  = 0.001" "= 0.002" "Greek" "incident/consecutive"
    "Dutch" "rs3834129" "Netherlands" "Czech" "England" "USA" "Spain"
    "penetrance" "95% CI " "Ruzzo" "Goekkurt" "HJ" "Shim" "399 Gln" "5-year"
    "2-year" "A/A" "G/A" "Asians" "0.74–1.90" "0.99–1.71" "0.94–1.46"
    "Arg399Gln" "Polymorphism" "399Gln" "XRCC1 Arg194Trp" "Arg194Trp" "194Trp"
    "Ji" "Potential confounders" "confounders" "Genotypes" "English" "duplexes"
    "HRs" "Hayden" "CNKI" "MEDLINE" "= 0.04" "p = 0.001" "95%CI" "G/" "95%CIs"
    "C→G" "SNU688" "TargetScan" "subdiploid" "≥IB" "non-protein" "Gastrectomy"
    "miRNA-135a" "= 0.014" "12q13.13" "rs7705526" "GWAS  "
    "previously reported SNPs" "SNPs" "YRI" "Yoruba" "CEU" "JPT" "eigenvectors"
    "Hapmap" "PCA" "GWAS" "Soerensen" "drawn" "at 5p15.33" "congenita" "TTAGGG"
    "T/S" "rs17653722" "rs2736100" "5p15.33" "×10" "archival biopsies" "AFA"
    "French" "Aebersold" "Seiwert" "T3/T4" "N1-3" "30/143" "57/143" "formol"
    "monosomy" "PolyPhen" "SIFT" "Exons" "chemoradiotherapy (CRT)" "AJCC"
    "the tonsillar fossae" "fossae" "≥6" "HNSCC" "7q31"
    "HPV-positive and HPV-negative OPC's" "OPC" "≥10%" "Sanger" "Pre" "OPSCC"
    "non-metastatic" "vaccinology" "non-progressors" "non-functional"
    "dileucine" "diserine" "DSGxxS" "I9M" "McNatt" "LTNP 3" "A15V"
    "potential enhancer" "transmitted/founder" "LTNP 1" "invariant" "LTNP 4"
    "co-localisation" "IEDB" "CD8+" "A14L" "II43,46SL" "frameshift"
    "antagonise" "co-immunoprecipitions" "SGxx" "A19E" "ExxLV" "ExxxLV" "helix"
    "helices" "DSGNES" "alpha-helix" "LTNP1v4_1_67" "NP2v11_2_1" "RP2v16_2_87"
    "_67" "LTNP1v4_1" "_2_1" "_87" "_2" "Alamos" "_1" "offs" "genomes"
    "a premature stop codon" "_4" "_5" "naïve" "LTNPs" "progressors (NP)"
    "progressors (RP)" "non-progressors (LTNP)" "progressors" "LTNP"
    "timepoint" "co-infected" "the virological synapse" "retroviruses" "clades"
    "orthologue" "SIVcpz" "haplotype" "clade" "3 p  "
    "a specific PAI-1 allelic polymorphism" "anti-mitogenic" "proto"
    "-deoxyuridine" "deoxyuridine" "hrs" "Alexa" "UMUC-14" "/S" "tixplaxtinin"
    "KD-" "KD" "G 0 /G 1 -phase" "/G 1" "zymography" "UMUC" "NMIBC" "MIBC"
    "urothelia" "G0/G1-phase" "p = 0.0002" "BALB/c" "g/mL" "postmortem"
    "Alzheimer’s" "Alzheimer" "mEPSC" "olf" "the synaptic AKAPs"
    "synaptic AKAPs" "dendritic shaft AKAPs" "adenylate" "Δ1-158" "thinner"
    "+/R1441C" "+/RC" "18-month-old" "R1441C/R1441C"
    "significantly more pS845 GluR1" "synapses" "pS845 GluR1" "Δ2–5–MTBD"
    "PKARIIβ-" "PKARII" "MTDB" "Δ2–5" "forebrain" "co-exists" "PKARII β"
    "co-IPed" "homogenates" "PKACα" "pCREB" "LRKK2" "FSK" "pre-" "mEPSCs"
    "littermate" "AKAPs" "striosomes" "midbrain" "missense" "PKARIIβ" "IIβ"
    "–5–" "co-localization" "Co-immunoprecipitation" "2  +" "2 +"
    "Nrf1involved" "Cederbaum" "MT-1 expression" "MRE’s" "Nrfs"
    "oxidative stressors" "stressors" "Kwong" "Chorley" "CNS" "MTF-1" "pGCSLuc"
    "p150Luc" "Luc" "and/Nrf2" "GOEAST" "PAINT" "mannosyl" "oxygenase-1" "MRE"
    "transcriptome" "GCS" "glutamylcysteine" "sulfhydryl" "MREs" "Nrf" "1 +"
    "Kamal" "Perhaps" "simplest" "C-domain" "Mollapour" "lysis" "YPEG"
    "phenocopy" "Non-SUMOylatable" "anti-His 6" "yHsp90His 6" "non-SUMOylated"
    "two mutated protomers" "the mutated protomer" "/WT" "/K178R" "imidazole"
    "protomers" "Kd" "yAha1" "non-SUMOylatable" "hHsp90α" "pulldowns"
    "N-domains" "Ni" "hexahistidine" "oxygens" "carbonyl" "x" "yHsp90" "Hsp90α"
    "co-chaperones" "iii" "ii" "protomer" "co-chaperone" "N-domain"
    "co-transfected" "RLAF" "Rpd3S" "H4K16" "weak exons" "oncomine" "Spearman"
    "p-IWS1-" "Levene" "anti-phospho-IWS1" "21/24" "shIWS1/mutant" "shIWS1/wt"
    "DMEM" "non-directional" "IIIb/IIIc" "polypyrimidine" "H3K36" "perhaps"
    "shControl" "shSetD" "EV" "-IIIc" "IWS1S720A/T721A" "primarily FGFR-2 IIIc"
    "shIWS1" "shIWS" "Venn" "StageTip" "phosphopeptides" "phosphosubstrate"
    "Ser720/Thr721" "IIIc" "proteome" "trimethyl" "Cerevisciae"
    "phosphoproteome" "phosphoproteomes" "CD-associated" "myofibroblasts"
    "mucosa" "transducers" "re-operation" "genotypes" "=0.018" "=0.001"
    "=0.024" "=0.022" "CD-related" "polymorphisms" "unmet" "Crohn’s"
    "Canadians" "UC" "Americans" "Meier" "Covariates" "Massachusetts"
    "80% Crohn’s" "Crohn" "Nur" "contradistinct" "desirable anti-cancer"
    "anti-cancer" "covariates" "histology" "univariates" "Immunohistochemistry"
    "immunohistochemisty" "p " "non-tumor" "Horst" "der" "boluses" "NCI" "Cmax"
    "transwell" "Pfizer" "Wyeth" "Mahajan" "Singaporean"
    "non-receptor tyrosine kinase" "GAGAGAGAA" "nt" "6p21.3" "pseudogenes"
    "the soft agar" "agar" "TGAGAAATCG" "∼1.2 " "non-specific" "ATGAATGT"
    "∼1.8 " "codon (TAA)" "hESC" "LET1-1" "5p" "and 3p" "miR-34a-3p" "Nts"
    "miR-34a-5p" "p" "ΔNp63" "miR-34c" "non-transformed" "c" "b" "hESCs" "3p"
    "g/" "stem-like" "PEP-3" "YGRKKRRQRRR" "immunocytochemistry" "stemness"
    "Yu" "Ires" "multilineage" "stem-cell-like" "hemichannels" "Albor" "IKKs"
    "Luciani" "Allografts" "EACs" "cisplatin-resistant (CR-EAC) Ehrlich's"
    "Ehrlich" "quencher" "transfectants" "co-precipitated" "p38MAPK"
    "p65NF κ B" "∼60%" "chemoresistant" "switchover" "transducer" "allograft"
    "chemoresistance" "a generic GJ blocker (CBX)" "blocker (CBX)" "GJICs"
    "pyridinecarbonitrile" "dichlorophenyl" "CHIR" "≤0.05" "neurospheres"
    "blocker" "TUNEL" "-bromo-2-deoxyuridine" "shCx43" "≤0.01" "Tuj1" "MOI"
    "MOIs" "co-transfection" "hCx43" "Multipotent hNPCs" "neurosphere" "Naus"
    "Matsuuchi" "adhesiveness" "Giepmans" "hNPC"
    "this protein fetal cortex-derived hNPCs" "hNPCs" "Gs" "Ts" "∼290%"
    "renilla" "IRES" "pulldown" "UV" "doxo" "Doxo" "g/ml" "-CYYYYCYYYY"
    "CYYYYCYYYY" "UCA1-1" "hnRP" "biotin" "CUDR" "suppresser" "PANDA"
    "non-coding" "UCA" "UCA1" "antitumour" "the intestinal subtype" "Laurén"
    "Japanese" "HER2 /CEP17" "co-amplification" "Co-amplification"
    "non-amplified" "=0.0002" "=0.0073" "histological subtype" "subtype" "pN"
    "Korean/Chinese" "UK/Chinese/Korean" "Chinese/Korean" "UK/Korean"
    "UK/Chinese" "endometrium" "Korean" "Korea" "=0.03" "taxanes+trastuzumab"
    "GeparQuinto" "NSBAP" "NeoALTTO" "lapaninib" "lymphopenia" "leucopenia"
    "HER2+" "=0.0112" "=0.2873" "=0.014" "=7.5" "=3.6" "Univariate" "ER+" "ORR"
    "Payne" "=0.0065" "LVEF" "febrile neutropenia" "neutropenia"
    "one grade 3 supraventricular arrhythmia" "estomatitis" "arrhythmia"
    "CONSORT" "ER+PR−" "PR+" "and 3+" "German" "Neoadjuvant" "Multivariate"
    "axilla" "oestrogen" "–9" "95% CIs" "95% CI" "EED-CBX-" "CBXs" "dataset"
    "uH2A" "MYT" "shRNA" "mono-nucleosomes" "Cruz" "EC50" "AlphaScreen"
    "potential co-localization" "anti-FLAG" "aa429-441" "aa186-304" "XEN"
    "endoderm" "mESCs" "Millipore" "H3K27" "H2AK119" "epigenome" "ZL" "XZ" "CW"
    "JZ" "non-small-cell" "Meyer" "Kaplan" "Capuzzo" "disomy" "trisomy"
    "hyperaldosteronism" "myxoid" "monotherapy" "Weiss" "polysomy" "multi"
    "African" "CC" "GG" "95% CI " "provid" "the Egger’s" "Begg’s" "Begg" "PCC"
    "SCHNN" "homozygote" "G/C " "G/C" "95%CI " "G/G " "0.43-1.59" "HWE"
    "genotype" "polymorphism(RFLP)" "RFLP" "Australia" "American" "Asian"
    "15q15.1" "genome" "polymorphism (SNP)" "C/C" "G/G" "ORs" "CBM" "135G/C"
    "polymorphism" "fluoropyrimidine-based preoperative CCRT" "germline"
    "capecitabine/RT" "Boskos" "eniluracil" "dihydrofluorouracil"
    "diphosphate (FUDP)" "monophosphate (FUMP)" "FUDP" "diphosphate" "FUMP"
    "triphosphate (FUTP)" "FUTP" "fluorouridine" "FdUTP" "triphosphate"
    "fluoro" "FdUMP" "monophosphate" "Caucasians" "Berho" "Taiwanese" "Gy"
    "García" "newer" "clinicians" "unnecessary toxicities" "univariate" "0-1"
    "pre" "WEnCA" "Medline" "phosphoribosyl" "broader" "ELISA" "poorer"
    "priori" "DFS" "preoperative CCRT" "Preoperative CCRT" "sphincter"
    "concurrent chemoradiotherapy (CCRT)" "neoadjuvant" "responders" "ORPT"
    "fluoropyrimidine-based concurrent chemoradiotherapy (CCRT)" "CCRT"
    "chemoradiotherapy" "Wnt/" "oligos" "hr" "Affymetrix" "Zimmermann"
    "state-of-the-art" "co-aggregation" "mEGFP" "13.0±6.6%" "73.5±5.8%" "siLAT"
    "37.6±14.8%" "36.9±13.2%" "siFyn" "89.4±10.1%" "siNeg" "siLck"
    "co-immobilization" "TIRF" "13.4±1.6%" "1.6±0.4%" "34.4±16.3%" "72.0±16.6%"
    "EYFP" "algorithm" "TCR/CD3-" "TCR/CD3" "co-patterning" "coworkers"
    "codons" "dysplasia" "IHC" "the gastric fundus" "2+" "columnar epithelium"
    "such cases squamous epithelium" "Barrett" "epithelium" "intra"
    "the pyloric antrum" "mucinous/signet" "as 2+" "tzus" "Shih" "plastica"
    "linitis" "pyloric antrum" "gastric fundus" "antrum" "fundus" "cardia"
    "Lauren’s" "Lauren" "mortem" "biopsies" "proven" "1+"
    "immunohistochemistry" "3+" "GEJ" "gastro" "codon" "oncology"
    "biomolecules" "vivo" "cardiocytes" "atrial pathophysiology"
    "pathophysiology" "P2X7R" "undergone" "atria" "myocardium" "Smad 2/3"
    "HAFs" "HAF" "bi" "greater" "trichrome" "Masson" "carboxyl" "et"
    "invaginations" "anti-fibrotic" "I/III" "siRNA" "atrium" "organelles" "KPS"
    "ones" "co-morbidities" "RT/TMZ" "endpoints" "multivariate"
    "A quantitative readout" "readout" "even mild toxicities" "toxicities"
    "REMARK" "Egger’s" "Egger" "subset" "estimations" "frozen" "adducts"
    "alkyl" "O6-methylguanine-DNA methyltransferase" "0.90–1.44" "0.77–1.21"
    "younger" "Cochrane" "COTL1 mutant" "COTL1mutant" "undergoes"
    "activation/inactivation" "co-stimulation" "melanogaster" "co-depletion"
    "transfectant" "timeframe" "nearly 3-times" "coverslip" "coverslips" "CMAC"
    "suppression/re-expression" "ABM" "utant" "ctin-" "ctin" "ortholog"
    "TCR+CD28" "retrovirus" "JREM" "NKAP" "discoideum" "Dictyostelium"
    "twinfilins" "synapse (IS)" "coactosin-like" "synapse" "re-express"
    "introns" "+1331" "+640/+882" "exons" "Profiler" "bp" "MethPrimer"
    "European" "EMBOSS" "OA" "pC/EBPβ" "monocyte/macrophage" "C/EBPβ/C/EBPδ"
    "dinucleotides" "RNAPII" "intron" "C/EBPδ" "re-expression" "enhancer"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-11701-12000*
  '(("Epac and Rap-1" . SPARSER::COLLECTION) ("p24-gag" . SPARSER::COLLECTION)
    ("Gag/Gag-Pol" . SPARSER::COLLECTION)
    ("Gag and Gag/Pol polyprotein" . SPARSER::COLLECTION)
    ("Gag/Pol" . SPARSER::COLLECTION) ("Gag and Env" . SPARSER::COLLECTION)
    ("proviral DNA" . SPARSER::DNA) ("ERK and PI3K" . SPARSER::COLLECTION)
    ("Epac/Rap1" . SPARSER::COLLECTION)
    ("Rho family and phospholipases" . SPARSER::COLLECTION)
    ("phospholipases" . SPARSER::PROTEIN)
    ("an inactive guanosine diphosphate (GDP)-bound state and an active guanosine triphosphate (GTP)-bound state"
     . SPARSER::COLLECTION)
    ("Rap1 and Rap2" . SPARSER::COLLECTION)
    ("PKA or Epac" . SPARSER::COLLECTION)
    ("PKA and cAMP-gated ion channels" . SPARSER::COLLECTION)
    ("CD4, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("COX and/or PG" . SPARSER::COLLECTION)
    ("COX and PGs" . SPARSER::COLLECTION)
    ("IL-4 and IL-5" . SPARSER::COLLECTION)
    ("several cellular effectors and soluble factors" . SPARSER::COLLECTION)
    ("/PKB/Akt" . SPARSER::COLLECTION) ("phosphatidyl" . SPARSER::MOLECULE)
    ("p-CREB" . SPARSER::COLLECTION)
    ("PKA or Epac, 6-Bnz-cAMP and 8-pCPT-2-" . SPARSER::COLLECTION)
    ("Epac, 6-Bnz-cAMP and 8-pCPT-2-" . SPARSER::COLLECTION)
    ("Epac and PKA" . SPARSER::COLLECTION)
    ("EP2 and possibly EP4 receptors" . SPARSER::COLLECTION)
    ("possibly EP4 receptors" . SPARSER::RECEPTOR)
    ("Misoprostol and butaprost" . SPARSER::COLLECTION)
    ("Misoprostol" . SPARSER::DRUG)
    ("a preferential EP3/EP2 agonist" . SPARSER::AGONIST)
    ("EP1/EP3" . SPARSER::COLLECTION) ("EP3/EP2" . SPARSER::COLLECTION)
    ("sulprostone" . SPARSER::DRUG) ("misoprostol" . SPARSER::DRUG)
    ("butaprost" . SPARSER::DRUG)
    ("viral CA p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD4 and CCR5" . SPARSER::COLLECTION) ("HXB" . SPARSER::PROTEIN)
    ("pNL" . SPARSER::PROTEIN) ("c/EBP" . SPARSER::COLLECTION)
    ("the cortical actin" . SPARSER::PROTEIN)
    ("CD4/CXCR4" . SPARSER::COLLECTION) ("VSV-Luc" . SPARSER::COLLECTION)
    ("integrase" . SPARSER::PROTEIN)
    ("the attached viral proteins" . SPARSER::PROTEIN)
    ("enzyme (RT)" . SPARSER::PROTEIN)
    ("CD4, CXCR4 and CCR5" . SPARSER::COLLECTION)
    ("human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("integrase activity, or -LTR" . SPARSER::COLLECTION)
    ("viral protein" . SPARSER::PROTEIN)
    ("the treated and untreated PBL" . SPARSER::PROTEIN)
    ("dpi" . SPARSER::PROTEIN) ("PBL" . SPARSER::PROTEIN)
    ("actin or tubulin" . SPARSER::COLLECTION)
    ("cortical actin" . SPARSER::PROTEIN) ("Epac-Rap1" . SPARSER::COLLECTION)
    ("cAMP response element binding protein (CREB)" . SPARSER::PROTEIN)
    ("the classic downstream target" . SPARSER::TARGET-PROTEIN)
    ("EP2 and EP4" . SPARSER::COLLECTION)
    ("diverse cytokines" . SPARSER::PROTEIN)
    ("inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)"
     . SPARSER::COLLECTION)
    ("both cellular effectors and soluble factors" . SPARSER::COLLECTION)
    ("EP2/EP4" . SPARSER::COLLECTION) ("CXCR4 and CCR5" . SPARSER::COLLECTION)
    ("PGE 2 and the signal transduction pathways" . SPARSER::COLLECTION)
    ("possible new targets" . SPARSER::TARGET-PROTEIN)
    ("Gag-Pol" . SPARSER::PROTEIN) ("F- actin" . SPARSER::BIO-COMPLEX)
    ("Rap1A" . SPARSER::PROTEIN) ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("Rap2" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("EP3" . SPARSER::PROTEIN)
    ("Agp24" . SPARSER::PROTEIN) ("integrase activity" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("PC5" . SPARSER::PROTEIN)
    ("PC7" . SPARSER::PROTEIN) ("RD1" . SPARSER::PROTEIN)
    ("Rap-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prostaglandin E 2" . SPARSER::MOLECULE) ("KT5720" . SPARSER::DRUG)
    ("cytochalasin D" . SPARSER::DRUG)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("MYC or NOTCH/IKZF1" . SPARSER::COLLECTION)
    ("Myc, Runx, Ikzf1, Gfi1, Notch1, and Bmi1" . SPARSER::COLLECTION)
    ("a haplo-insufficient tumour suppressor" . SPARSER::SUPPRESSOR)
    ("DN/CD8ISP" . SPARSER::COLLECTION) ("ISP" . SPARSER::PROTEIN)
    ("Notch1 or Gfi1" . SPARSER::COLLECTION) ("-Myc" . SPARSER::COLLECTION)
    ("CD2-Runx2/MYC" . SPARSER::COLLECTION) ("Mmtv" . SPARSER::PROTEIN)
    ("Myc and Runx" . SPARSER::COLLECTION)
    ("available target genes" . SPARSER::GENE)
    ("telomerase, p53 and ATM" . SPARSER::COLLECTION)
    ("‘TKO’" . SPARSER::PROTEIN) ("TKO" . SPARSER::PROTEIN)
    ("Gfi1 and Bmi1" . SPARSER::COLLECTION)
    ("only one other target gene" . SPARSER::PROTEIN)
    ("the Runx genes ( Runx2 and Runx3 ) and Myc family" . SPARSER::COLLECTION)
    ("Runx2 and Runx3" . SPARSER::COLLECTION)
    ("a tiny fraction" . SPARSER::COMPONENT)
    ("Runx2 or Runx3" . SPARSER::COLLECTION) ("Runx3" . SPARSER::PROTEIN)
    ("Southern blot" . SPARSER::PROTEIN) ("unique RISs" . SPARSER::PROTEIN)
    ("parental CD2- MYC" . SPARSER::PROTEIN) ("-Runx2" . SPARSER::COLLECTION)
    ("Runx2 and Ikzf1" . SPARSER::COLLECTION)
    ("The respective chemokine genes" . SPARSER::GENE)
    ("Ccr7 and Ccr9" . SPARSER::COLLECTION) ("Ccl25" . SPARSER::PROTEIN)
    ("Ccl" . SPARSER::DRUG) ("Jdp2" . SPARSER::PROTEIN)
    ("Ccnd1" . SPARSER::PROTEIN) ("Runx2/MYC" . SPARSER::COLLECTION)
    ("chemokine-receptor" . SPARSER::COLLECTION)
    ("a placental poly-U endonuclease" . SPARSER::PROTEIN)
    ("Tprbk" . SPARSER::PROTEIN)
    ("an atypical nuclear myosin" . SPARSER::PROTEIN-FAMILY)
    ("MYC and Runx2" . SPARSER::COLLECTION) ("CD2-Runx2" . SPARSER::COLLECTION)
    ("Gfi1 and Notch1" . SPARSER::COLLECTION)
    ("Mycn and Runx" . SPARSER::COLLECTION) ("Myc/Pvt1" . SPARSER::COLLECTION)
    ("Mycn" . SPARSER::PROTEIN)
    ("the most discordant examples" . SPARSER::EXAMPLE)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("Ikzf3, Mad1l1, Als2, Ppp1r16b, Prex1, Ttc28 and Ptprc"
     . SPARSER::COLLECTION)
    ("Mad1l1" . SPARSER::PROTEIN) ("Ptprc" . SPARSER::PROTEIN)
    ("Als" . SPARSER::PROTEIN) ("the most frequent CIS" . SPARSER::PROTEIN)
    ("Rasgrp1" . SPARSER::PROTEIN) ("Pik3cd" . SPARSER::PROTEIN)
    ("Ccnd3" . SPARSER::PROTEIN) ("Rasgrp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pik" . SPARSER::BIO-COMPLEX) ("Myb" . SPARSER::PROTEIN)
    ("19,923 unique RIS" . SPARSER::PROTEIN) ("shot" . SPARSER::PROTEIN)
    ("RIS" . SPARSER::PROTEIN) ("RISs" . SPARSER::PROTEIN)
    ("LCR" . SPARSER::PROTEIN) ("MYC and CD2-" . SPARSER::COLLECTION)
    ("a surprisingly large fraction" . SPARSER::COMPONENT)
    ("shotgun" . SPARSER::PROTEIN) ("MYC/Runx2" . SPARSER::COLLECTION)
    ("Myc and Runx2" . SPARSER::COLLECTION)
    ("oncogene or mutant" . SPARSER::COLLECTION)
    ("the Myc oncogene and the p53 tumour suppressor" . SPARSER::COLLECTION)
    ("overcoming p53" . SPARSER::PROTEIN) ("Ikzf1" . SPARSER::PROTEIN)
    ("CIS" . SPARSER::PROTEIN) ("cytokine and T-cell" . SPARSER::COLLECTION)
    ("CD2-" . SPARSER::PROTEIN) ("RIM/DS" . SPARSER::COLLECTION)
    ("RIM" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("Gpr132" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("Ccl19" . SPARSER::PROTEIN) ("Ccl21a" . SPARSER::PROTEIN)
    ("Xrra1" . SPARSER::PROTEIN) ("Pp11" . SPARSER::PROTEIN)
    ("Myo16" . SPARSER::PROTEIN) ("Otx2" . SPARSER::PROTEIN)
    ("Pvt1" . SPARSER::PROTEIN) ("Ttc28" . SPARSER::PROTEIN)
    ("Prex1" . SPARSER::PROTEIN) ("Ppp1r16b" . SPARSER::PROTEIN)
    ("Ikzf3" . SPARSER::PROTEIN) ("Pik3r" . SPARSER::PROTEIN-FAMILY)
    ("Ahi1" . SPARSER::PROTEIN) ("Pim-1" . SPARSER::PROTEIN)
    ("Pim1" . SPARSER::PROTEIN) ("Gfi1" . SPARSER::PROTEIN)
    ("Ccr7" . SPARSER::PROTEIN) ("TRIM19/PML" . SPARSER::COLLECTION)
    ("endoribonuclease" . SPARSER::PROTEIN)
    ("IRF3, STAT1 and IFN" . SPARSER::COLLECTION)
    ("PMLIV and PMLIII" . SPARSER::COLLECTION)
    ("the viral polymerase 3D" . SPARSER::PROTEIN-FAMILY)
    ("VSV-" . SPARSER::PROTEIN) ("PMLIV" . SPARSER::PROTEIN)
    ("viral mRNA" . SPARSER::RNA) ("PML and PML" . SPARSER::COLLECTION)
    ("all PML isoforms or the specific depletion of PMLIV ( xref )"
     . SPARSER::COLLECTION)
    ("VSV or SeV" . SPARSER::COLLECTION)
    ("the RIPA insoluble fraction" . SPARSER::COMPONENT)
    ("the RIPA soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("Pin1 and PML" . SPARSER::COLLECTION)
    ("STAT1 or IRF3" . SPARSER::COLLECTION) ("post-VSV" . SPARSER::COLLECTION)
    ("IFN-β or S PMLIV supernatant ( xref , right panel)"
     . SPARSER::COLLECTION)
    ("IFN-β and S PMLIV supernatant" . SPARSER::COLLECTION)
    ("STAT1 and PKR" . SPARSER::COLLECTION)
    ("a longer period" . SPARSER::PROTEIN)
    ("the central transcription factor" . SPARSER::PROTEIN)
    ("the only PML isoform" . SPARSER::ISOFORM)
    ("IFN-β, IFN-α, TNF-α or IL8" . SPARSER::COLLECTION)
    ("PML and its SUMOylated forms" . SPARSER::COLLECTION)
    ("PML and viral proteins" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID) ("RNA or DNA" . SPARSER::COLLECTION)
    ("PRRs" . SPARSER::PROTEIN) ("receptor (PRR)" . SPARSER::RECEPTOR)
    ("PRR" . SPARSER::PROTEIN) ("a 2-log" . SPARSER::COLLECTION)
    ("TNF-α and IL-8" . SPARSER::COLLECTION)
    ("IFN-α, IFN-β, TNF-α and IL8" . SPARSER::COLLECTION)
    ("IFN-α, TNF-α or IL8" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("VSV-N mRNA ( xref , left panel) and VSV-L mRNA" . SPARSER::COLLECTION)
    ("Northern blot" . SPARSER::PROTEIN) ("viral step" . SPARSER::PROTEIN)
    ("the same Western blot and their supernatants" . SPARSER::COLLECTION)
    ("PML and VSV" . SPARSER::COLLECTION)
    ("proteins and VSV" . SPARSER::COLLECTION)
    ("B-box, and Coiled-Coil" . SPARSER::COLLECTION)
    ("RBCC/TRIM" . SPARSER::COLLECTION) ("Coil" . SPARSER::PROTEIN)
    ("NB" . SPARSER::PROTEIN) ("/ISG54" . SPARSER::COLLECTION)
    ("Ifit2" . SPARSER::PROTEIN) ("PKR" . SPARSER::PROTEIN)
    ("These viral mRNA" . SPARSER::RNA)
    ("a unique glycoprotein G" . SPARSER::PROTEIN)
    ("5 viral proteins" . SPARSER::PROTEIN)
    ("an antiviral state" . SPARSER::BIO-STATE) ("IFNs" . SPARSER::DRUG)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN) ("VSV" . SPARSER::PROTEIN)
    ("RBCC" . SPARSER::PROTEIN) ("RNA and DNA" . SPARSER::COLLECTION)
    ("PML/TRIM19" . SPARSER::COLLECTION)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PML" . SPARSER::PROTEIN)
    ("TRIM25" . SPARSER::PROTEIN) ("TRIM5α" . SPARSER::PROTEIN)
    ("ORF23" . SPARSER::PROTEIN) ("IRF-3" . SPARSER::PROTEIN)
    ("6–16" . SPARSER::PROTEIN) ("IFNAR1" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("K65" . SPARSER::PROTEIN)
    ("ProMyelocytic Leukemia" . SPARSER::PROTEIN) ("ISG54" . SPARSER::PROTEIN)
    ("ISG20" . SPARSER::PROTEIN)
    ("double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("glycoprotein G" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("TRIM19" . SPARSER::PROTEIN)
    ("kinesin-1 heavy chain (KIF5B) and WD repeat–containing protein 1 (WDR1)"
     . SPARSER::COLLECTION)
    ("CLIP" . SPARSER::PROTEIN) ("SET and MYND" . SPARSER::COLLECTION)
    ("RPL3L, RPL19, RPLP2, and RPS6" . SPARSER::COLLECTION)
    ("SET" . SPARSER::PROTEIN) ("HSPB2 and HSPA5" . SPARSER::COLLECTION)
    ("CAND2, TRIM21, HINT1, and TCEB1" . SPARSER::COLLECTION)
    ("cullin-associated NEDD8-dissociated protein 2" . SPARSER::PROTEIN)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("OCs and/or T2D" . SPARSER::COLLECTION)
    ("CAV1, and protein-glutamine" . SPARSER::COLLECTION)
    ("EMMPRIN" . SPARSER::PROTEIN) ("BSG" . SPARSER::PROTEIN)
    ("IRS1 and several mitochondrial proteins" . SPARSER::COLLECTION)
    ("NDUFS8, NDUFV1, NDUFA2, NDUFA10, NDUFB7, and NDUFS6"
     . SPARSER::COLLECTION)
    ("UQCRB" . SPARSER::PROTEIN) ("LC, OC and T2D" . SPARSER::COLLECTION)
    ("PP2Ac/IRS1" . SPARSER::COLLECTION) ("S6K1 and Akt" . SPARSER::COLLECTION)
    ("abnormal IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classic signaling proteins" . SPARSER::PROTEIN)
    ("red and cyan" . SPARSER::COLLECTION) ("ESI" . SPARSER::PROTEIN)
    ("insulin receptor and insulin-like growth factor" . SPARSER::COLLECTION)
    ("OCs and T2D" . SPARSER::COLLECTION) ("OCs" . SPARSER::PROTEIN)
    ("WDR1" . SPARSER::PROTEIN) ("kinesin-1 heavy chain" . SPARSER::PROTEIN)
    ("CLASP2" . SPARSER::PROTEIN) ("IPO5" . SPARSER::PROTEIN)
    ("importin-5" . SPARSER::PROTEIN) ("RPLP2" . SPARSER::PROTEIN)
    ("RPL19" . SPARSER::PROTEIN) ("RPL3L" . SPARSER::PROTEIN)
    ("EIF3B" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 3 subunit B" . SPARSER::PROTEIN)
    ("SMYD1" . SPARSER::PROTEIN) ("TRIM21" . SPARSER::PROTEIN)
    ("HSPA5" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("HSPB2" . SPARSER::PROTEIN) ("β-2" . SPARSER::PROTEIN)
    ("TCEB1" . SPARSER::PROTEIN)
    ("transcription elongation factor B polypeptide 1" . SPARSER::PROTEIN)
    ("HINT1" . SPARSER::PROTEIN)
    ("E3 ubiquitin-protein ligase TRIM21" . SPARSER::PROTEIN)
    ("CAND2" . SPARSER::PROTEIN) ("NEDD8" . SPARSER::PROTEIN)
    ("TGM2" . SPARSER::PROTEIN)
    ("3-hydroxyisobutyrate dehydrogenase" . SPARSER::PROTEIN)
    ("COX6C" . SPARSER::PROTEIN) ("NDUFS6" . SPARSER::PROTEIN)
    ("NDUFB7" . SPARSER::PROTEIN) ("NDUFA10" . SPARSER::PROTEIN)
    ("NDUFA2" . SPARSER::PROTEIN) ("NDUFV1" . SPARSER::PROTEIN)
    ("NDUFS8" . SPARSER::PROTEIN) ("Complex I" . SPARSER::PROTEIN)
    ("HbA 1" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("PPP2CA" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("p85β" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("growth factor receptor-binding protein" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("detailed biomarker" . SPARSER::MOLECULE)
    ("tolerable drug" . SPARSER::DRUG) ("p-FOXO3A" . SPARSER::COLLECTION)
    ("Stat-3, p38 MAPK and MEK1" . SPARSER::COLLECTION)
    ("p-SMAD3" . SPARSER::COLLECTION) ("p-STAT6" . SPARSER::COLLECTION)
    ("KIT, FLT3, or RAS" . SPARSER::COLLECTION)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("pharmacologic target" . SPARSER::TARGET-PROTEIN)
    ("Bcl-2 ( P =0.036), Smad3 ( P =0.028), HER2 ( P =0.064), pY705 Stat-3 ( P =0.033), p38 MAPK ( P =0.039) and MEK1 ( P =0.01)"
     . SPARSER::COLLECTION)
    ("downstream targets or other proteins" . SPARSER::COLLECTION)
    ("pS6 and p4EBP1" . SPARSER::COLLECTION)
    ("fludarabine and cytarabine" . SPARSER::COLLECTION)
    ("fludarabine" . SPARSER::DRUG) ("clofarabine" . SPARSER::DRUG)
    ("antecedent chronic myelomonocytic leukemia" . SPARSER::PROTEIN)
    ("normal-karyotype secondary AML" . SPARSER::PROTEIN)
    ("FLT3, KIT or RAS" . SPARSER::COLLECTION)
    ("only 1 CRp" . SPARSER::PROTEIN) ("CRp" . SPARSER::PROTEIN)
    ("MV" . SPARSER::PROTEIN) ("the drug’s" . SPARSER::DRUG)
    ("3 primary AML" . SPARSER::PROTEIN)
    ("PRAS40 and the mTOR" . SPARSER::COLLECTION)
    ("S6 kinase (at Ser240) and 4EBP1 (Thr37/45)" . SPARSER::COLLECTION)
    ("a rational drug target" . SPARSER::TARGET-PROTEIN)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("primary AML" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("Stat-3" . SPARSER::PROTEIN) ("THP1" . SPARSER::PROTEIN)
    ("pS21" . SPARSER::PROTEIN) ("Prof" . SPARSER::PROTEIN)
    ("both common and rare forms" . SPARSER::FORM)
    ("functional SMAD3" . SPARSER::PROTEIN)
    ("patient A (a male born in 1979) both demonstrated AEI"
     . SPARSER::PROTEIN)
    ("Quad" . SPARSER::DRUG) ("either allelic form" . SPARSER::FORM)
    ("TT and CC haplotypes" . SPARSER::COLLECTION)
    ("both allelic forms" . SPARSER::FORM) ("AEI" . SPARSER::PROTEIN)
    ("AOS" . SPARSER::PROTEIN) ("OA risk alleles" . SPARSER::ALLELE)
    ("GDF5 , ASPN and SMAD3" . SPARSER::COLLECTION) ("ASPN" . SPARSER::PROTEIN)
    ("six 3" . SPARSER::PROTEIN) ("HPRT1" . SPARSER::PROTEIN)
    ("GDF5" . SPARSER::PROTEIN) ("CHIP and MDM2" . SPARSER::COLLECTION)
    ("Atrogin1 and MuRF1" . SPARSER::COLLECTION)
    ("muscle-specific protein ubiquitin ligases" . SPARSER::LIGASE)
    ("c-Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("VEGFa and its receptor" . SPARSER::COLLECTION)
    ("PI3 kinase and other SH2 domain-containing molecules"
     . SPARSER::COLLECTION)
    ("Akt and Erk 1/2" . SPARSER::COLLECTION)
    ("VEGFa and VEGFr2" . SPARSER::COLLECTION)
    ("the E3 ubiquitin ligase and adaptor molecule c-Cbl"
     . SPARSER::COLLECTION)
    ("VEGFa and its downstream receptor" . SPARSER::COLLECTION)
    ("Erk 1/2 and AKT" . SPARSER::COLLECTION)
    ("its corresponding endothelial receptors VEGF receptor (VEGFr)1 and VEGFr2"
     . SPARSER::COLLECTION)
    ("extracellular ligand" . SPARSER::LIGAND)
    ("sham and MI" . SPARSER::COLLECTION) ("VEGFb" . SPARSER::PROTEIN)
    ("VEGFa/b" . SPARSER::COLLECTION) ("VEGFa" . SPARSER::PROTEIN)
    ("shRNA or 70Z-Cbl" . SPARSER::COLLECTION)
    ("ERK 1/2 or JNK" . SPARSER::COLLECTION)
    ("ERK 1/2 and AKT" . SPARSER::COLLECTION)
    ("H 2 O 2 or EGF" . SPARSER::COLLECTION)
    ("c-Cbl KO and WT shams" . SPARSER::COLLECTION)
    ("EGFR or FAK" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and focal adhesion kinase (FAK)"
     . SPARSER::COLLECTION)
    ("shams" . SPARSER::DRUG) ("EGFR and FAK" . SPARSER::COLLECTION)
    ("cardiac c-Cbl" . SPARSER::PROTEIN) ("KO and c-Cbl" . SPARSER::COLLECTION)
    ("CM-Cbl" . SPARSER::COLLECTION) ("CM" . SPARSER::PROTEIN)
    ("c-IAP" . SPARSER::COLLECTION) ("c-Cbl-KO" . SPARSER::COLLECTION)
    ("c-IAP-1" . SPARSER::COLLECTION)
    ("total-Akt or c-IAP1" . SPARSER::COLLECTION)
    ("SH2 or SH3 domain-containing signaling proteins" . SPARSER::COLLECTION)
    ("the cardiac-specific isoform" . SPARSER::PROTEIN)
    ("cTnI" . SPARSER::PROTEIN) ("troponin" . SPARSER::PROTEIN)
    ("AAR" . SPARSER::PROTEIN) ("dP/dt" . SPARSER::COLLECTION)
    ("dt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LAD" . SPARSER::PROTEIN)
    ("hypertrophic agonists" . SPARSER::AGONIST)
    ("hypertrophic agonists norepinephrine" . SPARSER::DRUG)
    ("thrombin, or TNF-α" . SPARSER::COLLECTION)
    ("norepinephrine" . SPARSER::DRUG)
    ("blot and immunohistochemistry" . SPARSER::COLLECTION)
    ("3d and 7d post-natal (-30 ±2% at 1d, -37 ±2% at 3d, and −46 ±3% at 7d compared to E12.5)"
     . SPARSER::COLLECTION)
    ("a ubiquitin-conjugating enzyme (E2) and a ubiquitin ligase (E3)"
     . SPARSER::COLLECTION)
    ("Crk and Grb2" . SPARSER::COLLECTION)
    ("proteins, and Src" . SPARSER::COLLECTION)
    ("ubiquitin-protein" . SPARSER::COLLECTION)
    ("chronic myocardial ischemia" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors and focal adhesion kinase"
     . SPARSER::COLLECTION)
    ("Atrogin1" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("VEGFr2" . SPARSER::PROTEIN) ("IAP-1" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("3d" . SPARSER::PROTEIN-FAMILY)
    ("E19" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an archetypical tumor suppressor gene" . SPARSER::PROTEIN)
    ("autochthonous SCCs" . SPARSER::PROTEIN)
    ("Pten-PI3K-mTOR" . SPARSER::COLLECTION)
    ("Torin and rapamycin" . SPARSER::COLLECTION)
    ("pAKT and Fgf10" . SPARSER::COLLECTION) ("inLe-Cre" . SPARSER::COLLECTION)
    ("Fgfr2 and Fgfr1" . SPARSER::COLLECTION)
    ("a constitutively active chick β-actin promoter" . SPARSER::PROMOTER)
    ("Fgf10-Fgfr2" . SPARSER::COLLECTION) ("UTR-GFP" . SPARSER::COLLECTION)
    ("Torin" . SPARSER::PROTEIN) ("at least five pyrimidines" . SPARSER::DRUG)
    ("pyrimidines" . SPARSER::DRUG)
    ("translational suppressor 4EBP1" . SPARSER::PROTEIN)
    ("Pten-PI3K" . SPARSER::COLLECTION) ("PI3K and FGF" . SPARSER::COLLECTION)
    ("PTEN and FGF10" . SPARSER::COLLECTION)
    ("pAKT, pS6, p4EBP1 and Fgf10" . SPARSER::COLLECTION)
    ("suprabasal media" . SPARSER::PROTEIN)
    ("Fgfs ( Fgf1 , 2 , 7 , and 10) and Fgfrs ( Fgfr1, 2, 3 and 4 )"
     . SPARSER::COLLECTION)
    ("Fgfr1" . SPARSER::PROTEIN) ("Fgf1" . SPARSER::PROTEIN)
    ("Fgfs" . SPARSER::PROTEIN)
    ("Ki67 and phospho-Histone" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("oldLe-Cre" . SPARSER::COLLECTION)
    ("CKO" . SPARSER::PROTEIN) ("flox" . SPARSER::PROTEIN)
    ("Le-Cre" . SPARSER::COLLECTION) ("Pten-mTOR" . SPARSER::COLLECTION)
    ("nearly all mRNAs" . SPARSER::PROTEIN)
    ("AKT or RHEB" . SPARSER::COLLECTION)
    ("PI3K-AKT-mTOR" . SPARSER::COLLECTION) ("Ia" . SPARSER::MOLECULE)
    ("RHEB" . SPARSER::PROTEIN) ("Fgfr2" . SPARSER::PROTEIN)
    ("Fgf10" . SPARSER::PROTEIN) ("Fgf" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::COLLECTION) ("Torin 2" . SPARSER::DRUG)
    ("Keratin 10" . SPARSER::PROTEIN) ("Fgf7" . SPARSER::PROTEIN)
    ("4EBPs" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("GRHL3" . SPARSER::PROTEIN)
    ("extracellular and tyrosine kinase" . SPARSER::COLLECTION)
    ("CD2/CD25" . SPARSER::COLLECTION)
    ("the immunomodulating transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("CD117, CD25, CD2, CD203c, CD63 or CD69" . SPARSER::COLLECTION)
    ("both the KIT K509I and control HuMCs ( xref )" . SPARSER::COLLECTION)
    ("either KIT K509I or KIT D816V ( xref )" . SPARSER::COLLECTION)
    ("GNNK" . SPARSER::AMINO-ACID) ("amino acids (GNNK)" . SPARSER::AMINO-ACID)
    ("Immunoreactive proteins" . SPARSER::PROTEIN) ("puro" . SPARSER::PROTEIN)
    ("IC2" . SPARSER::PROTEIN) ("MOX" . SPARSER::PROTEIN)
    ("Prostaglandin" . SPARSER::PROTEIN) ("hex" . SPARSER::PROTEIN)
    ("CD117-APC" . SPARSER::COLLECTION) ("CD2-PE" . SPARSER::COLLECTION)
    ("XR" . SPARSER::PROTEIN) ("Thin" . SPARSER::PROTEIN)
    ("osmium" . SPARSER::MOLECULE) ("glutaraldehyde" . SPARSER::MOLECULE)
    ("Light and electron" . SPARSER::COLLECTION) ("Light" . SPARSER::PROTEIN)
    ("IL-3 (30 ng/ml, first week only) and IL-6 (100 ng/ml)"
     . SPARSER::COLLECTION)
    ("StemPro complete media" . SPARSER::PROTEIN) ("Tech" . SPARSER::PROTEIN)
    ("Prednisone" . SPARSER::DRUG) ("prednisone" . SPARSER::DRUG)
    ("tryptase" . SPARSER::PROTEIN)
    ("significant ligand and molecular regulation" . SPARSER::COLLECTION)
    ("CD25/CD2" . SPARSER::COLLECTION)
    ("SCF and selective KIT" . SPARSER::COLLECTION)
    ("CD226" . SPARSER::PROTEIN) ("PGD2" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN)
    ("p72 and other possible regulators" . SPARSER::COLLECTION)
    ("other possible regulators" . SPARSER::REGULATOR)
    ("SRp20/SRSF3" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("TRBP" . SPARSER::PROTEIN) ("S94A/5SA" . SPARSER::PROTEIN)
    ("YAP S94A/5SA" . SPARSER::PROTEIN) ("Nf2-" . SPARSER::PROTEIN)
    ("numerous mature miRNAs" . SPARSER::MICRO-RNA)
    ("transgenic YAP S127A (hYAP, xref ) and YAP target genes ( xref )"
     . SPARSER::COLLECTION)
    ("Luc-MYC 3" . SPARSER::COLLECTION)
    ("YAP S94A and YAP S94A/5SA" . SPARSER::COLLECTION)
    ("Numerous mature miRNAs" . SPARSER::MICRO-RNA)
    ("YAP and YAP-target genes CTGF, CYR61 and AMOTL2" . SPARSER::COLLECTION)
    ("CTGF, CYR61 and AMOTL2" . SPARSER::COLLECTION)
    ("NF2/LATS" . SPARSER::COLLECTION)
    ("the shortest mutant" . SPARSER::MUTANT)
    ("recombinant p72 protein ( xref ) and in vitro transcribed pri-miRNAs"
     . SPARSER::COLLECTION)
    ("p72 and pri-miR-21" . SPARSER::COLLECTION)
    ("Global impact" . SPARSER::PROTEIN)
    ("DGCR8, p72 or NF2 and LATS2" . SPARSER::COLLECTION)
    ("Flag-DROSHA" . SPARSER::COLLECTION) ("YAP and TAZ" . SPARSER::COLLECTION)
    ("YAP/p72" . SPARSER::COLLECTION)
    ("cell density-dependent, and nuclear YAP" . SPARSER::PROTEIN)
    ("pre- and mature miR-125b" . SPARSER::COLLECTION)
    ("pri-, pre- and mature miR-125b" . SPARSER::COLLECTION)
    ("pri-" . SPARSER::PROTEIN) ("NF2/LATS2" . SPARSER::COLLECTION)
    ("p72 and YAP" . SPARSER::COLLECTION)
    ("p72 and DROSHA/DGCR8 complex" . SPARSER::COLLECTION)
    ("DROSHA/DGCR8" . SPARSER::COLLECTION)
    ("YAP and p72" . SPARSER::COLLECTION)
    ("the Microprocessor accessory proteins p68 (DDX5) and p72 (DDX17)"
     . SPARSER::COLLECTION)
    ("the Microprocessor accessory proteins p68" . SPARSER::PROTEIN)
    ("DEAD" . SPARSER::PROTEIN)
    ("YAP and DROSHA or DGCR8" . SPARSER::COLLECTION)
    ("YAP S94A and its nuclear-targeted version YAP S94A/5SA"
     . SPARSER::COLLECTION)
    ("Lats1-" . SPARSER::PROTEIN)
    ("NF2, LATS2 or α-catenin" . SPARSER::COLLECTION)
    ("either YAP or a nuclear-targeted phospho-mutant YAP S127A"
     . SPARSER::COLLECTION)
    ("NF2 and LATS2" . SPARSER::COLLECTION)
    ("the upstream kinase LATS2 and other upstream negative regulatory molecules"
     . SPARSER::COLLECTION)
    ("DICER or TRBP2" . SPARSER::COLLECTION) ("Dgcr8" . SPARSER::PROTEIN)
    ("mature miR-125b" . SPARSER::MOLECULE)
    ("DROSHA or DGCR8" . SPARSER::COLLECTION)
    ("DROSHA and DGCR8" . SPARSER::COLLECTION)
    ("adherens junction proteins E-cadherin ( xref ) and α-catenin ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("TRBP2 ( xref ) and XPO5 ( xref )" . SPARSER::COLLECTION)
    ("Dicer ( xref ), TRBP2 ( xref ) and XPO5 ( xref )" . SPARSER::COLLECTION)
    ("mature miRNAs" . SPARSER::MICRO-RNA)
    ("the ribonuclease DICER and the double-stranded RNA-binding protein TRBP2"
     . SPARSER::COLLECTION)
    ("DICER" . SPARSER::PROTEIN) ("NF90-NF45" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN) ("Musashi" . SPARSER::PROTEIN)
    ("p68 and p72" . SPARSER::COLLECTION)
    ("DDX5 and DDX17" . SPARSER::COLLECTION) ("FUS/TLS" . SPARSER::COLLECTION)
    ("KHSRP" . SPARSER::PROTEIN) ("ssRNA" . SPARSER::RNA)
    ("the ribonuclease DROSHA and its double-stranded RNA-binding partner DGCR8 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("DROSHA" . SPARSER::PROTEIN) ("ribonuclease" . SPARSER::PROTEIN)
    ("the mature ~22 nucleotide miRNA" . SPARSER::MICRO-RNA)
    ("Dicer" . SPARSER::PROTEIN) ("YAP" . SPARSER::PROTEIN)
    ("GL2" . SPARSER::PROTEIN) ("Pri-miRNA" . SPARSER::RNA)
    ("Ad5" . SPARSER::PROTEIN) ("SRSF3" . SPARSER::PROTEIN)
    ("SRp20" . SPARSER::PROTEIN) ("Ago2" . SPARSER::PROTEIN)
    ("Nf2" . SPARSER::PROTEIN) ("Keratin 14" . SPARSER::PROTEIN)
    ("MYC 3" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("AMOTL2" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TEAD1" . SPARSER::PROTEIN)
    ("RNA helicases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lats2" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("LATS2" . SPARSER::PROTEIN)
    ("TRBP2" . SPARSER::PROTEIN) ("XPO5" . SPARSER::PROTEIN)
    ("Exportin-5" . SPARSER::PROTEIN) ("Pre-miRNAs" . SPARSER::RNA)
    ("NF45" . SPARSER::PROTEIN) ("NF90" . SPARSER::PROTEIN)
    ("MSI2" . SPARSER::PROTEIN) ("Lin28A" . SPARSER::PROTEIN)
    ("DDX5" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("DGCR8" . SPARSER::PROTEIN) ("pri-miRNAs" . SPARSER::RNA)
    ("DDX17" . SPARSER::PROTEIN) ("p72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARF6 and the activation state" . SPARSER::COLLECTION)
    ("collagen or thrombin" . SPARSER::COLLECTION)
    ("CRP and the TxA2 analogue U46619" . SPARSER::COLLECTION)
    ("thrombin, CRP and the TxA2 analogue U46619" . SPARSER::COLLECTION)
    ("GGA3-GST" . SPARSER::COLLECTION)
    ("thrombin (Fig. xref C) or CRP (Fig. xref F)" . SPARSER::COLLECTION)
    ("thrombin (Fig. xref A) and CRP (Fig. xref D)" . SPARSER::COLLECTION)
    ("0.3 μg mL −1 (Fig. xref Ci-ii) and 1 μg mL −1 (Fig. xref Ci,iii) CRP"
     . SPARSER::PROTEIN)
    ("0.075 U mL −1 (Fig. xref Ai,iii) and 0.2 U mL −1 (Fig. xref Ai,iv) thrombin"
     . SPARSER::COLLECTION)
    ("0.05 U mL −1 (Fig. xref Ai,ii), 0.075 U mL −1 (Fig. xref Ai,iii) and 0.2 U mL −1 (Fig. xref Ai,iv) thrombin"
     . SPARSER::COLLECTION)
    ("thrombin and CRP" . SPARSER::COLLECTION)
    ("ARF-GEF" . SPARSER::COLLECTION) ("ruboxistaurin" . SPARSER::DRUG)
    ("CRP (Fig. xref E) and U46619 (Fig. xref G)" . SPARSER::COLLECTION)
    ("thrombin (Fig. xref C), CRP (Fig. xref E) and U46619 (Fig. xref G)"
     . SPARSER::COLLECTION)
    ("PKC-mediated autocrine-produced ADP" . SPARSER::PROTEIN)
    ("collagen-related peptide (CRP) (Fig. xref D) and the thromboxane A 2 mimetic U46619 (Fig. xref F)"
     . SPARSER::COLLECTION)
    ("peptide (CRP)" . SPARSER::PEPTIDE)
    ("the commercially available phospho-(Ser) PKC substrate (pSer PKC substrate) antibody"
     . SPARSER::ANTIBODY)
    ("catecholamine" . SPARSER::MOLECULE)
    ("ARF nucleotide-binding site opener (ARNO)" . SPARSER::PROTEIN)
    ("ARNO" . SPARSER::PROTEIN) ("GSK3 and PDE3A" . SPARSER::COLLECTION)
    ("pleckstrin" . SPARSER::PROTEIN)
    ("arginine or lysine" . SPARSER::COLLECTION)
    ("−3, −2 and +2" . SPARSER::COLLECTION) ("ARF1" . SPARSER::PROTEIN)
    ("TxA2" . SPARSER::MOLECULE) ("P2Y 12" . SPARSER::PROTEIN)
    ("α IIb β 3" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("GGA3" . SPARSER::PROTEIN) ("LY 333531" . SPARSER::DRUG)
    ("Go 6983" . SPARSER::DRUG) ("GF 109203X" . SPARSER::DRUG)
    ("Ro 31-8220" . SPARSER::DRUG) ("SEC7" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("ARF nucleotide-binding site opener" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("ARF6" . SPARSER::PROTEIN)
    ("α II" . SPARSER::PROTEIN) ("SecinH3" . SPARSER::DRUG)
    ("FMS and FS" . SPARSER::COLLECTION) ("FS" . SPARSER::PROTEIN)
    ("FMS" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("PTEN/PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("a defective ion" . SPARSER::MOLECULE) ("CLC" . SPARSER::PROTEIN)
    ("MRI, karyotype, FRAXA and FRAXE" . SPARSER::COLLECTION)
    ("DSM" . SPARSER::MOLECULE) ("VPA" . SPARSER::PROTEIN)
    ("variants (SNV)" . SPARSER::VARIANT)
    ("allelic variants" . SPARSER::VARIANT) ("Seizures" . SPARSER::PROTEIN)
    ("no identifiable variants" . SPARSER::VARIANT)
    ("gene ( HEPACAM )" . SPARSER::PROTEIN) ("HEPACAM" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog ( PTEN )" . SPARSER::PROTEIN)
    ("idiopathic ASD" . SPARSER::PROTEIN)
    ("seizures or paroxysmal EEG" . SPARSER::COLLECTION)
    ("AEP" . SPARSER::PROTEIN) ("ASD" . SPARSER::PROTEIN)
    ("Kir4.1" . SPARSER::PROTEIN) ("ClC-2" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("MLC2B" . SPARSER::PROTEIN)
    ("MLC1" . SPARSER::PROTEIN) ("MLC2A" . SPARSER::PROTEIN)
    ("the pathology-associated HDAC4 or HDAC" . SPARSER::COLLECTION)
    ("HDAC4 or HDAC" . SPARSER::COLLECTION)
    ("histones and HDAC4" . SPARSER::COLLECTION)
    ("an orally active antiangiogenic drug" . SPARSER::DRUG)
    ("Tasquinimod" . SPARSER::DRUG) ("HDAC1 or HDAC3" . SPARSER::COLLECTION)
    ("an essential part" . SPARSER::COMPONENT)
    ("PLU-1/JARID1B" . SPARSER::COLLECTION)
    ("acetyl-histone" . SPARSER::PROTEIN) ("WAF" . SPARSER::PROTEIN)
    ("miR-200a directly targets HDAC4" . SPARSER::PROTEIN)
    ("the Sp1/Sp3 binding site-rich p21 (WAF1/Cip1) proximal promoter"
     . SPARSER::PROMOTER)
    ("WAF1/Cip1" . SPARSER::COLLECTION) ("Sp1/Sp3" . SPARSER::COLLECTION)
    ("BCL6 and PLZF" . SPARSER::COLLECTION)
    ("the leukemic PLZF-RARa fusion protein" . SPARSER::PROTEIN)
    ("differentiation-associated genes" . SPARSER::GENE)
    ("RARalpha" . SPARSER::PROTEIN) ("promyelocytic" . SPARSER::PROTEIN)
    ("PLZF" . SPARSER::PROTEIN) ("somatostatin" . SPARSER::PROTEIN)
    ("HDAC4, -5, and -9" . SPARSER::COLLECTION)
    ("beta- and delta-cells" . SPARSER::COLLECTION)
    ("seizures" . SPARSER::PROTEIN) ("PPARgamma" . SPARSER::PROTEIN)
    ("HDAC4, Rcor1 and Rgs2" . SPARSER::COLLECTION)
    ("Rcor1" . SPARSER::PROTEIN) ("MEF2-HDAC4" . SPARSER::COLLECTION)
    ("MEF2 and cAMP response element-binding protein" . SPARSER::COLLECTION)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("MEF2-" . SPARSER::PROTEIN)
    ("Z-disc-associated protein" . SPARSER::PROTEIN)
    ("PCAF and HDAC4" . SPARSER::COLLECTION)
    ("HDAC4 and PCAF" . SPARSER::COLLECTION)
    ("HDAC4, and HAT" . SPARSER::COLLECTION)
    ("Sirt1 and HDAC4" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("CaMKIV" . SPARSER::PROTEIN) ("MEF-2/HDAC" . SPARSER::COLLECTION)
    ("GATA4 and cardiac alpha-actin" . SPARSER::COLLECTION)
    ("transcripts Nkx2-5, MEF2C, GATA4 and cardiac alpha-actin"
     . SPARSER::COLLECTION)
    ("cardiac alpha-actin" . SPARSER::PROTEIN)
    ("GATA4 and Nkx2-5" . SPARSER::COLLECTION) ("Nkx2-5" . SPARSER::PROTEIN)
    ("TGF-beta1-" . SPARSER::PROTEIN) ("Smad3/Runx2" . SPARSER::COLLECTION)
    ("smurf" . SPARSER::PROTEIN)
    ("p300 and acetylated-Runx2" . SPARSER::COLLECTION)
    ("prehypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("HP1 and SUV39H1" . SPARSER::COLLECTION) ("AChE" . SPARSER::PROTEIN)
    ("acetylcholinesterase" . SPARSER::PROTEIN)
    ("Atrial natriuretic peptide (ANP) and B-type Natriuretic Peptide (BNP)"
     . SPARSER::COLLECTION)
    ("Natriuretic Peptide (BNP)" . SPARSER::PROTEIN)
    ("HDAC4 and HP1" . SPARSER::COLLECTION)
    ("ANP and BNP" . SPARSER::COLLECTION) ("BNP" . SPARSER::PROTEIN)
    ("ANP" . SPARSER::PROTEIN) ("SUV39H1 and HP1" . SPARSER::COLLECTION)
    ("this epigenetic mark" . SPARSER::PROTEIN)
    ("Euchromatin" . SPARSER::BIO-COMPLEX)
    ("H3K4, H3K36, or H3K79" . SPARSER::COLLECTION)
    ("MEKK2 [ xref ] and STAT1 [ xref ]" . SPARSER::COLLECTION)
    ("HIF-1α [ xref – xref ], MEKK2 [ xref ] and STAT1 [ xref ]"
     . SPARSER::COLLECTION)
    ("HDAC4 and HDAC5" . SPARSER::COLLECTION) ("Smurf" . SPARSER::PROTEIN)
    ("Smurf1-" . SPARSER::PROTEIN) ("p300-" . SPARSER::PROTEIN)
    ("subsequent deacetylase activity" . SPARSER::PROTEIN)
    ("SMRT-NCoR" . SPARSER::COLLECTION) ("NCoR" . SPARSER::PROTEIN)
    ("SMRT" . SPARSER::PROTEIN)
    ("HDAC6, HDAC4 and HDAC5" . SPARSER::COLLECTION)
    ("HDAC3 and RbAp48" . SPARSER::COLLECTION) ("RbAp48" . SPARSER::PROTEIN)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("HAT and HDAC" . SPARSER::COLLECTION)
    ("nucleosomal histones" . SPARSER::PROTEIN)
    ("complex (NPC)" . SPARSER::BIO-COMPLEX)
    ("microRNA and RNA" . SPARSER::COLLECTION) ("Runx2-" . SPARSER::PROTEIN)
    ("a strong repressor" . SPARSER::REPRESSOR)
    ("caspase-2 and -3" . SPARSER::COLLECTION)
    ("Polyubiquitination mainly targets proteins" . SPARSER::PROTEIN)
    ("enzymes and E3" . SPARSER::COLLECTION) ("three-step" . SPARSER::PROTEIN)
    ("SUMO1, SUMO2, and SUMO3" . SPARSER::COLLECTION)
    ("phenylephrine" . SPARSER::DRUG) ("thiols" . SPARSER::MOLECULE)
    ("oncogenic Ras or constitutively active MAPK/ERK kinase 1"
     . SPARSER::COLLECTION)
    ("Ras–MAPK" . SPARSER::COLLECTION) ("MEF2-HDAC" . SPARSER::COLLECTION)
    ("which escorts phospho- HDAC4" . SPARSER::PROTEIN)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("miRNAs specifically target HDAC4" . SPARSER::PROTEIN)
    ("dwarf" . SPARSER::PROTEIN)
    ("Cartilage specific miR-140 directly targets HDAC4 3" . SPARSER::PROTEIN)
    ("activin" . SPARSER::PROTEIN) ("MyoD" . SPARSER::PROTEIN)
    ("miR-200a and its promoter activity" . SPARSER::COLLECTION)
    ("Sp1 and Sp3" . SPARSER::COLLECTION)
    ("the perinatal period" . SPARSER::PROTEIN)
    ("HDACs and class II HDACs" . SPARSER::COLLECTION)
    ("HDAC 4 and HDAC 5" . SPARSER::COLLECTION)
    ("HDAC4, HDA5, HDAC7 and HDAC9" . SPARSER::COLLECTION)
    ("HDAC6 and HDAC10" . SPARSER::COLLECTION) ("IIb" . SPARSER::DRUG)
    ("HDA" . SPARSER::PROTEIN) ("SIR" . SPARSER::PROTEIN)
    ("at least 18 HDACs" . SPARSER::PROTEIN)
    ("sequence-specific DNA-binding proteins" . SPARSER::PROTEIN)
    ("HATs and HDACs" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC), which induces deacetylation, chromatin condensation, and transcriptional repression"
     . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("JARID1B" . SPARSER::PROTEIN) ("PLU-1" . SPARSER::PROTEIN)
    ("forkhead box P3" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("PLZF-RARalpha" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("brachydactyly-mental retardation syndrome" . SPARSER::PROTEIN)
    ("Rgs2" . SPARSER::PROTEIN) ("ataxin-1" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("atrial natriuretic factor" . SPARSER::PROTEIN)
    ("MEF-2" . SPARSER::PROTEIN) ("alpha-actin" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("TGF-beta1" . SPARSER::PROTEIN)
    ("Ubc9" . SPARSER::PROTEIN) ("Natriuretic Peptide" . SPARSER::PROTEIN)
    ("Atrial natriuretic peptide" . SPARSER::PROTEIN)
    ("SUV39H1" . SPARSER::PROTEIN) ("Smurf1" . SPARSER::PROTEIN)
    ("BMP-2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone 4" . SPARSER::PROTEIN) ("MEKK2" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("Nup155" . SPARSER::PROTEIN) ("nucleoporin 155" . SPARSER::PROTEIN)
    ("importin 1" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("RANBP2" . SPARSER::PROTEIN) ("SUMO-protein ligase" . SPARSER::PROTEIN)
    ("SUMO3" . SPARSER::PROTEIN) ("SUMO2" . SPARSER::PROTEIN)
    ("SUMO1" . SPARSER::PROTEIN) ("thioredoxin-1" . SPARSER::PROTEIN)
    ("MAPK/ERK kinase 1" . SPARSER::PROTEIN) ("N-CoR" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("miR- 155" . SPARSER::PROTEIN)
    ("DUSP2" . SPARSER::PROTEIN) ("CTNNBIP1" . SPARSER::PROTEIN)
    ("ACVR2A" . SPARSER::PROTEIN) ("TGF-β3" . SPARSER::PROTEIN)
    ("miR-29b" . SPARSER::MOLECULE) ("miR-200a" . SPARSER::MOLECULE)
    ("Sp3" . SPARSER::PROTEIN) ("HDAC 5" . SPARSER::PROTEIN)
    ("HDAC 4" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("HDAC7" . SPARSER::PROTEIN)
    ("Hda1" . SPARSER::PROTEIN) ("HD 1" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("some homozygous variants" . SPARSER::VARIANT)
    ("only two genes" . SPARSER::GENE)
    ("the polymorphic variants of NF-κB and risk" . SPARSER::COLLECTION)
    ("the polymorphic variants" . SPARSER::VARIANT) ("Ins" . SPARSER::PROTEIN)
    ("rs28362491 deletion allelle and rs230496 AG or GG genotype"
     . SPARSER::COLLECTION)
    ("NFKBIA , rs3138053 and rs2273650" . SPARSER::COLLECTION)
    ("GA or AA" . SPARSER::COLLECTION)
    ("rs230525 AG or GG genotypes" . SPARSER::COLLECTION)
    ("p105 and p50" . SPARSER::COLLECTION)
    ("p100 and p52" . SPARSER::COLLECTION)
    ("RelB and c-Rel" . SPARSER::COLLECTION)
    ("GA and AA" . SPARSER::COLLECTION)
    ("two prospective cohorts" . SPARSER::MOLECULE)
    ("NFKB1 and NFKBIA" . SPARSER::COLLECTION) ("ORs 1" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("associated alleles" . SPARSER::ALLELE)
    ("STXBP5, PLAT and STX2" . SPARSER::COLLECTION)
    ("pair-wise LD" . SPARSER::PROTEIN) ("perfect LD" . SPARSER::PROTEIN)
    ("a traditional LD" . SPARSER::PROTEIN)
    ("SERPINE1 and PLAT" . SPARSER::COLLECTION)
    ("STXBP5 or STX2" . SPARSER::COLLECTION)
    ("PLAT/POLB" . SPARSER::COLLECTION)
    ("these circulating hemostatic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("syntaxin" . SPARSER::PROTEIN)
    ("STXBP5 (rs9399599) and STX2 (rs7301826)" . SPARSER::COLLECTION)
    ("tPA and vWF" . SPARSER::COLLECTION) ("NSF" . SPARSER::PROTEIN)
    ("SNARE" . SPARSER::PROTEIN) ("residual LD" . SPARSER::PROTEIN)
    ("ACE, AGT, AGTR1, BDKRB2, and SERPINE1" . SPARSER::COLLECTION)
    ("AGT" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("Previously Implicated Genes" . SPARSER::GENE)
    ("incident CAD" . SPARSER::PROTEIN) ("tPA-antigen" . SPARSER::COLLECTION)
    ("histamine" . SPARSER::PROTEIN) ("STX2 and STXBP5" . SPARSER::COLLECTION)
    ("POLB-PLAT" . SPARSER::COLLECTION)
    ("log-transformed tPA" . SPARSER::PROTEIN)
    ("the largely female Twins UK" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE)
    ("the associated genetic variants" . SPARSER::VARIANT)
    ("STXBP5 and STX2" . SPARSER::COLLECTION) ("modest LD" . SPARSER::PROTEIN)
    ("POLB" . SPARSER::PROTEIN) ("Syntaxin 4" . SPARSER::PROTEIN)
    ("BDKRB2" . SPARSER::PROTEIN) ("AGTR1" . SPARSER::PROTEIN)
    ("STX2" . SPARSER::PROTEIN) ("STXBP5" . SPARSER::PROTEIN)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("fractalkine/CX3CR1" . SPARSER::COLLECTION)
    ("CCL2/CCR2" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("decreased inflammatory cytokines" . SPARSER::PROTEIN)
    ("ApoE" . SPARSER::PROTEIN) ("the distal limb" . SPARSER::PROTEIN)
    ("both membrane-bound and soluble forms" . SPARSER::COLLECTION)
    ("a multifunctional chemokine" . SPARSER::PROTEIN)
    ("chromatin folding and transcription  xref" . SPARSER::COLLECTION)
    ("the angiogenic chemokine fractalkine" . SPARSER::PROTEIN)
    ("damped" . SPARSER::MOLECULE)
    ("the angiogenic and inflammatory chemokine" . SPARSER::PROTEIN)
    ("post-ischemia" . SPARSER::COLLECTION) ("FKN" . SPARSER::PROTEIN)
    ("distal KO" . SPARSER::PROTEIN)
    ("a soluble signaling molecule" . SPARSER::MOLECULE)
    ("Fractalkine" . SPARSER::PROTEIN)
    ("phospho-H3S10-bound chromatin" . SPARSER::PROTEIN)
    ("cx3cl1" . SPARSER::PROTEIN) ("cx" . SPARSER::PROTEIN-FAMILY)
    ("associated DNA" . SPARSER::DNA)
    ("CS-MKP-1-bound chromatin" . SPARSER::PROTEIN) ("BS" . SPARSER::PROTEIN)
    ("the ischemic limb" . SPARSER::PROTEIN)
    ("both proximal and distal parts" . SPARSER::COMPONENT)
    ("curve-fit" . SPARSER::PROTEIN-FAMILY)
    ("the angiogenic and inflammatory gene" . SPARSER::GENE)
    ("endothelial MKP-1" . SPARSER::PROTEIN) ("CS-MKP-1" . SPARSER::COLLECTION)
    ("DUSP1 or CL100" . SPARSER::COLLECTION) ("Thr/Tyr" . SPARSER::COLLECTION)
    ("p38, and c-Jun" . SPARSER::COLLECTION)
    ("proteins or gene" . SPARSER::COLLECTION)
    ("the most potent cytokines capable of initiating and maintaining this process"
     . SPARSER::PROTEIN)
    ("pro- and anti-angiogenic" . SPARSER::COLLECTION)
    ("angiogenic genes" . SPARSER::GENE) ("exonic DNA" . SPARSER::DNA)
    ("fractalkine, and MKP-1" . SPARSER::COLLECTION)
    ("fractalkine" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ly6C" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("IL1α" . SPARSER::PROTEIN) ("CX3CR1" . SPARSER::PROTEIN)
    ("FOSL1" . SPARSER::PROTEIN) ("CCN1" . SPARSER::PROTEIN)
    ("CL100" . SPARSER::PROTEIN) ("DUSP1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase phosphatase-1" . SPARSER::PROTEIN)
    ("MKP-1" . SPARSER::PROTEIN) ("the optimal reagent" . SPARSER::MOLECULE)
    ("guanidino" . SPARSER::MOLECULE) ("astato" . SPARSER::MOLECULE)
    ("the major transporters" . SPARSER::PROTEIN)
    ("an anti-HER2 (scFv-C H 2-C H 3) 2" . SPARSER::ANTIBODY)
    ("Nanobodies" . SPARSER::PROTEIN) ("Nanobody" . SPARSER::PROTEIN)
    ("receptor–Nanobody" . SPARSER::PROTEIN-PAIR)
    ("only 5 lysines" . SPARSER::AMINO-ACID) ("lysines" . SPARSER::AMINO-ACID)
    ("guanidine" . SPARSER::MOLECULE)
    ("a 105-kDa anti-HER2 (scFv-C H 2-C H 3) 2" . SPARSER::ANTIBODY)
    ("artificial protein scaffolds" . SPARSER::SCAFFOLD)
    ("similarly sized Affibody and DAR-Pin molecules" . SPARSER::MOLECULE)
    ("These approximately 15-kDa proteins" . SPARSER::PROTEIN)
    ("DAR" . SPARSER::PROTEIN) ("a functional mAb" . SPARSER::DRUG)
    ("A significantly higher fraction" . SPARSER::COMPONENT)
    ("Immunoreactive fractions" . SPARSER::COMPONENT)
    ("IODO" . SPARSER::PROTEIN)
    ("N -succinimidyl 4-guanidinomethyl-3-iodobenzoate (SGMIB)"
     . SPARSER::DRUG)
    ("lysosomal pH ( xref , xref ) and short D–amino acid peptides"
     . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("radiopharmaceuticals" . SPARSER::DRUG)
    ("Iodine" . SPARSER::MOLECULE) ("scFv" . SPARSER::PROTEIN)
    ("intact mAbs" . SPARSER::DRUG)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("the monoclonal antibodies (mAbs) trastuzumab and pertuzumab, and tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("trastuzumab and pertuzumab, and tyrosine kinase" . SPARSER::COLLECTION)
    ("pertuzumab, and tyrosine kinase" . SPARSER::COLLECTION)
    ("PET and SPECT" . SPARSER::COLLECTION) ("IODO-GEN" . SPARSER::COLLECTION)
    ("GEN" . SPARSER::PROTEIN) ("Mal" . SPARSER::PROTEIN)
    ("SGMIB" . SPARSER::DRUG) ("iodobenzoate" . SPARSER::MOLECULE)
    ("GGC" . SPARSER::PROTEIN)
    ("naturally occurring heavy chain–only antibodies" . SPARSER::ANTIBODY)
    ("approximately 15-kDa proteins" . SPARSER::PROTEIN)
    ("EAAT3" . SPARSER::PROTEIN) ("glutamic acid" . SPARSER::AMINO-ACID)
    ("CDR3" . SPARSER::PROTEIN) ("ankyrin repeat" . SPARSER::PROTEIN)
    ("N  2" . SPARSER::PROTEIN) ("N  1" . SPARSER::PROTEIN)
    ("N -succinimidyl 4-guanidinomethyl-3-iodobenzoate" . SPARSER::DRUG)
    ("TGF β or tumor necrosis factor" . SPARSER::COLLECTION)
    ("profibrotic and proinflammatory cytokines" . SPARSER::PROTEIN)
    ("MAPK and Smad2/3" . SPARSER::COLLECTION)
    ("socioeconomic, behavioral, and environmental factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagen and α -SMA" . SPARSER::COLLECTION)
    ("RI and TGF β" . SPARSER::COLLECTION) ("JNK or p38" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("F-actin and CXCR4 expression" . SPARSER::COLLECTION)
    ("SSc and monocytes" . SPARSER::COLLECTION)
    ("full-length caveolin-1 or the caveolin-1 scaffolding domain (CSD) peptide ( xref , xref )"
     . SPARSER::COLLECTION)
    ("monocytes, and neutrophils" . SPARSER::COLLECTION)
    ("ligand–receptor" . SPARSER::PROTEIN)
    ("TGF β and caveolin-1" . SPARSER::COLLECTION)
    ("the major profibrotic cytokine TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor (HGF) and several other cytokines (insulin-like growth factor binding protein, osteoprotegerin, stem cell factor, thrombopoietin, and vascular endothelial growth factor)"
     . SPARSER::COLLECTION)
    ("insulin-like growth factor binding protein, osteoprotegerin, stem cell factor, thrombopoietin, and vascular endothelial growth factor"
     . SPARSER::COLLECTION)
    ("thrombopoietin" . SPARSER::PROTEIN)
    ("osteoprotegerin" . SPARSER::PROTEIN) ("BAL" . SPARSER::PROTEIN)
    ("various profibrotic and antifibrotic cytokines" . SPARSER::PROTEIN)
    ("SSc and ILD" . SPARSER::COLLECTION)
    ("the more severe diffuse form" . SPARSER::FORM)
    ("ERK, JNK, p38, and Smad2/3" . SPARSER::COLLECTION)
    ("JNK, p38, or Smad2/3" . SPARSER::COLLECTION)
    ("SDF-1 receptor" . SPARSER::PROTEIN) ("Cola1" . SPARSER::PROTEIN)
    ("phospho–ERK" . SPARSER::PROTEIN) ("anti–ERK" . SPARSER::PROTEIN)
    ("α -SMA" . SPARSER::PROTEIN) ("receptor type" . SPARSER::PROTEIN)
    ("proton pump" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE)
    ("derived factor" . SPARSER::PROTEIN)
    ("AS, MS, PS, and CS" . SPARSER::COLLECTION)
    ("disulfide" . SPARSER::MOLECULE)
    ("CS and FGFR2-dependent PS" . SPARSER::COLLECTION)
    ("AS, MS, CS, and PS" . SPARSER::COLLECTION) ("orbit" . SPARSER::DRUG)
    ("PCAs" . SPARSER::PROTEIN) ("PS-CS" . SPARSER::COLLECTION)
    ("AS, CS, MS and PS" . SPARSER::COLLECTION)
    ("AS, CS, and PS" . SPARSER::COLLECTION)
    ("AS, CS, MS, OR PS" . SPARSER::COLLECTION)
    ("AS, and theFGFR3 P250R" . SPARSER::COLLECTION) ("PC2" . SPARSER::PROTEIN)
    ("PC1" . SPARSER::PROTEIN) ("PCs" . SPARSER::PROTEIN)
    ("AS AND MS" . SPARSER::COLLECTION) ("GENOTYPE" . SPARSER::PROTEIN)
    ("AS, CS, MS, and PS" . SPARSER::COLLECTION)
    ("CS, MS, or PS" . SPARSER::COLLECTION) ("dys" . SPARSER::PROTEIN)
    ("CS and PS" . SPARSER::COLLECTION) ("PS and CS" . SPARSER::COLLECTION)
    ("Robin" . SPARSER::PROTEIN) ("AS and MS" . SPARSER::COLLECTION)
    ("fibroblast growth factor receptor (FGFR)" . SPARSER::PROTEIN)
    ("PS-MS" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("gene or polymorphisms" . SPARSER::COLLECTION)
    ("approximately 200 base" . SPARSER::PROTEIN)
    ("nuclear and extranuclear receptors" . SPARSER::COLLECTION)
    ("extranuclear receptors" . SPARSER::PROTEIN)
    ("the AF and control group" . SPARSER::COLLECTION)
    ("LL" . SPARSER::PROTEIN) ("longer alleles" . SPARSER::ALLELE)
    ("cardiac sexual steroid receptors" . SPARSER::RECEPTOR)
    ("AF and nucleotide" . SPARSER::COLLECTION)
    ("etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lone AF" . SPARSER::PROTEIN)
    ("vBCL2 and vFLIP viral proteins" . SPARSER::PROTEIN)
    ("Beclin1and Atg3" . SPARSER::COLLECTION) ("vFLIP" . SPARSER::PROTEIN)
    ("Beclin1-Mcl-1" . SPARSER::COLLECTION)
    ("TH2 and/or TH17" . SPARSER::COLLECTION) ("TH1/TH2" . SPARSER::COLLECTION)
    ("p62 and Mcl1" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN) ("BCL-xL and BCL-2" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION)
    ("viral encoded proteins" . SPARSER::PROTEIN)
    ("pre-treated DCs" . SPARSER::PROTEIN)
    ("subunit and AKT" . SPARSER::COLLECTION)
    ("NF-kB and AKT" . SPARSER::COLLECTION)
    ("mock-treated DCs" . SPARSER::PROTEIN)
    ("macrophages and DCs" . SPARSER::COLLECTION)
    ("macrophages/monocytes" . SPARSER::COLLECTION)
    ("PI3K and NF-kB" . SPARSER::COLLECTION) ("nonintegrin" . SPARSER::PROTEIN)
    ("DCs or their monocyte precursors xref  xref  xref" . SPARSER::COLLECTION)
    ("DCs, myeloid DCs" . SPARSER::MOLECULE)
    ("DCs, myeloid DCs or their monocyte precursors xref  xref  xref"
     . SPARSER::COLLECTION)
    ("costimulatory molecules" . SPARSER::MOLECULE) ("MCD" . SPARSER::PROTEIN)
    ("PEL" . SPARSER::PROTEIN) ("KS" . SPARSER::PROTEIN)
    ("IL-10, IL-6 and IL-23" . SPARSER::COLLECTION)
    ("monocytes and dendritic cells DCs" . SPARSER::COLLECTION)
    ("β-globin" . SPARSER::PROTEIN) ("ORF26" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN) ("D35" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K8" . SPARSER::PROTEIN) ("Atg3" . SPARSER::PROTEIN)
    ("IL12p70" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("heparan sulfates" . SPARSER::MOLECULE)
    ("CD209" . SPARSER::PROTEIN) ("ICAM-3" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("primary MNs" . SPARSER::PROTEIN)
    ("riluzole" . SPARSER::DRUG)
    ("primary cultured MNs (control 48.8%, scramble 44.1% and siPTEN 25.2%, respectively) and iPS-derived MNs (Control 50.5%, scramble 48.9% and siPTEN 27.9%, respectively)"
     . SPARSER::COLLECTION)
    ("-AMPA" . SPARSER::COLLECTION)
    ("toxic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GluR1 and PtdIns" . SPARSER::COLLECTION)
    ("primary cultured MNs ( xref ) or iPS-derived MNs ( xref )"
     . SPARSER::COLLECTION)
    ("primary cultured MNs ( xref ) and iPS-derived MNs ( xref )"
     . SPARSER::COLLECTION)
    ("GluR1 and GluR2" . SPARSER::COLLECTION) ("AMPA-" . SPARSER::PROTEIN)
    ("primary cultured MNs and iPS-derived MNs" . SPARSER::COLLECTION)
    ("Akt and Bad" . SPARSER::COLLECTION)
    ("neurotrophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ChAT" . SPARSER::PROTEIN)
    ("RA and sonic hedgehog (SHH)" . SPARSER::COLLECTION)
    ("RA and sonic hedgehog" . SPARSER::COLLECTION)
    ("PAX6 and OTX2" . SPARSER::COLLECTION) ("EBs" . SPARSER::PROTEIN-FAMILY)
    ("functional MNs" . SPARSER::PROTEIN)
    ("a pluripotent state" . SPARSER::BIO-STATE)
    ("the pluripotent-associated gene Oct4" . SPARSER::PROTEIN)
    ("pMXs-GFP" . SPARSER::COLLECTION) ("iPS-MN" . SPARSER::COLLECTION)
    ("spinal MNs" . SPARSER::PROTEIN) ("Leptin" . SPARSER::PROTEIN)
    ("inosine" . SPARSER::MOLECULE)
    ("Ca 2+ -permeable AMPA receptors" . SPARSER::RECEPTOR)
    ("Riluzole" . SPARSER::DRUG)
    ("calcium-permeable AMPA receptors" . SPARSER::RECEPTOR)
    ("α -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors"
     . SPARSER::PROTEIN)
    ("MN" . SPARSER::PROTEIN) ("sporadic ALS" . SPARSER::PROTEIN)
    ("ALS and ∼10%" . SPARSER::COLLECTION) ("MNs" . SPARSER::PROTEIN)
    ("iPS" . SPARSER::PROTEIN)
    ("the α -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors"
     . SPARSER::PROTEIN)
    ("Glutamate receptor" . SPARSER::PROTEIN)
    ("Glutamate receptor 3" . SPARSER::PROTEIN)
    ("Glutamate receptor 2" . SPARSER::PROTEIN)
    ("Glutamate receptor 1" . SPARSER::PROTEIN) ("MK- 801" . SPARSER::MOLECULE)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutamate receptor 1" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Klf4" . SPARSER::PROTEIN) ("GLUR2" . SPARSER::PROTEIN)
    ("GLUR4" . SPARSER::PROTEIN) ("GLUR1" . SPARSER::PROTEIN)
    ("GluR4" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("choline acetyltransferase" . SPARSER::PROTEIN)
    ("Islet1" . SPARSER::PROTEIN) ("sonic hedgehog" . SPARSER::PROTEIN)
    ("PAX6" . SPARSER::PROTEIN) ("REX1" . SPARSER::PROTEIN)
    ("LIN28" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("ADAR2" . SPARSER::PROTEIN) ("adenosine deaminase" . SPARSER::PROTEIN)
    ("GluR3" . SPARSER::PROTEIN) ("glutamate receptor 2" . SPARSER::PROTEIN)
    ("chromosome 9 open reading frame 72" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("GluR2" . SPARSER::PROTEIN)
    ("/Smad3" . SPARSER::COLLECTION) ("IGF-R and c-Met" . SPARSER::COLLECTION)
    ("ARMS-associated PAX3/7-Foxo1 fusion proteins" . SPARSER::PROTEIN)
    ("a pivotal and required step" . SPARSER::PROTEIN)
    ("Pax7 or PAX3" . SPARSER::COLLECTION)
    ("myosin heavy chain and desmin" . SPARSER::COLLECTION)
    ("FKHR" . SPARSER::PROTEIN) ("MRF" . SPARSER::PROTEIN)
    ("GSK3 β and MYOGENIN" . SPARSER::COLLECTION)
    ("HA-GSK3 β" . SPARSER::COLLECTION)
    ("two predominant forms" . SPARSER::FORM)
    ("MYOGENIN and GSK3 β" . SPARSER::COLLECTION)
    ("calf-intestinal phosphatases" . SPARSER::PHOSPHATASE)
    ("GSK3 β and MyBP" . SPARSER::COLLECTION)
    ("MyBP" . SPARSER::PROTEIN-FAMILY) ("GST-GSK3 β" . SPARSER::COLLECTION)
    ("GST-MYOGENIN" . SPARSER::COLLECTION)
    ("constitutively active GSK3 β (S9A) and MYOGENIN" . SPARSER::COLLECTION)
    ("proliferating C2C12 myoblasts" . SPARSER::PROTEIN)
    ("MRFs and MEF2" . SPARSER::COLLECTION)
    ("pro-myogenic" . SPARSER::COLLECTION) ("myotube" . SPARSER::PROTEIN)
    ("GM and DM" . SPARSER::COLLECTION) ("media (DM)" . SPARSER::PROTEIN)
    ("media (GM)" . SPARSER::PROTEIN) ("HA-PAX3-FOXO1" . SPARSER::COLLECTION)
    ("MCK-eGFP" . SPARSER::COLLECTION) ("MEF2 and MRFs" . SPARSER::COLLECTION)
    ("MYOD and MYOGENIN" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION) ("XXX" . SPARSER::PROTEIN)
    ("PAX3 and Foxo1" . SPARSER::COLLECTION)
    ("MYF-5, MRF4 and MYOGENIN" . SPARSER::COLLECTION)
    ("MRFs" . SPARSER::PROTEIN) ("MYOD" . SPARSER::PROTEIN)
    ("MCK" . SPARSER::PROTEIN) ("PAX3-FOXO1" . SPARSER::COLLECTION)
    ("MYOGENIN" . SPARSER::PROTEIN) ("β -mercaptoethanol" . SPARSER::MOLECULE)
    ("L -glutamine" . SPARSER::MOLECULE) ("Myf-5" . SPARSER::PROTEIN)
    ("MEF2A" . SPARSER::PROTEIN) ("KLF6" . SPARSER::PROTEIN)
    ("IGF-R" . SPARSER::PROTEIN)
    ("myosin heavy chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pax7" . SPARSER::PROTEIN) ("AR-A014418" . SPARSER::DRUG)
    ("pcDNA3" . SPARSER::PROTEIN) ("p57 Kip2" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("MRF4" . SPARSER::PROTEIN) ("MYF-5" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("RH30" . SPARSER::PROTEIN)
    ("GSK3 β" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("Beclin" . SPARSER::PROTEIN) ("Beclin-1/Atg5" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("Stat3 and its direct targets" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclin D1" . SPARSER::COLLECTION)
    ("LC3 or Atg5" . SPARSER::COLLECTION)
    ("metformin and CQ" . SPARSER::COLLECTION)
    ("cyclin D1 and Bcl-2" . SPARSER::COLLECTION)
    ("Stat3 and Bcl-2" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("protein kinase (AMPK)" . SPARSER::PROTEIN)
    ("GFP-LC-3" . SPARSER::COLLECTION)
    ("phosphorylated Stat3 and its target cyclin D1" . SPARSER::COLLECTION)
    ("Stat3/Bcl-2" . SPARSER::COLLECTION)
    ("Beclin-1 or Atg5" . SPARSER::COLLECTION)
    ("siRNA or Atg5" . SPARSER::COLLECTION)
    ("Beclin-1 and Atg5" . SPARSER::COLLECTION)
    ("chemosensitizer" . SPARSER::DRUG) ("TEM" . SPARSER::PROTEIN)
    ("autophagosomal membrane-bound form" . SPARSER::FORM)
    ("Microtubule-associated protein light chain 3" . SPARSER::PROTEIN)
    ("acridine orange (AO)" . SPARSER::MOLECULE)
    ("monodansylcadaverine (MDC)" . SPARSER::DRUG) ("MDC" . SPARSER::PROTEIN)
    ("monodansylcadaverine" . SPARSER::DRUG) ("AO" . SPARSER::PROTEIN)
    ("phospho-Histone" . SPARSER::PROTEIN) ("a monomeric form" . SPARSER::FORM)
    ("iodide (PI)" . SPARSER::PROTEIN)
    ("cytokines, growth factors and oncogenes" . SPARSER::COLLECTION)
    ("the antidiabetic drug metformin" . SPARSER::DRUG)
    ("Stat3-Bcl-2" . SPARSER::COLLECTION)
    ("signal transducer and activator of transcription 3 (Stat3) and its downstream target Bcl-2"
     . SPARSER::COLLECTION)
    ("The antidiabetic drug metformin" . SPARSER::DRUG)
    ("P- value" . SPARSER::PROTEIN) ("FL2" . SPARSER::PROTEIN)
    ("LC-3" . SPARSER::PROTEIN) ("Atg5" . SPARSER::PROTEIN)
    ("Beclin-1" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("acridine orange" . SPARSER::MOLECULE) ("JC-1" . SPARSER::MOLECULE)
    ("TCF7, TCF7L1, TCF7L2 and LEF1" . SPARSER::COLLECTION)
    ("MEFs and Jurkat" . SPARSER::COLLECTION)
    ("specifically deconjugates K63-linked polyubiquitin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cIAP1 or CYLD" . SPARSER::COLLECTION) ("proteasomes" . SPARSER::PROTEIN)
    ("primarily target proteins" . SPARSER::PROTEIN)
    ("cIAP-1 and cIAP-2" . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("TNF and TRAIL" . SPARSER::COLLECTION) ("Antagonists" . SPARSER::MOLECULE)
    ("Selenite" . SPARSER::MOLECULE)
    ("both FACS and western blot" . SPARSER::COLLECTION)
    ("cIAP1-" . SPARSER::PROTEIN) ("RIP1 and caspase-8" . SPARSER::COLLECTION)
    ("tBid" . SPARSER::PROTEIN) ("caspases and PARP" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("caspase-7 and caspase-9" . SPARSER::COLLECTION)
    ("caspase-8 and FADD" . SPARSER::COLLECTION)
    ("a baculoviral IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RIP1/FADD/caspase-8" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("the death-inducing signalling complex (DISC) and activation of caspase-8"
     . SPARSER::COLLECTION)
    ("caspase-9, cytochrome c and Apaf-1" . SPARSER::COLLECTION)
    ("PARP and caspase" . SPARSER::COLLECTION) ("Selenium" . SPARSER::MOLECULE)
    ("LEF1 and cIAP" . SPARSER::COLLECTION)
    ("ubiquitinases" . SPARSER::UBIQUITINASE) ("selenite" . SPARSER::MOLECULE)
    ("a 20 " . SPARSER::PROTEIN) ("TCF7L1" . SPARSER::PROTEIN)
    ("deubiquitinating enzyme CYLD" . SPARSER::PROTEIN)
    ("z-IETD-fmk" . SPARSER::DRUG) ("caspase-2" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("USP2" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN)
    ("a well-known angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI, LP or VI" . SPARSER::COLLECTION)
    ("all unfavourable prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LP" . SPARSER::PROTEIN) ("CD34 and IL-8" . SPARSER::COLLECTION)
    ("both KRAS -mutant and EGFR -mutant" . SPARSER::COLLECTION)
    ("-mutants" . SPARSER::MUTANT) ("-mutant" . SPARSER::MUTANT)
    ("pathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("age and IL-8" . SPARSER::COLLECTION)
    ("an angiogenic growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS or EGFR" . SPARSER::COLLECTION) ("IL- 8" . SPARSER::PROTEIN)
    ("EGFR–TKI" . SPARSER::PROTEIN)
    ("both the viral and cellular DNA" . SPARSER::DNA)
    ("p53 or IE72" . SPARSER::COLLECTION) ("Integrase" . SPARSER::PROTEIN)
    ("p53 and Rad51" . SPARSER::COLLECTION)
    ("proteins, p53 and Rad51" . SPARSER::COLLECTION)
    ("protein’s" . SPARSER::PROTEIN)
    ("a single viral protein" . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN) ("deoxycholate" . SPARSER::MOLECULE)
    ("RIPA" . SPARSER::PROTEIN) ("TNT" . SPARSER::PROTEIN)
    ("pGEX-p53" . SPARSER::PROTEIN-PAIR)
    ("dye, aprotinin and leupeptin" . SPARSER::COLLECTION)
    ("Bromophenol" . SPARSER::MOLECULE) ("lysozyme" . SPARSER::PROTEIN)
    ("ice" . SPARSER::PROTEIN) ("DTT" . SPARSER::MOLECULE)
    ("leupeptin" . SPARSER::DRUG) ("aprotinin" . SPARSER::PROTEIN)
    ("NaCl" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("PIs" . SPARSER::PROTEIN) ("LB/amp" . SPARSER::COLLECTION)
    ("amp" . SPARSER::PROTEIN) ("ampicillin" . SPARSER::DRUG)
    ("peroxidase (HRP)" . SPARSER::PROTEIN)
    ("Secondary Abs" . SPARSER::PROTEIN)
    ("IgG 2a and IgG 2b" . SPARSER::COLLECTION) ("TRITC" . SPARSER::MOLECULE)
    ("isothiocyanate" . SPARSER::MOLECULE)
    ("Primary mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("-IE2" . SPARSER::COLLECTION)
    ("PBS, trypsinized and re-plated" . SPARSER::COLLECTION)
    ("pCDNA3-p53pro-p53DsRed" . SPARSER::COLLECTION)
    ("pCDNA3" . SPARSER::PROTEIN) ("pCDNA3-DsRed" . SPARSER::PROTEIN-PAIR)
    ("pCLNCX-p53pro-p53GFP" . SPARSER::COLLECTION)
    ("p53-green fluorescent protein" . SPARSER::COLLECTION)
    ("control vector pSG5 (Stratagene/Agilent Technologies, Santa Clara, CA, USA) or 6 µg"
     . SPARSER::COLLECTION)
    ("puromycin" . SPARSER::DRUG) ("ON" . SPARSER::PROTEIN)
    ("minimal essential media (MEM)" . SPARSER::PROTEIN)
    ("slightly less avid" . SPARSER::DRUG)
    ("Rad51 and pGEX72" . SPARSER::COLLECTION)
    ("p53 or pGEX-KG" . SPARSER::COLLECTION)
    ("p53 or Rad51" . SPARSER::COLLECTION)
    ("Rad51 and IE72" . SPARSER::COLLECTION)
    ("wt p53 or the p53 K382R mutant" . SPARSER::COLLECTION)
    ("DNA, or introduction" . SPARSER::COLLECTION)
    ("the wt p53 and the mutant p53 genes" . SPARSER::COLLECTION)
    ("the weak wt p53 promoter" . SPARSER::PROMOTER) ("hpi" . SPARSER::PROTEIN)
    ("dL" . SPARSER::PROTEIN) ("functional GFP" . SPARSER::PROTEIN)
    ("MPZ" . SPARSER::PROTEIN) ("p53 and IE72" . SPARSER::COLLECTION)
    ("HDR" . SPARSER::PROTEIN) ("IE2" . SPARSER::PROTEIN)
    ("IgG 2a" . SPARSER::PROTEIN) ("IgG 2b" . SPARSER::BIO-COMPLEX)
    ("myelin protein zero" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("pERK and cyclin D1" . SPARSER::COLLECTION)
    ("RAS/MAP kinase" . SPARSER::COLLECTION)
    ("RAS or BRAF" . SPARSER::COLLECTION) ("Lisch" . SPARSER::PROTEIN)
    ("siRNA and shRNA" . SPARSER::COLLECTION) ("/NF1" . SPARSER::COLLECTION)
    ("ETV1 , MYC and SPRY4" . SPARSER::COLLECTION)
    ("PD0325901, AZD6244, or MEK162" . SPARSER::COLLECTION)
    ("PD0325901 or trametinib" . SPARSER::COLLECTION)
    ("AZD6244 and MEK162" . SPARSER::COLLECTION)
    ("PD0325901 and trametinib" . SPARSER::COLLECTION)
    ("Trametinib" . SPARSER::DRUG)
    ("PD0325901 and the pan-AKT inhibitor MK2206" . SPARSER::COLLECTION)
    ("pan-AKT" . SPARSER::COLLECTION) ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("CDKN2A and/or TP53" . SPARSER::COLLECTION)
    ("the NF1 and the RAS genes" . SPARSER::COLLECTION)
    ("KRAS, HRAS, and NRAS" . SPARSER::COLLECTION)
    ("the predominant RAS GTPase activating protein" . SPARSER::PROTEIN)
    ("KRAS- and NRAS-mutant" . SPARSER::COLLECTION)
    ("KRAS-" . SPARSER::PROTEIN) ("KRAS and HRAS" . SPARSER::COLLECTION)
    ("/NRAS" . SPARSER::COLLECTION) ("/RAS" . SPARSER::COLLECTION)
    ("RTKs, RAS, and RAF" . SPARSER::COLLECTION)
    ("the MEK1/2 (mitogen-activated protein kinase kinase) and ERK1/2 (extracellular signaling-regulated kinase) kinases"
     . SPARSER::COLLECTION)
    ("CRAF/RAF1" . SPARSER::COLLECTION) ("RAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION) ("MEK162" . SPARSER::DRUG)
    ("GSK1120212" . SPARSER::DRUG) ("MEK2" . SPARSER::PROTEIN)
    ("RAS GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Raf1" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS-GTP" . SPARSER::PROTEIN) ("invasive BCa" . SPARSER::PROTEIN)
    ("ACY-1215 and Tubastatin A" . SPARSER::COLLECTION)
    ("a triple-negative BCa" . SPARSER::PROTEIN) ("Danusertib" . SPARSER::DRUG)
    ("HDAC6 and AURKA" . SPARSER::COLLECTION)
    ("CTTN, AURKA, and HDAC6" . SPARSER::COLLECTION)
    ("directly binds CTTN" . SPARSER::PROTEIN)
    ("CTTN and AURKA" . SPARSER::COLLECTION)
    ("an essential effector" . SPARSER::EFFECTOR)
    ("NEDD9/AURKA" . SPARSER::COLLECTION)
    ("CTTN and HDAC6" . SPARSER::COLLECTION)
    ("tubulin and CTTN" . SPARSER::COLLECTION) ("CTC" . SPARSER::PROTEIN)
    ("BLI" . SPARSER::PROTEIN) ("HDAC6 or AURKA" . SPARSER::COLLECTION)
    ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("NEDD9-AURKA-HDAC6" . SPARSER::COLLECTION)
    ("NEDD9, AURKA, and CTTN" . SPARSER::COLLECTION)
    ("AURKA and NEDD9" . SPARSER::COLLECTION)
    ("HDAC6, CTTN and AURKA" . SPARSER::COLLECTION)
    ("AURKA-HDAC6" . SPARSER::COLLECTION)
    ("AURKA-CTTN-HDAC6" . SPARSER::COLLECTION)
    ("CTTN and the actin" . SPARSER::COLLECTION)
    ("antibody and phalloidin" . SPARSER::COLLECTION)
    ("NEDD9 and full length CTTN" . SPARSER::COLLECTION)
    ("NEDD9-CTTN" . SPARSER::COLLECTION)
    ("NEDD9 and CTTN" . SPARSER::COLLECTION)
    ("CTTN and the active Y166-phosphorylated form" . SPARSER::COLLECTION)
    ("cortactin (CTTN)" . SPARSER::PROTEIN)
    ("siN1 and siN2" . SPARSER::COLLECTION) ("siN" . SPARSER::PROTEIN)
    ("AURKA or HDAC6" . SPARSER::COLLECTION) ("BCa" . SPARSER::PROTEIN)
    ("Aurora A (AURKA)" . SPARSER::PROTEIN)
    ("resultant F-actin" . SPARSER::BIO-COMPLEX)
    ("FAK and Src" . SPARSER::COLLECTION)
    ("AURKA and HDAC6" . SPARSER::COLLECTION) ("Alisertib" . SPARSER::DRUG)
    ("KR" . SPARSER::PROTEIN) ("NEDD9 or AURKA" . SPARSER::COLLECTION)
    ("kinase (AURKA)" . SPARSER::KINASE) ("AURKA" . SPARSER::PROTEIN)
    ("The prometastatic protein NEDD9" . SPARSER::PROTEIN)
    ("PHA680632" . SPARSER::DRUG) ("SIRT-1" . SPARSER::PROTEIN)
    ("siN1" . SPARSER::PROTEIN) ("ACY-1215" . SPARSER::DRUG)
    ("MLN8054" . SPARSER::DRUG) ("Il2rg" . SPARSER::PROTEIN)
    ("alpha tubulin" . SPARSER::PROTEIN) ("MLN8237" . SPARSER::DRUG)
    ("P300/CBP-associated factor" . SPARSER::PROTEIN)
    ("NEDD9" . SPARSER::PROTEIN)
    ("monocytes and antigen" . SPARSER::COLLECTION)
    ("Tcf-1 and chromatin" . SPARSER::COLLECTION)
    ("Foxp3 and RORγt" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("bona fide promoter and intragenic regions of the RORγt gene"
     . SPARSER::COLLECTION)
    ("Rorc" . SPARSER::PROTEIN) ("IL-17, IFNγ, and TNFα" . SPARSER::COLLECTION)
    ("TH1" . SPARSER::PROTEIN) ("IL-17, TNFα, and IL6" . SPARSER::COLLECTION)
    ("CD69, CD122, and NKG2D" . SPARSER::COLLECTION)
    ("blot (WB)" . SPARSER::PROTEIN) ("CD4 and CD8" . SPARSER::COLLECTION)
    ("mast cell" . SPARSER::PROTEIN) ("Foxp3-Cre" . SPARSER::COLLECTION)
    ("CD4Cre" . SPARSER::PROTEIN) ("progeny" . SPARSER::PROTEIN)
    ("Ctnnb1" . SPARSER::PROTEIN) ("IL-17 and RORγt" . SPARSER::COLLECTION)
    ("the mutated APC allele" . SPARSER::ALLELE) ("MLN" . SPARSER::PROTEIN)
    ("Foxp3-GFP" . SPARSER::COLLECTION)
    ("the Adenomatous Polyposis Coli (APC) gene" . SPARSER::PROTEIN)
    ("β-catenin and CD3" . SPARSER::COLLECTION)
    ("CD3 and β-catenin" . SPARSER::COLLECTION)
    ("CD3 (T-cells) and β-catenin" . SPARSER::COLLECTION)
    ("secondary fluorescent conjugated antibodies" . SPARSER::ANTIBODY)
    ("β-catenin and Wnt" . SPARSER::COLLECTION)
    ("the adenomatous polyposis coli (APC) gene" . SPARSER::PROTEIN)
    ("IBD and colon cancer" . SPARSER::COLLECTION) ("ROR" . SPARSER::PROTEIN)
    ("sporadic colon cancer" . SPARSER::PROTEIN) ("IL-17 R" . SPARSER::PROTEIN)
    ("IL-17 F" . SPARSER::PROTEIN) ("Triton x-100" . SPARSER::MOLECULE)
    ("CD45RB" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("tm2" . SPARSER::PROTEIN-FAMILY)
    ("CD62L" . SPARSER::PROTEIN) ("CD122" . SPARSER::PROTEIN)
    ("Rag2" . SPARSER::PROTEIN) ("orphan receptor" . SPARSER::PROTEIN)
    ("Tcf-1" . SPARSER::PROTEIN) ("RORγt" . SPARSER::PROTEIN)
    ("MAPs-" . SPARSER::PROTEIN) ("Ser or Thr" . SPARSER::COLLECTION)
    ("Asp or Glu" . SPARSER::COLLECTION)
    ("microtubule-associated proteins (MAPs) and GTP molecules"
     . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("taxol" . SPARSER::DRUG) ("GEFs/GAPs" . SPARSER::COLLECTION)
    ("GDP–GTP" . SPARSER::PROTEIN-PAIR)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("IQGAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a membrane-associated GTPase" . SPARSER::GTPASE)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("EB1, CLIP-170, or CLASP" . SPARSER::COLLECTION)
    ("CLASP" . SPARSER::PROTEIN) ("The dramatic impact" . SPARSER::PROTEIN)
    ("PDBu" . SPARSER::MOLECULE)
    ("a membrane-permeable PKC activator" . SPARSER::ACTIVATOR)
    ("highly pure components" . SPARSER::COMPONENT)
    ("The resulting negatively-charged phosphate group" . SPARSER::MOLECULE)
    ("pseudo-phosphorylated S165D-α-tubulin" . SPARSER::PROTEIN)
    ("This cell-permeable molecule" . SPARSER::MOLECULE)
    ("Cdc42 or RhoA" . SPARSER::COLLECTION)
    ("Rac1 and Cdc42, or Rhotekin-agarose" . SPARSER::COLLECTION)
    ("Cdc42, or Rhotekin-agarose" . SPARSER::COLLECTION)
    ("α6-tubulin (S165D) or phosphorylation-resistant mutant (S165N)"
     . SPARSER::COLLECTION)
    ("Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("EB1-EGFP" . SPARSER::COLLECTION)
    ("the pseudo-phosphorylated mutant produced a 37" . SPARSER::PROTEIN)
    ("myc-α6-tubulin" . SPARSER::COLLECTION)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("the insoluble and soluble fractions" . SPARSER::COMPONENT)
    ("anti-myc or anti-α-tubulin" . SPARSER::COLLECTION)
    ("VC" . SPARSER::MOLECULE) ("DsRed and EGFP" . SPARSER::COLLECTION)
    ("a large fluorescent fusion protein" . SPARSER::PROTEIN)
    ("expressed DsRed and the mutant" . SPARSER::COLLECTION)
    ("pBI" . SPARSER::PROTEIN)
    ("a pseudo-phosphorylated α6-tubulin" . SPARSER::PROTEIN)
    ("a cell permeable PKC activator" . SPARSER::ACTIVATOR)
    ("EGFP-α-tubulin" . SPARSER::COLLECTION)
    ("Ser-165 mutants or DAG-lactone" . SPARSER::COLLECTION)
    ("the pseudo-phosphorylated mutant" . SPARSER::MUTANT)
    ("specific substrates as well as substrates" . SPARSER::COLLECTION)
    ("the atypical isoforms" . SPARSER::ISOFORM)
    ("structurally-related isoforms" . SPARSER::ISOFORM)
    ("nocodazole or vinblastine" . SPARSER::COLLECTION)
    ("polymers" . SPARSER::MOLECULE)
    ("monomeric (soluble) tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymer" . SPARSER::MOLECULE) ("Taxol" . SPARSER::DRUG)
    ("GFP-EB1" . SPARSER::COLLECTION) ("pan-PKC" . SPARSER::COLLECTION)
    ("bis" . SPARSER::PROTEIN)
    ("a pseudo-phosphorylated S165D-α6-tubulin mutant" . SPARSER::MUTANT)
    ("GFP-α-tubulin" . SPARSER::COLLECTION)
    ("trypsin inhibitor" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("β–tubulin" . SPARSER::PROTEIN) ("TUBA1C" . SPARSER::PROTEIN)
    ("Kα1" . SPARSER::PROTEIN) ("TUBA1B" . SPARSER::PROTEIN)
    ("anti-mitotic" . SPARSER::MOLECULE) ("α6-tubulin" . SPARSER::PROTEIN)
    ("a potentially translatable biomarker" . SPARSER::MOLECULE)
    ("an attractive PET" . SPARSER::PROTEIN) ("PEG" . SPARSER::PROTEIN)
    ("isatin" . SPARSER::MOLECULE)
    ("mutant BRAF and a PI3K/mTOR inhibitor" . SPARSER::COLLECTION)
    ("prodrug-" . SPARSER::DRUG)
    ("physically plausible low-energy complex" . SPARSER::BIO-COMPLEX)
    ("VAD-FMK peptides irreversibly bind active caspase" . SPARSER::PROTEIN)
    ("the dual-agent-treated cohort" . SPARSER::MOLECULE)
    ("BEZ-235 or PLX-4720" . SPARSER::COLLECTION)
    ("mutant BRAF and a PI3K family inhibitor" . SPARSER::COLLECTION)
    ("correlative PET" . SPARSER::PROTEIN)
    ("other relevant caspases" . SPARSER::PROTEIN)
    ("Peptide" . SPARSER::PEPTIDE) ("Crash" . SPARSER::PROTEIN)
    ("thiol" . SPARSER::MOLECULE) ("ketone" . SPARSER::MOLECULE)
    ("IZ-VAD-FMK" . SPARSER::COLLECTION) ("VAD-FMK" . SPARSER::COLLECTION)
    ("tripeptide" . SPARSER::MOLECULE)
    ("Clinically robust molecular imaging biomarkers" . SPARSER::MOLECULE)
    ("potentially translatable biomarker" . SPARSER::MOLECULE)
    ("mutant BRAF and a dual PI3K/mTOR inhibitor" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("two-step" . SPARSER::PROTEIN) ("FB-VAD-FMK" . SPARSER::COLLECTION)
    ("PET" . SPARSER::PROTEIN) ("FMK" . SPARSER::PROTEIN)
    ("FB" . SPARSER::PROTEIN) ("proteases, or caspases" . SPARSER::COLLECTION)
    ("Cysteine" . SPARSER::AMINO-ACID) ("caspases-3" . SPARSER::PROTEIN)
    ("BEZ-235" . SPARSER::DRUG) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("ID 3" . SPARSER::PROTEIN) ("ID 2" . SPARSER::PROTEIN)
    ("Val-Ala" . SPARSER::MOLECULE) ("the unequal GOF" . SPARSER::PROTEIN)
    ("the exact mutation form" . SPARSER::FORM)
    ("unequal p53 GOF" . SPARSER::PROTEIN)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("types and strengths" . SPARSER::COLLECTION)
    ("unequal GOF" . SPARSER::PROTEIN)
    ("different types and magnitudes" . SPARSER::COLLECTION)
    ("soluble guanylyl cyclase" . SPARSER::PROTEIN)
    ("eNOS and caveolin 1" . SPARSER::COLLECTION)
    ("GUCY1A3/GUCY1B3" . SPARSER::COLLECTION)
    ("reproductive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("da" . SPARSER::MOLECULE) ("c-FOS, and SNPs" . SPARSER::COLLECTION)
    ("CDR" . SPARSER::PROTEIN) ("Hg" . SPARSER::MOLECULE)
    ("sGC" . SPARSER::PROTEIN) ("caveolin 1 and eNOS" . SPARSER::COLLECTION)
    ("caveolin 1 and caveolin 2" . SPARSER::COLLECTION)
    ("CAV1 and CAV2" . SPARSER::COLLECTION) ("BAS" . SPARSER::PROTEIN)
    ("OPTN" . SPARSER::PROTEIN) ("MYOC" . SPARSER::PROTEIN)
    ("MACH" . SPARSER::PROTEIN) ("CAV1/CAV2" . SPARSER::COLLECTION)
    ("GUCY1B3" . SPARSER::PROTEIN) ("GUCY1A3" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN)
    ("soluble guanylate cyclase" . SPARSER::PROTEIN)
    ("NOS3" . SPARSER::PROTEIN) ("caveolin 2" . SPARSER::PROTEIN)
    ("CDKN2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIX6" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("TMCO1" . SPARSER::PROTEIN)
    ("open angle" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("CAV2" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("TW and YC" . SPARSER::COLLECTION) ("TW" . SPARSER::PROTEIN)
    ("cyclin E2 and the cytoskeletal protein talin2" . SPARSER::COLLECTION)
    ("the cytoskeletal protein talin2" . SPARSER::PROTEIN)
    ("the humanized monoclonal erbB2/HER2 antibody trastuzumab"
     . SPARSER::DRUG)
    ("the most threatening pathological types" . TYPE)
    ("miR-375 directly targets IGF1R" . SPARSER::PROTEIN)
    ("EMBL-EBI" . SPARSER::PROTEIN-PAIR) ("EBI" . SPARSER::PROTEIN)
    ("differentially expressed miRNAs" . SPARSER::MICRO-RNA)
    ("humanized monoclonal erbB2/HER2 antibody" . SPARSER::ANTIBODY)
    ("erbB2/HER2" . SPARSER::COLLECTION) ("Herceptin" . SPARSER::DRUG)
    ("talin2" . SPARSER::PROTEIN) ("cyclin E2" . SPARSER::PROTEIN)
    ("IGFR1" . SPARSER::PROTEIN) ("miR-181a" . SPARSER::MOLECULE)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("YF" . SPARSER::MOLECULE) ("ZW" . SPARSER::PROTEIN)
    ("stab1, ccnd2, and fscn1" . SPARSER::COLLECTION)
    ("fscn1" . SPARSER::PROTEIN) ("ccnd2" . SPARSER::PROTEIN)
    ("stab1" . SPARSER::PROTEIN)
    ("cyclin D1, VEGF, IL-8, COX2, and MMP9" . SPARSER::COLLECTION)
    ("siRNA or miR-425" . SPARSER::COLLECTION)
    ("PTEN, and PTEN" . SPARSER::COLLECTION)
    ("the DNA binding subunit p50 and the transactivation subunit p65 [ xref ]"
     . SPARSER::COLLECTION)
    ("a heterodimeric transcription activator" . SPARSER::ACTIVATOR)
    ("AKT/PKB" . SPARSER::COLLECTION)
    ("a modulatory cytokine" . SPARSER::PROTEIN)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("exogenous PTEN" . SPARSER::PROTEIN)
    ("monoclonal anti-NF-kappaB antibodies" . SPARSER::ANTIBODY)
    ("offs" . SPARSER::PROTEIN) ("lib" . SPARSER::DRUG)
    ("pri" . SPARSER::PROTEIN) ("an essential kinase" . SPARSER::KINASE)
    ("PTEN-CDS" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("BD LSR II flow cytometry" . SPARSER::PROTEIN) ("LSR" . SPARSER::PROTEIN)
    ("annexin-V and propidium" . SPARSER::COLLECTION)
    ("A positive control antibody (RNA polymerase II) and a negative control non-immune IgG"
     . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("luciferase and renilla" . SPARSER::COLLECTION)
    ("IRdye-labeled secondary antibodies" . SPARSER::ANTIBODY)
    ("LI-COR" . SPARSER::COLLECTION) ("NE" . SPARSER::PROTEIN)
    ("COR" . SPARSER::PROTEIN)
    ("a mouse monoclonal anti-PTEN antibody (1:500, Santa Cruz, sc-7974) and a NF-kappaB p65 Phospho (pS536) (RELA) antibody"
     . SPARSER::COLLECTION)
    ("a mouse monoclonal anti-PTEN antibody" . SPARSER::ANTIBODY)
    ("PVDF" . SPARSER::DRUG) ("TRIzol" . SPARSER::DRUG)
    ("Sigma-Aldrich" . SPARSER::PROTEIN-PAIR) ("TX" . SPARSER::PROTEIN)
    ("streptomycin" . SPARSER::DRUG)
    ("the human gastric adenocarcinoma cell line AGS" . SPARSER::PROTEIN)
    ("CRL-" . SPARSER::PROTEIN) ("HTB" . SPARSER::DRUG)
    ("IκBα, IκBβ, and IκB" . SPARSER::COLLECTION)
    ("RelA- or cRel-containing complexes [ xref ]" . SPARSER::COLLECTION)
    ("RelA-" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("Interleukin-1" . SPARSER::PROTEIN) ("TPCA-1" . SPARSER::DRUG)
    ("IκBβ" . SPARSER::PROTEIN) ("FY" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION) ("NAA" . SPARSER::MOLECULE)
    ("mRNA and secretion" . SPARSER::COLLECTION)
    ("MCP-1, IL-8, and IL-6" . SPARSER::COLLECTION)
    ("adipocytes" . SPARSER::PROTEIN)
    ("both maraviroc and TAK-779" . SPARSER::COLLECTION)
    ("receptor and CCR5 or CXCR4" . SPARSER::COLLECTION)
    ("CCR5 or CXCR4" . SPARSER::COLLECTION)
    ("co-receptors and cytoskeletal actin [ xref ]" . SPARSER::COLLECTION)
    ("cytoskeletal actin" . SPARSER::PROTEIN)
    ("ERK1/2, AKT, and STAT" . SPARSER::COLLECTION)
    ("the predominant Rac isoform" . SPARSER::ISOFORM)
    ("integrin-" . SPARSER::PROTEIN)
    ("cellular integrins and adhesion molecules" . SPARSER::COLLECTION)
    ("cellular integrins" . SPARSER::PROTEIN)
    ("IL6, and STAT1" . SPARSER::COLLECTION)
    ("the neuronal marker MAP2" . SPARSER::PROTEIN)
    ("Cytoskeletal-associated proteins" . SPARSER::PROTEIN)
    ("MPs cytoskeletal-associated proteins" . SPARSER::PROTEIN)
    ("a slowly reversible CCR5 antagonist [ xref ] and the only FDA-approved entry inhibitor"
     . SPARSER::COLLECTION)
    ("Maraviroc" . SPARSER::DRUG) ("Chemokine" . SPARSER::PROTEIN)
    ("the CCR5 antagonists maraviroc and TAK-779 diminished HIV-induced phosphorylation of Rac1 and ERK1/2 (Figure  xref E)"
     . SPARSER::COLLECTION)
    ("Rac1 and ERK1/2" . SPARSER::COLLECTION)
    ("2.4-fold (P < 0.001) and 1.6-fold (P < 0.01) higher CTTN mRNA"
     . SPARSER::RNA)
    ("RAC1 and CTTN" . SPARSER::COLLECTION)
    ("age and PMI" . SPARSER::COLLECTION)
    ("post-mortem" . SPARSER::PROTEIN-PAIR) ("PMI" . SPARSER::PROTEIN)
    ("cortactin and Rac1, and Rac1" . SPARSER::COLLECTION)
    ("Rac1, and Rac1" . SPARSER::COLLECTION)
    ("gp120 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Gag" . SPARSER::PROTEIN) ("gag and tat mRNA" . SPARSER::COLLECTION)
    ("MCSF" . SPARSER::PROTEIN)
    ("p24 or reverse transcriptase" . SPARSER::COLLECTION)
    ("chemokine and integrin" . SPARSER::COLLECTION)
    ("these cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("vasodilator-stimulated phosphoprotein (VASP)" . SPARSER::PROTEIN)
    ("VASP" . SPARSER::PROTEIN)
    ("8 cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("the remaining 128 cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("the cytoskeleton-associated protein" . SPARSER::PROTEIN)
    ("Both maraviroc (Figure  xref A-F) and TAK-779 (Figure  xref G-L) significantly diminished MDM infection"
     . SPARSER::COLLECTION)
    ("proteins, and CCR5" . SPARSER::COLLECTION)
    ("Cortactin and Rac1" . SPARSER::COLLECTION)
    ("Cortactin" . SPARSER::PROTEIN)
    ("cortactin gene ( CTTN ) and RAC1" . SPARSER::COLLECTION)
    ("gene ( CTTN )" . SPARSER::PROTEIN) ("CTTN" . SPARSER::PROTEIN)
    ("monocytes cytoskeletal proteins" . SPARSER::PROTEIN)
    ("macrophages (MDM)" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("antiretroviral drugs" . SPARSER::DRUG)
    ("receptor, CCR5 or CXCR4" . SPARSER::COLLECTION)
    ("the CD4 receptor and/or co-receptors" . SPARSER::COLLECTION)
    ("CCR5 and CXCR4" . SPARSER::COLLECTION) ("MPs" . SPARSER::PROTEIN)
    ("cytoskeletal proteins" . SPARSER::PROTEIN) ("maraviroc" . SPARSER::DRUG)
    ("Rac1 and cortactin" . SPARSER::COLLECTION)
    ("cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("Rac1/cdc42" . SPARSER::COLLECTION) ("IBA1" . SPARSER::PROTEIN)
    ("CD163" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("G-I" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("pRac1" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::PROTEIN) ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vasodilator-stimulated phosphoprotein" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("A-F" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("envelope glycoprotein gp160" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN)
    ("using selective mTORC1 inhibitors and/or p70S6K1 inhibitors"
     . SPARSER::COLLECTION)
    ("PI3K-PDK1" . SPARSER::COLLECTION)
    ("the basic helix-loop-helix factors, TCF3 and Twist1"
     . SPARSER::COLLECTION)
    ("proteins, Snail, Slug, Zeb1, and Zeb2" . SPARSER::COLLECTION)
    ("factors, TCF3 and Twist1" . SPARSER::COLLECTION)
    ("rapamycin and its derivatives" . SPARSER::COLLECTION)
    ("LAM [ xref ] and Tuberous Sclerosis Complex [ xref ]"
     . SPARSER::COLLECTION)
    ("immunomodulators" . SPARSER::DRUG)
    ("Vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("Vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("E-Cadherin and Vimentin" . SPARSER::COLLECTION)
    ("LiCl and MG132" . SPARSER::COLLECTION)
    ("Indeed Snail, Zeb2, and Twist1 mRNAs" . SPARSER::PROTEIN)
    ("LiCl, a GSK-3β inhibitor, and E-cadherin repressor complex mRNA expression"
     . SPARSER::COLLECTION)
    ("Snail, Zeb2, and Twist" . SPARSER::COLLECTION)
    ("Akt/GSK-3β" . SPARSER::COLLECTION) ("Akt-GSK-3" . SPARSER::COLLECTION)
    ("mTORC1, mTORC2 and Rheb" . SPARSER::COLLECTION)
    ("E-cadherin and the other components" . SPARSER::COLLECTION)
    ("catenin-δ-1" . SPARSER::COLLECTION)
    ("rapamycin, an mTOR inhibitor, and expression of E-cadherin"
     . SPARSER::COLLECTION)
    ("E-cadherin and EMT" . SPARSER::COLLECTION)
    ("Akt and GSK-3β" . SPARSER::COLLECTION)
    ("IRS1 [ xref , xref ] or Grb10 [ xref ]" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("EMT and mTOR" . SPARSER::COLLECTION)
    ("Akt and serum/glucocorticoid regulated kinase 1" . SPARSER::COLLECTION)
    ("4E-BP1 and 4E-BP2" . SPARSER::COLLECTION)
    ("mSin1, and Protor" . SPARSER::COLLECTION)
    ("mLST8/GβL" . SPARSER::COLLECTION) ("Protor" . SPARSER::PROTEIN-FAMILY)
    ("TSC" . SPARSER::PROTEIN) ("AKT/GSK-3β" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("Snail, Zeb2, and Twist1" . SPARSER::COLLECTION)
    ("Zeb2 and Twist1" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("regulatory-associated protein" . SPARSER::PROTEIN)
    ("E-cadherin and rapamycin" . SPARSER::COLLECTION)
    ("Rapamycin-insensitive companion of mTOR" . SPARSER::PROTEIN)
    ("Regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("plasma)" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("δ-1" . SPARSER::PROTEIN) ("IPO8" . SPARSER::PROTEIN)
    ("PDPK1" . SPARSER::PROTEIN) ("IGF-1-" . SPARSER::PROTEIN)
    ("serum/glucocorticoid regulated kinase 1" . SPARSER::PROTEIN)
    ("4E-BP2" . SPARSER::PROTEIN) ("mSin1" . SPARSER::PROTEIN)
    ("GβL" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("factor-kappaB" . SPARSER::COLLECTION) ("janus" . SPARSER::PROTEIN-FAMILY)
    ("PP2A-NDRG2" . SPARSER::COLLECTION)
    ("a contributory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NDRG2-PP2A" . SPARSER::COLLECTION)
    ("NDRG2 and PP2A" . SPARSER::COLLECTION)
    ("SGK1 (serum- and glucocorticoid-induced kinase 1), PKCθ (protein kinase C-θ) and AKT"
     . SPARSER::COLLECTION)
    ("hypoxia-ischemia" . SPARSER::COLLECTION) ("NDRG2-" . SPARSER::PROTEIN)
    ("NDRG2 and as yet unidentified protein kinases" . SPARSER::COLLECTION)
    ("a possible tumour suppressor" . SPARSER::SUPPRESSOR)
    ("NDRG2 and PP2Ac" . SPARSER::COLLECTION)
    ("PP2Ac and the structural A subunit" . SPARSER::COLLECTION)
    ("PP1c or PP5c" . SPARSER::COLLECTION) ("KK1/NDRG2" . SPARSER::COLLECTION)
    ("pThr" . SPARSER::PROTEIN)
    ("phosphatases, PP1 and PP2A" . SPARSER::COLLECTION)
    ("NDRG" . SPARSER::PROTEIN-FAMILY) ("NDR" . SPARSER::PROTEIN)
    ("hydrolase" . SPARSER::PROTEIN)
    ("Exogenously expressed green fluorescent protein (GFP)-tagged PTEN and FLAG-tagged NDRG2 co-precipitated"
     . SPARSER::COLLECTION)
    ("NDRG2 and PTEN" . SPARSER::COLLECTION)
    ("antibody and co-localized" . SPARSER::COLLECTION)
    ("NDRG2-associated proteins" . SPARSER::PROTEIN)
    ("CX" . SPARSER::PROTEIN-FAMILY) ("TBB" . SPARSER::PROTEIN)
    ("KK1-NDRG2" . SPARSER::COLLECTION) ("Shi-" . SPARSER::PROTEIN)
    ("NOG" . SPARSER::PROTEIN) ("Shi" . SPARSER::PROTEIN)
    ("PTEN and PIK3CA" . SPARSER::COLLECTION)
    ("PTEN and NDRG2" . SPARSER::COLLECTION)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("a PTEN-associated protein" . SPARSER::PROTEIN)
    ("serine–threonine" . SPARSER::COLLECTION)
    ("ligases, NEDD4-1 and WWP2" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN) ("refs" . SPARSER::PROTEIN)
    ("HBZ" . SPARSER::PROTEIN)
    ("the viral transactivating protein Tax" . SPARSER::PROTEIN)
    ("Tax" . SPARSER::PROTEIN) ("PTEN and PI3KCA" . SPARSER::COLLECTION)
    ("-AKT" . SPARSER::COLLECTION) ("RP23" . SPARSER::PROTEIN)
    ("PR65" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSC4" . SPARSER::PROTEIN) ("HSC2" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("MT4" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("regulatory subunit B" . SPARSER::PROTEIN)
    ("Clk2" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("PP5" . SPARSER::PROTEIN) ("PP1c" . SPARSER::PROTEIN)
    ("PP2Ac" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("forkhead box protein O" . SPARSER::PROTEIN) ("KK1" . SPARSER::PROTEIN)
    ("SHIP1" . SPARSER::PROTEIN) ("SO4" . SPARSER::PROTEIN)
    ("alpha–" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("WWP2" . SPARSER::PROTEIN) ("NEDD4-1" . SPARSER::PROTEIN)
    ("NDRG2" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene 2" . SPARSER::PROTEIN)
    ("decitabine and temozolomide" . SPARSER::COLLECTION)
    ("temozolomide, streptozotocin, and dacarbazine" . SPARSER::COLLECTION)
    ("BCNU" . SPARSER::DRUG) ("carmustine" . SPARSER::DRUG)
    ("neuro-oncology" . SPARSER::PROTEIN-PAIR) ("neuro" . SPARSER::PROTEIN)
    ("a hypermethylated MGMT promoter" . SPARSER::PROMOTER)
    ("decitabine and azacitidine" . SPARSER::COLLECTION)
    ("azacitidine" . SPARSER::DRUG)
    ("either epigenetic mark" . SPARSER::PROTEIN)
    ("exon-intron" . SPARSER::COLLECTION)
    ("factors and chromatin" . SPARSER::COLLECTION)
    ("the promoter and increase MGMT expression" . SPARSER::COLLECTION)
    ("a methylated promoter" . SPARSER::PROMOTER)
    ("IDH1 and IDH2" . SPARSER::COLLECTION)
    ("an unmodified promoter and high levels of MGMT expression"
     . SPARSER::COLLECTION)
    ("Decitabine" . SPARSER::DRUG)
    ("an unmodified promoter and high levels of gene body cytosine modification (Group 1)"
     . SPARSER::COLLECTION)
    ("promoter and gene" . SPARSER::COLLECTION)
    ("Cytosine" . SPARSER::NUCLEOBASE) ("SNP and MGMT" . SPARSER::COLLECTION)
    ("mC" . SPARSER::PROTEIN)
    ("A temozolomide-associated SNP" . SPARSER::PROTEIN)
    ("a more highly methylated promoter" . SPARSER::PROMOTER)
    ("protein, and 16/40" . SPARSER::COLLECTION)
    ("an aberrantly hypermethylated MGMT promoter" . SPARSER::PROMOTER)
    ("-guanine" . SPARSER::COLLECTION) ("Temozolomide" . SPARSER::DRUG)
    ("nitrosamines" . SPARSER::MOLECULE) ("MGMT-" . SPARSER::PROTEIN)
    ("decitabine" . SPARSER::DRUG) ("U87MG" . SPARSER::PROTEIN)
    ("( beta" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("EC and EK" . SPARSER::COLLECTION) ("EK" . SPARSER::PROTEIN)
    ("Stimulatory α subunit" . SPARSER::FRAGMENT)
    ("uridine" . SPARSER::PROTEIN)
    ("ATM, PP2A and NF-κB" . SPARSER::COLLECTION)
    ("receptors and prostaglandin E2" . SPARSER::COLLECTION)
    ("IκB and NF-κB" . SPARSER::COLLECTION)
    ("NEMO, and ATM" . SPARSER::COLLECTION)
    ("directly link DNA" . SPARSER::DNA)
    ("TRF1
[ xref ] and NBS1
[ xref ]"
     . SPARSER::COLLECTION)
    ("proteins, p53, and histone deacetylase" . SPARSER::COLLECTION)
    ("KU55933, and siRNA" . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::MOLECULE) ("MRE11–RAD50–NBS1" . SPARSER::COLLECTION)
    ("Prostaglandin E2 or isoproterenol" . SPARSER::COLLECTION)
    ("Isoproterenol" . SPARSER::PROTEIN)
    ("prostaglandin E2 and isoproterenol" . SPARSER::COLLECTION)
    ("Prostaglandin E2 and isoproterenol" . SPARSER::COLLECTION)
    ("Ray" . SPARSER::PROTEIN)
    ("PDTC, BAY 11–7082, and IKK" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("benzoyl" . SPARSER::MOLECULE) ("p53 and CHK2" . SPARSER::COLLECTION)
    ("the subcellular fractions" . SPARSER::COMPONENT)
    ("ATM and H2AX" . SPARSER::COLLECTION)
    ("Rad50, Ku70, and Ku80" . SPARSER::COLLECTION)
    ("stimulatory heterotrimeric GTP binding protein" . SPARSER::PROTEIN)
    ("EE" . SPARSER::PROTEIN) ("γ-ray-induced DNA" . SPARSER::DNA)
    ("Bcl-2 family proteins
[ xref , xref ] and the inhibitor"
     . SPARSER::COLLECTION)
    ("monomeric G protein Raps" . SPARSER::PROTEIN)
    ("protein kinase (PKA)" . SPARSER::PROTEIN) ("Raps" . SPARSER::PROTEIN)
    ("stimulatory heterotrimeric GTP-binding proteins" . SPARSER::PROTEIN)
    ("-AMP" . SPARSER::AMP) ("cyclases" . SPARSER::PROTEIN)
    ("radiosensitizers" . SPARSER::DRUG)
    ("ATR, DNA-PKcs and mTOR" . SPARSER::COLLECTION) ("PIKK" . SPARSER::KINASE)
    ("RAD" . SPARSER::PROTEIN) ("SSBs" . SPARSER::PROTEIN)
    ("prostaglandin E2 or isoproterenol" . SPARSER::COLLECTION)
    ("ATM and NF-κB" . SPARSER::COLLECTION)
    ("PDTC or inhibition of ATM using KU55933 or siRNA" . SPARSER::COLLECTION)
    ("KU55933 or siRNA" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("ATM and protein phosphatase 2A" . SPARSER::COLLECTION)
    ("cytometry, and TUNNEL" . SPARSER::COLLECTION)
    ("constitutively active stimulatory G protein" . SPARSER::PROTEIN)
    ("radiation-induced DNA" . SPARSER::DNA)
    ("Protein phosphatase 2A" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("glutamine residue" . SPARSER::MOLECULE)
    ("Phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("KU-55933" . SPARSER::DRUG) ("cAMP phosphodiesterase" . SPARSER::PROTEIN)
    ("Prostaglandin E2" . SPARSER::MOLECULE) ("BAY 11–7082" . SPARSER::DRUG)
    ("long form" . SPARSER::PROTEIN)
    ("G protein coupled receptor" . SPARSER::PROTEIN)
    ("Cyclic adenosine 3', 5'-monophosphate" . SPARSER::CAMP)
    ("kinase-like" . SPARSER::PROTEIN-FAMILY) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("TIGAR and Glut3" . SPARSER::COLLECTION) ("TIGAR" . SPARSER::PROTEIN)
    ("p53/Mdm2" . SPARSER::COLLECTION) ("Tg" . SPARSER::PROTEIN)
    ("PGAM-Tg" . SPARSER::COLLECTION) ("p53 and PGAM" . SPARSER::COLLECTION)
    ("cancer-associated Mdm2 mutants" . SPARSER::MUTANT)
    ("Mdm2 and PGAM" . SPARSER::COLLECTION) ("Merlin" . SPARSER::PROTEIN)
    ("p53–Mdm2" . SPARSER::COLLECTION)
    ("HIF-1α ( xref ) or c-Myc ( xref )" . SPARSER::COLLECTION)
    ("both Mdm2 and the glycolytic enzyme PGAM" . SPARSER::COLLECTION)
    ("the relevant mutants" . SPARSER::MUTANT)
    ("the cytomegalovirus immediate-to-early enhancer element and chicken β-actin promoters"
     . SPARSER::PROMOTER)
    ("Ras-G12V–expressing wild-type MEFs" . SPARSER::PROTEIN)
    ("Mdm2 and either PGAM or p53 (Fig. S5, F and G)" . SPARSER::COLLECTION)
    ("PGAM or p53" . SPARSER::COLLECTION)
    ("the cancer-associated Mdm2-M459I variant" . SPARSER::VARIANT)
    ("p21 CIP1 , Bax, and Mdm2" . SPARSER::COLLECTION)
    ("the three cancer-associated variants" . SPARSER::VARIANT)
    ("PGAM and p53" . SPARSER::COLLECTION)
    ("ID1 and ID2" . SPARSER::COLLECTION) ("TN and TC" . SPARSER::COLLECTION)
    ("ligase, and PGAM2" . SPARSER::COLLECTION)
    ("PGAM-FLAG" . SPARSER::COLLECTION) ("HA-Pak1" . SPARSER::COLLECTION)
    ("Myc-Mdm2–expressing DKO MEFs" . SPARSER::PROTEIN)
    ("Myc-Mdm2" . SPARSER::COLLECTION) ("inp53" . SPARSER::PROTEIN)
    ("the relevant ubiquitin ligase" . SPARSER::PROTEIN)
    ("p53-GFP" . SPARSER::COLLECTION) ("TGP" . SPARSER::PROTEIN)
    ("PGAM2-FLAG" . SPARSER::COLLECTION)
    ("Nonphosphorylatable mutants" . SPARSER::MUTANT)
    ("Cys or Ala" . SPARSER::COLLECTION)
    ("Pak1-expressing primary MEFs" . SPARSER::PROTEIN)
    ("stress-induced Pak1" . SPARSER::PROTEIN)
    ("etoposide ( xref and Fig. S1 M) or RasG12V ( xref and Fig. S1 N)"
     . SPARSER::COLLECTION)
    ("TIG3" . SPARSER::PROTEIN) ("PGAM1 and PGAM2" . SPARSER::COLLECTION)
    ("PFK, PGK, enolase, and GAPDH" . SPARSER::COLLECTION)
    ("enolase" . SPARSER::PROTEIN) ("PGK" . SPARSER::PROTEIN)
    ("antiserum" . SPARSER::PROTEIN)
    ("the respective homodimers" . SPARSER::HOMODIMER)
    ("PGAM1 (brain form) and PGAM2 (muscle form)" . SPARSER::COLLECTION)
    ("SIS" . SPARSER::PROTEIN) ("Cdc42/Rac1" . SPARSER::COLLECTION)
    ("the muscle-specific form" . SPARSER::FORM)
    ("the only glycolytic enzyme" . SPARSER::PROTEIN)
    ("specifically target PGAM" . SPARSER::PROTEIN)
    ("phosphoglycerate mutase (PGAM)" . SPARSER::PROTEIN)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("PGAM and Mdm2" . SPARSER::COLLECTION)
    ("oncogene- or DNA" . SPARSER::COLLECTION)
    ("a ubiquitin ligase and downstream effector" . SPARSER::COLLECTION)
    ("Mdm2, a ubiquitin ligase and downstream effector" . SPARSER::COLLECTION)
    ("PGAM" . SPARSER::PROTEIN) ("RPL13" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("PO 3" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("Glut3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ID2" . SPARSER::PROTEIN) ("ID1" . SPARSER::PROTEIN)
    ("UbcH5b" . SPARSER::PROTEIN) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("3 B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2 B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PGAM2" . SPARSER::PROTEIN)
    ("PGAM1" . SPARSER::PROTEIN) ("d -glucose" . SPARSER::MOLECULE)
    ("phosphoglycerate mutase" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("SCG" . SPARSER::PROTEIN) ("GD" . SPARSER::PROTEIN)
    ("regulators-" . SPARSER::REGULATOR)
    ("a natural flavonoid" . SPARSER::MOLECULE)
    ("the cancer chemopreventive agent Silibinin" . SPARSER::DRUG)
    ("Silibinin" . SPARSER::DRUG) ("GSK-3β and/or PKD1" . SPARSER::COLLECTION)
    ("Vimentin or other EMT regulators" . SPARSER::COLLECTION)
    ("Maspin and/or RKIP" . SPARSER::COLLECTION)
    ("Raf-1/MEK/ERK" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("mesenchymal markers Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("ZEB-1 and LEF-1" . SPARSER::COLLECTION) ("Maspin" . SPARSER::PROTEIN)
    ("CCL5 and ERK" . SPARSER::COLLECTION)
    ("survival factor and inhibitor of cellular senescence"
     . SPARSER::INHIBITOR)
    ("factor and inhibitor" . SPARSER::COLLECTION)
    ("Integrins" . SPARSER::PROTEIN) ("metastatic CSC" . SPARSER::PROTEIN)
    ("stationary CSC" . SPARSER::PROTEIN) ("MNU" . SPARSER::DRUG)
    ("SNAI1 and prostasphere" . SPARSER::COLLECTION)
    ("β-catenin and p65" . SPARSER::COLLECTION)
    ("SNAI1, β-catenin, and NF-κB" . SPARSER::COLLECTION)
    ("β-catenin, CXCR4 and RANKL" . SPARSER::COLLECTION)
    ("uPA, RANKL and RunX2" . SPARSER::COLLECTION)
    ("N-cadherin and OB-cadherin" . SPARSER::COLLECTION)
    ("Vimentin and Integrin" . SPARSER::COLLECTION)
    ("neuro-endocrine" . SPARSER::PROTEIN-PAIR)
    ("mesenchymal genes" . SPARSER::GENE) ("occludin" . SPARSER::PROTEIN)
    ("drosophila) and Slug" . SPARSER::COLLECTION)
    ("ZEB1 and SIP1" . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src and CD44" . SPARSER::COLLECTION)
    ("CXCR4, uPA, RANKL and RunX2" . SPARSER::COLLECTION)
    ("Notch1 and Egr-1" . SPARSER::COLLECTION)
    ("E-cadherin and SNAI1" . SPARSER::COLLECTION)
    ("Sh-PC3" . SPARSER::COLLECTION) ("ShEC-PC3" . SPARSER::COLLECTION)
    ("the adherens junction protein E-cadherin and its transcriptional repressor SNAI1"
     . SPARSER::COLLECTION)
    ("two epithelial-to-mesenchymal transition (EMT) regulators"
     . SPARSER::REGULATOR)
    ("nuclear factor kappa-B ligand" . SPARSER::PROTEIN)
    ("early growth response" . SPARSER::PROTEIN) ("PKD1" . SPARSER::PROTEIN)
    ("protein kinase D1" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3 beta" . SPARSER::PROTEIN)
    ("Raf kinase inhibitor protein" . SPARSER::PROTEIN)
    ("LEF-1" . SPARSER::PROTEIN) ("ZEB-1" . SPARSER::PROTEIN)
    ("metalloproteinases 2" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("OB-cadherin" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("drosophila)" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("RunX2" . SPARSER::PROTEIN) ("Egr-1" . SPARSER::PROTEIN)
    ("SMZ" . SPARSER::PROTEIN) ("LZ and JG" . SPARSER::COLLECTION)
    ("LZ" . SPARSER::PROTEIN) ("MTDH, EZH2 and SLC7A11" . SPARSER::COLLECTION)
    ("SODD" . SPARSER::PROTEIN) ("MTDH" . SPARSER::PROTEIN)
    ("CCND2, CCNE1/2, CDK6, and EZH2" . SPARSER::COLLECTION)
    ("Doxorubicin and its analogs" . SPARSER::COLLECTION)
    ("daunorubicin" . SPARSER::DRUG)
    ("NC- or non-transfected" . SPARSER::COLLECTION) ("NC-" . SPARSER::PROTEIN)
    ("siNC" . SPARSER::DRUG) ("MAP3K7 and MAP3K7IP3" . SPARSER::COLLECTION)
    ("the TNFα-treated NC-transfectants" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::COLLECTION)
    ("the classical NF-κB activator" . SPARSER::ACTIVATOR)
    ("NC-transfectants" . SPARSER::COLLECTION) ("TNFα-" . SPARSER::PROTEIN)
    ("the HCC-associated miRNAs" . SPARSER::MICRO-RNA)
    ("Very few miRNAs" . SPARSER::MICRO-RNA)
    ("ERK5, Bcl-2 and p65" . SPARSER::COLLECTION)
    ("a sequence-specific DNA-binding transcription factor" . SPARSER::PROTEIN)
    ("TGFβ-activated kinase-1 (TAK1) and its adaptors TAB2/3"
     . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE)
    ("the receptor proximal signaling complex" . SPARSER::BIO-COMPLEX)
    ("TAB2/3" . SPARSER::PROTEIN) ("The predominant form" . SPARSER::FORM)
    ("RelB, and c-Rel" . SPARSER::COLLECTION)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("p100/p52" . SPARSER::COLLECTION) ("p105/p50" . SPARSER::COLLECTION)
    ("TAK1 or TAB3" . SPARSER::COLLECTION)
    ("TAK1 and TAB3" . SPARSER::COLLECTION)
    ("TNFα and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin hydrochloride" . SPARSER::DRUG)
    ("SLC7A11" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("MAP3K" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Histone deacetylase" . SPARSER::PROTEIN)
    ("DNA topoisomerase II" . SPARSER::PROTEIN)
    ("MAP3K7IP3" . SPARSER::PROTEIN) ("MAP3K7" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("301a" . SPARSER::PROTEIN)
    ("TAB2" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("TAB3" . SPARSER::PROTEIN)
    ("ART" . SPARSER::PROTEIN) ("Monocloncal antibodies" . SPARSER::ANTIBODY)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("Formalin" . SPARSER::MOLECULE)
    ("the selected optimal antibody" . SPARSER::ANTIBODY)
    ("PTEN IHC using 5 potential PTEN antibodies" . SPARSER::ANTIBODY)
    ("FISH and PTEN" . SPARSER::COLLECTION)
    ("microsatellite unstable CRCs" . SPARSER::PROTEIN)
    ("Ali" . SPARSER::PROTEIN) ("MAX" . SPARSER::PROTEIN)
    ("cut-offs" . SPARSER::PROTEIN-PAIR)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("primary CRC" . SPARSER::PROTEIN)
    ("mCRC
[ xref , xref , xref ] and a predictive biomarker"
     . SPARSER::COLLECTION)
    ("retrospective cohorts" . SPARSER::MOLECULE)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("anti-EGFR monocloncal antibodies (MoAbs) cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exo84 and Sec5" . SPARSER::COLLECTION) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("fluorescent protein-tagged Sec8" . SPARSER::PROTEIN)
    ("Sec3, Sec8, Sec15, and Exo70" . SPARSER::COLLECTION)
    ("Sec5 or Exo84" . SPARSER::COLLECTION)
    ("Sec3, Sec6, Sec8, Sec10, Sec15, and Exo70" . SPARSER::COLLECTION)
    ("Sec5 and Exo84" . SPARSER::COLLECTION)
    ("Sec15, and Exo70" . SPARSER::COLLECTION)
    ("Exo84 or Sec5" . SPARSER::COLLECTION)
    ("Sec3 and Exo70" . SPARSER::COLLECTION)
    ("an octameric protein complex" . SPARSER::BIO-COMPLEX)
    ("Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84"
     . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec3" . SPARSER::PROTEIN)
    ("Exocyst" . SPARSER::BIO-COMPLEX) ("Rab35" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("Sec4" . SPARSER::PROTEIN)
    ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("Sec5" . SPARSER::PROTEIN)
    ("SAHA or LBH589" . SPARSER::COLLECTION)
    ("mTOR/HDAC" . SPARSER::COLLECTION)
    ("HDAC42 and SAHA" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC6" . SPARSER::COLLECTION)
    ("those dual drug" . SPARSER::DRUG)
    ("a well-studied hydroxamic acid pan-HDAC inhibitor" . SPARSER::INHIBITOR)
    ("MLN0128 and TSA, or GDC0941" . SPARSER::COLLECTION)
    ("TSA, or GDC0941" . SPARSER::COLLECTION)
    ("AKT, S6, and 4eBP1 phosphorylation" . SPARSER::COLLECTION)
    ("MLN0128 or TSA" . SPARSER::COLLECTION) ("Adriamycin" . SPARSER::DRUG)
    ("Annexin V, and sub-G1" . SPARSER::COLLECTION)
    ("Vorinostat" . SPARSER::DRUG)
    ("ER, PR, HER2, PIK3CA, or PTEN and TSA" . SPARSER::COLLECTION)
    ("PTEN and TSA" . SPARSER::COLLECTION)
    ("ER, PR, HER2, PIK3CA, or PTEN" . SPARSER::COLLECTION)
    ("CellTiter-Glo" . SPARSER::COLLECTION) ("Glo" . SPARSER::PROTEIN)
    ("the mTORC1/2 inhibitor PP242 and the pan-HDAC inhibitor vorinostat (SAHA, Merck)"
     . SPARSER::COLLECTION)
    ("vorinostat" . SPARSER::DRUG)
    ("The dual pan-PI3K/mTORC1/2 inhibitors BEZ235" . SPARSER::DRUG)
    ("pan-PI3K" . SPARSER::COLLECTION)
    ("ATP-competitive mTOR inhibitors and dual PI3K/mTOR inhibitors"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("entinostat" . SPARSER::DRUG) ("mutagen" . SPARSER::MOLECULE)
    ("Pan-HDAC" . SPARSER::COLLECTION) ("Classic HDACs" . SPARSER::PROTEIN)
    ("p21 and other tumor suppressors [ xref ]" . SPARSER::COLLECTION)
    ("HER2−" . SPARSER::PROTEIN)
    ("BCR-ABL-driven B cell acute lymphoblastic leukemia and MYC-driven Burkitt’s"
     . SPARSER::COLLECTION)
    ("mRNA’s" . SPARSER::RNA)
    ("BCR-ABL-driven B cell acute lymphoblastic leukemia and MYC-driven Burkitt"
     . SPARSER::COLLECTION)
    ("BCR-ABL-driven B cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("phosphoinositide-3" . SPARSER::COLLECTION)
    ("Anti-receptor monoclonal antibodies and anti-estrogenic agents (tamoxifen, aromatase inhibitors) target"
     . SPARSER::TARGET-PROTEIN)
    ("antibodies and anti-estrogenic" . SPARSER::COLLECTION)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("polysome" . SPARSER::BIO-COMPLEX)
    ("MLN0128 and TSA" . SPARSER::COLLECTION)
    ("the hydroxamic acid pan-HDAC inhibitor TSA" . SPARSER::PROTEIN)
    ("the investigational drug MLN0128" . SPARSER::DRUG)
    ("mTORC 1 and mTORC2" . SPARSER::COLLECTION)
    ("HR and HER2" . SPARSER::COLLECTION)
    ("targeted hormone receptor (HR) or human epidermal growth factor receptor 2 (HER2) inhibitors"
     . SPARSER::COLLECTION)
    ("receptor (HR)" . SPARSER::RECEPTOR)
    ("protein kinase B/AKT/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("RPL24" . SPARSER::PROTEIN) ("HDAC42" . SPARSER::DRUG)
    ("4eBp1" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("Suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("GDC0941" . SPARSER::DRUG) ("PP242" . SPARSER::DRUG)
    ("MS-275" . SPARSER::DRUG) ("valproic acid" . SPARSER::MOLECULE)
    ("INK128" . SPARSER::DRUG)
    ("eukaryotic initiation factor 4e" . SPARSER::PROTEIN-FAMILY)
    ("4eBP1" . SPARSER::PROTEIN) ("mTORC 1" . SPARSER::PROTEIN)
    ("MLN0128" . SPARSER::DRUG)
    ("type I and ATP-binding cassette" . SPARSER::COLLECTION)
    ("antioxidant, anti-inflammatory and anti-apoptotic" . SPARSER::COLLECTION)
    ("NF-κB or AP-1" . SPARSER::COLLECTION)
    ("IL-17R/TRAF3IP2" . SPARSER::COLLECTION) ("IP/IB" . SPARSER::COLLECTION)
    ("LOX-1 and TRAF3IP2" . SPARSER::COLLECTION)
    ("OxLDL/LOX-1" . SPARSER::COLLECTION)
    ("chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("various proinflammatory cytokines, chemokines and adhesion molecules"
     . SPARSER::COLLECTION)
    ("various proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IKK, and AP-1" . SPARSER::COLLECTION) ("JNK/IKKγ" . SPARSER::COLLECTION)
    ("DPI or Nox2" . SPARSER::COLLECTION)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("the predominant ROS-generating enzymes" . SPARSER::ENZYME)
    ("adiponectin and AICAR" . SPARSER::COLLECTION) ("ACh" . SPARSER::PROTEIN)
    ("AMPK and TRAF3IP2" . SPARSER::COLLECTION) ("lucigenin" . SPARSER::DRUG)
    ("Superoxide" . SPARSER::MOLECULE)
    ("AICAR (Fig. xref ) and metformin ( xref )" . SPARSER::COLLECTION)
    ("adiponectin ( xref ), AICAR (Fig. xref ) and metformin ( xref )"
     . SPARSER::COLLECTION)
    ("AICAR and metformin" . SPARSER::COLLECTION)
    ("the proinflammatory and proapoptotic cytokines" . SPARSER::PROTEIN)
    ("OxLDL/LOX-1/TRAF3IP2" . SPARSER::COLLECTION) ("HDLs" . SPARSER::PROTEIN)
    ("OxLDL and its lipid constituents" . SPARSER::COLLECTION)
    ("Palmitoyl-LPC" . SPARSER::COLLECTION) ("Stearoyl" . SPARSER::MOLECULE)
    ("Palmitoyl" . SPARSER::PROTEIN) ("LPCs" . SPARSER::PROTEIN)
    ("Lysophosphatidylcholine" . SPARSER::MOLECULE)
    ("Tiron, DPI and Nox2" . SPARSER::COLLECTION)
    ("very few monocytes" . SPARSER::PROTEIN)
    ("lentiviral TRAF3IP2 shRNA" . SPARSER::PROTEIN)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("IL-18 and other proinflammatory genes" . SPARSER::COLLECTION)
    ("both LOX1 and other proinflammatory genes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("IKKβ, and OxLDL" . SPARSER::COLLECTION)
    ("TRAF3IP2 and LOX-1" . SPARSER::COLLECTION) ("TIR" . SPARSER::PROTEIN)
    ("SEFIR-SEFIR" . SPARSER::COLLECTION) ("SEFIR" . SPARSER::PROTEIN-FAMILY)
    ("p65 and JNK1" . SPARSER::COLLECTION)
    ("p65 and c-Jun" . SPARSER::COLLECTION) ("p-c-Jun" . SPARSER::COLLECTION)
    ("p-p65" . SPARSER::COLLECTION)
    ("both IKK ( xref ) and JNK ( xref )" . SPARSER::COLLECTION)
    ("IKK and JNK" . SPARSER::COLLECTION)
    ("LOX-1/TRAF3IP2" . SPARSER::COLLECTION)
    ("OxLDL and LOX-1" . SPARSER::COLLECTION) ("OxLDL-" . SPARSER::PROTEIN)
    ("the anti-diabetic drug metformin, that exerts both anti-oxidant and anti-inflammatory"
     . SPARSER::COLLECTION)
    ("Adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("15LO" . SPARSER::PROTEIN)
    ("15LO-HDL" . SPARSER::PROTEIN-PAIR) ("LO" . SPARSER::PROTEIN)
    ("anti-oxidant and anti-inflammatory properties [ xref ]"
     . SPARSER::COLLECTION)
    ("lipoprotein (HDL)" . SPARSER::PROTEIN)
    ("an NF-κB and AP-1-responsive gene [ xref , xref ]" . SPARSER::COLLECTION)
    ("adiponectin, AICAR and metformin" . SPARSER::COLLECTION)
    ("AMPK/Akt" . SPARSER::COLLECTION)
    ("oxLDL (16:0-LPC and 18:0-LPC) and minimally modified LDL"
     . SPARSER::COLLECTION)
    ("LPC" . SPARSER::PROTEIN) ("IKK/p65" . SPARSER::COLLECTION)
    ("TRAF3IP2 or the lectin-like OxLDL receptor 1 (LOX-1)"
     . SPARSER::COLLECTION)
    ("a redox-sensitive cytoplasmic adapter protein and an upstream regulator"
     . SPARSER::COLLECTION)
    ("JNK/AP-1" . SPARSER::COLLECTION) ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("scavenger receptor class B" . SPARSER::PROTEIN)
    ("IRF-1" . SPARSER::PROTEIN) ("insulin-sensitizing drug" . SPARSER::DRUG)
    ("IL-17R" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("K 2" . SPARSER::PROTEIN) ("LOX1" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("Ox-LDL" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("Act1" . SPARSER::PROTEIN) ("OLR1" . SPARSER::PROTEIN)
    ("oxidized low density lipoprotein receptor 1" . SPARSER::PROTEIN)
    ("cytoplasmic adapter protein" . SPARSER::PROTEIN)
    ("TRAF3IP2" . SPARSER::PROTEIN) ("proteins-MCAK" . SPARSER::COLLECTION)
    ("CREST" . SPARSER::PROTEIN) ("Aurora" . SPARSER::PROTEIN)
    ("MCAK" . SPARSER::PROTEIN) ("Mad1, ZW10, and BubR1" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN)
    ("γ-tubulin, pericentrin, and EB1" . SPARSER::COLLECTION)
    ("the centriolar protein centrin" . SPARSER::PROTEIN)
    ("Kif2a" . SPARSER::PROTEIN) ("centrin" . SPARSER::PROTEIN)
    ("MT-anchoring and plus-end binding proteins (EB1) and MT-nucleation regulators (Ran-GTP and its binding protein RanBP2)"
     . SPARSER::COLLECTION)
    ("γ-tubulin and pericentrin" . SPARSER::COLLECTION)
    ("EB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynein and Rab11" . SPARSER::COLLECTION)
    ("Rab11 (data not shown) or expressing dominant-negative Rab11(S25N)"
     . SPARSER::COLLECTION)
    ("histone 2B-RFP" . SPARSER::COLLECTION)
    ("Rab11 or expressing dominant-negative Rab11" . SPARSER::COLLECTION)
    ("expressing dominant-negative Rab11" . SPARSER::PROTEIN)
    ("Rab11(Q70L) and dynein" . SPARSER::COLLECTION)
    ("neither Rab11(S25N) nor dynein" . SPARSER::COLLECTION)
    ("either Rab11(Q70L) or Rab11(S25N)" . SPARSER::COLLECTION)
    ("a dominant-negative Rab11 mutant" . SPARSER::MUTANT)
    ("Rab11 and dynein" . SPARSER::COLLECTION)
    ("a specific membrane permeable dynein inhibitor" . SPARSER::INHIBITOR)
    ("RFP-EEA1" . SPARSER::COLLECTION)
    ("FIP3 and γ-tubulin" . SPARSER::COLLECTION) ("TfR" . SPARSER::PROTEIN)
    ("Rab11 or FIP3" . SPARSER::COLLECTION)
    ("significantly more Rab11 and γ-tubulin" . SPARSER::COLLECTION)
    ("Rab11 and γ-tubulin" . SPARSER::COLLECTION)
    ("GFP-FIP3" . SPARSER::COLLECTION) ("mitotic Rab11" . SPARSER::PROTEIN)
    ("dominant-negative Rab11" . SPARSER::PROTEIN)
    ("significantly more Rab11" . SPARSER::PROTEIN)
    ("cytoskeletal modulators" . SPARSER::PROTEIN) ("SOP" . SPARSER::PROTEIN)
    ("mitotic regulators" . SPARSER::REGULATOR) ("REs" . SPARSER::PROTEIN)
    ("Rab11 and its associated endosomes co-contribute" . SPARSER::COLLECTION)
    ("astral microtubules" . SPARSER::PROTEIN)
    ("mitotic recycling endosomes bind γ-TuRC components" . SPARSER::COMPONENT)
    ("U20" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("RanBP2" . SPARSER::PROTEIN) ("histone 2B" . SPARSER::PROTEIN)
    ("GCP4" . SPARSER::PROTEIN) ("S25" . SPARSER::PROTEIN)
    ("Evi5" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("FIP3" . SPARSER::PROTEIN)
    ("its downstream angiogenic effectors" . SPARSER::EFFECTOR)
    ("inadvertent cAMP" . SPARSER::PROTEIN)
    ("core angiogenic proteins" . SPARSER::PROTEIN)
    ("FoxO1 and the subsequent activation/inactivation" . SPARSER::COLLECTION)
    ("Epac" . SPARSER::PROTEIN) ("E-Selectin and ICAM-1" . SPARSER::COLLECTION)
    ("insulin and other growth factors [ xref ]" . SPARSER::COLLECTION)
    ("sacs" . SPARSER::PROTEIN) ("REGγ-PKA-FoxO1" . SPARSER::COLLECTION)
    ("ROP" . SPARSER::PROTEIN)
    ("endothelial-cell-specific marker vWF" . SPARSER::PROTEIN)
    ("vWF" . SPARSER::PROTEIN)
    ("angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a novel modulatory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plvx-REGγ" . SPARSER::COLLECTION) ("TNFalpha" . SPARSER::PROTEIN)
    ("FoxO1 responsible genes" . SPARSER::GENE)
    ("simultaneous silencing REGγ and PKAca" . SPARSER::COLLECTION)
    ("REGγ-PKA" . SPARSER::COLLECTION) ("cAMP/PKA" . SPARSER::COLLECTION)
    ("REGγ ( xref ) or PKAca ( xref )" . SPARSER::COLLECTION)
    ("anti-PKAca or anti-REGγ" . SPARSER::COLLECTION)
    ("REGγ and PKAca" . SPARSER::COLLECTION)
    ("primary MEFs" . SPARSER::PROTEIN) ("PKA-FoxO1" . SPARSER::COLLECTION)
    ("anti-angiogenic and anti-tumor properties" . SPARSER::COLLECTION)
    ("PS-341 and MG132" . SPARSER::COLLECTION)
    ("SRC-3 and p21" . SPARSER::COLLECTION) ("VIP" . SPARSER::PROTEIN)
    ("Forskolin" . SPARSER::PROTEIN) ("PKA–FoxO1" . SPARSER::COLLECTION)
    ("SGK (serum and glucocorticoid-regulated kinase) and CK1 (casein kinase 1)"
     . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase" . SPARSER::COLLECTION)
    ("intercompartmental FoxO1" . SPARSER::PROTEIN)
    ("soluble E-selectin" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1 ( VCAM-1 ) and endothelial-Selectin ( E-Selectin )"
     . SPARSER::COLLECTION)
    ("soluble forms" . SPARSER::FORM)
    ("Known angiogenic mediators" . SPARSER::PROTEIN)
    ("Selectin" . SPARSER::PROTEIN-FAMILY)
    ("key angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("REGγ–PKA–FoxO1" . SPARSER::COLLECTION)
    ("a novel angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VCAM-1 and E-Selectin" . SPARSER::COLLECTION)
    ("PKAca" . SPARSER::PROTEIN) ("short-cut" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("pp60" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("n1" . SPARSER::PROTEIN)
    ("PSME3" . SPARSER::PROTEIN) ("PA28γ" . SPARSER::PROTEIN)
    ("Forkhead box O1" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("E-Selectin" . SPARSER::PROTEIN) ("REGγ" . SPARSER::PROTEIN)
    ("the relevant target genes" . SPARSER::GENE)
    ("Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAGE4/c-Jun" . SPARSER::COLLECTION)
    ("c-Jun and PAGE4" . SPARSER::COLLECTION) ("liposomes" . SPARSER::PROTEIN)
    ("the predominant HIPK1" . SPARSER::PROTEIN)
    ("recombinant protein and 33 P-labeled γATP" . SPARSER::COLLECTION)
    ("-methionine" . SPARSER::COLLECTION) ("methionine" . SPARSER::AMINO-ACID)
    ("either the mutant or the WT V5-tagged
PAGE4"
     . SPARSER::COLLECTION)
    ("the WT V5-tagged
PAGE4"
     . SPARSER::PROTEIN)
    ("GAL4-c-Jun" . SPARSER::COLLECTION)
    ("PAGE4-Myc-FLAG" . SPARSER::COLLECTION)
    ("JNK-1/c-Jun" . SPARSER::COLLECTION)
    ("PAGE4 and c-Jun" . SPARSER::COLLECTION)
    ("CT-X antigens and
a remarkably prostate-specific CT-X antigen"
     . SPARSER::COLLECTION)
    ("prostate-associated
gene 4"
     . SPARSER::PROTEIN)
    ("IDP" . SPARSER::PROTEIN) ("PINs" . SPARSER::PROTEIN)
    ("IDPs" . SPARSER::PROTEIN) ("Acta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prostate-associated gene 4" . SPARSER::PROTEIN)
    ("E. coli )" . SPARSER::PROTEIN) ("glucose oxidase" . SPARSER::PROTEIN)
    ("nV5" . SPARSER::PROTEIN) ("P102" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("MAGE family" . SPARSER::PROTEIN-FAMILY) ("HIPK1" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase 1" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("PAGE4" . SPARSER::PROTEIN)
    ("TSH, JJL, and SPC" . SPARSER::COLLECTION)
    ("TSH and SPC" . SPARSER::COLLECTION) ("TSH" . SPARSER::PROTEIN)
    ("the viral DNA and protein" . SPARSER::COLLECTION)
    ("a prosurvival state" . SPARSER::BIO-STATE)
    ("v-raf" . SPARSER::COLLECTION) ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The only established epidemiological factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA and protein" . SPARSER::COLLECTION)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B19" . SPARSER::PROTEIN) ("type 6" . SPARSER::PROTEIN)
    ("IE1" . SPARSER::PROTEIN) ("UL123" . SPARSER::PROTEIN)
    ("GL" . SPARSER::PROTEIN) ("NPT and AHS" . SPARSER::COLLECTION)
    ("NPT" . SPARSER::PROTEIN)
    ("possibly co-deleted 11q22 genes" . SPARSER::GENE)
    ("the conclusive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 and YAP1" . SPARSER::COLLECTION)
    ("the distal part" . SPARSER::COMPONENT)
    ("a treatment predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LIFR" . SPARSER::PROTEIN) ("KLF5 and YAP1" . SPARSER::COLLECTION)
    ("EtOH, E2 or E2" . SPARSER::COLLECTION)
    ("ER and PgR" . SPARSER::COLLECTION)
    ("pERE-luciferase" . SPARSER::COLLECTION)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cyclin D1 and cyclin A2" . SPARSER::COLLECTION)
    ("17β-estradiol (E2) or E2" . SPARSER::COLLECTION)
    ("absent YAP1" . SPARSER::PROTEIN) ("proximal 11q22 genes" . SPARSER::GENE)
    ("b and c" . SPARSER::COLLECTION) ("CCND1 and YAP1" . SPARSER::COLLECTION)
    ("YAP1 and cyclin D1" . SPARSER::COLLECTION)
    ("ER and cyclin D1" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) and progesterone receptor (PgR)"
     . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION)
    ("the frequent loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("Runx2, TEAD, p73, ErbB4, Smad7 and Smad1" . SPARSER::COLLECTION)
    ("TEAD" . SPARSER::PROTEIN)
    ("The Yes-associated protein" . SPARSER::PROTEIN)
    ("Yes-associated protein" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("WBP-2" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor receptor" . SPARSER::PROTEIN)
    ("KLF5" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("E2 " . SPARSER::MOLECULE)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cyclin A2" . SPARSER::PROTEIN) ("SP4" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("MTA-1" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("Ca 2+ and DAG" . SPARSER::COLLECTION) ("toxins" . SPARSER::MOLECULE)
    ("its substrate receptors and signaling proteins" . SPARSER::COLLECTION)
    ("The extensive bilayer" . SPARSER::PROTEIN)
    ("PKCα or PKCβ" . SPARSER::COLLECTION)
    ("PKCα and PKCβ" . SPARSER::COLLECTION)
    ("essential step" . SPARSER::PROTEIN)
    ("pseudosubstrate and C1B" . SPARSER::COLLECTION)
    ("the aqueous state" . SPARSER::BIO-STATE)
    ("PS-PIP 2" . SPARSER::COLLECTION) ("PC and PS" . SPARSER::COLLECTION)
    ("the two observed C1A diffusional
states"
     . SPARSER::BIO-STATE)
    ("two diffusional states" . SPARSER::BIO-STATE)
    ("fully deployed active kinase (VI)" . SPARSER::KINASE)
    ("deployed active kinase (VI)" . SPARSER::KINASE)
    ("kinase (VI)" . SPARSER::KINASE) ("PMA and DAG" . SPARSER::COLLECTION)
    ("a significantly better
kinase activator"
     . SPARSER::ACTIVATOR)
    ("Diacylglycerol and Phorbol" . SPARSER::COLLECTION)
    ("Ester" . SPARSER::MOLECULE) ("Phorbol" . SPARSER::DRUG)
    ("Diacylglycerol" . SPARSER::PROTEIN)
    ("the C1A–C1B ( p < 0.05) and C1B–C2
( p < 0.05)"
     . SPARSER::COLLECTION)
    ("the bilayer and bind one DAG" . SPARSER::COLLECTION)
    ("C1B and/or the pseudosubstrate" . SPARSER::COLLECTION)
    ("pseudosubstrate" . SPARSER::PROTEIN) ("C1B" . SPARSER::PROTEIN)
    ("C1B–bilayer" . SPARSER::COLLECTION) ("EPR" . SPARSER::PROTEIN)
    ("pseudosubstrate–bilayer" . SPARSER::COLLECTION)
    ("MARCKS" . SPARSER::PROTEIN)
    ("at least
one additional PS molecule"
     . SPARSER::MOLECULE)
    ("Bilayers" . SPARSER::PROTEIN) ("PS and DAG" . SPARSER::COLLECTION)
    ("PC/PS/PIP 2" . SPARSER::COLLECTION) ("PC/PS" . SPARSER::COLLECTION)
    ("Bilayer" . SPARSER::PROTEIN)
    ("immobile misfolded or aggregated protein" . SPARSER::PROTEIN)
    ("PKCα, C1B, C2,
and
C1B–C2"
     . SPARSER::COLLECTION)
    ("fluor" . SPARSER::MOLECULE)
    ("the highly viscous bilayer" . SPARSER::PROTEIN)
    ("bilayers" . SPARSER::PROTEIN) ("bilayer" . SPARSER::PROTEIN)
    ("protein–bilayer" . SPARSER::PROTEIN-PAIR)
    ("Molecule" . SPARSER::MOLECULE)
    ("either diacylglycerol (DAG) or phorbol ester" . SPARSER::COLLECTION)
    ("PS and PIP 2" . SPARSER::COLLECTION)
    ("the predominant state" . SPARSER::BIO-STATE)
    ("PS or PS and
PIP 2"
     . SPARSER::COLLECTION)
    ("PS and
PIP 2"
     . SPARSER::COLLECTION)
    ("Lipid" . SPARSER::LIPID) ("PKCα and fragments" . SPARSER::COLLECTION)
    ("phosphatidylserine (PS) and phosphatidylinositol
4,5-bisphosphate (PIP 2 )"
     . SPARSER::COLLECTION)
    ("Membrane-Bound" . SPARSER::PROTEIN) ("Full-Length" . SPARSER::PROTEIN)
    ("membrane
protein"
     . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN)
    ("Protein
Kinase"
     . SPARSER::PROTEIN)
    ("Tween
20"
     . SPARSER::MOLECULE)
    ("for
3"
     . SPARSER::PROTEIN)
    ("BC2" . SPARSER::PROTEIN)
    ("phosphoinositol
4,5-bisphosphate"
     . SPARSER::PIP2)
    ("PDK-1" . SPARSER::PROTEIN)
    ("protein
kinase"
     . SPARSER::PROTEIN)
    ("phosphatidylinositol
4,5-bisphosphate"
     . SPARSER::PIP2)
    ("Protein
kinase"
     . SPARSER::PROTEIN)
    ("diterpenes" . SPARSER::MOLECULE) ("p65/p50" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION) ("p52 or RelB" . SPARSER::COLLECTION)
    ("NIK/IKK" . SPARSER::COLLECTION)
    ("the NFκB subunits p50 and p65/RelA" . SPARSER::COLLECTION)
    ("p65/RelA" . SPARSER::COLLECTION) ("CuZnSOD" . SPARSER::PROTEIN)
    ("NF-κB/CTCF" . SPARSER::COLLECTION) ("Cast" . SPARSER::PROTEIN)
    ("CBP and co-repressor" . SPARSER::COLLECTION)
    ("Noncanonical pathway p52 proteins" . SPARSER::PROTEIN)
    ("cRel" . SPARSER::PROTEIN)
    ("CTCF protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("PPC1 (14 fold) and 9E6/E7 (2.3 fold)" . SPARSER::COLLECTION)
    ("PPC1 and 9E6/E7" . SPARSER::COLLECTION)
    ("both PPC1 (3-fold) and 9E6/E7 (1.5-fold)" . SPARSER::COLLECTION)
    ("a minimal (m)CMV promoter" . SPARSER::PROMOTER)
    ("a stress-induced transcription factor" . SPARSER::PROTEIN)
    ("canonical NF-κB" . SPARSER::PROTEIN)
    ("IκB, and NF-κB" . SPARSER::COLLECTION)
    ("heterodimers or homodimers" . SPARSER::COLLECTION)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("PIA" . SPARSER::PROTEIN)
    ("prooxidant-antioxidant" . SPARSER::PROTEIN)
    ("prooxidant" . SPARSER::MOLECULE)
    ("CCCTC-binding factor (CTCF)" . SPARSER::PROTEIN)
    ("the Insulin-like growth factor 2 ( IGF2 ) and other genes"
     . SPARSER::COLLECTION)
    ("NF-κB and IGF2" . SPARSER::COLLECTION)
    ("CCCTC-binding factor(CTCF)" . SPARSER::PROTEIN)
    ("age 1" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("PPC1" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("CCCTC-binding factor" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor" . SPARSER::PROTEIN)
    ("ERBB2/HER2" . SPARSER::COLLECTION) ("ER-α and PR" . SPARSER::COLLECTION)
    ("ALDH1, EGFR and HER2" . SPARSER::COLLECTION)
    ("CK18 and ER-α66" . SPARSER::COLLECTION)
    ("prolactin and progesterone receptor" . SPARSER::COLLECTION)
    ("the parental MCF7" . SPARSER::PROTEIN)
    ("a predominant nuclear" . SPARSER::PROTEIN)
    ("AKT and GSK3β" . SPARSER::COLLECTION)
    ("PI3K, AKT and GSK3β" . SPARSER::COLLECTION)
    ("AKT, GSK-3β and β-catenin" . SPARSER::COLLECTION)
    ("PI3K/AKT/GSK3β/β-catenin" . SPARSER::COLLECTION)
    ("PCNA and CK18" . SPARSER::COLLECTION)
    ("CK18 and the proliferating cell nuclear antigen (PCNA)"
     . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("different MCF7 and T47D derivatives" . SPARSER::COLLECTION)
    ("estrogen, and estrogen" . SPARSER::COLLECTION)
    ("parental MCF7" . SPARSER::PROTEIN)
    ("estrogen and antiestrogen" . SPARSER::COLLECTION)
    ("the last 138 amino acids of ER-α66" . SPARSER::PROTEIN)
    ("the last 138 amino acids" . SPARSER::AMINO-ACID)
    ("PTEN/Akt/β-catenin" . SPARSER::COLLECTION)
    ("AKT/GSK3β" . SPARSER::COLLECTION) ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("phenol-red" . SPARSER::DRUG)
    ("CD 10" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("ALDH1" . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN) ("normal p53" . SPARSER::PROTEIN)
    ("a heterozygous mutant" . SPARSER::MUTANT)
    ("residual normal p53" . SPARSER::PROTEIN)
    ("a heterozygous state" . SPARSER::BIO-STATE)
    ("p21 and caspase 3" . SPARSER::COLLECTION)
    ("the novel mutated form" . SPARSER::FORM) ("nearly every type" . TYPE)
    ("TD" . SPARSER::PROTEIN) ("only 393 amino acids" . SPARSER::AMINO-ACID)
    ("DNA or protein" . SPARSER::COLLECTION)
    ("BRCA1 and PARP 1" . SPARSER::COLLECTION)
    ("p53 and downstream effector molecules" . SPARSER::COLLECTION)
    ("intact p53" . SPARSER::PROTEIN) ("held" . SPARSER::PROTEIN)
    ("PARP 1" . SPARSER::PROTEIN) ("Nfκb" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bad" . SPARSER::PROTEIN)
    ("ASK-1, caspase-3, and caspase-8" . SPARSER::COLLECTION)
    ("Fas and TNF" . SPARSER::COLLECTION) ("viral genomic RNA" . SPARSER::RNA)
    ("GTP and aminoacyl-tRNA" . SPARSER::COLLECTION)
    ("a viral protein" . SPARSER::PROTEIN)
    ("eEF1A and cytochrome c" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("TM or TG" . SPARSER::COLLECTION) ("of 45-kDa" . SPARSER::COLLECTION)
    ("Nef-treated MDMs" . SPARSER::PROTEIN) ("normal MDMs" . SPARSER::PROTEIN)
    ("BFA-treated MDMs" . SPARSER::PROTEIN)
    ("Exp-1 or Exp-5" . SPARSER::COLLECTION)
    ("siRNA, or Exp-5" . SPARSER::COLLECTION) ("p20/p17" . SPARSER::COLLECTION)
    ("pro-caspase-3" . SPARSER::COLLECTION)
    ("Exp-1 or siRNA" . SPARSER::COLLECTION)
    ("tunicamycin (TM) or thapsigargin (TG)" . SPARSER::COLLECTION)
    ("TM" . SPARSER::PROTEIN) ("tunicamycin" . SPARSER::MOLECULE)
    ("BFA" . SPARSER::MOLECULE) ("rNef-treated MDMs" . SPARSER::PROTEIN)
    ("eEF1A and Exp-1" . SPARSER::COLLECTION)
    ("eEF1A and Exp-t" . SPARSER::COLLECTION)
    ("Exp-1, and Exp-5" . SPARSER::COLLECTION)
    ("exportins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t and rNef" . SPARSER::COLLECTION)
    ("relatively more eEF1A" . SPARSER::PROTEIN) ("pVP" . SPARSER::MOLECULE)
    ("pG5-Luc" . SPARSER::COLLECTION) ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pACT" . SPARSER::PROTEIN) ("eEF1A and rNef" . SPARSER::COLLECTION)
    ("no associated eEF1A protein" . SPARSER::PROTEIN)
    ("primary MDMs" . SPARSER::PROTEIN)
    ("spliced viral mRNAs" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN)
    ("aminoacyl-tRNA" . SPARSER::PROTEIN)
    ("the nuclear aminoacylation-dependent tRNA" . SPARSER::RNA)
    ("proteins and RNA" . SPARSER::COLLECTION)
    ("Bcl-2 and TRX" . SPARSER::COLLECTION)
    ("Bcl-2 and thioredoxin" . SPARSER::COLLECTION) ("TRX" . SPARSER::PROTEIN)
    ("eEF1A and tRNAs" . SPARSER::COLLECTION)
    ("Nef-treated monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("Exp-t" . SPARSER::COLLECTION) ("MDMs" . SPARSER::PROTEIN)
    ("Exp" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("N-glycans" . SPARSER::MOLECULE) ("aa 1" . SPARSER::PROTEIN)
    ("EF-1 α" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("p17" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p20" . SPARSER::PROTEIN)
    ("Brefeldin A" . SPARSER::MOLECULE) ("leptomycin B" . SPARSER::MOLECULE)
    ("Exp-1" . SPARSER::PROTEIN) ("eEF1A 1" . SPARSER::PROTEIN)
    ("pG5" . SPARSER::PROTEIN) ("VP16" . SPARSER::DRUG)
    ("eEF2" . SPARSER::PROTEIN) ("ASK-1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("pre-miRNAs" . SPARSER::RNA) ("EF1A" . SPARSER::PROTEIN)
    ("brefeldin A" . SPARSER::MOLECULE)
    ("exportin-t" . SPARSER::HUMAN-PROTEIN-FAMILY) ("eEF1A" . SPARSER::PROTEIN)
    ("herceptin" . SPARSER::DRUG)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("BRCA1 and HSP90" . SPARSER::COLLECTION) ("p53/p63" . SPARSER::COLLECTION)
    ("HOP–HSP70" . SPARSER::COLLECTION)
    ("HSP90 and HSP70" . SPARSER::COLLECTION)
    ("p300 and CHIP" . SPARSER::COLLECTION)
    ("HSP70 and HSP90" . SPARSER::COLLECTION) ("psoriasin" . SPARSER::PROTEIN)
    ("HOP–HSP90" . SPARSER::COLLECTION)
    ("the native form and an increase in the denatured form of mutant p53 ( xref and xref )"
     . SPARSER::COLLECTION)
    ("DO" . SPARSER::PROTEIN) ("PAb" . SPARSER::PROTEIN)
    ("BRCA1 and ΔNp63siRNA" . SPARSER::COLLECTION)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("HME1 and MCF10-A" . SPARSER::COLLECTION) ("kB" . SPARSER::PROTEIN)
    ("BRCA1 and ΔNp63 siRNA" . SPARSER::COLLECTION)
    ("the proximal S100A2 promoter" . SPARSER::PROMOTER)
    ("TA-p63" . SPARSER::COLLECTION) ("TAp63-" . SPARSER::PROTEIN)
    ("ΔNp63" . SPARSER::PROTEIN) ("BRCA1–ΔNp63" . SPARSER::COLLECTION)
    ("proteins and mRNAs" . SPARSER::COLLECTION) ("HME" . SPARSER::PROTEIN)
    ("BR" . SPARSER::PROTEIN) ("AAG" . SPARSER::PROTEIN)
    ("S100A2-" . SPARSER::PROTEIN) ("HSP70/HSP90" . SPARSER::COLLECTION)
    ("mutant and basal-like" . SPARSER::COLLECTION)
    ("a functional BRCA1" . SPARSER::PROTEIN)
    ("BRCA1 and ΔNp63" . SPARSER::COLLECTION)
    ("cytochrome c oxidase I" . SPARSER::PROTEIN)
    ("Caveolin1" . SPARSER::PROTEIN) ("CyclinG2" . SPARSER::PROTEIN)
    ("HME1" . SPARSER::PROTEIN) ("AP2 α" . SPARSER::PROTEIN)
    ("HSP-90" . SPARSER::PROTEIN)
    ("KPNA4 , ITGAL , and PLUNC family" . SPARSER::COLLECTION)
    ("MPPED2 , AJAP1 and RPS6KA2" . SPARSER::COLLECTION)
    ("the associated variant" . SPARSER::VARIANT)
    ("genes and loci" . SPARSER::COLLECTION) ("basigin" . SPARSER::PROTEIN)
    ("PLUNC and BASE" . SPARSER::COLLECTION) ("BASE" . SPARSER::PROTEIN)
    ("PLUNC" . SPARSER::PROTEIN) ("plausible caries genes" . SPARSER::GENE)
    ("this gene or adjacent genes" . SPARSER::COLLECTION)
    ("1.031 and 1.028" . SPARSER::PROTEIN) ("IFS" . SPARSER::PROTEIN)
    ("factors, and gene-by-environment" . SPARSER::COLLECTION)
    ("chronic pain" . SPARSER::PROTEIN)
    ("associated genetic variants" . SPARSER::VARIANT)
    ("MPPED2 (p-value = 6.9E-6), AJAP1 (p-value = 1.6E-6) and RPS6KA2 (p-value = 7.3E-6)"
     . SPARSER::COLLECTION)
    ("ITGAL (p-value = 2.1E-7) and PLUNC family genes (p-value = 2.0E-6)"
     . SPARSER::COLLECTION)
    ("ITGAL" . SPARSER::PROTEIN) ("pit" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("p14" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("age 2" . SPARSER::PROTEIN)
    ("RPS6KA2" . SPARSER::PROTEIN) ("MPPED2" . SPARSER::PROTEIN)
    ("PLUNC family" . SPARSER::PROTEIN) ("KPNA4" . SPARSER::PROTEIN)
    ("olaparib" . SPARSER::DRUG) ("ABC" . SPARSER::PROTEIN)
    ("The carboxylic acid metabolite" . SPARSER::MOLECULE)
    ("PARP-1 null MEFs" . SPARSER::PROTEIN)
    ("nicotinamide and its metabolites" . SPARSER::COLLECTION)
    ("Pilot" . SPARSER::PROTEIN) ("rucaparib and PARP" . SPARSER::COLLECTION)
    ("neither the nucleoside transport inhibitor, dipyridamole, nor the amino-acid transport inhibitor"
     . SPARSER::COLLECTION)
    ("the amino-acid transport inhibitor" . SPARSER::INHIBITOR)
    ("BCH" . SPARSER::PROTEIN) ("dipyridamole" . SPARSER::DRUG)
    ("cytochalasin" . SPARSER::MOLECULE) ("Ouabain" . SPARSER::DRUG)
    ("poisons" . SPARSER::MOLECULE) ("PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("p or 150 mg kg −1 p" . SPARSER::COLLECTION) ("Rucaparib" . SPARSER::DRUG)
    ("rucaparib" . SPARSER::DRUG) ("K+" . SPARSER::MOLECULE)
    ("Na+" . SPARSER::MOLECULE) ("anti-PAR" . SPARSER::DRUG)
    ("a  2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pH3" . SPARSER::PROTEIN)
    ("AG14361" . SPARSER::DRUG) ("AG014699" . SPARSER::DRUG)
    ("PARP-3" . SPARSER::PROTEIN) ("PARP-2" . SPARSER::PROTEIN)
    ("the cerebral vasculature" . SPARSER::PROTEIN)
    ("its total soluble protein" . SPARSER::PROTEIN)
    ("dimeric proteins" . SPARSER::PROTEIN) ("signed-rank" . SPARSER::PROTEIN)
    ("a spinal tap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intravenous glycerol" . SPARSER::PROTEIN)
    ("ataxia, and diplopia" . SPARSER::COLLECTION)
    ("glycerol" . SPARSER::PROTEIN)
    ("acetaminophen and naproxen" . SPARSER::COLLECTION)
    ("naproxen" . SPARSER::DRUG) ("acetaminophen" . SPARSER::DRUG)
    ("Creutzfeldt-Jakob disease (CJD)" . SPARSER::PROTEIN)
    ("CJD" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("CSF 2" . SPARSER::PROTEIN) ("CT8" . SPARSER::PROTEIN)
    ("Creutzfeldt-Jakob disease" . SPARSER::PROTEIN) ("STH" . SPARSER::PROTEIN)
    ("SMP" . SPARSER::PROTEIN)
    ("Epithelial growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Amphiregulin" . SPARSER::PROTEIN) ("AR and HB-EGF" . SPARSER::COLLECTION)
    ("allergens as well as time" . SPARSER::COLLECTION)
    ("macrophage-colony-stimulating factor" . SPARSER::COLLECTION)
    ("EGFR and Erk" . SPARSER::COLLECTION)
    ("healthy human volunteers involving neutrophils" . SPARSER::PROTEIN)
    ("antibodies or the AG1478 EGFR-selective tyrosine kinase inhibitor"
     . SPARSER::COLLECTION)
    ("the predominant ligand" . SPARSER::LIGAND)
    ("HB-EGF and TGF-α" . SPARSER::COLLECTION)
    ("pro-TGF-α" . SPARSER::COLLECTION)
    ("TGF-α and HB-EGF" . SPARSER::COLLECTION)
    ("antibodies and AG1478" . SPARSER::COLLECTION)
    ("TGFα, AR and HB-EGF" . SPARSER::COLLECTION) ("CB " . SPARSER::PROTEIN)
    ("transforming growth factor α (TGFα) heparin-binding EGF-like growth factor (HB-EGF) and amphiregulin (AR) [ xref ]"
     . SPARSER::COLLECTION)
    ("amphiregulin (AR)" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CSE" . SPARSER::PROTEIN) ("IL-8 and RANTES" . SPARSER::COLLECTION)
    ("soluble Intercellular Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("the organic fraction" . SPARSER::COMPONENT) ("PM" . SPARSER::PROTEIN)
    ("-EGF" . SPARSER::COLLECTION)
    ("growth factor, and amphiregulin (AR)" . SPARSER::COLLECTION)
    ("IL-8 and EGFR" . SPARSER::COLLECTION)
    ("growth factor, and amphiregulin" . SPARSER::COLLECTION)
    ("Heparin-binding EGF-like growth factor" . SPARSER::PROTEIN)
    ("Transforming growth factor alpha" . SPARSER::PROTEIN)
    ("LDL receptor" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR antibody" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("Lactic acid" . SPARSER::MOLECULE) ("Lactic Acid " . SPARSER::MOLECULE)
    ("SO 4" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Intercellular Adhesion Molecule 1" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("Monocyte Chemotactic Protein 1" . SPARSER::PROTEIN)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("KIF1A , LITAF , and NEFL" . SPARSER::COLLECTION)
    ("microtubules, and KIF1A" . SPARSER::COLLECTION)
    ("frabin" . SPARSER::PROTEIN)
    ("neuropathy-associated genes" . SPARSER::GENE) ("ACTG" . SPARSER::PROTEIN)
    ("the 46 neuropathy-associated genes" . SPARSER::GENE)
    ("nuclear variants and risk" . SPARSER::COLLECTION)
    ("The dideoxynucleoside reverse transcriptase inhibitors didanosine (ddI) and stavudine (d4T)"
     . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN) ("stavudine" . SPARSER::DRUG)
    ("NEFL" . SPARSER::PROTEIN) ("LITAF" . SPARSER::PROTEIN)
    ("46 neuropathy-associated genes" . SPARSER::GENE)
    ("lamivudine" . SPARSER::DRUG) ("zidovudine" . SPARSER::DRUG)
    ("ddI" . SPARSER::DRUG) ("didanosine" . SPARSER::DRUG)
    ("the most widely prescribed antiretroviral drugs" . SPARSER::DRUG)
    ("Stavudine" . SPARSER::DRUG)
    ("neurofilament light polypeptide" . SPARSER::PROTEIN)
    ("CMT1" . SPARSER::PROTEIN)
    ("hereditary sensory neuropathy" . SPARSER::PROTEIN)
    ("KIF1B" . SPARSER::PROTEIN) ("Type 4" . SPARSER::PROTEIN)
    ("angiopoietin 4" . SPARSER::PROTEIN) ("ANGPT4" . SPARSER::PROTEIN)
    ("R-spondin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RSPO4" . SPARSER::PROTEIN)
    ("interleukin-2 receptor alpha" . SPARSER::PROTEIN)
    ("FGD4" . SPARSER::PROTEIN) ("ZNF648" . SPARSER::PROTEIN)
    ("KRR1" . SPARSER::PROTEIN) ("KIF1A" . SPARSER::PROTEIN)
    ("d4T" . SPARSER::DRUG) ("MINT" . SPARSER::PROTEIN)
    ("lapatinib [ xref , xref ] and gefitinib [ xref ]" . SPARSER::COLLECTION)
    ("tamoxifen-" . SPARSER::MOLECULE) ("Fulvestrant" . SPARSER::DRUG)
    ("the equipotent dual EGFR/HER2 TKI AZD8931" . SPARSER::DRUG)
    ("EGFR and ligand" . SPARSER::COLLECTION)
    ("both the EGFR TKI gefitinib and the dual EGFR/HER2 TKI lapatinib"
     . SPARSER::COLLECTION)
    ("the dual EGFR/HER2 TKI lapatinib" . SPARSER::DRUG)
    ("the EGFR and HER2 receptors and/or their ligands" . SPARSER::COLLECTION)
    ("pEGFR and HER2" . SPARSER::COLLECTION)
    ("continued Tam, Tam+AZD8931, Ful, or Ful+AZD8931" . SPARSER::COLLECTION)
    ("Tam, Tam+AZD8931, Ful, or Ful+AZD8931" . SPARSER::COLLECTION)
    ("lapatinib and gefitinib" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("Tam and Ful" . SPARSER::COLLECTION) ("Tam or Ful" . SPARSER::COLLECTION)
    ("gefitinib or lapatinib" . SPARSER::COLLECTION)
    ("pAKT and pMAPK" . SPARSER::COLLECTION)
    ("both MCF7 and T47D TamRes" . SPARSER::COLLECTION)
    ("HER2 and EGFR, AKT and MAPK" . SPARSER::COLLECTION)
    ("EGFR, AKT and MAPK" . SPARSER::COLLECTION)
    ("a potent inhibitor of EGF- and HRG-mediated signaling and growth"
     . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN)
    ("HER receptors and/or ligands" . SPARSER::COLLECTION)
    ("neither AZD8931 nor lapatinib" . SPARSER::COLLECTION)
    ("AZD8931 and lapatinib" . SPARSER::COLLECTION)
    ("ER and HER" . SPARSER::COLLECTION)
    ("a novel dual EGFR and HER2 tyrosine kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("EGFR, HER2, and HER3" . SPARSER::COLLECTION)
    ("The dual EGFR/HER2 tyrosine kinase inhibitor lapatinib" . SPARSER::DRUG)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("letrozole" . SPARSER::DRUG)
    ("AI" . SPARSER::PROTEIN)
    ("anastrozole and tamoxifen" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("EGFR or HER1" . SPARSER::COLLECTION)
    ("HER2, HER3, and HER4" . SPARSER::COLLECTION) ("AIs" . SPARSER::PROTEIN)
    ("SERDs" . SPARSER::DRUG) ("F11" . SPARSER::PROTEIN)
    ("β estradiol" . SPARSER::MOLECULE) ("AZD8931" . SPARSER::DRUG)
    ("MALT1-Bcl10" . SPARSER::COLLECTION)
    ("the larger IKK activation complex" . SPARSER::BIO-COMPLEX)
    ("mask" . SPARSER::PROTEIN) ("Bcl10 and MALT1" . SPARSER::COLLECTION)
    ("Bcl10 or MALT1" . SPARSER::COLLECTION) ("MALT" . SPARSER::PROTEIN)
    ("PHLPP2-Bcl10" . SPARSER::COLLECTION)
    ("PHLPP2 and Bcl10" . SPARSER::COLLECTION)
    ("Bcl10 and mucosa-associated lymphoid-tissue-1 (MALT1) protein"
     . SPARSER::COLLECTION)
    ("mucosa-associated lymphoid-tissue-1 (MALT1) protein" . SPARSER::PROTEIN)
    ("nondegradative K63-linked polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("TAK1 or MEKK3" . SPARSER::COLLECTION)
    ("NOS2, cyclin D1, CSF2, AREG and Jun" . SPARSER::COLLECTION)
    ("AREG" . SPARSER::PROTEIN) ("NF-κB and Jun" . SPARSER::COLLECTION)
    ("even wild-type PHLPP2" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("the homologous PP2C phosphatase" . SPARSER::PROTEIN)
    ("mutant and IKK kinases ( xref )" . SPARSER::COLLECTION)
    ("PHLPP2-PI" . SPARSER::COLLECTION)
    ("PHLPP1α-IKKα" . SPARSER::PROTEIN-PAIR)
    ("PHLPP2-IKKβ" . SPARSER::COLLECTION) ("IKKβ-KD" . SPARSER::COLLECTION)
    ("IKKα-KD" . SPARSER::COLLECTION)
    ("isoforms and FLAG-tagged IKKα and IKKβ wild-type or kinase-dead (KD) forms in 293T cells ( xref )"
     . SPARSER::COLLECTION)
    ("Myc-PHLPP2" . SPARSER::COLLECTION)
    ("PHLPP2 and IKKβ" . SPARSER::COLLECTION)
    ("PHLPP2 and PHLPP1α" . SPARSER::COLLECTION)
    ("IKKβ and IKKα" . SPARSER::COLLECTION)
    ("PHLPP2-associated proteins" . SPARSER::PROTEIN)
    ("IKKβ and NEMO" . SPARSER::COLLECTION)
    ("kinases, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("NEMO/IKKγ" . SPARSER::COLLECTION) ("Bcl10-MALT1" . SPARSER::COLLECTION)
    ("MEKK3" . SPARSER::PROTEIN) ("CSF2" . SPARSER::PROTEIN)
    ("NOS2" . SPARSER::PROTEIN) ("PP2C" . SPARSER::PROTEIN)
    ("protein phosphatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PHLPP2" . SPARSER::PROTEIN) ("ARF-p53" . SPARSER::COLLECTION)
    ("PTEN-PI3K-AKT" . SPARSER::COLLECTION)
    ("variants and lies" . SPARSER::COLLECTION) ("bim-" . SPARSER::PROTEIN)
    ("dominant-negative FOXO" . SPARSER::PROTEIN-FAMILY)
    ("DMSO or BEZ235" . SPARSER::COLLECTION)
    ("our previously published cohort" . SPARSER::MOLECULE)
    ("BIM and MYC" . SPARSER::COLLECTION)
    ("BEZ235 or both drugs" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("activated MYC and/or AKT transgenes ( xref )" . SPARSER::COLLECTION)
    ("EGFP-bcl2" . SPARSER::COLLECTION) ("MYC-ER" . SPARSER::COLLECTION)
    ("rag2:mCherry" . SPARSER::BIO-COMPLEX)
    ("rag2:EGFP-bcl2" . SPARSER::BIO-COMPLEX)
    ("rag2:MYC-ER" . SPARSER::BIO-COMPLEX)
    ("mCherry or rag2" . SPARSER::COLLECTION)
    ("AKT and MYC" . SPARSER::COLLECTION) ("MYC and AKT" . SPARSER::COLLECTION)
    ("INK4a and ARF" . SPARSER::COLLECTION)
    ("bim homozygous mutants" . SPARSER::MUTANT)
    ("heterozygotes" . SPARSER::PROTEIN) ("bim" . SPARSER::PROTEIN)
    ("proapoptotic BIM" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("small nucleolar RNA" . SPARSER::RNA)
    ("β - actin" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-7" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("rag2" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("JAG" . SPARSER::PROTEIN)
    ("DS and SC" . SPARSER::COLLECTION) ("PR and IB" . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("diphenyl" . SPARSER::DRUG) ("beta and AR" . SPARSER::COLLECTION)
    ("the c-myc, cyclin D1 and cyclin A genes" . SPARSER::GENE)
    ("c-myc, cyclin D1 and cyclin" . SPARSER::COLLECTION)
    ("Waf1/Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("-AGAACAnnnTGTTGT-3" . SPARSER::COLLECTION)
    ("at least two different promoters" . SPARSER::PROMOTER)
    ("AR and ER" . SPARSER::COLLECTION)
    ("androgen and AR" . SPARSER::COLLECTION)
    ("ER beta knockdown reverses mibolerone’s" . SPARSER::DRUG)
    ("AR or RNA-polymerase" . SPARSER::COLLECTION)
    ("Protein-chromatin" . SPARSER::COLLECTION)
    ("OCT-1, GATA, and ARE" . SPARSER::COLLECTION)
    ("mibolerone and DHT" . SPARSER::COLLECTION)
    ("S1B and S1C" . SPARSER::COLLECTION) ("hydroxyflutamide" . SPARSER::DRUG)
    ("Mibolerone" . SPARSER::DRUG) ("ARs" . SPARSER::PROTEIN)
    ("the predominant isoform" . SPARSER::PROTEIN)
    ("ER beta’s" . SPARSER::PROTEIN)
    ("Estrogen and androgen" . SPARSER::COLLECTION)
    ("p21 and cyclin D1" . SPARSER::COLLECTION)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("anti-estrogenic" . SPARSER::DRUG)
    ("RNA-polymerase" . SPARSER::PROTEIN) ("OCT-1" . SPARSER::PROTEIN)
    ("OH-" . SPARSER::MOLECULE) ("CYCD1" . SPARSER::PROTEIN)
    ("beta)" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("polymerase II" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("l-glutamine" . SPARSER::MOLECULE) ("DAX1" . SPARSER::PROTEIN)
    ("ER-beta" . SPARSER::PROTEIN) ("ER-alpha" . SPARSER::PROTEIN)
    ("primary NPC" . SPARSER::MOLECULE)
    ("p70S6K and eIF4E-binding protein 1" . SPARSER::COLLECTION)
    ("eIF4E-binding protein 1" . SPARSER::PROTEIN)
    ("prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the histological type" . TYPE) ("Impact" . SPARSER::PROTEIN)
    ("the matched relapsed NPC" . SPARSER::MOLECULE)
    ("the primary NPC" . SPARSER::MOLECULE)
    ("the matched primary and relapsed NPC" . SPARSER::MOLECULE)
    ("the matched primary and metastatic NPC" . SPARSER::MOLECULE)
    ("Primary NPC and the Matched Metastatic or Relapsed NPC"
     . SPARSER::COLLECTION)
    ("the Matched Metastatic or Relapsed NPC" . SPARSER::MOLECULE)
    ("Primary NPC" . SPARSER::MOLECULE)
    ("NPC and low positive staining" . SPARSER::COLLECTION)
    ("Mnk1/eIF4E" . SPARSER::COLLECTION)
    ("tumor relevant proteins" . SPARSER::PROTEIN)
    ("dominant oncogenes and recessive oncogenes/tumor-suppressor genes"
     . SPARSER::COLLECTION)
    ("valuable biomarkers" . SPARSER::MOLECULE)
    ("histological type, age and gender" . SPARSER::COLLECTION)
    ("type, age and gender" . SPARSER::COLLECTION)
    ("the matched primary NPC" . SPARSER::MOLECULE)
    ("metastatic NPC" . SPARSER::MOLECULE) ("p-Mnk1" . SPARSER::COLLECTION)
    ("p-eIF4E" . SPARSER::COLLECTION)
    ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("Mnk1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("MIF and TGF-β" . SPARSER::COLLECTION)
    ("directly bind CD74" . SPARSER::PROTEIN) ("TrCP" . SPARSER::PROTEIN)
    ("NFκB, TGF-β, Bst2 and Vpu" . SPARSER::COLLECTION)
    ("anti-TGF-β antibodies and a chemical inhibitor" . SPARSER::COLLECTION)
    ("a profibrotic cytokine" . SPARSER::PROTEIN) ("DMN" . SPARSER::PROTEIN)
    ("ShRNA" . SPARSER::PROTEIN)
    ("a secretory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the HIV-1 accessory proteins" . SPARSER::PROTEIN)
    ("monocytes and CD8+" . SPARSER::COLLECTION)
    ("U937-GFP and U937-VpuGFP" . SPARSER::COLLECTION)
    ("MIF or CD74" . SPARSER::COLLECTION)
    ("a pantropic TGF-β antibody or an isotype control antibody"
     . SPARSER::COLLECTION)
    ("a pantropic TGF-β antibody" . SPARSER::ANTIBODY)
    ("U937-GFP or U937-VpuGFP" . SPARSER::COLLECTION)
    ("VEGF and MMP2" . SPARSER::COLLECTION)
    ("Bst2 and CD4" . SPARSER::COLLECTION)
    ("protein or GFP" . SPARSER::COLLECTION)
    ("Tetherin or CD317" . SPARSER::COLLECTION) ("Bst2" . SPARSER::PROTEIN)
    ("the four accessory proteins Vif" . SPARSER::PROTEIN)
    ("soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophage migration inhibitory factor (MIF)" . SPARSER::PROTEIN)
    ("TGF-β or a TGF-β receptor inhibitor (SB431452)" . SPARSER::COLLECTION)
    ("HIV-1 Vpu accessory protein" . SPARSER::PROTEIN)
    ("profibrogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAK1" . SPARSER::PROTEIN) ("GW6604" . SPARSER::DRUG)
    ("CD74" . SPARSER::PROTEIN) ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("xAP1" . SPARSER::PROTEIN) ("transmembrane protein" . SPARSER::PROTEIN)
    ("actin-1" . SPARSER::PROTEIN)
    ("macrophage migration inhibitory factor" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("transforming growth factor beta" . SPARSER::PROTEIN)
    ("gp160" . SPARSER::PROTEIN)
    ("the chemokine and inflammatory cytokines" . SPARSER::COLLECTION)
    ("TGF-β and IL-1β" . SPARSER::COLLECTION)
    ("MMP-2, MT1-MMP, and MMP-9" . SPARSER::COLLECTION)
    ("the homologous protein" . SPARSER::PROTEIN)
    ("Rho and Rac" . SPARSER::COLLECTION)
    ("the chemokines or inflammatory cytokines" . SPARSER::COLLECTION)
    ("Several inflammatory cytokines" . SPARSER::PROTEIN)
    ("TGF-β, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, and MCP-1" . SPARSER::COLLECTION)
    ("cytokines or chemokines" . SPARSER::COLLECTION)
    ("TNF-α (100 ng/ml) or IL-6 (100 ng/ml)" . SPARSER::COLLECTION)
    ("these two inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1β or TGF-β" . SPARSER::COLLECTION)
    ("IL-1β (100 ng/ml) or TGF-β (100 ng/ml)" . SPARSER::COLLECTION)
    ("IL-1β, TGF-β, and TNF-α" . SPARSER::COLLECTION)
    ("these chemokine and inflammatory cytokines" . SPARSER::COLLECTION)
    ("oncogene (GRO)" . SPARSER::PROTEIN) ("GRO" . SPARSER::PROTEIN)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("TNF-α or IL-6" . SPARSER::COLLECTION)
    ("TNF-α and IL-6" . SPARSER::COLLECTION) ("Leucine" . SPARSER::AMINO-ACID)
    ("parental BM-MSCs" . SPARSER::PROTEIN)
    ("CD73, CD90, and CD105" . SPARSER::COLLECTION)
    ("endopeptidase" . SPARSER::PROTEIN)
    ("most cellular proteases" . SPARSER::PROTEIN) ("DPP" . SPARSER::MOLECULE)
    ("IL-1β and TGF-β" . SPARSER::COLLECTION)
    ("the inflammatory cytokines interleukin-1beta (IL-1β) and transforming growth factor-beta (TGF-β)"
     . SPARSER::COLLECTION)
    ("FAP" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("CARMA-1" . SPARSER::PROTEIN) ("M 2" . SPARSER::MOLECULE)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD90" . SPARSER::PROTEIN)
    ("CD105" . SPARSER::PROTEIN) ("AS3" . SPARSER::PROTEIN)
    ("dipeptidase activity" . SPARSER::PROTEIN)
    ("a polypeptide" . SPARSER::PROTEIN) ("DPP9" . SPARSER::PROTEIN)
    ("DPP4" . SPARSER::PROTEIN) ("peptidase activity" . SPARSER::PROTEIN)
    ("interleukin-1beta" . SPARSER::PROTEIN)
    ("Fibroblast activation protein" . SPARSER::PROTEIN)
    ("GNEF" . SPARSER::GEF)
    ("an oncogene or a tumor suppressor gene" . SPARSER::COLLECTION)
    ("further evidence supporting Tiam1" . SPARSER::PROTEIN)
    ("pEZ" . SPARSER::PROTEIN) ("Tiam1-3" . SPARSER::COLLECTION)
    ("a significant prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanine nucleotide exchange factor (GNEF)" . SPARSER::GEF)
    ("Dbl" . SPARSER::PROTEIN) ("LO2" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("Tiam1" . SPARSER::PROTEIN)
    ("COX-2 and IL6" . SPARSER::COLLECTION)
    ("demographic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and IL-6" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("IL6 and COX-2" . SPARSER::COLLECTION)
    ("all the acute phase proteins" . SPARSER::PROTEIN)
    ("C-reactive protein, serum amyloid A, fibrinogen, α1-chymotrypsin and haptoglobin"
     . SPARSER::COLLECTION)
    ("haptoglobin" . SPARSER::PROTEIN) ("chymotrypsin" . SPARSER::PROTEIN)
    ("IL-6 or COX-2" . SPARSER::COLLECTION)
    ("IL-6 and COX-2" . SPARSER::COLLECTION) ("PEG2" . SPARSER::PROTEIN)
    ("IL 6" . SPARSER::PROTEIN) ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("serum amyloid A" . SPARSER::PROTEIN)
    ("telomerase and several genes" . SPARSER::COLLECTION)
    ("most mammalian genes and the recent miRNA database (miRBase 18) lists 1921 mature miRNAs encoded by 1527 hairpin genes in Homo sapiens"
     . SPARSER::COLLECTION)
    ("the recent miRNA database (miRBase 18) lists 1921 mature miRNAs"
     . SPARSER::MICRO-RNA)
    ("c-Myc and N-Myc" . SPARSER::COLLECTION)
    ("aggressive variants" . SPARSER::VARIANT)
    ("telomerase and Wnt" . SPARSER::COLLECTION)
    ("hTERT and genes" . SPARSER::COLLECTION)
    ("both a target gene and an activator" . SPARSER::COLLECTION)
    ("at least five additional miRNAs" . SPARSER::MICRO-RNA)
    ("MIX1 and MIX3" . SPARSER::COLLECTION)
    ("the principal regulators" . SPARSER::REGULATOR)
    ("mixtures" . SPARSER::MOLECULE)
    ("two proteins approximately 39 and 43 kDa" . SPARSER::PROTEIN)
    ("TCF7 and MSI1" . SPARSER::COLLECTION)
    ("PITA and RNAhybrid" . SPARSER::COLLECTION) ("PITA" . SPARSER::PROTEIN)
    ("Telomerase and TCF7, MSI1 and PAX5" . SPARSER::COLLECTION)
    ("MIX1 and MIX2" . SPARSER::COLLECTION)
    ("UTR and individual miRNAs" . SPARSER::COLLECTION)
    ("MIX" . SPARSER::PROTEIN) ("TCF7, MSI1 and PAX5" . SPARSER::COLLECTION)
    ("MSI1 and PAX5" . SPARSER::COLLECTION)
    ("most bilaterian metazoans" . SPARSER::PROTEIN-FAMILY)
    ("multiple miRNAs and these regulatory networks" . SPARSER::COLLECTION)
    ("the hTERT gene promoter and post-transcriptional modifications of the hTERT mRNA"
     . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mature miRNAs" . SPARSER::MICRO-RNA)
    ("two mature targeting miRNAs" . SPARSER::MICRO-RNA)
    ("RISC" . SPARSER::PROTEIN) ("RISCs" . SPARSER::PROTEIN)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("hTERT and Wnt" . SPARSER::COLLECTION)
    ("TCF7, MSI1, and PAX5" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("Musashi 1" . SPARSER::PROTEIN) ("MIX2" . SPARSER::PROTEIN)
    ("MIX1" . SPARSER::PROTEIN) ("Telomerase Activity" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("anti-oncogenes" . SPARSER::PROTEIN) ("PAX5" . SPARSER::PROTEIN)
    ("MSI1" . SPARSER::PROTEIN) ("TCF7" . SPARSER::PROTEIN)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("primary or advanced BTC" . SPARSER::PROTEIN)
    ("EGFR , ERRB2 , ERRB3 and ERRB4" . SPARSER::COLLECTION)
    ("BRAF , KRAS , EGFR and PIK3CA" . SPARSER::COLLECTION)
    ("angiogenic kinases" . SPARSER::KINASE) ("CKIT" . SPARSER::PROTEIN)
    ("treating T315I mutant chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("differentially expressed Wnt signaling genes" . SPARSER::GENE)
    ("BICC1-FGFR2" . SPARSER::COLLECTION) ("BICC1" . SPARSER::PROTEIN)
    ("FGFR2-BICC1" . SPARSER::PROTEIN-PAIR)
    ("the last coding exon" . SPARSER::PROTEIN)
    ("the last intron" . SPARSER::PROTEIN)
    ("MGEA5 , BICC1 and TACC3" . SPARSER::COLLECTION)
    ("FGFR2 , FGFR3 and FGFR4" . SPARSER::COLLECTION)
    ("EGFR and BRAF" . SPARSER::COLLECTION)
    ("the allelic fraction" . SPARSER::COMPONENT)
    ("abdominal pain" . SPARSER::PROTEIN)
    ("RECIST criteria v1.1" . SPARSER::PROTEIN)
    ("a ruptured ovarian cyst" . SPARSER::PROTEIN)
    ("NPM3 and FGF8" . SPARSER::COLLECTION)
    ("TGFBR3 and MGEA5" . SPARSER::COLLECTION) ("Ponatinib" . SPARSER::DRUG)
    ("FGFR2 and FGFR3" . SPARSER::COLLECTION) ("hyaluronidase" . SPARSER::DRUG)
    ("gemcitabine and capecitabine" . SPARSER::COLLECTION)
    ("Hep-par 1" . SPARSER::COLLECTION) ("Hep" . SPARSER::PROTEIN)
    ("FGF8 (p<0.05) and the genome" . SPARSER::COLLECTION)
    ("NAV3 , LAMC3 , PLXNB3 , and PTPRK" . SPARSER::COLLECTION)
    ("FGFR/EGFR" . SPARSER::COLLECTION) ("PTPRK" . SPARSER::PROTEIN)
    ("the microtubule-associated motor protein complex" . SPARSER::BIO-COMPLEX)
    ("dynein" . SPARSER::PROTEIN)
    ("PLCG1 , MAP2K1 , and MAPK8" . SPARSER::COLLECTION)
    ("FGFR and EGFR" . SPARSER::COLLECTION)
    ("CDCA8, BUB1, and TACC1" . SPARSER::COLLECTION)
    ("HDAC1 , TP53 , MDM2 and AKT1" . SPARSER::COLLECTION)
    ("EphrinB" . SPARSER::PROTEIN) ("chemoattractants" . SPARSER::PROTEIN)
    ("FGF7 and FGF10" . SPARSER::COLLECTION) ("fluke" . SPARSER::PROTEIN)
    ("GRIN3A (n = 2) and PLXBN3 (n = 2)" . SPARSER::COLLECTION)
    ("the predominant class" . CLASS) ("EGFR and FGFR" . SPARSER::COLLECTION)
    ("ponatinib and again demonstrated tumor shrinkage" . SPARSER::COLLECTION)
    ("FGFR2-MGEA5" . SPARSER::COLLECTION)
    ("therapeutically relevant targets" . SPARSER::TARGET-PROTEIN)
    ("FGFR2-AHCYL1" . SPARSER::COLLECTION) ("sporadic BTC" . SPARSER::PROTEIN)
    ("IDH1 (codon 132) and IDH2 (codons 140 and 172)" . SPARSER::COLLECTION)
    ("TP53 , KRAS , CDKN2A and SMAD4" . SPARSER::COLLECTION)
    ("MLL3 , ROBO2 , RNF43 , GNAS , PEG3 , XIRP2 , PTEN , RADIL , NCD80 , LAMA2 and PCDHA13"
     . SPARSER::COLLECTION)
    ("NCD" . SPARSER::PROTEIN-FAMILY) ("RADIL" . SPARSER::PROTEIN)
    ("BTC" . SPARSER::PROTEIN) ("ERRFI" . SPARSER::PROTEIN)
    ("ponatinib" . SPARSER::DRUG) ("FGFR2-TACC3" . SPARSER::COLLECTION)
    ("pazopanib" . SPARSER::DRUG) ("VEGFR1" . SPARSER::PROTEIN)
    ("Ki23057" . SPARSER::DRUG)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("FGFR2-IIIb" . SPARSER::PROTEIN) ("FGFR2 -IIIc" . SPARSER::PROTEIN)
    ("FGFR2 -IIIb" . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("FGF8  " . SPARSER::PROTEIN) ("NPM3  " . SPARSER::PROTEIN)
    ("NPM3" . SPARSER::PROTEIN) ("TGFBR3" . SPARSER::PROTEIN)
    ("O-GlcNAc" . SPARSER::PROTEIN) ("PEGPH20" . SPARSER::DRUG)
    ("par 1" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("PLXNB3" . SPARSER::PROTEIN)
    ("LAMC3" . SPARSER::PROTEIN) ("NAV3" . SPARSER::PROTEIN)
    ("MAPK8" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("PLCG1" . SPARSER::PROTEIN) ("TACC1" . SPARSER::PROTEIN)
    ("BUB1" . SPARSER::PROTEIN) ("CDCA8" . SPARSER::PROTEIN)
    ("FGF10" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("Beta1" . SPARSER::PROTEIN) ("PDGFR-beta" . SPARSER::PROTEIN)
    ("GRIN3A" . SPARSER::PROTEIN) ("CSPG4" . SPARSER::PROTEIN)
    ("MGEA5" . SPARSER::PROTEIN) ("AHCYL1" . SPARSER::PROTEIN)
    ("ERRB2" . SPARSER::PROTEIN) ("ABCB11" . SPARSER::PROTEIN)
    ("ABCB4" . SPARSER::PROTEIN) ("ROS1" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("LAMA2" . SPARSER::PROTEIN)
    ("XIRP2" . SPARSER::PROTEIN) ("RNF43" . SPARSER::PROTEIN)
    ("ROBO2" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("ERRFI1" . SPARSER::PROTEIN) ("TACC3" . SPARSER::PROTEIN)
    ("enzymes and transporters" . SPARSER::COLLECTION)
    ("secretory proteins" . SPARSER::PROTEIN)
    ("enzymes and glucose" . SPARSER::COLLECTION)
    ("anabolic metabolites" . SPARSER::PROTEIN)
    ("central metabolites" . SPARSER::PROTEIN)
    ("hexokinase and phosphofructokinase" . SPARSER::COLLECTION)
    ("p66Shc and p52Shc" . SPARSER::COLLECTION)
    ("IGF-1 and insulin" . SPARSER::COLLECTION)
    ("the ribosomal protein S6 kinase (S6K1), a substrate of mTORC1, and Thr 473 in Akt which is a direct target of mTORC2 ( xref )"
     . SPARSER::COLLECTION)
    ("labeled-glucose" . SPARSER::PROTEIN)
    ("downstream anabolic metabolites" . SPARSER::PROTEIN)
    ("acetyl-CoA and citrate" . SPARSER::COLLECTION)
    ("citrate and acetyl-CoA" . SPARSER::COLLECTION)
    ("extracellular lactate" . SPARSER::LACTATE)
    ("the pyrimidine synthesis intermediates orotate and dihydroorotate"
     . SPARSER::COLLECTION)
    ("phospholipid and glycoconjugate" . SPARSER::COLLECTION)
    ("dCTP and UTP" . SPARSER::COLLECTION) ("UTP" . SPARSER::MOLECULE)
    ("dCTP" . SPARSER::MOLECULE) ("Pyrimidine" . SPARSER::DRUG)
    ("nitrogen" . SPARSER::MOLECULE)
    ("alanine, serine and aspartate" . SPARSER::COLLECTION)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("an anabolic metabolite" . SPARSER::MOLECULE)
    ("Malonyl" . SPARSER::PROTEIN)
    ("acetyl-CoA and malonyl-CoA" . SPARSER::COLLECTION)
    ("PEP and lactate" . SPARSER::COLLECTION)
    ("GFP or 3xFLAG-p66Shc" . SPARSER::COLLECTION)
    ("KO and p66" . SPARSER::COLLECTION) ("xylulose" . SPARSER::MOLECULE)
    ("UDP-GlcNAc" . SPARSER::MOLECULE) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("hexosamine" . SPARSER::MOLECULE)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("p52/p46" . SPARSER::COLLECTION)
    ("MAP kinase and phosphatidylinositol" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("Ras-Erk" . SPARSER::COLLECTION)
    ("scaffolds" . SPARSER::SCAFFOLD)
    ("p66Shc and p52Shc or p46Shc" . SPARSER::COLLECTION)
    ("p52/p46Shc" . SPARSER::COLLECTION)
    ("p46, p52 and p66" . SPARSER::COLLECTION)
    ("insulin and mTOR" . SPARSER::COLLECTION)
    ("calyculin A" . SPARSER::MOLECULE) ("MgSO4" . SPARSER::DRUG)
    ("d-glucose" . SPARSER::MOLECULE) ("GS2" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("UDP-" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN) ("CH1" . SPARSER::PROTEIN)
    ("p66" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p46" . SPARSER::PROTEIN)
    ("Grb10" . SPARSER::PROTEIN) ("Shc1" . SPARSER::PROTEIN)
    ("p66Shc" . SPARSER::PROTEIN) ("PKCβII" . SPARSER::PROTEIN)
    ("STAT3-PKCβII" . SPARSER::PROTEIN-PAIR) ("enzastaurin" . SPARSER::DRUG)
    ("clinically applicable pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("esters, or PKCβ" . SPARSER::COLLECTION)
    ("IL-6, G-CSF, and VEGF" . SPARSER::COLLECTION)
    ("ERK and NF-κB" . SPARSER::COLLECTION)
    ("monocytes and myeloid" . SPARSER::COLLECTION)
    ("cytokines and phorbol" . SPARSER::COLLECTION)
    ("the mutated promoter" . SPARSER::PROMOTER)
    ("recombinant IL-6 ( xref ) and the CA-STAT3 mutant ( xref )"
     . SPARSER::COLLECTION)
    ("STAT1 or STAT5" . SPARSER::COLLECTION)
    ("the pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("PKCβII protein (p < 0.001, xref ) and PRKCB2 mRNA" . SPARSER::COLLECTION)
    ("stably expressing wild-type STAT3, dominant negative STAT3 (DN-STAT3), or constitutively active STAT3 (CA-STAT3) in the human myeloid progenitor cell line K562 ( xref )"
     . SPARSER::COLLECTION)
    ("DN-STAT3" . SPARSER::COLLECTION)
    ("CSF3R (which encodes G-CSFR, p < 0.05) and KDR (which encodes VEGFR2, p < 0.001)"
     . SPARSER::COLLECTION)
    ("IL-6, VEGF, and G-CSF" . SPARSER::COLLECTION)
    ("GM-CSF and G-CSF" . SPARSER::COLLECTION)
    ("G -CSF and GM-CSF" . SPARSER::COLLECTION) ("TDF" . SPARSER::PROTEIN)
    ("the CMV promoter–driven PRKCB2" . SPARSER::PROTEIN)
    ("mRNA and PKCβII" . SPARSER::COLLECTION)
    ("GM-CSF, IL-4, and TNF-α" . SPARSER::COLLECTION)
    ("CD11c, CD40, CD80, CD83, and CD86" . SPARSER::COLLECTION)
    ("TCM" . SPARSER::PROTEIN) ("Monocytes" . SPARSER::PROTEIN)
    ("GM-CSF and tumor necrosis factor" . SPARSER::COLLECTION)
    ("media (TCM)" . SPARSER::PROTEIN)
    ("Tumor-secreted soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and ERK" . SPARSER::COLLECTION)
    ("enhanced green fluorescent protein (EGFP) and small interfering RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("EGFP and a negative control siRNA (pEGFP-siEmpty)" . SPARSER::COLLECTION)
    ("pEGFP" . SPARSER::PROTEIN) ("GM-CSF and IL-4" . SPARSER::COLLECTION)
    ("MCA" . SPARSER::PROTEIN)
    ("significantly less Prkcb2 mRNA" . SPARSER::RNA)
    ("Prkcb2" . SPARSER::PROTEIN) ("Prkcb" . SPARSER::PROTEIN)
    ("significantly fewer PKCβII-containing CD11b + CD5" . SPARSER::PROTEIN)
    ("EL4" . SPARSER::PROTEIN)
    ("the second messengers diacylglycerol (DAG) and Ca 2+"
     . SPARSER::COLLECTION)
    ("diacylglycerol (DAG)" . SPARSER::DAG)
    ("mature immunostimulatory DCs" . SPARSER::PROTEIN)
    ("STAT3 and PKCβII" . SPARSER::COLLECTION)
    ("cytokine and growth factor receptors" . SPARSER::COLLECTION)
    ("PRKCB" . SPARSER::PROTEIN) ("TDFs" . SPARSER::DRUG)
    ("anti -" . SPARSER::ANTIBODY) ("CD309" . SPARSER::PROTEIN)
    ("CD126" . SPARSER::PROTEIN) ("CD114" . SPARSER::PROTEIN)
    ("FLLL32" . SPARSER::DRUG) ("G-CSFR" . SPARSER::PROTEIN)
    ("CSF3R" . SPARSER::PROTEIN) ("IL-6RA" . SPARSER::PROTEIN)
    ("G -CSF" . SPARSER::PROTEIN) ("glucose-6-phosphatase" . SPARSER::PROTEIN)
    ("CD83" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gr1" . SPARSER::PROTEIN) ("AT3" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("PRKCB2" . SPARSER::PROTEIN)
    ("IFN and ISG" . SPARSER::COLLECTION)
    ("specifically target IRF kinases TBK1 and IKKε" . SPARSER::COLLECTION)
    ("proteins and complexes" . SPARSER::COLLECTION)
    ("phosphatases or deubiquitinases" . SPARSER::COLLECTION)
    ("proteins or regulators" . SPARSER::COLLECTION)
    ("SINTBAD" . SPARSER::PROTEIN) ("TRIMs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ABIN" . SPARSER::PROTEIN) ("TBK1 or TBK1" . SPARSER::COLLECTION)
    ("TANK or TRAF3" . SPARSER::COLLECTION)
    ("phosphatases (SHIP-1) and scaffold-specific complexes (TRAF3, TRAF2, TANK, MAVS, NEMO, optineurin)"
     . SPARSER::COLLECTION)
    ("CYLD, A20, and DUBA" . SPARSER::COLLECTION) ("DUBA" . SPARSER::PROTEIN)
    ("optineurin" . SPARSER::PROTEIN)
    ("polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBK1 and its homologue IKKε ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("GnGc proteins or their cellular regulatory targets"
     . SPARSER::COLLECTION)
    ("the ANDV N protein nor the GnGc protein" . SPARSER::COLLECTION)
    ("SeV" . SPARSER::PROTEIN) ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymerase and GnT" . SPARSER::COLLECTION)
    ("an alternate S segment ORF" . SPARSER::PROTEIN)
    ("MAVS-" . SPARSER::PROTEIN) ("MDA5-" . SPARSER::PROTEIN)
    ("RIG-I-" . SPARSER::PROTEIN) ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("a ubiquitous inhibitor" . SPARSER::INHIBITOR)
    ("NF-κB or type I" . SPARSER::COLLECTION) ("IκB-SR" . SPARSER::COLLECTION)
    ("IFN-α- or TNF-α-induced ISRE" . SPARSER::COLLECTION)
    ("IFN-α-" . SPARSER::PROTEIN)
    ("ISRE or NF-κB transcriptional response" . SPARSER::COLLECTION)
    ("IFN-α or TNF-α" . SPARSER::COLLECTION)
    ("IFN or TNF" . SPARSER::COLLECTION)
    ("IRF3 and NF-κB" . SPARSER::COLLECTION)
    ("functionally homologous kinases" . SPARSER::KINASE)
    ("IKKε and TBK1" . SPARSER::COLLECTION) ("GnT" . SPARSER::PROTEIN)
    ("κB, or IFN-β" . SPARSER::COLLECTION)
    ("TBK1 or IKKε" . SPARSER::COLLECTION)
    ("homologous downstream kinases TBK1 and IKKε" . SPARSER::COLLECTION)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("RIG-I/MDA5/MAVS" . SPARSER::COLLECTION)
    ("RIG-I, MDA5, or MAVS" . SPARSER::COLLECTION)
    ("RIG-I, MDA5, or MAVS and ISRE-luciferase" . SPARSER::COLLECTION)
    ("MAVS and ISRE-luciferase" . SPARSER::COLLECTION)
    ("downstream MAVS and TBK1/IKKε signaling effectors" . SPARSER::COLLECTION)
    ("RIG-I/MDA5" . SPARSER::COLLECTION) ("cellular mRNAs" . SPARSER::PROTEIN)
    ("ISRE-" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("RIG-I or TBK1" . SPARSER::COLLECTION) ("TBK1/IKKε" . SPARSER::COLLECTION)
    ("TBK1, and IKKε" . SPARSER::COLLECTION)
    ("κB, and IFN-β" . SPARSER::COLLECTION) ("enhanceosome" . SPARSER::PROTEIN)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("/melanoma differentiation-associated protein 5" . SPARSER::COLLECTION)
    ("IFN-β and ISG" . SPARSER::COLLECTION) ("ISG" . SPARSER::GENE)
    ("IFN-β and IFN-stimulated genes (ISGs)" . SPARSER::COLLECTION)
    ("interferon (alpha/beta" . SPARSER::COLLECTION)
    ("heterodimeric surface glycoproteins (Gn and Gc) and a highly expressed cytoplasmic nucleocapsid (N) protein ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("a polymerase, heterodimeric surface glycoproteins (Gn and Gc) and a highly expressed cytoplasmic nucleocapsid (N) protein ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("heterodimeric surface glycoproteins" . SPARSER::PROTEIN)
    ("gene (ISG)" . SPARSER::PROTEIN)
    ("MAVS, TBK1, and IκB" . SPARSER::COLLECTION)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("IFN-β-" . SPARSER::PROTEIN) ("Sin" . SPARSER::PROTEIN)
    ("RIG-I and MDA5" . SPARSER::COLLECTION) ("NA 3 VO 4" . SPARSER::MOLECULE)
    ("nucleocapsid protein" . SPARSER::PROTEIN)
    ("Virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("NAP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OTUB1" . SPARSER::PROTEIN)
    ("RNF11" . SPARSER::PROTEIN) ("TAX1" . SPARSER::PROTEIN)
    ("SHIP-1" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN)
    ("mitochondrial antiviral signaling protein" . SPARSER::PROTEIN)
    ("TANK binding kinase 1" . SPARSER::PROTEIN)
    ("melanoma differentiation-associated protein 5" . SPARSER::PROTEIN)
    ("interferon (alpha" . SPARSER::PROTEIN) ("α v β 3" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN) ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("KRAS/RAF/MEK" . SPARSER::COLLECTION)
    ("KRAS G12V and wild-type TP53" . SPARSER::COLLECTION)
    ("only KRAS G12V" . SPARSER::PROTEIN)
    ("KRAS G12V and KRAS G12D" . SPARSER::COLLECTION)
    ("KRAS G12D and KRAS G12V" . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG)
    ("wild-type KRAS or rare KRAS variants" . SPARSER::COLLECTION)
    ("bar" . SPARSER::PROTEIN) ("was run" . SPARSER::PROTEIN)
    ("run" . SPARSER::PROTEIN)
    ("approximately 1% KRAS G12D" . SPARSER::PROTEIN)
    ("Ion Torrent PGM" . SPARSER::PROTEIN)
    ("the mutated allele" . SPARSER::ALLELE)
    ("fallopian tube" . SPARSER::PROTEIN)
    ("the fallopian tube" . SPARSER::PROTEIN) ("PGM" . SPARSER::PROTEIN)
    ("mutated alleles" . SPARSER::ALLELE) ("AZD6244" . SPARSER::DRUG)
    ("SAS" . SPARSER::PROTEIN) ("tetra" . SPARSER::MOLECULE)
    ("ethylenediamine" . SPARSER::DRUG)
    ("discovery cohort and replication cohort" . SPARSER::COLLECTION)
    ("RA and systemic lupus erythematosus" . SPARSER::COLLECTION)
    ("ACPA" . SPARSER::PROTEIN) ("ETS1 and WDFY4" . SPARSER::COLLECTION)
    ("RA" . SPARSER::PROTEIN) ("interleukin-10" . SPARSER::PROTEIN)
    ("WDFY4" . SPARSER::PROTEIN) ("WDFY family member 4" . SPARSER::PROTEIN)
    ("an indispensible signaling component" . SPARSER::COMPONENT)
    ("PKCβ or PKCθ" . SPARSER::COLLECTION)
    ("Carma1 and MALT1" . SPARSER::COLLECTION)
    ("PI3K, and Akt and PKCθ" . SPARSER::COLLECTION)
    ("Akt and PKCθ" . SPARSER::COLLECTION)
    ("CaMKII, CK1α, HPK1, and IKKβ" . SPARSER::COLLECTION)
    ("both the S637A/S645A (Akt sites) and S551A/S552A (PKC/HPK1 sites) Carma1 mutants"
     . SPARSER::COLLECTION)
    ("PKC/HPK1" . SPARSER::COLLECTION) ("S637A/S645A" . SPARSER::PROTEIN)
    ("both the classical NF-κB" . SPARSER::PROTEIN)
    ("CD28- or Akt-mediated co-stimulation" . SPARSER::COLLECTION)
    ("CD28-" . SPARSER::PROTEIN) ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("GST-Carma1" . SPARSER::COLLECTION) ("GST-GSK3" . SPARSER::COLLECTION)
    ("anti-Myc or anti-HA" . SPARSER::COLLECTION)
    ("CARD and coiled-coil" . SPARSER::COLLECTION)
    ("MAGUK" . SPARSER::PROTEIN-FAMILY)
    ("a band around 150 kD" . SPARSER::PROTEIN)
    ("other possible direct targets" . SPARSER::TARGET-PROTEIN)
    ("serine and threonine" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("a slower mobility form" . SPARSER::FORM) ("Myr" . SPARSER::MOLECULE)
    ("possibly other CBM components" . SPARSER::COMPONENT)
    ("Akt and Carma1" . SPARSER::COLLECTION)
    ("PDK1 and Akt" . SPARSER::COLLECTION)
    ("IKKβ ( xref ) and CaMKII ( xref )" . SPARSER::COLLECTION)
    ("the CARD protein Bcl10 and the caspase-like protein Malt1"
     . SPARSER::COLLECTION)
    ("Malt1" . SPARSER::PROTEIN)
    ("Carma1, Carma2 and Carma3" . SPARSER::COLLECTION)
    ("Carma3" . SPARSER::PROTEIN)
    ("membrane-associated guanylate kinase (GUK) (Carma1) proteins"
     . SPARSER::PROTEIN)
    ("guanylate kinase (GUK)" . SPARSER::PROTEIN) ("GUK" . SPARSER::PROTEIN)
    ("CARD" . SPARSER::PROTEIN)
    ("receptor and co-stimulatory" . SPARSER::COLLECTION)
    ("Carma1" . SPARSER::PROTEIN) ("MALT1" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("150 kD" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG) ("MnCl2" . SPARSER::DRUG)
    ("PKBα" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("HPK1" . SPARSER::PROTEIN)
    ("hematopoietic progenitor kinase" . SPARSER::PROTEIN)
    ("anti-EGRF monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("RAD21 and KRAS" . SPARSER::COLLECTION)
    ("multiple genes modulating the Ras and Rho GTPase-dependent signalling pathways"
     . SPARSER::COLLECTION)
    ("RhoB" . SPARSER::PROTEIN) ("RAD21 or cohesin" . SPARSER::COLLECTION)
    ("DNA–platinum" . SPARSER::DNA) ("guanines" . SPARSER::NUCLEOBASE)
    ("Oxaliplatin" . SPARSER::DRUG)
    ("reduced functional RAD21" . SPARSER::PROTEIN)
    ("RAD21 or other cohesin gene ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("RAD21 or SMC3" . SPARSER::COLLECTION)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("the novel chromosomal DNA repair protein" . SPARSER::PROTEIN)
    ("RAD21 and c-Myc" . SPARSER::COLLECTION)
    ("another core cohesin subunit and RAD21's" . SPARSER::COLLECTION)
    ("subunit and RAD21" . SPARSER::COLLECTION)
    ("APC, KRAS, BRAF and p53" . SPARSER::COLLECTION)
    ("SMC1A, SMC3 and STAG3" . SPARSER::COLLECTION)
    ("several accessory and regulatory proteins" . SPARSER::PROTEIN)
    ("cohesin" . SPARSER::PROTEIN) ("shorter DSS" . SPARSER::PROTEIN)
    ("BRAF and KRAS" . SPARSER::COLLECTION) ("DSS" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("Rad21" . SPARSER::PROTEIN)
    ("SMC1A" . SPARSER::PROTEIN) ("RAD21" . SPARSER::PROTEIN)
    ("The unusual conformation" . SPARSER::BIO-CONFORMATION)
    ("FFAs" . SPARSER::PROTEIN)
    ("relatively weak deacetylase activity" . SPARSER::PROTEIN)
    ("SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("subcutaneous fat" . SPARSER::PROTEIN) ("ELK4-" . SPARSER::PROTEIN)
    ("MYC-" . SPARSER::PROTEIN) ("a global regulator" . SPARSER::PROTEIN)
    ("active polysomal ribosomes" . SPARSER::BIO-COMPLEX)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("multiple ribosomal proteins" . SPARSER::PROTEIN)
    ("mTOR and the TFIIIC2 transcription factor" . SPARSER::COLLECTION)
    ("POLIII" . SPARSER::PROTEIN) ("TFIIIC" . SPARSER::PROTEIN)
    ("several nucleolar chromatin" . SPARSER::PROTEIN)
    ("WICH" . SPARSER::PROTEIN) ("NoRC" . SPARSER::PROTEIN)
    ("POLI and rDNA" . SPARSER::COLLECTION) ("POLI" . SPARSER::PROTEIN)
    ("ribosomal complexes" . SPARSER::BIO-COMPLEX)
    ("ribosomal RNA" . SPARSER::RNA)
    ("HIF-1a and HIF-2a" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("SIRT1-SIRT7" . SPARSER::COLLECTION)
    ("Class I and Class II deacetylases" . SPARSER::COLLECTION)
    ("a promising pharmacologic target" . SPARSER::TARGET-PROTEIN)
    ("tRNA" . SPARSER::RNA) ("the transformed state" . SPARSER::BIO-STATE)
    ("an emerging epigenetic biomarker" . SPARSER::MOLECULE)
    ("transfer RNA" . SPARSER::RNA) ("PAF53" . SPARSER::PROTEIN)
    ("HIF-2" . SPARSER::PROTEIN) ("ELK4" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the functional SNP" . SPARSER::PROTEIN)
    ("only common variants" . SPARSER::VARIANT)
    ("delta and epsilon" . SPARSER::COLLECTION) ("delta" . SPARSER::PROTEIN)
    ("the peri-conceptional period" . SPARSER::PROTEIN)
    ("the MTHFD2 (rs702465, rs7571842) and TYMS (rs2847159, rs1001761, rs502396) genes"
     . SPARSER::COLLECTION)
    ("MTHFD2 and TYMS" . SPARSER::COLLECTION) ("dTMP" . SPARSER::MOLECULE)
    ("methylenetetrahydrofolate" . SPARSER::MOLECULE)
    ("thymidylate" . SPARSER::MOLECULE)
    ("Fetal genetic variants" . SPARSER::VARIANT)
    ("harmful xenobiotics" . SPARSER::MOLECULE)
    ("Cellular glutathione" . SPARSER::DRUG)
    ("xenobiotics" . SPARSER::MOLECULE) ("The maternal SNP" . SPARSER::PROTEIN)
    ("Maternal genetic variants" . SPARSER::VARIANT)
    ("fetal and maternal genes" . SPARSER::GENE)
    ("fetal genes" . SPARSER::GENE) ("synthase ( PGDS )" . SPARSER::PROTEIN)
    ("Other maternal genes" . SPARSER::GENE)
    ("BHMT2 and BHMT" . SPARSER::COLLECTION) ("PGDS" . SPARSER::PROTEIN)
    ("Replication factor C (activator 1) 1 ( RFC-1 ) gene" . SPARSER::GENE)
    ("O-6-methylguanine-DNA methyltransferase ( MGMT )" . SPARSER::PROTEIN)
    ("adenosylhomocysteinase" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN)
    ("synthetase ( MTHFS )" . SPARSER::PROTEIN)
    ("s-methyltransferase" . SPARSER::COLLECTION) ("BHMT" . SPARSER::PROTEIN)
    ("GLRX" . SPARSER::PROTEIN) ("glutaredoxin" . SPARSER::PROTEIN)
    ("MTRR" . SPARSER::PROTEIN) ("methyltetrahydrofolate" . SPARSER::MOLECULE)
    ("MTHFS" . SPARSER::PROTEIN) ("variant or region" . SPARSER::COLLECTION)
    ("case-" . SPARSER::PROTEIN)
    ("tobacco or multivitamins containing" . SPARSER::COLLECTION)
    ("aortic arch type B" . SPARSER::PROTEIN)
    ("the blood-derived DNA" . SPARSER::DNA) ("Genotype" . SPARSER::PROTEIN)
    ("study subject WGA amplified DNA using Illumina’s" . SPARSER::DNA)
    ("Sigma" . SPARSER::PROTEIN) ("Reagents" . SPARSER::MOLECULE)
    ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("the Replication factor C (activator 1) 1 ( RFC-1 ) gene" . SPARSER::GENE)
    ("the predicted optimal oligonucleotide" . SPARSER::MOLECULE)
    ("variants and CTDs" . SPARSER::COLLECTION)
    ("common maternal and fetal genetic variants" . SPARSER::VARIANT)
    ("the periconceptional period" . SPARSER::PROTEIN)
    ("teratogens" . SPARSER::MOLECULE)
    ("interrupted aortic arch type B" . SPARSER::PROTEIN)
    ("heterogeneous cardiac malformations" . SPARSER::PROTEIN)
    ("homocysteine and pathways" . SPARSER::COLLECTION)
    ("MTHFD2" . SPARSER::PROTEIN)
    ("cystathionine-beta-synthase" . SPARSER::PROTEIN)
    ("methenyltetrahydrofolate synthetase" . SPARSER::PROTEIN)
    ("BHMT2" . SPARSER::PROTEIN) ("O-6" . SPARSER::PROTEIN)
    ("NOS2A" . SPARSER::PROTEIN) ("TCN2" . SPARSER::PROTEIN)
    ("transcobalamin II" . SPARSER::PROTEIN) ("KIAA0828" . SPARSER::PROTEIN)
    ("MGST1" . SPARSER::PROTEIN)
    ("microsomal glutathione S-transferase 1" . SPARSER::PROTEIN)
    ("GSTM4" . SPARSER::PROTEIN)
    ("glutathione S-transferase mu 4" . SPARSER::PROTEIN)
    ("GPX4" . SPARSER::PROTEIN)
    ("superoxide dismutase 2, mitochondrial" . SPARSER::PROTEIN)
    ("a beta" . SPARSER::PROTEIN) ("SLC19A1" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("RREB1 and NF-κB" . SPARSER::COLLECTION)
    ("a gene's" . SPARSER::PROTEIN) ("n  " . SPARSER::PROTEIN)
    ("the region around PARP1" . SPARSER::PROTEIN)
    ("NF-κB and TATA-binding proteins (Supporting Information xref )"
     . SPARSER::COLLECTION)
    ("DNAse" . SPARSER::PROTEIN) ("the Austrian cohort" . SPARSER::MOLECULE)
    ("MAF " . SPARSER::PROTEIN)
    ("the poly(adenosine diphosphate-ribose) polymerase 1 ( PARP1 ) gene"
     . SPARSER::GENE)
    ("Runt-related transcription factor 1" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN) ("SDS 1" . SPARSER::PROTEIN)
    ("MC1R" . SPARSER::PROTEIN) ("melanocortin receptor 1" . SPARSER::PROTEIN)
    ("Imatinib" . SPARSER::DRUG) ("p53 and c-KIT" . SPARSER::COLLECTION)
    ("c-KIT and p53" . SPARSER::COLLECTION)
    ("p53, c-KIT and kinases" . SPARSER::COLLECTION) ("aHR" . SPARSER::PROTEIN)
    ("histological examples" . SPARSER::EXAMPLE)
    ("an Australian cohort" . SPARSER::MOLECULE)
    ("vulvar melanoma, and LS" . SPARSER::COLLECTION)
    ("melanoma, and LS" . SPARSER::COLLECTION) ("CD117" . SPARSER::PROTEIN)
    ("clinically available MEK inhibitors" . SPARSER::INHIBITOR)
    ("MEK and EGFR" . SPARSER::COLLECTION) ("ERK-MAPK" . SPARSER::COLLECTION)
    ("NF1 (shNF1) or a non-silencing control shRNA (shSC)"
     . SPARSER::COLLECTION)
    ("erlotinib or afatinib" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("Kras, Hras and Nras" . SPARSER::COLLECTION) ("Hras" . SPARSER::PROTEIN)
    ("erlotinib and MEK" . SPARSER::COLLECTION)
    ("erlotinib or MEK" . SPARSER::COLLECTION)
    ("erlotinib and AZD-6244" . SPARSER::COLLECTION)
    ("erlotinib or AZD-6244" . SPARSER::COLLECTION)
    ("EGFR or MEK" . SPARSER::COLLECTION)
    ("CI-1040 and PD0325901" . SPARSER::COLLECTION)
    ("AZD-6244 or erlotinib" . SPARSER::COLLECTION)
    ("EGFR and AKT" . SPARSER::COLLECTION)
    ("NF1 or a non-silencing control shRNA" . SPARSER::COLLECTION)
    ("cisplatin or docetaxel" . SPARSER::COLLECTION)
    ("the previously used siRNA" . SPARSER::PROTEIN)
    ("the previously identified 242 siRNA" . SPARSER::PROTEIN)
    ("pre- and post-treatment" . SPARSER::COLLECTION)
    ("the AXL receptor or its ligand" . SPARSER::COLLECTION)
    ("MET, HER2 or MAPK1" . SPARSER::COLLECTION)
    ("gene ( EGFR )" . SPARSER::PROTEIN) ("EGFR and MEK" . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("POLR2A" . SPARSER::PROTEIN) ("GL3" . SPARSER::PROTEIN)
    ("AZD-6244" . SPARSER::DRUG) ("shNF1" . SPARSER::PROTEIN)
    ("MED12" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("IDE" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("APP and
its metabolites"
     . SPARSER::COLLECTION)
    ("APOE" . SPARSER::PROTEIN) ("APP and CTXN3" . SPARSER::COLLECTION)
    ("CHS and ADNI" . SPARSER::COLLECTION) ("angiotensin" . SPARSER::PROTEIN)
    ("renin" . SPARSER::PROTEIN) ("at least one SNP" . SPARSER::PROTEIN)
    ("available cohorts" . SPARSER::MOLECULE) ("bad" . SPARSER::PROTEIN)
    ("principal components" . SPARSER::COMPONENT)
    ("CHS-CS" . SPARSER::COLLECTION) ("CHS" . SPARSER::PROTEIN)
    ("oligomeric Aβ peptides" . SPARSER::PEPTIDE)
    ("APP and its metabolites" . SPARSER::COLLECTION)
    ("cortexin" . SPARSER::PROTEIN-FAMILY) ("ANK3" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("MEGF10" . SPARSER::PROTEIN)
    ("DAB1" . SPARSER::PROTEIN) ("disabled homolog 1" . SPARSER::PROTEIN)
    ("β-Amyloid" . SPARSER::MOLECULE) ("K3" . SPARSER::PROTEIN)
    ("monoclonal
antibody"
     . SPARSER::DRUG)
    ("Amyloid precursor protein" . SPARSER::PROTEIN)
    ("amyloid beta" . SPARSER::PROTEIN) ("CTXN3" . SPARSER::PROTEIN)
    ("amyloid
precursor protein"
     . SPARSER::PROTEIN)
    ("Amyloid beta" . SPARSER::PROTEIN) ("sugar" . SPARSER::MOLECULE)
    ("Lp(a) and uric acid" . SPARSER::COLLECTION)
    ("severe CAD" . SPARSER::PROTEIN) ("CAD or DM" . SPARSER::COLLECTION)
    ("angiographically proven CAD" . SPARSER::PROTEIN)
    ("a negative autocrine growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multifunctional peptide" . SPARSER::PEPTIDE)
    ("both TGF-β1 (AUC ROC : 0.678, 95% confidence interval [CI]: 0.633–0.723) and SMAD3 (AUC ROC : 0.715, 95% CI: 0.672–0.758)"
     . SPARSER::COLLECTION)
    ("Lp(a) (p < 0.0203) and uric acid (p < 0.0001)" . SPARSER::COLLECTION)
    ("TG, HDL, LDL, ApoA1, and ApoB" . SPARSER::COLLECTION)
    ("ApoA1" . SPARSER::PROTEIN) ("ApoB" . SPARSER::PROTEIN)
    ("TGF-β1/SMAD3" . SPARSER::COLLECTION)
    ("SMAD2 or SMAD3" . SPARSER::COLLECTION)
    ("a heteromeric complex" . SPARSER::BIO-COMPLEX)
    ("receptors and forms" . SPARSER::COLLECTION)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("extracellular-regulated kinase" . SPARSER::COLLECTION)
    ("macrophage and fibroblast chemotaxis" . SPARSER::COLLECTION)
    ("CAD, and transforming growth factor-β1" . SPARSER::COLLECTION)
    ("BUN" . SPARSER::PROTEIN) ("ApoA" . SPARSER::PROTEIN)
    ("AMI, SAP, and UAP" . SPARSER::COLLECTION)
    ("SAP and UAP" . SPARSER::COLLECTION) ("SAP" . SPARSER::PROTEIN)
    ("AMI" . SPARSER::PROTEIN) ("TGF-β1 and SMAD3" . SPARSER::COLLECTION)
    ("TGF-β1 and mothers against decapentaplegic homolog 3"
     . SPARSER::COLLECTION)
    ("CAD" . SPARSER::PROTEIN) ("Lp(a)" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("mothers against decapentaplegic homolog 3" . SPARSER::PROTEIN)
    ("ANS" . SPARSER::PROTEIN)
    ("caveolin-1, stomatin and flotillins" . SPARSER::COLLECTION)
    ("stomatin and flotillins" . SPARSER::COLLECTION)
    ("Sp1 and Ets-1" . SPARSER::COLLECTION) ("MFPs" . SPARSER::PROTEIN)
    ("malignant STS" . SPARSER::PROTEIN)
    ("the more aggressive metastasizing forms" . SPARSER::FORM)
    ("an unfavorable factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stomatin and caveolin-1" . SPARSER::COLLECTION)
    ("HR " . SPARSER::PROTEIN)
    ("stomatin, flotillin-1, flotillin-2, and caveolin-1α"
     . SPARSER::COLLECTION)
    ("the two main histological types" . TYPE)
    ("caveolin-1 and stomatin" . SPARSER::COLLECTION)
    ("caveolin-1 and flotillin-1" . SPARSER::COLLECTION)
    ("stomatin and flotillin-1" . SPARSER::COLLECTION)
    ("caveolin-1, stomatin, and flotillin-1" . SPARSER::COLLECTION)
    ("flotillin-1, stomatin, and caveolin-1" . SPARSER::COLLECTION)
    ("MFP and caveolin-1α" . SPARSER::COLLECTION)
    ("100 histological variants" . SPARSER::VARIANT)
    ("a tumor suppressor gene as well as an oncogene" . SPARSER::COLLECTION)
    ("many residential signaling molecules" . SPARSER::MOLECULE)
    ("proteins (MFP)" . SPARSER::PROTEIN) ("A special type" . TYPE)
    ("caveolins and SPFH" . SPARSER::COLLECTION) ("flK" . SPARSER::PROTEIN)
    ("MFP" . SPARSER::PROTEIN) ("sphingolipids" . SPARSER::MOLECULE)
    ("STOM and FLOT-1" . SPARSER::COLLECTION) ("STOM" . SPARSER::PROTEIN)
    ("Stomatin" . SPARSER::PROTEIN)
    ("flotillins, stomatin, and caveolin-1" . SPARSER::COLLECTION)
    ("caveolins and SPFH-domain" . SPARSER::COLLECTION)
    ("flotillins and stomatin" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN) ("stomatin" . SPARSER::PROTEIN)
    ("flotillins" . SPARSER::PROTEIN-FAMILY) ("flotillin-1" . SPARSER::PROTEIN)
    ("FLOT-1" . SPARSER::PROTEIN) ("Flotillin-2" . SPARSER::PROTEIN)
    ("the probable solution" . SPARSER::MOLECULE)
    ("a Rho effector kinase and this activated form" . SPARSER::COLLECTION)
    ("RhoC mRNA as well as protein expression" . SPARSER::COLLECTION)
    ("SNAIL" . SPARSER::PROTEIN) ("Rhotekin or ROCK" . SPARSER::COLLECTION)
    ("Rhotekin and ROCK" . SPARSER::COLLECTION) ("Rhotekin" . SPARSER::PROTEIN)
    ("nanog, sox2, and oct3/4" . SPARSER::COLLECTION)
    ("total and phosphorylated STAT3" . SPARSER::PROTEIN)
    ("factors, nanog, sox2, and oct3/4" . SPARSER::COLLECTION)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR) ("Transducers" . SPARSER::PROTEIN)
    ("sox2 and nanog" . SPARSER::COLLECTION)
    ("nanog and oct3/4" . SPARSER::COLLECTION)
    ("trypsinized and re-plated" . SPARSER::COLLECTION)
    ("trypsinized" . SPARSER::PROTEIN)
    ("non adherent serum free media" . SPARSER::PROTEIN)
    ("the fluorescent labeled ALDH antibody" . SPARSER::ANTIBODY)
    ("GFP-RhoC-shRNA" . SPARSER::COLLECTION)
    ("RhoC-siRNA" . SPARSER::COLLECTION) ("Puromycin" . SPARSER::DRUG)
    ("IL-6/JAK" . SPARSER::COLLECTION)
    ("factors, nanog, sox2 and oct3/4" . SPARSER::COLLECTION)
    ("CD44 and ALDH" . SPARSER::COLLECTION)
    ("a complex and multistep process" . SPARSER::COLLECTION)
    ("nanog, oct3/4 and sox2" . SPARSER::COLLECTION) ("tyr" . SPARSER::PROTEIN)
    ("nanog" . SPARSER::PROTEIN) ("ALDH and CD44" . SPARSER::COLLECTION)
    ("RhoC" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("sox2" . SPARSER::PROTEIN) ("oct3" . SPARSER::PROTEIN)
    ("a potentially valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ITGB4–FAK" . SPARSER::COLLECTION) ("Integrin/FAK" . SPARSER::COLLECTION)
    ("integrin and growth factors" . SPARSER::COLLECTION)
    ("FAK-Src" . SPARSER::COLLECTION) ("FAK and c-Src" . SPARSER::COLLECTION)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an anti-ITGB4" . SPARSER::ANTIBODY) ("ITGB4-FAK" . SPARSER::COLLECTION)
    ("LAMC2, ITGA5, LAMA3, ITGB4, COL1A1, THBS1 and COL5A1"
     . SPARSER::COLLECTION)
    ("ECM-receptor" . SPARSER::COLLECTION)
    ("genes and 12 down-regulated genes" . SPARSER::COLLECTION)
    ("-receptor" . SPARSER::COLLECTION)
    ("Differentially Expressed Genes" . SPARSER::GENE)
    ("DEGs" . SPARSER::PROTEIN) ("GANT61 or DMSO" . SPARSER::COLLECTION)
    ("Hh receptors (Ptch and Smo) and effectors (Gli1 and Gli2)"
     . SPARSER::COLLECTION)
    ("Ptch and Smo" . SPARSER::COLLECTION)
    ("integrin-associated proteins" . SPARSER::PROTEIN)
    ("paxillin and talin" . SPARSER::COLLECTION) ("talin" . SPARSER::PROTEIN)
    ("paxillin" . SPARSER::PROTEIN)
    ("unique downstream targets" . SPARSER::TARGET-PROTEIN)
    ("Gli1 and Gli2" . SPARSER::COLLECTION) ("GLI" . SPARSER::PROTEIN)
    ("ANTagonist" . SPARSER::MOLECULE) ("cyclopamine" . SPARSER::DRUG)
    ("Patched or Smoothened" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("Indian Hedgehog (Ihh) or Desert Hedgehog (Dhh)" . SPARSER::COLLECTION)
    ("Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) or Desert Hedgehog (Dhh)"
     . SPARSER::COLLECTION)
    ("Smo" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("Ihh" . SPARSER::PROTEIN) ("FAK and ITGB4" . SPARSER::COLLECTION)
    ("ITGB4 and the phosphorylated FAK" . SPARSER::COLLECTION)
    ("p200" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F-Actin" . SPARSER::BIO-COMPLEX)
    ("PF573228" . SPARSER::DRUG) ("THBS1" . SPARSER::PROTEIN)
    ("LAMA3" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("cytokine receptor" . SPARSER::PROTEIN) ("IPI-926" . SPARSER::DRUG)
    ("GDC-0449" . SPARSER::DRUG) ("Desert Hedgehog" . SPARSER::PROTEIN)
    ("Indian Hedgehog" . SPARSER::PROTEIN)
    ("Sonic Hedgehog" . SPARSER::PROTEIN) ("ITGB4" . SPARSER::PROTEIN)
    ("GANT61" . SPARSER::DRUG)
    ("PIK3CA and EGFR/KRAS co-mutation" . SPARSER::COLLECTION)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("few predictive biomarkers" . SPARSER::MOLECULE)
    ("the true prognostic impact" . SPARSER::PROTEIN)
    ("smoking history and histologic type" . TYPE)
    ("additional activators and downstream targets xref" . SPARSER::COLLECTION)
    ("kinases and Ras" . SPARSER::COLLECTION)
    ("a negative prognostic impact" . SPARSER::PROTEIN)
    ("the largest cohort" . SPARSER::MOLECULE)
    ("PI3k" . SPARSER::PROTEIN-FAMILY) ("a longer RFS" . SPARSER::PROTEIN)
    ("a shorter RFS" . SPARSER::PROTEIN)
    ("group and PIK3CA" . SPARSER::COLLECTION)
    ("PIK3CA/EGFR" . SPARSER::COLLECTION) ("S3A–S3B" . SPARSER::COLLECTION)
    ("mTOR or PTEN" . SPARSER::COLLECTION)
    ("PTEN and other proteins" . SPARSER::COLLECTION)
    ("inTable S2" . SPARSER::MOLECULE) ("TFG-ALK" . SPARSER::COLLECTION)
    ("KIF5B-ALK" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("pathological types" . TYPE) ("mTOR and PTEN" . SPARSER::COLLECTION)
    ("EGFR , KRAS , HER2 and ALK" . SPARSER::COLLECTION)
    ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("PIK3CA , EGFR , KRAS , HER2 , BRAF, AKT1 and ALK" . SPARSER::COLLECTION)
    ("EGFR -TKI" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("KIF5" . SPARSER::PROTEIN) ("SOC" . SPARSER::PROTEIN)
    ("IL6/Stat3" . SPARSER::COLLECTION) ("IL6-NF-κB" . SPARSER::COLLECTION)
    ("exogenous IL6" . SPARSER::PROTEIN)
    ("IL6 (>1000 fold) and TGF-β (>2 fold)" . SPARSER::COLLECTION)
    ("EMT and stem cell genes ( xref , xref )" . SPARSER::COLLECTION)
    ("Vimentin, Snail and N-Cadherin" . SPARSER::COLLECTION)
    ("Mani" . SPARSER::PROTEIN) ("tocilizumab" . SPARSER::DRUG)
    ("mouse mammary fat" . SPARSER::PROTEIN)
    ("IL6/NF-κB" . SPARSER::COLLECTION) ("GFP and DsRed" . SPARSER::COLLECTION)
    ("DsRed" . SPARSER::PROTEIN) ("Stat3 and NF-κB" . SPARSER::COLLECTION)
    ("normal macrophages" . SPARSER::PROTEIN)
    ("parental or single gene" . SPARSER::GENE)
    ("flag-Ubiquitin" . SPARSER::COLLECTION)
    ("SOCS3-GFP" . SPARSER::COLLECTION) ("IL6 and SOCS3" . SPARSER::COLLECTION)
    ("Stat3 (Stat3 Inh) or NF-κB (Bay11)" . SPARSER::COLLECTION)
    ("IL6R (Tocilizumab), TGF-β (A831), Stat3 (Stat3 Inh) or NF-κB (Bay11)"
     . SPARSER::COLLECTION)
    ("Tocilizumab" . SPARSER::DRUG) ("IL6 or TGF-β" . SPARSER::COLLECTION)
    ("IL6 or AZA" . SPARSER::COLLECTION)
    ("luminal and HER2+ subtypes ( xref )" . SPARSER::COLLECTION)
    ("deoxycytidine (AZA)" . SPARSER::PROTEIN) ("AZA" . SPARSER::DRUG)
    ("luminal or HER2+ cell lines ( xref )" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL6 and TGF-β" . SPARSER::COLLECTION)
    ("P53 and PTEN" . SPARSER::COLLECTION)
    ("Vimentin, N-cadherin and Snail" . SPARSER::COLLECTION)
    ("EpCAM, E-Cadherin, Claudin, BMPR2 and Occludin" . SPARSER::COLLECTION)
    ("the mouse mammary fat" . SPARSER::PROTEIN)
    ("EpCAM/CD49f" . SPARSER::COLLECTION)
    ("cleared mouse mammary fat" . SPARSER::PROTEIN)
    ("p53 and/or PTEN" . SPARSER::COLLECTION) ("EMT/CSC" . SPARSER::COLLECTION)
    ("Vimentin, N-Cad and Snail" . SPARSER::COLLECTION)
    ("EpCAM, E-Cad, Claudin, Occludin and BMPR" . SPARSER::COLLECTION)
    ("BMPR" . SPARSER::PROTEIN) ("Occludin" . SPARSER::PROTEIN)
    ("Claudin" . SPARSER::PROTEIN)
    ("EMT and stem cell related genes" . SPARSER::COLLECTION)
    ("CD44 and CD49f" . SPARSER::COLLECTION)
    ("CD24 and EpCAM" . SPARSER::COLLECTION)
    ("a distinct EpCAM" . SPARSER::PROTEIN) ("EpCAM" . SPARSER::PROTEIN)
    ("Stat3/NF-κB" . SPARSER::COLLECTION)
    ("Akt/β-catenin" . SPARSER::COLLECTION)
    ("p53 (p53 − ) and PTEN (PTEN − )" . SPARSER::COLLECTION)
    ("a potent pleiotropic cytokine" . SPARSER::PROTEIN)
    ("claudin" . SPARSER::PROTEIN) ("IL6/Stat3/NF-κB" . SPARSER::COLLECTION)
    ("TP53 and PTEN" . SPARSER::COLLECTION) ("IL6 receptor" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("Let7" . SPARSER::RNA)
    ("BMPR2" . SPARSER::PROTEIN) ("E-Cad" . SPARSER::PROTEIN)
    ("N-Cad" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("oxidative stress-activated GSK3β" . SPARSER::PROTEIN)
    ("ALF, and GSK3β" . SPARSER::COLLECTION)
    ("GSK3β, and GSK3β" . SPARSER::COLLECTION)
    ("β-catenin/Wnt" . SPARSER::COLLECTION)
    ("SOD and GSH" . SPARSER::COLLECTION)
    ("glutathione peroxidase (GSH-P X ) and catalase, and non-enzymatic antioxidants"
     . SPARSER::COLLECTION)
    ("catalase, and non-enzymatic" . SPARSER::COLLECTION)
    ("p-GSK3β" . SPARSER::COLLECTION) ("GSH and SOD" . SPARSER::COLLECTION)
    ("ALF and GSK3β" . SPARSER::COLLECTION) ("sALT" . SPARSER::MOLECULE)
    ("JNK and β-actin" . SPARSER::COLLECTION) ("Cyt" . SPARSER::MOLECULE)
    ("ROS and MDA" . SPARSER::COLLECTION) ("AST" . SPARSER::PROTEIN)
    ("ALT" . SPARSER::PROTEIN) ("oxidative stress-GSK3β" . SPARSER::PROTEIN)
    ("The stress-induced GSK3β" . SPARSER::PROTEIN)
    ("two highly homologous isoforms" . SPARSER::ISOFORM)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("H 2 O 2 or Antimycin" . SPARSER::COLLECTION)
    ("Antimycin" . SPARSER::DRUG)
    ("aminotransferase and aspartate aminotransferase" . SPARSER::COLLECTION)
    ("aminotransferase" . SPARSER::PROTEIN)
    ("N -acetylcysteine (300 mg/kg) or SB216763 (25 mg/kg)"
     . SPARSER::COLLECTION)
    ("ALF" . SPARSER::PROTEIN) ("GSK 3β" . SPARSER::PROTEIN)
    ("vitamin C" . SPARSER::MOLECULE)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("superoxide dismutase activity" . SPARSER::PROTEIN)
    ("N -acetylcysteine" . SPARSER::DRUG) ("d -GalN" . SPARSER::MOLECULE)
    ("d -galactosamine" . SPARSER::MOLECULE)
    ("a longitudinal Colombian cohort" . SPARSER::MOLECULE)
    ("functional CagA" . SPARSER::PROTEIN) ("CagA" . SPARSER::PROTEIN)
    ("pEGFR, pEGFR–ERBB2, and pERBB2" . SPARSER::COLLECTION)
    ("EGFR/ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 and AKT" . SPARSER::COLLECTION)
    ("EGFR and downstream ERBB2" . SPARSER::COLLECTION)
    ("IM, dysplasia or GC" . SPARSER::COLLECTION)
    ("IM or GC" . SPARSER::COLLECTION) ("IM, or GC" . SPARSER::COLLECTION)
    ("irradiation-induced DNA" . SPARSER::DNA)
    ("IM or dysplasia" . SPARSER::COLLECTION)
    ("a longitudinal cohort" . SPARSER::MOLECULE)
    ("IM or Dysplasia" . SPARSER::COLLECTION)
    ("pEGFR and pERBB2" . SPARSER::COLLECTION)
    ("the intestinal or diffuse type" . TYPE)
    ("IM and GC" . SPARSER::COLLECTION)
    ("basolateral pEGFR–ERBB2" . SPARSER::COLLECTION)
    ("both the pEGFR–ERBB2 heterodimer ( xref ) and pERBB2 ( xref ) in tissues"
     . SPARSER::COLLECTION)
    ("heterodimer and pERBB2" . SPARSER::COLLECTION)
    ("Heterodimer and pERBB2" . SPARSER::COLLECTION)
    ("Heterodimer" . SPARSER::HETERODIMER)
    ("pEGFR and ERBB2" . SPARSER::COLLECTION)
    ("Phosphoproteins" . SPARSER::PROTEIN)
    ("ERBB3 or ERBB4" . SPARSER::COLLECTION)
    ("EGFR and its downstream kinases ERK and AKT ( xref )"
     . SPARSER::COLLECTION)
    ("779 unique phosphoproteins" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("light and heavy amino acids" . SPARSER::COLLECTION)
    ("SMOX or DNA" . SPARSER::COLLECTION)
    ("H pylori -induced oxidative DNA" . SPARSER::DNA)
    ("SMOX or pEGFR" . SPARSER::COLLECTION)
    ("pEGFR and SMOX" . SPARSER::COLLECTION)
    ("IM, and SMOX" . SPARSER::COLLECTION)
    ("SMOX and pEGFR" . SPARSER::COLLECTION)
    ("SMOX-mediated oxidative DNA" . SPARSER::DNA)
    ("SMOX and 8-oxoguanosine" . SPARSER::COLLECTION)
    ("SMOX and DNA" . SPARSER::COLLECTION)
    ("heterodimer, and pERBB2" . SPARSER::COLLECTION)
    ("spermidine" . SPARSER::MOLECULE) ("spermine" . SPARSER::MOLECULE)
    ("polyamine" . SPARSER::MOLECULE)
    ("ERBB2, ERBB3, and ERBB4" . SPARSER::COLLECTION)
    ("MAG" . SPARSER::PROTEIN)
    ("pEGFR, pERBB2, and SMOX" . SPARSER::COLLECTION)
    ("pEGFR" . SPARSER::PROTEIN) ("pEGFR–ERBB2" . SPARSER::COLLECTION)
    ("EGFR–ERBB2" . SPARSER::COLLECTION)
    ("EGFR and ERBB2" . SPARSER::COLLECTION) ("wa" . SPARSER::MOLECULE)
    ("spermine oxidase (SMOX)" . SPARSER::PROTEIN) ("SMOX" . SPARSER::PROTEIN)
    ("AIMS" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("Spermine Oxidase" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("ERBB1" . SPARSER::PROTEIN)
    ("spermine oxidase" . SPARSER::PROTEIN)
    ("NF-κB dimers and different competitive complexes" . SPARSER::COLLECTION)
    ("different competitive complexes" . SPARSER::BIO-COMPLEX)
    ("each NF-κB-driven gene" . SPARSER::GENE)
    ("atypical IκB-family proteins" . SPARSER::PROTEIN)
    ("p50, p52 and BCL3" . SPARSER::COLLECTION)
    ("repressive homodimers" . SPARSER::HOMODIMER)
    ("repressive homodimer" . SPARSER::HOMODIMER)
    ("p50 or p52" . SPARSER::COLLECTION)
    ("NFKB1 and NFKB2" . SPARSER::COLLECTION)
    ("Homodimers" . SPARSER::HOMODIMER)
    ("protein or complex" . SPARSER::COLLECTION)
    ("the indirect inhibition arm" . SPARSER::PROTEIN)
    ("IL8, TNFAIP3 and NFKBIA" . SPARSER::COLLECTION)
    ("survival-associated genes" . SPARSER::GENE)
    ("transcriptionally competent NF-κB" . SPARSER::PROTEIN)
    ("a promoter’s" . SPARSER::PROMOTER)
    ("transcriptionally competent and incompetent protein" . SPARSER::PROTEIN)
    ("IL8 and NFKBIA" . SPARSER::COLLECTION)
    ("p50, p52, and BCL3" . SPARSER::COLLECTION)
    ("other possible confounding factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCL3, p50 or p52" . SPARSER::COLLECTION)
    ("p50 and BCL3" . SPARSER::COLLECTION)
    ("candidate competitor proteins (si-p50, si-p52 and si-BCL3 which respectively target NFKB1 , NFKB2 and BCL3 ) or control siRNA"
     . SPARSER::COLLECTION)
    ("NFKB1 , NFKB2 and BCL3" . SPARSER::COLLECTION)
    ("si-BCL3" . SPARSER::COLLECTION) ("si-p52" . SPARSER::COLLECTION)
    ("NF-κB-regulated transcriptionally incompetent p50-p50 and p52-p52 homodimers or BCL3"
     . SPARSER::COLLECTION)
    ("NF-κB-regulated transcriptionally incompetent p50-p50 and p52-p52 homodimers"
     . SPARSER::HOMODIMER)
    ("a transcriptionally incompetent DNA-binding protein" . SPARSER::PROTEIN)
    ("bin" . SPARSER::PROTEIN) ("asF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFKBIA , IL8 and TNFAIP3" . SPARSER::COLLECTION)
    ("IL8 , TNFAIP3 or NFKBIA" . SPARSER::COLLECTION)
    ("IL8 , TNFAIP3 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKBIA and TNFAIP3" . SPARSER::COLLECTION) ("IKB" . SPARSER::PROTEIN)
    ("IL8 and TNFAIP3" . SPARSER::COLLECTION)
    ("IL8 , TNFAIP3 , and NFKBIA" . SPARSER::COLLECTION)
    ("IL-8, A20 and IκBα" . SPARSER::COLLECTION)
    ("fluorescent protein-RelA" . SPARSER::COLLECTION)
    ("FP-RelA" . SPARSER::COLLECTION) ("protein-RelA" . SPARSER::COLLECTION)
    ("FP" . SPARSER::PROTEIN) ("EGFP-RelA" . SPARSER::COLLECTION)
    ("dynamical protein" . SPARSER::PROTEIN)
    ("this global regulator" . SPARSER::PROTEIN)
    ("IL6 and IL8" . SPARSER::COLLECTION) ("NFKBIA" . SPARSER::PROTEIN)
    ("cytokines (e.g. IL-8 and IL-6) as well as regulators"
     . SPARSER::COLLECTION)
    ("IL-8 and IL-6" . SPARSER::COLLECTION)
    ("A20 and IκBα" . SPARSER::COLLECTION)
    ("TNF and other inducers" . SPARSER::COLLECTION)
    ("IκBα/RelA-p50" . SPARSER::COLLECTION)
    ("the transcriptionally competent RelA-p50 heterodimer"
     . SPARSER::HETERODIMER)
    ("p52-p52" . SPARSER::COLLECTION)
    ("the RelA-p50 heterodimer and the p50-p50 homodimer ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("The predominant NF-κB dimers" . SPARSER::DIMER)
    ("RelA-p50" . SPARSER::COLLECTION)
    ("RelA, RelB and c-Rel" . SPARSER::COLLECTION) ("Rel" . SPARSER::PROTEIN)
    ("RelB, c-Rel, p50 and p52" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("TNF and NF-κB" . SPARSER::COLLECTION)
    ("DF2" . SPARSER::PROTEIN) ("NFKB2" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("BCL3" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("CP" . SPARSER::PROTEIN) ("IDH1:p" . SPARSER::BIO-COMPLEX)
    ("FAM131B, MACF1, FXR1, RNF130, CLCN6, MKRN1 and GNAI1"
     . SPARSER::COLLECTION)
    ("a prominent pilocytic component" . SPARSER::COMPONENT)
    ("an idiosyncratic glial component" . SPARSER::COMPONENT)
    ("admixed mature glial" . SPARSER::PROTEIN) ("MCP" . SPARSER::PROTEIN)
    ("ETV6-NTRK3" . SPARSER::COLLECTION) ("KRAS:p" . SPARSER::BIO-COMPLEX)
    ("synaptophysin and neurofilament proteins (Figures  xref and xref )"
     . SPARSER::COLLECTION)
    ("MAP2, synaptophysin and neurofilament proteins (Figures  xref and xref )"
     . SPARSER::COLLECTION)
    ("a fine fibrillary component" . SPARSER::COMPONENT)
    ("PXAs" . SPARSER::PROTEIN-FAMILY) ("PXA" . SPARSER::PROTEIN-FAMILY)
    ("the cerebral lobes" . SPARSER::PROTEIN)
    ("neoplastic glial" . SPARSER::PROTEIN) ("BRAF:p" . SPARSER::BIO-COMPLEX)
    ("KIAA1549-BRAF" . SPARSER::COLLECTION) ("two morphologic types" . TYPE)
    ("the temporal lobe" . SPARSER::PROTEIN) ("GNAI1" . SPARSER::PROTEIN)
    ("MKRN1" . SPARSER::PROTEIN) ("CLCN6" . SPARSER::PROTEIN)
    ("RNF130" . SPARSER::PROTEIN) ("FXR1" . SPARSER::PROTEIN)
    ("MACF1" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("NTRK3" . SPARSER::PROTEIN) ("B23" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("KIAA1549" . SPARSER::PROTEIN) ("group I" . SPARSER::PROTEIN)
    ("p65 and p50" . SPARSER::COLLECTION) ("protein/p65" . SPARSER::COLLECTION)
    ("p65 and c-Rel" . SPARSER::COLLECTION) ("DCs" . SPARSER::PROTEIN)
    ("a nonspecific antisera" . SPARSER::PROTEIN)
    ("siRNA or p65" . SPARSER::COLLECTION) ("Mel-RM" . SPARSER::COLLECTION)
    ("RM" . SPARSER::PROTEIN)
    ("newly developed PI3K inhibitor PI103" . SPARSER::DRUG)
    ("Mule" . SPARSER::PROTEIN) ("si-p65" . SPARSER::COLLECTION)
    ("si-p50" . SPARSER::COLLECTION) ("p50 or p65" . SPARSER::COLLECTION)
    ("chromatin and IgG" . SPARSER::COLLECTION)
    ("p50, p52, p65, c-Rel and RelB" . SPARSER::COLLECTION)
    ("p50, p52 and p65" . SPARSER::COLLECTION)
    ("p50, p52, p65, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("p50, p52 or p65" . SPARSER::COLLECTION)
    ("κB oligonucleotide (lane 3) or κB consensus" . SPARSER::COLLECTION)
    ("p65, c-Rel and RelB" . SPARSER::COLLECTION)
    ("p50 and p52" . SPARSER::COLLECTION) ("Naa" . SPARSER::MOLECULE)
    ("κB" . SPARSER::PROTEIN) ("Mcl-1-κB" . SPARSER::COLLECTION)
    ("specific NF-κB inhibitor Bay11-7082 or dominant inhibitory molecule DNMIκBα in TE-1 and KYSE150 cells"
     . SPARSER::COLLECTION)
    ("VGH" . SPARSER::PROTEIN)
    ("the relevant downstream genes" . SPARSER::GENE)
    ("p52/p100" . SPARSER::COLLECTION) ("p50/p105" . SPARSER::COLLECTION)
    ("rational therapeutics" . SPARSER::THERAPEUTICS)
    ("Acetyltransferase" . SPARSER::PROTEIN)
    ("NF-κB and Mcl-1" . SPARSER::COLLECTION)
    ("Ets family members Elk-1 [ xref ] and PU.1 [ xref ]"
     . SPARSER::COLLECTION)
    ("CRE-BP" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("SRE" . SPARSER::PROTEIN) ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("the most aggressive types" . TYPE) ("p50 and p65" . SPARSER::COLLECTION)
    ("Mcl-1-kappaB" . SPARSER::COLLECTION)
    ("specific NF-kappaB inhibitor Bay11-7082 or dominant inhibitory molecule DNMIkappaBalpha in TE-1 and KYSE150 cell lines"
     . SPARSER::COLLECTION)
    ("kappaB" . SPARSER::PROTEIN) ("PI103" . SPARSER::DRUG)
    ("AG490" . SPARSER::DRUG) ("miR29b" . SPARSER::RNA)
    ("USP9X" . SPARSER::PROTEIN) ("band 3" . SPARSER::PROTEIN)
    ("IκBs" . SPARSER::PROTEIN) ("NF-κB2" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("PU.1" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("Mcl-1 protein" . SPARSER::PROTEIN)
    ("Bay11-7082" . SPARSER::DRUG) ("NF-kappaB" . SPARSER::PROTEIN)
    ("DG" . SPARSER::PROTEIN)
    ("PKC inhibitors (calphoatin C) and activators (PMA)"
     . SPARSER::COLLECTION)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("urothelial line" . SPARSER::PROTEIN)
    ("PKC α and netrin-1" . SPARSER::COLLECTION)
    ("a classical Protein" . SPARSER::PROTEIN)
    ("PKC α and UNC5B" . SPARSER::COLLECTION)
    ("inhibitor and agonist" . SPARSER::COLLECTION)
    ("Log-rank" . SPARSER::COLLECTION)
    ("PKC α, netrin-1and UNC5B" . SPARSER::COLLECTION)
    ("ERK1/2 and NF-κB" . SPARSER::COLLECTION) ("hub" . SPARSER::PROTEIN)
    ("netrin-1/UNC5B" . SPARSER::COLLECTION)
    ("PMA and PKC" . SPARSER::COLLECTION)
    ("Netrin-1 and UNC5B" . SPARSER::COLLECTION)
    ("PKC α, netrin-1 and UNC5B" . SPARSER::COLLECTION)
    ("Netrin-1 and its receptor" . SPARSER::COLLECTION)
    ("Protein Kinase" . SPARSER::PROTEIN) ("TTC 3" . SPARSER::PROTEIN)
    ("GAT 3" . SPARSER::PROTEIN) ("TGA 3" . SPARSER::PROTEIN)
    ("AT 3" . SPARSER::PROTEIN) ("netrin-1" . SPARSER::PROTEIN)
    ("UNC5B" . SPARSER::PROTEIN) ("Netrin-1" . SPARSER::PROTEIN)
    ("Nanog, and Sox4" . SPARSER::COLLECTION)
    ("fibronectin, vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin, and γ-catenin" . SPARSER::COLLECTION)
    ("CAFs" . SPARSER::PROTEIN) ("IL6-Stat3" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION) ("PI 3 K/AKT" . SPARSER::COLLECTION)
    ("wt-Ras" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("N-Ras or K-Ras" . SPARSER::COLLECTION)
    ("staurosporine and rottlerin" . SPARSER::COLLECTION)
    ("highly-specific inhibitor" . SPARSER::INHIBITOR)
    ("monolayers" . SPARSER::PROTEIN) ("SFA" . SPARSER::PROTEIN)
    ("the most formidable barrier" . SPARSER::PROTEIN)
    ("PI 3 K-AKT" . SPARSER::COLLECTION) ("pERK or pAKT" . SPARSER::COLLECTION)
    ("Ras or Ras" . SPARSER::COLLECTION)
    ("the treated cohort" . SPARSER::MOLECULE)
    ("CD24/CD44" . SPARSER::COLLECTION) ("BCSC" . SPARSER::PROTEIN)
    ("KAM" . SPARSER::PROTEIN) ("maleimide" . SPARSER::DRUG)
    ("Rottlerin" . SPARSER::DRUG) ("cellular LDH" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN) ("PKCδ-shRNA" . SPARSER::COLLECTION)
    ("Nestin" . SPARSER::PROTEIN) ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE) ("CD44 and CD24" . SPARSER::COLLECTION)
    ("PKC-delta" . SPARSER::PROTEIN)
    ("Protein kinase C delta" . SPARSER::PROTEIN) ("Sox4" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("CO 3" . SPARSER::PROTEIN) ("Cl2" . SPARSER::PROTEIN)
    ("CH2" . SPARSER::PROTEIN) ("PdCl2" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("Aldehyde Dehydrogenase" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("SSEA3" . SPARSER::MOLECULE) ("10C" . SPARSER::PROTEIN)
    ("protein kinase C delta" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("REP" . SPARSER::PROTEIN) ("MFN" . SPARSER::PROTEIN)
    ("phosphatidylnositol 3 kinase (PI3K) and integrin-linked kinase (ILK) [ xref ]"
     . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE)
    ("SB431542 and Smad3" . SPARSER::COLLECTION)
    ("TGFβ1/Smad3" . SPARSER::COLLECTION) ("pSG5-AKT" . SPARSER::COLLECTION)
    ("ILK" . SPARSER::PROTEIN) ("integrins and ECM" . SPARSER::COLLECTION)
    ("TGF-β1-" . SPARSER::PROTEIN) ("Phalloidin" . SPARSER::MOLECULE)
    ("Rhodamine" . SPARSER::PROTEIN) ("PAI-1 and CTCF" . SPARSER::COLLECTION)
    ("caldesmon and calponin" . SPARSER::COLLECTION)
    ("calponin" . SPARSER::PROTEIN) ("HLF" . SPARSER::PROTEIN)
    ("the provisional bone matrix" . SPARSER::PROTEIN-FAMILY)
    ("phosphatase (TRAP)" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor-3 (eIF3) multi-protein"
     . SPARSER::COLLECTION)
    ("avid" . SPARSER::DRUG) ("TGF beta" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("EIF3I" . SPARSER::PROTEIN)
    ("SB-431542" . SPARSER::DRUG) ("eIF3" . SPARSER::BIO-COMPLEX)
    ("factor-3" . SPARSER::PROTEIN)
    ("receptor interacting protein" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("TRIP-1" . SPARSER::PROTEIN)
    ("receptor interacting protein 1" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XHL" . SPARSER::PROTEIN)
    ("BX" . SPARSER::PROTEIN) ("ROCK or Rho" . SPARSER::COLLECTION)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY) ("actin-myosin" . SPARSER::COLLECTION)
    ("LIMK" . SPARSER::PROTEIN) ("RhoA/ROCK" . SPARSER::COLLECTION)
    ("LIMK2 and cofilin" . SPARSER::COLLECTION)
    ("ROCK/LIMK2/cofilin" . SPARSER::COLLECTION)
    ("LIMK2 and Cofilin" . SPARSER::COLLECTION)
    ("ROCK-2 siRNA and negative control group ( P  > 0.05)"
     . SPARSER::COLLECTION)
    ("actin and tubulin" . SPARSER::COLLECTION)
    ("Y-27632 or ROCK-1" . SPARSER::COLLECTION)
    ("Y-27632, ROCK-1 and ROCK-2" . SPARSER::COLLECTION)
    ("ROCK-1 and ROCK-2" . SPARSER::COLLECTION) ("LIMK2" . SPARSER::PROTEIN)
    ("ROCK-2" . SPARSER::PROTEIN) ("ROCK-1" . SPARSER::PROTEIN)
    ("EDR, AJT and MB" . SPARSER::COLLECTION) ("EDR" . SPARSER::PROTEIN)
    ("AG, FH and JRJ" . SPARSER::COLLECTION) ("FH" . SPARSER::PROTEIN)
    ("IP, CDJ and JH" . SPARSER::COLLECTION) ("TFM" . SPARSER::PROTEIN)
    ("a defective telomerase activity" . SPARSER::PROTEIN)
    ("PARP1 and PARP3" . SPARSER::COLLECTION)
    ("the mitotic factor NuMA" . SPARSER::PROTEIN)
    ("Tankyrase" . SPARSER::PROTEIN) ("PARPs" . SPARSER::MOLECULE)
    ("media " . SPARSER::PROTEIN)
    ("telomerase activity and PARP3" . SPARSER::COLLECTION)
    ("Delta" . SPARSER::PROTEIN) ("Tankyrase 1 and NuMA" . SPARSER::COLLECTION)
    ("the mitotic components NuMA and Tankyrase 1" . SPARSER::COLLECTION)
    ("NuMA and Tankyrase 1" . SPARSER::COLLECTION) ("NuMA" . SPARSER::PROTEIN)
    ("PARP1 and PARP2" . SPARSER::COLLECTION)
    ("a group of enzymes that synthesize poly (ADP-ribose) on themselves or other acceptor proteins"
     . SPARSER::COLLECTION)
    ("GW" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("nuclear mitotic apparatus protein 1" . SPARSER::PROTEIN)
    ("ECL 2" . SPARSER::PROTEIN) ("Cyclophilin A" . SPARSER::PROTEIN)
    ("Tankyrase 1" . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("Telomerase activity" . SPARSER::PROTEIN) ("PARP3" . SPARSER::PROTEIN)
    ("the respective DHHC proteins" . SPARSER::PROTEIN)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("the responsible protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular proteases" . SPARSER::PROTEIN) ("calpains" . SPARSER::PROTEIN)
    ("thioesterases" . SPARSER::PROTEIN-FAMILY)
    ("CD95/Fas" . SPARSER::COLLECTION)
    ("BAX/mitochondria" . SPARSER::COLLECTION)
    ("monomeric BAX" . SPARSER::PROTEIN) ("BAX and GST" . SPARSER::COLLECTION)
    ("BAX and DHHC" . SPARSER::COLLECTION)
    ("Asp-His-His-Cys" . SPARSER::COLLECTION) ("GFP-BAX" . SPARSER::COLLECTION)
    ("Calnexin" . SPARSER::PROTEIN)
    ("galactosyltransferase" . SPARSER::PROTEIN)
    ("different subcellular fractions" . SPARSER::COMPONENT)
    ("EGFP-WT BAX or EGFP-BAX C62S" . SPARSER::COLLECTION)
    ("EGFP-BAX" . SPARSER::COLLECTION) ("Cos7" . SPARSER::PROTEIN)
    ("VDAC" . SPARSER::PROTEIN) ("anti-BAX or anti-MYC" . SPARSER::COLLECTION)
    ("kDa and BAX" . SPARSER::COLLECTION)
    ("Crude cell protein" . SPARSER::PROTEIN) ("oligomers" . SPARSER::PROTEIN)
    ("the full-length 21 kDa protein and a fragment" . SPARSER::COLLECTION)
    ("exogenous BAX" . SPARSER::PROTEIN) ("Cos" . SPARSER::MOLECULE)
    ("ABE" . SPARSER::PROTEIN) ("HL" . SPARSER::PROTEIN)
    ("acyltransferases" . SPARSER::PROTEIN)
    ("palmitoyltransferase" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("anchor (TA)" . SPARSER::ANCHOR)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN) ("MOMP" . SPARSER::PROTEIN)
    ("the BCL-2-associated X (BAX) protein" . SPARSER::PROTEIN)
    ("MOM" . SPARSER::PROTEIN) ("Asp-Glu" . SPARSER::MOLECULE)
    ("DHHC 3" . SPARSER::PROTEIN) ("GAP43" . SPARSER::PROTEIN)
    ("G-protein subunit" . SPARSER::PROTEIN) ("HA14-1" . SPARSER::DRUG)
    ("C62" . SPARSER::PROTEIN) ("Protein S" . SPARSER::PROTEIN)
    ("XRCC1 and TXNL1" . SPARSER::COLLECTION)
    ("PARP1-XRCC1" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("fluorouracil, capecitabine, and epirubicine" . SPARSER::COLLECTION)
    ("MG132 or PS-341" . SPARSER::COLLECTION)
    ("flag-TXNL1" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("Flag-TXNL1" . SPARSER::COLLECTION)
    ("TXNL1 and XRCC1" . SPARSER::COLLECTION) ("Trx" . SPARSER::PROTEIN)
    ("cisplatin and irinotecan" . SPARSER::COLLECTION)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("intrinsic DNA-PK" . SPARSER::PROTEIN) ("GFP-XRCC1" . SPARSER::COLLECTION)
    ("XRCC1 and DNA-PK" . SPARSER::COLLECTION)
    ("DNA-PK, and XRCC1" . SPARSER::COLLECTION) ("p-CHK" . SPARSER::COLLECTION)
    ("CHK" . SPARSER::PROTEIN)
    ("FANCD2, DNA-PK, and XRCC1" . SPARSER::COLLECTION)
    ("p-CHK1" . SPARSER::COLLECTION) ("EM9" . SPARSER::PROTEIN)
    ("RFP-XRCC1" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("TdT" . SPARSER::PROTEIN) ("RI" . SPARSER::PROTEIN)
    ("XRCC1 and cisplatin" . SPARSER::COLLECTION) ("NER" . SPARSER::PROTEIN)
    ("platinum and fluorouracil or capecitabine" . SPARSER::COLLECTION)
    ("fluorouracil or capecitabine" . SPARSER::COLLECTION)
    ("Adjuvant" . SPARSER::DRUG) ("TXNL1-XRCC1" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN) ("Irinotecan" . SPARSER::DRUG)
    ("DDP" . SPARSER::PROTEIN)
    ("diamminedichloridoplatinum" . SPARSER::MOLECULE)
    ("Top-I" . SPARSER::PROTEIN) ("MRP2" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein 2" . SPARSER::PROTEIN)
    ("CTR1" . SPARSER::PROTEIN) ("As 2 O 3" . SPARSER::DRUG)
    ("PS-341" . SPARSER::DRUG) ("FANCD2" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("TXNL1" . SPARSER::PROTEIN) ("Ras-ATR/Chk1" . SPARSER::COLLECTION)
    ("at least two Ras-GTP molecules" . SPARSER::MOLECULE)
    ("GDP-" . SPARSER::NUCLEOTIDE)
    ("both GDP and GTP-bound Ras levels" . SPARSER::COLLECTION)
    ("Sos1" . SPARSER::PROTEIN) ("catastrophic DNA" . SPARSER::DNA)
    ("ATM/Chk2/p53" . SPARSER::COLLECTION)
    ("irinotecan or vehicle" . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION) ("CPT" . SPARSER::PROTEIN)
    ("SN38 and oxaliplatin" . SPARSER::COLLECTION)
    ("SN38 or oxaliplatin" . SPARSER::COLLECTION)
    ("crosslinker" . SPARSER::PROTEIN) ("Erk/Akt" . SPARSER::COLLECTION)
    ("Erk and AKT" . SPARSER::COLLECTION)
    ("an isogenic derivative" . SPARSER::DERIVATIVE)
    ("TREX" . SPARSER::PROTEIN-FAMILY) ("Erk or Akt" . SPARSER::COLLECTION)
    ("MAPK or Akt" . SPARSER::COLLECTION)
    ("MAPK-activated protein kinase" . SPARSER::COLLECTION)
    ("Raf/MAPK" . SPARSER::COLLECTION) ("Raf/Erk" . SPARSER::COLLECTION)
    ("MAPK and Akt" . SPARSER::COLLECTION)
    ("SN38 or UV-C" . SPARSER::COLLECTION) ("UV-C-induced DNA" . SPARSER::DNA)
    ("NRas" . SPARSER::PROTEIN) ("KO and K-Ras" . SPARSER::COLLECTION)
    ("DLD1-K-Ras" . SPARSER::COLLECTION) ("A defective DDR" . SPARSER::PROTEIN)
    ("phospho-histone" . SPARSER::PROTEIN) ("theK-RAS" . SPARSER::COLLECTION)
    ("Mut" . SPARSER::PROTEIN)
    ("mutant K-Ras and wild-type (WT) H/N-Ras" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("Ras and Rho" . SPARSER::COLLECTION) ("SOS" . SPARSER::PROTEIN)
    ("mutant K-Ras-dependent autocrine-activated EGFR" . SPARSER::PROTEIN)
    ("KRas or HRas" . SPARSER::COLLECTION) ("HRas" . SPARSER::PROTEIN)
    ("a complex and context-dependent modulation by wild-type Ras proteins"
     . SPARSER::COLLECTION)
    ("HRAS, NRAS , and KRAS" . SPARSER::COLLECTION)
    ("ATR/Chk1" . SPARSER::COLLECTION) ("H-Ras or N-Ras" . SPARSER::COLLECTION)
    ("Erk/p90RSK" . SPARSER::COLLECTION) ("SN-38" . SPARSER::DRUG)
    ("RasG12V" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("SON OF SEVENLESS" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("p90" . SPARSER::PROTEIN) ("SYK or FLT3" . SPARSER::COLLECTION)
    ("LYN" . SPARSER::PROTEIN)
    ("the secondary transplantable AML" . SPARSER::PROTEIN)
    ("fostamatinib" . SPARSER::DRUG) ("SYK/FLT3-ITD" . SPARSER::COLLECTION)
    ("β2 and β3" . SPARSER::COLLECTION) ("SYK-FLT3" . SPARSER::COLLECTION)
    ("PRT062607 and AC220" . SPARSER::COLLECTION)
    ("AC220 and PRT062607" . SPARSER::COLLECTION)
    ("the dual inhibitor" . SPARSER::INHIBITOR)
    ("KD SYK or SYK-TEL mutants ( xref )" . SPARSER::COLLECTION)
    ("the dual SYK/FLT3 inhibitor" . SPARSER::INHIBITOR)
    ("SYK/FLT3" . SPARSER::COLLECTION)
    ("AC220, those expressing either SYK or SYK-TEL as well as FLT3-ITD"
     . SPARSER::COLLECTION)
    ("Quizartinib" . SPARSER::DRUG) ("FLT3-ITD/SYK" . SPARSER::COLLECTION)
    ("BCR-ABL, or CD34+" . SPARSER::COLLECTION) ("BL6" . SPARSER::PROTEIN)
    ("a potentially promiscuous kinase" . SPARSER::KINASE)
    ("FLT3-ITD ‘s" . SPARSER::COLLECTION) ("/GFP" . SPARSER::COLLECTION)
    ("MEP and CMP" . SPARSER::COLLECTION) ("/CD34" . SPARSER::COLLECTION)
    ("immature myeloid" . SPARSER::PROTEIN) ("Hematoxylin" . SPARSER::MOLECULE)
    ("MSCV-EGFP-FLT3-ITD" . SPARSER::COLLECTION)
    ("FLT3-ITD-MPD" . SPARSER::COLLECTION) ("FLT3-" . SPARSER::PROTEIN)
    ("Map" . SPARSER::PROTEIN) ("relapsed AML" . SPARSER::PROTEIN)
    ("NPM1, DNMT3A, IDH1/2, RUNX1, TET2, TP53, KRAS, NRAS, CEBPA, WT1 and KIT"
     . SPARSER::COLLECTION)
    ("CEBPA" . SPARSER::PROTEIN)
    ("the two largest cohorts" . SPARSER::MOLECULE) ("FAB" . SPARSER::PROTEIN)
    ("shRNA or small-molecule inhibitors" . SPARSER::COLLECTION)
    ("SYK specific inhibitors PRT062607 and Merck SYKi" . SPARSER::COLLECTION)
    ("the late myeloid markers GR-1" . SPARSER::PROTEIN)
    ("PLT" . SPARSER::PROTEIN) ("HCT" . SPARSER::PROTEIN)
    ("the tomato-positive cell fraction" . SPARSER::COMPONENT)
    ("MSCV-EGFP" . SPARSER::COLLECTION) ("/c-KIT" . SPARSER::COLLECTION)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("CMP and GMP" . SPARSER::COLLECTION)
    ("stably and efficiently knockdown Sykb" . SPARSER::PROTEIN)
    ("Sykb" . SPARSER::PROTEIN) ("Myeloid" . SPARSER::PROTEIN)
    ("Only SYK mutants" . SPARSER::MUTANT) ("RAR" . SPARSER::PROTEIN)
    ("GGI" . SPARSER::MOLECULE) ("V5-tagged FLT3" . SPARSER::PROTEIN)
    ("STAT5, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("PRT062607 ( xref ) and Merck SYKi ( xref )" . SPARSER::COLLECTION)
    ("STAT5 and ERK1/2" . SPARSER::COLLECTION)
    ("Only two mutants" . SPARSER::MUTANT)
    ("FLT3-KD YY589/591AA" . SPARSER::PROTEIN)
    ("FLT3-KD" . SPARSER::COLLECTION)
    ("V5-tagged kinase dead FLT3" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("TK1-TK2" . SPARSER::COLLECTION) ("GST-SYK" . SPARSER::COLLECTION)
    ("GST-FLT3" . SPARSER::COLLECTION) ("/CD14" . SPARSER::COLLECTION)
    ("ZAP70, PIK3R1, and SHC1" . SPARSER::COLLECTION)
    ("FLT3 and KIT" . SPARSER::COLLECTION)
    ("the tyrosine kinases or tyrosine kinase-regulated proteins"
     . SPARSER::COLLECTION)
    ("FLT3 receptor and two other PDGFR family receptors, KIT and PDGFRα"
     . SPARSER::COLLECTION)
    ("receptors, KIT and PDGFRα" . SPARSER::COLLECTION)
    ("PIK3R1 ( xref ) and SHC1 ( xref )" . SPARSER::COLLECTION)
    ("SYK-TEL" . SPARSER::COLLECTION)
    ("receptor and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("TEL-SYK" . SPARSER::COLLECTION) ("ITK-SYK" . SPARSER::COLLECTION)
    ("MDS" . SPARSER::PROTEIN) ("ITK" . SPARSER::PROTEIN)
    ("MLL-AF9/Nras" . SPARSER::COLLECTION) ("Nras" . SPARSER::PROTEIN)
    ("BET" . SPARSER::PROTEIN) ("MLL" . SPARSER::PROTEIN)
    ("SYK and FLT3" . SPARSER::COLLECTION)
    ("primary human FLT3-ITD-positive AML" . SPARSER::PROTEIN)
    ("BCR-ABL -rearranged chronic myelogenous leukemia (CML)"
     . SPARSER::PROTEIN)
    ("CML" . SPARSER::PROTEIN) ("MPD" . SPARSER::PROTEIN)
    ("ITD" . SPARSER::PROTEIN) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("SYK" . SPARSER::PROTEIN)
    ("mutant oncoproteins and wild-type proteins" . SPARSER::COLLECTION)
    ("AC220" . SPARSER::DRUG) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("GR-1" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("PRT062607" . SPARSER::DRUG) ("PDGFRα" . SPARSER::PROTEIN)
    ("ZAP70" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("AF9" . SPARSER::PROTEIN)
    ("BRD4" . SPARSER::PROTEIN) ("DOT1L" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("PKCι and Hh inhibitors" . SPARSER::COLLECTION)
    ("Prkci and Sox2" . SPARSER::COLLECTION)
    ("phosphoproteome" . SPARSER::PROTEIN) ("Shh" . SPARSER::PROTEIN)
    ("Patched, Smoothened or Suppressor" . SPARSER::COLLECTION)
    ("Fused" . SPARSER::PROTEIN) ("Smoothened" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::PROTEIN) ("HMG" . SPARSER::PROTEIN)
    ("either alanine (T118A) or aspartic acid (T118D)" . SPARSER::COLLECTION)
    ("purified recombinant human PKCι and recombinant human SOX2"
     . SPARSER::COLLECTION)
    ("atypical PKC" . SPARSER::PROTEIN) ("PKCι or SOX2" . SPARSER::COLLECTION)
    ("PKCι, SOX2 or HHAT" . SPARSER::COLLECTION)
    ("PKCι, SOX2 and HHAT" . SPARSER::COLLECTION)
    ("SOX2 and HHAT" . SPARSER::COLLECTION)
    ("The proximal human HHAT promoter" . SPARSER::PROMOTER)
    ("a SRY-related HMG-box (Sox) transcription factor and master regulator"
     . SPARSER::COLLECTION)
    ("SOX2 , a SRY-related HMG-box (Sox) transcription factor and master regulator"
     . SPARSER::COLLECTION)
    ("Sox" . SPARSER::PROTEIN) ("SRY" . SPARSER::PROTEIN)
    ("other possible genetic regulators" . SPARSER::REGULATOR)
    ("PKCι, HHAT, and GLI1" . SPARSER::COLLECTION)
    ("HRP-Neutra-avidin" . SPARSER::COLLECTION)
    ("FLAG-SHH" . SPARSER::COLLECTION) ("avidin" . SPARSER::PROTEIN)
    ("PKCι and HHAT" . SPARSER::COLLECTION) ("palmitate" . SPARSER::PROTEIN)
    ("SHH" . SPARSER::PROTEIN) ("GLI1, ADRBK1 and CDK19" . SPARSER::COLLECTION)
    ("ligand, and GLI1" . SPARSER::COLLECTION)
    ("PKCι or GLI1" . SPARSER::COLLECTION)
    ("PKCι, HHAT and GLI1" . SPARSER::COLLECTION)
    ("HHAT or GLI1" . SPARSER::COLLECTION)
    ("HHAT and GLI1" . SPARSER::COLLECTION)
    ("neither HHAT nor GLI1" . SPARSER::COLLECTION) ("SMO" . SPARSER::PROTEIN)
    ("HHAT and Gli1" . SPARSER::COLLECTION) ("salt" . SPARSER::MOLECULE)
    ("ANF" . SPARSER::PROTEIN) ("auranofin" . SPARSER::DRUG)
    ("ADRBK1, CDK19 and GLI1" . SPARSER::COLLECTION)
    ("SOX2, OCT3/4, NANOG, ALDHA1, CD133, and MMP10" . SPARSER::COLLECTION)
    ("PROM1/CD133" . SPARSER::COLLECTION)
    ("PRKCI and SOX2" . SPARSER::COLLECTION)
    ("theLSL-Kras" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("Prkci" . SPARSER::PROTEIN) ("LAC" . SPARSER::PROTEIN)
    ("PKCι and SOX2" . SPARSER::COLLECTION)
    ("PKCι, SOX2, and HHAT" . SPARSER::COLLECTION)
    ("PKCι-SOX2-HHAT" . SPARSER::COLLECTION) ("HHAT" . SPARSER::PROTEIN)
    ("PRKCI" . SPARSER::PROTEIN) ("dimethyl sulfate" . SPARSER::DRUG)
    ("palmitic acid" . SPARSER::MOLECULE) ("LDE225" . SPARSER::DRUG)
    ("Gli1" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("CDK19" . SPARSER::PROTEIN) ("ADRBK1" . SPARSER::PROTEIN)
    ("MMP10" . SPARSER::PROTEIN) ("new Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nonspecific protein" . SPARSER::PROTEIN) ("bleomycin" . SPARSER::DRUG)
    ("intravenous metoclopramide" . SPARSER::MOLECULE)
    ("metoclopramide" . SPARSER::MOLECULE) ("selenium" . SPARSER::MOLECULE)
    ("TLR4 and TLR2" . SPARSER::COLLECTION)
    ("TNF α , IL-1b, IL-6, and chemokine" . SPARSER::COLLECTION)
    ("CD11b/CD18" . SPARSER::COLLECTION)
    ("exogenous Hsp72, and Hsp72 inhibitors or agonists" . SPARSER::COLLECTION)
    ("Hsp72, and Hsp72" . SPARSER::COLLECTION)
    ("inhibitors or agonists" . SPARSER::COLLECTION)
    ("attenuated proinflammatory cytokines" . SPARSER::PROTEIN)
    ("HSF1-p" . SPARSER::COLLECTION) ("HMGB1 and TLR4" . SPARSER::COLLECTION)
    ("-N-acetylglucosamine" . SPARSER::MOLECULE)
    ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("exogenous human Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LPS- or TNF α" . SPARSER::COLLECTION) ("LPS-" . SPARSER::PROTEIN)
    ("Gln's" . SPARSER::AMINO-ACID) ("systemic endotoxin" . SPARSER::MOLECULE)
    ("proteins, and proteins" . SPARSER::COLLECTION)
    ("IkappaBalpha" . SPARSER::PROTEIN) ("-nTTCnnGAAn-3" . SPARSER::COLLECTION)
    ("-nGAAnnTTCn-3" . SPARSER::COLLECTION) ("HSE" . SPARSER::PROTEIN)
    ("the nonactive HSF1 monomers" . SPARSER::MONOMER)
    ("chaperones and cochaperones" . SPARSER::COLLECTION)
    ("chaperones or cochaperones" . SPARSER::COLLECTION)
    ("powerful dichotomous immune-modulatory molecules" . SPARSER::MOLECULE)
    ("LPS or CLP" . SPARSER::COLLECTION)
    ("inhibitor or agonist" . SPARSER::COLLECTION) ("CLP" . SPARSER::PROTEIN)
    ("adenoviral vector Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hspa12b" . SPARSER::PROTEIN) ("Hspa" . SPARSER::PROTEIN-FAMILY)
    ("vasopressor" . SPARSER::DRUG)
    ("reduced proinflammatory cytokines" . SPARSER::PROTEIN)
    ("whey protein" . SPARSER::PROTEIN) ("IL-1b" . SPARSER::PROTEIN)
    ("Heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD18" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("I κ B" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("inducible NO synthase" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("IRE1a" . SPARSER::PROTEIN) ("Hsps70" . SPARSER::PROTEIN)
    ("sodium arsenite" . SPARSER::DRUG) ("target cell" . SPARSER::PROTEIN)
    ("Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("ABT" . SPARSER::PROTEIN) ("FAK or PYK2" . SPARSER::COLLECTION)
    ("B-RAF, PI3K, and AKT" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION) ("RAS/RAF" . SPARSER::COLLECTION)
    ("MEK/ERK1/2" . SPARSER::COLLECTION)
    ("the anti-apoptotic proteins MCL1 and BCL-XL/BCL-2" . SPARSER::COLLECTION)
    ("MCL" . SPARSER::PROTEIN) ("caspase-8 and PARP" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-8, PARP, and FAK" . SPARSER::COLLECTION)
    ("caspase-8, PARP, and FAK" . SPARSER::COLLECTION)
    ("caspase-8, caspase-3, PARP, and FAK" . SPARSER::COLLECTION)
    ("ABT-737 and PF271" . SPARSER::COLLECTION)
    ("BCL-XL and MCL1" . SPARSER::COLLECTION)
    ("BEZ235 and ABT-737" . SPARSER::COLLECTION)
    ("ABT-737, and BEZ235" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-XL" . SPARSER::COLLECTION) ("ES2" . SPARSER::PROTEIN)
    ("proteins, and phospho-AKT" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("dual FAK and PYK2 inhibitors" . SPARSER::INHIBITOR)
    ("FAK and PYK2" . SPARSER::COLLECTION)
    ("FAK and BCL-2/BCL-XL inhibitors" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("BCL-XL or MCL1" . SPARSER::COLLECTION)
    ("genes or signaling pathways" . SPARSER::COLLECTION)
    ("A potential compensatory gene" . SPARSER::GENE)
    ("compensatory genes or pathways" . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("FAK and EGFR" . SPARSER::COLLECTION)
    ("FAK and c-MET" . SPARSER::COLLECTION)
    ("FAK and SRC" . SPARSER::COLLECTION)
    ("Integrin/FAK/SRC" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("other scaffold and signaling molecules" . SPARSER::COLLECTION)
    ("SRC and p85" . SPARSER::COLLECTION)
    ("first-line platinum- and taxane-based chemotherapies"
     . SPARSER::COLLECTION)
    ("platinum-" . SPARSER::MOLECULE) ("FAK/PYK2" . SPARSER::COLLECTION)
    ("BCL-XL/BCL-2" . SPARSER::COLLECTION)
    ("BCL-2/BCL-XL" . SPARSER::COLLECTION)
    ("FAK/PI3K/AKT" . SPARSER::COLLECTION) ("procaspase-8" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("GSK-3B" . SPARSER::PROTEIN)
    ("BCL-XL protein" . SPARSER::PROTEIN) ("p-value " . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE) ("BEZ235" . SPARSER::DRUG)
    ("PF-573228" . SPARSER::DRUG) ("SLC41A2" . SPARSER::PROTEIN)
    ("IL5" . SPARSER::PROTEIN) ("PPP2R1A" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("PF228" . SPARSER::DRUG) ("SLE" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("IL-6, TNF- α and VEGF" . SPARSER::COLLECTION)
    ("IL-6 and TNF- α" . SPARSER::COLLECTION)
    ("TNF- α , IL-6, and VEGF" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("these three inflammatory cytokines" . SPARSER::PROTEIN)
    ("cytokines, IL-6, TNF- α , VEGF, and IL-10" . SPARSER::COLLECTION)
    ("resp" . SPARSER::PROTEIN) ("TNF- α and IL-6" . SPARSER::COLLECTION)
    ("TNF- α (tumor necrosis factor- α ) and IL-6" . SPARSER::COLLECTION)
    ("tumor necrosis factor-" . SPARSER::PROTEIN)
    ("more proinflammatory cytokines" . SPARSER::PROTEIN)
    ("certain cytokine and the genetic variant" . SPARSER::COLLECTION)
    ("IL-10 and highest IL-6, TNF- α , and VEGF" . SPARSER::COLLECTION)
    ("IL-6, TNF- α , and VEGF" . SPARSER::COLLECTION)
    ("IL-6, TNF- α , VEGF, and IL-10" . SPARSER::COLLECTION)
    ("factor- κ B" . SPARSER::PROTEIN)
    ("B-myb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vascular endothelial" . SPARSER::PROTEIN) ("IL17A" . SPARSER::PROTEIN)
    ("HbA1" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("Type 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Foxp3" . SPARSER::PROTEIN)
    ("17 β -estradiol" . SPARSER::PROTEIN) ("ER- α" . SPARSER::PROTEIN)
    ("ICOS" . SPARSER::PROTEIN)
    ("the IL-17 family ( xref ) as well as the strongly immunosuppressive B7-type cell surface protein CD274 (PD-L1)"
     . SPARSER::COLLECTION)
    ("at least some type" . TYPE) ("CD80 or CD152" . SPARSER::COLLECTION)
    ("CD86 and CD80" . SPARSER::COLLECTION)
    ("CD86 preferentially binds CD28" . SPARSER::PROTEIN)
    ("the B7 proteins and their receptors" . SPARSER::COLLECTION)
    ("CD80 and CD152" . SPARSER::COLLECTION)
    ("CD86-CD28" . SPARSER::COLLECTION)
    ("CD28 and CD152" . SPARSER::COLLECTION)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("active heterodimers" . SPARSER::HETERODIMER)
    ("STAT5a/STAT5b" . SPARSER::COLLECTION)
    ("CD152 ( xref , upper right panel) or CD80 ( xref , lower right panel)"
     . SPARSER::COLLECTION)
    ("CD3/CD28" . SPARSER::COLLECTION)
    ("cell-stimulatory CD28 and cell-inhibitory CD152 (CTLA-4) proteins"
     . SPARSER::COLLECTION)
    ("cell-stimulatory CD28" . SPARSER::PROTEIN)
    ("STAT1 or NF-kB" . SPARSER::COLLECTION)
    ("STAT3 and STAT5" . SPARSER::COLLECTION)
    ("Jak1/Jak3" . SPARSER::COLLECTION) ("-CD3 complex" . SPARSER::COLLECTION)
    ("lymphoid and non-lymphoid" . SPARSER::COLLECTION)
    ("TCL" . SPARSER::PROTEIN) ("CD80-CD152" . SPARSER::COLLECTION)
    ("CD152-" . SPARSER::PROTEIN) ("STAT5a and STAT5b" . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN) ("PD-L1" . SPARSER::PROTEIN)
    ("CD274" . SPARSER::PROTEIN) ("B7-2" . SPARSER::PROTEIN)
    ("CD86" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("Jak3" . SPARSER::PROTEIN)
    ("CD30" . SPARSER::PROTEIN) ("CD152" . SPARSER::PROTEIN)
    ("B7-1" . SPARSER::PROTEIN) ("CD80" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN)
    ("metabolism related quantitative traits" . SPARSER::PROTEIN)
    ("our major aim" . SPARSER::PROTEIN) ("Mesenterial fat" . SPARSER::PROTEIN)
    ("arg/arg" . SPARSER::COLLECTION)
    ("pro- or arg-allele" . SPARSER::COLLECTION) ("arg" . SPARSER::PROTEIN)
    ("genotypes" . SPARSER::PROTEIN) ("only two cohorts" . SPARSER::MOLECULE)
    ("pro/pro" . SPARSER::COLLECTION)
    ("arginine/proline" . SPARSER::COLLECTION)
    ("these rs1042522-associated traits" . SPARSER::PROTEIN)
    ("age and tobacco" . SPARSER::COLLECTION)
    ("both episomal and integrated viral forms" . SPARSER::FORM)
    ("predominantly HPV type" . TYPE) ("Tobacco" . SPARSER::DRUG)
    ("p 53" . SPARSER::PROTEIN) ("pU-1" . SPARSER::PROTEIN)
    ("pEGFP-CRIF1" . SPARSER::PROTEIN-PAIR)
    ("pMyc-CRIF1" . SPARSER::COLLECTION)
    ("P15, P16, P21, and P53" . SPARSER::COLLECTION)
    ("P15, P16, P21, P27, and P53" . SPARSER::COLLECTION)
    ("Cyclin and CKI" . SPARSER::COLLECTION)
    ("Cyclin/CDK" . SPARSER::COLLECTION)
    ("a complex with CDK2 and the activation of cyclin E/CDK2 complex"
     . SPARSER::COLLECTION)
    ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("several essential proteins" . SPARSER::PROTEIN)
    ("cyclin E and cyclin" . SPARSER::COLLECTION)
    ("kinase (CAK)" . SPARSER::KINASE)
    ("cyclin D/CDK4/6" . SPARSER::COLLECTION) ("CAK" . SPARSER::PROTEIN)
    ("AML or IDA" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("CRIF1 (green) and CDK2 (red)" . SPARSER::COLLECTION)
    ("CRIF1 and CDK2" . SPARSER::COLLECTION)
    ("p15, p16, p21, p27 and p53" . SPARSER::COLLECTION)
    ("CDK2, CDK4, CDK6, Cyclin D and Cyclin E" . SPARSER::COLLECTION)
    ("Cyclins and CDKs" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jurkat and CRIF1" . SPARSER::COLLECTION) ("imatinib" . SPARSER::DRUG)
    ("G-CSF, and arsenic trioxide" . SPARSER::COLLECTION)
    ("soluble cytokines" . SPARSER::PROTEIN)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("AML-CR" . SPARSER::COLLECTION) ("IDA" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("As2O3" . SPARSER::DRUG)
    ("IFNα" . SPARSER::PROTEIN) ("interferon-alpha" . SPARSER::DRUG)
    ("CRIF1" . SPARSER::PROTEIN) ("CR6" . SPARSER::PROTEIN)
    ("v" . SPARSER::PROTEIN)
    ("unilateral mastectomy opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fig" . SPARSER::PROTEIN) ("fig 1" . SPARSER::PROTEIN)
    ("therapeutically target ADM" . SPARSER::PROTEIN)
    ("antibody or ADM" . SPARSER::COLLECTION)
    ("ADM, angiogenin, and PAI-1" . SPARSER::COLLECTION)
    ("angiogenin" . SPARSER::PROTEIN)
    ("hypoxia and inflammatory cytokines" . SPARSER::COLLECTION)
    ("K-ras and HIF-1α" . SPARSER::COLLECTION)
    ("-RTGCG-3" . SPARSER::COLLECTION) ("genotype" . SPARSER::PROTEIN)
    ("KRAS genotype" . SPARSER::PROTEIN)
    ("an angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGFA, ADM and P4HA2" . SPARSER::COLLECTION)
    ("the parental mutant KRAS allele" . SPARSER::ALLELE)
    ("a negative clinical prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases and phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("K-ras and hypoxia" . SPARSER::COLLECTION)
    ("Adrenomedullin" . SPARSER::PROTEIN) ("Anti-angiogenic" . SPARSER::DRUG)
    ("PFKFB3" . SPARSER::PROTEIN) ("P4HA2" . SPARSER::PROTEIN)
    ("CD-31" . SPARSER::PROTEIN) ("PI 3 K" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("lapatinib or crizotinib" . SPARSER::COLLECTION)
    ("MET/HER2" . SPARSER::COLLECTION) ("HER2 or FGFR2" . SPARSER::COLLECTION)
    ("lapatinib, PD173074 and crizotinib" . SPARSER::COLLECTION)
    ("MET and EGFR" . SPARSER::COLLECTION)
    ("MetMab and rilotumumab" . SPARSER::COLLECTION) ("MetMab" . SPARSER::DRUG)
    ("MET- and FGFR-targeted GC" . SPARSER::COLLECTION)
    ("MetMAb and rilotumumab" . SPARSER::COLLECTION)
    ("MET and HGF" . SPARSER::COLLECTION)
    ("dovitinib and AZD4547" . SPARSER::COLLECTION)
    ("crizotinib and
Docetaxel"
     . SPARSER::COLLECTION)
    ("Docetaxel" . SPARSER::DRUG)
    ("absolute
mRNA"
     . SPARSER::RNA)
    ("both FGFR2 (average copy number 5.22, FGFR2 / CEP10 ratio 2.2) and MET (average copy number
>20, MET / CEP7 ratio>4)"
     . SPARSER::COLLECTION)
    ("FGFR2/MET" . SPARSER::COLLECTION)
    ("HER2 , FGFR2 and MET" . SPARSER::COLLECTION)
    ("intestinal and diffused subtypes" . SPARSER::PROTEIN)
    ("MET , HER2 and FGFR2" . SPARSER::COLLECTION)
    ("FGFR or MET" . SPARSER::COLLECTION)
    ("HER2 and MET" . SPARSER::COLLECTION)
    ("MET , FGFR2 and HER2" . SPARSER::COLLECTION)
    ("HER2 , MET and FGFR2" . SPARSER::COLLECTION) ("vs" . SPARSER::PROTEIN)
    ("tivantinib and
MetMAb"
     . SPARSER::COLLECTION)
    ("finding predictive biomarkers" . SPARSER::MOLECULE)
    ("rilotumumab (AMG102) and MET TKIs such as tivantinib ( xref )"
     . SPARSER::COLLECTION)
    ("tivantinib" . SPARSER::DRUG) ("rilotumumab" . SPARSER::DRUG)
    ("MetMAb" . SPARSER::DRUG) ("AZD4547 and dovitinib" . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG)
    ("FGFR2
and MET"
     . SPARSER::COLLECTION)
    ("hoc" . SPARSER::PROTEIN) ("VEGFR and EGFR" . SPARSER::COLLECTION)
    ("fibroblast growth factor receptor 2 (FGFR2) and hepatocyte growth factor receptor (MET)"
     . SPARSER::COLLECTION)
    ("EGFR, VEGFR,
fibroblast growth factor receptor 2 (FGFR2) and hepatocyte growth factor receptor (MET)"
     . SPARSER::COLLECTION)
    ("VEGFR" . SPARSER::PROTEIN) ("MET-" . SPARSER::PROTEIN)
    ("MET and FGFR2" . SPARSER::COLLECTION)
    ("lapatinib or PD173074" . SPARSER::COLLECTION)
    ("lapatinib, PD173074 and
crizotinib"
     . SPARSER::COLLECTION)
    ("FGFR2 and MET" . SPARSER::COLLECTION)
    ("HER2, MET and FGFR2" . SPARSER::COLLECTION)
    ("HER2, FGFR2 and MET" . SPARSER::COLLECTION)
    ("MET and
fibroblast growth factor receptor 2"
     . SPARSER::COLLECTION)
    ("non-amplified" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 2" . SPARSER::PROTEIN)
    ("PI3K and KRAS" . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("p16 , and SMAD4" . SPARSER::COLLECTION)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION) ("LCM" . SPARSER::PROTEIN-FAMILY)
    ("AKT1 and PIK3CA" . SPARSER::COLLECTION)
    ("myristoylated" . SPARSER::PROTEIN) ("GAG-AKT" . SPARSER::COLLECTION)
    ("GAG" . SPARSER::PROTEIN) ("AKT1/PKB" . SPARSER::COLLECTION)
    ("mucin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor protein p53" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ink4a" . SPARSER::PROTEIN) ("DPC4" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMM" . SPARSER::PROTEIN) ("credible MM" . SPARSER::PROTEIN)
    ("CTCF" . SPARSER::PROTEIN) ("non-IG" . SPARSER::PROTEIN)
    ("MYC:non-IG" . SPARSER::PROTEIN-PAIR)
    ("MYC:IGH (24%) and MYC:IGL (8%)" . SPARSER::COLLECTION)
    ("the most telomeric VH" . SPARSER::PROTEIN) ("VH" . SPARSER::PROTEIN)
    ("LP1" . SPARSER::PROTEIN) ("IGH and IGL" . SPARSER::COLLECTION)
    ("IGH or IGL" . SPARSER::COLLECTION) ("MYC:TXNDC5" . SPARSER::BIO-COMPLEX)
    ("MYC and NSMCE2/TRIB1 enhancers" . SPARSER::COLLECTION)
    ("NSMCE2/TRIB1" . SPARSER::COLLECTION)
    ("CNA and breakpoints" . SPARSER::COLLECTION)
    ("PVT1 and NBEA" . SPARSER::COLLECTION) ("NBEA" . SPARSER::PROTEIN)
    ("LINC" . SPARSER::PROTEIN) ("AHNAK" . SPARSER::PROTEIN)
    ("seq and ChIP" . SPARSER::COLLECTION) ("seq" . SPARSER::PROTEIN)
    ("strong enhancers and stretch enhancers" . SPARSER::COLLECTION)
    ("strong enhancers" . SPARSER::PROTEIN)
    ("enhancers and super enhancers (SEs)" . SPARSER::COLLECTION)
    ("SEs" . SPARSER::PROTEIN) ("HY" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN) ("CYCLIN D1 or CYCLIN D3" . SPARSER::COLLECTION)
    ("only one MYC allele" . SPARSER::ALLELE)
    ("FISH or CGH" . SPARSER::COLLECTION) ("symptomatic MM" . SPARSER::PROTEIN)
    ("centromeric CNA" . SPARSER::PROTEIN)
    ("had MYC:IGH (11%) or MYC:IGL fusions" . SPARSER::COLLECTION)
    ("MYC:IGH or MYC:IGL" . SPARSER::COLLECTION)
    ("MYC:IGL" . SPARSER::BIO-COMPLEX) ("MYC:IGH" . SPARSER::BIO-COMPLEX)
    ("other telomeric CNA" . SPARSER::PROTEIN)
    ("FISH and CGH" . SPARSER::COLLECTION) ("CNA" . SPARSER::PROTEIN)
    ("MYCL or MYCN" . SPARSER::COLLECTION)
    ("MYCN or MYCL" . SPARSER::COLLECTION) ("MYCL" . SPARSER::PROTEIN)
    ("PCL" . SPARSER::PROTEIN) ("IG" . SPARSER::MOLECULE)
    ("super-enhancers" . SPARSER::PROTEIN) ("IGJ" . SPARSER::PROTEIN)
    ("IGL" . SPARSER::PROTEIN) ("IGH" . SPARSER::PROTEIN)
    ("MM" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("SUSD2" . SPARSER::PROTEIN) ("HSF2" . SPARSER::PROTEIN)
    ("TRIB1" . SPARSER::PROTEIN) ("MTSS1" . SPARSER::PROTEIN)
    ("PVT1" . SPARSER::PROTEIN) ("p11" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNX5" . SPARSER::PROTEIN) ("CTLA4" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("H3K4Me3" . SPARSER::PROTEIN)
    ("CD2" . SPARSER::PROTEIN) ("CYCLIN D3" . SPARSER::PROTEIN)
    ("CYCLIN D" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("chr8" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("FOXO3" . SPARSER::PROTEIN)
    ("TXNDC5" . SPARSER::PROTEIN) ("NSMCE2" . SPARSER::PROTEIN)
    ("third-line" . SPARSER::PROTEIN)
    ("pemetrexed and nedaplatin" . SPARSER::COLLECTION)
    ("nedaplatin" . SPARSER::DRUG) ("pemetrexed" . SPARSER::DRUG)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("CASE" . SPARSER::PROTEIN) ("Des" . SPARSER::PROTEIN)
    ("ALK +" . SPARSER::PROTEIN) ("v-Raf" . SPARSER::PROTEIN-PAIR)
    ("potentially relevant proteins" . SPARSER::PROTEIN)
    ("diagnostic or therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("AAA" . SPARSER::PROTEIN)
    ("an oncogene- and tumor suppressor gene-rich region"
     . SPARSER::COLLECTION)
    ("oncogene-" . SPARSER::ONCOGENE) ("ADC and SqCC" . SPARSER::COLLECTION)
    ("a membrane-associated phosphoprotein" . SPARSER::PROTEIN)
    ("GNAQ, DPYL2, and STMN1" . SPARSER::COLLECTION)
    ("each biomarker’s" . SPARSER::MOLECULE)
    ("RSSA and RUVB1" . SPARSER::COLLECTION) ("Biomarkers" . SPARSER::MOLECULE)
    ("GNAQ" . SPARSER::PROTEIN) ("137 unique proteins" . SPARSER::PROTEIN)
    ("E-cadherin, NCAM, and EGFR" . SPARSER::COLLECTION)
    ("Membrane-associated proteins" . SPARSER::PROTEIN)
    ("dihydropyrimidinase-related protein 2, guanine nucleotide–binding protein alpha-q, RUVB1, and stathmin 1"
     . SPARSER::COLLECTION)
    ("RSSA" . SPARSER::PROTEIN)
    ("Dihydropyrimidinase-related protein 2, guanine nucleotide–binding protein alpha-q, laminin receptor 1, pontin, and stathmin 1"
     . SPARSER::COLLECTION)
    ("pontin" . SPARSER::PROTEIN)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("laminin receptor" . SPARSER::PROTEIN)
    ("ubiquitin protein ligase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 1" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Serca2" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("neural cell adhesion molecule" . SPARSER::PROTEIN)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("N-hydroxysuccinimide" . SPARSER::DRUG)
    ("Membrane Protein" . SPARSER::PROTEIN) ("RUVB1" . SPARSER::PROTEIN)
    ("dihydropyrimidinase-related protein 2" . SPARSER::PROTEIN)
    ("stathmin 1" . SPARSER::PROTEIN) ("laminin receptor 1" . SPARSER::PROTEIN)
    ("guanine nucleotide–binding protein alpha-q" . SPARSER::PROTEIN)
    ("Dihydropyrimidinase-related protein 2" . SPARSER::PROTEIN)
    ("/PIP 2" . SPARSER::COLLECTION)
    ("scaffold or co-factor" . SPARSER::COLLECTION)
    ("PI 3-kinase/Akt/mTOR" . SPARSER::COLLECTION)
    ("insulin and amino acids" . SPARSER::COLLECTION)
    ("Polyphosphoinositide" . SPARSER::PROTEIN)
    ("active PDK1 monomers" . SPARSER::MONOMER)
    ("an active monomer" . SPARSER::MONOMER)
    ("an inactive dimer" . SPARSER::DIMER)
    ("Raptor-mTORC1" . SPARSER::COLLECTION)
    ("mTORC1-Raptor" . SPARSER::COLLECTION)
    ("PDK1 and RSK" . SPARSER::COLLECTION) ("MK" . SPARSER::PROTEIN)
    ("4EBP1, S6K, mTOR, HERT, Akt and HSP90" . SPARSER::COLLECTION)
    ("dystrophic" . SPARSER::PROTEIN) ("Raptor or mTOR" . SPARSER::COLLECTION)
    ("PI 3-kinase, PDK1, Akt and mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("Raptor ( xref ) or PDK1" . SPARSER::COLLECTION)
    ("anti-Raptor or PDK1" . SPARSER::COLLECTION)
    ("PI 3-kinase/Akt" . SPARSER::COLLECTION)
    ("insulin as well as α 2 M" . SPARSER::COLLECTION)
    ("dsRNAs" . SPARSER::RNA) ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("dsRNA" . SPARSER::RNA) ("mTOR or Raptor" . SPARSER::COLLECTION)
    ("mTOR, Raptor, and PDK1" . SPARSER::COLLECTION)
    ("PDK1 and Raptor" . SPARSER::COLLECTION)
    ("Raptor and PDK1" . SPARSER::COLLECTION)
    ("PDK1 or Raptor" . SPARSER::COLLECTION)
    ("Raptor or PDK1" . SPARSER::COLLECTION)
    ("Raptor, and mTOR" . SPARSER::COLLECTION)
    ("PDK1 and mTORC2" . SPARSER::COLLECTION)
    ("PKC and CARD11" . SPARSER::COLLECTION)
    ("IKK and NFκB" . SPARSER::COLLECTION) ("GEF" . SPARSER::PROTEIN)
    ("mTORC" . SPARSER::PROTEIN)
    ("other proteins which enable to simultaneously localize two or more other proteins"
     . SPARSER::COLLECTION)
    ("Scaffold" . SPARSER::SCAFFOLD) ("FAT and FATC" . SPARSER::COLLECTION)
    ("FATC" . SPARSER::PROTEIN) ("FAT" . SPARSER::PROTEIN)
    ("S6K and SGK" . SPARSER::COLLECTION) ("SGK" . SPARSER::PROTEIN)
    ("S6K and SGK1" . SPARSER::COLLECTION) ("PIF" . SPARSER::PROTEIN)
    ("ERK and RSK" . SPARSER::COLLECTION) ("RSK" . SPARSER::PROTEIN)
    ("mAKAP" . SPARSER::PROTEIN) ("phosphoinositide" . SPARSER::PROTEIN)
    ("the TNF receptor-associated factor (TRAF6) ligase" . SPARSER::LIGASE)
    ("Akt and PDK1" . SPARSER::COLLECTION) ("pH" . SPARSER::PROTEIN)
    ("Akt (PKB) isoforms, S6-kinase (S6K), and PKC isoforms"
     . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN)
    ("PI 3-kinase/PDK1/Akt/mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("methylamine or ammonia" . SPARSER::COLLECTION)
    ("ammonia" . SPARSER::MOLECULE) ("methylamine" . SPARSER::DRUG)
    ("nucleophiles" . SPARSER::MOLECULE)
    ("this protein as well as various proteinases" . SPARSER::COLLECTION)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tetrameric human α 2 -macroglobulin" . SPARSER::PROTEIN)
    ("Raptor or PDK" . SPARSER::COLLECTION) ("Raptor-" . SPARSER::PROTEIN)
    ("PDK1, Raptor, and mTOR" . SPARSER::COLLECTION)
    ("PIP 2" . SPARSER::PROTEIN) ("TFII-I" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("p81" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("- 3" . SPARSER::PROTEIN)
    ("l protein" . SPARSER::PROTEIN) ("FBS 2" . SPARSER::PROTEIN)
    ("GSK2334470" . SPARSER::DRUG) ("FREUD1" . SPARSER::PROTEIN)
    ("protein1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GRB14" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glucose regulated protein" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("α 2 M" . SPARSER::PROTEIN) ("α 2 -macroglobulin" . SPARSER::PROTEIN)
    ("other BRCA1 pathogenic variants" . SPARSER::VARIANT)
    ("ubiquitin-ligase activity" . SPARSER::COLLECTION)
    ("the Breast Cancer Information Core (BIC) database (URL:) map"
     . SPARSER::PROTEIN)
    ("two distinct Zn 2+" . SPARSER::MOLECULE)
    ("the naturally occurring Δexon5q isoform" . SPARSER::ISOFORM)
    ("underwent BRCA gene" . SPARSER::PROTEIN)
    ("the constitutional wild-type allele" . SPARSER::ALLELE)
    ("age " . SPARSER::PROTEIN) ("HER2/Neu" . SPARSER::COLLECTION)
    ("the medullary type" . TYPE) ("The prevalent histological type" . TYPE)
    ("BRCA1-wt" . SPARSER::PROTEIN-PAIR)
    ("the soluble fraction" . SPARSER::COMPONENT) ("IMAC" . SPARSER::PROTEIN)
    ("the strong interacting anti-parallel Z-NfrGFP/Z-CfrGFP fusion peptides"
     . SPARSER::PEPTIDE)
    ("NfrGFP" . SPARSER::PROTEIN) ("BARD1-NfrGFP" . SPARSER::COLLECTION)
    ("IPTG" . SPARSER::MOLECULE) ("BRCA1/BARD1" . SPARSER::COLLECTION)
    ("a naturally occurring isoform" . SPARSER::PROTEIN)
    ("Fragment" . SPARSER::FRAGMENT)
    ("Italian HBOC families" . SPARSER::PROTEIN-FAMILY)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("virtually all HBOC families" . SPARSER::PROTEIN-FAMILY)
    ("-fragment" . SPARSER::FRAGMENT)
    ("43 hereditary breast/ovarian cancer (HBOC) families"
     . SPARSER::PROTEIN-FAMILY)
    ("L-arabinose" . SPARSER::MOLECULE)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("6-carboxyfluorescein" . SPARSER::DRUG)
    ("a profound impact" . SPARSER::PROTEIN)
    ("key oncoproteins" . SPARSER::PROTEIN)
    ("MACC1 and its target gene FAK" . SPARSER::COLLECTION)
    ("shorter OS post-LT" . SPARSER::COLLECTION)
    ("a powerful independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MACC1 and its downstream genes MET and FAK" . SPARSER::COLLECTION)
    ("FAK and HGF" . SPARSER::COLLECTION) ("post-LT" . SPARSER::COLLECTION)
    ("/FAK" . SPARSER::COLLECTION) ("MACC1 and MET" . SPARSER::COLLECTION)
    ("AFP" . SPARSER::PROTEIN) ("alphafetoprotein" . SPARSER::PROTEIN)
    ("MACC1 and its downstream genes" . SPARSER::COLLECTION)
    ("MACC1 and FAK" . SPARSER::COLLECTION)
    ("MACC1, MET and FAK" . SPARSER::COLLECTION)
    ("vascular invasive HCC" . SPARSER::PROTEIN)
    ("HCC and MACC1" . SPARSER::COLLECTION) ("HGF/MET" . SPARSER::COLLECTION)
    ("HGF-MET" . SPARSER::COLLECTION) ("-MET" . SPARSER::COLLECTION)
    ("microscopic extrahepatic metastatic foci" . SPARSER::PROTEIN)
    ("MACC1/FAK" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("MACC1 and its target genes MET and FAK" . SPARSER::COLLECTION)
    ("MET and FAK" . SPARSER::COLLECTION) ("LT" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("MACC1" . SPARSER::PROTEIN)
    ("cyclin D1, p53, IGFBP-1, PTEN, and p27 Kip1" . SPARSER::COLLECTION)
    ("187 FOXA1/AR dual target genes" . SPARSER::GENE)
    ("distal enhancers and proximal promoters" . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("its proximal promoters" . SPARSER::PROMOTER)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("Androgens and AR" . SPARSER::COLLECTION)
    ("ER and progesterone receptor" . SPARSER::COLLECTION)
    ("a tumor oncogene or a tumor suppressor gene" . SPARSER::COLLECTION)
    ("acute myelocytic leukemia" . SPARSER::PROTEIN)
    ("Ki67 and PCNA" . SPARSER::COLLECTION)
    ("FOXA1, AR, Notch1, Hes1, Ki67, or PCNA" . SPARSER::COLLECTION)
    ("the MFE-296/NC group and the MFE-296 group (Figure  xref A)"
     . SPARSER::COLLECTION)
    ("Notch1 and the Notch pathway target protein" . SPARSER::COLLECTION)
    ("FOXA1/AR dual target genes" . SPARSER::GENE)
    ("FOXA1/AR" . SPARSER::COLLECTION) ("Enh" . SPARSER::PROTEIN)
    ("FOXA1-AR" . SPARSER::COLLECTION) ("AR or FOXA1" . SPARSER::COLLECTION)
    ("AR and AR-regulated genes" . SPARSER::COLLECTION)
    ("flutamide" . SPARSER::DRUG)
    ("AR and its target genes (Figure  xref A and xref B)"
     . SPARSER::COLLECTION)
    ("NICD" . SPARSER::PROTEIN) ("forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Endocrine" . SPARSER::PROTEIN) ("hormone-receptor" . SPARSER::COLLECTION)
    ("Notch1 and Hes1" . SPARSER::COLLECTION)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("XBP1, MYC, ZBTB16, and UHRF1" . SPARSER::COLLECTION)
    ("siRNA or short hairpin RNA (shRNA)" . SPARSER::COLLECTION)
    ("FOXA1 and AR" . SPARSER::COLLECTION) ("anti-androgens" . SPARSER::DRUG)
    ("IGFBP-1" . SPARSER::PROTEIN) ("Forkhead box" . SPARSER::PROTEIN)
    ("Protein A " . SPARSER::PROTEIN) ("PWP1" . SPARSER::PROTEIN)
    ("Forkhead box A1" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("UHRF1" . SPARSER::PROTEIN) ("ZBTB16" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("forkhead box A1" . SPARSER::PROTEIN)
    ("accurate prognostic biomarkers" . SPARSER::MOLECULE)
    ("phosphoinositide 3-kinase/AKT" . SPARSER::COLLECTION)
    ("the encoded latency-associated nuclear antigen protein"
     . SPARSER::PROTEIN)
    ("membrane-bound E-cadherin and/or γ -catenin" . SPARSER::COLLECTION)
    ("E6-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin and alpha-catenin" . SPARSER::COLLECTION)
    ("EGF and TGF β" . SPARSER::COLLECTION)
    ("APC or CTNNB1" . SPARSER::COLLECTION)
    ("APC and Axin" . SPARSER::COLLECTION)
    ("beta-catenin and the cadherin" . SPARSER::COLLECTION)
    ("Dsh" . SPARSER::PROTEIN)
    ("a major etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the main prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clinical-pathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OP-SCCs" . SPARSER::PROTEIN-PAIR) ("OP" . SPARSER::PROTEIN)
    ("γ -catenin" . SPARSER::PROTEIN) ("BCL9" . SPARSER::PROTEIN)
    ("alpha-catenin" . SPARSER::PROTEIN) ("p68" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("for 3 " . SPARSER::PROTEIN)
    ("GSK3- β" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("human SDC or guiding target therapeutics" . SPARSER::COLLECTION)
    ("the most aggressive subtypes" . SPARSER::PROTEIN)
    ("The invasive components" . SPARSER::COMPONENT)
    ("The intraductal component" . SPARSER::COMPONENT)
    ("both intraductal and invasive components" . SPARSER::COMPONENT)
    ("and 1–3" . SPARSER::COLLECTION) ("SDCs" . SPARSER::PROTEIN)
    ("a plausible drug target" . SPARSER::TARGET-PROTEIN)
    ("SDC" . SPARSER::PROTEIN) ("SDC3" . SPARSER::PROTEIN)
    ("SDC2" . SPARSER::PROTEIN) ("Beta-actin" . SPARSER::PROTEIN)
    ("p110 α" . SPARSER::PROTEIN) ("PI3 K" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YAP1 and paclitaxel" . SPARSER::COLLECTION)
    ("poor prognostic gene" . SPARSER::GENE)
    ("YAP1 and TAZ" . SPARSER::COLLECTION) ("OV" . SPARSER::MOLECULE)
    ("Taxane" . SPARSER::DRUG) ("cohort and CCP" . SPARSER::COLLECTION)
    ("CCP" . SPARSER::PROTEIN) ("YA and YI" . SPARSER::COLLECTION)
    ("-inactive" . SPARSER::INACTIVE) ("-active" . SPARSER::ACTIVE)
    ("YA" . SPARSER::PROTEIN)
    ("the most well-known activated oncogene" . SPARSER::PROTEIN)
    ("multiple ovarian cancer cohorts" . SPARSER::MOLECULE)
    ("Sav1 and Mst1/2" . SPARSER::COLLECTION)
    ("the Yes-Associated Protein 1 ( YAP1 ) and Transcriptional Coactivator"
     . SPARSER::COLLECTION)
    ("the Yes-Associated Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAZ" . SPARSER::PROTEIN) ("Activator" . SPARSER::ACTIVATOR)
    ("LATS" . SPARSER::PROTEIN) ("MST" . SPARSER::PROTEIN)
    ("an independent ovarian cancer cohort" . SPARSER::MOLECULE)
    ("Yes-Associated Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LATS1" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("Sav1" . SPARSER::PROTEIN)
    ("Transcriptional Coactivator" . SPARSER::PROTEIN)
    ("MOB1" . SPARSER::PROTEIN) ("SAV1" . SPARSER::PROTEIN)
    ("Salvador Homolog 1" . SPARSER::PROTEIN) ("STE20" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an established prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nodal" . SPARSER::PROTEIN)
    ("a well-established negative prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/p16" . SPARSER::COLLECTION)
    ("HPV DNA− p16 INKA4a -negative CUP" . SPARSER::PROTEIN)
    ("FISH and p16" . SPARSER::COLLECTION) ("amplifiable DNA" . SPARSER::DNA)
    ("p16 INK4a and p53" . SPARSER::COLLECTION) ("DNA−" . SPARSER::DNA)
    ("p16 INK4A and p53" . SPARSER::COLLECTION) ("CUP" . SPARSER::PROTEIN)
    ("β -globin" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("Cln2" . SPARSER::PROTEIN) ("B55β" . SPARSER::PROTEIN)
    ("B55β-shRNA" . SPARSER::PROTEIN-PAIR)
    ("the mammary fat" . SPARSER::PROTEIN) ("luc" . SPARSER::PROTEIN)
    ("protein and B55β and CCNE1" . SPARSER::COLLECTION)
    ("Myc-cyclin E1" . SPARSER::COLLECTION)
    ("proteasome inhibitor MG132 or chemical inhibitors" . SPARSER::COLLECTION)
    ("the B55 and B56 β-subunit families" . SPARSER::COLLECTION)
    ("cyclin E1-Cdk2" . SPARSER::COLLECTION) ("primase" . SPARSER::PROTEIN)
    ("Cdk2 and GSK3" . SPARSER::COLLECTION)
    ("important clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CPDs" . SPARSER::PROTEIN) ("E2F and c-Myc" . SPARSER::COLLECTION)
    ("Cdc55" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("Fbxw7" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("MAF and DEPTOR" . SPARSER::COLLECTION)
    ("MEK or mTOR" . SPARSER::COLLECTION) ("cytarabine" . SPARSER::MOLECULE)
    ("melanoma, and colon cancer" . SPARSER::COLLECTION)
    ("TSC2 and RAPTOR" . SPARSER::COLLECTION) ("RAPTOR" . SPARSER::PROTEIN)
    ("MYB" . SPARSER::PROTEIN) ("RasV12 and B-Raf" . SPARSER::COLLECTION)
    ("/MEK" . SPARSER::COLLECTION)
    ("BLBP, MBP , and S100β" . SPARSER::COLLECTION)
    ("MEK-ERK-FOS" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("the first cancer relevant NF1 target" . SPARSER::TARGET-PROTEIN)
    ("NF1 and MAF" . SPARSER::COLLECTION)
    ("MAPK and mTOR" . SPARSER::COLLECTION)
    ("Ras/MAPK/AP1" . SPARSER::COLLECTION)
    ("S100β and MBP" . SPARSER::COLLECTION)
    ("BLBP/FABP7" . SPARSER::COLLECTION)
    ("pS6 and p4E-BP1" . SPARSER::COLLECTION)
    ("pS6 and DEPTOR" . SPARSER::COLLECTION)
    ("MAF target and negative regulator of the AKT/mTOR pathway ( xref )"
     . SPARSER::NEGATIVE-REGULATOR)
    ("target and negative regulator" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("PI and Annexin" . SPARSER::COLLECTION)
    ("Annexin" . SPARSER::PROTEIN) ("SOX9 and MAF" . SPARSER::COLLECTION)
    ("lenti-MAF" . SPARSER::COLLECTION) ("bot" . SPARSER::PROTEIN)
    ("S100β, MBP, and BLBP" . SPARSER::COLLECTION) ("BLBP" . SPARSER::PROTEIN)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION) ("RAS-Gap" . SPARSER::COLLECTION)
    ("EGFL5 , MAF , PCDH20 , and FOXD1" . SPARSER::COLLECTION)
    ("SOX9 and SPRY4" . SPARSER::COLLECTION)
    ("Ras-GTP and downstream P-MEK and P-ERK ( xref )" . SPARSER::COLLECTION)
    ("NF1-GRD" . SPARSER::COLLECTION) ("GRD" . SPARSER::PROTEIN)
    ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("MafA, MafB and c-Maf" . SPARSER::COLLECTION) ("MafB" . SPARSER::PROTEIN)
    ("MafA" . SPARSER::PROTEIN) ("Nf1" . SPARSER::PROTEIN)
    ("pERK and pAKT and pS6K and p4EBP1" . SPARSER::COLLECTION)
    ("pAKT and pS6K and p4EBP1" . SPARSER::COLLECTION)
    ("pS6K and p4EBP1" . SPARSER::COLLECTION)
    ("neurofibromin" . SPARSER::PROTEIN)
    ("GTPase activating protein (GAP)" . SPARSER::PROTEIN)
    ("RAS/MAPK/AP-1" . SPARSER::COLLECTION) ("β-ACTIN" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("FABP7" . SPARSER::PROTEIN) ("BP1" . SPARSER::PROTEIN)
    ("P-S6" . SPARSER::PROTEIN) ("S100β" . SPARSER::PROTEIN)
    ("RasV12" . SPARSER::DRUG) ("SPRY4" . SPARSER::PROTEIN)
    ("FOXD1" . SPARSER::PROTEIN) ("PCDH20" . SPARSER::PROTEIN)
    ("EGFL5" . SPARSER::PROTEIN) ("DACH1" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("Ras-GDP" . SPARSER::PROTEIN)
    ("c-Maf" . SPARSER::PROTEIN) ("c-MAF" . SPARSER::PROTEIN)
    ("EBP1" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pS6K" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("NF1" . SPARSER::PROTEIN)
    ("more potent and selective ALK inhibitors such as CH5424802 or TAE684 structure-based molecules"
     . SPARSER::COLLECTION)
    ("TAE684 structure-based molecules" . SPARSER::MOLECULE)
    ("crizotinib and the next-generation ALK inhibitor CH5424802"
     . SPARSER::COLLECTION)
    ("Vega" . SPARSER::PROTEIN) ("Sharp" . SPARSER::PROTEIN)
    ("DLT" . SPARSER::PROTEIN)
    ("both crizotinib and CH5424802 bind" . SPARSER::COLLECTION)
    ("DFG" . SPARSER::PROTEIN) ("HSP90 and STAT3" . SPARSER::COLLECTION)
    ("ALK and downstream proteins STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("ALK and its crucial downstream signaling intermediates ERK1/2 and STAT3"
     . SPARSER::COLLECTION)
    ("ERK1/2 and STAT3" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("ALK and its downstream effectors" . SPARSER::COLLECTION)
    ("STAT3 or ERK" . SPARSER::COLLECTION)
    ("untreated parental line" . SPARSER::PROTEIN)
    ("crizotinib and CH5424802 in NPM-ALK+ Karpas299 cells"
     . SPARSER::COLLECTION)
    ("HSP90 and mTOR" . SPARSER::COLLECTION) ("ALK+" . SPARSER::PROTEIN)
    ("crizotinib and CH5424802" . SPARSER::COLLECTION)
    ("NPM-ALK+" . SPARSER::COLLECTION) ("unique scaffold" . SPARSER::SCAFFOLD)
    ("KIT or KRAS" . SPARSER::COLLECTION)
    ("the first dual ALK/MET inhibitor" . SPARSER::INHIBITOR)
    ("ALK/MET" . SPARSER::COLLECTION)
    ("crizotinib (NCT00939770, NCT01606878, NCT01524926, NCT00585195) and one"
     . SPARSER::COLLECTION)
    ("ALK/EGFR" . SPARSER::COLLECTION) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION) ("NPM-ALK" . SPARSER::COLLECTION)
    ("HSP90 or mTOR" . SPARSER::COLLECTION)
    ("ALK, HSP90 and mTOR" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("ALK inhibitor CH5424802" . SPARSER::DRUG)
    ("LDK378" . SPARSER::DRUG) ("as 2 " . SPARSER::PROTEIN)
    ("AUY922" . SPARSER::DRUG) ("S1b" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("TAE684" . SPARSER::DRUG)
    ("had at least 1 intact RB1 gene" . SPARSER::PROTEIN)
    ("MYCN, BCOR , or OTX2" . SPARSER::COLLECTION)
    ("our larger cohort" . SPARSER::MOLECULE)
    ("DEK, NUP153, E2F3 and TTRAP" . SPARSER::COLLECTION)
    ("only 5 genes" . SPARSER::GENE)
    ("RAB23, HCG18, C6orf64, SNRP48 and COX4I1" . SPARSER::COLLECTION)
    ("rod and cone photoreceptor genes [ xref , xref ]" . SPARSER::COLLECTION)
    ("rod" . SPARSER::PROTEIN) ("homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the RB1 gene and the BCOR gene" . SPARSER::COLLECTION)
    ("protein and MYCN" . SPARSER::COLLECTION)
    ("one allele and the 5" . SPARSER::COLLECTION)
    ("DNA and tumor" . SPARSER::COLLECTION)
    ("RB1 and MYCN" . SPARSER::COLLECTION)
    ("MYCN and OTX2" . SPARSER::COLLECTION)
    ("RB1 , and BCOR" . SPARSER::COLLECTION)
    ("identified recurrent genes" . SPARSER::GENE)
    ("Hedgehog" . SPARSER::PROTEIN)
    ("RAB23, HCG18, C6orf64 , and SNRNP48" . SPARSER::COLLECTION)
    ("orf" . SPARSER::PROTEIN) ("the entire arm" . SPARSER::PROTEIN)
    ("SVs" . SPARSER::MOLECULE)
    ("NUP153, E2F3 and TTRAP" . SPARSER::COLLECTION)
    ("TTRAP" . SPARSER::PROTEIN) ("DEK" . SPARSER::PROTEIN)
    ("RB1 and BCOR" . SPARSER::COLLECTION) ("BCOR" . SPARSER::PROTEIN)
    ("MYCN" . SPARSER::PROTEIN)
    ("loss of heterozygosity and promoter" . SPARSER::COLLECTION)
    ("90K" . SPARSER::PROTEIN) ("COX4I1" . SPARSER::PROTEIN)
    ("chr13" . SPARSER::PROTEIN) ("HLA complex" . SPARSER::PROTEIN)
    ("SNRNP48" . SPARSER::PROTEIN) ("RAB23" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("chr1" . SPARSER::PROTEIN)
    ("chr6" . SPARSER::PROTEIN) ("NUP153" . SPARSER::PROTEIN)
    ("RB 1" . SPARSER::PROTEIN) ("OTX2" . SPARSER::PROTEIN)
    ("traits, and emphasise" . SPARSER::COLLECTION) ("DHS" . SPARSER::PROTEIN)
    ("approximate LD" . SPARSER::PROTEIN) ("GCTA" . SPARSER::PROTEIN)
    ("SSR1 (at the SSR1/RREB1 locus) and ABCB9 , OGFOD2 , and PITPNM2 (at the MPHOSPH9 locus)"
     . SPARSER::COLLECTION)
    ("ABCB9 , OGFOD2 , and PITPNM2" . SPARSER::COLLECTION)
    ("strong LD" . SPARSER::PROTEIN)
    ("ABCB9 (liver, p =7.4×10 −12 ) and SETD8 (lung, p <2.0×10 −16 )"
     . SPARSER::COLLECTION)
    ("LPP" . SPARSER::PROTEIN) ("glycaemic traits" . SPARSER::PROTEIN)
    ("HOMA-IR" . SPARSER::PROTEIN-PAIR) ("Lipids" . SPARSER::LIPID)
    ("Traits" . SPARSER::PROTEIN) ("Insulin" . SPARSER::PROTEIN)
    ("more indolent form" . SPARSER::FORM) ("late-age" . SPARSER::PROTEIN)
    ("LADA" . SPARSER::PROTEIN) ("GLIS3 and 6q22.32" . SPARSER::COLLECTION)
    ("traditional T1D HLA risk alleles" . SPARSER::ALLELE)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("POU5F1/TCF19" . SPARSER::COLLECTION) ("SSR1/RREB1" . SPARSER::COLLECTION)
    ("PEPD (rs3786897,p Q =0.00055) and KLF14 (rs13233731,p Q =0.00064)"
     . SPARSER::COLLECTION)
    ("MAT" . SPARSER::PROTEIN) ("less extensive LD" . SPARSER::PROTEIN)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("SLC30A8" . SPARSER::PROTEIN) ("CREB5" . SPARSER::PROTEIN)
    ("JAZF1" . SPARSER::PROTEIN) ("MTNR1B" . SPARSER::PROTEIN)
    ("ELAVL4" . SPARSER::PROTEIN) ("FAF1" . SPARSER::PROTEIN)
    ("PITPNM2" . SPARSER::PROTEIN) ("OGFOD2" . SPARSER::PROTEIN)
    ("SETD8" . SPARSER::PROTEIN) ("ABCB9" . SPARSER::PROTEIN)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("ARL15" . SPARSER::PROTEIN) ("GLIS3" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("TCF19" . SPARSER::PROTEIN)
    ("MPHOSPH9" . SPARSER::PROTEIN) ("RREB1" . SPARSER::PROTEIN)
    ("SSR1" . SPARSER::PROTEIN) ("KLF14" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("SAT2" . SPARSER::PROTEIN)
    ("Enzalutamide" . SPARSER::DRUG)
    ("both AR and its coactivator SRC-3" . SPARSER::COLLECTION)
    ("prostate-cancer-associated mutants" . SPARSER::MUTANT)
    ("IE" . SPARSER::PROTEIN)
    ("MDM2, CHIP, RNF6, and SIAH2" . SPARSER::COLLECTION)
    ("TMPRSS2-ETS" . SPARSER::COLLECTION)
    ("androgen, and antiandrogen" . SPARSER::COLLECTION)
    ("all the hinge domain null AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the known prostate-cancer-associated mutants" . SPARSER::MUTANT)
    ("the prostate-cancer-associated SPOP mutant F133V" . SPARSER::PROTEIN)
    ("AR-SPOP" . SPARSER::COLLECTION) ("AR and SPOP" . SPARSER::COLLECTION)
    ("the prostate-cancer-associated mutants" . SPARSER::MUTANT)
    ("Prostate-Cancer-Associated Mutants" . SPARSER::MUTANT)
    ("Mutants" . SPARSER::MUTANT)
    ("hinge domain null AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SPOPΔBTB" . SPARSER::PROTEIN)
    ("the serine and/or threonine residues" . SPARSER::COLLECTION)
    ("Myc-SPOP" . SPARSER::COLLECTION) ("SPOP-AR" . SPARSER::COLLECTION)
    ("NTD and LBD, or GST" . SPARSER::COLLECTION)
    ("SPOP and AR" . SPARSER::COLLECTION) ("HA-SPOP" . SPARSER::COLLECTION)
    ("wild-type SPOP (SPOP WT) or enzymatic dead mutant (SPOP-ΔBTB)"
     . SPARSER::COLLECTION)
    ("polyubiquitination, HA-Ub and pCMV" . SPARSER::COLLECTION)
    ("ΔBTB" . SPARSER::PROTEIN) ("RBX1 or CUL3" . SPARSER::COLLECTION)
    ("CUL3-RBX1" . SPARSER::COLLECTION) ("SPOP-ΔBTB" . SPARSER::COLLECTION)
    ("CUL3 and RBX1" . SPARSER::COLLECTION) ("SPOP-" . SPARSER::PROTEIN)
    ("Puc, MacroH2A, Ci/Gli, and Daxx" . SPARSER::COLLECTION)
    ("SPOP-CUL3-RBX1" . SPARSER::COLLECTION) ("Ligase" . SPARSER::LIGASE)
    ("tin" . SPARSER::PROTEIN)
    ("Puc, Ci/Gli, MacroH2A, Daxx, and SRC-3" . SPARSER::COLLECTION)
    ("Daxx" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("Puc" . SPARSER::PROTEIN)
    ("the scaffold CUL3 and RING protein RBX1" . SPARSER::COLLECTION)
    ("Bric-a-brac/Tramtrack/Broad complex" . SPARSER::COLLECTION)
    ("CULLINs" . SPARSER::PROTEIN-FAMILY) ("distinct CRL" . SPARSER::PROTEIN)
    ("The largest E3 ligase" . SPARSER::LIGASE) ("CRL" . SPARSER::PROTEIN)
    ("CRLs" . SPARSER::PROTEIN) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("ligases, or E3s" . SPARSER::COLLECTION)
    ("E1, E2s, and E3s" . SPARSER::COLLECTION)
    ("ERG and ETV1" . SPARSER::COLLECTION)
    ("a pivotal transcription factor" . SPARSER::PROTEIN)
    ("antiandrogens" . SPARSER::DRUG)
    ("Prostate-cancer-associated mutants" . SPARSER::MUTANT)
    ("SPOP" . SPARSER::PROTEIN) ("SIAH2" . SPARSER::PROTEIN)
    ("RNF6" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("CULLIN3" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("SRC-3" . SPARSER::PROTEIN) ("Broad complex" . SPARSER::PROTEIN)
    ("Bric-a-brac" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN) ("CRL3" . SPARSER::PROTEIN)
    ("CUL1" . SPARSER::PROTEIN) ("E2s" . SPARSER::MOLECULE)
    ("MDV3100" . SPARSER::DRUG) ("ETV1" . SPARSER::PROTEIN)
    ("sorafenib" . SPARSER::DRUG)
    ("BRAF  V600E and BRAF  V600K" . SPARSER::COLLECTION)
    ("post-hoc" . SPARSER::PROTEIN-PAIR)
    ("dacarbazine and vemurafenib" . SPARSER::COLLECTION)
    ("BRAF  V600E (about 80%) and BRAF  V600K (5–30%)" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("trametinib" . SPARSER::DRUG)
    ("Dabrafenib" . SPARSER::DRUG) ("ipilimumab" . SPARSER::DRUG)
    ("vemurafenib and 338" . SPARSER::COLLECTION) ("Dec" . SPARSER::PROTEIN)
    ("NCT" . SPARSER::PROTEIN)
    ("either vemurafenib (960 mg orally twice daily) or dacarbazine (1000 mg/m 2 of body surface area intravenously every 3 weeks)"
     . SPARSER::COLLECTION)
    ("Group (ECOG)" . SPARSER::MOLECULE) ("dacarbazine" . SPARSER::DRUG)
    ("vemurafenib" . SPARSER::DRUG) ("gp100" . SPARSER::PROTEIN)
    ("M1a" . SPARSER::MOLECULE) ("CTLA-4" . SPARSER::PROTEIN)
    ("interleukin 2" . SPARSER::PROTEIN)
    ("ruthenium ruthenium(II)" . SPARSER::MOLECULE) ("KH" . SPARSER::PROTEIN)
    ("Bovine serum albumin" . SPARSER::PROTEIN)
    ("BRCA1-associated RING domain 1" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG) ("sulphate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("RPMI" . SPARSER::PROTEIN)
    ("ERE" . SPARSER::PROTEIN)
    ("conformation and the binding constant" . SPARSER::COLLECTION)
    ("BRCA1 and BARD1" . SPARSER::COLLECTION)
    ("cisplatin and Zn 2+" . SPARSER::COLLECTION)
    ("Zn 2+ or cisplatin" . SPARSER::COLLECTION)
    ("phenanthroline" . SPARSER::MOLECULE)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("a dysfunctional BRCA1" . SPARSER::PROTEIN) ("insC" . SPARSER::PROTEIN)
    ("ER-ERE" . SPARSER::PROTEIN-PAIR)
    ("tested metal-based drugs" . SPARSER::DRUG)
    ("endonuclease G, caspases, and c-Jun" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("a specific biological target" . SPARSER::TARGET-PROTEIN)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("p53 and BRCA1" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("the intercalative polypyridyl ligand" . SPARSER::MOLECULE)
    ("complexes and DNAs" . SPARSER::COLLECTION) ("DNAs" . SPARSER::DNA)
    ("a potential biomolecular target" . SPARSER::TARGET-PROTEIN)
    ("phen" . SPARSER::MOLECULE) ("platinum(II)" . SPARSER::MOLECULE)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("EGFR, and mTOR" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("Ruthenium" . SPARSER::MOLECULE)
    ("the conformation and binding constants" . SPARSER::COLLECTION)
    ("BRCA1 mRNA and replication" . SPARSER::COLLECTION)
    ("iodide and Annexin V" . SPARSER::COLLECTION)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("ICP-MS" . SPARSER::COLLECTION) ("ICP" . SPARSER::PROTEIN)
    ("RTCA" . SPARSER::PROTEIN) ("ruthenium(II)" . SPARSER::MOLECULE)
    ("ruthenium" . SPARSER::MOLECULE)
    ("progesterone receptor and human epidermal growth factor receptor 2"
     . SPARSER::COLLECTION)
    ("estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2"
     . SPARSER::COLLECTION)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN) ("KP1019" . SPARSER::DRUG)
    ("hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endonuclease G" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 2 s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Zn 2+" . SPARSER::MOLECULE)
    ("Cl 2" . SPARSER::PROTEIN)
    ("mononucleotide or nicotinamide" . SPARSER::COLLECTION)
    ("mononucleotide" . SPARSER::MOLECULE)
    ("peripheral targets" . SPARSER::TARGET-PROTEIN)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("Cocaine or morphine" . SPARSER::COLLECTION)
    ("morphine" . SPARSER::MOLECULE) ("Cocaine" . SPARSER::DRUG)
    ("substance" . SPARSER::SUBSTANCE)
    ("MAO inhibitors and selective serotonin reuptake inhibitors ( xref )"
     . SPARSER::COLLECTION)
    ("MAO" . SPARSER::PROTEIN) ("antidepressant" . SPARSER::DRUG)
    ("serotonin" . SPARSER::MOLECULE)
    ("depressive and remissive states" . SPARSER::BIO-STATE)
    ("SIRT1, SIRT2 and SIRT6" . SPARSER::COLLECTION)
    ("p53 and p65" . SPARSER::COLLECTION) ("a pathologic form" . SPARSER::FORM)
    ("PrP" . SPARSER::PROTEIN) ("prion" . SPARSER::PROTEIN-FAMILY)
    ("Prion" . SPARSER::PROTEIN-FAMILY)
    ("neurotrophic factor and NAD" . SPARSER::COLLECTION)
    ("SIRT1 or other proteins" . SPARSER::COLLECTION)
    ("AMPK or PGC1α" . SPARSER::COLLECTION) ("chronic EAE" . SPARSER::PROTEIN)
    ("antigens and form" . SPARSER::COLLECTION) ("myelin" . SPARSER::PROTEIN)
    ("EAE" . SPARSER::PROTEIN) ("polyglutamine" . SPARSER::MOLECULE)
    ("SBMA" . SPARSER::PROTEIN) ("HSP70 and HSP25" . SPARSER::COLLECTION)
    ("SOD" . SPARSER::PROTEIN)
    ("UBQLN2 (Deng et al.) and C9ORF72 (DeJesus-Hernandez et al.; Renton et al.)"
     . SPARSER::COLLECTION)
    ("SOD1 ( xref ), TDP43 ( xref ; xref ), FUS ( xref ), VCP ( xref ), UBQLN2 (Deng et al.) and C9ORF72 (DeJesus-Hernandez et al.; Renton et al.)"
     . SPARSER::COLLECTION)
    ("FUS" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("TrkB" . SPARSER::PROTEIN)
    ("a potential pharmacologic target" . SPARSER::TARGET-PROTEIN)
    ("PGC1α or resveratrol" . SPARSER::COLLECTION)
    ("α-synuclein and ubiquitin" . SPARSER::COLLECTION)
    ("APP, PS1 and PS2" . SPARSER::COLLECTION)
    ("APP/PS1" . SPARSER::COLLECTION)
    ("presenilin 1 (PS1) or presenilin 2 (PS2)" . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("BMAL1 and CLOCK" . SPARSER::COLLECTION)
    ("NAMPT" . SPARSER::PROTEIN) ("CLOCK" . SPARSER::PROTEIN)
    ("circadian clock proteins" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN) ("BMAL1 and PER2" . SPARSER::COLLECTION)
    ("spike" . SPARSER::PROTEIN) ("Nk2" . SPARSER::PROTEIN)
    ("DMH and LH" . SPARSER::COLLECTION) ("Ox2r" . SPARSER::PROTEIN)
    ("orexin" . SPARSER::PROTEIN) ("Ghrelin" . SPARSER::PROTEIN)
    ("ghrelin" . SPARSER::PROTEIN) ("minibrain/Dyrk1a" . SPARSER::COLLECTION)
    ("SF1 or POMC" . SPARSER::COLLECTION)
    ("agouti-related peptide (AgRP) and GABA" . SPARSER::COLLECTION)
    ("AgRP" . SPARSER::PROTEIN) ("agouti" . SPARSER::PROTEIN-FAMILY)
    ("NPY" . SPARSER::PROTEIN)
    ("hormone and cocaine-and-amphetamine-regulated" . SPARSER::COLLECTION)
    ("cocaine" . SPARSER::DRUG) ("POMC" . SPARSER::PROTEIN)
    ("glucose and insulin, and steroidogenic factor 1" . SPARSER::COLLECTION)
    ("insulin, and steroidogenic factor 1" . SPARSER::COLLECTION)
    ("SCN" . SPARSER::MOLECULE) ("DMH" . SPARSER::PROTEIN)
    ("ARC" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("CREB and BDNF" . SPARSER::COLLECTION)
    ("SIRT1 and these targets" . SPARSER::COLLECTION)
    ("neurotrophic factor (BDNF)" . SPARSER::PROTEIN)
    ("mIR" . SPARSER::MICRO-RNA) ("hippocampal genes" . SPARSER::GENE)
    ("CA1" . SPARSER::PROTEIN) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("NGF" . SPARSER::PROTEIN) ("NAD+ and SIRT1" . SPARSER::COLLECTION)
    ("CamKK" . SPARSER::PROTEIN)
    ("phosphodiesterases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("non-SIRT1 neuronal targets" . SPARSER::TARGET-PROTEIN)
    ("resveratrol and synthetic SIRT1 activators" . SPARSER::COLLECTION)
    ("a nucleolar protein" . SPARSER::PROTEIN)
    ("SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("deacetylase and ADP-ribosyltransferase" . SPARSER::COLLECTION)
    ("SIRT1, SIRT2 and SIRT3" . SPARSER::COLLECTION)
    ("non-histone proteins and several sirtuins" . SPARSER::COLLECTION)
    ("condensation and gene" . SPARSER::COLLECTION)
    ("histones and other substrates" . SPARSER::COLLECTION)
    ("Drugs" . SPARSER::DRUG) ("axonal elongation" . SPARSER::PROTEIN)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("activator protein 1" . SPARSER::PROTEIN) ("5-HIAA" . SPARSER::MOLECULE)
    ("MAO-A" . SPARSER::PROTEIN) ("monoamine oxidase A" . SPARSER::PROTEIN)
    ("NHLH2" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("HSP25" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("C9ORF72" . SPARSER::PROTEIN) ("UBQLN2" . SPARSER::PROTEIN)
    ("TDP43" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("Foxo3a" . SPARSER::PROTEIN) ("DARPP32" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock protein 70" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("α-synuclein" . SPARSER::PROTEIN) ("p25" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ADAM10" . SPARSER::PROTEIN) ("amyloid-β" . SPARSER::MOLECULE)
    ("γ-secretase" . SPARSER::PROTEIN) ("PS2" . SPARSER::PROTEIN)
    ("presenilin 2" . SPARSER::PROTEIN) ("presenilin 1" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("RORα" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("PER2" . SPARSER::PROTEIN) ("BMAL1" . SPARSER::PROTEIN)
    ("homeobox 1" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("type 2 receptor" . SPARSER::PROTEIN) ("Dyrk1a" . SPARSER::PROTEIN)
    ("neuropeptide Y" . SPARSER::PROTEIN)
    ("pro-opiomelanocortin" . SPARSER::PROTEIN) ("SF1" . SPARSER::PROTEIN)
    ("steroidogenic factor 1" . SPARSER::PROTEIN)
    ("Brain-specific" . SPARSER::PROTEIN) ("Sirtuin 1" . SPARSER::PROTEIN)
    ("Epac1" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN) ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("the diagnostic and therapeutic impact" . SPARSER::PROTEIN)
    ("p16ink4a and RB" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("antiestrogen or antiandrogen" . SPARSER::COLLECTION)
    ("antisera" . SPARSER::PROTEIN)
    ("a novel diagnostic and prognostic biomarker" . SPARSER::MOLECULE)
    ("ER, PR, HER2, EGFR, and CK5/6" . SPARSER::COLLECTION)
    ("novel targetable biomarkers" . SPARSER::MOLECULE)
    ("n  " . SPARSER::PROTEIN) ("EGFR and CK5/6" . SPARSER::COLLECTION)
    ("p53, EGFR and CK5/6" . SPARSER::COLLECTION)
    ("two independent Institutional cohorts" . SPARSER::MOLECULE)
    ("a prognostic impact" . SPARSER::PROTEIN)
    ("two major prognostic classes" . CLASS)
    ("ER, PR, HER2, EGFR, and cytokeratin 5/6" . SPARSER::COLLECTION)
    ("prognostic factors, and perhaps" . SPARSER::COLLECTION)
    ("factors, and perhaps" . SPARSER::COLLECTION)
    ("well-defined molecular targets" . SPARSER::TARGET-PROTEIN)
    ("the non-basal triple negative cancer group" . SPARSER::MOLECULE)
    ("p16ink4a" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("pneumolysin (PLY)" . SPARSER::PROTEIN) ("pneumolysin" . SPARSER::PROTEIN)
    ("ROS and PKC" . SPARSER::COLLECTION)
    ("chaperones, Hsp90 and Hsp70" . SPARSER::COLLECTION)
    ("camkII" . SPARSER::PROTEIN) ("Nox1 and Nox4" . SPARSER::COLLECTION)
    ("Nox1, Nox2 and Nox4" . SPARSER::COLLECTION)
    ("p40, p47, p67 and p22phox" . SPARSER::COLLECTION)
    ("a secondary molecule or kinase" . SPARSER::COLLECTION)
    ("molecule or kinase" . SPARSER::COLLECTION) ("myr-" . SPARSER::MOLECULE)
    ("common molecular targets and disparate chemical" . SPARSER::COLLECTION)
    ("disparate chemical" . SPARSER::MOLECULE)
    ("PKCα and conventional PKC isoforms" . SPARSER::COLLECTION)
    ("a distinct serine residue" . SPARSER::MOLECULE)
    ("RFP or Nox5" . SPARSER::COLLECTION) ("PLY" . SPARSER::PROTEIN)
    ("the Nox5 triple mutant (Nox5 S490A, T494A, S498A) and site-dependent phosphorylation of S490, T494 and S498"
     . SPARSER::COLLECTION)
    ("the Nox5 triple mutant" . SPARSER::MUTANT)
    ("Nox5 and PKCα" . SPARSER::COLLECTION) ("myr" . SPARSER::MOLECULE)
    ("active forms of PKCα and ε" . SPARSER::COLLECTION)
    ("PKCα or PKCε" . SPARSER::COLLECTION) ("DAG or PMA" . SPARSER::COLLECTION)
    ("The atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCζ and ι/λ" . SPARSER::COLLECTION)
    ("calcium and DAG" . SPARSER::COLLECTION)
    ("DAG or mimetics" . SPARSER::COLLECTION)
    ("the predominant PKC isoforms" . SPARSER::ISOFORM)
    ("EGTA" . SPARSER::PROTEIN) ("chelator" . SPARSER::MOLECULE)
    ("rottlerin and LY379196" . SPARSER::COLLECTION)
    ("-agonist" . SPARSER::AGONIST) ("RO" . SPARSER::PROTEIN)
    ("rottlerin" . SPARSER::DRUG) ("eNOS" . SPARSER::PROTEIN)
    ("vasodilator" . SPARSER::PROTEIN) ("PKCε and PKCδ" . SPARSER::COLLECTION)
    ("protein kinase/protein kinase" . SPARSER::COLLECTION)
    ("the last Nox enzyme" . SPARSER::PROTEIN)
    ("seven related Nox genes that include Nox1-5 and the Duoxes1 and 2"
     . SPARSER::COLLECTION)
    ("Nox5 derived superoxide" . SPARSER::MOLECULE)
    ("PKCα and PKCε" . SPARSER::COLLECTION) ("LY333531" . SPARSER::DRUG)
    ("Ro-31-8220" . SPARSER::DRUG) ("c-Abl" . SPARSER::PROTEIN)
    ("p22phox" . SPARSER::PROTEIN) ("p67" . SPARSER::PROTEIN)
    ("p47" . SPARSER::PROTEIN) ("p40" . SPARSER::PROTEIN)
    ("p47phox" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("D-Glucose" . SPARSER::MOLECULE) ("ι/λ" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("LY379196" . SPARSER::DRUG)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("Protein kinase" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("Go 6976" . SPARSER::DRUG)
    ("PKCα" . SPARSER::PROTEIN) ("NADPH oxidase5" . SPARSER::PROTEIN)
    ("oxidative DNA" . SPARSER::DNA) ("ATM-Chk1" . SPARSER::COLLECTION)
    ("ATR and ATM" . SPARSER::COLLECTION)
    ("a general antioxidant and a precursor" . SPARSER::COLLECTION)
    ("Cdk1 and Cyclin B1" . SPARSER::COLLECTION)
    ("Ser-216-phosphorylated Cdc25C" . SPARSER::PROTEIN)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("ATM-Chk2" . SPARSER::COLLECTION)
    ("ATM-Chk1-Cdc25C-Cdk1" . SPARSER::COLLECTION)
    ("ROS and DNA" . SPARSER::COLLECTION) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("the cyclin-dependent kinases (Cdks) and the cyclins"
     . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM (Ataxia telangiectasia mutated) and ATR (Ataxia telangiectasia and Rad3 related)"
     . SPARSER::COLLECTION)
    ("Ataxia telangiectasia and Rad3" . SPARSER::COLLECTION)
    ("cyclin D1 and Cdk1" . SPARSER::COLLECTION)
    ("JAK2, STAT3, and STAT5" . SPARSER::COLLECTION)
    ("HL60" . SPARSER::PROTEIN) ("cucurbitacin" . SPARSER::MOLECULE)
    ("highly oxidized tetracyclic triterpenoids" . SPARSER::MOLECULE)
    ("siRNA and Chk1" . SPARSER::COLLECTION)
    ("Chk1-Cdc25C-Cdk1" . SPARSER::COLLECTION)
    ("Cucurbitacin" . SPARSER::MOLECULE) ("triterpenoids" . SPARSER::MOLECULE)
    ("Cucurbitacins" . SPARSER::MOLECULE) ("B/Cdk1" . SPARSER::PROTEIN)
    ("PI3 Kinase" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("Cyclin B 1" . SPARSER::PROTEIN) ("Cyclin-B" . SPARSER::PROTEIN-FAMILY)
    ("Cyclin B1" . SPARSER::PROTEIN) ("Cdc25B" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("N-acetyl-l-cysteine" . SPARSER::MOLECULE) ("Cdc25C" . SPARSER::PROTEIN)
    ("exogenous p120ctn-1A" . SPARSER::PROTEIN)
    ("p120ctn-1A-siRNA" . SPARSER::COLLECTION)
    ("a transcription factor and master gene regulator" . SPARSER::COLLECTION)
    ("E-cadherin and p120ctn" . SPARSER::COLLECTION)
    ("Past" . SPARSER::PROTEIN)
    ("instead cleaved E-cadherin" . SPARSER::PROTEIN)
    ("E-cad/CTF2" . SPARSER::COLLECTION) ("sE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p120ctn-1A" . SPARSER::PROTEIN)
    ("N-cadherin, snail and vimentin" . SPARSER::COLLECTION)
    ("siRNA-p120ctn-1A" . SPARSER::COLLECTION)
    ("p120ctn and E-cadherin" . SPARSER::COLLECTION) ("HBE" . SPARSER::PROTEIN)
    ("EMT-related molecules and cell invasion" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("Zeppo1" . SPARSER::PROTEIN) ("SIP1/ZEB2" . SPARSER::COLLECTION)
    ("mesenchymal biomarkers" . SPARSER::MOLECULE)
    ("N-cadherin, vimentin, snail, slug and twist" . SPARSER::COLLECTION)
    ("keratin-" . SPARSER::PROTEIN)
    ("N-cadherin, vimentin and snail" . SPARSER::COLLECTION)
    ("p120ctn, E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("CTF2" . SPARSER::PROTEIN) ("E-cad" . SPARSER::PROTEIN)
    ("CTNND1" . SPARSER::PROTEIN) ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least one G allele" . SPARSER::ALLELE)
    ("polymorphic alleles" . SPARSER::ALLELE)
    ("factor and MMP-1" . SPARSER::COLLECTION)
    ("the TC and CC genotype" . SPARSER::COLLECTION) ("GCA" . SPARSER::PROTEIN)
    ("the Ets family proteins and partner proteins" . SPARSER::COLLECTION)
    ("-GGAT-3" . SPARSER::COLLECTION) ("PEA3/Ets" . SPARSER::COLLECTION)
    ("polymorphic genes" . SPARSER::GENE)
    ("metabolic enzymes and cell cycle regulators" . SPARSER::COLLECTION)
    ("some polymorphic genes" . SPARSER::GENE)
    ("quinone oxidoreductase and Cyclin D1" . SPARSER::COLLECTION)
    ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("polymorphic variant alleles" . SPARSER::ALLELE)
    ("complete LD" . SPARSER::PROTEIN) ("substantial LD" . SPARSER::PROTEIN)
    ("Promoter and Haplotype" . SPARSER::COLLECTION)
    ("TC and CC genotypes" . SPARSER::COLLECTION)
    ("TA and TT" . SPARSER::COLLECTION) ("AG and GG" . SPARSER::COLLECTION)
    ("TT, TA and TA+TT" . SPARSER::COLLECTION)
    ("AG, GG and AG+GG" . SPARSER::COLLECTION) ("AG" . SPARSER::PROTEIN)
    ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("MMP-1.3, MMP-1.4, and MMP-1" . SPARSER::COLLECTION)
    ("the clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GGA" . SPARSER::MOLECULE)
    ("the interstitial collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genetic, epigenetic and environmental factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("north-eastern and southern states" . SPARSER::BIO-STATE)
    ("Odd" . SPARSER::PROTEIN) ("interleukin-1" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("G-A-A" . SPARSER::PROTEIN) ("MMP 1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("cyclin D1 and/or CDK4 genes" . SPARSER::COLLECTION)
    ("cyclin D1 or CDK4" . SPARSER::COLLECTION)
    ("CASP8AP2, DDX58, cyclin D1, MAF, CDK4, and PRKCE" . SPARSER::COLLECTION)
    ("PRKCE" . SPARSER::PROTEIN)
    ("the possible targets" . SPARSER::TARGET-PROTEIN)
    ("miR-545 Directly Targets Cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN) ("HFL1" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN)
    ("oncogenes or tumor suppressor genes in lung cancer"
     . SPARSER::COLLECTION)
    ("Cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION) ("DDX58" . SPARSER::PROTEIN)
    ("CASP8AP2" . SPARSER::PROTEIN)
    ("mPGES-1 and an increase in 15-PGDH" . SPARSER::COLLECTION)
    ("mPGES-1 and EP4" . SPARSER::COLLECTION)
    ("mPGES-1 or EP4" . SPARSER::COLLECTION) ("AE1" . SPARSER::PROTEIN)
    ("the major amino acid of collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hydroxyproline" . SPARSER::MOLECULE)
    ("a major vascular wall component" . SPARSER::COMPONENT)
    ("PGE 2 or EP4" . SPARSER::COLLECTION)
    ("PGE 2 and MMP" . SPARSER::COLLECTION)
    ("PGE 2 and MMPs" . SPARSER::COLLECTION)
    ("only total MMP" . SPARSER::PROTEIN)
    ("pro- and active-" . SPARSER::COLLECTION) ("active-" . SPARSER::ACTIVE)
    ("PGE 2 and EP4 receptor" . SPARSER::COLLECTION)
    ("COX-2 and microsomal PGES-1" . SPARSER::COLLECTION)
    ("thromboxane A 2 and PGD 2" . SPARSER::COLLECTION)
    ("pro-MMP" . SPARSER::COLLECTION) ("MMP-1 and MMP-2" . SPARSER::COLLECTION)
    ("TIMP-1 and TIMP-2" . SPARSER::COLLECTION)
    ("MMPs and TIMPs" . SPARSER::COLLECTION)
    ("TxA 2 and PGD 2" . SPARSER::COLLECTION) ("Enzyme" . SPARSER::ENZYME)
    ("mPGES-2 and cPGES" . SPARSER::COLLECTION)
    ("PGES and COX" . SPARSER::COLLECTION)
    ("PGE 2 and the enzymes" . SPARSER::COLLECTION)
    ("MMP, TIMP and collagen" . SPARSER::COLLECTION)
    ("mPGES-1 and COX-2" . SPARSER::COLLECTION) ("PGES" . SPARSER::PROTEIN)
    ("synthases" . SPARSER::PROTEIN) ("Prostanoids" . SPARSER::MOLECULE)
    ("EP1" . SPARSER::PROTEIN) ("prostanoids" . SPARSER::MOLECULE)
    ("exogenous PGE 2" . SPARSER::DRUG) ("MMP/TIMP" . SPARSER::COLLECTION)
    ("TIMP" . SPARSER::PROTEIN) ("mPGES-1 and 15-PGDH" . SPARSER::COLLECTION)
    ("PGDH" . SPARSER::PROTEIN) ("mPGES and cPGES" . SPARSER::COLLECTION)
    ("PGE-synthases" . SPARSER::PROTEIN-PAIR) ("cPGES" . SPARSER::PROTEIN)
    ("mPGES" . SPARSER::PROTEIN) ("PGE" . SPARSER::PROTEIN)
    ("SV" . SPARSER::MOLECULE) ("EP2 receptor" . SPARSER::PROTEIN)
    ("MMP -1" . SPARSER::PROTEIN) ("thromboxane A 2" . SPARSER::MOLECULE)
    ("EP4 Receptor" . SPARSER::PROTEIN) ("15d-PGJ 2" . SPARSER::MOLECULE)
    ("TxA 2" . SPARSER::MOLECULE) ("α-actin" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("GW627368X" . SPARSER::DRUG)
    ("EP2" . SPARSER::PROTEIN) ("interstitial collagenase" . SPARSER::PROTEIN)
    ("EP4 receptor" . SPARSER::PROTEIN) ("TIMP -1" . SPARSER::PROTEIN)
    ("EP4" . SPARSER::PROTEIN) ("mPGES-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mPGES-2" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("growth factor receptors and Ca 2+" . SPARSER::COLLECTION)
    ("ABP" . SPARSER::PROTEIN)
    ("fascin, Arp and vinculin" . SPARSER::COLLECTION)
    ("Arp" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("an activated invasive state" . SPARSER::BIO-STATE)
    ("the stress fiber-associated protein MLC" . SPARSER::PROTEIN)
    ("the lamellipodia-associated signal protein Arp3"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the filopodia-associated signal protein fascin" . SPARSER::PROTEIN)
    ("EGF and MF" . SPARSER::COLLECTION)
    ("EGF and EGF+MF" . SPARSER::COLLECTION) ("CON" . SPARSER::PROTEIN)
    ("relevant signaling pathway molecules" . SPARSER::MOLECULE)
    ("pre-MLC" . SPARSER::COLLECTION) ("Sham" . SPARSER::DRUG)
    ("fascin and Arp3" . SPARSER::COLLECTION)
    ("fascin, Arp3 and vinculin" . SPARSER::COLLECTION)
    ("fascin, Arp3, and vinculin" . SPARSER::COLLECTION)
    ("fascin, Arp3, vinculin and MLC" . SPARSER::COLLECTION)
    ("significantly fewer filaments" . SPARSER::PROTEIN-FAMILY)
    ("groups presented well-formed branch-like actin filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("MF and EGF" . SPARSER::COLLECTION) ("MF-" . SPARSER::PROTEIN)
    ("FI" . SPARSER::PROTEIN) ("sham" . SPARSER::DRUG)
    ("IRPA" . SPARSER::PROTEIN) ("CHL" . SPARSER::PROTEIN)
    ("AFM" . SPARSER::PROTEIN) ("PD153035 (PD)" . SPARSER::DRUG)
    ("chemical external factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFRs" . SPARSER::PROTEIN) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("MLC" . SPARSER::PROTEIN) ("fascin" . SPARSER::PROTEIN)
    ("the key aims" . SPARSER::PROTEIN) ("Actin" . SPARSER::PROTEIN)
    ("vinculin" . SPARSER::PROTEIN) ("cytochalasin-D" . SPARSER::DRUG)
    ("Fluo-4" . SPARSER::DRUG) ("TGF-α" . SPARSER::PROTEIN)
    ("PD153035" . SPARSER::DRUG) ("myosin II" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the other independent favorable prognostic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leucovorin" . SPARSER::DRUG) ("bevacizumab-base" . SPARSER::PROTEIN)
    ("oxaliplatin, irinotecan, bevacizumab and cetuximab"
     . SPARSER::COLLECTION)
    ("IV CRC" . SPARSER::PROTEIN) ("crucial oxaliplatin" . SPARSER::DRUG)
    ("longer first-line PFS" . SPARSER::PROTEIN)
    ("an independent predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("significantly longer first-line PFS" . SPARSER::PROTEIN)
    ("fluorouracil and irinotecan" . SPARSER::COLLECTION)
    ("thymidylate synthase and topoisomerase I" . SPARSER::COLLECTION)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("169 KRAS mutant and 225 KRAS" . SPARSER::COLLECTION)
    ("mCRC" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("CDX2" . SPARSER::PROTEIN) ("CK20" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN)
    ("possible new biomarkers" . SPARSER::MOLECULE)
    ("ERα-ERK5-CFL1" . SPARSER::COLLECTION)
    ("nuclear receptors and their coregulators ( xref , xref – xref )"
     . SPARSER::COLLECTION)
    ("ERK5 and cofilin" . SPARSER::COLLECTION) ("JMY" . SPARSER::PROTEIN)
    ("myocardin" . SPARSER::PROTEIN) ("SRF" . SPARSER::PROTEIN)
    ("ERK5 and PAF1" . SPARSER::COLLECTION)
    ("protein and regulator" . SPARSER::COLLECTION)
    ("linking CFL1" . SPARSER::PROTEIN)
    ("the dynamic nuclear" . SPARSER::PROTEIN)
    ("ERK5 or ERα" . SPARSER::COLLECTION)
    ("kinase and cofilin" . SPARSER::COLLECTION)
    ("distal enhancers" . SPARSER::PROTEIN)
    ("Pol II and CFL1" . SPARSER::COLLECTION)
    ("fulvestrant or ERK5" . SPARSER::COLLECTION)
    ("CFL1 and ERK5" . SPARSER::COLLECTION)
    ("Cofilin/ADF" . SPARSER::COLLECTION) ("ERα/ERK5" . SPARSER::COLLECTION)
    ("ERα, and CFL1" . SPARSER::COLLECTION)
    ("ERK5 and ER" . SPARSER::COLLECTION)
    ("ERK5 and pSer5-RNA" . SPARSER::COLLECTION)
    ("Pol II and ERK5" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("ERK5 and pERK5" . SPARSER::COLLECTION)
    ("ERK5 and SC-35" . SPARSER::COLLECTION)
    ("ERα and ERK5" . SPARSER::COLLECTION)
    ("ERK5, or ERK5" . SPARSER::COLLECTION) ("MEK5-DN" . SPARSER::COLLECTION)
    ("ERK5-DN" . SPARSER::COLLECTION)
    ("pMAPK substrates and RNA Pol II" . SPARSER::COLLECTION)
    ("pMAPK substrates and RNA Pol II in the presence and absence of E2"
     . SPARSER::COLLECTION)
    ("ERK2 and ERα" . SPARSER::COLLECTION)
    ("ERK5 and RNA" . SPARSER::COLLECTION)
    ("ERα and ERK2" . SPARSER::COLLECTION)
    ("Pol II, ERK2, and ERα" . SPARSER::COLLECTION)
    ("pERK5" . SPARSER::PROTEIN) ("ERK5, ERK2 and pMAPK" . SPARSER::COLLECTION)
    ("ERα/MAPK" . SPARSER::COLLECTION) ("ERα and RNA" . SPARSER::COLLECTION)
    ("ERK5 or ERK2" . SPARSER::COLLECTION)
    ("typical MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38, JNKs and ERK5" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("the intragenic enhancers" . SPARSER::PROTEIN)
    ("two key factors, ERK5 and CFL1" . SPARSER::COLLECTION)
    ("factors, ERK5 and CFL1" . SPARSER::COLLECTION)
    ("ERK5 and Cofilin" . SPARSER::COLLECTION)
    ("ERα and protein kinase" . SPARSER::COLLECTION)
    ("new prognostic biomarkers and novel therapeutic avenues"
     . SPARSER::COLLECTION)
    ("ER/ERK5/CFL1" . SPARSER::COLLECTION)
    ("ERα, ERK5 and CFL1" . SPARSER::COLLECTION)
    ("ERK5 and CFL1" . SPARSER::COLLECTION)
    ("ERK5 and MEK5" . SPARSER::COLLECTION) ("/cofilin" . SPARSER::COLLECTION)
    ("/MAPK" . SPARSER::COLLECTION)
    ("serum response factor" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("XMD 8–92" . SPARSER::MOLECULE)
    ("1–C" . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("LRRC54" . SPARSER::PROTEIN) ("XMD8-92" . SPARSER::MOLECULE)
    ("WDR61" . SPARSER::PROTEIN) ("SPT5" . SPARSER::PROTEIN)
    ("nuclear hormone receptor" . SPARSER::PROTEIN) ("PAF1" . SPARSER::PROTEIN)
    ("MEK5" . SPARSER::PROTEIN) ("CFL1" . SPARSER::PROTEIN)
    ("ERK5" . SPARSER::PROTEIN) ("prometastatic genes" . SPARSER::GENE)
    ("some methodological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T4a and T4b" . SPARSER::COLLECTION) ("N2 and N3" . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN) ("T4a/b" . SPARSER::COLLECTION)
    ("TH2" . SPARSER::PROTEIN) ("T4b" . SPARSER::PROTEIN)
    ("T4a" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("GATA binding protein 3" . SPARSER::PROTEIN)
    ("p53 and c-Myc" . SPARSER::COLLECTION)
    ("CLIC5, and parchorin" . SPARSER::COLLECTION)
    ("Mucinous ADC" . SPARSER::PROTEIN)
    ("tropomyosins (TPM)" . SPARSER::PROTEIN)
    ("proteins (CLIC)" . SPARSER::PROTEIN) ("cathepsins" . SPARSER::PROTEIN)
    ("TPM" . SPARSER::PROTEIN) ("tropomyosins" . SPARSER::PROTEIN)
    ("PPM1a" . SPARSER::PROTEIN) ("ADCs" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("VIM, CTSL1, and CLIC4" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("mucinous ADC" . SPARSER::PROTEIN) ("ADC" . SPARSER::PROTEIN)
    ("S100A2 and S100A11" . SPARSER::COLLECTION)
    ("tropomyosin" . SPARSER::PROTEIN) ("CLIC5" . SPARSER::PROTEIN)
    ("CLIC1" . SPARSER::PROTEIN) ("p64" . SPARSER::PROTEIN)
    ("PPM1" . SPARSER::PROTEIN) ("CTSL1" . SPARSER::PROTEIN)
    ("pCL10" . SPARSER::PROTEIN) ("chloride channel" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("cathepsin L1" . SPARSER::PROTEIN) ("S100A11" . SPARSER::PROTEIN)
    ("S100A2" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("CLIC4" . SPARSER::PROTEIN)
    ("Chloride intracellular channel protein 4" . SPARSER::PROTEIN)
    ("CADM1-MPP3-Dlg" . SPARSER::COLLECTION)
    ("MAGuK-PI3K" . SPARSER::COLLECTION)
    ("CADM1 and its cytoplasmic binding proteins" . SPARSER::COLLECTION)
    ("PI3K-Rac1" . SPARSER::COLLECTION) ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("ATL" . SPARSER::PROTEIN) ("Akt and Rac-1" . SPARSER::COLLECTION)
    ("Akt- or Rac1-" . SPARSER::COLLECTION)
    ("MPP3, Dlg, and p85–appear" . SPARSER::COLLECTION)
    ("proteins–CADM1" . SPARSER::COLLECTION)
    ("MPP3 and p85" . SPARSER::COLLECTION)
    ("-3, CASK, and Pals-2" . SPARSER::COLLECTION)
    ("MPP2, MPP3, CASK, and Dlg" . SPARSER::COLLECTION)
    ("Nectin-3, and CRTAM" . SPARSER::COLLECTION)
    ("CADM3/Necl-1" . SPARSER::COLLECTION)
    ("CADM2/Necl-3" . SPARSER::COLLECTION) ("CRTAM" . SPARSER::PROTEIN)
    ("CADM1 or Dlg" . SPARSER::COLLECTION)
    ("AKT or Rac1" . SPARSER::COLLECTION) ("HA and Dlg" . SPARSER::COLLECTION)
    ("MPP3-HA" . SPARSER::COLLECTION)
    ("CADM1, MPP3, Dlg, and p85" . SPARSER::COLLECTION)
    ("MPP3, Dlg, and p85" . SPARSER::COLLECTION)
    ("GST or GST-CADM1-CΔ4" . SPARSER::COLLECTION)
    ("possible molecules" . SPARSER::MOLECULE)
    ("MPP3, Dlg, and PI3K" . SPARSER::COLLECTION)
    ("Multi-protein" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("Forms" . SPARSER::FORM) ("Akt- and Rac1-" . SPARSER::COLLECTION)
    ("Rac1-" . SPARSER::PROTEIN) ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a possible downstream effector" . SPARSER::EFFECTOR)
    ("GFP-Akt-PH" . SPARSER::COLLECTION)
    ("the exogenously expressed fluorescent Akt-PH" . SPARSER::COLLECTION)
    ("Akt-PH" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("PI3K, Akt, and Rac1" . SPARSER::COLLECTION)
    ("MAPK, JAK, and NF-KB" . SPARSER::COLLECTION)
    ("LY294002 and Wortmannin" . SPARSER::COLLECTION)
    ("PI3K, LY294002 and Wortmannin" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("ΔCT-YFP" . SPARSER::PROTEIN)
    ("CADM1-ΔCT-YFP" . SPARSER::COLLECTION) ("YFP" . SPARSER::PROTEIN)
    ("IgG- or CADM1-EC-Fc-coated" . SPARSER::COLLECTION)
    ("IgG-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CADM1-GFP" . SPARSER::COLLECTION) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("Bcl10" . SPARSER::PROTEIN)
    ("pre- and post-synaptic" . SPARSER::COLLECTION)
    ("SAP97/hDlg" . SPARSER::COLLECTION) ("hDlg" . SPARSER::PROTEIN)
    ("proteins and MAGuKs" . SPARSER::COLLECTION)
    ("CASK, and Pals-2" . SPARSER::COLLECTION) ("MPP1-3" . SPARSER::COLLECTION)
    ("CASK" . SPARSER::PROTEIN) ("MAGuKs" . SPARSER::PROTEIN-FAMILY)
    ("PSD95/Dlg/ZO-1 (PDZ)" . SPARSER::COLLECTION)
    ("PSD95/Dlg/ZO-1" . SPARSER::COLLECTION)
    ("TSLC1, Necl-2, IgSF4A, and SynCAM1" . SPARSER::COLLECTION)
    ("IgSF4A" . SPARSER::PROTEIN)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("N-cadherin and NCAM" . SPARSER::COLLECTION) ("NCAM" . SPARSER::PROTEIN)
    ("membrane-associated guanylate kinase homologs (MAGuK) proteins"
     . SPARSER::PROTEIN)
    ("MPP3 and Dlg" . SPARSER::COLLECTION) ("MAGuK" . SPARSER::PROTEIN-FAMILY)
    ("Dlg" . SPARSER::PROTEIN) ("Akt and Rac1" . SPARSER::COLLECTION)
    ("exogenous CADM1" . SPARSER::PROTEIN)
    ("suppressor of cancer cell invasion" . SPARSER::PROTEIN)
    ("L27" . SPARSER::PROTEIN) ("MPP2" . SPARSER::PROTEIN)
    ("Nectin-3" . SPARSER::PROTEIN) ("Necl-1" . SPARSER::PROTEIN)
    ("CADM3" . SPARSER::PROTEIN) ("Necl-3" . SPARSER::PROTEIN)
    ("CADM2" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("NF-KB" . SPARSER::PROTEIN) ("Cytochalasin D" . SPARSER::DRUG)
    ("N protein" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN) ("NFκ" . SPARSER::PROTEIN)
    ("CARMA1" . SPARSER::PROTEIN) ("SAP97" . SPARSER::PROTEIN)
    ("SAP102" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("MPP1" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("protein 4.1" . SPARSER::PROTEIN) ("SynCAM1" . SPARSER::PROTEIN)
    ("Necl-2" . SPARSER::PROTEIN) ("TSLC1" . SPARSER::PROTEIN)
    ("guanylate kinase" . SPARSER::PROTEIN) ("MPP3" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("Cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("CADM1" . SPARSER::PROTEIN) ("MMRd/BRAFV66E" . SPARSER::COLLECTION)
    ("MMR proficient CRCs" . SPARSER::PROTEIN)
    ("MMR and BRAF" . SPARSER::COLLECTION)
    ("a powerful prognostic biomarker" . SPARSER::MOLECULE)
    ("a very large and unselected cohort" . SPARSER::MOLECULE)
    ("CI " . SPARSER::PROTEIN) ("Rank" . SPARSER::PROTEIN)
    ("Log" . SPARSER::PROTEIN) ("MMRd/BRAFV600E" . SPARSER::COLLECTION)
    ("BRAFV" . SPARSER::PROTEIN) ("MMR/BRAF" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN)
    ("myc IHC positive (MYC over-expressed, n = 980, 69.0%) CRCs"
     . SPARSER::PROTEIN)
    ("this widely available rabbit monoclonal antibody" . SPARSER::DRUG)
    ("MYC and BCL2" . SPARSER::COLLECTION)
    ("MYC and CYCLIN D1" . SPARSER::COLLECTION)
    ("kappa " . SPARSER::PROTEIN-FAMILY)
    ("a retrospective cohort" . SPARSER::MOLECULE)
    ("a novel commercially available rabbit monoclonal antibody"
     . SPARSER::DRUG)
    ("a favorable prognostic biomarker" . SPARSER::MOLECULE)
    ("bcl2" . SPARSER::PROTEIN) ("CYCLIN D1" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("myc protein" . SPARSER::PROTEIN)
    ("Akt, integrins, and MMPs" . SPARSER::COLLECTION)
    ("FN and LM" . SPARSER::COLLECTION)
    ("COL-3 and COL-5 expression" . SPARSER::COLLECTION)
    ("Gal-1 and smad2/3" . SPARSER::COLLECTION)
    ("Cav-1 and PKC" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and src-dependent fibroblast growth factor receptor-1 (FGFR-1)"
     . SPARSER::COLLECTION)
    ("FN/LM" . SPARSER::COLLECTION) ("collagenase" . SPARSER::PROTEIN)
    ("COL, FN, and LM" . SPARSER::COLLECTION)
    ("mRNA and FN/LM-5" . SPARSER::COLLECTION)
    ("c-Src, Cav, and PKC" . SPARSER::COLLECTION)
    ("laminin and fibronectin" . SPARSER::COLLECTION)
    ("Gal and glycans" . SPARSER::COLLECTION)
    ("c-Src/Cav-1" . SPARSER::COLLECTION)
    ("FAK, Akt, and Erk" . SPARSER::COLLECTION)
    ("MMP2, and integrin" . SPARSER::COLLECTION) ("COL-3-" . SPARSER::DRUG)
    ("siRNA, and Gal-1" . SPARSER::COLLECTION)
    ("UCM-MSC" . SPARSER::COLLECTION)
    ("COL-3 or COL-5 expression ( xref )" . SPARSER::COLLECTION)
    ("COL-3 and COL-5 ( xref )" . SPARSER::COLLECTION)
    ("only Smad2/3 siRNA" . SPARSER::PROTEIN)
    ("smad2/3 siRNA or nontargeting siRNA" . SPARSER::COLLECTION)
    ("bisindolylmaleimide and staurosporine" . SPARSER::COLLECTION)
    ("bisindolylmaleimide" . SPARSER::DRUG) ("Cav" . SPARSER::PROTEIN)
    ("c-Src and Cav-1" . SPARSER::COLLECTION)
    ("essential factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bisindolylmaleimide I and staurosporine" . SPARSER::COLLECTION)
    ("PKC α , PKC δ , and PKC ζ" . SPARSER::COLLECTION)
    ("COL-3 and COL-5" . SPARSER::COLLECTION) ("FN1 ( FN )" . SPARSER::PROTEIN)
    ("COL , FN , and LM" . SPARSER::COLLECTION)
    ("intrinsic Gal-1" . SPARSER::PROTEIN) ("AD-MSC" . SPARSER::COLLECTION)
    ("AD-MSCs" . SPARSER::COLLECTION) ("exogenous Gal-1" . SPARSER::PROTEIN)
    ("Gal-1 and ECM" . SPARSER::COLLECTION)
    ("galactosidase" . SPARSER::PROTEIN)
    ("smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LM" . SPARSER::PROTEIN)
    ("Gal-1 and extracellular matrix (ECM) proteins" . SPARSER::COLLECTION)
    ("galactoside" . SPARSER::MOLECULE) ("galectin" . SPARSER::PROTEIN)
    ("FAK, Akt, Erk, integrins, and MMP2" . SPARSER::COLLECTION)
    ("siRNA or FN/LM-5" . SPARSER::COLLECTION)
    ("FN and LM-5 proteins" . SPARSER::COLLECTION)
    ("kinase, Akt, Erk, integrins, and matrix metalloproteinase-2"
     . SPARSER::COLLECTION)
    ("UCB-MSC" . SPARSER::PROTEIN-PAIR)
    ("c-Src, and caveolin-1" . SPARSER::COLLECTION)
    ("collagen genes COL3A1 ( COL-3 ) and COL5A1 ( COL-5 )"
     . SPARSER::COLLECTION)
    ("fibronectin (FN) and laminin 5 (LM-5)" . SPARSER::COLLECTION)
    ("COL" . SPARSER::PROTEIN) ("UCB-MSCs" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN) ("sugars" . SPARSER::MOLECULE)
    ("and 1 " . SPARSER::PROTEIN) ("gal-1" . SPARSER::PROTEIN)
    ("PKC γ" . SPARSER::PROTEIN) ("PKC β" . SPARSER::PROTEIN)
    ("flotillin-2" . SPARSER::PROTEIN) ("β -Actin" . SPARSER::PROTEIN)
    ("PDGFR- β" . SPARSER::PROTEIN) ("FGFR-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("bay 11-7082" . SPARSER::DRUG)
    ("β -cyclodextrin" . SPARSER::MOLECULE)
    ("bisindolylmaleimide I" . SPARSER::DRUG) ("PKC ζ" . SPARSER::PROTEIN)
    ("PKC δ" . SPARSER::PROTEIN) ("PKC α" . SPARSER::PROTEIN)
    ("LAMC2" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("Gal-3" . SPARSER::PROTEIN)
    ("collagen-1" . SPARSER::PROTEIN) ("smad2" . SPARSER::PROTEIN)
    ("β -CD" . SPARSER::MOLECULE) ("laminin 5" . SPARSER::PROTEIN)
    ("COL5A1" . SPARSER::PROTEIN) ("COL-3" . SPARSER::DRUG)
    ("COL3A1" . SPARSER::PROTEIN) ("cis-trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION) ("prolyl" . SPARSER::PROTEIN)
    ("phytoalexin" . SPARSER::MOLECULE) ("Resveratrol" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("Bad/Bcl-X" . SPARSER::COLLECTION) ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("AIF" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("Akt and JNK" . SPARSER::COLLECTION) ("-acetyl" . SPARSER::MOLECULE)
    ("antioxidant and pro-oxidant" . SPARSER::COLLECTION)
    ("Bax and SIRT3" . SPARSER::COLLECTION) ("flavonoid" . SPARSER::MOLECULE)
    ("Kaempferol" . SPARSER::DRUG) ("SIRT3 and NMNAT2" . SPARSER::COLLECTION)
    ("Fas/RIP/FAK" . SPARSER::COLLECTION) ("protein (RIP)" . SPARSER::PROTEIN)
    ("Tam" . SPARSER::PROTEIN) ("Ku70-Bax" . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::PROTEIN) ("MnSOD and SOD2" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("PGC-1 α and ERR α" . SPARSER::COLLECTION) ("ERR" . SPARSER::PROTEIN)
    ("Peroxisome" . SPARSER::PROTEIN)
    ("resveratrol and oroxylin A" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::MOLECULE) ("carboxamide" . SPARSER::MOLECULE)
    ("SOD2 and catalase" . SPARSER::COLLECTION)
    ("dehydrogenase (GDH)" . SPARSER::PROTEIN)
    ("GDH and AceCS" . SPARSER::COLLECTION) ("GDH" . SPARSER::PROTEIN)
    ("AceCS" . SPARSER::PROTEIN) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("oncogene or tumor" . SPARSER::COLLECTION)
    ("trans isomerase" . SPARSER::PROTEIN) ("Oroxylin A" . SPARSER::MOLECULE)
    ("voltage-dependent" . SPARSER::PROTEIN) ("HK II" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN) ("NMNAT2" . SPARSER::PROTEIN)
    ("nicotinamide mononucleotide adenylyltransferase 2" . SPARSER::PROTEIN)
    ("AT1" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("Acetyl-CoA" . SPARSER::MOLECULE) ("ERR α" . SPARSER::PROTEIN)
    ("PGC-1 α" . SPARSER::PROTEIN) ("ETC." . SPARSER::PROTEIN)
    ("oroxylin A" . SPARSER::MOLECULE) ("zinc atom" . SPARSER::MOLECULE)
    ("two domains" . SPARSER::PROTEIN) ("FoxO3a" . SPARSER::PROTEIN)
    ("cyclophilin D" . SPARSER::PROTEIN) ("MRPL10" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("FGFR4-" . SPARSER::PROTEIN)
    ("the polymorphic FGFR4 G388R variant" . SPARSER::VARIANT)
    ("FGFR1 and FGFR3" . SPARSER::COLLECTION)
    ("phospholipase C (PLC γ ) and STAT3" . SPARSER::COLLECTION)
    ("ERK or Akt" . SPARSER::COLLECTION)
    ("oxaliplatin- and SN38-resistant cell lines" . SPARSER::COLLECTION)
    ("oxaliplatin and 5-FU" . SPARSER::COLLECTION)
    ("FUR and OXR" . SPARSER::COLLECTION)
    ("oxaliplatin- (HCT116 OXR) and SN38-resistant (HCT116 SNR) cells"
     . SPARSER::COLLECTION)
    ("oxaliplatin-" . SPARSER::DRUG)
    ("5-FU, oxaliplatin or SN38" . SPARSER::COLLECTION)
    ("FLIP" . SPARSER::PROTEIN)
    ("A STAT3-driven luciferase reporter gene" . SPARSER::PROTEIN)
    ("using other FGFR-targeting siRNAs ( xref ) and BGJ398 ( xref )"
     . SPARSER::COLLECTION)
    ("c-FLIP and Bcl-2" . SPARSER::COLLECTION)
    ("caspase 8 (extrinsic pathway) or caspase 9 (intrinsic pathway)"
     . SPARSER::COLLECTION)
    ("pan-caspase" . SPARSER::COLLECTION)
    ("two further FGFR4 siRNA" . SPARSER::PROTEIN)
    ("5-FU and siFGFR4" . SPARSER::COLLECTION) ("poly-ADP" . SPARSER::PROTEIN)
    ("using two further FGFR4 siRNA" . SPARSER::PROTEIN)
    ("BRAF (RKO) and PIK3CA (HCT116, HKH2, LS174T, RKO)" . SPARSER::COLLECTION)
    ("KRAS (HCT116, LS174T), BRAF (RKO) and PIK3CA (HCT116, HKH2, LS174T, RKO)"
     . SPARSER::COLLECTION)
    ("significantly higher nuclear" . SPARSER::PROTEIN)
    ("FGFR1 or FGFR3" . SPARSER::COLLECTION)
    ("FGF19 and BGJ398" . SPARSER::COLLECTION)
    ("FGFR1, FGFR2 or FGFR3" . SPARSER::COLLECTION)
    ("5-FU or oxaliplatin" . SPARSER::COLLECTION) ("5-FU-" . SPARSER::PROTEIN)
    ("parental and drug-resistant CRC" . SPARSER::PROTEIN)
    ("the anti-apoptotic proteins cellular FLICE-inhibitory protein (c-FLIP) and B-cell lymphoma-2 (Bcl-2)"
     . SPARSER::COLLECTION)
    ("FLICE" . SPARSER::PROTEIN) ("FGF19-FGFR4" . SPARSER::COLLECTION)
    ("a targetable regulator" . SPARSER::PROTEIN)
    ("5-FU and oxaliplatin" . SPARSER::COLLECTION)
    ("5-FU, oxaliplatin and SN38" . SPARSER::COLLECTION)
    ("Caspase 9" . SPARSER::PROTEIN) ("Granzyme B" . SPARSER::PROTEIN)
    ("PLC γ" . SPARSER::PROTEIN-FAMILY) ("FRS2 α" . SPARSER::PROTEIN)
    ("FGFR substrate 2" . SPARSER::PROTEIN)
    ("p18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("caspase 9" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("IA6" . SPARSER::PROTEIN) ("FGF19" . SPARSER::PROTEIN)
    ("β -Klotho" . SPARSER::PROTEIN) ("SN38" . SPARSER::DRUG)
    ("c-FLIP" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("TGFβ and extracellular matrix protein" . SPARSER::COLLECTION)
    ("a soluble IL-1R" . SPARSER::PROTEIN) ("anakinra" . SPARSER::PROTEIN)
    ("TIMPs" . SPARSER::PROTEIN)
    ("exogenous recombinant cytokines" . SPARSER::PROTEIN)
    ("a probable target" . SPARSER::TARGET-PROTEIN)
    ("proteins and integrins" . SPARSER::COLLECTION)
    ("proteins and form" . SPARSER::COLLECTION)
    ("the ECM proteins (procollagen, laminin, fibronectin, etc) and ECM"
     . SPARSER::COLLECTION)
    ("cAMP and IL-1" . SPARSER::COLLECTION)
    ("STC1 and FSTL1" . SPARSER::COLLECTION)
    ("glyco-proteins" . SPARSER::PROTEIN-PAIR)
    ("cathepsin B, filamin, STC2 and IGFBP5" . SPARSER::COLLECTION)
    ("filamin" . SPARSER::PROTEIN) ("follistatin" . SPARSER::PROTEIN)
    ("progranulin (PGRN)" . SPARSER::PROTEIN)
    ("Gal-1 and CTGF" . SPARSER::COLLECTION)
    ("IL-8, and IGFBP6" . SPARSER::COLLECTION) ("PGRN" . SPARSER::PROTEIN)
    ("progranulin" . SPARSER::PROTEIN)
    ("the mesenchymal subtype marker chitinase-3-like protein 1"
     . SPARSER::PROTEIN)
    ("IL-1α and IL-1β" . SPARSER::COLLECTION)
    ("STC1 and STC2" . SPARSER::COLLECTION)
    ("a tryptic peptide" . SPARSER::PEPTIDE)
    ("N-terminal tryptic peptides" . SPARSER::PEPTIDE)
    ("detected tryptic peptides" . SPARSER::PEPTIDE)
    ("two different N-terminal tryptic peptides" . SPARSER::PEPTIDE)
    ("a larger protein" . SPARSER::PROTEIN) ("peptidase" . SPARSER::PROTEIN)
    ("a principal inhibitor" . SPARSER::INHIBITOR)
    ("Amino acids (AA)" . SPARSER::AMINO-ACID)
    ("plasminogen activator and urokinase" . SPARSER::COLLECTION)
    ("STY" . SPARSER::PROTEIN) ("IPI" . SPARSER::PROTEIN)
    ("tryptic peptides" . SPARSER::PEPTIDE)
    ("COL4A2 and CTGF" . SPARSER::COLLECTION)
    ("IL-1 and TGFβ" . SPARSER::COLLECTION) ("Clusterin" . SPARSER::PROTEIN)
    ("neuropeptide" . SPARSER::PROTEIN)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("a TGFβ-inducible gene as well as a suppressor" . SPARSER::COLLECTION)
    ("Follistatin" . SPARSER::PROTEIN) ("STC" . SPARSER::PROTEIN)
    ("calcium and phosphate" . SPARSER::COLLECTION) ("fish" . SPARSER::PROTEIN)
    ("STCs" . SPARSER::PROTEIN)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("galectins" . SPARSER::PROTEIN)
    ("yet another novel tumor target" . SPARSER::TARGET-PROTEIN)
    ("antithrombic molecules" . SPARSER::MOLECULE)
    ("TIMP1 and TIMP2" . SPARSER::COLLECTION)
    ("tissue plasminogen activator (tPA) and urokinase (uPA)"
     . SPARSER::COLLECTION)
    ("the principal inhibitor" . SPARSER::INHIBITOR)
    ("nexin" . SPARSER::PROTEIN) ("Plasmin and MMPs" . SPARSER::COLLECTION)
    ("Plasmin" . SPARSER::PROTEIN) ("PLAT" . SPARSER::PROTEIN)
    ("PLAU" . SPARSER::PROTEIN)
    ("ECM- and TGFβ-modulating enzymes" . SPARSER::COLLECTION)
    ("ECM-" . SPARSER::PROTEIN)
    ("a neurosecretory molecule" . SPARSER::MOLECULE) ("type (MT)" . TYPE)
    ("-MMPs" . SPARSER::COLLECTION) ("VCAN" . SPARSER::PROTEIN)
    ("versican" . SPARSER::PROTEIN) ("CSPG" . SPARSER::PROTEIN)
    ("chondroitin" . SPARSER::MOLECULE) ("heparan" . SPARSER::MOLECULE)
    ("THBS" . SPARSER::PROTEIN)
    ("collagen and integrins" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("an adhesive glycoprotein" . SPARSER::PROTEIN)
    ("tenascin-C and CTGF" . SPARSER::COLLECTION)
    ("a matricellular protein" . SPARSER::PROTEIN)
    ("Matricellular proteins" . SPARSER::PROTEIN)
    ("osteonectin" . SPARSER::PROTEIN) ("SPARC" . SPARSER::PROTEIN)
    ("tenascin" . SPARSER::PROTEIN)
    ("this migratory inhibitor protein" . SPARSER::PROTEIN)
    ("ECM-TGFβ" . SPARSER::COLLECTION) ("TGFβ-ECM" . SPARSER::COLLECTION)
    ("overactive TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ECM and integrins" . SPARSER::COLLECTION)
    ("fibrillins and other ECM components" . SPARSER::COLLECTION)
    ("latent TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibrillins" . SPARSER::PROTEIN)
    ("latency-associated protein (LAP)" . SPARSER::PROTEIN)
    ("LTBP" . SPARSER::PROTEIN) ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ and related proteins" . SPARSER::COLLECTION)
    ("Regulator" . SPARSER::PROTEIN) ("ECM and integrin" . SPARSER::COLLECTION)
    ("α4, α5 and γ1" . SPARSER::COLLECTION)
    ("COL18A1, COL11A1, COL4A2, and CLO6A1" . SPARSER::COLLECTION)
    ("CLO" . SPARSER::MOLECULE) ("laminin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular matrix proteins (ECMs) and related proteins"
     . SPARSER::COLLECTION)
    ("cytokine/growth factor" . SPARSER::COLLECTION) ("LIF" . SPARSER::PROTEIN)
    ("several growth factors and related proteins" . SPARSER::COLLECTION)
    ("Growth factors and related proteins" . SPARSER::COLLECTION)
    ("PTX3, IL-8 and lysyl oxidase (LOX)" . SPARSER::COLLECTION)
    ("PTX3, IL-8 and lysyl oxidase" . SPARSER::COLLECTION)
    ("LOX" . SPARSER::PROTEIN)
    ("C-reactive protein and serum amyloid P-component (short pentraxins) and pentraxin 3 (PTX3, long pentraxin)"
     . SPARSER::COLLECTION)
    ("amyloid" . SPARSER::PROTEIN) ("aka" . SPARSER::PROTEIN)
    ("inflammation-induced IL-8" . SPARSER::PROTEIN)
    ("neutrophil" . SPARSER::PROTEIN) ("pro-MMP2" . SPARSER::COLLECTION)
    ("two downregulated proteins, stanniocalcin-2 (STC2) and plasminogen activator inhibitor 1 (SERPINE1)"
     . SPARSER::COLLECTION)
    ("IL-8 (52-fold on average) and CCL2 (4.6-fold on average)"
     . SPARSER::COLLECTION)
    ("ig-h3 (TGFBI)" . SPARSER::PROTEIN) ("TGFBI" . SPARSER::PROTEIN)
    ("stanniocalcin" . SPARSER::PROTEIN)
    ("tenascin-C (TNC) and galectin-1 (LGALS1)" . SPARSER::COLLECTION)
    ("IL-8 and CCL2" . SPARSER::COLLECTION)
    ("Extracellular" . SPARSER::PROTEIN) ("DAT" . SPARSER::PROTEIN)
    ("MS/MS" . SPARSER::COLLECTION) ("complete media" . SPARSER::PROTEIN)
    ("ECM and related proteins" . SPARSER::COLLECTION)
    ("cytokines, growth factors, ECM and related proteins"
     . SPARSER::COLLECTION)
    ("tumor-associated microglia" . SPARSER::PROTEIN)
    ("the soluble mediators" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN) ("Microglia" . SPARSER::PROTEIN)
    ("the cell-associated proteins" . SPARSER::PROTEIN)
    ("the ECM and related proteins" . SPARSER::COLLECTION)
    ("IL-8, CCL2, TNC, Gal-1 and PTX3" . SPARSER::COLLECTION)
    ("SERPINE1, STC2, CTGF and COL4A2" . SPARSER::COLLECTION)
    ("CTGF" . SPARSER::PROTEIN) ("TNC" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("IL-1R" . SPARSER::PROTEIN) ("miR-155" . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("fibulin 1" . SPARSER::PROTEIN) ("IGFBP6" . SPARSER::PROTEIN)
    ("chitinase-3-like protein 1" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN)
    ("serpin peptidase inhibitor" . SPARSER::PROTEIN)
    ("apolipoprotein J" . SPARSER::PROTEIN) ("CPA4" . SPARSER::PROTEIN)
    ("Carboxypeptidase A" . SPARSER::PROTEIN)
    ("neuropilin-1" . SPARSER::PROTEIN) ("SEMA3A" . SPARSER::PROTEIN)
    ("Semaphorin 3A" . SPARSER::PROTEIN) ("FSTL1" . SPARSER::PROTEIN)
    ("Stanniocalcin 1" . SPARSER::PROTEIN)
    ("galactoside-binding" . SPARSER::PROTEIN)
    ("Antithrombin-III" . SPARSER::PROTEIN) ("TIMP2" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("SERPINC1" . SPARSER::PROTEIN) ("SERPINA5" . SPARSER::PROTEIN)
    ("plasma serine protease inhibitor" . SPARSER::PROTEIN)
    ("SERPINE2" . SPARSER::PROTEIN) ("glia-derived nexin" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("TGFβ2" . SPARSER::PROTEIN)
    ("SCG2" . SPARSER::PROTEIN) ("secretogranin-2" . SPARSER::PROTEIN)
    ("SPOCK1" . SPARSER::PROTEIN) ("type V" . SPARSER::PROTEIN)
    ("THBS-1" . SPARSER::PROTEIN) ("Thrombospondin 1" . SPARSER::PROTEIN)
    ("Connective tissue growth factor" . SPARSER::PROTEIN)
    ("thrombospondin-1" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("angiogenesis inhibitor" . SPARSER::DRUG) ("RGD motif" . SPARSER::PROTEIN)
    ("fibulin 3" . SPARSER::PROTEIN) ("fibrillin 1" . SPARSER::PROTEIN)
    ("ECM1" . SPARSER::PROTEIN)
    ("extracellular matrix protein 1" . SPARSER::PROTEIN)
    ("NID1" . SPARSER::PROTEIN) ("nidogen-1" . SPARSER::PROTEIN)
    ("COL11A1" . SPARSER::PROTEIN) ("COL18A1" . SPARSER::PROTEIN)
    ("Smad-2" . SPARSER::PROTEIN) ("IGFBP7" . SPARSER::PROTEIN)
    ("PDGF-D" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("lysyl oxidase" . SPARSER::PROTEIN) ("pentraxin 3" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("ig-h3" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("LOXL2" . SPARSER::PROTEIN) ("Lysyl oxidase homolog 2" . SPARSER::PROTEIN)
    ("FBLN1" . SPARSER::PROTEIN) ("fibulin-1" . SPARSER::PROTEIN)
    ("EFEMP1" . SPARSER::PROTEIN)
    ("EGF-containing fibulin-like extracellular matrix protein 1"
     . SPARSER::PROTEIN)
    ("TIMP1" . SPARSER::PROTEIN)
    ("metalloproteinase inhibitor 1" . SPARSER::PROTEIN)
    ("STC1" . SPARSER::PROTEIN) ("FBN1" . SPARSER::PROTEIN)
    ("fibrillin-1" . SPARSER::PROTEIN) ("tenascin-C" . SPARSER::PROTEIN)
    ("pentraxin-related" . SPARSER::PROTEIN) ("log 2" . SPARSER::PROTEIN)
    ("B4GALT1" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("math3" . SPARSER::PROTEIN) ("Pentraxin 3" . SPARSER::PROTEIN)
    ("Tenascin-C" . SPARSER::PROTEIN) ("COL4A2" . SPARSER::PROTEIN)
    ("STC2" . SPARSER::PROTEIN) ("PTX3" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("NRF2-AHR" . SPARSER::COLLECTION)
    ("most classical NRF2 target genes" . SPARSER::GENE)
    ("NQO1 and the novel NRF2" . SPARSER::COLLECTION)
    ("various other classical NRF2 target genes" . SPARSER::GENE)
    ("EPGN , SPRR2D, and SLPI" . SPARSER::COLLECTION)
    ("hyperproliferative keratinocytes" . SPARSER::PROTEIN)
    ("AHR and NRF2" . SPARSER::COLLECTION)
    ("SLPI , SPRR2D, and SLPI" . SPARSER::COLLECTION)
    ("NRF2 and AHR" . SPARSER::COLLECTION)
    ("SLPI and EPGN" . SPARSER::COLLECTION) ("Sprr2a" . SPARSER::PROTEIN)
    ("growth factors or proteins" . SPARSER::COLLECTION)
    ("NQO1, SLPI, SPRR2, and EPGN" . SPARSER::COLLECTION)
    ("allergens" . SPARSER::MOLECULE)
    ("the follicular barrier" . SPARSER::PROTEIN)
    ("a distal ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("AHR-NRF2" . SPARSER::COLLECTION)
    ("NQO1 , SLPI , SPRR2D, and EPGN" . SPARSER::COLLECTION)
    ("NRF2 and NQO1" . SPARSER::COLLECTION)
    ("aryl hydrocarbon receptor (AHR)" . SPARSER::PROTEIN)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION) ("AHR" . SPARSER::PROTEIN)
    ("SLPI , SPRR2D, and EPGN" . SPARSER::COLLECTION)
    ("TCDD" . SPARSER::PROTEIN)
    ("SLPI, SPRR2D, and EPGN" . SPARSER::COLLECTION)
    ("Dioxin" . SPARSER::MOLECULE)
    ("SLPI, SPRR2, and EPGN" . SPARSER::COLLECTION)
    ("the classical NRF2 target NQO1" . SPARSER::PROTEIN)
    ("SPRR2, SLPI, and NQO1" . SPARSER::COLLECTION)
    ("SPRR2 and SLPI" . SPARSER::COLLECTION)
    ("the classical Nrf2 target genes Nqo1 (Fig  xref A) and Srxn1 (Fig  xref B)"
     . SPARSER::COLLECTION)
    ("the classical Nrf2 target genes Nqo1" . SPARSER::PROTEIN)
    ("Cyst" . SPARSER::PROTEIN) ("Sprr2d and Slpi" . SPARSER::COLLECTION)
    ("the IFN and infundibular stratum corneum (Fig  xref D lower panel)"
     . SPARSER::COLLECTION)
    ("a classical antioxidant response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Epigen" . SPARSER::PROTEIN) ("Mc5r, and Scd1" . SPARSER::COLLECTION)
    ("EPGN" . SPARSER::PROTEIN) ("Hbegf" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN) ("betacellulin" . SPARSER::PROTEIN)
    ("Areg" . SPARSER::PROTEIN) ("Epgn" . SPARSER::PROTEIN)
    ("wax" . SPARSER::MOLECULE) ("Scds" . SPARSER::PROTEIN)
    ("the late SG differentiation marker melanocortin-5 receptor"
     . SPARSER::RECEPTOR)
    ("Mc5r" . SPARSER::PROTEIN) ("Pparg" . SPARSER::PROTEIN)
    ("K10 and loricrin" . SPARSER::COLLECTION) ("Lor" . SPARSER::PROTEIN)
    ("loricrin" . SPARSER::PROTEIN)
    ("Nrf2 (endogenous Nrf2 plus transgene-derived caNrf2 ) and its target genes Nqo1 , Gclc, Gclm, and sulfiredoxin1 ( Srxn1 )"
     . SPARSER::COLLECTION)
    ("Nqo1 , Gclc, Gclm, and sulfiredoxin1" . SPARSER::COLLECTION)
    ("malformations" . SPARSER::PROTEIN) ("fur" . SPARSER::PROTEIN)
    ("a mechanical barrier" . SPARSER::PROTEIN)
    ("sulforaphane or tert-butyl" . SPARSER::COLLECTION)
    ("adipophilin" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("responsible target genes" . SPARSER::GENE)
    ("kallikrein" . SPARSER::PROTEIN)
    ("-dinitrofluorobenzene" . SPARSER::MOLECULE)
    ("dinitrofluorobenzene" . SPARSER::MOLECULE) ("Gao" . SPARSER::PROTEIN)
    ("resveratrol" . SPARSER::PROTEIN) ("tBHQ" . SPARSER::DRUG)
    ("hydroquinone" . SPARSER::MOLECULE) ("Gclc" . SPARSER::PROTEIN)
    ("Gclm" . SPARSER::PROTEIN) ("cellular macromolecules" . SPARSER::MOLECULE)
    ("toxic chemicals" . SPARSER::MOLECULE)
    ("SLPI, SPRR2, and epigen" . SPARSER::COLLECTION)
    ("SLPI" . SPARSER::PROTEIN) ("dioxin" . SPARSER::MOLECULE)
    ("cyst" . SPARSER::PROTEIN) ("epigen" . SPARSER::PROTEIN)
    ("P18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K33" . SPARSER::PROTEIN)
    ("S100A7" . SPARSER::PROTEIN) ("Sprr1a" . SPARSER::PROTEIN)
    ("CYP1B1" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("Sprr2" . SPARSER::PROTEIN-FAMILY) ("Scd1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("P32" . SPARSER::PROTEIN) ("K10" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("Srxn1" . SPARSER::PROTEIN)
    ("sulfiredoxin1" . SPARSER::PROTEIN) ("perilipin 2" . SPARSER::PROTEIN)
    ("keratin 5" . SPARSER::PROTEIN) ("tert-butyl" . SPARSER::MOLECULE)
    ("multidrug resistance" . SPARSER::PROTEIN) ("Nqo1" . SPARSER::PROTEIN)
    ("erythroid derived 2, like 2" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("SPRR2" . SPARSER::PROTEIN-FAMILY)
    ("Sprr2d" . SPARSER::PROTEIN) ("proline-rich protein" . SPARSER::PROTEIN)
    ("secretory leukocyte peptidase inhibitor" . SPARSER::PROTEIN)
    ("cAMP and PKC" . SPARSER::COLLECTION)
    ("c-Jun and Cyclin D1" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND) ("Chemical" . SPARSER::MOLECULE)
    ("the major non-histone nucleolar protein" . SPARSER::PROTEIN)
    ("ribosomal genes" . SPARSER::GENE) ("nucleolin" . SPARSER::PROTEIN)
    ("FGFR1 and gene" . SPARSER::COLLECTION)
    ("the predominantly nuclear HMW isoforms" . SPARSER::ISOFORM)
    ("generally extracellular" . SPARSER::PROTEIN)
    ("matrix and FGF2" . SPARSER::COLLECTION)
    ("pan-FGFR" . SPARSER::COLLECTION)
    ("significantly more nuclear FGFR1" . SPARSER::PROTEIN)
    ("PD173074 or DMSO" . SPARSER::COLLECTION)
    ("FGF2 (HMW)" . SPARSER::PROTEIN) ("FGF2 or FGFR1" . SPARSER::COLLECTION)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("receptor and ligand" . SPARSER::COLLECTION)
    ("-extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("nuclear FGF2 (both LMW and HMW) and FGFR1" . SPARSER::COLLECTION)
    ("FGF2 (HMW and LMW) and FGFR1" . SPARSER::COLLECTION)
    ("DEC-hTERT" . SPARSER::COLLECTION) ("DEC" . SPARSER::PROTEIN)
    ("FGFR1/αSMA" . SPARSER::COLLECTION)
    ("FGFR1/vimentin" . SPARSER::COLLECTION)
    ("FGF2/cytokeratin" . SPARSER::COLLECTION)
    ("intranuclear FGF2" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("FGFs and FGFRs" . SPARSER::COLLECTION)
    ("FGFR1 and HMW" . SPARSER::COLLECTION)
    ("HMW and LMW" . SPARSER::COLLECTION)
    ("MAPK/MEK/ERK" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("α-smooth muscle actin (αSMA) and vimentin (Apte et al , xref )"
     . SPARSER::COLLECTION)
    ("myo" . SPARSER::PROTEIN)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("FGF/FGFR" . SPARSER::COLLECTION) ("PSC" . SPARSER::PROTEIN)
    ("FGFR1 and FGF2" . SPARSER::COLLECTION)
    ("FGF2 and FGFR1" . SPARSER::COLLECTION)
    ("FGFs and their receptors" . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("SC-35" . SPARSER::PROTEIN)
    ("FRS2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor substrate 2" . SPARSER::PROTEIN)
    ("PD173074" . SPARSER::DRUG) ("G–I" . SPARSER::PROTEIN)
    ("2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PS1" . SPARSER::PROTEIN)
    ("Fig 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("αSMA" . SPARSER::PROTEIN) ("BL" . SPARSER::PROTEIN)
    ("CHIP" . SPARSER::PROTEIN) ("DNMT1 and BRCA1" . SPARSER::COLLECTION)
    ("abnormal E2F1 and H3K9ac" . SPARSER::COLLECTION)
    ("E2F1 and H3K9ac" . SPARSER::COLLECTION) ("CGC-3" . SPARSER::COLLECTION)
    ("the significant prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GCN5, PCAF and E2F1" . SPARSER::COLLECTION)
    ("GCN5 and PCAF" . SPARSER::COLLECTION) ("PCAF" . SPARSER::PROTEIN)
    ("the repressive histone markers H3K9" . SPARSER::PROTEIN)
    ("con" . SPARSER::PROTEIN) ("thymine" . SPARSER::NUCLEOBASE)
    ("Aii" . SPARSER::PROTEIN)
    ("an independent and reliable prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CH 3" . SPARSER::MOLECULE) ("Na +" . SPARSER::MOLECULE)
    ("GCN5" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("CB, JT and PRH" . SPARSER::COLLECTION) ("PRH" . SPARSER::PROTEIN)
    ("VS" . SPARSER::PROTEIN)
    ("non-productive proviral states" . SPARSER::BIO-STATE)
    ("protein kinase (JNK)" . SPARSER::PROTEIN)
    ("p65 and IκBα" . SPARSER::COLLECTION)
    ("NFκB and SP1" . SPARSER::COLLECTION)
    ("highly variable T-cell signaling states" . SPARSER::BIO-STATE)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("viral state" . SPARSER::BIO-STATE)
    ("DMSO and TNFα" . SPARSER::COLLECTION)
    ("DMSO or TNFα" . SPARSER::COLLECTION)
    ("IκBα and p65" . SPARSER::COLLECTION)
    ("fresh complete media" . SPARSER::PROTEIN)
    ("JNK-MAPK" . SPARSER::COLLECTION)
    ("SAHA (HDAC inhibitor) or DMSO (control)" . SPARSER::COLLECTION)
    ("TNFα and PMA/Iono" . SPARSER::COLLECTION)
    ("NFκB-eGFP" . SPARSER::COLLECTION)
    ("p50 and p65-S529-phospho" . SPARSER::COLLECTION)
    ("p50-p50" . SPARSER::COLLECTION) ("p65-p50" . SPARSER::COLLECTION)
    ("NFκB and the activated form" . SPARSER::COLLECTION)
    ("approximately 2.3 and 4.5 fold more CD69" . SPARSER::PROTEIN)
    ("transcriptional regulation-associated histone" . SPARSER::PROTEIN)
    ("nucleosomes and histone" . SPARSER::COLLECTION)
    ("slightly less gene" . SPARSER::PROTEIN)
    ("nucleosome-associated DNA" . SPARSER::DNA)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY) ("mCherry-" . SPARSER::PROTEIN)
    ("eGFP-" . SPARSER::PROTEIN) ("gag-eGFP" . SPARSER::COLLECTION)
    ("gag" . SPARSER::PROTEIN) ("Red-Green-HIV-1 (RGH)" . SPARSER::PROTEIN)
    ("CDK9/Cyclin T1" . SPARSER::COLLECTION) ("pTEF-b" . SPARSER::COLLECTION)
    ("per 1 " . SPARSER::PROTEIN) ("pLP2" . SPARSER::PROTEIN)
    ("α-2" . SPARSER::PROTEIN) ("BMS-345541" . SPARSER::DRUG)
    ("S3B" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("Cyclin T1" . SPARSER::PROTEIN) ("CDK9" . SPARSER::PROTEIN)
    ("APC and other β-catenin interactors" . SPARSER::COLLECTION)
    ("γ-tubulin and microtubules" . SPARSER::COLLECTION)
    ("C-Nap1 and rootletin" . SPARSER::COLLECTION)
    ("Nek2 or Plk1" . SPARSER::COLLECTION)
    ("Aurora A, γ-tubulin, or β-catenin" . SPARSER::COLLECTION)
    ("β-catenin or centrosomes" . SPARSER::COLLECTION)
    ("α-tubulin and the centrosome marker γ-tubulin" . SPARSER::COLLECTION)
    ("antibody and antibodies" . SPARSER::COLLECTION)
    ("β-catenin or phospho-S33/S37/T41" . SPARSER::COLLECTION)
    ("pericentrin" . SPARSER::PROTEIN) ("PCM" . SPARSER::PROTEIN)
    ("Plk1 inhibitor or Eg5 inhibitor ( xref )" . SPARSER::COLLECTION)
    ("DMSO or GSK3β" . SPARSER::COLLECTION)
    ("the microtubule marker α-tubulin and centrosomal marker γ-tubulin"
     . SPARSER::COLLECTION)
    ("centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("double-thymidine" . SPARSER::PROTEIN) ("monastrol" . SPARSER::DRUG)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KD-Nek2" . SPARSER::COLLECTION)
    ("β-catenin and the centrosomal marker γ-tubulin" . SPARSER::COLLECTION)
    ("the centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("Nek2 or HA-WT-Nek2" . SPARSER::COLLECTION)
    ("HA-KD" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("dimethyl sulfoxide (DMSO)" . SPARSER::MOLECULE)
    ("oxime" . SPARSER::MOLECULE) ("SDS" . SPARSER::PROTEIN)
    ("a wild-type β-catenin allele and a β-catenin mutant allele"
     . SPARSER::COLLECTION)
    ("Par" . SPARSER::PROTEIN) ("only ΔS45 β-catenin" . SPARSER::PROTEIN)
    ("mitotic centrosome-enriched fractions" . SPARSER::COMPONENT)
    ("β-catenin and phospho-S33/S37/T41" . SPARSER::COLLECTION)
    ("centrosome-enriched peak fractions (*13/14; defined by the peak of γ-tubulin in the gradient) and fractions"
     . SPARSER::COLLECTION)
    ("mitotic centrosome fractions" . SPARSER::COMPONENT)
    ("neither phospho-S33/S37/T41 β-catenin nor Aurora A ( xref , B and D)"
     . SPARSER::COLLECTION)
    ("β-catenin and γ-tubulin" . SPARSER::COLLECTION)
    ("phospho-S33/S37/T41 β-catenin or the centrosome marker proteins (*13/14 in xref and xref )"
     . SPARSER::COLLECTION)
    ("HMW" . SPARSER::PROTEIN) ("β-catenin and Aurora A" . SPARSER::COLLECTION)
    ("γ-tubulin and the mitotic centrosome marker Aurora A ( xref , A and C)"
     . SPARSER::COLLECTION)
    ("the mitotic centrosome marker Aurora A" . SPARSER::PROTEIN)
    ("centrosomal phospho-S33/S37/T41 β-catenin" . SPARSER::PROTEIN)
    ("Myc or β-catenin" . SPARSER::COLLECTION)
    ("Myc–β-TrCP" . SPARSER::COLLECTION)
    ("Nek2 and β-catenin" . SPARSER::COLLECTION)
    ("Nek2 and KD" . SPARSER::COLLECTION) ("Usp2" . SPARSER::PROTEIN)
    ("Usp" . SPARSER::PROTEIN)
    ("HA-ubiquitin–bound β-catenin" . SPARSER::PROTEIN)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("HA- and GFP-specific antibodies ( xref )" . SPARSER::COLLECTION)
    ("HA-" . SPARSER::PROTEIN) ("-ubiquitin" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK3β/CK1α" . SPARSER::COLLECTION)
    ("GFP-β-catenin" . SPARSER::COLLECTION)
    ("neither Nek2 nor KD Nek2" . SPARSER::COLLECTION)
    ("exogenous Nek2" . SPARSER::PROTEIN)
    ("GSK3β and CK1α" . SPARSER::COLLECTION)
    ("GFP–β-catenin" . SPARSER::COLLECTION)
    ("the GSK3β inhibitor SB216763 and the CK1α inhibitor D4476 ( xref )"
     . SPARSER::COLLECTION)
    ("Nek2 or KD" . SPARSER::COLLECTION)
    ("either Nek2 ( xref , lane 4, asterisk) or GSK3β/CK1 ( xref , lane 2, asterisk)"
     . SPARSER::COLLECTION)
    ("GSK3β and CK1" . SPARSER::COLLECTION)
    ("rootletin and C-Nap1" . SPARSER::COLLECTION)
    ("rootletin" . SPARSER::PROTEIN)
    ("γ-tubulin and other centrosome components" . SPARSER::COLLECTION)
    ("an important mitotic kinase" . SPARSER::KINASE)
    ("regulating centrosomal β-catenin" . SPARSER::PROTEIN)
    ("GSK3β/CK1" . SPARSER::COLLECTION)
    ("GSK3β and its priming kinase" . SPARSER::COLLECTION)
    ("β-catenin and glycogen synthase" . SPARSER::COLLECTION)
    ("axin" . SPARSER::PROTEIN)
    ("β-catenin ( xref ) and E-cadherin ( xref )" . SPARSER::COLLECTION)
    ("cadherin–catenin" . SPARSER::COLLECTION)
    ("catenin–cadherin" . SPARSER::COLLECTION)
    ("Plk1, Nek2, and β-catenin" . SPARSER::COLLECTION)
    ("NIMA" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("mitotic centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("YL1" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("Cdk1" . SPARSER::PROTEIN)
    ("BI 2536" . SPARSER::DRUG) ("GSK-3" . SPARSER::PROTEIN)
    ("Plk-1" . SPARSER::PROTEIN) ("Eg5" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("CK1α" . SPARSER::PROTEIN)
    ("SB216763" . SPARSER::DRUG)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("S29" . SPARSER::PROTEIN) ("S23" . SPARSER::PROTEIN)
    ("C-Nap1" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("casein kinase 1" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("protein kinase 2" . SPARSER::PROTEIN) ("S33" . SPARSER::PROTEIN)
    ("Nek2" . SPARSER::PROTEIN) ("pmiR-cezanne" . SPARSER::PROTEIN-PAIR)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("FAK and TGFβ-induced α-SMA" . SPARSER::COLLECTION)
    ("Cezanne" . SPARSER::PROTEIN) ("SB431542 and PP2" . SPARSER::COLLECTION)
    ("endothelin" . SPARSER::PROTEIN) ("profibrotic mRNAs" . SPARSER::PROTEIN)
    ("α-SMA and CCN2" . SPARSER::COLLECTION)
    ("ET-1 and FAK" . SPARSER::COLLECTION)
    ("FAK and ET-1" . SPARSER::COLLECTION) ("FAK/src" . SPARSER::COLLECTION)
    ("an ancient component" . SPARSER::COMPONENT)
    ("posttranscriptional and transcriptional gene" . SPARSER::GENE)
    ("cezanne/FAK" . SPARSER::COLLECTION) ("cezanne" . SPARSER::PROTEIN)
    ("p -value" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pre-miRNA" . SPARSER::RNA) ("pGL4" . SPARSER::PROTEIN)
    ("A20" . SPARSER::PROTEIN) ("PD145065" . SPARSER::DRUG)
    ("SB431542" . SPARSER::DRUG) ("ALK5" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("CCN2" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ET-1" . SPARSER::PROTEIN) ("α-SMA" . SPARSER::PROTEIN)
    ("IL-1β and IL-10" . SPARSER::COLLECTION)
    ("bacterial endotoxin" . SPARSER::MOLECULE)
    ("endotoxin" . SPARSER::MOLECULE) ("autoantibody" . SPARSER::PROTEIN)
    ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("IL-8, RANTES, and MCP-1" . SPARSER::COLLECTION)
    ("pain and infertiltiy" . SPARSER::COLLECTION)
    ("a proximal co-expression network around macrophage" . SPARSER::PROTEIN)
    ("recurrent somatic variants" . SPARSER::VARIANT)
    ("Src, PCK, and PI3K" . SPARSER::COLLECTION) ("PCK" . SPARSER::PROTEIN)
    ("Jak1 and p38" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("JNK and MEK1" . SPARSER::COLLECTION) ("par" . SPARSER::PROTEIN)
    ("whose downstream transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("p38 and Jak" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun and its AP-1 binding partner c-Fos" . SPARSER::COLLECTION)
    ("JNK, MEK1, and IKK" . SPARSER::COLLECTION)
    ("RelA and NFκB" . SPARSER::COLLECTION)
    ("AP-1 and ATF-2" . SPARSER::COLLECTION)
    ("AP-1, and STAT1" . SPARSER::COLLECTION) ("c-Ets-1" . SPARSER::COLLECTION)
    ("NFκB:RelA" . SPARSER::BIO-COMPLEX)
    ("cytokine/receptor" . SPARSER::COLLECTION) ("iron" . SPARSER::MOLECULE)
    ("nod" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRIS and HICT" . SPARSER::COLLECTION)
    ("MIP-3β/CCL19" . SPARSER::COLLECTION) ("Macrophage" . SPARSER::PROTEIN)
    ("cytokine-receptor" . SPARSER::COLLECTION)
    ("cytokines, and growth factors" . SPARSER::COLLECTION)
    ("stimulants" . SPARSER::DRUG)
    ("consensus cytokines or their cognate receptors" . SPARSER::COLLECTION)
    ("IRIS" . SPARSER::PROTEIN) ("severe pain" . SPARSER::PROTEIN)
    ("protein and leukocytes" . SPARSER::COLLECTION)
    ("IL-4, IL-9, IFNγ, and TNFα" . SPARSER::COLLECTION)
    ("IL-8, RANTES, MIF, IL-6, MCP-1, G-CSF, MIG, HGF, IL-10, IL-16, IL-1ra, GROα, and IL-1β"
     . SPARSER::COLLECTION)
    ("MIG" . SPARSER::PROTEIN) ("NMF" . SPARSER::DRUG)
    ("G-CSF, IL-9, IL-1β, and IL-4" . SPARSER::COLLECTION)
    ("MIF, RANTES, IL-16, IFNγ, and TNFα" . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN) ("MIF" . SPARSER::PROTEIN)
    ("mL" . SPARSER::PROTEIN) ("non-cyclic pelvic pain" . SPARSER::PROTEIN)
    ("c-Jun and NFκB" . SPARSER::COLLECTION)
    ("fifty inflammatory cytokines, chemokines, and growth factors"
     . SPARSER::COLLECTION)
    ("cytokines, chemokines, and growth factors" . SPARSER::COLLECTION)
    ("TNF-α, COX-2, and PPAR-γ" . SPARSER::COLLECTION)
    ("protein, and metabolite" . SPARSER::COLLECTION)
    ("symptomatic pain" . SPARSER::PROTEIN)
    ("endometriotic foci" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("reproductive age" . SPARSER::PROTEIN)
    ("chronic pelvic pain" . SPARSER::PROTEIN)
    ("c-Jun, c-Fos, and AP-1" . SPARSER::COLLECTION)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VCAM-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("ATF-2" . SPARSER::PROTEIN)
    ("Transcriptional Regulators" . SPARSER::PROTEIN-FAMILY)
    ("CCR1" . SPARSER::PROTEIN) ("CXCL5" . SPARSER::PROTEIN)
    ("ENA-78" . SPARSER::DRUG) ("CCL19" . SPARSER::PROTEIN)
    ("MIP-3β" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD68" . SPARSER::PROTEIN) ("GROα" . SPARSER::PROTEIN)
    ("IL-1ra" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("IL-16" . SPARSER::PROTEIN) ("IL-9" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("Interleukin-8" . SPARSER::PROTEIN)
    ("TNFβ" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("MLP" . SPARSER::PROTEIN)
    ("Frizzled/lipoprotein receptor-related protein" . SPARSER::COLLECTION)
    ("FZD/LRP" . SPARSER::COLLECTION) ("Partial" . SPARSER::PROTEIN)
    ("LRP" . SPARSER::PROTEIN) ("Casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carboplatin-" . SPARSER::DRUG) ("CAM-DR" . SPARSER::COLLECTION)
    ("cisplatin, temozolomide and doxorubicin" . SPARSER::COLLECTION)
    ("cisplatin, paclitaxel and vincristine" . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG) ("AKT or SRC" . SPARSER::COLLECTION)
    ("BTAK/Aurora-A" . SPARSER::COLLECTION) ("BTAK" . SPARSER::PROTEIN)
    ("an adverse prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WNT-1 and WNT-2" . SPARSER::COLLECTION)
    ("WNT-5a, WNT-7a and WNT-7b" . SPARSER::COLLECTION)
    ("WNT-3 and WNT-4" . SPARSER::COLLECTION)
    ("WNT-7a and WNT-7b" . SPARSER::COLLECTION)
    ("PI3K-p85" . SPARSER::COLLECTION) ("CR " . SPARSER::PROTEIN)
    ("an unfavourable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an independent adverse prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin or WNT-1" . SPARSER::COLLECTION)
    ("shorter PFS" . SPARSER::PROTEIN)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("only membrane β-catenin" . SPARSER::PROTEIN) ("Serous type" . TYPE)
    ("several prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the serous type" . TYPE)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("factor/lymphoid" . SPARSER::COLLECTION)
    ("FZD/LRP5/6" . SPARSER::COLLECTION) ("FZD" . SPARSER::PROTEIN-FAMILY)
    ("frizzled" . SPARSER::PROTEIN) ("GSK3β and CKI" . SPARSER::COLLECTION)
    ("CKI" . SPARSER::PROTEIN) ("casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Axin" . SPARSER::PROTEIN) ("E-cadherin and forms" . SPARSER::COLLECTION)
    ("The most important prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prognostic and predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("an adverse independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin, β-catenin and WNT-1" . SPARSER::COLLECTION)
    ("β-catenin, E-cadherin and WNT-1" . SPARSER::COLLECTION)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("δ-catenin" . SPARSER::PROTEIN) ("γ-catenin" . SPARSER::PROTEIN)
    ("claudin-7" . SPARSER::PROTEIN)
    ("connexin 43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Aurora-A" . SPARSER::PROTEIN) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("WNT-2" . SPARSER::PROTEIN) ("WNT protein" . SPARSER::PROTEIN)
    ("WNT-7b" . SPARSER::PROTEIN) ("WNT-7a" . SPARSER::PROTEIN)
    ("WNT-4" . SPARSER::PROTEIN) ("WNT-3" . SPARSER::PROTEIN)
    ("WNT-5a" . SPARSER::PROTEIN) ("LRP5/6" . SPARSER::PROTEIN)
    ("lipoprotein receptor-related protein 5" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::DRUG) ("WNT-1" . SPARSER::PROTEIN)
    ("Src and EGFR" . SPARSER::COLLECTION)
    ("monoclonal antibodies and tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies and tyrosine kinase" . SPARSER::COLLECTION)
    ("anti-EGFR or anti-STAT3" . SPARSER::COLLECTION)
    ("gefitinib, and STAT3" . SPARSER::COLLECTION)
    ("S3I-201 or JSI-124" . SPARSER::COLLECTION)
    ("EGFR and siSTAT3" . SPARSER::COLLECTION)
    ("EGFR/STAT3" . SPARSER::COLLECTION) ("EGFR-" . SPARSER::PROTEIN)
    ("pY-STAT3" . SPARSER::COLLECTION) ("EGFR-STAT3" . SPARSER::COLLECTION)
    ("iNOS, B-Myb, Aurora A and COX-2" . SPARSER::COLLECTION)
    ("iNOS and STAT1" . SPARSER::COLLECTION)
    ("STAT3, E2F1, STAT5 and TIF2" . SPARSER::COLLECTION)
    ("LMP1/STAT3" . SPARSER::COLLECTION) ("LMP1/EGFR" . SPARSER::COLLECTION)
    ("STAT3 and STAT" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("STAT3 or both proteins" . SPARSER::COLLECTION)
    ("EGFR, STAT3 or both proteins" . SPARSER::COLLECTION)
    ("nonspecific siRNA" . SPARSER::PROTEIN)
    ("the mutated EGFR or nonspecific nucleotide NF-κB (Figure  xref C lanes 6 and 7)"
     . SPARSER::COLLECTION)
    ("nonspecific nucleotide NF-κB" . SPARSER::PROTEIN)
    ("CNE1-" . SPARSER::PROTEIN)
    ("functional mutated cyclin D1 promoters" . SPARSER::PROMOTER)
    ("EGFR or STAT3" . SPARSER::COLLECTION)
    ("promoter and protein" . SPARSER::COLLECTION)
    ("the ErbB family and other receptor tyrosine kinases (RTKs)"
     . SPARSER::COLLECTION)
    ("a dominant-negative (DN) variant" . SPARSER::VARIANT)
    ("EGFR-DN" . SPARSER::COLLECTION) ("anti" . SPARSER::PROTEIN)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("anti-EGFR (Figure  xref A) or anti-STAT3 (Figure  xref B) specific antibodies"
     . SPARSER::COLLECTION)
    ("CNE1-LMP1" . SPARSER::COLLECTION)
    ("STAT3 and EGFR" . SPARSER::COLLECTION)
    ("c-Jun/Jun" . SPARSER::COLLECTION)
    ("STAT3 and other target genes" . SPARSER::COLLECTION)
    ("/ERK" . SPARSER::COLLECTION)
    ("cytokines or growth factors" . SPARSER::COLLECTION)
    ("cyclin D1, c-fos, c-Myc, Bcl-XL, and VEGF" . SPARSER::COLLECTION)
    ("directly target genes" . SPARSER::GENE)
    ("this viral oncoprotein" . SPARSER::PROTEIN)
    ("an essential factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("The principal Epstein–Barr virus (EBV) oncoprotein" . SPARSER::PROTEIN)
    ("JSI-124" . SPARSER::DRUG) ("S3I-201" . SPARSER::MOLECULE)
    ("B-Myb" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("A 20 " . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("pSG5" . SPARSER::PROTEIN) ("CNE1" . SPARSER::PROTEIN)
    ("TIF2" . SPARSER::PROTEIN)
    ("transcriptional intermediary factor 2" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("Janus kinase 3" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN)
    ("Latent membrane protein 1" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("NADPH hinge-open state" . SPARSER::BIO-STATE) ("PDB" . SPARSER::MOLECULE)
    ("the hinge-open complexes" . SPARSER::BIO-COMPLEX)
    ("the hinge-open state" . SPARSER::BIO-STATE)
    ("rotameric state" . SPARSER::BIO-STATE)
    ("Substrate and Product" . SPARSER::COLLECTION)
    ("NADP" . SPARSER::MOLECULE)
    ("the binary complexes" . SPARSER::BIO-COMPLEX)
    ("a unique χ 1 conformation" . SPARSER::BIO-CONFORMATION)
    ("the hinge-open conformation" . SPARSER::BIO-CONFORMATION)
    ("Conformation" . SPARSER::BIO-CONFORMATION) ("pterin" . SPARSER::MOLECULE)
    ("Leu, Ile,
or Val"
     . SPARSER::COLLECTION)
    ("DHFR" . SPARSER::PROTEIN) ("solution" . SPARSER::MOLECULE)
    ("hinge-open
states"
     . SPARSER::BIO-STATE)
    ("calc" . SPARSER::PROTEIN) ("meas" . SPARSER::PROTEIN)
    ("Side" . SPARSER::PROTEIN)
    ("the ternary complexes" . SPARSER::BIO-COMPLEX)
    ("THF binary complexes" . SPARSER::BIO-COMPLEX) ("THF" . SPARSER::MOLECULE)
    ("the average χ 1 dihedral angle conformation and rotamer"
     . SPARSER::COLLECTION)
    ("conformation and rotamer" . SPARSER::COLLECTION)
    ("Substrate" . SPARSER::SUBSTRATE) ("ecE:NADPH" . SPARSER::BIO-COMPLEX)
    ("substrate or product" . SPARSER::COLLECTION)
    ("a hinge-open state" . SPARSER::BIO-STATE) ("ecE" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("p  180" . SPARSER::PROTEIN)
    ("p  60" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("CHD 2" . SPARSER::PROTEIN) ("NADP +" . SPARSER::MOLECULE)
    ("dihydrofolate
reductase"
     . SPARSER::PROTEIN)
    ("nicotinamide
adenine dinucleotide"
     . SPARSER::MOLECULE)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("constitutional PTEN gene" . SPARSER::PROTEIN) ("RZ" . SPARSER::PROTEIN)
    ("LMP" . SPARSER::PROTEIN) ("The consent form" . SPARSER::FORM)
    ("the specific gene and the type" . SPARSER::COLLECTION)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("a haploinsufficient gene" . SPARSER::GENE)
    ("a classical tumor suppressor gene" . SPARSER::PROTEIN)
    ("PTEN, PI3KCA and AKT" . SPARSER::COLLECTION)
    ("PTEN and AKT" . SPARSER::COLLECTION)
    ("AKT and S6RP" . SPARSER::COLLECTION) ("Blot" . SPARSER::PROTEIN)
    ("Asn" . SPARSER::AMINO-ACID) ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("the heterozygous transversion c" . SPARSER::PROTEIN)
    ("Paclitaxel and Trastuzumab" . SPARSER::COLLECTION)
    ("Paclitaxel" . SPARSER::DRUG) ("anastrozole" . SPARSER::DRUG)
    ("LHRH" . SPARSER::PROTEIN) ("Sentinel" . SPARSER::DRUG)
    ("micropapillary type" . TYPE) ("Tamoxifen" . SPARSER::MOLECULE)
    ("Epirubicin" . SPARSER::DRUG) ("HER2/neu" . SPARSER::COLLECTION)
    ("PTEN-" . SPARSER::PROTEIN)
    ("PIK3CA (exons 10 and 21) and AKT1 (exon 2)" . SPARSER::COLLECTION)
    ("germ-line" . SPARSER::PROTEIN)
    ("TP53 , STK11 , CDH1 and PTEN" . SPARSER::COLLECTION)
    ("PI3" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("pT2" . SPARSER::PROTEIN) ("letter" . SPARSER::MOLECULE)
    ("stimulatory protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an apical protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ins" . SPARSER::PROTEIN) ("Caspase8" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("SPC and LTE" . SPARSER::COLLECTION)
    ("DDK" . SPARSER::BIO-COMPLEX)
    ("ChIP and Luciferase" . SPARSER::COLLECTION)
    ("Siamois, c-Fos, Cyclin-D1, and c-Myc" . SPARSER::COLLECTION)
    ("kaiso" . SPARSER::PROTEIN) ("Siamois" . SPARSER::PROTEIN)
    ("BSP" . SPARSER::PROTEIN) ("DKK-MYC" . SPARSER::COLLECTION)
    ("DKK" . SPARSER::PROTEIN)
    ("methylated CpG dinucleotide" . SPARSER::MOLECULE)
    ("CG-dinucleotides" . SPARSER::COLLECTION)
    ("Kaiso/p120ctn" . SPARSER::COLLECTION)
    ("the previously characterized POZ proteins" . SPARSER::PROTEIN)
    ("dinucleotides" . SPARSER::PROTEIN) ("brac/Pox" . SPARSER::COLLECTION)
    ("Pox" . SPARSER::PROTEIN)
    ("p120ctn and its isoforms" . SPARSER::COLLECTION)
    ("Isoforms" . SPARSER::ISOFORM)
    ("E-cadherin/catenin" . SPARSER::COLLECTION)
    ("P120-catenin" . SPARSER::COLLECTION)
    ("CpG-dinucleotides" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("Kaiso" . SPARSER::PROTEIN)
    ("p120-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC-tagged" . SPARSER::PROTEIN) ("Cyclin-D" . SPARSER::PROTEIN)
    ("isoform 3" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("broad complex" . SPARSER::PROTEIN) ("P120" . SPARSER::PROTEIN)
    ("p120ctn" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("predominantly KRAS/BRAF mutant" . SPARSER::MUTANT)
    ("KRAS/BRAF" . SPARSER::COLLECTION) ("GNAS/BRAF" . SPARSER::COLLECTION)
    ("GNAS/KRAS" . SPARSER::COLLECTION) ("GNAS and KRAS" . SPARSER::COLLECTION)
    ("heterotrimeric G-proteins" . SPARSER::PROTEIN)
    ("known oncogene" . SPARSER::ONCOGENE)
    ("growth-hormone" . SPARSER::PROTEIN)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("GNAS" . SPARSER::PROTEIN)
    ("microenvironemtal cues" . SPARSER::PROTEIN-FAMILY)
    ("DNMT3a and/or histone deacetylases (HDACs)" . SPARSER::COLLECTION)
    ("path" . SPARSER::PROTEIN)
    ("complex and multi-factorial" . SPARSER::COLLECTION)
    ("MEFs and re-enforces" . SPARSER::COLLECTION)
    ("Plk4-p53" . SPARSER::COLLECTION) ("the DNMT's" . SPARSER::PROTEIN)
    ("Plk4 heterozygous MEFs" . SPARSER::PROTEIN)
    ("DNMT1 and DNMT3b" . SPARSER::COLLECTION)
    ("DNMT3a and DNMT3b" . SPARSER::COLLECTION)
    ("HCC and MEFs" . SPARSER::COLLECTION)
    ("MEFs and HCC" . SPARSER::COLLECTION)
    ("PLK2 and PLK3" . SPARSER::COLLECTION) ("Post" . SPARSER::PROTEIN)
    ("a functional p53" . SPARSER::PROTEIN)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("ras-associated domain family 1" . SPARSER::PROTEIN)
    ("etoposide and UV" . SPARSER::COLLECTION)
    ("an indirect impact" . SPARSER::PROTEIN)
    ("Plk4 and Plk1" . SPARSER::COLLECTION)
    ("Plk2 and Plk3" . SPARSER::COLLECTION)
    ("the treated wild-type MEFs" . SPARSER::PROTEIN)
    ("ROS-treated heterozygous MEFs" . SPARSER::PROTEIN)
    ("the heterozygous MEFs" . SPARSER::PROTEIN) ("EtOH" . SPARSER::MOLECULE)
    ("methyltransferases (DNMT)" . SPARSER::PROTEIN)
    ("runt" . SPARSER::PROTEIN)
    ("treated Plk4 heterozygous MEFs" . SPARSER::PROTEIN)
    ("nitric oxide (NO)" . SPARSER::MOLECULE) ("Plks" . SPARSER::PROTEIN)
    ("ROS or hypoxia" . SPARSER::COLLECTION)
    ("p14ARF , p16INK4a , and BRCA1" . SPARSER::COLLECTION)
    ("bidirectional molecular cues" . SPARSER::PROTEIN-FAMILY)
    ("microenvironmental cues" . SPARSER::PROTEIN-FAMILY)
    ("functional p53" . SPARSER::PROTEIN)
    ("PLK1 and PLK4" . SPARSER::COLLECTION)
    ("hypoxia and ROS" . SPARSER::COLLECTION)
    ("Plk1 and Plk4" . SPARSER::COLLECTION) ("Plk4" . SPARSER::PROTEIN)
    ("Plk" . SPARSER::PROTEIN) ("PLK" . SPARSER::PROTEIN)
    ("PLKs" . SPARSER::PROTEIN) ("DNMT3b" . SPARSER::PROTEIN)
    ("HIF1a" . SPARSER::PROTEIN) ("PLK3" . SPARSER::PROTEIN)
    ("DNMT3a" . SPARSER::PROTEIN)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN) ("Plk3" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("transcription factor 3" . SPARSER::PROTEIN)
    ("Hif1α" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("PLK5" . SPARSER::PROTEIN) ("polo-like" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("polo-like kinase" . SPARSER::PROTEIN)
    ("p53 and downstream cell cycle regulators" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN) ("mdm2 and p53" . SPARSER::COLLECTION)
    ("p21 and Bax" . SPARSER::COLLECTION)
    ("p53, Mdm2, Bax and Bcl-2" . SPARSER::COLLECTION)
    ("pro-apoptotic p53" . SPARSER::PROTEIN)
    ("Mdm2, Bcl-2, Mcl-1 and inhibitors" . SPARSER::COLLECTION)
    ("Bax/Bak" . SPARSER::COLLECTION) ("smac" . SPARSER::PROTEIN)
    ("IAPs" . SPARSER::PROTEIN) ("cytokeratin" . SPARSER::PROTEIN)
    ("p53, Mdm2, Bax, Bak and Bcl-2" . SPARSER::COLLECTION)
    ("p53 and Bax" . SPARSER::COLLECTION) ("PE and FGR" . SPARSER::COLLECTION)
    ("pro-apoptotic p53 and anti-apoptotic Mdm2" . SPARSER::PROTEIN)
    ("p53 and anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 and downstream components" . SPARSER::COLLECTION)
    ("p21 and Puma" . SPARSER::COLLECTION)
    ("p53, Mdm2 or Bax" . SPARSER::COLLECTION)
    ("p53, Mdm2, p21, Puma or Bax" . SPARSER::COLLECTION)
    ("Nutlin-3 and attenuation" . SPARSER::COLLECTION)
    ("p53, Mdm2, p21 and Puma" . SPARSER::COLLECTION)
    ("SNA" . SPARSER::PROTEIN) ("Mib-1" . SPARSER::PROTEIN)
    ("Mib" . SPARSER::PROTEIN)
    ("The latter highlighting increased chromatin condensation"
     . SPARSER::PROTEIN-FAMILY)
    ("siRNA or p53" . SPARSER::COLLECTION)
    ("fluorescent labeled siRNA" . SPARSER::PROTEIN)
    ("Bak and Bcl-2" . SPARSER::COLLECTION)
    ("gestational age" . SPARSER::PROTEIN)
    ("Nutlin-3 and Pifithrin-α" . SPARSER::COLLECTION)
    ("FGR" . SPARSER::PROTEIN)
    ("normal circumstances cellular p53" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("release vasoactive or inflammatory factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("severe PE" . SPARSER::PROTEIN)
    ("more recently termed syncytial nuclear" . SPARSER::PROTEIN)
    ("proteinuria" . SPARSER::PROTEIN) ("Nutlin" . SPARSER::DRUG)
    ("siRNA and Nutlin-3" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("p53, p21 and Bax" . SPARSER::COLLECTION)
    ("p53 and downstream effector proteins, p21, Bax and caspases 3"
     . SPARSER::COLLECTION)
    ("proteins, p21, Bax and caspases 3" . SPARSER::COLLECTION)
    ("cytokeratin-18" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("Caspase 8" . SPARSER::PROTEIN) ("Z-Vad-FMK" . SPARSER::DRUG)
    ("Cytochrome c" . SPARSER::PROTEIN) ("Myosin Light Chain" . SPARSER::MLC)
    ("subunit A" . SPARSER::PROTEIN)
    ("Succinate dehydrogenase complex" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("APAF-1" . SPARSER::PROTEIN)
    ("WAF-1" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("SERM" . SPARSER::DRUG) ("SERMs" . SPARSER::DRUG)
    ("prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MicroRNA" . SPARSER::MICRO-RNA) ("CDKN1C/p57" . SPARSER::COLLECTION)
    ("PR, cyclinD1 and pS2" . SPARSER::COLLECTION)
    ("five ERα-regulating miRNAs (e.g. miR-18a, miR-18b, miR-193b, miR-302c, and miR-206) directly targeted ERα"
     . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN)
    ("a classic etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and TIMP3" . SPARSER::COLLECTION) ("LV" . SPARSER::MOLECULE)
    ("cyclinD1 (P>0.05) and PR (P = 0.0151)" . SPARSER::COLLECTION)
    ("pS2 (P = 0.0086), cyclinD1 (P>0.05) and PR (P = 0.0151)"
     . SPARSER::COLLECTION)
    ("cyclinD1 (P = 0.0003) and PR (P<0.0001)" . SPARSER::COLLECTION)
    ("pS2 (P<0.0001), cyclinD1 (P = 0.0003) and PR (P<0.0001)"
     . SPARSER::COLLECTION)
    ("pmiR-ERα" . SPARSER::COLLECTION)
    ("MiR-222-3p directly targets ERα" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("either oncogenes or tumor suppressors xref" . SPARSER::COLLECTION)
    ("EC and normal endometrium" . SPARSER::COLLECTION)
    ("des" . SPARSER::PROTEIN)
    ("a classical etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antiestrogen" . SPARSER::DRUG) ("raloxifene" . SPARSER::PROTEIN)
    ("oestrogen-receptor" . SPARSER::PROTEIN) ("p27kip1" . SPARSER::PROTEIN)
    ("p57" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1C" . SPARSER::PROTEIN)
    ("TRPS1" . SPARSER::PROTEIN) ("miR-193b" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("MiR-222-3p" . SPARSER::MOLECULE) ("miR-222-3p" . SPARSER::MOLECULE)
    ("viral latency promoters" . SPARSER::PROMOTER)
    ("a growth suppressive DDR" . SPARSER::PROTEIN)
    ("a growth-suppressive DDR" . SPARSER::PROTEIN)
    ("p53 or Rb" . SPARSER::COLLECTION)
    ("persistent heterochromatic foci" . SPARSER::PROTEIN)
    ("Hyper" . SPARSER::PROTEIN) ("CD40/IL-4" . SPARSER::COLLECTION)
    ("the slower proliferating CD40L/IL-4" . SPARSER::COLLECTION)
    ("p53 and Cdc25" . SPARSER::COLLECTION)
    ("CpG and αCD40/IL-4" . SPARSER::COLLECTION)
    ("PARP and caspase 3" . SPARSER::COLLECTION)
    ("DEVD-FAM" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("Mitogens" . SPARSER::MITOGEN) ("CD40L/IL-4" . SPARSER::COLLECTION)
    ("MDN" . SPARSER::PROTEIN) ("ODN" . SPARSER::PROTEIN)
    ("Period" . SPARSER::PROTEIN) ("Mitogen" . SPARSER::MITOGEN)
    ("viral DNA" . SPARSER::DNA) ("ATM and Chk2" . SPARSER::COLLECTION)
    ("pace" . SPARSER::PROTEIN)
    ("unique and diverse antibodies" . SPARSER::ANTIBODY)
    ("their Ig genes and class switch recombination (CSR)"
     . SPARSER::COLLECTION)
    ("antigen and T-cell" . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::PROTEIN) ("BAFF" . SPARSER::PROTEIN)
    ("a modest DDR" . SPARSER::PROTEIN) ("ATM/Chk2" . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("AMPD1" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("Interleukin-4" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("EBNA3C" . SPARSER::PROTEIN)
    ("EBNA2" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("Bcl-6" . SPARSER::PROTEIN) ("cytidine deaminase" . SPARSER::PROTEIN)
    ("CD40 ligand" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("p53 and wt" . SPARSER::COLLECTION)
    ("the dual PI3K- and mTOR-inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("PI3K- and mTOR-inhibitor" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::PROTEIN) ("PTEN and/or p53" . SPARSER::COLLECTION)
    ("PTEN and wt" . SPARSER::COLLECTION) ("p53 or PTEN" . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("indirect inhibitors" . SPARSER::INHIBITOR)
    ("p53, PTEN and FAS" . SPARSER::COLLECTION)
    ("a possible impact" . SPARSER::PROTEIN)
    ("either p53 (GaMG) or PTEN (U87-MG)" . SPARSER::COLLECTION)
    ("PTEN/p53" . SPARSER::COLLECTION)
    ("native adherent state" . SPARSER::BIO-STATE) ("EDTA" . SPARSER::MOLECULE)
    ("patch-clamp" . SPARSER::COLLECTION)
    ("wild type PTEN and wild type p53" . SPARSER::COLLECTION)
    ("PI3K and phospho-AKT" . SPARSER::COLLECTION)
    ("in turn targets p53" . SPARSER::PROTEIN)
    ("mTOR, and FAS" . SPARSER::COLLECTION)
    ("p53 and several marker proteins" . SPARSER::COLLECTION)
    ("FAS and Marker Proteins" . SPARSER::COLLECTION)
    ("p53, MDM2, PTEN, FAS and Marker Proteins" . SPARSER::COLLECTION)
    ("FAS" . SPARSER::PROTEIN) ("the osmotic water" . SPARSER::MOLECULE)
    ("small organic osmolytes" . SPARSER::MOLECULE)
    ("inositol and sucrose" . SPARSER::COLLECTION)
    ("osmolyte" . SPARSER::MOLECULE) ("disaccharide" . SPARSER::MOLECULE)
    ("osmolytes" . SPARSER::MOLECULE)
    ("sucrose and inositol" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("sucrose or inositol" . SPARSER::COLLECTION)
    ("inositol- or sucrose-substituted media" . SPARSER::COLLECTION)
    ("inositol-" . SPARSER::PROTEIN) ("sucrose" . SPARSER::MOLECULE)
    ("mh" . SPARSER::MOLECULE) ("mh  " . SPARSER::MOLECULE)
    ("PTEN or p53" . SPARSER::COLLECTION) ("CRF" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE) ("pF" . SPARSER::PROTEIN)
    ("oncogenes (e.g. EGFR, CDK4 ) and deletion of tumor suppressor genes"
     . SPARSER::COLLECTION)
    ("PTEN and TP53" . SPARSER::COLLECTION)
    ("light and electron" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION) ("cm 2" . SPARSER::PROTEIN)
    ("mTOR and several other marker proteins" . SPARSER::COLLECTION)
    ("ROT" . SPARSER::PROTEIN) ("PTEN and p53" . SPARSER::COLLECTION)
    ("NVP-BEZ235" . SPARSER::DRUG) ("NVP-AUY922" . SPARSER::MOLECULE)
    ("6.3 µ" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("Fatty Acid Synthase" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("a nonsynonymous SNP" . SPARSER::PROTEIN)
    ("the IRS1 gene and 1704 SNP" . SPARSER::COLLECTION)
    ("IRS1 and IRS2" . SPARSER::COLLECTION) ("Akt-Foxo1" . SPARSER::COLLECTION)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("IRS-1and IRS-2" . SPARSER::COLLECTION) ("IRs" . SPARSER::PROTEIN)
    ("-kinase" . SPARSER::KINASE) ("P85" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-4" . SPARSER::PROTEIN)
    ("Insulin receptor substrate2" . SPARSER::PROTEIN)
    ("Foxo1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-cell" . SPARSER::PROTEIN) ("IRS -1" . SPARSER::PROTEIN)
    ("IRS -2" . SPARSER::PROTEIN) ("IRS2" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("Insulin receptor" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN) ("Trp/Trp" . SPARSER::COLLECTION)
    ("Arg/Trp" . SPARSER::COLLECTION)
    ("DNA polymerase-b" . SPARSER::PROTEIN-PAIR)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HNC or the XRCC1 Arg194Trp" . SPARSER::COLLECTION)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("these three polymorphic variants" . SPARSER::VARIANT)
    ("DNA repair protein" . SPARSER::PROTEIN)
    ("/SNX9/p85/CD28" . SPARSER::COLLECTION) ("WASp" . SPARSER::PROTEIN)
    ("hyper-IgE" . SPARSER::COLLECTION) ("JAK2-STAT5" . SPARSER::COLLECTION)
    ("an oncogene or a tumor suppressor" . SPARSER::COLLECTION)
    ("CDKAL1 , DNM2 , DUSP5 , MBP , ARL4C , CBS , PPP2R2B , LNPEP , PTGER1 and DIDO1"
     . SPARSER::COLLECTION)
    ("further distant genes" . SPARSER::GENE)
    ("STATs and non-STAT" . SPARSER::COLLECTION)
    ("a STAT5B- and Stat5b-binding co-activator" . SPARSER::COLLECTION)
    ("centrosomal P4.1-associated protein" . SPARSER::PROTEIN)
    ("STAT5B and Stat5b" . SPARSER::COLLECTION) ("STAT5B-" . SPARSER::PROTEIN)
    ("Crkl" . SPARSER::PROTEIN)
    ("anti-STAT5A and anti-STAT5B" . SPARSER::COLLECTION)
    ("each gene's" . SPARSER::PROTEIN) ("IgE" . SPARSER::PROTEIN)
    ("SGK1 (decreased similarly in both KDs) and ST3GAL1 (decreased specifically in STAT5A KD, no change in STAT5B KD)"
     . SPARSER::COLLECTION)
    ("GTF2H5 (decreased similarly in both KDs) and TNFSF10 (deceased specifically in STAT5B KD, no change in STAT5A KD)"
     . SPARSER::COLLECTION)
    ("CDKAL1 (no change in both KDs) and SAMD4A (decreased specifically in STAT5A KD, no change in STAT5B KD)"
     . SPARSER::COLLECTION)
    ("DNM2 (no change in both KDs) and NDRG1 (decreased specifically in STAT5A KD, no change in STAT5B KD)"
     . SPARSER::COLLECTION)
    ("DNAJC6 (decreased specifically in STAT5A KD, no change in STAT5B KD) and DOCK8 (decreased specifically in STAT5B KD, no change in STAT5A KD)"
     . SPARSER::COLLECTION)
    ("MBP and LNPEP" . SPARSER::COLLECTION)
    ("PTGER1 and DIDO1" . SPARSER::COLLECTION) ("CBS" . SPARSER::PROTEIN)
    ("DOCK8 , SNX9 , SKAP1 , TNFSF10 , FOXP3 , IL2RA , and UGCG"
     . SPARSER::COLLECTION)
    ("UGCG" . SPARSER::PROTEIN)
    ("NDRG1 , DNAJC6 , ST3GAL1 , SAMD4A , SSH2 , MAP3K5 and BCL2L1"
     . SPARSER::COLLECTION)
    ("SGK1 , GTF2H5 and SLC22A5" . SPARSER::COLLECTION)
    ("CDKAL1 , DNM2 , DUSP5 , MBP and ARL4C" . SPARSER::COLLECTION)
    ("KDs" . SPARSER::PROTEIN) ("ARL" . SPARSER::PROTEIN)
    ("FOXP3 and PPP1R3F" . SPARSER::COLLECTION)
    ("SGK1 , MBP , and DUSP5" . SPARSER::COLLECTION)
    ("LNPEP" . SPARSER::PROTEIN) ("MBP" . SPARSER::PROTEIN)
    ("FOXP3 and IL2RA" . SPARSER::COLLECTION) ("-GAA" . SPARSER::COLLECTION)
    ("“TTC-GAA" . SPARSER::COLLECTION) ("GAA" . SPARSER::PROTEIN)
    ("STAT5A- or STAT5B-dominant" . SPARSER::COLLECTION)
    ("STAT5A-" . SPARSER::PROTEIN)
    ("the genes and their binding sequences" . SPARSER::COLLECTION)
    ("PHA" . SPARSER::PROTEIN) ("monomers or dimers" . SPARSER::COLLECTION)
    ("FOXP3 and IL-2RA" . SPARSER::COLLECTION) ("prolactin" . SPARSER::PROTEIN)
    ("Stat5a and Stat5b" . SPARSER::COLLECTION) ("Stat5a" . SPARSER::PROTEIN)
    ("STAT5A and/or STAT5B" . SPARSER::COLLECTION)
    ("NDRG1 , DNAJC6 , and SSH2" . SPARSER::COLLECTION)
    ("DOCK8 , SNX9 , FOXP3 and IL2RA" . SPARSER::COLLECTION)
    ("STAT5A and/or STAT5B, and quantitative-PCR" . SPARSER::COLLECTION)
    ("STAT5B, and quantitative-PCR" . SPARSER::COLLECTION)
    ("STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("proteins, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("p85" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sorting nexin 9" . SPARSER::PROTEIN) ("P4.1" . SPARSER::PROTEIN)
    ("DIDO1" . SPARSER::PROTEIN) ("PTGER1" . SPARSER::PROTEIN)
    ("PPP2R2B" . SPARSER::PROTEIN) ("SKAP1" . SPARSER::PROTEIN)
    ("MAP3K5" . SPARSER::PROTEIN) ("SLC22A5" . SPARSER::PROTEIN)
    ("PPP1R3F" . SPARSER::PROTEIN) ("DUSP5" . SPARSER::PROTEIN)
    ("DNM2" . SPARSER::PROTEIN) ("SAMD4A" . SPARSER::PROTEIN)
    ("CDKAL1" . SPARSER::PROTEIN) ("GTF2H5" . SPARSER::PROTEIN)
    ("ST3GAL1" . SPARSER::PROTEIN) ("Il4ra" . SPARSER::PROTEIN)
    ("β-glucuronidase" . SPARSER::PROTEIN)
    ("antimicrobial agent" . SPARSER::MOLECULE) ("IL-2RA" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN)
    ("growth hormone receptor" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("IL4RA" . SPARSER::PROTEIN)
    ("IL2RA" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("SNX9" . SPARSER::PROTEIN) ("DOCK8" . SPARSER::PROTEIN)
    ("SSH2" . SPARSER::PROTEIN) ("DNAJC6" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN)
    ("tumor-associated antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HD" . SPARSER::PROTEIN)
    ("cetuximab, nimotuzumab, and matuzumab" . SPARSER::COLLECTION)
    ("matuzumab" . SPARSER::DRUG)
    ("simple and non-invasive" . SPARSER::COLLECTION)
    ("DEL" . SPARSER::PROTEIN) ("HER or Erb-B" . SPARSER::COLLECTION)
    ("grasp" . SPARSER::PROTEIN)
    ("possible confounding factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lasso" . SPARSER::DRUG) ("a significantly longer PFS" . SPARSER::PROTEIN)
    ("CTL" . SPARSER::PROTEIN) ("PPV" . SPARSER::MOLECULE)
    ("delE" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("a prototypic cell-surface receptor" . SPARSER::RECEPTOR)
    ("egfr" . SPARSER::PROTEIN) ("beta3" . SPARSER::PROTEIN)
    ("secreted growth factor" . SPARSER::PROTEIN) ("Erb-B" . SPARSER::PROTEIN)
    ("p-value" . SPARSER::PROTEIN) ("VEM" . SPARSER::DRUG)
    ("Mult-HCL" . SPARSER::COLLECTION)
    ("immobilized anti-sIgM" . SPARSER::ANTIBODY)
    ("IgM and IgD" . SPARSER::COLLECTION)
    ("only anti-IgM antibodies" . SPARSER::ANTIBODY)
    ("IgD and IgM" . SPARSER::COLLECTION) ("CD40:CD40L" . SPARSER::BIO-COMPLEX)
    ("AICD" . SPARSER::PROTEIN) ("Vemurafenib" . SPARSER::DRUG)
    ("‘antigen’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sIgM or other isotypes" . SPARSER::COLLECTION)
    ("mutant B-RAF and wild type A-RAF and C-RAF" . SPARSER::COLLECTION)
    ("A-RAF and C-RAF" . SPARSER::COLLECTION)
    ("CD103 and/or CD11c" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("2/2 primary HCL" . SPARSER::PROTEIN) ("-HCL" . SPARSER::COLLECTION)
    ("dysfunctional sIgA" . SPARSER::PROTEIN)
    ("soluble anti-sIgM" . SPARSER::ANTIBODY)
    ("post-BCR" . SPARSER::COLLECTION) ("soluble antibody" . SPARSER::ANTIBODY)
    ("soluble goat F(ab’) 2 anti-human antibody" . SPARSER::ANTIBODY)
    ("sIgG or light" . SPARSER::COLLECTION)
    ("sIgG or sIgκ" . SPARSER::COLLECTION)
    ("sIgG and sIgκ" . SPARSER::COLLECTION)
    ("sIgH and sIgL" . SPARSER::COLLECTION) ("dual light" . SPARSER::PROTEIN)
    ("slg" . SPARSER::PROTEIN) ("sIgD, sIgM and sIgλ" . SPARSER::COLLECTION)
    ("sIgG" . SPARSER::PROTEIN) ("sIgD and sIgλ" . SPARSER::COLLECTION)
    ("sIgA" . SPARSER::PROTEIN) ("FITC-" . SPARSER::MOLECULE)
    ("sIgH/IgL" . SPARSER::COLLECTION)
    ("a FITC-labelled rabbit F(ab’) 2 anti-goat F(ab’) 2 secondary antibody"
     . SPARSER::ANTIBODY)
    ("IgH/IgL" . SPARSER::COLLECTION) ("goat" . SPARSER::PROTEIN)
    ("IgL" . SPARSER::PROTEIN)
    ("the co-expressed IgM (cases 2, 3, 4, 5, 10 and 11) or IgG (case 5) or IgA (cases 10 and 11)"
     . SPARSER::COLLECTION)
    ("IgG (case 5) or IgA (cases 10 and 11)" . SPARSER::COLLECTION)
    ("IgG and/or IgM" . SPARSER::COLLECTION)
    ("anti-CD19/CD103/CD11c" . SPARSER::COLLECTION)
    ("IgA and IgM" . SPARSER::COLLECTION)
    ("IgA (72%) and IgM (18%)" . SPARSER::COLLECTION)
    ("IgM (48%) or kappa (86%)" . SPARSER::COLLECTION)
    ("IgG/kappa" . SPARSER::COLLECTION)
    ("IgM (89%) and kappa (88%)" . SPARSER::COLLECTION)
    ("IgM (20%) and kappa (72%)" . SPARSER::COLLECTION)
    ("IgD/IgG/IgM/kappa" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("FC" . SPARSER::PROTEIN)
    ("FcR" . SPARSER::PROTEIN-FAMILY) ("functional BCR" . SPARSER::PROTEIN)
    ("typical HCL" . SPARSER::PROTEIN)
    ("durable IgM+ or isotype class" . CLASS)
    ("SHM and CSR" . SPARSER::COLLECTION) ("AID" . SPARSER::PROTEIN)
    ("IgH" . SPARSER::PROTEIN) ("CSR" . SPARSER::PROTEIN)
    ("SHM" . SPARSER::DRUG)
    ("bacterial polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("B-RAF and C-RAF" . SPARSER::COLLECTION)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("MEK1 and MEK 2" . SPARSER::COLLECTION) ("MAP/ERK" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN) ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("signalosome" . SPARSER::PROTEIN) ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Igα/Igβ" . SPARSER::COLLECTION) ("a functional BCR" . SPARSER::PROTEIN)
    ("dual sIgL" . SPARSER::PROTEIN) ("sIgL" . SPARSER::PROTEIN)
    ("sIgM" . SPARSER::PROTEIN) ("sIgH" . SPARSER::PROTEIN)
    ("sIgD" . SPARSER::PROTEIN) ("IgD" . SPARSER::PROTEIN)
    ("BRAF and IGHV" . SPARSER::COLLECTION) ("normal BCR" . SPARSER::PROTEIN)
    ("Typical mult-HCL" . SPARSER::COLLECTION)
    ("mult-HCL" . SPARSER::COLLECTION) ("HCL" . SPARSER::PROTEIN)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("anti-IgM" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("Ca2 +" . SPARSER::CALCIUM-ION)
    ("Apo2" . SPARSER::PROTEIN) ("fluo3" . SPARSER::MOLECULE)
    ("Fluo-3" . SPARSER::MOLECULE) ("CD22" . SPARSER::PROTEIN)
    ("IGHV4-34" . SPARSER::PROTEIN) ("CARD11" . SPARSER::PROTEIN)
    ("CD27" . SPARSER::PROTEIN)
    ("activation induced cytidine deaminase" . SPARSER::PROTEIN)
    ("B-raf" . SPARSER::PROTEIN) ("Ets1" . SPARSER::PROTEIN)
    ("MEK 2" . SPARSER::PROTEIN) ("C-RAF" . SPARSER::PROTEIN)
    ("Igβ" . SPARSER::PROTEIN) ("Igα" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("CD103" . SPARSER::PROTEIN)
    ("a temperature-sensitive cell lethal mutant" . SPARSER::MUTANT)
    ("EGFR and MAPK" . SPARSER::COLLECTION)
    ("suppressors and three" . SPARSER::COLLECTION)
    ("Warts" . SPARSER::PROTEIN)
    ("Eiger- and AiP-induced" . SPARSER::COLLECTION)
    ("Eiger-" . SPARSER::PROTEIN) ("kek" . SPARSER::PROTEIN)
    ("the dorsal part" . SPARSER::COMPONENT)
    ("the eye imaginal disc" . SPARSER::BIO-COMPLEX)
    ("Bsk/JNK" . SPARSER::COLLECTION) ("Bsk" . SPARSER::PROTEIN)
    ("kek-lacZ" . SPARSER::PROTEIN-PAIR)
    ("hid-p35 eye imaginal discs" . SPARSER::BIO-COMPLEX)
    ("EGFR/Ras/MAPK" . SPARSER::COLLECTION)
    ("Ras ( Dras ) and MAPK" . SPARSER::COLLECTION)
    ("orthologs" . SPARSER::PROTEIN) ("Egfr" . SPARSER::PROTEIN)
    ("available mutants and UAS-RNAi" . SPARSER::COLLECTION)
    ("available mutants" . SPARSER::MUTANT) ("Enhancers" . SPARSER::PROTEIN)
    ("enhancers" . SPARSER::PROTEIN) ("just expressing GFP" . SPARSER::PROTEIN)
    ("Gal4 and tub -Gal80 ts (ptc ts > hid )" . SPARSER::COLLECTION)
    ("ptc" . SPARSER::HUMAN-PROTEIN-FAMILY) ("puc" . SPARSER::PROTEIN)
    ("hid/p35" . SPARSER::COLLECTION) ("FLP" . SPARSER::PROTEIN)
    ("Eiger" . SPARSER::PROTEIN) ("eiger" . SPARSER::PROTEIN)
    ("GMR-eiger" . SPARSER::COLLECTION)
    ("further place Rho1" . SPARSER::PROTEIN)
    ("Rho1 and Traf2" . SPARSER::COLLECTION)
    ("p35 eye imaginal discs" . SPARSER::BIO-COMPLEX)
    ("JNK, Eiger/Wengen and Pvf/PVR" . SPARSER::COLLECTION)
    ("Pvf" . SPARSER::MOLECULE) ("Traf6" . SPARSER::PROTEIN)
    ("Traf2" . SPARSER::PROTEIN) ("Traf" . SPARSER::PROTEIN-FAMILY)
    ("hep and MKK4" . SPARSER::COLLECTION)
    ("the JNKKK dTak1 and the JNKKs" . SPARSER::COLLECTION)
    ("hep" . SPARSER::PROTEIN) ("jra" . SPARSER::PROTEIN)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GMR-hid" . SPARSER::COLLECTION)
    ("GMR" . SPARSER::PROTEIN) ("drICE" . SPARSER::PROTEIN)
    ("TRE-dsRed" . SPARSER::COLLECTION) ("puc-lacZ" . SPARSER::COLLECTION)
    ("dsRed" . SPARSER::PROTEIN) ("TRE" . SPARSER::PROTEIN)
    ("dpp-lacZ" . SPARSER::COLLECTION) ("lacZ" . SPARSER::PROTEIN)
    ("ELAV" . SPARSER::PROTEIN) ("hid-p35 )" . SPARSER::COLLECTION)
    ("Gal4" . SPARSER::PROTEIN) ("Gal" . SPARSER::PROTEIN)
    ("hid-p35" . SPARSER::COLLECTION) ("hid" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX)
    ("essential component" . SPARSER::COMPONENT)
    ("eye imaginal discs" . SPARSER::BIO-COMPLEX)
    ("genes and mechanisms" . SPARSER::COLLECTION) ("Fas" . SPARSER::PROTEIN)
    ("wing imaginal discs" . SPARSER::BIO-COMPLEX) ("Dpp" . SPARSER::MOLECULE)
    ("mitogens" . SPARSER::MITOGEN) ("dpp" . SPARSER::PROTEIN)
    ("wingless" . SPARSER::PROTEIN)
    ("p53 and the stress-kinase JNK" . SPARSER::COLLECTION)
    ("bsk" . SPARSER::PROTEIN)
    ("usually wing and eye discs" . SPARSER::BIO-COMPLEX)
    ("larval imaginal discs" . SPARSER::BIO-COMPLEX)
    ("Drosophila imaginal discs" . SPARSER::BIO-COMPLEX)
    ("Hid" . SPARSER::PROTEIN) ("Diap1" . SPARSER::PROTEIN)
    ("proteins (IAP)" . SPARSER::PROTEIN)
    ("DrICE and Dcp-1" . SPARSER::COLLECTION) ("discs" . SPARSER::BIO-COMPLEX)
    ("DrICE" . SPARSER::PROTEIN) ("Caspases" . SPARSER::PROTEIN)
    ("multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("apoptosome" . SPARSER::BIO-COMPLEX) ("Wnt and BMP" . SPARSER::COLLECTION)
    ("BMP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apoptotic caspases" . SPARSER::PROTEIN) ("caspases" . SPARSER::PROTEIN)
    ("β-GAL" . SPARSER::PROTEIN) ("PH3" . SPARSER::MOLECULE)
    ("dcp - 1" . SPARSER::PROTEIN) ("DE -" . SPARSER::MOLECULE)
    ("C40" . SPARSER::PROTEIN) ("sec5" . SPARSER::PROTEIN)
    ("DE-" . SPARSER::MOLECULE) ("β-Gal" . SPARSER::PROTEIN)
    ("Cas3" . SPARSER::PROTEIN) ("dTak1" . SPARSER::PROTEIN)
    ("dcp-1" . SPARSER::PROTEIN) ("p35 )" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("death receptor" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p35" . SPARSER::PROTEIN)
    ("P35" . SPARSER::PROTEIN) ("Apaf-1" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("Dcp-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arm 2" . SPARSER::PROTEIN-FAMILY) ("Rho1" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("the exact gene" . SPARSER::GENE)
    ("a unique gene" . SPARSER::GENE) ("KO and NEMO" . SPARSER::COLLECTION)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("siRNA or Smac" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("ubiquitinase" . SPARSER::UBIQUITINASE)
    ("gene or genes" . SPARSER::COLLECTION)
    ("IKK or IKK-like" . SPARSER::COLLECTION)
    ("IKKα ( xref ) and TBK1 ( xref )" . SPARSER::COLLECTION)
    ("IKKβ or NEMO" . SPARSER::COLLECTION)
    ("the heterotrimeric IKK complex" . SPARSER::BIO-COMPLEX)
    ("catalytically competent IKK complex" . SPARSER::BIO-COMPLEX)
    ("NEMO and IKKβ" . SPARSER::COLLECTION)
    ("TRAF-associated NF-κB activator (TANK)" . SPARSER::ACTIVATOR)
    ("activator (TANK)" . SPARSER::ACTIVATOR) ("TANK" . SPARSER::PROTEIN)
    ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("non-canonical NF-κB signaling directly controls class" . CLASS)
    ("the classical IKK complex" . SPARSER::BIO-COMPLEX)
    ("a signal-competent IKK complex" . SPARSER::BIO-COMPLEX)
    ("a heterotrimeric IKK complex" . SPARSER::BIO-COMPLEX)
    ("classical NF-κB" . SPARSER::PROTEIN) ("aberrant NIK" . SPARSER::PROTEIN)
    ("NEMO, IKKβ, or p65" . SPARSER::COLLECTION)
    ("exogenous NIK" . SPARSER::PROTEIN)
    ("TRAF3, TRAF2, and cIAP1" . SPARSER::COLLECTION)
    ("NEMO or p65" . SPARSER::COLLECTION)
    ("cIAP1, TRAF2, and TRAF3" . SPARSER::COLLECTION)
    ("p65 KO and wild-type MEFs ( xref )" . SPARSER::COLLECTION)
    ("a classical NF-κB target gene" . SPARSER::PROTEIN)
    ("birc3" . SPARSER::PROTEIN)
    ("TRAF2, TRAF3, cIAP1, and cIAP2" . SPARSER::COLLECTION)
    ("TRAF2:TRAF3:cIAP1:cIAP2" . SPARSER::BIO-COMPLEX)
    ("the prototypic classical NF-κB subunit p65" . SPARSER::PROTEIN)
    ("In contrast unphosphorylated NIK" . SPARSER::PROTEIN)
    ("KO and DKO" . SPARSER::COLLECTION) ("basal NIK" . SPARSER::PROTEIN)
    ("NEMO- or IKKβ-deficient MEFs" . SPARSER::COLLECTION)
    ("NEMO-" . SPARSER::PROTEIN) ("KO and IKKβ" . SPARSER::COLLECTION)
    ("NEMO, IKKβ, or TRAF3" . SPARSER::COLLECTION)
    ("KO , and IKKβ" . SPARSER::COLLECTION)
    ("catalytically active IKK complex" . SPARSER::BIO-COMPLEX)
    ("LIGHT or anti-LTβR" . SPARSER::COLLECTION)
    ("NEMO-IKKα" . SPARSER::COLLECTION)
    ("either wild-type IKKα (IKKα WT ) or a mutant IKKα" . SPARSER::COLLECTION)
    ("NBD" . SPARSER::PROTEIN) ("MigR" . SPARSER::PROTEIN)
    ("exogenous NEMO" . SPARSER::PROTEIN) ("Rat" . SPARSER::PROTEIN)
    ("KO , and NEMO" . SPARSER::COLLECTION) ("map3k14" . SPARSER::PROTEIN)
    ("intact NEMO" . SPARSER::PROTEIN)
    ("a hypomorphic NEMO fragment" . SPARSER::FRAGMENT)
    ("p52 and RelB" . SPARSER::COLLECTION)
    ("LIGHT or an agonistic anti-LTβR antibody ( xref and xref )"
     . SPARSER::COLLECTION)
    ("an agonistic anti-LTβR antibody" . SPARSER::ANTIBODY)
    ("cellular p100" . SPARSER::PROTEIN)
    ("the TNF superfamily member LIGHT" . SPARSER::PROTEIN)
    ("LIGHT" . SPARSER::PROTEIN)
    ("the intact classical IKK complex" . SPARSER::BIO-COMPLEX)
    ("hyper" . SPARSER::PROTEIN) ("hyper-IgA" . SPARSER::COLLECTION)
    ("Noncanonical NF-κB" . SPARSER::PROTEIN)
    ("TNF receptor–associated factor 2" . SPARSER::PROTEIN)
    ("NEMO or IKKβ" . SPARSER::COLLECTION)
    ("cxcl12 , cxcl13 , ccl19 , ccl21 , and tnfsf13b" . SPARSER::COLLECTION)
    ("tnfsf13b" . SPARSER::PROTEIN) ("ccl21" . SPARSER::PROTEIN)
    ("ccl19" . SPARSER::PROTEIN) ("cxcl13" . SPARSER::PROTEIN)
    ("cxcl12" . SPARSER::PROTEIN) ("ccl" . SPARSER::DRUG)
    ("p52-RelB" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("TNF-related weak inducer" . SPARSER::PROTEIN)
    ("BAFF-R or TNFRSF13C" . SPARSER::COLLECTION)
    ("TNFRSF12A, Fn14, or CD266" . SPARSER::COLLECTION)
    ("TRANCE" . SPARSER::PROTEIN) ("TWEAK" . SPARSER::PROTEIN)
    ("the heterotrimeric inhibitor" . SPARSER::INHIBITOR)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("functional NEMO" . SPARSER::PROTEIN)
    ("noncanonical NF-κB" . SPARSER::PROTEIN)
    ("NF-κB–inducing kinase (NIK) and IKKα" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE) ("NIK" . SPARSER::PROTEIN)
    ("NEMO-ID" . SPARSER::COLLECTION) ("ID" . SPARSER::PROTEIN)
    ("ikbkg" . SPARSER::PROTEIN) ("NEMO" . SPARSER::PROTEIN)
    ("histone-H3" . SPARSER::PROTEIN) ("Anti–" . SPARSER::ANTIBODY)
    ("OTUD7B" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("Rat1" . SPARSER::PROTEIN) ("k14" . SPARSER::PROTEIN)
    ("map3" . SPARSER::PROTEIN) ("TNFSF14" . SPARSER::PROTEIN)
    ("cIAP2" . SPARSER::PROTEIN) ("cIAP1" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("Fn14" . SPARSER::PROTEIN) ("TNFRSF12A" . SPARSER::PROTEIN)
    ("TNFRSF13C" . SPARSER::PROTEIN) ("BAFF-R" . SPARSER::PROTEIN)
    ("activating factor receptor" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("lymphotoxin-β" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("IKKγ" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN)
    ("Temsirolimus and Everolimus" . SPARSER::COLLECTION)
    ("Everolimus" . SPARSER::MOLECULE) ("Temsirolimus" . SPARSER::DRUG)
    ("p70S6K and eIF-4E binding protein 1 (4E-BP1)" . SPARSER::COLLECTION)
    ("further downstream mTOR" . SPARSER::PROTEIN)
    ("HIF-1 directly targets Gal-1" . SPARSER::PROTEIN)
    ("matrix-metalloproteinases" . SPARSER::COLLECTION)
    ("mTOR (S2448) and p70S6 kinase" . SPARSER::COLLECTION)
    ("HIF-1 α and Gal-1" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN) ("primary RCC" . SPARSER::PROTEIN)
    ("Gal-1 and HIF-1α" . SPARSER::COLLECTION)
    ("HSP27, JNK, JNK2, RSK1, RSK2, TOR, p38 delta and p38 gamma"
     . SPARSER::COLLECTION)
    ("both Akt (S473) and mTOR (S2448)" . SPARSER::COLLECTION)
    ("a non-targeting siRNA or transfection reagent" . SPARSER::COLLECTION)
    ("actin ( xref ) and vimentin ( xref )" . SPARSER::COLLECTION)
    ("actin and vimentin" . SPARSER::COLLECTION) ("ACHN" . SPARSER::PROTEIN)
    ("metastatic RCC" . SPARSER::PROTEIN) ("HIF1-" . SPARSER::PROTEIN)
    ("HIF/mTOR" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN)
    ("Only one group" . SPARSER::MOLECULE)
    ("Metastatic RCC" . SPARSER::PROTEIN) ("integrins" . SPARSER::PROTEIN)
    ("Galectins" . SPARSER::PROTEIN) ("–mTOR" . SPARSER::COLLECTION)
    ("Gal-1 and HIF-1 α" . SPARSER::COLLECTION)
    ("Akt, mTOR and p70" . SPARSER::COLLECTION)
    ("the biological impact" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("p38 gamma" . SPARSER::PROTEIN)
    ("p38 delta" . SPARSER::PROTEIN) ("RSK2" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("JNK3" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("CAK-1" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("CoCl 2" . SPARSER::MOLECULE)
    ("P -value" . SPARSER::PROTEIN)
    ("peptidylprolyl isomerase A" . SPARSER::PROTEIN)
    ("LGALS1" . SPARSER::PROTEIN) ("Galectin-1" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("Gal-1" . SPARSER::PROTEIN)
    ("galectin-1" . SPARSER::PROTEIN) ("obinutuzumab" . SPARSER::DRUG)
    ("anti-HER2/neu" . SPARSER::COLLECTION)
    ("CD16 and KRAS" . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN) ("NKT" . SPARSER::PROTEIN)
    ("second-line" . SPARSER::PROTEIN) ("RG" . SPARSER::PROTEIN)
    ("EGFR/EGF" . SPARSER::COLLECTION) ("oligosaccharides" . SPARSER::MOLECULE)
    ("receptors and mAbs" . SPARSER::COLLECTION)
    ("antibody/Fc receptor" . SPARSER::COLLECTION)
    ("cetuximab ( xref ) and the anti-CD20 mAb rituximab ( xref )"
     . SPARSER::COLLECTION)
    ("rituximab" . SPARSER::DRUG)
    ("apoptosis-inducing and lytic proteins" . SPARSER::COLLECTION)
    ("granzymes and perforin" . SPARSER::COLLECTION)
    ("perforin" . SPARSER::PROTEIN) ("granzymes" . SPARSER::PROTEIN-FAMILY)
    ("EGFR, cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("the anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("innovative biologics" . SPARSER::DRUG)
    ("oxaliplatin and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("further enhancing ADCC" . SPARSER::PROTEIN) ("killer" . SPARSER::PROTEIN)
    ("ADCC" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GA101" . SPARSER::DRUG) ("LAMP-1" . SPARSER::PROTEIN)
    ("NKG2D" . SPARSER::PROTEIN) ("P -values" . SPARSER::PROTEIN)
    ("CD107a" . SPARSER::PROTEIN) ("Fc receptor" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("IgG2" . SPARSER::BIO-COMPLEX)
    ("Fc γ RIIIa" . SPARSER::PROTEIN) ("VI, and VII" . SPARSER::COLLECTION)
    ("VII" . SPARSER::PROTEIN)
    ("proteins, lipids and organelles" . SPARSER::COLLECTION)
    ("replicative helicase" . SPARSER::PROTEIN)
    ("ribonucleic acids and proteins" . SPARSER::COLLECTION)
    ("ribosome, telomerease, and vault" . SPARSER::COLLECTION)
    ("RNPs" . SPARSER::PROTEIN) ("DNA- and RNA" . SPARSER::COLLECTION)
    ("DNA-" . SPARSER::DNA) ("RNP" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("relevant protein biomarkers" . SPARSER::MOLECULE)
    ("proteins, collagen and elastin" . SPARSER::COLLECTION)
    ("MCM7 and MCM6" . SPARSER::COLLECTION) ("DOX" . SPARSER::DRUG)
    ("a human TRIPZ lentiviral inducible shRNAmir target gene"
     . SPARSER::PROTEIN)
    ("p21 and p16" . SPARSER::COLLECTION) ("Rapa" . SPARSER::DRUG)
    ("ANOVA" . SPARSER::PROTEIN) ("almost 3,200 proteins" . SPARSER::PROTEIN)
    ("p21 (CDKN1A) and p16 (CDKN2A)" . SPARSER::COLLECTION)
    ("employing LC3" . SPARSER::PROTEIN) ("concanamycin" . SPARSER::MOLECULE)
    ("MCM6 and MCM7" . SPARSER::COLLECTION) ("SILAC" . SPARSER::PROTEIN)
    ("ribonucleoside" . SPARSER::MOLECULE)
    ("one unique peptide" . SPARSER::PEPTIDE)
    ("protein and peptide" . SPARSER::COLLECTION)
    ("SILAC-MS" . SPARSER::PROTEIN-PAIR)
    ("potentially causative proteins" . SPARSER::PROTEIN)
    ("macromolecules and organelles" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (MTOR)" . SPARSER::PROTEIN)
    ("MTOR" . SPARSER::PROTEIN)
    ("defective macromolecules and organelles, and deterioration"
     . SPARSER::COLLECTION)
    ("macromolecules and organelles, and deterioration" . SPARSER::COLLECTION)
    ("defective macromolecules" . SPARSER::MOLECULE)
    ("SASP and SSc" . SPARSER::COLLECTION) ("SASP" . SPARSER::PROTEIN)
    ("collagen and other ECM components" . SPARSER::COLLECTION)
    ("proteins and actin" . SPARSER::COLLECTION)
    ("collagens and other extracellular matrix (ECM) components"
     . SPARSER::COLLECTION)
    ("insoluble ECM" . SPARSER::PROTEIN) ("age and SSc" . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN) ("DNA and RNA" . SPARSER::COLLECTION)
    ("SSc" . SPARSER::PROTEIN) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("L-arginine" . SPARSER::MOLECULE)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("ribonucleic acids" . SPARSER::RNA)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("LC3-II" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID) ("MCM6" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID) ("MCM7" . SPARSER::PROTEIN)
    ("Stat5 and NF-κB" . SPARSER::COLLECTION)
    ("leukemic T cell mitochondria" . SPARSER::PROTEIN)
    ("CoxIII" . SPARSER::PROTEIN)
    ("NF-κB, CREB and MEF2D" . SPARSER::COLLECTION)
    ("p53, IRF3, NF-κB and STATs" . SPARSER::COLLECTION)
    ("COX IV and COXVIII" . SPARSER::COLLECTION)
    ("PGC-1α or NRF-1" . SPARSER::COLLECTION)
    ("genes and rRNAs" . SPARSER::COLLECTION)
    ("a polycistronic mRNA" . SPARSER::RNA)
    ("HSP1, HSP2 and LSP" . SPARSER::COLLECTION) ("LSP" . SPARSER::PROTEIN)
    ("HSP" . SPARSER::PROTEIN) ("Survivin and Bcl-2" . SPARSER::COLLECTION)
    ("the constitutively active/dimerized Stat3C mutant" . SPARSER::MUTANT)
    ("endogenous Stat3 homodimers as well as monomers" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("mitoStat3" . SPARSER::PROTEIN)
    ("a possible mitoStat3-PKC dependent mitochondrial"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitoStat3-PKC" . SPARSER::PROTEIN-PAIR)
    ("PKCε and PKCε" . SPARSER::COLLECTION)
    ("TPA or UVB" . SPARSER::COLLECTION) ("Stat3-PKCε" . SPARSER::COLLECTION)
    ("TPA or EGF" . SPARSER::COLLECTION)
    ("Stat3 and ETC" . SPARSER::COLLECTION)
    ("the nuclear-encoded mitochondrial proteins cytochrome c oxidiase subunit VIIIa ( Cox8a ) or cytochrome c oxidase subunit IV ( Cox4 )"
     . SPARSER::COLLECTION)
    ("Cox4" . SPARSER::PROTEIN) ("Cox8a" . SPARSER::PROTEIN)
    ("VIIIa" . SPARSER::PROTEIN)
    ("mTERF, PGC-1α and NRF-1" . SPARSER::COLLECTION)
    ("mTERF" . SPARSER::PROTEIN) ("resazurin" . SPARSER::DRUG)
    ("Stat3 and TFAM" . SPARSER::COLLECTION)
    ("TFAM-Stat3" . SPARSER::COLLECTION)
    ("TFAM and Stat3" . SPARSER::COLLECTION) ("acetone" . SPARSER::MOLECULE)
    ("transcription factor A (TFAM)" . SPARSER::PROTEIN)
    ("a constitutively active/dimerized Stat3 mutant" . SPARSER::MUTANT)
    ("BK" . SPARSER::PROTEIN) ("Stat3 and BrdU" . SPARSER::COLLECTION)
    ("Stat or GAS" . SPARSER::COLLECTION) ("TTN" . SPARSER::PROTEIN)
    ("Stat" . SPARSER::PROTEIN)
    ("approximately 90 kDa and 180 kDa" . SPARSER::COLLECTION)
    ("approximately 90 kDa" . SPARSER::PROTEIN) ("monomer" . SPARSER::MONOMER)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCδ and PKCε" . SPARSER::COLLECTION) ("ester" . SPARSER::MOLECULE)
    ("phorbol" . SPARSER::DRUG) ("EGF or TPA" . SPARSER::COLLECTION)
    ("p-Stat3" . SPARSER::COLLECTION) ("phosho-Stat3" . SPARSER::COLLECTION)
    ("DMBA/TPA" . SPARSER::COLLECTION) ("DMBA" . SPARSER::PROTEIN)
    ("SCCs" . SPARSER::PROTEIN) ("Stat3 and COX IV" . SPARSER::COLLECTION)
    ("the mitochondrial marker cytochrome c oxidase subunit IV (COX IV) and Stat3"
     . SPARSER::COLLECTION)
    ("methanol" . SPARSER::MOLECULE) ("MLS-Stat3" . SPARSER::COLLECTION)
    ("MLS" . SPARSER::PROTEIN) ("v-Src and v-Abl" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("PGC-1α and NRF-1" . SPARSER::COLLECTION) ("ETC" . SPARSER::PROTEIN)
    ("EGF and TPA" . SPARSER::COLLECTION) ("TPA" . SPARSER::PROTEIN)
    ("MEF2D" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("mitochondrial RNA" . SPARSER::RNA) ("HSP1" . SPARSER::PROTEIN)
    ("ND6" . SPARSER::PROTEIN) ("NADH dehydrogenase 6" . SPARSER::PROTEIN)
    ("ND5" . SPARSER::PROTEIN) ("NADH dehydrogenase 5" . SPARSER::PROTEIN)
    ("cytochrome b" . SPARSER::PROTEIN)
    ("transcription factor A" . SPARSER::PROTEIN) ("Bim-1" . SPARSER::PROTEIN)
    ("Bisindolylmaleimide I" . SPARSER::DRUG) ("PKCε" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("COX IV" . SPARSER::PROTEIN)
    ("cytochrome c oxidase subunit IV" . SPARSER::PROTEIN)
    ("v-Abl" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("NRF-1" . SPARSER::PROTEIN) ("allele and 4G/4G" . SPARSER::COLLECTION)
    ("gene and 4G/5G" . SPARSER::COLLECTION)
    ("allele, 4G/4G and 4G/5G" . SPARSER::COLLECTION)
    ("introns" . SPARSER::PROTEIN)
    ("tissue-type and urokinase" . SPARSER::COLLECTION)
    ("SERPINs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the three interactive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mediterranean Fever" . SPARSER::PROTEIN) ("gene 4" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN)
    ("pituitary adenylate cyclase activating polypeptide (PACAP)"
     . SPARSER::PROTEIN)
    ("PACAP" . SPARSER::PROTEIN) ("BB" . SPARSER::PROTEIN)
    ("bombesin" . SPARSER::PROTEIN) ("tiron" . SPARSER::MOLECULE)
    ("Endothelin" . SPARSER::PROTEIN)
    ("amphiregulin or heparin" . SPARSER::COLLECTION)
    ("a transcriptionally active β-catenin/TCF complex" . SPARSER::BIO-COMPLEX)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("FAK or PYK-2" . SPARSER::COLLECTION)
    ("FAK and PYK-2" . SPARSER::COLLECTION) ("SH2-" . SPARSER::PROTEIN)
    ("FAK and/or PYK-2" . SPARSER::COLLECTION)
    ("EGFR, ERK, and Src" . SPARSER::COLLECTION)
    ("Stat5b and the EGFR ( xref )" . SPARSER::COLLECTION)
    ("c-Src, Stat5b and the EGFR ( xref )" . SPARSER::COLLECTION)
    ("EGFR, Src, PYK-2 and β-catenin" . SPARSER::COLLECTION)
    ("Gq" . SPARSER::DRUG) ("SR48692 and/or gefitinib" . SPARSER::COLLECTION)
    ("SR48692 and gefitinib" . SPARSER::COLLECTION)
    ("Gefitinib and SR48692" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG)
    ("EGFR, Src or β-catenin" . SPARSER::COLLECTION)
    ("BAPTA" . SPARSER::MOLECULE) ("PLC" . SPARSER::PROTEIN)
    ("EGFR, PYK-2, Src and β-catenin" . SPARSER::COLLECTION)
    ("NTS and H 2 O 2" . SPARSER::COLLECTION)
    ("prepro-TGFα" . SPARSER::COLLECTION)
    ("anti-amphiregulin or anti-HB-EGF" . SPARSER::COLLECTION)
    ("Amph" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("TGFα and EGFR" . SPARSER::COLLECTION)
    ("1 µg/ml SR48692 (p < 0.05) and 10 µg/ml SR48692 (p < 0.01)"
     . SPARSER::COLLECTION)
    ("EGFR or ERK" . SPARSER::COLLECTION)
    ("NTS and 0.5 µg/ml SR48692" . SPARSER::COLLECTION)
    ("EGFR or tubulin" . SPARSER::COLLECTION)
    ("siRNA-NTSR1" . SPARSER::COLLECTION) ("Ac-NTS" . SPARSER::COLLECTION)
    ("SR48692, gefitinib or levocabastine" . SPARSER::COLLECTION)
    ("levocabastine" . SPARSER::DRUG)
    ("blot and receptor" . SPARSER::COLLECTION)
    ("gefitinib or SR48692" . SPARSER::COLLECTION)
    ("Tiron (superoxide scavenger) and U73122 (phospholipase C inhibitor)"
     . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN)
    ("significantly NTSR1 protein" . SPARSER::PROTEIN)
    ("NTS and NTSR1" . SPARSER::COLLECTION)
    ("focal adhesion kinase (FAK) ( xref ) and Src ( xref )"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("Akt and NF-κB" . SPARSER::COLLECTION)
    ("ERK and PKD" . SPARSER::COLLECTION) ("PKD" . SPARSER::PROTEIN)
    ("PK" . SPARSER::PROTEIN) ("DAG" . SPARSER::DAG)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("phosphatidylinositol (PI)" . SPARSER::MOLECULE)
    ("NTSR1 and NTSR2" . SPARSER::COLLECTION)
    ("Neurotensin (NTS)" . SPARSER::PROTEIN) ("Neurotensin" . SPARSER::PROTEIN)
    ("Tiron (superoxide scavenger) or U73122 (phospholipase C inhibitor) but not H89 (PKA inhibitor)"
     . SPARSER::COLLECTION)
    ("Tiron" . SPARSER::MOLECULE) ("metalloprotease" . SPARSER::PROTEIN)
    ("SR48692 or gefitinib" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION) ("NTS" . SPARSER::PROTEIN)
    ("neurotensin" . SPARSER::PROTEIN)
    ("pituitary adenylate cyclase activating polypeptide" . SPARSER::PROTEIN)
    ("endothelin 1" . SPARSER::PROTEIN) ("Stat5b" . SPARSER::PROTEIN)
    ("PYK-2" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NTS 1" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("PYK2" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("NT 1" . SPARSER::PROTEIN) ("IP 3" . SPARSER::IP3)
    ("NTSR2" . SPARSER::PROTEIN) ("phospholipase C" . SPARSER::PROTEIN)
    ("GM6001" . SPARSER::DRUG) ("NTSR1" . SPARSER::PROTEIN)
    ("SR48692" . SPARSER::DRUG) ("MIN" . SPARSER::PROTEIN)
    ("Stratifin" . SPARSER::PROTEIN)
    ("probable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("promoter, and vice" . SPARSER::COLLECTION)
    ("LA and LB" . SPARSER::COLLECTION) ("-fcDNA" . SPARSER::COLLECTION)
    ("the prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ESR" . SPARSER::PROTEIN) ("fcDNA" . SPARSER::PROTEIN)
    ("ERS 1-fcDNA" . SPARSER::PROTEIN-PAIR)
    ("the principal prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ESR1-" . SPARSER::PROTEIN) ("Adr" . SPARSER::PROTEIN)
    ("-DNA" . SPARSER::DNA) ("Estrogen receptor1" . SPARSER::PROTEIN)
    ("ERS 1" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("ESR1  " . SPARSER::PROTEIN) ("ERS1" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN)
    ("integrin and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("lectins and cadherin" . SPARSER::COLLECTION)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin D and stromal cell derived factor-1-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("a potent apoptotic inducer" . SPARSER::PROTEIN)
    ("DPN" . SPARSER::PROTEIN) ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα, ERβ, PR-A and PR-B" . SPARSER::COLLECTION)
    ("ERα and PR" . SPARSER::COLLECTION) ("EST" . SPARSER::PROTEIN)
    ("DDD" . SPARSER::PROTEIN) ("gastro-enteric" . SPARSER::PROTEIN-PAIR)
    ("enteric" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("cathepsin D" . SPARSER::PROTEIN) ("GRIM-19" . SPARSER::PROTEIN)
    ("PR-B" . SPARSER::PROTEIN) ("PR-A" . SPARSER::PROTEIN)
    ("17β-estradiol" . SPARSER::PROTEIN) ("GW112" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("OLFM4" . SPARSER::PROTEIN) ("Olfactomedin 4" . SPARSER::PROTEIN)
    ("that PTEN's" . SPARSER::PROTEIN)
    ("Rac-1 and CDC 42" . SPARSER::COLLECTION)
    ("PI3kinase/Akt" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION) ("subtle ROS" . SPARSER::PROTEIN)
    ("FAK and p130cas" . SPARSER::COLLECTION)
    ("FAK and Src kinase" . SPARSER::COLLECTION)
    ("p130cas and FAK" . SPARSER::COLLECTION)
    ("the dual protein and lipid phosphatase PTEN" . SPARSER::PROTEIN)
    ("protein and lipid" . SPARSER::COLLECTION) ("PTP" . SPARSER::PROTEIN)
    ("pKa" . SPARSER::PROTEIN) ("which links FAK" . SPARSER::PROTEIN)
    ("Redox" . SPARSER::PROTEIN)
    ("pro- and anti-migratory" . SPARSER::COLLECTION)
    ("p130cas and PTEN" . SPARSER::COLLECTION)
    ("suppressor and phosphatase" . SPARSER::COLLECTION)
    ("Crk" . SPARSER::PROTEIN) ("Catalase" . SPARSER::PROTEIN)
    ("Sod2" . SPARSER::PROTEIN) ("DNA and cell" . SPARSER::COLLECTION)
    ("MR3" . SPARSER::PROTEIN) ("P200" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("18 h" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("a 37 " . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("PIP2" . SPARSER::PROTEIN) ("CDC 42" . SPARSER::PROTEIN)
    ("s protein" . SPARSER::PROTEIN) ("PI3kinase" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src kinase" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("Rac-1" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("p130cas" . SPARSER::PROTEIN)
    ("p16INK4a, survivin, MMP, MEF2B, CK18, and PKCepsilon"
     . SPARSER::COLLECTION)
    ("Nox1 and Nox1-derived ROS" . SPARSER::COLLECTION)
    ("chronic ethanol" . SPARSER::PROTEIN)
    ("Nox1 and PKCepsilon" . SPARSER::COLLECTION)
    ("PKCepsilon-" . SPARSER::PROTEIN) ("DPI" . SPARSER::PROTEIN)
    ("Ub-CK18" . SPARSER::COLLECTION) ("oxidants" . SPARSER::MOLECULE)
    ("keratin" . SPARSER::PROTEIN) ("Nox1, PKC and ROS" . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID) ("Nox1 and ROS" . SPARSER::COLLECTION)
    ("Gö6983 or PKCepsilon" . SPARSER::COLLECTION)
    ("beta-, delta- and epsilon" . SPARSER::COLLECTION)
    ("beta-" . SPARSER::PROTEIN) ("epsilon" . SPARSER::PROTEIN)
    ("PKCepsilon" . SPARSER::PROTEIN)
    ("CK18 and pS52CK18" . SPARSER::COLLECTION)
    ("diphenyleneiodonium or apocynin" . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE) ("diphenyleneiodonium" . SPARSER::DRUG)
    ("Nox1-" . SPARSER::PROTEIN) ("very weak CK18" . SPARSER::PROTEIN)
    ("CK8/CK18" . SPARSER::COLLECTION) ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("keratins" . SPARSER::PROTEIN) ("CK8 and CK18" . SPARSER::COLLECTION)
    ("stromelysin" . SPARSER::PROTEIN) ("latent MMP-9" . SPARSER::PROTEIN)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("MEF2, vimentin and non-muscle" . SPARSER::COLLECTION)
    ("mRNA and myofibroblast" . SPARSER::COLLECTION)
    ("the only MEF2 isoform" . SPARSER::ISOFORM) ("‘EMT’" . SPARSER::PROTEIN)
    ("mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("NOXO1 instead of p67 phox" . SPARSER::COLLECTION)
    ("NuB1 and FIB" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("p47 phox and p67 phox" . SPARSER::COLLECTION)
    ("Nox1, Rac1, p47 phox , p67 phox , NOXO1, and NOXA1"
     . SPARSER::COLLECTION)
    ("cIAP-2 as well as anti-apoptosis family member Bclx, and Bcl-2 proteins"
     . SPARSER::COLLECTION)
    ("increased cIAP-1, cIAP-2 as well as anti-apoptosis family member Bclx, and Bcl-2 proteins"
     . SPARSER::COLLECTION)
    ("Bclx, and Bcl-2" . SPARSER::COLLECTION) ("Bclx" . SPARSER::PROTEIN)
    ("survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein (IAP)" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NuB1, FuB1, NuB2, FuB2, and NuB3" . SPARSER::COLLECTION)
    ("ERK and phospho-ERK" . SPARSER::COLLECTION) ("iNOS" . SPARSER::PROTEIN)
    ("EPI or FIB" . SPARSER::COLLECTION)
    ("differential trypsinization" . SPARSER::PROTEIN)
    ("EPI and FIB" . SPARSER::COLLECTION) ("EPI" . SPARSER::PROTEIN)
    ("trypsinization" . SPARSER::PROTEIN) ("Ethanol" . SPARSER::PROTEIN)
    ("Nox1, Nox2, and Nox4" . SPARSER::COLLECTION)
    ("smoke" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("asbestos" . SPARSER::MOLECULE)
    ("human gingival mucosal (GM) keratinocytes" . SPARSER::PROTEIN)
    ("GM" . SPARSER::PROTEIN) ("the latter case" . SPARSER::PROTEIN)
    ("multi-step" . SPARSER::COLLECTION)
    ("oncogene or oncogene-like" . SPARSER::COLLECTION)
    ("a mitogenic oxidase" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("Mox1" . SPARSER::PROTEIN) ("Mox" . SPARSER::PROTEIN)
    ("the respiratory burst oxidase" . SPARSER::PROTEIN)
    ("Nox1, Nox3, Nox4 and Nox5" . SPARSER::COLLECTION)
    ("Nox2" . SPARSER::PROTEIN) ("Nox5" . SPARSER::PROTEIN)
    ("oxidase" . SPARSER::PROTEIN) ("ROS and NADPH" . SPARSER::COLLECTION)
    ("ROS-" . SPARSER::PROTEIN)
    ("mesenchymal vimentin and simple cytokeratins (CK)" . SPARSER::COLLECTION)
    ("cytokeratins (CK)" . SPARSER::PROTEIN-FAMILY)
    ("mesenchymal vimentin" . SPARSER::PROTEIN)
    ("actin and caldesmon" . SPARSER::COLLECTION)
    ("caldesmon" . SPARSER::PROTEIN) ("myogenic" . SPARSER::PROTEIN)
    ("CK" . SPARSER::PROTEIN) ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("FIB and NuB1" . SPARSER::COLLECTION) ("NuB1" . SPARSER::PROTEIN)
    ("NuB" . SPARSER::PROTEIN) ("FIB" . SPARSER::PROTEIN)
    ("E6/E7" . SPARSER::COLLECTION) ("Nox1" . SPARSER::PROTEIN)
    ("ethanol" . SPARSER::PROTEIN) ("Gö6983" . SPARSER::DRUG)
    ("N-acetyl- l -cysteine" . SPARSER::MOLECULE) ("MMP-3" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("MEF2B" . SPARSER::PROTEIN) ("NOXA1" . SPARSER::PROTEIN)
    ("NOXO1" . SPARSER::PROTEIN) ("p67 phox" . SPARSER::PROTEIN)
    ("p47 phox" . SPARSER::PROTEIN) ("cIAP-2" . SPARSER::PROTEIN)
    ("p27KIP1" . SPARSER::PROTEIN) ("p16 INK4a" . SPARSER::PROTEIN)
    ("FuB1" . SPARSER::PROTEIN) ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("12-O- tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogenic oxidase1" . SPARSER::PROTEIN) ("Nox3" . SPARSER::PROTEIN)
    ("gp91 phox" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("somewhat different types" . TYPE) ("PFK" . SPARSER::PROTEIN)
    ("P-value" . SPARSER::PROTEIN) ("P-values" . SPARSER::PROTEIN)
    ("MNF" . SPARSER::PROTEIN) ("meta-P-value" . SPARSER::PROTEIN-PAIR)
    ("PFKM" . SPARSER::PROTEIN) ("phosphofructokinase" . SPARSER::PROTEIN)
    ("type VII" . SPARSER::PROTEIN)
    ("fructose-1,6-bisphosphate" . SPARSER::PROTEIN)
    ("MAP3K1" . SPARSER::PROTEIN) ("Colon Cancer" . SPARSER::PROTEIN)
    ("a GPCR and the synthase" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE)
    ("cyclooxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DP1 and ERK1/2" . SPARSER::COLLECTION)
    ("L-PGDS–ERK1/2" . SPARSER::COLLECTION)
    ("proper conformation or assembly of DP1" . SPARSER::COLLECTION)
    ("L-PGDS–DP1" . SPARSER::COLLECTION)
    ("effectors and regulators" . SPARSER::COLLECTION)
    ("DP1–L-PGDS–ERK1/2" . SPARSER::COLLECTION) ("–Rac1" . SPARSER::COLLECTION)
    ("rhodopsin" . SPARSER::PROTEIN)
    ("L-PGDS–W43A/G47A" . SPARSER::PROTEIN-PAIR)
    ("Hsp90–DP1" . SPARSER::COLLECTION)
    ("Hsp90–L-PGDS–DP1" . SPARSER::COLLECTION)
    ("its intrinsic ATPase activity" . SPARSER::PROTEIN)
    ("L-PGDS and H-PGDS" . SPARSER::COLLECTION) ("PG" . SPARSER::PROTEIN)
    ("class A GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER and TGN" . SPARSER::COLLECTION)
    ("DP1, ERK1/2, and L-PGDS" . SPARSER::COLLECTION)
    ("DP1 and endogenous ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2 and L-PGDS" . SPARSER::COLLECTION)
    ("L-PGDS and ERK1/2" . SPARSER::COLLECTION) ("BWA" . SPARSER::PROTEIN)
    ("exogenous PGD 2" . SPARSER::PROTEIN)
    ("DP1 and β 2" . SPARSER::COLLECTION) ("DP1 or β 2" . SPARSER::COLLECTION)
    ("LPGDS" . SPARSER::PROTEIN) ("DP1–L-PGDS–Hsp90" . SPARSER::COLLECTION)
    ("L-PGDS–Hsp90" . SPARSER::COLLECTION)
    ("chaperone and L-PGDS" . SPARSER::COLLECTION)
    ("Hsp90–DP1 receptor" . SPARSER::COLLECTION)
    ("Hsp90 and the receptor" . SPARSER::COLLECTION)
    ("DP1 and the Hsp90 ΔMEEVD mutant" . SPARSER::COLLECTION)
    ("receptor and full-length" . SPARSER::COLLECTION)
    ("L-PGDS and the receptor" . SPARSER::COLLECTION)
    ("Hsp90 and DP1" . SPARSER::COLLECTION)
    ("endogenous Hsp90 and the L-PGDS–W43A/G47A mutant" . SPARSER::COLLECTION)
    ("Glu and Asp" . SPARSER::COLLECTION) ("Val or Met" . SPARSER::COLLECTION)
    ("TPR" . SPARSER::PROTEIN) ("L-PGDS and Hsc70" . SPARSER::COLLECTION)
    ("L-PGDS and Hsp90" . SPARSER::COLLECTION)
    ("L-PGDS and the Hsp90 ΔMEEVD mutant" . SPARSER::COLLECTION)
    ("L-PGDS and full-length" . SPARSER::COLLECTION)
    ("Hsp90-HA" . SPARSER::COLLECTION) ("L-PGDS–Myc" . SPARSER::COLLECTION)
    ("TPRs" . SPARSER::PROTEIN)
    ("chaperones and co-chaperones" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT) ("BW" . SPARSER::PROTEIN)
    ("HA-DP1" . SPARSER::COLLECTION)
    ("CRTH2 (the other PGD 2 receptor) and other GPCRs" . SPARSER::COLLECTION)
    ("the wild-type arginine vasopressin receptor 2 and its intracellularly trapped W164S and Y205C mutants ( xref )"
     . SPARSER::COLLECTION)
    ("-adrenergic" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("DP1–L-PGDS" . SPARSER::COLLECTION)
    ("proteins and receptor" . SPARSER::COLLECTION)
    ("DP1 or L-PGDS" . SPARSER::COLLECTION)
    ("GST-DP1-ICL3" . SPARSER::COLLECTION)
    ("GST-DP1-ICL1" . SPARSER::COLLECTION)
    ("GST-DP1-ICL2" . SPARSER::COLLECTION) ("ICL" . SPARSER::PROTEIN)
    ("TGN" . SPARSER::PROTEIN) ("L-PGDS–HA" . SPARSER::COLLECTION)
    ("Flag-DP1" . SPARSER::COLLECTION) ("PDI" . SPARSER::PROTEIN)
    ("L-PGDS and DP1" . SPARSER::COLLECTION)
    ("DP1 and L-PGDS" . SPARSER::COLLECTION)
    ("ubiquitous cytoplasmic chaperone" . SPARSER::PROTEIN)
    ("the D prostanoid receptor (DP1) and the chemoattractant receptor-homologous molecule"
     . SPARSER::COLLECTION)
    ("G protein–coupled receptors (GPCRs), the D prostanoid receptor (DP1) and the chemoattractant receptor-homologous molecule"
     . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("The glutathione-dependent hematopoietic PGD 2 synthase"
     . SPARSER::PROTEIN)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PGs" . SPARSER::PROTEIN)
    ("a DP1–ERK1/2 complex and increases DP1-mediated ERK1/2 signaling"
     . SPARSER::COLLECTION)
    ("DP1–ERK1/2" . SPARSER::COLLECTION) ("DP1–Hsp90" . SPARSER::COLLECTION)
    ("synthase" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("lipocalin" . SPARSER::PROTEIN) ("V2R" . SPARSER::PROTEIN)
    ("β 2 AR" . SPARSER::PROTEIN) ("R-250" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("Grp94" . SPARSER::PROTEIN)
    ("B12)" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("COX-1" . SPARSER::PROTEIN) ("CB2" . SPARSER::PROTEIN)
    ("PAR1" . SPARSER::PROTEIN) ("protein 4" . SPARSER::PROTEIN)
    ("RTP4" . SPARSER::PROTEIN) ("opioid receptor" . SPARSER::PROTEIN)
    ("ANKRD13" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("DP1 receptor" . SPARSER::PROTEIN)
    ("arginine vasopressin receptor 2" . SPARSER::PROTEIN)
    ("thromboxane A 2 receptor" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ICL1" . SPARSER::PROTEIN)
    ("ICL2" . SPARSER::PROTEIN) ("TGN46" . SPARSER::PROTEIN)
    ("protein disulfide isomerase" . SPARSER::PROTEIN)
    ("DP2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRTH2" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("H-PGDS" . SPARSER::PROTEIN)
    ("PGD 2 synthase" . SPARSER::PROTEIN) ("PGH 2" . SPARSER::MOLECULE)
    ("G protein–coupled" . SPARSER::PROTEIN) ("PGD 2" . SPARSER::PROTEIN)
    ("L-PGDS" . SPARSER::PROTEIN) ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERBB2 or PyMT" . SPARSER::COLLECTION) ("MEC" . SPARSER::PROTEIN)
    ("MECs" . SPARSER::PROTEIN) ("AKT1 and EGFR" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor and tyrosine kinase"
     . SPARSER::COLLECTION)
    ("ERBB2 and basal-like" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("indirect autophagy inhibitor chloroquine (CQ)" . SPARSER::PROTEIN)
    ("chloroquine (CQ)" . SPARSER::PROTEIN)
    ("ERBB2, LC3B, SQSTM1 and MKI67" . SPARSER::COLLECTION)
    ("NEU-" . SPARSER::PROTEIN) ("NEU" . SPARSER::PROTEIN)
    ("BECN1 and LC3B" . SPARSER::COLLECTION)
    ("BCL2-expressing Becn1  +/+ and Becn1  +/− iMMECs" . SPARSER::COLLECTION)
    ("autophagic puncta" . SPARSER::PROTEIN)
    ("the essential autophagy regulators BECN1 and ATG7" . SPARSER::COLLECTION)
    ("BECN1 and ATG7" . SPARSER::COLLECTION)
    ("SQSTM1/p62" . SPARSER::COLLECTION)
    ("the autophagic flux inhibitor" . SPARSER::INHIBITOR)
    ("EGFP-LC3B" . SPARSER::COLLECTION) ("BafA" . SPARSER::PROTEIN)
    ("larger human breast cancer gene" . SPARSER::PROTEIN)
    ("Neu and MMTV-" . SPARSER::COLLECTION) ("MMTV-" . SPARSER::PROTEIN)
    ("Neu" . SPARSER::PROTEIN) ("MMTV" . SPARSER::PROTEIN)
    ("the humanized mouse monoclonal ERBB2 antibody trastuzumab"
     . SPARSER::DRUG)
    ("TP53 , PTEN, and PIK3CA" . SPARSER::COLLECTION)
    ("BECN1 and ERBB2" . SPARSER::COLLECTION)
    ("ERBB2-TOP2A" . SPARSER::COLLECTION)
    ("ERBB3, and ERBB4" . SPARSER::COLLECTION)
    ("ERBB2/HER2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("the essential autophagy gene" . SPARSER::PROTEIN)
    ("ERBB2-" . SPARSER::PROTEIN) ("Becn1" . SPARSER::PROTEIN)
    ("the essential autophagy regulator BECN1" . SPARSER::PROTEIN)
    ("mas5" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("MM1" . SPARSER::PROTEIN) ("Bafilomycin A 1" . SPARSER::DRUG)
    ("cc1" . SPARSER::PROTEIN) ("MKI67" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("p62" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SQSTM1" . SPARSER::PROTEIN)
    ("bafilomycin A 1" . SPARSER::DRUG) ("LC3B" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("homolog 2" . SPARSER::PROTEIN)
    ("v-erb" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("ERBB2" . SPARSER::PROTEIN)
    ("CBP, PTEN and p27 KIP1" . SPARSER::COLLECTION)
    ("DAB2IP and p27 KIP1" . SPARSER::COLLECTION)
    ("two Cbp alleles and one Pten allele" . SPARSER::COLLECTION)
    ("the AKT phosphatase PHLPP1 and the impaired FKBP51-PHLPP1 complex"
     . SPARSER::COLLECTION)
    ("FKBP51-PHLPP1" . SPARSER::COLLECTION) ("abl" . SPARSER::PROTEIN)
    ("primary PCa" . SPARSER::PROTEIN) ("metastatic PCa" . SPARSER::PROTEIN)
    ("a generic histone acetyltransferase" . SPARSER::PROTEIN)
    ("CBP and/or PTEN co-depletion" . SPARSER::COLLECTION)
    ("XIAP and BCL-xL" . SPARSER::COLLECTION)
    ("Caspase 3 and PARP" . SPARSER::COLLECTION) ("XIAP" . SPARSER::PROTEIN)
    ("H3K27Ac and a decrease in H3K27me3 levels" . SPARSER::COLLECTION)
    ("SAHA" . SPARSER::DRUG) ("chondrocytes" . SPARSER::PROTEIN)
    ("Cinnamic acid hydroxamate panobinostat" . SPARSER::DRUG)
    ("hydroxamate" . SPARSER::MOLECULE)
    ("H3K27Ac and an increase in H3K27me3 in bulk histones in human PCa cells and an H3K27Ac-to-H3K27me3 switch in the mouse prostate"
     . SPARSER::COLLECTION)
    ("the adjacent noncancerous Cbp" . SPARSER::PROTEIN)
    ("S21-p" . SPARSER::COLLECTION) ("PTEN and CBP" . SPARSER::COLLECTION)
    ("Dab2ip , p27 Kip1 and p21 Cip1" . SPARSER::COLLECTION)
    ("Ezh2" . SPARSER::PROTEIN)
    ("H3K27me3 and downregulation of H3K27Ac" . SPARSER::COLLECTION)
    ("MEF and DU145" . SPARSER::COLLECTION)
    ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("EZH2-mediated H3K27me3 and gene repression ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("H3K27Ac and H3K27me3" . SPARSER::COLLECTION)
    ("CBP and/or PTEN" . SPARSER::COLLECTION)
    ("p27 KIP1 , p21 CIP1 and DAB2IP" . SPARSER::COLLECTION)
    ("p27 Kip1 and Dab2ip" . SPARSER::COLLECTION)
    ("P27 Kip1 and Dab2ip" . SPARSER::COLLECTION)
    ("surprisingly Pten protein" . SPARSER::PROTEIN)
    ("Akt-p" . SPARSER::COLLECTION)
    ("p27 Kip1 , p21 Cip1 and Dab2ip" . SPARSER::COLLECTION)
    ("Dab2ip" . SPARSER::PROTEIN)
    ("KIP1 ,p21 CIP1 and DAB2IP" . SPARSER::COLLECTION)
    ("p27 KIP1 and p21 CIP1" . SPARSER::COLLECTION)
    ("several key cell cycle-driven proteins" . SPARSER::PROTEIN)
    ("CDK1, CDK2, CDK6 and cyclin B1" . SPARSER::COLLECTION)
    ("CBP/PTEN" . SPARSER::COLLECTION)
    ("p27 KIP1 and DAB2IP" . SPARSER::COLLECTION) ("VP" . SPARSER::PROTEIN)
    ("DLP" . SPARSER::PROTEIN) ("TMA and IHC approaches" . SPARSER::COLLECTION)
    ("Cbp and Pten" . SPARSER::COLLECTION)
    ("a hematologic tumor suppressor" . SPARSER::SUPPRESSOR)
    ("CREBBP" . SPARSER::PROTEIN) ("panobinostat" . SPARSER::DRUG)
    ("Cbp" . SPARSER::PROTEIN) ("CBP and PTEN" . SPARSER::COLLECTION)
    ("FKBP51" . SPARSER::PROTEIN) ("BCL-xL" . SPARSER::PROTEIN)
    ("PHLPP1" . SPARSER::PROTEIN) ("P27 Kip1" . SPARSER::PROTEIN)
    ("Dab2" . SPARSER::PROTEIN) ("KIP1" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDK6" . SPARSER::PROTEIN)
    ("LBH589" . SPARSER::DRUG) ("H3K27Ac" . SPARSER::MOLECULE)
    ("CIP1" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("DAB2IP" . SPARSER::PROTEIN)
    ("the mesenchymal markers vimentin and MMP9" . SPARSER::COLLECTION)
    ("vimentin and MMP9" . SPARSER::COLLECTION)
    ("Snail, Slug and Twist" . SPARSER::COLLECTION)
    ("SOCS3 and miR203" . SPARSER::COLLECTION)
    ("JAK and the gp130 IL-6 receptor" . SPARSER::COLLECTION)
    ("IL6-IL6R-JAK" . SPARSER::COLLECTION)
    ("IL-6 or STAT3" . SPARSER::COLLECTION) ("HBx" . SPARSER::PROTEIN)
    ("x" . SPARSER::PROTEIN) ("a secondary target" . SPARSER::TARGET-PROTEIN)
    ("the mature form" . SPARSER::FORM) ("p16 or p53" . SPARSER::COLLECTION)
    ("siRNA and let-7a" . SPARSER::COLLECTION)
    ("relatively less phospho-STAT3" . SPARSER::PROTEIN)
    ("protein inhibitor of activated STAT3 (PIAS3) and SOCS3"
     . SPARSER::COLLECTION)
    ("exogenous IL-6" . SPARSER::PROTEIN)
    ("STAT3 or IL-6" . SPARSER::COLLECTION)
    ("STAT3 and IL-6" . SPARSER::COLLECTION)
    ("VEGF and CycD1" . SPARSER::COLLECTION)
    ("VEGF, CycD1 and MMP9" . SPARSER::COLLECTION)
    ("HMGA2, Lin28a and Lin28b" . SPARSER::COLLECTION)
    ("Lin28b" . SPARSER::PROTEIN) ("Lin28a" . SPARSER::PROTEIN)
    ("KRas (in both lines) and HMGA2 (in Panc1 only) proteins"
     . SPARSER::COLLECTION)
    ("KRas" . SPARSER::PROTEIN) ("miRNA or let-7a" . SPARSER::COLLECTION)
    ("mesenchymal marker vimentin and fibronectin" . SPARSER::COLLECTION)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("only few E-cadherin" . SPARSER::PROTEIN)
    ("Sh-RNA and let-7a or let-7f" . SPARSER::COLLECTION)
    ("Twist" . SPARSER::PROTEIN) ("distinct nuclear" . SPARSER::PROTEIN)
    ("c" . SPARSER::PROTEIN) ("MP-Sh" . SPARSER::COLLECTION)
    ("Sh" . SPARSER::PROTEIN-FAMILY) ("MP" . SPARSER::PROTEIN)
    ("the angiogenic factor VEGF" . SPARSER::PROTEIN)
    ("ASPC" . SPARSER::PROTEIN)
    ("STAT3 or its activator IL-6" . SPARSER::COLLECTION)
    ("Panc1 and MiaPaCa" . SPARSER::COLLECTION)
    ("c-src" . SPARSER::PROTEIN-PAIR) ("src" . SPARSER::PROTEIN)
    ("kinase (JAK)" . SPARSER::KINASE)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("these frequently-mutated genes" . SPARSER::GENE)
    ("p16/CDKN2A" . SPARSER::COLLECTION)
    ("STAT3 protein or its activator cytokine interleukin 6 (IL-6)"
     . SPARSER::COLLECTION)
    ("Let -7" . SPARSER::RNA) ("IL6R" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("protein inhibitor of activated STAT3" . SPARSER::PROTEIN)
    ("CycD1" . SPARSER::PROTEIN) ("e-cadherin" . SPARSER::PROTEIN)
    ("PANC1" . SPARSER::PROTEIN) ("PIAS3" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("Sh-RNA" . SPARSER::RNA)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("murine leukemia virus" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN)
    ("cell cycle regulatory protein" . SPARSER::PROTEIN)
    ("high mobility group AT-hook 2" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("Let-7" . SPARSER::RNA)
    ("CB" . SPARSER::PROTEIN) ("MR and BP" . SPARSER::COLLECTION)
    ("BP" . SPARSER::PROTEIN) ("SH" . SPARSER::PROTEIN)
    ("AsA" . SPARSER::PROTEIN) ("Antioxidant" . SPARSER::PROTEIN)
    ("urethane" . SPARSER::MOLECULE) ("VEGFA and ADM" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 and/or oncogenes" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream target NQO1" . SPARSER::COLLECTION)
    ("both ST and oncogenic Ras" . SPARSER::COLLECTION)
    ("NADPH oxidase 4 (NOX4) and aldehyde oxidase 1 (AOX1)"
     . SPARSER::COLLECTION)
    ("PRAD-GSE21034" . SPARSER::COLLECTION)
    ("GCLM, GCLC and NQO1" . SPARSER::COLLECTION)
    ("adrenomedullin (ADM)" . SPARSER::PROTEIN) ("ADM" . SPARSER::PROTEIN)
    ("adrenomedullin" . SPARSER::PROTEIN)
    ("an angiogenic HIF-1α-downstream gene" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG)
    ("Annexin-V (FITC) and Propidium Iodide (Figure  xref A and Additional file xref : Figure S4)"
     . SPARSER::COLLECTION)
    ("Annexin-V (FITC) and Propidium Iodide (Figure  xref A)"
     . SPARSER::COLLECTION)
    ("Iodide" . SPARSER::PROTEIN) ("Propidium" . SPARSER::MOLECULE)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("tMSC and tHMEC" . SPARSER::COLLECTION) ("TBHQ" . SPARSER::PROTEIN)
    ("Keap1 (which is wild type in MSC, data not shown) and Cul3"
     . SPARSER::COLLECTION)
    ("Nrf2 nor NQO1 (Figure  xref D)" . SPARSER::COLLECTION)
    ("GSK690693, or PI3K" . SPARSER::COLLECTION)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("RAS and RAF" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("RAS and some RAS-downstream effectors" . SPARSER::COLLECTION)
    ("Nrf2 and ARE-containing genes" . SPARSER::COLLECTION)
    ("ST- and H-Ras" . SPARSER::COLLECTION) ("ST-" . SPARSER::PROTEIN)
    ("glutathione (GSH)" . SPARSER::DRUG) ("form (GSH)" . SPARSER::FORM)
    ("GSR" . SPARSER::PROTEIN) ("GCLC and GCLM" . SPARSER::COLLECTION)
    ("GSS" . SPARSER::PROTEIN) ("a major redox" . SPARSER::PROTEIN)
    ("the most powerful antioxidants" . SPARSER::DRUG) ("GSSG" . SPARSER::DRUG)
    ("MSC3 and MSC4" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("soft agarose" . SPARSER::MOLECULE)
    ("immortal MSC3 (Figure  xref E) or MSC1 (data not shown)"
     . SPARSER::COLLECTION)
    ("immortal MSC3" . SPARSER::PROTEIN) ("DCFDA" . SPARSER::DRUG)
    ("immortal MSC1" . SPARSER::PROTEIN) ("Red" . SPARSER::PROTEIN)
    ("MitoSOX" . SPARSER::DRUG) ("tMSC" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("p53 and pRB" . SPARSER::COLLECTION)
    ("the human telomerase (hTERT) gene (MSC1) and the oncoproteins E6 and E7"
     . SPARSER::COLLECTION)
    ("primary MSC" . SPARSER::PROTEIN) ("E6 and E7" . SPARSER::COLLECTION)
    ("MSC1" . SPARSER::PROTEIN) ("Keap1 or Nrf2" . SPARSER::COLLECTION)
    ("family and genes" . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("antioxidant and detoxification genes
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("VEGFA" . SPARSER::PROTEIN) ("RAS/RAF/ERK" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG) ("transformed MSC" . SPARSER::PROTEIN)
    ("MSC" . SPARSER::PROTEIN) ("Tert-butylhydroquinone" . SPARSER::DRUG)
    ("Glo 3" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G6PD" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("AOX1" . SPARSER::PROTEIN) ("aldehyde oxidase 1" . SPARSER::PROTEIN)
    ("NOX4" . SPARSER::PROTEIN) ("NADPH oxidase 4" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("topoisomerase II" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG) ("Cul3" . SPARSER::PROTEIN)
    ("GSK690693" . SPARSER::DRUG) ("H-RAS" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("glutathione synthetase" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("CM-H" . SPARSER::MOLECULE)
    ("MSC3" . SPARSER::PROTEIN) ("nrf2" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("PYC, LSC and CHC" . SPARSER::COLLECTION) ("LSC" . SPARSER::PROTEIN)
    ("PYC, SFC, and CHC" . SPARSER::COLLECTION) ("CHC" . SPARSER::PROTEIN)
    ("SFC" . SPARSER::PROTEIN) ("PYC and SCL" . SPARSER::COLLECTION)
    ("SCL" . SPARSER::PROTEIN) ("PYC" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE) ("deoxycytidine" . SPARSER::PROTEIN)
    ("the cardiovascular risk factors oxLDL and homocysteine"
     . SPARSER::COLLECTION)
    ("homocysteine and oxLDL" . SPARSER::COLLECTION)
    ("oxLDL and homocysteine" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("LOX-1 , ANXA5 , BAX , and CASP3" . SPARSER::COLLECTION)
    ("BCL2 and cIAP-1" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE) ("atherogenic oxLDL" . SPARSER::PROTEIN)
    ("oxLDL-FGF2" . SPARSER::COLLECTION) ("anion" . SPARSER::MOLECULE)
    ("oxLDL and MDA-LDL" . SPARSER::COLLECTION)
    ("both oxLDL and electronegative LDL" . SPARSER::COLLECTION)
    ("a heterotrimeric G protein" . SPARSER::PROTEIN)
    ("electronegative LDL" . SPARSER::PROTEIN)
    ("a potent angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("DNMT3A , and DNMT3B" . SPARSER::COLLECTION) ("AS" . SPARSER::PROTEIN)
    ("OxLDL and MDA" . SPARSER::COLLECTION)
    ("MDA and oxLDL" . SPARSER::COLLECTION)
    ("oxLDL and anti-MDA" . SPARSER::COLLECTION) ("PBS " . SPARSER::PROTEIN)
    ("trypan" . SPARSER::DRUG) ("FGF2 and oxLDL" . SPARSER::COLLECTION)
    ("oxLDL and MDA" . SPARSER::COLLECTION)
    ("endothelial FGF2" . SPARSER::PROTEIN)
    ("a pleiotropic protein" . SPARSER::PROTEIN)
    ("exogenous FGF2" . SPARSER::PROTEIN)
    ("Malondialdehyde" . SPARSER::MOLECULE)
    ("chemokines, cytokines, and growth factors" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN)
    ("the FGF2 promoter and repression of FGF2 transcription"
     . SPARSER::COLLECTION)
    ("OxLDL" . SPARSER::PROTEIN)
    ("prosurvival fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("apoB" . SPARSER::PROTEIN) ("MDA" . SPARSER::DRUG)
    ("malondialdehyde" . SPARSER::MOLECULE) ("oxLDL" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("Apolipoprotein B" . SPARSER::PROTEIN) ("cIAP-1" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("ANXA5" . SPARSER::PROTEIN) ("LOX-1" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("1 L" . SPARSER::PROTEIN) ("thiobarbituric acid" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("clathrin and caveolin" . SPARSER::COLLECTION)
    ("RAS-PI3K" . SPARSER::COLLECTION) ("MEK-ERK" . SPARSER::COLLECTION)
    ("U0126 and PDGF-AA" . SPARSER::COLLECTION)
    ("PDGFRA and Giantin" . SPARSER::COLLECTION)
    ("Rab11 and EEA-1" . SPARSER::COLLECTION)
    ("The other endocytotic protein clathrin" . SPARSER::PROTEIN)
    ("PDGFRA and caveolin-1" . SPARSER::COLLECTION)
    ("caveolin- and clathrin" . SPARSER::COLLECTION)
    ("caveolin-" . SPARSER::PROTEIN)
    ("PD98059, PD325901 and CI-1040" . SPARSER::COLLECTION)
    ("western-blot" . SPARSER::PROTEIN)
    ("PD0325901, PD098059 and CI-1040" . SPARSER::COLLECTION)
    ("KU-0063794, Deforolimus and Rapamycin" . SPARSER::COLLECTION)
    ("Deforolimus" . SPARSER::DRUG) ("Perifosine" . SPARSER::PROTEIN)
    ("a strong and reversible inhibitor" . SPARSER::INHIBITOR)
    ("PI3K-AKT" . SPARSER::COLLECTION) ("Dyn" . SPARSER::PROTEIN)
    ("dynasore" . SPARSER::MOLECULE) ("LB" . SPARSER::PROTEIN)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("PDGFRA or other RTKs" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("the retroviral gene" . SPARSER::GENE) ("PDGFB" . SPARSER::PROTEIN)
    ("RAB11 and early endosomal antigen-1" . SPARSER::COLLECTION)
    ("Giantin" . SPARSER::PROTEIN)
    ("tubulin, actin and dynamin" . SPARSER::COLLECTION)
    ("dynamin" . SPARSER::PROTEIN)
    ("an essential pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p42 MAPK" . SPARSER::PROTEIN) ("ml 7" . SPARSER::MOLECULE)
    ("vitamin A" . SPARSER::MOLECULE) ("sodium bicarbonate" . SPARSER::DRUG)
    ("FGF2" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("KU0063794" . SPARSER::DRUG) ("PD184352" . SPARSER::DRUG)
    ("Growth Factors" . SPARSER::GROWTH-FACTOR) ("EEA1" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("EEA-1" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN) ("PD325901" . SPARSER::DRUG)
    ("PD98059" . SPARSER::MOLECULE) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("KU-0063794" . SPARSER::DRUG) ("CI-1040" . SPARSER::DRUG)
    ("PD098059" . SPARSER::DRUG) ("PD0325901" . SPARSER::DRUG)
    ("LY290042" . SPARSER::DRUG) ("latrunculin B" . SPARSER::DRUG)
    ("IDH1" . SPARSER::PROTEIN) ("RAB11" . SPARSER::PROTEIN)
    ("pleiotropic genes" . SPARSER::GENE)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("ABAT and VEGFC" . SPARSER::COLLECTION)
    ("FYN , VEGFC , and PDE3A" . SPARSER::COLLECTION)
    ("These pleiotropic genetic variants" . SPARSER::VARIANT)
    ("ion" . SPARSER::MOLECULE) ("associated genes" . SPARSER::GENE)
    ("NTKR2" . SPARSER::PROTEIN) ("BDNF-NTRK2" . SPARSER::COLLECTION)
    ("BDNF-NTKR2" . SPARSER::PROTEIN-PAIR) ("PRPN" . SPARSER::MOLECULE)
    ("phosphoprotein" . SPARSER::PROTEIN) ("PRNP" . SPARSER::PROTEIN)
    ("calcium/calmodulin-dependent protein kinase II alpha)"
     . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN) ("PGC" . SPARSER::PROTEIN)
    ("ADHD" . SPARSER::PROTEIN) ("VEGFC" . SPARSER::PROTEIN)
    ("Fgr" . SPARSER::PROTEIN) ("FYN" . SPARSER::PROTEIN)
    ("ABAT" . SPARSER::PROTEIN)
    ("at least one additional proximal SNP" . SPARSER::PROTEIN)
    ("nominal p" . SPARSER::PROTEIN) ("GC  " . SPARSER::PROTEIN)
    ("receptors and inositol-1,4" . SPARSER::COLLECTION)
    ("inositol" . SPARSER::PROTEIN) ("NDMA" . SPARSER::MOLECULE)
    ("State" . SPARSER::BIO-STATE) ("CACNA1C" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN)
    ("N-methyl-d-aspartate" . SPARSER::MOLECULE) ("NTRK2" . SPARSER::PROTEIN)
    ("STIP1" . SPARSER::PROTEIN) ("prion protein" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("CAMK2A" . SPARSER::PROTEIN)
    ("leucine rich repeat containing 7" . SPARSER::PROTEIN)
    ("LRRC7" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor C" . SPARSER::PROTEIN)
    ("cGMP-inhibited" . SPARSER::PROTEIN)
    ("phosphodiesterase 3A" . SPARSER::PROTEIN) ("PDE3A" . SPARSER::PROTEIN)
    ("4-aminobutyrate aminotransferase" . SPARSER::PROTEIN)
    ("IP3" . SPARSER::IP3) ("only one SNP" . SPARSER::PROTEIN)
    ("ADPRT/PARP1" . SPARSER::COLLECTION)
    ("ADP-ribo-syl" . SPARSER::COLLECTION) ("syl" . SPARSER::PROTEIN)
    ("generated wider CIs" . SPARSER::PROTEIN) ("FPRP " . SPARSER::PROTEIN)
    ("Rest" . SPARSER::PROTEIN) ("XRCC1 or APE" . SPARSER::COLLECTION)
    ("APE" . SPARSER::PROTEIN)
    ("only 46 publications met" . SPARSER::AMINO-ACID)
    ("MAF" . SPARSER::PROTEIN) ("ADPRT" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::PROTEIN)
    ("genotoxic chemicals and products" . SPARSER::COLLECTION)
    ("genotoxic chemicals" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE)
    ("Ala variant (Ala/Ala or Ala/Val genotype) and cancer risk"
     . SPARSER::COLLECTION)
    ("Ala/Val" . SPARSER::COLLECTION) ("Ala/Ala" . SPARSER::COLLECTION)
    ("FPRP" . SPARSER::PROTEIN) ("DNA-binding protein" . SPARSER::PROTEIN)
    ("ADPRT 1" . SPARSER::PROTEIN) ("ADPRT1" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("family member 1" . SPARSER::PROTEIN)
    ("abrogated ubiquitin ligase" . SPARSER::PROTEIN)
    ("Gly" . SPARSER::AMINO-ACID)
    ("another exhibited inconclusive ligase activity" . SPARSER::PROTEIN)
    ("ions" . SPARSER::MOLECULE)
    ("clearly not pathogenic variants" . SPARSER::VARIANT)
    ("ENIGMA" . SPARSER::PROTEIN)
    ("naturally occurring isoforms" . SPARSER::ISOFORM)
    ("Pro" . SPARSER::AMINO-ACID) ("Leu" . SPARSER::AMINO-ACID)
    ("LMO4, JunB and HDACs" . SPARSER::COLLECTION) ("JunB" . SPARSER::PROTEIN)
    ("polypeptides and small nuclear RNAs" . SPARSER::COLLECTION)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("the 19 exonic variants" . SPARSER::VARIANT)
    ("variant, and class" . SPARSER::COLLECTION) ("NMD" . SPARSER::PROTEIN)
    ("HSF and MaxEntScan" . SPARSER::COLLECTION)
    ("the last base" . SPARSER::PROTEIN)
    ("the last nucleotide" . SPARSER::NUCLEOTIDE)
    ("HSF, MaxEntScan and NNsplice" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN) ("Variants" . SPARSER::VARIANT)
    ("19 BRCA1 and BRCA2 exonic variants" . SPARSER::VARIANT)
    ("the intron-exon boundary or silent variants" . SPARSER::VARIANT)
    ("exonic variants" . SPARSER::VARIANT)
    ("an exonic variant" . SPARSER::VARIANT)
    ("intron-exon" . SPARSER::COLLECTION) ("Class" . CLASS)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("LMO4" . SPARSER::PROTEIN)
    ("small nuclear RNAs" . SPARSER::RNA) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("Class 4" . SPARSER::PROTEIN) ("class 2" . SPARSER::PROTEIN)
    ("Class 2" . SPARSER::PROTEIN) ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("BARD1" . SPARSER::PROTEIN)
    ("the healthy control group" . SPARSER::MOLECULE)
    ("IMPACT" . SPARSER::PROTEIN)
    ("a retrospective female cohort" . SPARSER::MOLECULE)
    ("two distinct cohorts" . SPARSER::MOLECULE)
    ("IL-22 and IL-10" . SPARSER::COLLECTION) ("dimers" . SPARSER::DIMER)
    ("IKK" . SPARSER::PROTEIN) ("IkB" . SPARSER::PROTEIN)
    ("pERK" . SPARSER::PROTEIN) ("epithelial TLR4" . SPARSER::PROTEIN)
    ("IL-17 or CXCL13" . SPARSER::COLLECTION)
    ("IL-17-CXCL13" . SPARSER::COLLECTION) ("Il10" . SPARSER::PROTEIN)
    ("CREB, C/EBP, STAT3 and AP-1" . SPARSER::COLLECTION)
    ("IL-6 and the anti-inflammatory IL-22" . SPARSER::COLLECTION)
    ("CREB and NF-κB" . SPARSER::COLLECTION)
    ("p38, ERK1/2 and AP-1" . SPARSER::COLLECTION)
    ("Akt and p38" . SPARSER::COLLECTION)
    ("ERK1/2, p38 and JNK" . SPARSER::COLLECTION)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adhesin" . SPARSER::PROTEIN) ("invasin" . SPARSER::PROTEIN)
    ("TLR2 (p = 0.0063) or TLR4 (p = 0.0047)" . SPARSER::COLLECTION)
    ("TLR2 or TLR4" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::PROTEIN) ("TNFα or IFNγ" . SPARSER::COLLECTION)
    ("IL-6 and IL-10" . SPARSER::COLLECTION)
    ("IFNγ and TNFα" . SPARSER::COLLECTION)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IκB and pGSK3αβ" . SPARSER::COLLECTION) ("NF-κB-" . SPARSER::PROTEIN)
    ("ERK1/2 and cFos" . SPARSER::COLLECTION) ("cFos" . SPARSER::PROTEIN)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("kDa and LAM" . SPARSER::COLLECTION)
    ("mycobacterial virulence factor LAM" . SPARSER::PROTEIN)
    ("the virulence factor 19 kDa and the TLR4 agonist LPS ( xref )"
     . SPARSER::COLLECTION)
    ("p38 and pGSK3αβ" . SPARSER::COLLECTION)
    ("LAM and 19 kDa" . SPARSER::COLLECTION)
    ("mycobacterial virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("p38 and Akt" . SPARSER::COLLECTION) ("LPS" . SPARSER::PROTEIN)
    ("BCG" . SPARSER::DRUG) ("alveolar nuclear" . SPARSER::PROTEIN)
    ("NF-κB and c-Jun" . SPARSER::COLLECTION)
    ("Akt or p38" . SPARSER::COLLECTION)
    ("proteins and c-Jun" . SPARSER::COLLECTION)
    ("IRAK-NF-κB" . SPARSER::COLLECTION) ("IRAK" . SPARSER::PROTEIN)
    ("Ligand" . SPARSER::LIGAND) ("PPAR" . SPARSER::PROTEIN)
    ("LAM" . SPARSER::PROTEIN) ("TLR" . SPARSER::PROTEIN)
    ("tilt" . SPARSER::DRUG) ("the infectious foci" . SPARSER::PROTEIN)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("TNFα and IFNγ" . SPARSER::COLLECTION)
    ("IL-10 and IL-22" . SPARSER::COLLECTION) ("peroxisome" . SPARSER::PROTEIN)
    ("kinase (GSK)" . SPARSER::KINASE) ("TLR2 and TLR4" . SPARSER::COLLECTION)
    ("PI3K–Akt" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("NF-kB" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("CREB-1" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("RSK1" . SPARSER::PROTEIN) ("Pyk2" . SPARSER::PROTEIN)
    ("S46" . SPARSER::PROTEIN) ("p38 alpha" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("S21" . SPARSER::PROTEIN) ("GSK-3 alpha" . SPARSER::PROTEIN)
    ("Chk-2" . SPARSER::PROTEIN) ("beta-Catenin" . SPARSER::PROTEIN)
    ("AMPK alpha2" . SPARSER::PROTEIN) ("AMPK alpha1" . SPARSER::PROTEIN)
    ("Phospho-Kinase" . SPARSER::PROTEIN) ("Phospho-kinase" . SPARSER::PROTEIN)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("NBP1" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("Collagen-1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP3Ks" . SPARSER::PROTEIN-FAMILY) ("IL-22" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR4" . SPARSER::PROTEIN) ("FoxOs and CHD" . SPARSER::COLLECTION)
    ("T-cell receptor and B-cell receptor (TCR and BCR)" . SPARSER::COLLECTION)
    ("IL-1, IL-6, TNF-α, T-cell receptor and B-cell receptor (TCR and BCR)"
     . SPARSER::COLLECTION)
    ("BCR" . SPARSER::PROTEIN) ("T-cell and macrophage" . SPARSER::COLLECTION)
    ("apoE" . SPARSER::PROTEIN)
    ("oxidant and antioxidant" . SPARSER::COLLECTION)
    ("oxidant" . SPARSER::PROTEIN)
    ("uncontrollable and controllable factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Oxygen" . SPARSER::MOLECULE) ("elastin" . SPARSER::PROTEIN)
    ("neither FoxO1 nor FoxO3" . SPARSER::COLLECTION)
    ("FoxO1/FoxO3" . SPARSER::COLLECTION)
    ("FoxO1 and two tagging SNPs" . SPARSER::COLLECTION)
    ("MetS" . SPARSER::PROTEIN)
    ("458 age- and sex-matched non-CHD" . SPARSER::COLLECTION)
    ("829 age- and sex-matched non-CHD" . SPARSER::COLLECTION)
    ("age-" . SPARSER::PROTEIN) ("agonists" . SPARSER::AGONIST)
    ("FoxO1 and/or FoxO3 are/is" . SPARSER::COLLECTION)
    ("FoxO1, FoxO3, FoxO4 and FoxO6" . SPARSER::COLLECTION)
    ("FoxO6" . SPARSER::PROTEIN) ("insulin/IGF-1" . SPARSER::COLLECTION)
    ("Forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("modifiable factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FoxO1 and FoxO3" . SPARSER::COLLECTION)
    ("FoxO1 nor the variants" . SPARSER::COLLECTION)
    ("FoxO1 and two SNPs" . SPARSER::COLLECTION)
    ("FoxO1 (rs2755209, rs2721072, rs4325427 and rs17592371) and two tagging SNPs"
     . SPARSER::COLLECTION)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY) ("CHD" . SPARSER::PROTEIN)
    ("peroxiredoxin III" . SPARSER::PROTEIN) ("HDL-C" . SPARSER::MOLECULE)
    ("FoxO4" . SPARSER::PROTEIN) ("FoxO3" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COOH" . SPARSER::PROTEIN) ("rays" . SPARSER::PROTEIN)
    ("Base" . SPARSER::PROTEIN)
    ("neoconservative amino acid" . SPARSER::AMINO-ACID)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("bind MDM2 and/or MDM4" . SPARSER::COLLECTION)
    ("both p53 and Nbs1-mediated DNA" . SPARSER::COLLECTION)
    ("Mdm2 and Nbs1" . SPARSER::COLLECTION)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION)
    ("Mdm4 and p53" . SPARSER::COLLECTION) ("only lack p53" . SPARSER::PROTEIN)
    ("MDM2 or MDM4" . SPARSER::COLLECTION)
    ("MDM2 and/or MDM4" . SPARSER::COLLECTION)
    ("MDM2 and/or MDM4 ( xref ; xref ; xref ; xref ; xref ; xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("An adjacent SNP" . SPARSER::PROTEIN) ("Modifiers" . SPARSER::MOLECULE)
    ("mutant p53 as well as wild-type p53 ( xref )" . SPARSER::COLLECTION)
    ("the tumor type and the rate" . SPARSER::COLLECTION)
    ("the type and the number of primary tumors that develop"
     . SPARSER::COLLECTION)
    ("MDM" . SPARSER::PROTEIN) ("MDM4 or MDM2" . SPARSER::COLLECTION)
    ("an artificial promoter" . SPARSER::PROMOTER)
    ("MDM2 and/or MDM4 ( xref ; xref )" . SPARSER::COLLECTION)
    ("just one allele" . SPARSER::ALLELE)
    ("proteins and p53" . SPARSER::COLLECTION) ("Mdm" . SPARSER::PROTEIN)
    ("-myc" . SPARSER::COLLECTION)
    ("precisely Mdm2 and Mdm4" . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION) ("Mdm2 or Mdm4" . SPARSER::COLLECTION)
    ("Hausp/USP7" . SPARSER::COLLECTION) ("Hausp" . SPARSER::PROTEIN)
    ("Arf and/or p53" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("lacked just Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arf and p53" . SPARSER::COLLECTION)
    ("ARF and TP53" . SPARSER::COLLECTION)
    ("functionally incompetent p53" . SPARSER::PROTEIN)
    ("p53 or ARF" . SPARSER::COLLECTION)
    ("a classic tumor suppressor" . SPARSER::SUPPRESSOR)
    ("p14 ARF and p16" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mdm4, and Mdm4:Mdm2" . SPARSER::COLLECTION)
    ("Mdm4:Mdm2" . SPARSER::BIO-COMPLEX)
    ("directly binds Mdm2 and holds Mdm2" . SPARSER::COLLECTION)
    ("directly binds Mdm2" . SPARSER::PROTEIN)
    ("Numerous other proteins bind Mdm2 and/or p53" . SPARSER::COLLECTION)
    ("a key cofactor" . SPARSER::MOLECULE) ("Mdm2-Mdm4" . SPARSER::COLLECTION)
    ("Mdm2/Mdm4" . SPARSER::COLLECTION) ("Melanoma" . SPARSER::PROTEIN)
    ("Retinoblastoma" . SPARSER::PROTEIN) ("retina" . SPARSER::DRUG)
    ("MdmX" . SPARSER::PROTEIN)
    ("the TP53 inhibitors MDM2 and/or MDM4" . SPARSER::COLLECTION)
    ("Sv" . SPARSER::MOLECULE) ("LFS" . SPARSER::PROTEIN)
    ("ultraviolet light" . SPARSER::PROTEIN) ("aflatoxin" . SPARSER::MOLECULE)
    ("NM" . SPARSER::PROTEIN) ("Mdm2 and Mdm4" . SPARSER::COLLECTION)
    ("p53 and its inhibitors" . SPARSER::COLLECTION)
    ("Mdm2 (MIM#164785) and Mdm4 (MIM#602704)" . SPARSER::COLLECTION)
    ("MIM" . SPARSER::PROTEIN) ("MDM2 and MDM4" . SPARSER::COLLECTION)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("USP7" . SPARSER::PROTEIN)
    ("herpesvirus-associated ubiquitin-specific protease" . SPARSER::PROTEIN)
    ("Ink4a" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("Mdm4" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("WANG, and Jin-su" . SPARSER::COLLECTION)
    ("Hui-min" . SPARSER::COLLECTION) ("WANG" . SPARSER::PROTEIN)
    ("HAN" . SPARSER::PROTEIN) ("longer PFS" . SPARSER::PROTEIN)
    ("NSE" . SPARSER::PROTEIN) ("Pan" . SPARSER::PROTEIN)
    ("Iressa" . SPARSER::DRUG) ("NCCN" . SPARSER::PROTEIN)
    ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("-tyrosine kinase" . SPARSER::COLLECTION) ("TKIs" . SPARSER::PROTEIN)
    ("Aim" . SPARSER::PROTEIN) ("CA125" . SPARSER::PROTEIN)
    ("neuron specific enolase" . SPARSER::PROTEIN)
    ("Carcinoembryonic antigen" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN)
    ("ATM or its downstream target Chk2" . SPARSER::COLLECTION)
    ("functional (wild-type) p53" . SPARSER::PROTEIN)
    ("Chk2 and other important substrates" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("ATM or TP53" . SPARSER::COLLECTION)
    ("Clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cerebellar ataxia" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("p53 and Chk2" . SPARSER::COLLECTION)
    ("PALB2, ATM , p16, PRSS1 and STK11" . SPARSER::COLLECTION)
    ("BRCA2, PALB2, p16, STK11, PRSS1 and ATM" . SPARSER::COLLECTION)
    ("normal TP53" . SPARSER::PROTEIN)
    ("found tumoral ATM loss/normal TP53" . SPARSER::PROTEIN)
    ("tumoral ATM loss/normal TP53" . SPARSER::PROTEIN)
    ("ATM and TP53" . SPARSER::COLLECTION)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SMAD4" . SPARSER::PROTEIN)
    ("PRSS1" . SPARSER::PROTEIN) ("CI1" . SPARSER::PROTEIN)
    ("dasatinib, paclitaxel, and carboplatin" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("NSC" . SPARSER::PROTEIN)
    ("ER/PR" . SPARSER::COLLECTION) ("RAF or MEK" . SPARSER::COLLECTION)
    ("BRAF/CRAF" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("MEK/ERK" . SPARSER::COLLECTION) ("Braf" . SPARSER::PROTEIN)
    ("HRAS/RAF/ERK" . SPARSER::COLLECTION)
    ("EphA2 and CAV-1" . SPARSER::COLLECTION) ("Eph" . SPARSER::PROTEIN)
    ("Ras, RAF-1, and MAPK" . SPARSER::COLLECTION)
    ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("receptor tyrosine kinases and their signaling effectors ( xref )"
     . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX)
    ("BRaf ( xref , top) and EphA2 ( xref , bottom)" . SPARSER::COLLECTION)
    ("complementary oligonucleotides" . SPARSER::MOLECULE)
    ("The secondary antibodies" . SPARSER::ANTIBODY)
    ("fluorochrome" . SPARSER::MOLECULE)
    ("BRaf or EphA2" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("BRaf and EphA2" . SPARSER::COLLECTION)
    ("BRaf and CAV-1" . SPARSER::COLLECTION)
    ("EphA2 and CAV-1, EphA2 and BRaf, and CAV-1 and BRaf"
     . SPARSER::COLLECTION)
    ("CAV-1, EphA2 and BRaf, and CAV-1 and BRaf" . SPARSER::COLLECTION)
    ("BRaf, and CAV-1 and BRaf" . SPARSER::COLLECTION)
    ("EphA2, CAV-1, and BRaf" . SPARSER::COLLECTION)
    ("CAV-1 and BRaf" . SPARSER::COLLECTION)
    ("KRAS and PI3K" . SPARSER::COLLECTION)
    ("total EphA2" . SPARSER::PROTEIN-FAMILY)
    ("wild-type EphA2" . SPARSER::PROTEIN-FAMILY)
    ("the traditional targets" . SPARSER::TARGET-PROTEIN)
    ("pSrc" . SPARSER::PROTEIN) ("FAK" . SPARSER::PROTEIN)
    ("HEC" . SPARSER::PROTEIN) ("EphA2 and BRaf" . SPARSER::COLLECTION)
    ("an oral dual inhibitor" . SPARSER::INHIBITOR)
    ("Bcr/Abl" . SPARSER::COLLECTION) ("Abl" . SPARSER::PROTEIN)
    ("Bcr" . SPARSER::PROTEIN) ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("BRaf/CRaf" . SPARSER::COLLECTION) ("BRaf" . SPARSER::PROTEIN)
    ("p70S6k" . SPARSER::PROTEIN) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("CRaf" . SPARSER::PROTEIN) ("RPPA" . SPARSER::PROTEIN)
    ("EphA2 and other kinases" . SPARSER::COLLECTION)
    ("Dasatinib" . SPARSER::DRUG) ("EphA2" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY) ("steroid hormone" . SPARSER::MOLECULE)
    ("p42/44" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("EPHA2" . SPARSER::PROTEIN) ("CAV-1" . SPARSER::PROTEIN)
    ("PDP1 and PDHA" . SPARSER::COLLECTION)
    ("ACAT1-PDP1-PDHA" . SPARSER::COLLECTION)
    ("acetoacetyl" . SPARSER::MOLECULE) ("lyase (ACLY)" . SPARSER::PROTEIN)
    ("ATP-citrate" . SPARSER::ATP) ("ACLY" . SPARSER::PROTEIN)
    ("lyase" . SPARSER::PROTEIN) ("citrate" . SPARSER::MOLECULE)
    ("SIRT2, and K5" . SPARSER::COLLECTION) ("Lv" . SPARSER::MOLECULE)
    ("Part" . SPARSER::COMPONENT)
    ("EGFR, FGFR1, FLT3 and JAK2" . SPARSER::COLLECTION)
    ("PDP1 and PDK1" . SPARSER::COLLECTION)
    ("PDP1 or PDHA1 and ACAT1" . SPARSER::COLLECTION)
    ("PDHA1 and ACAT1" . SPARSER::COLLECTION)
    ("either not part of PDC or the presence of these proteins"
     . SPARSER::COLLECTION)
    ("ACAT1, SIRT3 and PDP1" . SPARSER::COLLECTION)
    ("either not part of PDC or their presence" . SPARSER::COLLECTION)
    ("ACAT1 and PDK1" . SPARSER::COLLECTION)
    ("FGFR1 and EGFR" . SPARSER::COLLECTION)
    ("recombinant EGFR ( xref ) and several other tyrosine kinases"
     . SPARSER::COLLECTION)
    ("ABL, FLT3 and JAK2" . SPARSER::COLLECTION)
    ("PDP1-SIRT3" . SPARSER::COLLECTION) ("PDP1-ACAT1" . SPARSER::COLLECTION)
    ("PDHA1-SIRT3" . SPARSER::COLLECTION) ("PDHA1-ACAT1" . SPARSER::COLLECTION)
    ("a huge complex" . SPARSER::BIO-COMPLEX)
    ("PDP1 or PDHA1" . SPARSER::COLLECTION)
    ("ACAT1 and/or SIRT3" . SPARSER::COLLECTION)
    ("Myc-SIRT3" . SPARSER::COLLECTION) ("FLAG-ACAT1" . SPARSER::COLLECTION)
    ("PDHA and PDP1" . SPARSER::COLLECTION) ("PDHA" . SPARSER::PROTEIN)
    ("PDHA1, PDP1, ACAT1 and SIRT3" . SPARSER::COLLECTION)
    ("PDP1 and ACAT1" . SPARSER::COLLECTION)
    ("PDHA1 and SIRT3" . SPARSER::COLLECTION) ("IM" . SPARSER::PROTEIN)
    ("IMS" . SPARSER::PROTEIN-FAMILY)
    ("SIRT3-treated PDHA1 and PDP1" . SPARSER::COLLECTION)
    ("catalytically more active PDP1 K202R" . SPARSER::PROTEIN)
    ("FLAG-PDP1" . SPARSER::COLLECTION)
    ("catalytically less active PDP1 K202Q mutant" . SPARSER::MUTANT)
    ("HIF-1a and its target GLUT1 ( xref )" . SPARSER::COLLECTION)
    ("VEGF, GLUT1, CA9 and BHLHB2" . SPARSER::COLLECTION)
    ("PDP1 K202R or PDHA1 K321R" . SPARSER::COLLECTION)
    ("PDP-PDHA1" . SPARSER::COLLECTION)
    ("TAFII31 and AA-NAT" . SPARSER::COLLECTION) ("NAT" . SPARSER::PROTEIN)
    ("particular acetyltransferases" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("PDP1 and PDHA1" . SPARSER::COLLECTION)
    ("acetyl-deficient PDHA1 K321R or PDP1 K202R" . SPARSER::COLLECTION)
    ("PDHA1 or PDP1" . SPARSER::COLLECTION) ("AML" . SPARSER::PROTEIN)
    ("distinct leukemogenic tyrosine kinases" . SPARSER::KINASE)
    ("TEL-TrkC" . SPARSER::COLLECTION) ("TrkC" . SPARSER::PROTEIN)
    ("TEL" . SPARSER::PROTEIN) ("FOP" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN)
    ("acetyl-PDHA1 and acetyl-PDP1" . SPARSER::COLLECTION)
    ("beads-bound GST-PDP1 protein" . SPARSER::PROTEIN)
    ("PDP1-PDHA1" . SPARSER::COLLECTION)
    ("beads-bound purified GST-PDK1" . SPARSER::COLLECTION)
    ("GST-PDK1" . SPARSER::COLLECTION) ("FLAG-PDHA1" . SPARSER::COLLECTION)
    ("acetyl-mimetic K321Q variants" . SPARSER::VARIANT)
    ("PDHA1 as well as K202R and K202Q mutants" . SPARSER::COLLECTION)
    ("catalytically less active" . SPARSER::ACTIVE)
    ("catalytically more active" . SPARSER::ACTIVE)
    ("acetyl-mimetic K321Q mutants" . SPARSER::MUTANT)
    ("recombinant PDHA1 (~70%) and PDP1 (~50%)" . SPARSER::COLLECTION)
    ("acetyl-mimetic K→Q mutants" . SPARSER::MUTANT)
    ("GST-PDP1" . SPARSER::COLLECTION) ("GST-PDHA1" . SPARSER::COLLECTION)
    ("PDHA1 ( xref ; lower ) and PDP1 ( xref ; right )" . SPARSER::COLLECTION)
    ("PDHA1 () and PDP1 ()" . SPARSER::COLLECTION) ("CST" . SPARSER::PROTEIN)
    ("deacetylase inhibitors nicotinamide (NAM) and Trichostatin A (TSA)"
     . SPARSER::COLLECTION)
    ("nicotinamide (NAM)" . SPARSER::MOLECULE)
    ("Trichostatin" . SPARSER::MOLECULE) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("nicotinamide" . SPARSER::PROTEIN)
    ("Myc and HIF-1α" . SPARSER::COLLECTION)
    ("ATP and electron donors" . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE)
    ("dihydrolipoamide dehydrogenase (E3) as well as pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) ( xref )"
     . SPARSER::COLLECTION)
    ("pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) ( xref )"
     . SPARSER::COLLECTION)
    ("which binds pyruvate dehydrogenase" . SPARSER::PROTEIN)
    ("dihydrolipoyl" . SPARSER::PROTEIN)
    ("E1, E2 and E3" . SPARSER::COLLECTION) ("Glucose" . SPARSER::PROTEIN)
    ("lactate" . SPARSER::LACTATE) ("ACAT1 and SIRT3" . SPARSER::COLLECTION)
    ("acetyltransferase and deacetylase" . SPARSER::COLLECTION)
    ("PDHA1 and PDP1" . SPARSER::COLLECTION)
    ("phosphatase (PDP)" . SPARSER::PROTEIN) ("kinase (PDK)" . SPARSER::KINASE)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN) ("PDP" . SPARSER::PROTEIN)
    ("PDK" . SPARSER::PROTEIN) ("PDH" . SPARSER::PROTEIN)
    ("complex (PDC)" . SPARSER::BIO-COMPLEX) ("PDC" . SPARSER::PROTEIN)
    ("protein acetyltransferase" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("LDH-A" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("TKI258" . SPARSER::DRUG) ("SIRT5" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("BHLHB2" . SPARSER::PROTEIN)
    ("CA9" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("TAFII31" . SPARSER::PROTEIN) ("acetyltransferase 1" . SPARSER::PROTEIN)
    ("JAK2 V617F" . SPARSER::PROTEIN) ("K29" . SPARSER::PROTEIN)
    ("dihydrolipoamide dehydrogenase" . SPARSER::PROTEIN)
    ("E3BP" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("SIRT3" . SPARSER::PROTEIN)
    ("ACAT1" . SPARSER::PROTEIN) ("PDP1" . SPARSER::PROTEIN)
    ("PDHA1" . SPARSER::PROTEIN) ("BRCA2-" . SPARSER::PROTEIN)
    ("essential regulators" . SPARSER::REGULATOR)
    ("helicase" . SPARSER::PROTEIN) ("SDSA" . SPARSER::PROTEIN)
    ("Polymerases" . SPARSER::PROTEIN)
    ("at least 13 nuclear DNA polymerases" . SPARSER::PROTEIN)
    ("TLS" . SPARSER::PROTEIN) ("BRCA2 and PALB2—two" . SPARSER::COLLECTION)
    ("MUS81-EME1" . SPARSER::COLLECTION) ("nucleoprotein" . SPARSER::PROTEIN)
    ("WRN, BLM or SMARCAL1" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("helicases" . SPARSER::PROTEIN)
    ("BRCA2/PALB2" . SPARSER::COLLECTION)
    ("PALB2 and Polη" . SPARSER::COLLECTION)
    ("PALB2 and the BRC3/4" . SPARSER::COLLECTION)
    ("BRC3/4 or BRCA2" . SPARSER::COLLECTION) ("BRC3/4" . SPARSER::PROTEIN)
    ("GST-BRC3/4" . SPARSER::PROTEIN-PAIR)
    ("a smaller GST fragment" . SPARSER::FRAGMENT)
    ("PALB2 and piBRCA2" . SPARSER::COLLECTION) ("BRC" . SPARSER::PROTEIN)
    ("Exo" . SPARSER::PROTEIN) ("exonuclease" . SPARSER::PROTEIN)
    ("RecA" . SPARSER::PROTEIN) ("SSB" . SPARSER::PROTEIN)
    ("PALB2 or piBRCA2" . SPARSER::COLLECTION) ("exo" . SPARSER::PROTEIN)
    ("PALB2/BRCA2" . SPARSER::COLLECTION) ("minute-period" . SPARSER::PROTEIN)
    ("BRCA2 or piBRCA2" . SPARSER::COLLECTION)
    ("a homologous duplex DNA" . SPARSER::DNA)
    ("PALB2 or BRCA2" . SPARSER::COLLECTION)
    ("RAD51 and HR" . SPARSER::COLLECTION)
    ("PALB2, RAD51 or γ-H2AX" . SPARSER::COLLECTION)
    ("RPA and/or γ-H2AX co-localized" . SPARSER::COLLECTION)
    ("PALB2, BRCA2, RAD51, PCNA, RPA and/or γ-H2AX co-localized"
     . SPARSER::COLLECTION)
    ("Hela or Polη-εGFP-complemented" . SPARSER::COLLECTION)
    ("Hela" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("MMC, HU, and aphidicolin" . SPARSER::COLLECTION)
    ("aphidicolin or mitomicyn" . SPARSER::COLLECTION)
    ("MMC" . SPARSER::PROTEIN) ("aphidicolin" . SPARSER::PROTEIN)
    ("dimer (CPD)" . SPARSER::DIMER) ("-methylguanine" . SPARSER::MOLECULE)
    ("cyclobutane" . SPARSER::MOLECULE) ("variant (XPV)" . SPARSER::VARIANT)
    ("XPV" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("PCNA and RFC" . SPARSER::COLLECTION) ("I-SceI-" . SPARSER::PROTEIN)
    ("Ig" . SPARSER::MOLECULE) ("replicative-associated DNA" . SPARSER::DNA)
    ("p12" . SPARSER::PROTEIN) ("HR and gene" . SPARSER::COLLECTION)
    ("polymerases" . SPARSER::PROTEIN)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("PALB2 (FANCN) and BRCA2 (FANCD1)" . SPARSER::COLLECTION)
    ("FANCN" . SPARSER::PROTEIN)
    ("Tumor suppressor proteins PALB2 (Partner and localizer of BRCA2) and BRCA2 (breast cancer type 2 susceptibility protein)"
     . SPARSER::COLLECTION)
    ("PALB2 and BRCA2" . SPARSER::COLLECTION)
    ("PALB2, BRCA2 and Polη" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG) ("BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("Pol" . SPARSER::PROTEIN) ("eta" . SPARSER::PROTEIN)
    ("E.coli )" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("EME1" . SPARSER::PROTEIN) ("MUS81" . SPARSER::PROTEIN)
    ("SMARCAL1" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("RAD52" . SPARSER::PROTEIN) ("RAD51 D" . SPARSER::PROTEIN)
    ("cdt2" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN)
    ("Partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("transdermal estradiol" . SPARSER::PROTEIN)
    ("gonadotropins and testosterone" . SPARSER::COLLECTION)
    ("Transdermal estradiol" . SPARSER::PROTEIN)
    ("gonadotropin and testosterone" . SPARSER::COLLECTION)
    ("medroxyprogesterone" . SPARSER::DRUG)
    ("the chronological age" . SPARSER::PROTEIN)
    ("its potent androgenic metabolite dihydrotestosterone" . SPARSER::DRUG)
    ("dihydrotestosterone" . SPARSER::DRUG) ("Estrogens" . SPARSER::MOLECULE)
    ("The possible impact" . SPARSER::PROTEIN)
    ("ovarian estrogen" . SPARSER::MOLECULE)
    ("gonadotropins" . SPARSER::PROTEIN)
    ("placental sulfatase" . SPARSER::PROTEIN)
    ("isomerase" . SPARSER::ISOMERASE)
    ("fetal and maternal adrenals" . SPARSER::DRUG)
    ("adrenals" . SPARSER::DRUG)
    ("LH, FSH and testosterone" . SPARSER::COLLECTION)
    ("HDL" . SPARSER::PROTEIN) ("LDL" . SPARSER::PROTEIN)
    ("x-ray" . SPARSER::COLLECTION)
    ("androstenedione and 17α-" . SPARSER::COLLECTION)
    ("spurt" . SPARSER::PROTEIN) ("FSH and LH" . SPARSER::COLLECTION)
    ("estradiol and estrone" . SPARSER::COLLECTION) ("FSH" . SPARSER::PROTEIN)
    ("GnRH" . SPARSER::PROTEIN) ("hCG" . SPARSER::PROTEIN)
    ("deoxycortisol" . SPARSER::MOLECULE) ("ACTH" . SPARSER::PROTEIN)
    ("estriol or estradiol" . SPARSER::COLLECTION)
    ("sulfatase" . SPARSER::PROTEIN)
    ("estradiol and estriol" . SPARSER::COLLECTION) ("LH" . SPARSER::PROTEIN)
    ("a functional aromatase enzyme (ArKO) or estrogen receptor-α (α-ERKO)"
     . SPARSER::COLLECTION)
    ("Testosterone" . SPARSER::MOLECULE)
    ("VI and intron" . SPARSER::COLLECTION) ("arom" . SPARSER::PROTEIN)
    ("VI" . SPARSER::PROTEIN) ("steroidogenic" . SPARSER::PROTEIN)
    ("estrone, estradiol and estriol" . SPARSER::COLLECTION)
    ("estrone" . SPARSER::DRUG) ("sulfate" . SPARSER::MOLECULE)
    ("Estrogen" . SPARSER::MOLECULE)
    ("androgen and estrogen" . SPARSER::COLLECTION)
    ("androstenedione and testosterone" . SPARSER::COLLECTION)
    ("androstenedione" . SPARSER::PROTEIN) ("DHEAS" . SPARSER::MOLECULE)
    ("estradiol and 300–450 micromoles (80–120 mg)" . SPARSER::COLLECTION)
    ("pg" . SPARSER::MOLECULE) ("estriol" . SPARSER::DRUG)
    ("the CYP19A1 (aromatase) and ESR1 (estrogen receptor-α, ERα) genes"
     . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN) ("XX" . SPARSER::PROTEIN)
    ("Aromatase" . SPARSER::PROTEIN) ("ethinyl estradiol" . SPARSER::DRUG)
    ("of pregnancy" . SPARSER::PROTEIN) ("P450arom" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY)
    ("aromatase activity" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("dehydroepiandrosterone sulfate" . SPARSER::MOLECULE)
    ("CYP19A1" . SPARSER::PROTEIN) ("LS" . SPARSER::PROTEIN)
    ("ABF" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("undefined tumor-suppressive targets" . SPARSER::TARGET-PROTEIN)
    ("Smurf2 -null MEFs" . SPARSER::PROTEIN)
    ("The exact impact" . SPARSER::PROTEIN) ("RB-" . SPARSER::PROTEIN)
    ("Smurf2 mRNA and modestly increased levels of the protein"
     . SPARSER::COLLECTION)
    ("MDM2/HDM2" . SPARSER::COLLECTION)
    ("the type I TGF-β receptor and the Smad-associated co-repressor SnoN"
     . SPARSER::COLLECTION)
    ("the Smad-associated co-repressor SnoN" . SPARSER::PROTEIN)
    ("Smurf2-Smad7" . SPARSER::COLLECTION) ("SnoN" . SPARSER::PROTEIN)
    ("the expansive state" . SPARSER::BIO-STATE)
    ("GFP-RB" . SPARSER::COLLECTION) ("protein (GFP)" . SPARSER::PROTEIN)
    ("tumor suppressor gene (RB)" . SPARSER::PROTEIN)
    ("miR16" . SPARSER::PROTEIN) ("miR-15b and miR-16" . SPARSER::COLLECTION)
    ("family and miR-128" . SPARSER::COLLECTION)
    ("miR-15b and miR-16 (binding to Smurf2 3′UTR, 5′-GCUGCUA-3′)"
     . SPARSER::COLLECTION)
    ("-GCUGCUA-3" . SPARSER::COLLECTION) ("-CACUGUGA-3" . SPARSER::COLLECTION)
    ("TN" . SPARSER::PROTEIN) ("robust Smurf2" . SPARSER::PROTEIN)
    ("estrogen receptor (ER) and progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("HECT" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Progesterone receptor" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("E2F-1" . SPARSER::PROTEIN)
    ("RB protein" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNF20" . SPARSER::PROTEIN) ("miR-15b" . SPARSER::MOLECULE)
    ("SMURF2" . SPARSER::PROTEIN) ("Smurf2" . SPARSER::PROTEIN)
    ("RS, SS and HK" . SPARSER::COLLECTION) ("HK" . SPARSER::PROTEIN)
    ("RS" . SPARSER::PROTEIN)
    ("an indirect metformin target" . SPARSER::TARGET-PROTEIN)
    ("the MID1 translational regulator complex" . SPARSER::BIO-COMPLEX)
    ("CAM" . SPARSER::PROTEIN)
    ("androgen and/or AR
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("PCOS" . SPARSER::PROTEIN) ("PDPK" . SPARSER::PROTEIN)
    ("PTEN-Akt" . SPARSER::COLLECTION) ("bicalutamide" . SPARSER::DRUG)
    ("antiandrogen" . SPARSER::DRUG) ("α4" . SPARSER::PROTEIN)
    ("this translational regulator complex" . SPARSER::BIO-COMPLEX)
    ("metformin and AR" . SPARSER::COLLECTION)
    ("the MID1-α4/PP2A ribonuclear protein complex" . SPARSER::BIO-COMPLEX)
    ("its associated mRNAs" . SPARSER::PROTEIN)
    ("α4-IP" . SPARSER::PROTEIN-PAIR) ("MIDAS" . SPARSER::PROTEIN)
    ("MID1, α4 and PP2A" . SPARSER::COLLECTION)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("the responsible target" . SPARSER::TARGET-PROTEIN)
    ("the MID1-α4/PP2A translational regulator complex" . SPARSER::BIO-COMPLEX)
    ("MID1 and α4" . SPARSER::COLLECTION)
    ("metformin and compound-C" . SPARSER::COLLECTION)
    ("the AMP mimetic AICAR" . SPARSER::PROTEIN) ("AICAR" . SPARSER::PROTEIN)
    ("AR positive cell lines LNCaP and DuCaP AMPK" . SPARSER::COLLECTION)
    ("Du145 and PC3" . SPARSER::COLLECTION) ("EP" . SPARSER::PROTEIN)
    ("PC-3" . SPARSER::COLLECTION) ("PC" . SPARSER::PROTEIN)
    ("the MID1 ribonuclear complex" . SPARSER::BIO-COMPLEX)
    ("huntingtin" . SPARSER::PROTEIN) ("associated mRNAs" . SPARSER::PROTEIN)
    ("complex-associated mRNAs" . SPARSER::PROTEIN)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a microtubule-associated ribonuclear protein complex"
     . SPARSER::BIO-COMPLEX)
    ("tau" . SPARSER::PROTEIN) ("kinase kinase" . SPARSER::KINASE)
    ("p53-p21" . SPARSER::COLLECTION) ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("a catabolic state" . SPARSER::BIO-STATE)
    ("protein, glucose and lipid" . SPARSER::COLLECTION)
    ("GLUT1 and GLUT4" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN)
    ("enzymes and fructose-1" . SPARSER::COLLECTION)
    ("ATP/AMP" . SPARSER::PROTEIN-PAIR) ("fructose" . SPARSER::PROTEIN)
    ("these ambiguous data metformin" . SPARSER::DRUG)
    ("an important indirect target" . SPARSER::TARGET-PROTEIN)
    ("MID1 or α4" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("the associated AR mRNA" . SPARSER::RNA)
    ("the AR translational MID1 regulator complex" . SPARSER::BIO-COMPLEX)
    ("Metformin" . SPARSER::DRUG)
    ("5-Aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("MMP14" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("S1B" . SPARSER::PROTEIN) ("chemo-attractants" . SPARSER::PROTEIN)
    ("protein phosphatase 2A" . SPARSER::PROTEIN)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG) ("PP2A" . SPARSER::PROTEIN)
    ("MID1" . SPARSER::PROTEIN) ("PZP" . SPARSER::PROTEIN)
    ("FN and PEPD" . SPARSER::COLLECTION)
    ("IgG, IgA, and IgM" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("IgA" . SPARSER::PROTEIN) ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("both minimal and advanced PTB" . SPARSER::PROTEIN)
    ("retinoic acid, and RBP4" . SPARSER::COLLECTION)
    ("exogenous retinoic acid" . SPARSER::MOLECULE)
    ("metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an insoluble oligomer" . SPARSER::MOLECULE)
    ("cellular fibronectin" . SPARSER::PROTEIN)
    ("a soluble dimer" . SPARSER::DIMER) ("oligomer" . SPARSER::MOLECULE)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("the moderate and advanced PTB" . SPARSER::PROTEIN)
    ("the minimal, moderate, and advanced PTB" . SPARSER::PROTEIN)
    ("Swiss-Prot" . SPARSER::COLLECTION) ("Prot" . SPARSER::PROTEIN)
    ("hydroxyproline" . SPARSER::MOLECULE)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fibronectin" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::PROTEIN)
    ("mannose" . SPARSER::MOLECULE) ("MBL" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("defensins" . SPARSER::PROTEIN)
    ("MTB" . SPARSER::PROTEIN) ("TB" . SPARSER::PROTEIN)
    ("C4b, FN, and PEPD" . SPARSER::COLLECTION)
    ("C4b and globulin" . SPARSER::COLLECTION)
    ("PEPD and CRP" . SPARSER::COLLECTION)
    ("C4b and albumin" . SPARSER::COLLECTION) ("albumin" . SPARSER::PROTEIN)
    ("prealbumin" . SPARSER::PROTEIN) ("CRP" . SPARSER::PROTEIN)
    ("the minimal PTB group" . SPARSER::MOLECULE)
    ("the minimal and advanced PTB" . SPARSER::PROTEIN)
    ("C4b and PEPD" . SPARSER::COLLECTION) ("minimal PTB" . SPARSER::PROTEIN)
    ("PEPD" . SPARSER::PROTEIN) ("prolidase" . SPARSER::PROTEIN)
    ("FN" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("α 5 β 1" . SPARSER::PROTEIN)
    ("Retinol-binding protein 4" . SPARSER::PROTEIN)
    ("retinoic acid" . SPARSER::MOLECULE) ("P12955" . SPARSER::PROTEIN)
    ("P02751" . SPARSER::PROTEIN) ("P20851" . SPARSER::PROTEIN)
    ("TIMP-2" . SPARSER::PROTEIN)
    ("tissue inhibitor of metalloproteinases" . SPARSER::PROTEIN)
    ("mannose-binding" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN) ("C4b" . SPARSER::PROTEIN)
    ("GEM or other chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("pre- and post-chemotherapy" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::PROTEIN)
    ("acetylated-p53, p21, and FOXO3a" . SPARSER::COLLECTION)
    ("sirtinol and splitomicin, and siRNA" . SPARSER::COLLECTION)
    ("splitomicin, and siRNA" . SPARSER::COLLECTION)
    ("splitomicin" . SPARSER::DRUG) ("sirtinol" . SPARSER::DRUG)
    ("Ota" . SPARSER::MOLECULE) ("HIC1, p53, and p73" . SPARSER::COLLECTION)
    ("targets and factors" . SPARSER::COLLECTION)
    ("primary colon cancer" . SPARSER::PROTEIN)
    ("promoter or suppressor" . SPARSER::COLLECTION)
    ("FOXO3a and p21" . SPARSER::COLLECTION)
    ("FOXO3a, and p21 protein" . SPARSER::COLLECTION)
    ("AC-p53" . SPARSER::COLLECTION) ("AC" . SPARSER::PROTEIN)
    ("EX527 or GEM" . SPARSER::COLLECTION)
    ("GEM or EX527" . SPARSER::COLLECTION)
    ("GEM (50 μg/mL, 4.81 ± 0.68%) or EX527 (2 μM, 6.06 ± 0.63%)"
     . SPARSER::COLLECTION)
    ("GEM and EX527" . SPARSER::COLLECTION)
    ("EX527 and GEM" . SPARSER::COLLECTION)
    ("EX527 and chemotherapy drugs" . SPARSER::COLLECTION)
    ("IC" . SPARSER::PROTEIN) ("line, and SIRT1" . SPARSER::COLLECTION)
    ("factors, and NF-κB" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("GEM" . SPARSER::PROTEIN)
    ("SIRT1, acetylated-p53, FOXO3a, and p21" . SPARSER::COLLECTION)
    ("special inhibitor EX527" . SPARSER::DRUG) ("HIC1" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN)
    ("heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO3a" . SPARSER::PROTEIN) ("EX527" . SPARSER::DRUG)
    ("sirtuin 1" . SPARSER::PROTEIN)
    ("EGFR , MET , HER2 , and KRAS" . SPARSER::COLLECTION)
    ("Rac1-Pak-Mek1" . SPARSER::COLLECTION)
    ("PKCι-Par6-ECT2" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Normal ECT2" . SPARSER::PROTEIN)
    ("Rac 1, and Cdc42" . SPARSER::COLLECTION)
    ("the histological subtypes" . SPARSER::PROTEIN)
    ("Rho-specific exchange factors and cell cycle regulators"
     . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor and transforming protein"
     . SPARSER::COLLECTION)
    ("BACs, PACs, or cosmids" . SPARSER::COLLECTION)
    ("PACs" . SPARSER::PROTEIN) ("BACs" . SPARSER::PROTEIN)
    ("RFS" . SPARSER::PROTEIN) ("log–rank" . SPARSER::COLLECTION)
    ("ECT2 and Ki-67" . SPARSER::COLLECTION)
    ("ECT2 , EIF5A2 , PIK3CA , and TNFSF10" . SPARSER::COLLECTION)
    ("EVI1 , SKIL , and MUC4" . SPARSER::COLLECTION)
    ("ECT2 , EIF5A2 , EVI1 , PIK3CA , TNFSF10 , SKIL , and TERC"
     . SPARSER::COLLECTION)
    ("SKIL" . SPARSER::PROTEIN) ("pStage IA and those" . SPARSER::COLLECTION)
    ("Types" . TYPE) ("various histological types" . TYPE)
    ("KRAS , p53 , and EGFR" . SPARSER::COLLECTION)
    ("PIK3CA , BRAF , and HER2" . SPARSER::COLLECTION)
    ("ALK , ROS , and RET" . SPARSER::COLLECTION)
    ("new prognostic biomarkers" . SPARSER::MOLECULE)
    ("Erk1" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCι" . SPARSER::PROTEIN) ("Rac 1" . SPARSER::PROTEIN)
    ("HNF4a" . SPARSER::PROTEIN) ("TTF-1" . SPARSER::PROTEIN)
    ("transforming protein" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("CEN3" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MUC4" . SPARSER::PROTEIN) ("mucin 4" . SPARSER::PROTEIN)
    ("EVI1" . SPARSER::PROTEIN)
    ("ecotropic viral integration site 1" . SPARSER::PROTEIN)
    ("TNFSF10" . SPARSER::PROTEIN) ("member 10" . SPARSER::PROTEIN)
    ("tumor necrosis factor (ligand) superfamily" . SPARSER::PROTEIN)
    ("EIF5A2" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 5A2" . SPARSER::PROTEIN)
    ("epithelial cell transforming sequence 2 oncogene" . SPARSER::PROTEIN)
    ("A–F" . SPARSER::PROTEIN) ("ECT2" . SPARSER::PROTEIN)
    ("gene and risk" . SPARSER::COLLECTION)
    ("factors and complex" . SPARSER::COLLECTION) ("t " . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN) ("Lei" . SPARSER::PROTEIN)
    ("receptor ( VDR )" . SPARSER::RECEPTOR)
    ("genes and alleles" . SPARSER::COLLECTION)
    ("gene and estrogen receptor" . SPARSER::COLLECTION)
    ("etc" . SPARSER::PROTEIN) ("VDR" . SPARSER::PROTEIN)
    ("allele or genotype" . SPARSER::COLLECTION)
    ("a possible candidate gene" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("estradiol receptor" . SPARSER::PROTEIN) ("ESR 1" . SPARSER::PROTEIN)
    ("nuclear receptor" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("COL1A1" . SPARSER::PROTEIN)
    ("alpha 1" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE)
    ("the most aggressive form" . SPARSER::FORM)
    ("PI3-kinase or Akt" . SPARSER::COLLECTION)
    ("phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homozygous Pten inactivation synergizes" . SPARSER::PROTEIN)
    ("synergizes" . SPARSER::PROTEIN) ("CK19/Krt19" . SPARSER::COLLECTION)
    ("Krt7 and Krt18" . SPARSER::COLLECTION) ("Krt7" . SPARSER::PROTEIN)
    ("lobe" . SPARSER::PROTEIN) ("Adenoviral Cre" . SPARSER::PROTEIN)
    ("CGRP and synaptophysin" . SPARSER::COLLECTION)
    ("neuroendocrine markers calcitonin gene related peptide (CGRP) ( xref , inset) and synaptophysin ( xref )"
     . SPARSER::COLLECTION)
    ("calcitonin gene related peptide (CGRP)" . SPARSER::PROTEIN)
    ("CGRP" . SPARSER::PROTEIN) ("Cohorts" . SPARSER::MOLECULE)
    ("lox/lox" . SPARSER::COLLECTION) ("lox" . SPARSER::PROTEIN)
    ("This model uses Adenoviral Cre" . SPARSER::PROTEIN)
    ("AKT and mTOR" . SPARSER::COLLECTION) ("p53 and RB" . SPARSER::COLLECTION)
    ("PTEN/PI3-kinase" . SPARSER::COLLECTION)
    ("PTEN/PIK3CA" . SPARSER::COLLECTION) ("Krt19" . SPARSER::PROTEIN)
    ("Krt18" . SPARSER::PROTEIN) ("cytokeratin 19" . SPARSER::PROTEIN)
    ("calcitonin gene related peptide" . SPARSER::PROTEIN)
    ("CK19" . SPARSER::PROTEIN)
    ("calcitonin gene-related peptide" . SPARSER::PROTEIN)
    ("study both the direct regulators" . SPARSER::REGULATOR)
    ("this difficult task" . SPARSER::PROTEIN)
    ("Rheb, PRAS40 or astrin" . SPARSER::COLLECTION)
    ("astrin" . SPARSER::PROTEIN) ("task" . SPARSER::PROTEIN)
    ("the optimal mTORC1 inhibitor" . SPARSER::INHIBITOR)
    ("myocardial ischemia" . SPARSER::PROTEIN)
    ("streptozotocin" . SPARSER::DRUG) ("cardiac Akt2" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN)
    ("Rheb and mTORC1" . SPARSER::COLLECTION)
    ("peripheral ischemia" . SPARSER::PROTEIN)
    ("Akt/mTOR" . SPARSER::COLLECTION)
    ("lipids and amino acids" . SPARSER::COLLECTION)
    ("cytokines and adipokines" . SPARSER::COLLECTION)
    ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("decarboxylase" . SPARSER::PROTEIN) ("malonyl" . SPARSER::PROTEIN)
    ("ERRα, PGC-1α and PPAR-α" . SPARSER::COLLECTION)
    ("dehydrogenase and hydroxyacyl-CoA" . SPARSER::COLLECTION)
    ("palmitoyl" . SPARSER::PROTEIN) ("enoyl" . SPARSER::MOLECULE)
    ("CoA" . SPARSER::MOLECULE) ("hydroxyacyl" . SPARSER::PROTEIN)
    ("acute myocardial ischemia" . SPARSER::PROTEIN)
    ("Ischemia" . SPARSER::PROTEIN) ("mPTP" . SPARSER::PROTEIN)
    ("dominant-negative GSK-3β" . SPARSER::PROTEIN)
    ("Simvastatin" . SPARSER::DRUG) ("PI3K or Akt1" . SPARSER::COLLECTION)
    ("PRAS40 or Rheb" . SPARSER::COLLECTION)
    ("Rapamycin and S6K" . SPARSER::COLLECTION)
    ("prolonged myocardial ischemia" . SPARSER::PROTEIN)
    ("Rheb/mTORC1" . SPARSER::COLLECTION) ("desmin" . SPARSER::PROTEIN)
    ("cardiac mTOR" . SPARSER::PROTEIN) ("MuRF1" . SPARSER::PROTEIN)
    ("MuRF" . SPARSER::PROTEIN) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("cardiac-specific mTORC2" . SPARSER::PROTEIN) ("BPs" . SPARSER::PROTEIN)
    ("a dominant-negative form" . SPARSER::FORM)
    ("isoproterenol" . SPARSER::PROTEIN) ("TRPC" . SPARSER::PROTEIN)
    ("TAC" . SPARSER::PROTEIN) ("sarcomeric proteins" . SPARSER::PROTEIN)
    ("the actual impact" . SPARSER::PROTEIN)
    ("hypomorphic mTOR alleles" . SPARSER::ALLELE)
    ("mTOR or raptor" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("Eif4ebp1" . SPARSER::PROTEIN) ("MHC-Cre" . SPARSER::COLLECTION)
    ("mTOR and Raptor" . SPARSER::COLLECTION)
    ("the postnatal period" . SPARSER::PROTEIN)
    ("PKC-α and RhoA" . SPARSER::COLLECTION)
    ("Akt and SGK1" . SPARSER::COLLECTION)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("insulin and growth factors" . SPARSER::COLLECTION)
    ("GTPases" . SPARSER::GTPASE) ("Rag" . SPARSER::PROTEIN)
    ("Akt, ERK1/2 and IKKβ" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("PRAK" . SPARSER::PROTEIN) ("AMPK and GSK-3β" . SPARSER::COLLECTION)
    ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin, IGF-1, PDGF and EGF" . SPARSER::COLLECTION)
    ("Akt and AMPK" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor-1α and SREBP1/2" . SPARSER::COLLECTION)
    ("pentose" . SPARSER::MOLECULE)
    ("factor and the transcription factor EB (TFEB) that can induce autophagy through the upregulation of autophagic proteins"
     . SPARSER::COLLECTION)
    ("transcription factor EB (TFEB)" . SPARSER::PROTEIN)
    ("TFEB" . SPARSER::PROTEIN) ("autophagic proteins" . SPARSER::PROTEIN)
    ("ULK1/Atg13/FIP200" . SPARSER::COLLECTION)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("TOP" . SPARSER::PROTEIN)
    ("substrates and regulators" . SPARSER::COLLECTION)
    ("PROTOR" . SPARSER::PROTEIN) ("DEPTOR" . SPARSER::PROTEIN)
    ("Raptor" . SPARSER::PROTEIN)
    ("Rapamycin and its analogs bind" . SPARSER::COLLECTION)
    ("a physical target" . SPARSER::TARGET-PROTEIN)
    ("TOR1 and TOR2" . SPARSER::COLLECTION)
    ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("pathological states" . SPARSER::BIO-STATE)
    ("an atypical serine/threonine kinase" . SPARSER::KINASE)
    ("tissue factor" . SPARSER::PROTEIN) ("PPAR-α" . SPARSER::PROTEIN)
    ("ERRα" . SPARSER::PROTEIN) ("acyl-CoA" . SPARSER::MOLECULE)
    ("Bnip3" . SPARSER::PROTEIN) ("SERCA2" . SPARSER::PROTEIN)
    ("Nox4" . SPARSER::PROTEIN) ("TIP60" . SPARSER::PROTEIN)
    ("Ulk1" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("TRIM63" . SPARSER::PROTEIN) ("SHP2" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6Ks" . SPARSER::PROTEIN) ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("nitric oxide" . SPARSER::MOLECULE) ("angiotensin-II" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("atg5" . SPARSER::PROTEIN) ("Eif4ebp" . SPARSER::PROTEIN-FAMILY)
    ("S6K" . SPARSER::PROTEIN) ("rheb1" . SPARSER::PROTEIN)
    ("PKC-α" . SPARSER::PROTEIN) ("MARK4" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("REDD1" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1α" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("transcription factor EB" . SPARSER::PROTEIN) ("Atg7" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("SIN1" . SPARSER::PROTEIN)
    ("Tel2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRAS40" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("TOR2" . SPARSER::PROTEIN) ("TOR1" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("Mechanistic Target of Rapamycin" . SPARSER::PROTEIN)
    ("relatively few families" . SPARSER::PROTEIN-FAMILY)
    ("the relevant HR" . SPARSER::PROTEIN)
    ("its nominal predictive risk class" . CLASS)
    ("The corresponding ovarian cancer HR" . SPARSER::PROTEIN)
    ("genes and diseases" . SPARSER::COLLECTION)
    ("the variant’s" . SPARSER::VARIANT) ("multiple-case" . SPARSER::PROTEIN)
    ("tetramers" . SPARSER::TETRAMER) ("tetramer" . SPARSER::TETRAMER)
    ("ETS1 or p53 R273H" . SPARSER::COLLECTION)
    ("genes, and miRNAs" . SPARSER::COLLECTION)
    ("Promoters" . SPARSER::PROMOTER)
    ("ETS1, and p53 R273H" . SPARSER::COLLECTION) ("Seq" . SPARSER::PROTEIN)
    ("included bidirectional promoters" . SPARSER::PROMOTER)
    ("ETS1 (571 promoters, xref ) and GABPA (1594 promoters, xref )"
     . SPARSER::COLLECTION)
    ("ETS 1 or GABP" . SPARSER::COLLECTION) ("GABP" . SPARSER::PROTEIN)
    ("ETS1/GABPA" . SPARSER::COLLECTION)
    ("a unidirectional promoter" . SPARSER::PROMOTER)
    ("a bidirectional promoter" . SPARSER::PROMOTER)
    ("the 1081 bidirectional promoters" . SPARSER::PROMOTER)
    ("binding bidirectional promoters" . SPARSER::PROMOTER)
    ("GABPA and ETS1" . SPARSER::COLLECTION)
    ("cancer-related genes and DNA repair genes [ xref ]"
     . SPARSER::COLLECTION)
    ("Genes" . SPARSER::GENE) ("Bidirectional promoters" . SPARSER::PROMOTER)
    ("ChlP-Seq" . SPARSER::COLLECTION) ("ChlP" . SPARSER::PROTEIN)
    ("p53 and ETS1" . SPARSER::COLLECTION)
    ("SP1 and ETS1" . SPARSER::COLLECTION)
    ("proteins, p63 and p73" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("wild-type p53's" . SPARSER::PROTEIN) ("GOF" . SPARSER::PROTEIN)
    ("ETS1 and p53 R273H" . SPARSER::COLLECTION)
    ("bidirectional promoters" . SPARSER::PROMOTER)
    ("ETS1 and GABPA" . SPARSER::COLLECTION) ("GABPA" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("ETS 1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("Vitamin D" . SPARSER::MOLECULE)
    ("NF-Y" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("β -catenin/CBP/Oct4" . SPARSER::COLLECTION)
    ("siRNA-AGS-Wnt1" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin D2" . SPARSER::COLLECTION)
    ("CD44-" . SPARSER::PROTEIN) ("Wnt1 and CSC" . SPARSER::COLLECTION)
    ("CD44, Oct4, and Wnt1" . SPARSER::COLLECTION)
    ("gastric CSC" . SPARSER::PROTEIN) ("exogenous Wnt1" . SPARSER::PROTEIN)
    ("CD44 and Oct4" . SPARSER::COLLECTION)
    ("a significantly greater fraction" . SPARSER::COMPONENT)
    ("AGS-Wnt1" . SPARSER::COLLECTION) ("antibiotic" . SPARSER::DRUG)
    ("CD44 and Wnt1" . SPARSER::COLLECTION)
    ("Wnt1 and CD44" . SPARSER::COLLECTION)
    ("CSC-associated Oct4 gene" . SPARSER::PROTEIN)
    ("Aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("Frizzled" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY) ("salinomycin" . SPARSER::DRUG)
    ("Wnt1 and β -catenin" . SPARSER::COLLECTION)
    ("Salinomycin" . SPARSER::DRUG) ("Oct4 and CD44" . SPARSER::COLLECTION)
    ("CSC" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("CCK8" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("Aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 5" . SPARSER::PROTEIN)
    ("VP-16" . SPARSER::DRUG) ("Wnt1" . SPARSER::PROTEIN)
    ("Microrna" . SPARSER::RNA) ("HBEGF" . SPARSER::PROTEIN)
    ("heparin" . SPARSER::PROTEIN)
    ("chemical drugs and immunotherapy" . SPARSER::COLLECTION)
    ("TERT and telomerase activity" . SPARSER::COLLECTION)
    ("temsirolimus and cyclosporine" . SPARSER::COLLECTION)
    ("cyclosporine" . SPARSER::DRUG) ("temsirolimus" . SPARSER::DRUG)
    ("phosphoramidates" . SPARSER::MOLECULE) ("Abacavir" . SPARSER::DRUG)
    ("azido" . SPARSER::MOLECULE) ("Nucleoside" . SPARSER::MOLECULE)
    ("analogs" . SPARSER::ANALOG) ("nucleoside" . SPARSER::MOLECULE)
    ("ribozymes" . SPARSER::RNA) ("PCNA and Ki-67" . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN)
    ("the higher miRNA expression group (relative quantity of miRNA > the average relative quantity of miRNA of all patients) or the lower miRNA expression group (relative quantity of miRNA ≤ average relative quantity of miRNA)"
     . SPARSER::COLLECTION)
    ("exogenous hTERT" . SPARSER::PROTEIN)
    ("Luc-hTERT-3" . SPARSER::COLLECTION)
    ("UTR and these five miRNAs" . SPARSER::COLLECTION)
    ("only five miRNAs" . SPARSER::MICRO-RNA) ("miRs" . SPARSER::MICRO-RNA)
    ("RQ" . SPARSER::MOLECULE) ("HF" . SPARSER::PROTEIN)
    ("GSE" . SPARSER::PROTEIN) ("c-Myc, AP-1 and E2F" . SPARSER::COLLECTION)
    ("WT1 and p53" . SPARSER::COLLECTION)
    ("cytometry and transwell" . SPARSER::COLLECTION)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("n3" . SPARSER::PROTEIN)
    ("dual-luciferase" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("a novel nucleolar regulator" . SPARSER::PROTEIN)
    ("other nucleolar regulator" . SPARSER::PROTEIN)
    ("nucleolar protein NPM" . SPARSER::PROTEIN) ("c-Myc-" . SPARSER::PROTEIN)
    ("c-Myc or EBP2" . SPARSER::COLLECTION)
    ("CPD-mutated form" . SPARSER::FORM) ("EBP2-3TA" . SPARSER::COLLECTION)
    ("β -catenin or IκB- α" . SPARSER::COLLECTION)
    ("GST-EBP2" . SPARSER::COLLECTION) ("Fbw7" . SPARSER::PROTEIN)
    ("CPD" . SPARSER::PROTEIN) ("c-Myc and EBP2" . SPARSER::COLLECTION)
    ("HA-c-Myc" . SPARSER::COLLECTION) ("EBP2 and c-Myc" . SPARSER::COLLECTION)
    ("nucleostemin" . SPARSER::PROTEIN) ("Ebp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPM" . SPARSER::PROTEIN) ("rDNA" . SPARSER::PROTEIN)
    ("Nick" . SPARSER::PROTEIN)
    ("nucleolar protein ENBA1 binding protein 2" . SPARSER::PROTEIN)
    ("nucleolar c-Myc" . SPARSER::PROTEIN) ("oncoprotein" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("PC9" . SPARSER::PROTEIN)
    ("IκB- α" . SPARSER::PROTEIN) ("Yeast homolog" . SPARSER::PROTEIN)
    ("RNA polymerase I" . SPARSER::PROTEIN)
    ("F-box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("EBP2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exhibited more severe MPN" . SPARSER::PROTEIN)
    ("Jak2V617F" . SPARSER::PROTEIN) ("the MF splenic HSCs" . SPARSER::PROTEIN)
    ("MF" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("HSC" . SPARSER::PROTEIN) ("the most severe MPN" . SPARSER::PROTEIN)
    ("only one allele" . SPARSER::ALLELE) ("MPL" . SPARSER::PROTEIN)
    ("Stat5 and Erk1/2" . SPARSER::COLLECTION)
    ("Stat5, Erk1/2 and Akt" . SPARSER::COLLECTION)
    ("Erk1/2 and/or Akt" . SPARSER::COLLECTION)
    ("Stat5, Erk1/2 and/or Akt" . SPARSER::COLLECTION)
    ("reticulin" . SPARSER::MOLECULE) ("Reticulin" . SPARSER::MOLECULE)
    ("atypical nuclear" . SPARSER::PROTEIN) ("EPO" . SPARSER::PROTEIN)
    ("LSK, MEP, CMP and GMP" . SPARSER::COLLECTION) ("GMP" . SPARSER::MOLECULE)
    ("CMP" . SPARSER::PROTEIN) ("LSK and MEP" . SPARSER::COLLECTION)
    ("CD41/CD61" . SPARSER::COLLECTION)
    ("neutrophils, and platelets" . SPARSER::COLLECTION)
    ("RBC" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("MEP" . SPARSER::PROTEIN) ("LSK" . SPARSER::PROTEIN)
    ("VF/VF" . SPARSER::COLLECTION) ("VF" . SPARSER::PROTEIN)
    ("neutrophils, reticulocytes and platelets" . SPARSER::COLLECTION)
    ("wild-type JAK2 (JAK2 WT) and JAK2V617F alleles" . SPARSER::COLLECTION)
    ("F protein" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("Sca1" . SPARSER::PROTEIN) ("Thy1" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1/2" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("stem cell factor" . SPARSER::PROTEIN) ("IL-11" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("CD127" . SPARSER::PROTEIN)
    ("FcγR" . SPARSER::PROTEIN-FAMILY) ("CD16" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("Thy-1" . SPARSER::PROTEIN) ("Gr-1" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("pI-pC" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("a functional PTEN" . SPARSER::PROTEIN)
    ("an attractive anti-PCa target" . SPARSER::TARGET-PROTEIN)
    ("Procyanidin" . SPARSER::DRUG) ("procyanidin" . SPARSER::DRUG)
    ("diferuloylmethane" . SPARSER::DRUG)
    ("p300 and CBP" . SPARSER::COLLECTION) ("bromodomain" . SPARSER::PROTEIN)
    ("AR and p300" . SPARSER::COLLECTION)
    ("a key transcriptional coactivator" . SPARSER::PROTEIN)
    ("AR and histone" . SPARSER::COLLECTION)
    ("androgen/AR" . SPARSER::COLLECTION)
    ("androgens and androgen" . SPARSER::COLLECTION)
    ("a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("oncogenic viral proteins" . SPARSER::PROTEIN)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("AR and p53" . SPARSER::COLLECTION) ("RAS and Myc" . SPARSER::COLLECTION)
    ("PSA, NKX3.1, HK2 and TMPRSS2" . SPARSER::COLLECTION)
    ("mibolerone" . SPARSER::DRUG) ("Pai-1" . SPARSER::PROTEIN)
    ("Nkx3.1 , and Mme" . SPARSER::COLLECTION) ("Mme" . SPARSER::PROTEIN)
    ("CDK1/cyclin B1" . SPARSER::COLLECTION)
    ("CDK1 and cyclin B1" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RB" . SPARSER::PROTEIN)
    ("p300 and PTEN" . SPARSER::COLLECTION) ("p300-AR" . SPARSER::COLLECTION)
    ("HAT" . SPARSER::PROTEIN) ("Polyubiquitination" . SPARSER::PROTEIN)
    ("p53, E2F1, ERG and SP1" . SPARSER::COLLECTION)
    ("PTEN and p300" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("p300 and AR and H&E" . SPARSER::COLLECTION)
    ("AR and H&E" . SPARSER::COLLECTION) ("prostatic" . SPARSER::PROTEIN)
    ("approximately 1% nonmalignant acini" . SPARSER::PROTEIN)
    ("approximately 60% LGPIN" . SPARSER::PROTEIN)
    ("approximately 10% LGPIN" . SPARSER::PROTEIN)
    ("malignant acini" . SPARSER::PROTEIN) ("LGPIN" . SPARSER::PROTEIN)
    ("PIN" . SPARSER::PROTEIN) ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acini" . SPARSER::PROTEIN) ("smooth muscle" . SPARSER::PROTEIN)
    ("Pten and p300" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("Pten/p300" . SPARSER::COLLECTION) ("probasin-Cre" . SPARSER::COLLECTION)
    ("probasin" . SPARSER::PROTEIN) ("a functional p300" . SPARSER::PROTEIN)
    ("AR, p53 and NFκB" . SPARSER::COLLECTION)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("androgen-AR" . SPARSER::COLLECTION) ("enzalutamide" . SPARSER::DRUG)
    ("abiraterone" . SPARSER::DRUG)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("a well-studied AR transactivated gene" . SPARSER::GENE)
    ("PCa (CRPC)" . SPARSER::PROTEIN) ("Androgens" . SPARSER::DRUG)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("p300 and AR" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("C646" . SPARSER::MOLECULE)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("Nkx3.1" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("ERK2" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("histone acetyltransferase" . SPARSER::PROTEIN)
    ("P300" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("histone acetyltransferase p300" . SPARSER::PROTEIN)
    ("LW and JT" . SPARSER::COLLECTION) ("JT" . SPARSER::PROTEIN)
    ("LW" . SPARSER::PROTEIN) ("OX" . SPARSER::PROTEIN)
    ("YY, FX and WL" . SPARSER::COLLECTION) ("WL" . SPARSER::MOLECULE)
    ("FX" . SPARSER::PROTEIN) ("YY" . SPARSER::MOLECULE)
    ("LD" . SPARSER::PROTEIN) ("YL" . SPARSER::PROTEIN)
    ("JH" . SPARSER::PROTEIN) ("siRNA and JNK" . SPARSER::COLLECTION)
    ("lung metastatic foci" . SPARSER::PROTEIN)
    ("p38 siRNA and the p38 inhibitor SB202190" . SPARSER::COLLECTION)
    ("p38, MMP2 or MMP9" . SPARSER::COLLECTION) ("BiPs" . SPARSER::PROTEIN)
    ("p38 siRNA or the p38 inhibitor SB 202190" . SPARSER::COLLECTION)
    ("p38, and JNK" . SPARSER::COLLECTION)
    ("siRNA or JNK" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("the lung metastatic foci" . SPARSER::PROTEIN)
    ("p38, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("p38, MMP2, MMP9 and c-fos" . SPARSER::COLLECTION)
    ("p-p38, MMP2, MMP9 and c-fos" . SPARSER::COLLECTION)
    ("IL-1β or PBS" . SPARSER::COLLECTION) ("PBS" . SPARSER::PROTEIN)
    ("IL-1β, MMP2, MMP9 and AP-1" . SPARSER::COLLECTION)
    ("IL-1β, MMP2, MMP9 and c-fos" . SPARSER::COLLECTION)
    ("JNK siRNA nor JNK inhibitor SP600125" . SPARSER::COLLECTION)
    ("MNK" . SPARSER::PROTEIN)
    ("MMP2 or MMP9, or pre-treatment" . SPARSER::COLLECTION)
    ("MMP9, or pre-treatment" . SPARSER::COLLECTION)
    ("MMP2/MMP9" . SPARSER::COLLECTION)
    ("the respective wild-type control reporter genes" . SPARSER::GENE)
    ("NF" . SPARSER::PROTEIN) ("p-p38, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("siRNA and SB202190" . SPARSER::COLLECTION)
    ("siRNA or p38" . SPARSER::COLLECTION)
    ("siRNA, or GA" . SPARSER::COLLECTION)
    ("IL-1β and p-p38" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("skeletal muscle [ xref ] and p38-δ" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-1β (IL-β) and IL-6" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN) ("/MMP2" . SPARSER::COLLECTION)
    ("IL-1β/p38/AP-1" . SPARSER::COLLECTION)
    ("IL-1β, MMP2, MMP9, and c-fos" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("MMP2 or MMP9 siRNAs and the MMP2/9 inhibitor BiPS" . SPARSER::COLLECTION)
    ("MMP2 or MMP9" . SPARSER::COLLECTION) ("BiPS" . SPARSER::PROTEIN)
    ("p38 siRNA or the p38 inhibitor SB202190" . SPARSER::COLLECTION)
    ("IL-1β/p38" . SPARSER::COLLECTION) ("AGS" . SPARSER::PROTEIN)
    ("p38 and JNK" . SPARSER::COLLECTION) ("P38 and JNK" . SPARSER::COLLECTION)
    ("for 3 " . SPARSER::PROTEIN) ("SB 202190" . SPARSER::DRUG)
    ("Il-1β" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("interleukin-1β" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("SB202190" . SPARSER::DRUG)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-1β" . SPARSER::PROTEIN)
    ("Interleukin-1β" . SPARSER::PROTEIN) ("Pre" . SPARSER::PROTEIN)
    ("MB" . SPARSER::PROTEIN) ("TAK" . SPARSER::PROTEIN)
    ("AMG" . SPARSER::PROTEIN) ("BRCA2 or related genes" . SPARSER::COLLECTION)
    ("the 3 pure lumB families" . SPARSER::PROTEIN-FAMILY)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("delC" . SPARSER::PROTEIN)
    ("a 3-case" . SPARSER::COLLECTION)
    ("the BRCA1 / 2 genes or other susceptibility genes" . SPARSER::COLLECTION)
    ("two-case" . SPARSER::PROTEIN)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("MLPA" . SPARSER::PROTEIN) ("ME" . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN)
    ("lumA (33/70, 47%) or lumB (18/70, 26%)" . SPARSER::COLLECTION)
    ("BRCA2 and 8/12" . SPARSER::COLLECTION)
    ("lumA and lumB" . SPARSER::COLLECTION) ("PAM" . SPARSER::PROTEIN)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("genome-wide RNA" . SPARSER::RNA)
    ("luminal-associated genes" . SPARSER::GENE) ("Luminal" . SPARSER::DRUG)
    ("LumA" . SPARSER::PROTEIN) ("-gene" . SPARSER::GENE)
    ("lumA" . SPARSER::PROTEIN)
    ("TP53 , CDH1 , PTEN , STK11 , RAD51C , and RAD51D" . SPARSER::COLLECTION)
    ("ATM , CHEK2 , BRIP1 , and PALB2" . SPARSER::COLLECTION)
    ("rare low-penetrance alleles or rare moderate penetrance genes"
     . SPARSER::COLLECTION)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("a strong hereditary component" . SPARSER::COMPONENT)
    ("molecularly homogeneous subtypes" . SPARSER::PROTEIN)
    ("global RNA" . SPARSER::RNA)
    ("hereditary factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family 2" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("RAD51D" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN)
    ("neuronal Tau ( xref ) or MAP2 ( xref ) and MAP4 ( xref )"
     . SPARSER::COLLECTION)
    ("MAP2 ( xref ) and MAP4 ( xref )" . SPARSER::COLLECTION)
    ("neuronal Tau" . SPARSER::PROTEIN) ("Tau" . SPARSER::PROTEIN)
    ("MAPs" . SPARSER::PROTEIN) ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("RFP-RASS1A" . SPARSER::PROTEIN-PAIR)
    ("either endogenous RASSF1A or short hairpin RNA (shRNA)"
     . SPARSER::COLLECTION)
    ("EB3-GFP" . SPARSER::COLLECTION) ("nocodazole" . SPARSER::DRUG)
    ("EMTB" . SPARSER::PROTEIN) ("tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plus-tip" . SPARSER::PROTEIN) ("GFP-RASSF1A" . SPARSER::COLLECTION)
    ("tip" . SPARSER::PROTEIN) ("EB3" . SPARSER::PROTEIN)
    ("RFP-RASSF1A" . SPARSER::COLLECTION)
    ("fluorescently fused RASSF1A" . SPARSER::PROTEIN)
    ("red fluorescent protein (RFP)–fused RASSF1A" . SPARSER::PROTEIN)
    ("–fused" . SPARSER::COLLECTION) ("scaffold" . SPARSER::SCAFFOLD)
    ("MTs" . SPARSER::PROTEIN)
    ("a microtubule-associated protein" . SPARSER::PROTEIN)
    ("SP5" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("synapsin I" . SPARSER::PROTEIN) ("MAP4" . SPARSER::PROTEIN)
    ("MAP1B" . SPARSER::PROTEIN) ("GTPase Ran" . SPARSER::PROTEIN)
    ("GM130" . SPARSER::PROTEIN) ("protein 3" . SPARSER::PROTEIN)
    ("RPE1" . SPARSER::PROTEIN) ("Aurora A" . SPARSER::PROTEIN)
    ("family 1" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("AR and PSA" . SPARSER::COLLECTION)
    ("receptor and OPG" . SPARSER::COLLECTION)
    ("RANKL , or LN" . SPARSER::COLLECTION)
    ("targets and effectors" . SPARSER::COLLECTION)
    ("RelA, HIF1α, and Zeb1" . SPARSER::COLLECTION)
    ("/LN" . SPARSER::COLLECTION)
    ("RANKL, RANK, and c-Met" . SPARSER::COLLECTION)
    ("bone morphogenic proteins" . SPARSER::PROTEIN)
    ("VCAM1–integrin" . SPARSER::COLLECTION) ("Hormone" . SPARSER::PROTEIN)
    ("Neo-RFP-Luc" . SPARSER::COLLECTION) ("p-c-Met" . SPARSER::COLLECTION)
    ("Neo-RFP" . SPARSER::COLLECTION) ("NIR" . SPARSER::PROTEIN)
    ("FoxA2, SOX9, and HIF1α" . SPARSER::COLLECTION)
    ("higher intrinsic RANKL" . SPARSER::PROTEIN)
    ("denosumab and OPG" . SPARSER::COLLECTION)
    ("FOXA2, SYP, and chromogranin" . SPARSER::COLLECTION)
    ("chromogranin" . SPARSER::PROTEIN) ("SYP" . SPARSER::PROTEIN)
    ("LNCaP cell-derived RANKL or exogenously administered recombinant RANKL"
     . SPARSER::COLLECTION)
    ("pre" . SPARSER::PROTEIN)
    ("N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("RNA and protein" . SPARSER::COLLECTION)
    ("c-Myc, Max, and AP4" . SPARSER::COLLECTION)
    ("c-Myc and Max" . SPARSER::COLLECTION)
    ("c-Myc, c-Myc and Max, or AP4" . SPARSER::COLLECTION)
    ("Max, or AP4" . SPARSER::COLLECTION)
    ("shRNA or siRNA" . SPARSER::COLLECTION)
    ("c-Myc/Max heterodimer and/or AP4 homodimer" . SPARSER::COLLECTION)
    ("exogenous recombinant RANKL" . SPARSER::PROTEIN)
    ("RANKL- and c-Met" . SPARSER::COLLECTION)
    ("RANKL-, c-Met-, and AR-promoter" . SPARSER::COLLECTION)
    ("c-Met-" . SPARSER::PROTEIN) ("RANKL-" . SPARSER::PROTEIN)
    ("denosumab" . SPARSER::DRUG) ("genes and pathways" . SPARSER::COLLECTION)
    ("RELA" . SPARSER::PROTEIN)
    ("growth factor and growth factor receptor" . SPARSER::COLLECTION)
    ("chemotaxis, and EMT" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN) ("RANKL and LN" . SPARSER::COLLECTION)
    ("c-Met and AR" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("sRANKL" . SPARSER::PROTEIN) ("mature osteoclasts" . SPARSER::PROTEIN)
    ("pre-osteoclasts" . SPARSER::COLLECTION) ("TRAP" . SPARSER::PROTEIN)
    ("osteoclasts" . SPARSER::PROTEIN)
    ("a minor osteoblastic component" . SPARSER::COMPONENT)
    ("the indolent LN Neo-Luc" . SPARSER::COLLECTION)
    ("RANKL-Luc" . SPARSER::COLLECTION) ("Neo-Luc" . SPARSER::COLLECTION)
    ("RANKL, RANK, and OPG" . SPARSER::COLLECTION) ("OPG" . SPARSER::PROTEIN)
    ("respectively more intrinsic or transfected RANKL" . SPARSER::PROTEIN)
    ("ARCaP" . SPARSER::PROTEIN) ("regulator (MR)" . SPARSER::REGULATOR)
    ("EMT, stemness, neuroendocrine, and osteomimicry" . SPARSER::COLLECTION)
    ("bone metastatic PCa" . SPARSER::PROTEIN)
    ("c-Met, VEGFR2, KIT, and AXL" . SPARSER::COLLECTION)
    ("KIT" . SPARSER::PROTEIN) ("FDA" . SPARSER::PROTEIN)
    ("Cabozantinib" . SPARSER::DRUG)
    ("Hepatocyte growth factor (HGF) and its receptor tyrosine kinase c-Met"
     . SPARSER::COLLECTION)
    ("RANKL and non-collagenous" . SPARSER::COLLECTION)
    ("–RANK" . SPARSER::COLLECTION) ("pain" . SPARSER::PROTEIN)
    ("RANK–RANKL" . SPARSER::COLLECTION)
    ("Twist1, Slug, Zeb1, and Zeb2" . SPARSER::COLLECTION)
    ("Sox2, Myc, Oct3/4, and Nanog" . SPARSER::COLLECTION)
    ("Sox9, HIF1α, and FoxA2" . SPARSER::COLLECTION)
    ("Sox2, Sox9, HIF1α, and Runx2" . SPARSER::COLLECTION)
    ("FoxA2" . SPARSER::PROTEIN) ("RANKL–RANK" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("c-Myc/Max" . SPARSER::COLLECTION) ("Max" . SPARSER::PROTEIN)
    ("TF" . SPARSER::PROTEIN) ("RANKL and c-Met" . SPARSER::COLLECTION)
    ("RANK" . SPARSER::PROTEIN) ("ligand (RANKL)" . SPARSER::MOLECULE)
    ("RANKL" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("VCAM1" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD49f" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("let7" . SPARSER::RNA) ("decoy receptor" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("PROM1" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("LIN-28" . SPARSER::PROTEIN)
    ("Sox-2" . SPARSER::PROTEIN) ("Bis–Tris" . SPARSER::MOLECULE)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("erbB3" . SPARSER::PROTEIN)
    ("erbB2" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β2-microglobulin" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("Oct3" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("AP4" . SPARSER::PROTEIN)
    ("Cisplatin" . SPARSER::DRUG)
    ("moderately penetrant breast cancer genes" . SPARSER::GENE)
    ("the clinically important prognostic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CMF" . SPARSER::PROTEIN)
    ("adjuvant or neoadjuvant chemotherapy" . SPARSER::COLLECTION)
    ("modifiers" . SPARSER::MOLECULE)
    ("the relatively modest impact" . SPARSER::PROTEIN)
    ("highly penetrant genes" . SPARSER::GENE)
    ("negative prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neo" . SPARSER::PROTEIN) ("CBC" . SPARSER::PROTEIN)
    ("n  " . SPARSER::PROTEIN) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("autosomal dominant" . SPARSER::PROTEIN) ("FADD" . SPARSER::PROTEIN)
    ("CaMK" . SPARSER::PROTEIN)
    ("the phosphomimetic PED mutant" . SPARSER::MUTANT)
    ("TRAIL" . SPARSER::PROTEIN) ("S104/116" . SPARSER::PROTEIN)
    ("PED-S104/116" . SPARSER::COLLECTION)
    ("S104/116 A PED" . SPARSER::PROTEIN)
    ("a phosphomimetic PED mutant" . SPARSER::MUTANT)
    ("exogenous protein" . SPARSER::PROTEIN) ("chloroquine" . SPARSER::PROTEIN)
    ("ovalbumin" . SPARSER::PROTEIN)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and lysosomal" . SPARSER::COLLECTION)
    ("Hsc70 and LAMP-2A" . SPARSER::COLLECTION)
    ("PED and LAMP-2A" . SPARSER::COLLECTION)
    ("Hsc70-PED" . SPARSER::COLLECTION) ("PED and Hsc70" . SPARSER::COLLECTION)
    ("GST-PED" . SPARSER::COLLECTION) ("Sepharose" . SPARSER::MOLECULE)
    ("Glutathione" . SPARSER::DRUG) ("Myc-PED" . SPARSER::COLLECTION)
    ("PED-Hsc70" . SPARSER::COLLECTION) ("Hsc70 and PED" . SPARSER::COLLECTION)
    ("cochaperones" . SPARSER::PROTEIN) ("pentapeptide" . SPARSER::MOLECULE)
    ("cytosolic soluble proteins" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN)
    ("Another attractive PED-interacting protein" . SPARSER::PROTEIN)
    ("CMA" . SPARSER::PROTEIN) ("polypeptides" . SPARSER::PROTEIN)
    ("KDa" . SPARSER::PROTEIN) ("PED-Rac1" . SPARSER::COLLECTION)
    ("TAP" . SPARSER::PROTEIN) ("AKT or calcium" . SPARSER::COLLECTION)
    ("CamK" . SPARSER::PROTEIN) ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("DISC" . SPARSER::BIO-COMPLEX) ("PED/PEA-15" . SPARSER::COLLECTION)
    ("DED" . SPARSER::PROTEIN) ("Effector" . SPARSER::EFFECTOR)
    ("PED" . SPARSER::PROTEIN) ("Hsp27" . SPARSER::PROTEIN)
    ("Heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hsc70" . SPARSER::PROTEIN) ("β-hexosaminidase" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("LAMP2" . SPARSER::PROTEIN)
    ("ribonuclease A" . SPARSER::PROTEIN) ("LAMP-2" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("PEA-15" . SPARSER::PROTEIN)
    ("JAK2 and rs2736100_C" . SPARSER::COLLECTION)
    ("The recurrent somatic mutation JAK2 V617F" . SPARSER::PROTEIN)
    ("TERT and JAK2" . SPARSER::COLLECTION)
    ("the causative variant" . SPARSER::VARIANT)
    ("PMF, OR=1.56" . SPARSER::COLLECTION)
    ("MPN and a second variant" . SPARSER::COLLECTION)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN) ("keratinocytes" . SPARSER::PROTEIN)
    ("PKG" . SPARSER::PROTEIN) ("SP1 and AP2" . SPARSER::COLLECTION)
    ("SP1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Endothelin-1, Jagged 1, FGF9, FGF20, Sox9 and Sox17"
     . SPARSER::COLLECTION)
    ("ephrin" . SPARSER::PROTEIN) ("uPAR" . SPARSER::PROTEIN)
    ("RRP" . SPARSER::PROTEIN) ("latrunculin A" . SPARSER::DRUG)
    ("ROCK2" . SPARSER::PROTEIN) ("α-catenin" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("AP2" . SPARSER::PROTEIN)
    ("Sox17" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("FGF20" . SPARSER::PROTEIN) ("FGF9" . SPARSER::PROTEIN)
    ("Jagged 1" . SPARSER::PROTEIN)
    ("Endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("claudin1" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("DTCs and PTCs" . SPARSER::COLLECTION)
    ("TERT and BRAF" . SPARSER::COLLECTION)
    ("BRAF and TERT" . SPARSER::COLLECTION)
    ("Elk1 and Elk4" . SPARSER::COLLECTION) ("Elk1" . SPARSER::PROTEIN)
    ("Elk" . SPARSER::PROTEIN)
    ("extremely aggressive DTCs" . SPARSER::MOLECULE)
    ("fits" . SPARSER::PROTEIN-FAMILY)
    ("the clinicopathological and molecular factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDTCs (29.0%) and ATCs (33.3%)" . SPARSER::COLLECTION)
    ("oncocytic PTCs" . SPARSER::PROTEIN)
    ("oncocytic variant" . SPARSER::VARIANT)
    ("PTCs, and Warthin-like" . SPARSER::COLLECTION)
    ("a strong etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAX8/PPARG" . SPARSER::COLLECTION) ("BRAF and RAS" . SPARSER::COLLECTION)
    ("BRAF or RAS" . SPARSER::COLLECTION)
    ("PDTCs and ATCs" . SPARSER::COLLECTION)
    ("the only independent predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs and FTCs" . SPARSER::COLLECTION)
    ("PTCs and Warthin-like" . SPARSER::COLLECTION)
    ("follicular variant" . SPARSER::VARIANT) ("ATCs" . SPARSER::DRUG)
    ("PDTCs" . SPARSER::DRUG) ("BRAF/RAS" . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN) ("GGAA" . SPARSER::PROTEIN)
    ("sporadic PTCs" . SPARSER::PROTEIN) ("FTCs" . SPARSER::DRUG)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("DTC" . SPARSER::PROTEIN)
    ("PTCs" . SPARSER::PROTEIN) ("DTCs" . SPARSER::MOLECULE)
    ("Elk4" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::PROTEIN) ("PAX8" . SPARSER::PROTEIN)
    ("RAF-1, B-RAF, and A-RAF" . SPARSER::COLLECTION)
    ("the respective signalling molecule" . SPARSER::MOLECULE)
    ("probucol" . SPARSER::DRUG) ("pentamidine" . SPARSER::DRUG)
    ("SGK1 and SGK3" . SPARSER::COLLECTION) ("PIKfyve" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN) ("KDR" . SPARSER::PROTEIN)
    ("FITC" . SPARSER::MOLECULE) ("PLX-4720 and hERG" . SPARSER::COLLECTION)
    ("hERG and B-RAF" . SPARSER::COLLECTION) ("hERG-HA" . SPARSER::COLLECTION)
    ("wild-type B-RAF and Xenopus oocytes" . SPARSER::COLLECTION)
    ("mV" . SPARSER::PROTEIN) ("water" . SPARSER::MOLECULE)
    ("cRNA" . SPARSER::PROTEIN)
    ("cell surface proteins and flow cytometry" . SPARSER::COLLECTION)
    ("hERG and B-RAF-expressing Xenopus oocytes" . SPARSER::COLLECTION)
    ("pro-apoptotic drug" . SPARSER::DRUG)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B-RAF and hERG-expressing Xenopus oocytes" . SPARSER::COLLECTION)
    ("cell surface proteins as well as flow cytometry" . SPARSER::COLLECTION)
    ("clamp and hERG" . SPARSER::COLLECTION) ("Kinases" . SPARSER::KINASE)
    ("HERG" . SPARSER::PROTEIN) ("hERG" . SPARSER::PROTEIN)
    ("ether" . SPARSER::MOLECULE) ("voltage-gated" . SPARSER::PROTEIN)
    ("A-RAF" . SPARSER::PROTEIN) ("RAF-1" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("SGK3" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN)
    ("ether-a-go-go related gene" . SPARSER::PROTEIN)
    ("Kv11.1" . SPARSER::PROTEIN) ("Tween20" . SPARSER::MOLECULE)
    ("Sulfo-NHS" . SPARSER::DRUG) ("CaC1" . SPARSER::PROTEIN)
    ("MgC1" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KCNH2" . SPARSER::PROTEIN) ("PLX-4720" . SPARSER::DRUG)
    ("B-RAF" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("the general inhibitors TSA (HDACs) or 5-Aza-dC (DNMTs)"
     . SPARSER::COLLECTION)
    ("HDAC and DNMT1" . SPARSER::COLLECTION)
    ("platinum and taxane" . SPARSER::COLLECTION)
    ("repressive complexes" . SPARSER::BIO-COMPLEX)
    ("DNMT1 and MeCP2" . SPARSER::COLLECTION)
    ("DNMTs and HDACs" . SPARSER::COLLECTION)
    ("cancer-associated genes" . SPARSER::GENE)
    ("the chemotherapeutic drug cisplatin" . SPARSER::MOLECULE)
    ("further showed RGS10" . SPARSER::PROTEIN)
    ("DNMT1 and HDAC1" . SPARSER::COLLECTION)
    ("MeCP2-DNMT1" . SPARSER::COLLECTION)
    ("DNMT1 and methyl-CpG binding protein 2" . SPARSER::COLLECTION)
    ("HDAC1 and RGS10" . SPARSER::COLLECTION)
    ("annexin V-PE" . SPARSER::COLLECTION) ("AAD" . SPARSER::PROTEIN)
    ("Annexin V:PE" . SPARSER::BIO-COMPLEX) ("PE" . SPARSER::PROTEIN)
    ("TSA and/or 5-Aza-dC" . SPARSER::COLLECTION)
    ("TSA or 5-Aza-dC" . SPARSER::COLLECTION)
    ("TSA and 5-Aza-dC" . SPARSER::COLLECTION)
    ("TSA, and 5-Aza-dC" . SPARSER::COLLECTION)
    ("TSA and DNMT" . SPARSER::COLLECTION)
    ("HDACs and DNMTs" . SPARSER::COLLECTION) ("Aza" . SPARSER::DRUG)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("HDAC and DNMT" . SPARSER::COLLECTION)
    ("DNMT1 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("RGS10 and GAPDH" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN) ("HDAC1/DNMT1" . SPARSER::COLLECTION)
    ("deacetylases" . SPARSER::PROTEIN) ("DNMTs" . SPARSER::PROTEIN)
    ("RGS" . SPARSER::PROTEIN) ("GPCR" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("cisplatin and taxane" . SPARSER::COLLECTION) ("LPA" . SPARSER::PROTEIN)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC1 or DNMT1" . SPARSER::COLLECTION)
    ("DNMT or HDAC" . SPARSER::COLLECTION) ("DNMT" . SPARSER::PROTEIN)
    ("HDAC1 and DNMT1" . SPARSER::COLLECTION) ("AD" . SPARSER::PROTEIN)
    ("Sin3" . SPARSER::PROTEIN) ("MeCP2" . SPARSER::PROTEIN)
    ("methyl-CpG binding protein 2" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("H3 histone" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("CA-3" . SPARSER::PROTEIN)
    ("a 3D" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("Lysophosphatidic acid" . SPARSER::LPA)
    ("G-proteins" . SPARSER::PROTEIN) ("G-protein coupled" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("RGS10" . SPARSER::PROTEIN) ("iASPP, p63 and MDMX" . SPARSER::COLLECTION)
    ("TYR" . SPARSER::PROTEIN) ("cyclin B1/cdk1" . SPARSER::COLLECTION)
    ("Mel" . SPARSER::PROTEIN) ("TRP2-shRNA" . SPARSER::COLLECTION)
    ("strong TRP2" . SPARSER::PROTEIN)
    ("nuclear and light" . SPARSER::COLLECTION)
    ("TRP2 and p53" . SPARSER::COLLECTION) ("tyrosinase" . SPARSER::PROTEIN)
    ("microphthalmia transcription factor (MITF) and Sox10"
     . SPARSER::COLLECTION)
    ("transcription factor (MITF)" . SPARSER::PROTEIN)
    ("MITF" . SPARSER::PROTEIN) ("microphthalmia" . SPARSER::PROTEIN)
    ("viral oncoproteins" . SPARSER::PROTEIN) ("Parc" . SPARSER::PROTEIN)
    ("iASPP" . SPARSER::PROTEIN) ("oncoproteins" . SPARSER::PROTEIN)
    ("a prototypic tumor suppressor" . SPARSER::SUPPRESSOR)
    ("cytotoxic drugs or irradiation" . SPARSER::COLLECTION)
    ("p53 and TRP2" . SPARSER::COLLECTION)
    ("a central tumor suppressor protein" . SPARSER::PROTEIN)
    ("CEP-1" . SPARSER::PROTEIN) ("BCL2L12" . SPARSER::PROTEIN)
    ("cdk1" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("p61" . SPARSER::PROTEIN) ("p60" . SPARSER::PROTEIN)
    ("p59" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("KH1" . SPARSER::PROTEIN) ("Sox10" . SPARSER::PROTEIN)
    ("p53 regulator" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("TRP2" . SPARSER::PROTEIN)
    ("tyrosinase related protein 2" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("GAS and STAT1" . SPARSER::COLLECTION) ("-liganded" . SPARSER::MOLECULE)
    ("liganded" . SPARSER::MOLECULE) ("CIITA and HLA-II" . SPARSER::COLLECTION)
    ("CIITA and MHC" . SPARSER::COLLECTION) ("DRA" . SPARSER::PROTEIN)
    ("DR" . SPARSER::PROTEIN) ("AP1 or NFKβ" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("AP1" . SPARSER::PROTEIN) ("ERα or E 2" . SPARSER::COLLECTION)
    ("MC2 and its ERα" . SPARSER::COLLECTION)
    ("ERβ2/ERα" . SPARSER::COLLECTION)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("GPR30 and EGFR" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN) ("ERα and E 2" . SPARSER::COLLECTION)
    ("IFN-γ and HLA-II" . SPARSER::COLLECTION)
    ("IRF1 and GILT" . SPARSER::COLLECTION)
    ("proteins, IRF1, IRF9 and GILT" . SPARSER::COLLECTION)
    ("GILT" . SPARSER::PROTEIN) ("STAT1 and pSTAT1" . SPARSER::COLLECTION)
    ("-ERα" . SPARSER::COLLECTION)
    ("a fully active promoter" . SPARSER::PROMOTER) ("pIV" . SPARSER::PROTEIN)
    ("CIITA pIV" . SPARSER::PROTEIN) ("STAT1 and IRF1" . SPARSER::COLLECTION)
    ("E 2 and/or ICI" . SPARSER::COLLECTION)
    ("a mechanism whereby E 2 -activated ER" . SPARSER::PROTEIN)
    ("ESR1-siRNA" . SPARSER::COLLECTION)
    ("E 2 or vehicle control followed by IFN-γ stimulation for 24 hours"
     . SPARSER::COLLECTION)
    ("flow cytometry and Western blot" . SPARSER::COLLECTION)
    ("-DM" . SPARSER::COLLECTION) ("ERα and ERβ" . SPARSER::COLLECTION)
    ("ERs" . SPARSER::PROTEIN) ("-ER" . SPARSER::COLLECTION)
    ("estradiol (E 2 ) and ERα" . SPARSER::COLLECTION)
    ("Estradiol and anti-estrogens, tamoxifen and fulvestrant"
     . SPARSER::COLLECTION)
    ("anti-estrogens, tamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("Estradiol" . SPARSER::PROTEIN)
    ("growth factor and hormone" . SPARSER::COLLECTION)
    ("HLA-DR and Ii" . SPARSER::COLLECTION)
    ("IRF1 and STAT1" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("GAS" . SPARSER::PROTEIN) ("IFN" . SPARSER::PROTEIN)
    ("Janus kinase 2 (JAK2) and JAK1" . SPARSER::COLLECTION)
    ("receptors (IFNGR)" . SPARSER::RECEPTOR) ("IFNGR" . SPARSER::PROTEIN)
    ("pIII" . SPARSER::PROTEIN)
    ("class II transactivator (CIITA)" . SPARSER::PROTEIN)
    ("professional antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pAPC" . SPARSER::PROTEIN) ("HLA-DM" . SPARSER::COLLECTION)
    ("-DQ" . SPARSER::MOLECULE) ("-DP" . SPARSER::COLLECTION)
    ("DQ" . SPARSER::MOLECULE) ("DP" . SPARSER::PROTEIN)
    ("Antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT1 regulated genes" . SPARSER::GENE)
    ("ERα + MC2 (MDA-MB-231 c10A transfected with the wild type ERα gene) and ERα"
     . SPARSER::COLLECTION)
    ("E 2 and IFN-γ" . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN) ("CIITA" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("nuclear matrix protein p84" . SPARSER::PROTEIN)
    ("p48" . SPARSER::PROTEIN) ("ISGF-3" . SPARSER::PROTEIN)
    ("Phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Phospho-Tyrosine" . SPARSER::MOLECULE) ("Tal 1" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("JAK-STAT" . SPARSER::PROTEIN)
    ("SRC kinase" . SPARSER::PROTEIN) ("HLA-DRA" . SPARSER::PROTEIN)
    ("activator 1" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("SRC-1" . SPARSER::PROTEIN) ("ER β" . SPARSER::PROTEIN)
    ("ERβ2" . SPARSER::PROTEIN)
    ("gamma-interferon-inducible lysosomal thiol reductase" . SPARSER::PROTEIN)
    ("IRF family" . SPARSER::PROTEIN) ("IRF9" . SPARSER::PROTEIN)
    ("Del 1" . SPARSER::PROTEIN) ("Del 3" . SPARSER::PROTEIN)
    ("Site 1" . SPARSER::PROTEIN) ("GPR30" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRF2" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("DNA binding protein" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("ESR1" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("anti-estrogen" . SPARSER::DRUG) ("MC2" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN)
    ("class II transactivator" . SPARSER::PROTEIN) ("OTA" . SPARSER::MOLECULE)
    ("FTA" . SPARSER::PROTEIN) ("OTC" . SPARSER::PROTEIN)
    ("PDTC" . SPARSER::DRUG) ("an anaplastic component" . SPARSER::COMPONENT)
    ("a tyrosine kinase receptor and the predicted fusion protein"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("CEL" . SPARSER::PROTEIN)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("striatin" . SPARSER::PROTEIN)
    ("RAS family genes and BRAF mutations xref" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase genes RET (20 to 30%) and TRK (10%)"
     . SPARSER::COLLECTION)
    ("TRK" . SPARSER::PROTEIN) ("STRN and ALK" . SPARSER::COLLECTION)
    ("Case" . SPARSER::PROTEIN) ("STRN or ALK" . SPARSER::COLLECTION)
    ("ALK and STRN" . SPARSER::COLLECTION) ("gene ( STRN )" . SPARSER::PROTEIN)
    ("Striatin" . SPARSER::PROTEIN) ("p22" . SPARSER::PROTEIN)
    ("CGH" . SPARSER::PROTEIN) ("anaplastic components" . SPARSER::COMPONENT)
    ("component and lung" . SPARSER::COLLECTION) ("iodine" . SPARSER::MOLECULE)
    ("PTC and FTC" . SPARSER::COLLECTION) ("PTC or FTC" . SPARSER::COLLECTION)
    ("very aggressive form" . SPARSER::FORM) ("ATC" . SPARSER::PROTEIN)
    ("minimally invasive FTC" . SPARSER::DRUG)
    ("Some histological variants" . SPARSER::VARIANT)
    ("Fifteen histological variants" . SPARSER::VARIANT)
    ("FTC" . SPARSER::DRUG) ("STRN and exon" . SPARSER::COLLECTION)
    ("STRN/ALK" . SPARSER::COLLECTION) ("STRN" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG)
    ("The most aggressive forms" . SPARSER::FORM)
    ("insulin receptor" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN) ("DUX4" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("classical MPN" . SPARSER::PROTEIN) ("PMF or PV" . SPARSER::COLLECTION)
    ("classical MPNs" . SPARSER::PROTEIN) ("HEL" . SPARSER::PROTEIN)
    ("Net (ELN)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ELN" . SPARSER::PROTEIN)
    ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Leukemia" . SPARSER::PROTEIN)
    ("a potential mixture" . SPARSER::MOLECULE)
    ("typical BCR-ABL1 -negative MPNs" . SPARSER::PROTEIN)
    ("a healthy control DNA" . SPARSER::DNA)
    ("its corresponding experimental SD" . SPARSER::PROTEIN)
    ("allelic mRNA" . SPARSER::RNA) ("AB" . SPARSER::PROTEIN)
    ("Allele" . SPARSER::ALLELE)
    ("the MT and WT alleles" . SPARSER::COLLECTION)
    ("PV and PMF" . SPARSER::COLLECTION)
    ("STAT5- , AKT- and ERK" . SPARSER::COLLECTION)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STAT5-" . SPARSER::PROTEIN)
    ("myeloid" . SPARSER::PROTEIN) ("vera (PV)" . SPARSER::PROTEIN)
    ("PMF" . SPARSER::PROTEIN) ("ET" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("Phe" . SPARSER::AMINO-ACID)
    ("BCR-ABL-" . SPARSER::PROTEIN) ("MPN" . SPARSER::PROTEIN)
    ("genomic DNA (gDNA) and complementary DNA (cDNA)" . SPARSER::COLLECTION)
    ("vera" . SPARSER::PROTEIN) ("MPNs" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("WT 2" . SPARSER::PROTEIN)
    ("MT 2" . SPARSER::PROTEIN) ("WT 1" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("sun" . SPARSER::PROTEIN)
    ("other histopathologic subtypes" . SPARSER::PROTEIN)
    ("all established prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("No prognostic impact" . SPARSER::PROTEIN)
    ("independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an additional independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the entire cohort" . SPARSER::MOLECULE) ("SSM" . SPARSER::PROTEIN)
    ("BRAF or MEK" . SPARSER::COLLECTION) ("IIB" . SPARSER::PROTEIN)
    ("the prognostic impact" . SPARSER::PROTEIN)
    ("an unfavorable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NRAS or BRAF" . SPARSER::COLLECTION)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("temozolomide and bevacizumab" . SPARSER::COLLECTION)
    ("An interesting significant prognostic impact" . SPARSER::PROTEIN)
    ("Independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The prognostic impact" . SPARSER::PROTEIN) ("BRAF-" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("AR/ROS/p53" . SPARSER::COLLECTION)
    ("Phosphatidylserine" . SPARSER::PROTEIN)
    ("AR as well as the resultant mitochondrial" . SPARSER::COLLECTION)
    ("the resultant mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thromboxane" . SPARSER::MOLECULE)
    ("mitochondria and Bcl-2" . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN)
    ("ARI and antioxidant" . SPARSER::COLLECTION) ("NTg" . SPARSER::PROTEIN)
    ("glucose and DM" . SPARSER::COLLECTION)
    ("caspase-3 and cytochrome c" . SPARSER::COLLECTION)
    ("Such severe mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("superoxide and MPTP" . SPARSER::COLLECTION)
    ("ARI or PFT-μ" . SPARSER::COLLECTION)
    ("ARI and SB239063" . SPARSER::COLLECTION) ("ARI" . SPARSER::PROTEIN)
    ("z-DEVD-fmk" . SPARSER::COLLECTION) ("fmk" . SPARSER::PROTEIN)
    ("Pifithrin" . SPARSER::DRUG) ("normal platelets" . SPARSER::PROTEIN)
    ("5 mM glucose (NG) or 25 mM glucose (HG)" . SPARSER::COLLECTION)
    ("glucose (HG)" . SPARSER::MOLECULE) ("glucose (NG)" . SPARSER::MOLECULE)
    ("acute hyperglycemia" . SPARSER::PROTEIN) ("HG" . SPARSER::MOLECULE)
    ("diabetic platelets" . SPARSER::PROTEIN)
    ("the diabetic platelets" . SPARSER::PROTEIN)
    ("p53 and Bcl-x" . SPARSER::COLLECTION)
    ("p53, Bax and Bak" . SPARSER::COLLECTION)
    ("the pro-apoptotic mediators Bax and Bak" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN)
    ("the classic double-membrane mitochondria" . SPARSER::PROTEIN)
    ("EM" . SPARSER::PROTEIN) ("electron" . SPARSER::MOLECULE)
    ("Ionomycin" . SPARSER::DRUG)
    ("the severe mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cobalt" . SPARSER::MOLECULE) ("calcein" . SPARSER::MOLECULE)
    ("MPTP" . SPARSER::PROTEIN)
    ("rotenone and antimycin" . SPARSER::COLLECTION)
    ("superoxide" . SPARSER::MOLECULE) ("rotenone" . SPARSER::PROTEIN)
    ("antimycin" . SPARSER::DRUG) ("DM and ABT-737" . SPARSER::COLLECTION)
    ("FACS" . SPARSER::PROTEIN) ("healthy platelets" . SPARSER::PROTEIN)
    ("Severe mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyol" . SPARSER::MOLECULE) ("PS" . SPARSER::PROTEIN)
    ("BH3 mimetic compounds ABT-737 or ABT-263" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-263" . SPARSER::COLLECTION)
    ("SOD2 and PRDX3" . SPARSER::COLLECTION)
    ("hyperglycemia and mitochondrial" . SPARSER::COLLECTION)
    ("severe mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylserine" . SPARSER::PROTEIN) ("platelets" . SPARSER::PROTEIN)
    ("hyperglycemia" . SPARSER::PROTEIN)
    ("Mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitochondria" . SPARSER::PROTEIN) ("DM" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("P-selectin" . SPARSER::PROTEIN)
    ("SB239063" . SPARSER::MOLECULE) ("p38α" . SPARSER::PROTEIN)
    ("L protein" . SPARSER::PROTEIN) ("N-acetyl-cysteine" . SPARSER::DRUG)
    ("P53" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("ABT-263" . SPARSER::DRUG)
    ("ABT-737" . SPARSER::DRUG) ("PRDX3" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("caspase 3" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("aldose reductase" . SPARSER::PROTEIN)
    ("hemodynamic imaging biomarkers" . SPARSER::MOLECULE)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("arterial spin" . SPARSER::PROTEIN) ("spin" . SPARSER::PROTEIN)
    ("MRP" . SPARSER::PROTEIN) ("ROI" . SPARSER::PROTEIN)
    ("preoperative advanced MRI" . SPARSER::PROTEIN)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("the Mesenchymal, Proneural and Neural subtypes" . SPARSER::PROTEIN)
    ("bright" . SPARSER::PROTEIN)
    ("EGFR-non-amplified" . SPARSER::PROTEIN-PAIR) ("FDR" . SPARSER::PROTEIN)
    ("MRIs" . SPARSER::PROTEIN) ("MR" . SPARSER::PROTEIN)
    ("the primary aim" . SPARSER::PROTEIN)
    ("potential imaging biomarkers" . SPARSER::MOLECULE)
    ("gefitinib, erlotinib, afatinib and lapatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG)
    ("defining genetically unique subtypes" . SPARSER::PROTEIN)
    ("potential targets" . SPARSER::TARGET-PROTEIN) ("PSR" . SPARSER::PROTEIN)
    ("EGFRvIII" . SPARSER::PROTEIN) ("MRI" . SPARSER::PROTEIN)
    ("DSC" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("HDAC6 and CLIP-170" . SPARSER::COLLECTION)
    ("an attractive target" . SPARSER::TARGET-PROTEIN)
    ("the microtubule-associated deacetylase HDAC6" . SPARSER::PROTEIN)
    ("filaments and microtubules" . SPARSER::COLLECTION)
    ("siRNA and GFP" . SPARSER::COLLECTION) ("GFP-HDAC6" . SPARSER::COLLECTION)
    ("GFP-CLIP-170" . SPARSER::COLLECTION)
    ("both exogenous and endogenous CLIP-170" . SPARSER::PROTEIN)
    ("HDAC6 or its catalytically inactive mutant" . SPARSER::COLLECTION)
    ("MTT and SRB" . SPARSER::COLLECTION) ("SRB" . SPARSER::PROTEIN)
    ("tubacin and TSA" . SPARSER::COLLECTION)
    ("tubacin, a potent and selective HDAC6 inhibitor (Haggarty et al., xref ), and trichostatin A (TSA)"
     . SPARSER::COLLECTION)
    ("pan-HDAC" . SPARSER::COLLECTION) ("trichostatin" . SPARSER::MOLECULE)
    ("tubacin" . SPARSER::DRUG) ("cortactin" . SPARSER::PROTEIN)
    ("HDACs" . SPARSER::PROTEIN) ("Sun" . SPARSER::PROTEIN)
    ("diverse cytoskeleton-associated proteins" . SPARSER::PROTEIN)
    ("microtubules and actin" . SPARSER::COLLECTION)
    ("HDAC" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("zinc finger" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("heat shock protein 90" . SPARSER::PROTEIN)
    ("Histone deacetylase 6" . SPARSER::PROTEIN)
    ("CLIP-170" . SPARSER::PROTEIN) ("linker protein" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("attractive and novel drug" . SPARSER::DRUG)
    ("transient receptor potential (TRP) ion channels"
     . SPARSER::PROTEIN-FAMILY)
    ("OAADPR and macroH2A1" . SPARSER::COLLECTION) ("TRP" . SPARSER::PROTEIN)
    ("SCD1 and FASN" . SPARSER::COLLECTION)
    ("NAFLD-associated HCC" . SPARSER::PROTEIN) ("multi" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE)
    ("PARP1 and SIRT1" . SPARSER::COLLECTION) ("TLC" . SPARSER::PROTEIN)
    ("RBP4, FASN, LPL and SCD1" . SPARSER::COLLECTION)
    ("CYP2E1, CD36, PPARG, SREBF1, APOB, LDLR, HMGCR and SREBF2"
     . SPARSER::COLLECTION)
    ("HMGCR" . SPARSER::PROTEIN) ("LDLR" . SPARSER::PROTEIN)
    ("APOB" . SPARSER::PROTEIN) ("PPARG" . SPARSER::PROTEIN)
    ("LPL" . SPARSER::PROTEIN) ("FASN" . SPARSER::PROTEIN)
    ("G6PC, GCK, MLXIPL, PDK4 and RBP4" . SPARSER::COLLECTION)
    ("PCK2 and GSK3B" . SPARSER::COLLECTION)
    ("G6PC, GCK, MLXIPL and GSK3B" . SPARSER::COLLECTION)
    ("PCK2, PKLR and RBP4" . SPARSER::COLLECTION) ("PKLR" . SPARSER::PROTEIN)
    ("MLXIPL" . SPARSER::PROTEIN) ("GCK" . SPARSER::PROTEIN)
    ("beta" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("glycogen" . SPARSER::PROTEIN)
    ("metabolite-binding histone variant macroH2A1.1" . SPARSER::PROTEIN)
    ("esters" . SPARSER::MOLECULE) ("cholesteryl" . SPARSER::PROTEIN)
    ("FFA-treated macroH2A1" . SPARSER::PROTEIN) ("pink" . SPARSER::PROTEIN)
    ("DAPI" . SPARSER::DRUG) ("ORO" . SPARSER::MOLECULE)
    ("mixture" . SPARSER::MOLECULE)
    ("OAADPR-binding macroH2A1.1" . SPARSER::PROTEIN)
    ("tweak" . SPARSER::PROTEIN) ("just few amino acids" . SPARSER::AMINO-ACID)
    ("OAADPR" . SPARSER::MOLECULE) ("RNA alternative exon" . SPARSER::PROTEIN)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("canonical histones" . SPARSER::PROTEIN) ("FFA" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("lipidogenic genes" . SPARSER::GENE)
    ("hepatocytes" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("acetyl" . SPARSER::MOLECULE) ("deoxyribonuclease I" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("stearoyl-CoA" . SPARSER::MOLECULE) ("SREBF2" . SPARSER::PROTEIN)
    ("SREBF1" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("SCD1" . SPARSER::PROTEIN) ("GSK3B" . SPARSER::PROTEIN)
    ("PCK2" . SPARSER::PROTEIN) ("RBP4" . SPARSER::PROTEIN)
    ("PDK4" . SPARSER::PROTEIN) ("G6PC" . SPARSER::PROTEIN)
    ("H2A1" . SPARSER::PROTEIN) ("oleic acid" . SPARSER::MOLECULE)
    ("CDK8" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("macroH2A1" . SPARSER::PROTEIN)
    ("MacroH2A1" . SPARSER::PROTEIN)
    ("SP and trastuzumab" . SPARSER::COLLECTION)
    ("Capecitabine" . SPARSER::DRUG) ("especially histologic type" . TYPE)
    ("dl" . SPARSER::MOLECULE) ("an ineligible case" . SPARSER::PROTEIN)
    ("creatinine" . SPARSER::PROTEIN) ("Creatinine" . SPARSER::PROTEIN)
    ("CR or PR" . SPARSER::COLLECTION)
    ("cisplatin, and trastuzumab" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE) ("first-line" . SPARSER::PROTEIN)
    ("RRs" . SPARSER::MOLECULE) ("Gimeracil" . SPARSER::DRUG)
    ("gimeracil, and oteracil" . SPARSER::COLLECTION)
    ("oteracil" . SPARSER::DRUG) ("gimeracil" . SPARSER::DRUG)
    ("prodrug" . SPARSER::DRUG) ("tegafur" . SPARSER::DRUG)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("AGC, and trastuzumab" . SPARSER::COLLECTION) ("Food" . SPARSER::MOLECULE)
    ("capecitabine or fluorouracil" . SPARSER::COLLECTION)
    ("docetaxel or epirubicin" . SPARSER::COLLECTION)
    ("TTF" . SPARSER::PROTEIN) ("RR" . SPARSER::PROTEIN)
    ("SP" . SPARSER::PROTEIN) ("aspartate aminotransferase" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("chromosome 17" . SPARSER::PROTEIN)
    ("JMJD2B–STAT3" . SPARSER::COLLECTION)
    ("JMJD2B and DDR" . SPARSER::COLLECTION)
    ("mitochondria" . SPARSER::PROTEIN)
    ("mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prolonged hypoxia ( xref ; xref ) and severe hypoxia ( xref )"
     . SPARSER::COLLECTION)
    ("severe hypoxia" . SPARSER::PROTEIN) ("INK4A-ARF" . SPARSER::COLLECTION)
    ("ARF" . SPARSER::PROTEIN) ("-EZH2" . SPARSER::COLLECTION)
    ("DDR-associated chromatin" . SPARSER::PROTEIN)
    ("repressive H3K9" . SPARSER::PROTEIN) ("Kdm4b" . SPARSER::PROTEIN)
    ("ATR-CHK1" . SPARSER::COLLECTION) ("ATM-CHK2" . SPARSER::COLLECTION)
    ("p-JAK2" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("JMJD2B and γ H2AX" . SPARSER::COLLECTION) ("UNG" . SPARSER::PROTEIN)
    ("CLU" . SPARSER::PROTEIN) ("XPC" . SPARSER::PROTEIN)
    ("16 downregulated genes (criteria: fold change <0.5; P <0.05, t -test) and 23"
     . SPARSER::COLLECTION)
    ("siRNA or JMJD2B" . SPARSER::COLLECTION)
    ("Chk2 and Chk1" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION) ("ATM-" . SPARSER::PROTEIN)
    ("stress-induced DNA" . SPARSER::DNA)
    ("ultraviolet-induced DNA" . SPARSER::DNA) ("Hypoxia" . SPARSER::PROTEIN)
    ("histones" . SPARSER::PROTEIN)
    ("the promoter-repressive H3K9" . SPARSER::PROTEIN)
    ("the pericentric heterochromatin and euchromatin" . SPARSER::COLLECTION)
    ("heterochromatin and euchromatin" . SPARSER::COLLECTION)
    ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("heterochromatin" . SPARSER::PROTEIN) ("Jumonji" . SPARSER::PROTEIN)
    ("methyltransferases and demethylases" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("a potential anti-cancer target" . SPARSER::TARGET-PROTEIN)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("SALL4" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("JMJD3" . SPARSER::PROTEIN)
    ("p15 Ink4b" . SPARSER::PROTEIN) ("let-7" . SPARSER::RNA)
    ("NR4A2" . SPARSER::PROTEIN) ("MRE11A" . SPARSER::PROTEIN)
    ("PPM1D" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("CHEK1" . SPARSER::PROTEIN) ("RAD54L" . SPARSER::PROTEIN)
    ("RAD51AP1" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("CETN3" . SPARSER::PROTEIN) ("β -gal" . SPARSER::PROTEIN)
    ("β -galactosidase" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::MOLECULE)
    ("α -tubulin" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("JMJD2A" . SPARSER::PROTEIN)
    ("H3K9" . SPARSER::PROTEIN) ("JMJD2" . SPARSER::PROTEIN)
    ("JMJD2B" . SPARSER::PROTEIN) ("protein 2" . SPARSER::PROTEIN)
    ("Jumonji domain" . SPARSER::PROTEIN)
    ("STAT3, miR-146b, NF-κB, and IL-6" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("CAC" . SPARSER::PROTEIN)
    ("NF-κB/IL-6/STAT3" . SPARSER::COLLECTION)
    ("NF-κB and IL-6" . SPARSER::COLLECTION)
    ("factors and miR-146b" . SPARSER::COLLECTION)
    ("miR-125b and the miR-17/92" . SPARSER::COLLECTION)
    ("A classic example" . SPARSER::EXAMPLE)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("example" . SPARSER::EXAMPLE)
    ("nearly all other known STAT3 target genes" . SPARSER::GENE)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("IL-6/STAT3" . SPARSER::COLLECTION) ("autocrine IL-6" . SPARSER::PROTEIN)
    ("JAK or a neutralizing antibody" . SPARSER::COLLECTION)
    ("IL6 or the NF-κB subunit RelA" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN) ("SiRNAs" . SPARSER::PROTEIN)
    ("virtually all NF-κB target genes" . SPARSER::GENE)
    ("IRAK1 and TRAF6" . SPARSER::COLLECTION)
    ("IL-6 or IFN-γ" . SPARSER::COLLECTION)
    ("TRAF6 and IRAK1" . SPARSER::COLLECTION)
    ("NF-κB/IL-6" . SPARSER::COLLECTION)
    ("a possible tumor suppressor" . SPARSER::SUPPRESSOR)
    ("CpGs" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("RACE" . SPARSER::PROTEIN) ("dominant-negative STAT" . SPARSER::PROTEIN)
    ("Cytokine" . SPARSER::PROTEIN)
    ("STAT3 (IL-6) or STAT1 (IFN-γ)" . SPARSER::COLLECTION)
    ("MCF-10A" . SPARSER::PROTEIN) ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("STAT3, NF-κB, and IL-6" . SPARSER::COLLECTION)
    ("STAT3 and miRNAs" . SPARSER::COLLECTION)
    ("IL-6-STAT3" . SPARSER::COLLECTION) ("CYLD" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("NF-κB, IL-6, and STAT3" . SPARSER::COLLECTION)
    ("IL-6 and STAT3" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("log2" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("inhibitor 1" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("MYOD1" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("m67" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("protein kinase 1" . SPARSER::PROTEIN) ("MMP16" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("HNF4α" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor 4" . SPARSER::PROTEIN)
    ("messenger RNAs" . SPARSER::RNA) ("gp130" . SPARSER::PROTEIN)
    ("IL-6Rα" . SPARSER::PROTEIN) ("IL-6 receptor" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN) ("proper HR" . SPARSER::PROTEIN)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION) ("RBMX" . SPARSER::PROTEIN)
    ("mer" . SPARSER::PROTEIN)
    ("ancestral transposase and Alu" . SPARSER::COLLECTION)
    ("transposase and Alu" . SPARSER::COLLECTION)
    ("transposase" . SPARSER::PROTEIN) ("Alu" . SPARSER::PROTEIN)
    ("LNCaP and RWPE" . SPARSER::COLLECTION)
    ("LacZ and RWPE-" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("azacytidine" . SPARSER::DRUG) ("LacZ" . SPARSER::PROTEIN)
    ("TOP2A , E2F8 , BIRC5, and KIF15" . SPARSER::COLLECTION)
    ("Du145-" . SPARSER::PROTEIN) ("LNCaP and Du145" . SPARSER::COLLECTION)
    ("Du145 and RWPE" . SPARSER::COLLECTION)
    ("Du145 and LNCaP" . SPARSER::COLLECTION)
    ("gamma-H2AX" . SPARSER::COLLECTION) ("gamma" . SPARSER::PROTEIN)
    ("I-SceI-cut" . SPARSER::COLLECTION)
    ("Olaparib or ABT-888" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("PCAT-1 and BRCA2" . SPARSER::COLLECTION)
    ("sh-" . SPARSER::PROTEIN-FAMILY) ("defective HR" . SPARSER::PROTEIN)
    ("broken DNA" . SPARSER::DNA) ("fragments" . SPARSER::FRAGMENT)
    ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("STAU1" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("KIF15" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("TOP2A" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XRCC4" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("ABT-888" . SPARSER::DRUG)
    ("S11" . SPARSER::PROTEIN) ("PC3" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("Du145" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("Vps34/Beclin 1/Peg3" . SPARSER::COLLECTION)
    ("Beclin 1, and perhaps" . SPARSER::COLLECTION) ("DAPK" . SPARSER::PROTEIN)
    ("kinase ( xref ) and upstream regulator" . SPARSER::COLLECTION)
    ("an intrinsically staunch inhibitor" . SPARSER::INHIBITOR)
    ("AMPK/ULK1" . SPARSER::COLLECTION)
    ("Beclin 1 or Peg3" . SPARSER::COLLECTION)
    ("Beclin 1/Vps34" . SPARSER::COLLECTION)
    ("an unbeknownst intermediate kinase" . SPARSER::KINASE)
    ("arching" . SPARSER::PROTEIN)
    ("a supramolecular complex" . SPARSER::BIO-COMPLEX)
    ("a potential tumor suppressor" . SPARSER::SUPPRESSOR)
    ("anti- and pro-inflammatory" . SPARSER::COLLECTION)
    ("TLR2" . SPARSER::PROTEIN)
    ("proteoglycan and decorin" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("a master autophagic regulator" . SPARSER::PROTEIN)
    ("AMPK/ULK1/Vps34/Beclin 1" . SPARSER::COLLECTION)
    ("BECN1 ( xref ) and MAPLC3A ( xref )" . SPARSER::COLLECTION)
    ("VEGFR2 and this receptor" . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("Akt, mTOR, and p70S6K" . SPARSER::COLLECTION)
    ("soluble decorin" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("Vps34 (green) and Beclin 1 (red) co-localized" . SPARSER::COLLECTION)
    ("cfr" . SPARSER::DRUG) ("Vps34 and Beclin 1" . SPARSER::COLLECTION)
    ("VEGFR2 and Vps34" . SPARSER::COLLECTION)
    ("either Beclin 1 ( xref ) or Vps34 ( xref )" . SPARSER::COLLECTION)
    ("Peg3 or Beclin 1" . SPARSER::COLLECTION)
    ("Peg3/Beclin 1" . SPARSER::COLLECTION)
    ("Vps34 or Beclin 1" . SPARSER::COLLECTION)
    ("Peg3 and Beclin 1" . SPARSER::COLLECTION)
    ("Vps34 and AMPK" . SPARSER::COLLECTION)
    ("Peg3, Beclin 1, and LC3" . SPARSER::COLLECTION)
    ("WAF1 and p27 Kip1" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("a heterotrimeric ( e.g. α, β, and γ subunits) signaling complex"
     . SPARSER::BIO-COMPLEX)
    ("the various biomolecular relays decorin" . SPARSER::PROTEIN)
    ("decorin-VEGFR2" . SPARSER::COLLECTION)
    ("leucine-rich repeat (LRR)" . SPARSER::PROTEIN)
    ("EGFR and ErbB4" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("rapamycin and nutrient" . SPARSER::COLLECTION)
    ("transcriptionally upregulating autophagic effectors" . SPARSER::EFFECTOR)
    ("BECN1 and MAPLC3A" . SPARSER::COLLECTION)
    ("Beclin 1 and LC3" . SPARSER::COLLECTION)
    ("loss of heterozygosity or promoter" . SPARSER::COLLECTION)
    ("the genomically-imprinted tumor suppressor gene Peg3" . SPARSER::PROTEIN)
    ("stromal-specific genes" . SPARSER::GENE)
    ("pan-RTK" . SPARSER::COLLECTION) ("pan" . SPARSER::PROTEIN)
    ("antiangiogenic effectors" . SPARSER::EFFECTOR)
    ("Myc, β-catenin, and HIF-1α" . SPARSER::COLLECTION)
    ("IGF/IGF-IR" . SPARSER::COLLECTION) ("PDGFR" . SPARSER::PROTEIN)
    ("Met" . SPARSER::AMINO-ACID) ("Decorin" . SPARSER::PROTEIN)
    ("monomeric soluble decorin" . SPARSER::PROTEIN)
    ("both decorin and the tumor suppressor p53" . SPARSER::COLLECTION)
    ("a soluble tumor repressor" . SPARSER::REPRESSOR)
    ("decorin and the Toll-like family" . SPARSER::COLLECTION)
    ("the iconoclastic gene family" . SPARSER::PROTEIN-FAMILY)
    ("SLRP" . SPARSER::PROTEIN) ("AMPK" . SPARSER::PROTEIN)
    ("inhibitive Bcl-2/Beclin 1" . SPARSER::COLLECTION)
    ("Bcl-2/Beclin 1" . SPARSER::COLLECTION)
    ("Vps34/Beclin 1" . SPARSER::COLLECTION)
    ("Soluble monomeric decorin" . SPARSER::PROTEIN)
    ("decorin" . SPARSER::PROTEIN) ("Messenger RNA" . SPARSER::RNA)
    ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("ribonucleic acid" . SPARSER::RNA) ("Spautin-1" . SPARSER::DRUG)
    ("anti–" . SPARSER::ANTIBODY) ("anti- β" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN) ("Atg13" . SPARSER::PROTEIN)
    ("FIP200" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("MO25α" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("MO25" . SPARSER::PROTEIN) ("USP10" . SPARSER::PROTEIN)
    ("spautin-1" . SPARSER::DRUG) ("SU5416" . SPARSER::DRUG)
    ("ULK1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("BECN1" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("PEG3" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN) ("ErbB4" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN)
    ("phosphoinositide kinase" . SPARSER::PROTEIN) ("Vps34" . SPARSER::PROTEIN)
    ("Peg3" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN)
    ("robust and tissue-specific non-invasive biomarkers" . SPARSER::MOLECULE)
    ("six individual mature miRNAs" . SPARSER::MICRO-RNA)
    ("myc" . SPARSER::PROTEIN) ("c-myc or miR-17-92" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION) ("MiR" . SPARSER::MICRO-RNA)
    ("c-myc and miR-17-92" . SPARSER::COLLECTION)
    ("PGE2, c-myc and PTEN" . SPARSER::COLLECTION)
    ("PI3-K/Akt/mTOR" . SPARSER::COLLECTION)
    ("erlotinib or erlotinib" . SPARSER::COLLECTION)
    ("Celecoxib" . SPARSER::DRUG)
    ("the predominant mediators" . SPARSER::PROTEIN)
    ("c-myc and multiple miRNAs" . SPARSER::COLLECTION)
    ("cyclin D1 and c-fos" . SPARSER::COLLECTION)
    ("more robust biomarkers" . SPARSER::MOLECULE)
    ("MiRNAs" . SPARSER::MICRO-RNA) ("MiRNA" . SPARSER::MICRO-RNA)
    ("the predominant oncogenic miRNA" . SPARSER::MICRO-RNA)
    ("seven mature microRNAs" . SPARSER::MICRO-RNA)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("c-myc and PTEN" . SPARSER::COLLECTION)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("tensin" . SPARSER::PROTEIN)
    ("CMYC" . SPARSER::PROTEIN) ("MAPK/Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Myc and miR-17-92" . SPARSER::COLLECTION)
    ("c-Myc and miR-17-92-dependent" . SPARSER::COLLECTION)
    ("celecoxib" . SPARSER::DRUG) ("c-Myc (MYC)" . SPARSER::PROTEIN)
    ("immediate early response" . SPARSER::PROTEIN)
    ("growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-K" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("pMD2" . SPARSER::MOLECULE) ("C-myc" . SPARSER::PROTEIN)
    ("SCS 2" . SPARSER::PROTEIN) ("small nucleolar RNAs" . SPARSER::RNA)
    ("B2M" . SPARSER::PROTEIN) ("beta-2-microglobulin" . SPARSER::PROTEIN)
    ("RH2" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("c-myc" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ATDC/p38/MK2" . SPARSER::COLLECTION)
    ("mediating MK2’s" . SPARSER::PROTEIN)
    ("‘net’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38/MAPK" . SPARSER::COLLECTION) ("Chk2 and p53" . SPARSER::COLLECTION)
    ("ATM/MAPKAP kinase 2" . SPARSER::COLLECTION) ("IR-" . SPARSER::PROTEIN)
    ("TCF-" . SPARSER::PROTEIN) ("ATDC-" . SPARSER::PROTEIN)
    ("ATDC-Dvl2" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("Both ATDC and the S550A mutant" . SPARSER::COLLECTION)
    ("both ATDC and the S550A mutant" . SPARSER::COLLECTION)
    ("Myc tagged Dvl2" . SPARSER::PROTEIN)
    ("ATDC and the S550A mutant" . SPARSER::COLLECTION)
    ("TCF-Luc" . SPARSER::COLLECTION)
    ("ATDC and Disheveled2" . SPARSER::COLLECTION)
    ("ATDC or the ATDC(S550A) mutant ( xref )" . SPARSER::COLLECTION)
    ("ATDC and the ATDC S550A mutant" . SPARSER::COLLECTION)
    ("Mia" . SPARSER::PROTEIN) ("Radioprotective" . SPARSER::PROTEIN)
    ("GST-CDC25C" . SPARSER::COLLECTION)
    ("CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("p38 or Chk1/2" . SPARSER::COLLECTION)
    ("GST-p53-S15" . SPARSER::COLLECTION) ("GST-ATDC" . SPARSER::COLLECTION)
    ("ATDC or a ATDC550A mutant" . SPARSER::COLLECTION)
    ("ATM or another effector" . SPARSER::COLLECTION)
    ("calf intestinal phosphatase" . SPARSER::PHOSPHATASE)
    ("PPase" . SPARSER::PROTEIN) ("p-ATDC" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("transferrin" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN) ("gemcitabine" . SPARSER::DRUG)
    ("Gemcitabine" . SPARSER::DRUG) ("HEK" . SPARSER::PROTEIN)
    ("ataxia telangiectasia (AT)" . SPARSER::PROTEIN) ("AT" . SPARSER::PROTEIN)
    ("a B-box type 1 (B1) and B-box type 2 (B2)" . SPARSER::COLLECTION)
    ("the tripartite motif (TRIM) protein family" . SPARSER::PROTEIN-FAMILY)
    ("TRIM" . SPARSER::PROTEIN) ("a modest impact" . SPARSER::PROTEIN)
    ("defective p53" . SPARSER::PROTEIN) ("CDC25A-" . SPARSER::PROTEIN)
    ("p38/MK2" . SPARSER::COLLECTION) ("ATM/ATR" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("DDR" . SPARSER::PROTEIN)
    ("NBS1, MDC1, 53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("p53 and Chk1/2" . SPARSER::COLLECTION) ("TQ" . SPARSER::DRUG)
    ("SQ" . SPARSER::MOLECULE) ("MK2 and ATM" . SPARSER::COLLECTION)
    ("radioprotective" . SPARSER::PROTEIN)
    ("the DNA and p53 binding protein ATDC/TRIM29" . SPARSER::COLLECTION)
    ("ATDC/TRIM29" . SPARSER::COLLECTION) ("ATDC" . SPARSER::PROTEIN)
    ("PDAC" . SPARSER::PROTEIN) ("DVL2" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("Dvl2" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("S15" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("ten 1" . SPARSER::PROTEIN)
    ("group D" . SPARSER::PROTEIN) ("AZD7762" . SPARSER::DRUG)
    ("Panc1" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("B-box" . SPARSER::PROTEIN) ("Group D" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("MAPKAP kinase-2" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("MAPKAP kinase 2" . SPARSER::PROTEIN) ("TRIM29" . SPARSER::PROTEIN)
    ("triptolide" . SPARSER::DRUG) ("HER2-Akt" . SPARSER::COLLECTION)
    ("Akt and/or mTOR" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("Akt or mTOR" . SPARSER::COLLECTION)
    ("noxious substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("Akt-HSF-1-Slug" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases, HER2 and EGFR" . SPARSER::COLLECTION)
    ("HER2 and HSF-1" . SPARSER::COLLECTION) ("PI3K-Akt" . SPARSER::COLLECTION)
    ("LY294002 and Lapatinib" . SPARSER::COLLECTION)
    ("LY294002 and lapatinib" . SPARSER::COLLECTION)
    ("PI3K (LY294002; LY) and HER2 (Lapatinib; Lap)" . SPARSER::COLLECTION)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DN-Akt" . SPARSER::COLLECTION)
    ("cellular HSF-1" . SPARSER::PROTEIN) ("GST-HSF-1" . SPARSER::COLLECTION)
    ("HSF-1 and Akt" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("p38, ERK, JNK, and mTOR" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("heregulin/HER2" . SPARSER::COLLECTION)
    ("post-EMT" . SPARSER::COLLECTION) ("p-HSF-1" . SPARSER::COLLECTION)
    ("trimers" . SPARSER::TRIMER) ("HER2/heregulin" . SPARSER::COLLECTION)
    ("HER2/EGFR" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("Slug and Vimentin" . SPARSER::COLLECTION)
    ("the mesenchymal marker Vimentin" . SPARSER::PROTEIN)
    ("Vimentin" . SPARSER::PROTEIN)
    ("Slug, Snail and TWIST" . SPARSER::COLLECTION) ("HRG" . SPARSER::PROTEIN)
    ("EMT and Slug" . SPARSER::COLLECTION) ("Heregulin" . SPARSER::PROTEIN)
    ("new light" . SPARSER::PROTEIN) ("HER2-Akt-HSF-1" . SPARSER::COLLECTION)
    ("Active" . SPARSER::ACTIVE) ("HER2 and EMT" . SPARSER::COLLECTION)
    ("Akt and Ras" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("TWIST1, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("SNAI" . SPARSER::PROTEIN-FAMILY) ("Akt-HSF-1" . SPARSER::COLLECTION)
    ("dominant-negative Akt mutant" . SPARSER::MUTANT)
    ("Akt and HSF-1" . SPARSER::COLLECTION)
    ("HSF-1 and Slug" . SPARSER::COLLECTION)
    ("heregulin or HSF-1" . SPARSER::COLLECTION) ("HSF" . SPARSER::PROTEIN)
    ("HER2, or HER2" . SPARSER::COLLECTION)
    ("TWIST or Snail" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("TWIST" . SPARSER::PROTEIN) ("heregulin" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("m2" . SPARSER::MOLECULE)
    ("pGL2" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("KNK437" . SPARSER::DRUG) ("KRIBB11" . SPARSER::DRUG)
    ("LY294002" . SPARSER::MOLECULE) ("Hsp70" . SPARSER::PROTEIN)
    ("heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ZEB2" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("Akt-induced" . SPARSER::PROTEIN) ("HSF-1" . SPARSER::PROTEIN)
    ("highly penetrant MTC" . SPARSER::PROTEIN)
    ("mTOR, PI3K, AKT and MEK" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("progressive metastatic MTC" . SPARSER::PROTEIN)
    ("autologous matched primary MTC" . SPARSER::PROTEIN)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("lipid and protein" . SPARSER::COLLECTION) ("p-ERK" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("MAPK or AKT" . SPARSER::COLLECTION)
    ("Sesn2, Plk2 and Pten" . SPARSER::COLLECTION)
    ("p53 and mTOR" . SPARSER::COLLECTION)
    ("calcitonin and synaptophysin" . SPARSER::COLLECTION)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("mTOR pathway inhibitors in vivo" . SPARSER::INHIBITOR)
    ("potential mediators" . SPARSER::PROTEIN)
    ("Sestrin 2, TSC2 and PLK2" . SPARSER::COLLECTION)
    ("physiologically relevant p53" . SPARSER::PROTEIN)
    ("the p53 target genes DNA-damage-inducible transcript 4 (Ddit4) and protein kinase AMP-activated"
     . SPARSER::COLLECTION)
    ("Prkab1" . SPARSER::PROTEIN) ("Ddit4" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 3 (Igfbp3) and phosphatase and tensin homolog (Pten)"
     . SPARSER::COLLECTION)
    ("sestrin 2 (Sesn2), tuberous sclerosis 2 (Tsc2), polo-like kinase 2 (Plk2), insulin-like growth factor binding protein 3 (Igfbp3) and phosphatase and tensin homolog (Pten)"
     . SPARSER::COLLECTION)
    ("Igfbp3" . SPARSER::PROTEIN) ("Tsc2" . SPARSER::PROTEIN)
    ("Sesn2" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("p-MEK" . SPARSER::COLLECTION) ("p-S6K" . SPARSER::PROTEIN)
    ("IGF-1/AKT/mTOR" . SPARSER::COLLECTION)
    ("phenotypically mimic human MTC" . SPARSER::PROTEIN)
    ("calcitonin" . SPARSER::PROTEIN)
    ("moderately coarse nuclear chromatin" . SPARSER::BIO-COMPLEX)
    ("transgene" . SPARSER::PROTEIN) ("doxycycline" . SPARSER::MOLECULE)
    ("surfactant protein C (SPC)" . SPARSER::PROTEIN)
    ("tetracycline" . SPARSER::DRUG) ("SPC" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("AKT or MAPK" . SPARSER::COLLECTION) ("sporadic MTC" . SPARSER::PROTEIN)
    ("hereditary MTC" . SPARSER::PROTEIN)
    ("biomarkers and patient stratification algorithms" . SPARSER::COLLECTION)
    ("progressive MTC" . SPARSER::PROTEIN) ("vandetanib" . SPARSER::DRUG)
    ("/p53" . SPARSER::COLLECTION) ("MDM2 or MDMX" . SPARSER::COLLECTION)
    ("MDMX" . SPARSER::PROTEIN)
    ("p53 and the retinoblastoma (Rb) protein" . SPARSER::COLLECTION)
    ("AKT/MAPK" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("rapamycin" . SPARSER::DRUG) ("MTC" . SPARSER::PROTEIN)
    ("Ad-p53" . SPARSER::DRUG) ("H11" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("MEK-1" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H12" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("Surfactant protein C" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("PLK2" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("Sestrin 2" . SPARSER::PROTEIN) ("beta 1" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN)
    ("DNA-damage-inducible transcript 4" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 3" . SPARSER::PROTEIN)
    ("Plk2" . SPARSER::PROTEIN) ("polo-like kinase 2" . SPARSER::PROTEIN)
    ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("sestrin 2" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("IGF-1" . SPARSER::PROTEIN)
    ("surfactant protein C" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("AV, TS, EB, SL, JW, and PvD" . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN) ("RK" . SPARSER::PROTEIN)
    ("TS" . SPARSER::PROTEIN) ("SL, and AV" . SPARSER::COLLECTION)
    ("AV" . SPARSER::MOLECULE) ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tube" . SPARSER::PROTEIN) ("HE" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE) ("xylene" . SPARSER::MOLECULE)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("the PIK3CA gene or other genes" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("mTOR and p70S6K" . SPARSER::COLLECTION)
    ("favorable prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exemestane" . SPARSER::DRUG)
    ("Known prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2 and/or IGF-1R" . SPARSER::COLLECTION)
    ("PTEN, and overexpression/amplification" . SPARSER::COLLECTION)
    ("PgR" . SPARSER::PROTEIN) ("PIK3CA exon 9 and exon" . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN) ("Exon" . SPARSER::PROTEIN)
    ("known prognostic factors and downstream-activated proteins"
     . SPARSER::COLLECTION)
    ("known prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("ERα-" . SPARSER::PROTEIN) ("progesterone receptor-" . SPARSER::PROTEIN)
    ("p-ERK1/2, and p-p70S6K" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("p-mTOR" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("tamoxifen" . SPARSER::MOLECULE)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR) ("anti-estrogens" . SPARSER::DRUG)
    ("AKT1" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("S4" . SPARSER::PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone receptor" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("estrogen receptor" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("curcumin" . SPARSER::DRUG) ("sulforaphane" . SPARSER::PROTEIN)
    ("diamine" . SPARSER::MOLECULE) ("VCP/p97" . SPARSER::COLLECTION)
    ("VCP" . SPARSER::PROTEIN) ("Celastrol" . SPARSER::MOLECULE)
    ("The proteasomal inhibitor" . SPARSER::INHIBITOR)
    ("its smaller isoforms" . SPARSER::ISOFORM)
    ("more aggressive PCa" . SPARSER::PROTEIN)
    ("Nrf2/AR" . SPARSER::COLLECTION) ("nuclear and ER" . SPARSER::COLLECTION)
    ("Nrf1-AR" . SPARSER::COLLECTION) ("p65-Nrf1/AR" . SPARSER::COLLECTION)
    ("p120-Nrf1/AR" . SPARSER::COLLECTION)
    ("these proteins and the AR transcription complex" . SPARSER::COLLECTION)
    ("the oxidative stress-induced transcription factors Nrf1 and Nrf2"
     . SPARSER::COLLECTION)
    ("NOX-4 and NOX-5" . SPARSER::COLLECTION)
    ("AR and Nrf2" . SPARSER::COLLECTION) ("TCF11/MafG" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("MafG" . SPARSER::PROTEIN)
    ("oligonucleotide" . SPARSER::MOLECULE) ("Chip" . SPARSER::PROTEIN)
    ("the Nrf1 antibody or the AR antibody" . SPARSER::COLLECTION)
    ("p65- and p120-" . SPARSER::COLLECTION) ("p120-" . SPARSER::PROTEIN)
    ("p65-" . SPARSER::PROTEIN) ("Nrf1 and AR" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("DHT-treated LNCaP" . SPARSER::PROTEIN)
    ("TMPRSS2 and PSA" . SPARSER::COLLECTION)
    ("siRNA or NC1" . SPARSER::COLLECTION) ("Nuclear" . SPARSER::PROTEIN)
    ("Nrf2 and the p65 and p120 isoforms" . SPARSER::COLLECTION)
    ("p65 and p120" . SPARSER::COLLECTION) ("syngeneic PCa" . SPARSER::PROTEIN)
    ("sub-line" . SPARSER::PROTEIN) ("TRAMP" . SPARSER::PROTEIN)
    ("these smaller Nrf1 isoforms" . SPARSER::ISOFORM)
    ("both full length 120 kDa Nrf1 (p120-Nrf1) and several truncated (36, 55, 65, and 95 kDa) isoforms"
     . SPARSER::COLLECTION)
    ("which anchors Nrf1" . SPARSER::PROTEIN) ("NTD" . SPARSER::PROTEIN)
    ("normal homeostatic redox" . SPARSER::PROTEIN)
    ("electrophile" . SPARSER::MOLECULE)
    ("NOX and antioxidant" . SPARSER::COLLECTION)
    ("proteins and NADPH" . SPARSER::COLLECTION) ("NOX" . SPARSER::PROTEIN)
    ("NADPH" . SPARSER::PROTEIN)
    ("ROS induced antioxidant proteins" . SPARSER::PROTEIN)
    ("cofactors and chaperones" . SPARSER::COLLECTION)
    ("coactivators" . SPARSER::PROTEIN)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("p120-Nrf1" . SPARSER::COLLECTION) ("p65-Nrf1" . SPARSER::COLLECTION)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("DHT" . SPARSER::PROTEIN) ("Dihydrotestosterone" . SPARSER::DRUG)
    ("PCa" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("p97" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NOX-4" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("IP10" . SPARSER::PROTEIN)
    ("protein-G" . SPARSER::PROTEIN)
    ("transmembrane protease, serine 2" . SPARSER::PROTEIN)
    ("prostate specific antigen" . SPARSER::PROTEIN) ("NC1" . SPARSER::PROTEIN)
    ("TCF11" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("Prx-1" . SPARSER::PROTEIN)
    ("peroxiredoxin-1" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("RET-Cbl-c" . SPARSER::COLLECTION)
    ("RET and Enigma" . SPARSER::COLLECTION) ("lab" . SPARSER::PROTEIN)
    ("both isoforms and their MEN2A mutants in the absence of ligand activation"
     . SPARSER::COLLECTION)
    ("The shorter RET9" . SPARSER::PROTEIN)
    ("Shc and Grb2" . SPARSER::COLLECTION)
    ("an E3 which has been shown to ubiquitinate and downregulate activated RTKs ( e.g. , EGFR) and non-receptor TKs ( e.g. Src) xref"
     . SPARSER::COLLECTION)
    ("TKs" . SPARSER::PROTEIN) ("LIM1-3" . SPARSER::COLLECTION)
    ("Cbl-c or Enigma" . SPARSER::COLLECTION)
    ("RET, Cbl-c and Enigma" . SPARSER::COLLECTION)
    ("Enigma and RET9MEN2A" . SPARSER::COLLECTION)
    ("RET9MEN2A, GST-Cbl-c, and either full-length FLAG-Enigma or a mutant lacking both the RET binding domain"
     . SPARSER::COLLECTION)
    ("RET9 and GFRα1" . SPARSER::COLLECTION)
    ("wild-type RET9 and the RET co-receptor" . SPARSER::COLLECTION)
    ("Cbl-c and RET9MEN2A" . SPARSER::COLLECTION)
    ("mature form" . SPARSER::FORM)
    ("receptor and Cbl-c" . SPARSER::COLLECTION)
    ("RET and Cbl-c" . SPARSER::COLLECTION) ("HRP" . SPARSER::PROTEIN)
    ("GFR" . SPARSER::PROTEIN) ("RET9MEN2A" . SPARSER::PROTEIN)
    ("Sorafenib" . SPARSER::DRUG) ("Cbl-c and this RTK" . SPARSER::COLLECTION)
    ("Grb2 or Shc" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("Kinase" . SPARSER::KINASE) ("RET and InsR" . SPARSER::COLLECTION)
    ("FLAG-Enigma" . SPARSER::COLLECTION)
    ("endogenous Enigma (MB231, xref top panel, lane 1) or Cbl-c"
     . SPARSER::COLLECTION)
    ("GST-tagged human Cbl-c (GST-Cbl-c) or GST" . SPARSER::COLLECTION)
    ("GST-Cbl-c" . SPARSER::COLLECTION)
    ("a potential interacting protein" . SPARSER::PROTEIN)
    ("Cbl-c and RET" . SPARSER::COLLECTION) ("RET/PTC" . SPARSER::COLLECTION)
    ("PTC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY) ("GDNF" . SPARSER::PROTEIN)
    ("LIM2 and LIM3" . SPARSER::COLLECTION)
    ("Cbl or Cbl-b" . SPARSER::COLLECTION)
    ("a functional E3" . SPARSER::MOLECULE)
    ("EGFR and v-Src" . SPARSER::COLLECTION)
    ("Cbl and Cbl-b" . SPARSER::COLLECTION) ("proline" . SPARSER::AMINO-ACID)
    ("SL, and RNF57" . SPARSER::COLLECTION)
    ("c-Cbl, Cbl2, and RNF55" . SPARSER::COLLECTION)
    ("EGFR, MET, and RET" . SPARSER::COLLECTION)
    ("receptor, and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("RTKs" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("Cbl-c and Enigma" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("Enigma and Cbl-c" . SPARSER::COLLECTION)
    ("homologues, Cbl and Cbl-b" . SPARSER::COLLECTION)
    ("a new Cbl-c" . SPARSER::PROTEIN) ("Enigma" . SPARSER::PROTEIN)
    ("Cbl, Cbl-b, and Cbl-c" . SPARSER::COLLECTION) ("Cbl" . SPARSER::PROTEIN)
    ("glial cell derived neurotrophic factor" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("Phospho-ERK" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("155kD" . SPARSER::PROTEIN)
    ("protein Enigma" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("Protein A" . SPARSER::PROTEIN) ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("g protein" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("GAL7" . SPARSER::PROTEIN) ("ADE2" . SPARSER::PROTEIN)
    ("GAL2" . SPARSER::PROTEIN) ("leu 2" . SPARSER::PROTEIN)
    ("trp 1" . SPARSER::PROTEIN) ("ura 3" . SPARSER::PROTEIN)
    ("GAL4" . SPARSER::PROTEIN) ("RET51" . SPARSER::PROTEIN)
    ("RET9" . SPARSER::PROTEIN) ("GFRα1" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("scaffold protein" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotrophic factor" . SPARSER::PROTEIN) ("LIM3" . SPARSER::PROTEIN)
    ("LIM2" . SPARSER::PROTEIN) ("RNF57" . SPARSER::PROTEIN)
    ("Cbl-3" . SPARSER::PROTEIN) ("RNF56" . SPARSER::PROTEIN)
    ("RNF55" . SPARSER::PROTEIN) ("Cbl2" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LIM1" . SPARSER::PROTEIN) ("PDLIM7" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("Cbl-c" . SPARSER::PROTEIN)
    ("Cbl-b" . SPARSER::PROTEIN)
    ("virion-associated Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDB1 and DCAF1" . SPARSER::COLLECTION) ("ligases" . SPARSER::LIGASE)
    ("Wang" . SPARSER::PROTEIN)
    ("The viral proteins Vpr and Vif" . SPARSER::COLLECTION)
    ("Vpr and Vif" . SPARSER::COLLECTION) ("Vif" . SPARSER::PROTEIN)
    ("approximately 6.9% type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NES" . SPARSER::PROTEIN)
    ("ZsGreen1 fluorescent protein" . SPARSER::PROTEIN)
    ("an Alexa594 secondary antibody" . SPARSER::ANTIBODY)
    ("ECFP" . SPARSER::PROTEIN) ("MAb" . SPARSER::DRUG)
    ("Flag-Vpr" . SPARSER::COLLECTION) ("Neo" . SPARSER::PROTEIN)
    ("pME" . SPARSER::PROTEIN) ("protein (ECFP)" . SPARSER::PROTEIN)
    ("acceptor" . SPARSER::MOLECULE) ("protein–protein" . SPARSER::COLLECTION)
    ("mCherry-hCdt1" . SPARSER::COLLECTION)
    ("Cdt1 and Geminin" . SPARSER::COLLECTION)
    ("human Cdt1 (amino acids 30–120) and a monomeric mutant"
     . SPARSER::COLLECTION)
    ("a monomeric mutant" . SPARSER::MUTANT)
    ("a red monomeric fluorescent protein (mCherry) fused" . SPARSER::PROTEIN)
    ("Geminin" . SPARSER::PROTEIN)
    ("different fluorescent proteins" . SPARSER::PROTEIN)
    ("monomeric Azami Green" . SPARSER::PROTEIN) ("Green" . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE) ("Caffeine" . SPARSER::MOLECULE)
    ("ATR" . SPARSER::PROTEIN)
    ("the viral preintegration complex" . SPARSER::BIO-COMPLEX)
    ("The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SCAT" . SPARSER::PROTEIN) ("an accessory protein" . SPARSER::PROTEIN)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mfn2" . SPARSER::PROTEIN)
    ("mitofusin 2" . SPARSER::PROTEIN) ("DCAF1" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("Cul4" . SPARSER::PROTEIN)
    ("Cullin4" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caspase-3" . SPARSER::PROTEIN) ("hCdt1" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endoribonuclease Dicer" . SPARSER::PROTEIN)
    ("eRF3b and eRF3a" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("ERF3a and eRF3b" . SPARSER::COLLECTION) ("ERF3a" . SPARSER::PROTEIN)
    ("structural homologues" . SPARSER::PROTEIN)
    ("eRF3a and eRF3b" . SPARSER::COLLECTION)
    ("GSPT1 and GSPT2" . SPARSER::COLLECTION)
    ("eRF1 and eRF3" . SPARSER::COLLECTION) ("polypeptide" . SPARSER::PEPTIDE)
    ("ERF" . SPARSER::PROTEIN)
    ("the 4210 Da protein and the 1860 Da protein" . SPARSER::COLLECTION)
    ("proteins, the 4210 Da protein and the 1860 Da protein"
     . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("4E-BP1 and p70S6K1" . SPARSER::COLLECTION) ("eIF" . SPARSER::PROTEIN)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("-GSPT1" . SPARSER::COLLECTION) ("eRF3a/GSPT1" . SPARSER::COLLECTION)
    ("LC and HCC" . SPARSER::COLLECTION)
    ("CHB, LC and HCC" . SPARSER::COLLECTION) ("Trap" . SPARSER::PROTEIN)
    ("Ion" . SPARSER::MOLECULE) ("LTQ" . SPARSER::MOLECULE)
    ("only one protein" . SPARSER::PROTEIN)
    ("HCC and LC" . SPARSER::COLLECTION) ("LC and CHB" . SPARSER::COLLECTION)
    ("SD" . SPARSER::PROTEIN) ("Biomarker" . SPARSER::MOLECULE)
    ("LC/HCC" . SPARSER::COLLECTION)
    ("weak cation-exchange (WCX) magnetic bead purification and MALDI-TOF MS"
     . SPARSER::PROTEIN)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("states" . SPARSER::BIO-STATE) ("cirrhosis" . SPARSER::PROTEIN)
    ("LC or HCC" . SPARSER::COLLECTION) ("eRF3b/GSPT2" . SPARSER::COLLECTION)
    ("eukaryotic peptide chain release factor GTP-binding subunit eRF3b"
     . SPARSER::PROTEIN)
    ("HCC and CHB" . SPARSER::COLLECTION) ("Da" . SPARSER::MOLECULE)
    ("MS 3" . SPARSER::PROTEIN) ("and 1 µ" . SPARSER::PROTEIN)
    ("1 µL" . SPARSER::PROTEIN) ("Alpha-" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("initiation factor 4E-binding protein" . SPARSER::PROTEIN)
    ("eRF3" . SPARSER::PROTEIN) ("eRF1" . SPARSER::PROTEIN)
    ("p70S6K1" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("GSPT1" . SPARSER::PROTEIN) ("eRF3a" . SPARSER::PROTEIN)
    ("subunit 3" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("GSPT2" . SPARSER::PROTEIN) ("eRF3b" . SPARSER::PROTEIN)
    ("estrogens" . SPARSER::MOLECULE) ("receptors (ER)" . SPARSER::RECEPTOR)
    ("myoblasts" . SPARSER::PROTEIN)
    ("E 2 and grip strength and biceps" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("IT" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("E 2 and FE 2 levels" . SPARSER::COLLECTION) ("Fat" . SPARSER::PROTEIN)
    ("lower limb" . SPARSER::PROTEIN) ("limb" . SPARSER::PROTEIN)
    ("physical activity level and body fat" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN)
    ("androgens and muscle mass and function" . SPARSER::COLLECTION)
    ("androgen receptor ( AR )" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("Androgen" . SPARSER::PROTEIN)
    ("Skeletal muscle" . SPARSER::PROTEIN) ("Age" . SPARSER::PROTEIN)
    ("Arm" . SPARSER::PROTEIN) ("GGN" . SPARSER::PROTEIN)
    ("higher E 2 and FE 2 concentrations" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::MOLECULE) ("FT" . SPARSER::PROTEIN)
    ("androgens" . SPARSER::DRUG) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sex hormone binding globulin" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE) ("androgen receptor" . SPARSER::PROTEIN)
    ("the commonly used colorectal cancer cell line DLD1 and its derivatives"
     . SPARSER::COLLECTION)
    ("the commonly used colorectal cancer cell line DLD1" . SPARSER::PROTEIN)
    ("RasGAP and KRAS" . SPARSER::COLLECTION)
    ("KRAS and Rho" . SPARSER::COLLECTION) ("MEFs" . SPARSER::PROTEIN)
    ("RhoGAP/RasGAP" . SPARSER::COLLECTION)
    ("many cellular RhoGAPs" . SPARSER::PROTEIN) ("RhoGAPs" . SPARSER::PROTEIN)
    ("RhoA" . SPARSER::PROTEIN) ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pY" . SPARSER::PROTEIN) ("PDGF" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("GTPase" . SPARSER::GTPASE) ("HRAS or NRAS" . SPARSER::COLLECTION)
    ("NRAS" . SPARSER::PROTEIN) ("HRAS" . SPARSER::PROTEIN)
    ("RasGAP and mutant" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("NMR" . SPARSER::PROTEIN)
    ("pBp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("significantly less RASA1" . SPARSER::PROTEIN) ("Line" . SPARSER::PROTEIN)
    ("both the genomic DNA and the cDNA from DLD1 and DKO4 cells"
     . SPARSER::COLLECTION)
    ("DLD1 and DKO4" . SPARSER::COLLECTION) ("kDa" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE)
    ("RhoGAP-RasGAP" . SPARSER::COLLECTION) ("RhoGAP" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SH2" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN) ("wine" . SPARSER::MOLECULE)
    ("RasGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTP-ase activating proteins (GAPs)" . SPARSER::NUCLEOTIDE)
    ("GTP, and GTP" . SPARSER::COLLECTION) ("GTP-ase" . SPARSER::NUCLEOTIDE)
    ("GDP" . SPARSER::NUCLEOTIDE) ("GEFs" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("families" . SPARSER::PROTEIN-FAMILY) ("effectors" . SPARSER::EFFECTOR)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("KRAS and RasGAP" . SPARSER::COLLECTION) ("RasGAP" . SPARSER::PROTEIN)
    ("a heterozygous KRAS G13D allele" . SPARSER::ALLELE)
    ("DLD1" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("p190" . SPARSER::PROTEIN) ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("SPI1" . SPARSER::PROTEIN)
    ("glutathione- S -transferase" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("RAS-binding" . SPARSER::PROTEIN)
    ("ammonium chloride" . SPARSER::MOLECULE) ("RAS 1" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bp 2" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("RPS13" . SPARSER::PROTEIN)
    ("p190A" . SPARSER::PROTEIN) ("RASA1" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("p120RasGAP" . SPARSER::PROTEIN) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("ctf4 , ctf8 , ctf18 , and dscc1" . SPARSER::COLLECTION)
    ("mre11 , smc1 , smc3 , scc2 , and pds1" . SPARSER::COLLECTION)
    ("ctf8 , ctf18 , dscc1 , ctf4 , and rad27" . SPARSER::COLLECTION)
    ("dscc1" . SPARSER::PROTEIN) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("an alternate RFC" . SPARSER::PROTEIN)
    ("RFC2, RFC3, RFC4, and RFC5" . SPARSER::COLLECTION)
    ("Csm3 , Tof1 , Mrc1 , and Dscc1" . SPARSER::COLLECTION)
    ("inhibitor, and DNA-intercalator" . SPARSER::COLLECTION)
    ("DNA-intercalator" . SPARSER::DNA)
    ("E2Fs and their cofactors" . SPARSER::COLLECTION)
    ("polycomb" . SPARSER::PROTEIN)
    ("E2F1, E2F2, and E2F3" . SPARSER::COLLECTION)
    ("transcriptional activators, and E2F4, E2F5, E2F6, E2F7, and E2F8"
     . SPARSER::COLLECTION)
    ("E2F4, E2F5, E2F6, E2F7, and E2F8" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("EBS1 and EBS3" . SPARSER::COLLECTION)
    ("mismatch" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("an oncogene and a tumor suppressor" . SPARSER::COLLECTION)
    ("pRB" . SPARSER::PROTEIN) ("retinoblastoma" . SPARSER::PROTEIN)
    ("DNA-damage" . SPARSER::DNA)
    ("intercalator, or MG132" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("intercalator" . SPARSER::MOLECULE) ("reagents" . SPARSER::MOLECULE)
    ("camptothecin-" . SPARSER::DRUG) ("SW480-DSCC1" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("DSCC1#1" . SPARSER::PROTEIN)
    ("SW480 cells-expressing exogenous DSCC1" . SPARSER::PROTEIN)
    ("SW480-DSCC1#1, #3, and #8" . SPARSER::COLLECTION)
    ("SW480-DSCC1#1" . SPARSER::COLLECTION)
    ("exogenous DSCC1" . SPARSER::PROTEIN)
    ("EGFP, DSCC1#1scr, or DSCC1#2scr" . SPARSER::COLLECTION)
    ("scr" . SPARSER::PROTEIN) ("shRNAs" . SPARSER::PROTEIN)
    ("both DSCC1 shRNA (shDSCC1#1, or shDSCC1#2) and neomycin resistant gene"
     . SPARSER::COLLECTION)
    ("neomycin" . SPARSER::DRUG) ("DSCC1 and CDK1" . SPARSER::COLLECTION)
    ("Ctrl" . SPARSER::PROTEIN) ("EBS1 and EBS2" . SPARSER::COLLECTION)
    ("mut1, and mut1" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("EBS1, EBS2, and EBS3" . SPARSER::COLLECTION)
    ("EBS2 (+31/+38; 5′-CTTCCGGC-3′ ) and EBS3 (+57/+64; 5′-TTGCCCGC-3′ )"
     . SPARSER::COLLECTION)
    ("-TTGCCCGC-3" . SPARSER::COLLECTION) ("-CTTCCGGC-3" . SPARSER::COLLECTION)
    ("E2F1, E2F2, E2F3, and E2F4" . SPARSER::COLLECTION)
    ("-CTTGGCGC-3" . SPARSER::COLLECTION)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("leukocytes" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("An immunohistochemical staining showed accumulated DSCC1 protein"
     . SPARSER::PROTEIN)
    ("diagnostic biomarkers" . SPARSER::MOLECULE)
    ("DNA-replication" . SPARSER::DNA) ("CTF18-RFC" . SPARSER::COLLECTION)
    ("TOF1/MRC" . SPARSER::COLLECTION) ("MRC" . SPARSER::PROTEIN)
    ("CTF18-DSCC1-CTF8-RFC" . SPARSER::COLLECTION)
    ("component, Ctf18p, Ctf8p, or Dcc1p" . SPARSER::COLLECTION)
    ("alterative replication factor C (RFC) complex" . SPARSER::BIO-COMPLEX)
    ("RFC" . SPARSER::PROTEIN)
    ("components and regulators" . SPARSER::COLLECTION)
    ("SMC1L1 , CSPG6 , NIPBL , and STAG3" . SPARSER::COLLECTION)
    ("NIPBL" . SPARSER::PROTEIN) ("homologues" . SPARSER::PROTEIN)
    ("MRE11 , ZW10 , ZWILCH , ROD , and DING" . SPARSER::COLLECTION)
    ("DING" . SPARSER::PROTEIN) ("ROD" . SPARSER::PROTEIN)
    ("ZWILCH" . SPARSER::PROTEIN) ("MSI" . SPARSER::PROTEIN)
    ("Dscc1" . SPARSER::PROTEIN) ("pds1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scc2" . SPARSER::PROTEIN) ("smc3" . SPARSER::PROTEIN)
    ("smc1" . SPARSER::PROTEIN) ("mre11" . SPARSER::PROTEIN)
    ("rad27" . SPARSER::PROTEIN) ("ctf4" . SPARSER::PROTEIN)
    ("ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ctf8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRCA2" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("RFC5" . SPARSER::PROTEIN)
    ("RFC4" . SPARSER::PROTEIN) ("RFC3" . SPARSER::PROTEIN)
    ("RFC2" . SPARSER::PROTEIN) ("Mrc1" . SPARSER::PROTEIN)
    ("Tof1" . SPARSER::PROTEIN) ("Csm3" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("E2F8" . SPARSER::PROTEIN) ("E2F7" . SPARSER::PROTEIN)
    ("E2F5" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("ELK1" . SPARSER::PROTEIN) ("thymidylate synthase" . SPARSER::PROTEIN)
    ("topoisomerase I" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("EBS3" . SPARSER::PROTEIN) ("EBS2" . SPARSER::PROTEIN)
    ("E2F6" . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("EBS1" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("micrococcal nuclease" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("SW480" . SPARSER::PROTEIN) ("TOF1" . SPARSER::PROTEIN)
    ("RAD9" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("CTF8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CTF18" . SPARSER::PROTEIN)
    ("Ctf8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dcc1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DCC1" . SPARSER::PROTEIN)
    ("SCC2" . SPARSER::PROTEIN) ("SMC3" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN) ("STAG3" . SPARSER::PROTEIN)
    ("CSPG6" . SPARSER::PROTEIN) ("SMC1L1" . SPARSER::PROTEIN)
    ("ZW10" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN)
    ("DSCC1" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTO-ONCOGENE)
    ("DNA replication and sister chromatid cohesion 1" . SPARSER::PROTEIN)
    ("Ctf18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("any possible direct and indirect biological impact" . SPARSER::PROTEIN)
    ("cofactors" . SPARSER::PROTEIN) ("Lipoprotein" . SPARSER::PROTEIN)
    ("lipids and apolipoproteins" . SPARSER::COLLECTION)
    ("apolipoproteins" . SPARSER::PROTEIN) ("yrs" . SPARSER::PROTEIN)
    ("lipoprotein and apolipoprotein B" . SPARSER::COLLECTION)
    ("TT" . SPARSER::PROTEIN) ("GT" . SPARSER::PROTEIN)
    ("lipoprotein" . SPARSER::PROTEIN) ("triglycerides" . SPARSER::MOLECULE)
    ("extracellular lipids" . SPARSER::LIPID) ("lipids" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("Telomerase" . SPARSER::PROTEIN)
    ("telomerase RNA component (TERC)" . SPARSER::RNA)
    ("repetitive nucleotide" . SPARSER::NUCLEOTIDE)
    ("indirect bilirubin" . SPARSER::MOLECULE)
    ("bilirubin" . SPARSER::MOLECULE)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("apolipoprotein B" . SPARSER::PROTEIN)
    ("apolipoprotein A1" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("additional risk-associated variants" . SPARSER::VARIANT)
    ("mix" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("the deleted allele" . SPARSER::ALLELE) ("caspase-8" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN)
    ("The minor variant A allele" . SPARSER::ALLELE)
    ("the A allele and survival" . SPARSER::COLLECTION)
    ("the XRCC1 399 A allele" . SPARSER::ALLELE)
    ("the minor variant A allele" . SPARSER::ALLELE)
    ("meta" . SPARSER::PROTEIN) ("Platinum" . SPARSER::MOLECULE)
    ("TR and PFS" . SPARSER::COLLECTION) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the A allele" . SPARSER::ALLELE)
    ("minor variant A allele" . SPARSER::ALLELE) ("PRISMA" . SPARSER::DRUG)
    ("Gln" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("platinum" . SPARSER::MOLECULE) ("X-Ray repair" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("X-ray repair" . SPARSER::PROTEIN)
    ("a new biomarker" . SPARSER::MOLECULE)
    ("a new prognostic biomarker" . SPARSER::MOLECULE)
    ("the Rho-associated serine/threonine kinase family"
     . SPARSER::PROTEIN-FAMILY)
    ("MUT" . SPARSER::PROTEIN)
    ("a tumor suppressive regulator" . SPARSER::PROTEIN)
    ("N-cadherin and Slug" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("IA" . SPARSER::MOLECULE) ("odd" . SPARSER::PROTEIN)
    ("a tumor suppressive miRNA" . SPARSER::MICRO-RNA)
    ("nodal" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("the most important prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p " . SPARSER::PROTEIN) ("IB" . SPARSER::PROTEIN)
    ("LN" . SPARSER::PROTEIN) ("miRNAs" . SPARSER::MICRO-RNA)
    ("MicroRNAs" . SPARSER::MICRO-RNA) ("ROCK1 protein" . SPARSER::PROTEIN)
    ("its 3" . SPARSER::PROTEIN) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK2" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("GWAS  " . SPARSER::PROTEIN) ("GWAS" . SPARSER::PROTEIN)
    ("KRT80 and TERT" . SPARSER::COLLECTION)
    ("GWAS-Rep1  " . SPARSER::PROTEIN-PAIR)
    ("GWAS-Rep1" . SPARSER::PROTEIN-PAIR)
    ("het  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHB and JPT" . SPARSER::COLLECTION) ("CHB" . SPARSER::PROTEIN)
    ("two further Han Chinese cohorts" . SPARSER::MOLECULE)
    ("Han" . SPARSER::PROTEIN) ("TERT and TERC" . SPARSER::COLLECTION)
    ("The latter component" . SPARSER::COMPONENT)
    ("a large RNA–protein complex consisting of a reverse transcriptase (TERT) and an RNA template (TERC) xref"
     . SPARSER::COLLECTION)
    ("reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("TERC" . SPARSER::PROTEIN) ("telomerase" . SPARSER::PROTEIN)
    ("sib" . SPARSER::DRUG) ("TERT" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN) ("C12orf44" . SPARSER::PROTEIN)
    ("ACVR1B" . SPARSER::PROTEIN) ("Rep3  " . SPARSER::PROTEIN)
    ("Rep3" . SPARSER::PROTEIN) ("Rep2  " . SPARSER::PROTEIN)
    ("Rep2" . SPARSER::PROTEIN) ("Rep1  " . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("Rep1" . SPARSER::PROTEIN)
    ("OBFC1" . SPARSER::PROTEIN) ("Type 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p15" . SPARSER::PROTEIN) ("KRT80" . SPARSER::PROTEIN)
    ("keratin 80" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("pilot" . SPARSER::PROTEIN) ("mutated DNA" . SPARSER::DNA)
    ("radical" . SPARSER::MOLECULE) ("SS and MET" . SPARSER::COLLECTION)
    ("SS" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("max" . SPARSER::PROTEIN) ("p-MET" . SPARSER::COLLECTION)
    ("pYY" . SPARSER::PROTEIN) ("Only three cases met" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("Lys" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID) ("Ala" . SPARSER::AMINO-ACID)
    ("Ile" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("RT or CRT" . SPARSER::COLLECTION) ("CRT" . SPARSER::PROTEIN)
    ("N1-N3" . SPARSER::COLLECTION)
    ("alcohol and tobacco" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("tobacco" . SPARSER::DRUG) ("SF" . SPARSER::PROTEIN)
    ("HGF" . SPARSER::PROTEIN) ("SEMA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HNC" . SPARSER::PROTEIN) ("only 3 cases met" . SPARSER::AMINO-ACID)
    ("met" . SPARSER::AMINO-ACID) ("Asp" . SPARSER::AMINO-ACID)
    ("c-Met" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("SP44" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN) ("scatter factor" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("certain accessory gene" . SPARSER::GENE)
    ("call" . SPARSER::PROTEIN)
    ("disease-relevant Vpu alleles" . SPARSER::ALLELE)
    ("CD4 and tetherin" . SPARSER::COLLECTION)
    ("NTB-A and CD1d" . SPARSER::COLLECTION)
    ("PVR and CD1-d" . SPARSER::COLLECTION) ("CD1" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("the secondary aim" . SPARSER::PROTEIN)
    ("NP2 and LTNP 3" . SPARSER::COLLECTION)
    ("a pattern-recognition receptor and potential enhancer"
     . SPARSER::COLLECTION)
    ("Env" . SPARSER::PROTEIN) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("NP 1 and RP 2" . SPARSER::COLLECTION) ("RP 3" . SPARSER::PROTEIN)
    ("CTLs" . SPARSER::PROTEIN) ("HLA" . SPARSER::PROTEIN)
    ("fell" . SPARSER::PROTEIN) ("env" . SPARSER::PROTEIN)
    ("tetherin or MAVS" . SPARSER::COLLECTION)
    ("tetherin and MAVS" . SPARSER::COLLECTION)
    ("tetherin-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a central adaptor protein" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("Minor" . SPARSER::PROTEIN)
    ("more modest mutants" . SPARSER::MUTANT)
    ("physically antagonise tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpu and β-TrCP" . SPARSER::COLLECTION)
    ("a highly conserved hydrophilic asparagine" . SPARSER::AMINO-ACID)
    ("histidine" . SPARSER::AMINO-ACID) ("asparagine" . SPARSER::AMINO-ACID)
    ("patch" . SPARSER::PROTEIN) ("SE" . SPARSER::PROTEIN)
    ("NP 2 and LTNP" . SPARSER::COLLECTION)
    ("valine or threonine" . SPARSER::COLLECTION)
    ("valine" . SPARSER::AMINO-ACID) ("Vpu/tetherin" . SPARSER::COLLECTION)
    ("face" . SPARSER::PROTEIN) ("alanines" . SPARSER::AMINO-ACID)
    ("tryptophan" . SPARSER::AMINO-ACID)
    ("amino acids or motifs" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("RH" . SPARSER::MOLECULE) ("SN" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN)
    ("only one or two amino acids" . SPARSER::AMINO-ACID)
    ("SGA" . SPARSER::PROTEIN) ("serines" . SPARSER::AMINO-ACID)
    ("Los" . SPARSER::MOLECULE) ("NP 1 and LTNP" . SPARSER::COLLECTION)
    ("p  " . SPARSER::PROTEIN) ("rest" . SPARSER::PROTEIN)
    ("CH" . SPARSER::PROTEIN) ("Mutant" . SPARSER::MUTANT)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("304 unique amino acid" . SPARSER::AMINO-ACID)
    ("unique nucleotide" . SPARSER::NUCLEOTIDE)
    ("nucleotide and amino acid" . SPARSER::COLLECTION)
    ("representative minor viral variants" . SPARSER::VARIANT)
    ("NPs" . SPARSER::PROTEIN) ("RPs" . SPARSER::PROTEIN)
    ("MACS" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("RP" . SPARSER::PROTEIN) ("sub-optimal Vpu proteins" . SPARSER::PROTEIN)
    ("viral alleles" . SPARSER::ALLELE) ("interferon" . SPARSER::PROTEIN)
    ("Tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the only virus group" . SPARSER::MOLECULE)
    ("tetherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("available group N Vpu proteins" . SPARSER::PROTEIN)
    ("PVR/CD155" . SPARSER::COLLECTION) ("NTB-A/SLAMF6" . SPARSER::COLLECTION)
    ("PVR" . SPARSER::PROTEIN) ("accessory genes" . SPARSER::GENE)
    ("nef , vpu , vif and vpr" . SPARSER::COLLECTION)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("vif" . SPARSER::PROTEIN)
    ("nef" . SPARSER::PROTEIN) ("a host antiviral protein" . SPARSER::PROTEIN)
    ("MHC" . SPARSER::PROTEIN) ("class I" . SPARSER::PROTEIN)
    ("vpu" . SPARSER::PROTEIN)
    ("the antiviral protein tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BST2/CD317" . SPARSER::COLLECTION)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vpu" . SPARSER::PROTEIN)
    ("IPS1" . SPARSER::PROTEIN) ("a11" . SPARSER::PROTEIN)
    ("CAT-3" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Env protein" . SPARSER::PROTEIN)
    ("mannose-6-phosphate receptor" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE) ("IκB" . SPARSER::PROTEIN)
    ("RP 2" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("RP 1" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("NP3" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("NP1" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("NP2" . SPARSER::PROTEIN)
    ("NP 1" . SPARSER::PROTEIN) ("NP 3" . SPARSER::PROTEIN)
    ("NP 2" . SPARSER::PROTEIN) ("RP2" . SPARSER::PROTEIN)
    ("APOBEC3" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN) ("KIR2DL2" . SPARSER::PROTEIN)
    ("NK-T" . SPARSER::PROTEIN) ("CD1d" . SPARSER::PROTEIN)
    ("CD155" . SPARSER::PROTEIN) ("poliovirus receptor" . SPARSER::PROTEIN)
    ("SLAMF6" . SPARSER::PROTEIN) ("NTB-A" . SPARSER::PROTEIN)
    ("interferon-induced" . SPARSER::PROTEIN) ("CD317" . SPARSER::PROTEIN)
    ("BST2" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("hope" . SPARSER::PROTEIN) ("anoikis" . SPARSER::PROTEIN)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("strong urokinase plasminogen activator" . SPARSER::PROTEIN)
    ("urokinase" . SPARSER::PROTEIN) ("PAI-1 and TGF-1" . SPARSER::COLLECTION)
    ("a strong inducer" . SPARSER::PROTEIN)
    ("cyclin-cdk" . SPARSER::COLLECTION)
    ("cyclin E and its binding partner cdk2" . SPARSER::COLLECTION)
    ("functional PAI-1" . SPARSER::PROTEIN) ("CDKs" . SPARSER::PROTEIN)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D3/cdk4/6" . SPARSER::COLLECTION)
    ("further studying PAI-1's" . SPARSER::PROTEIN)
    ("further studying PAI-1" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("cyclin/cdk" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin E, CDK2 or p53" . SPARSER::COLLECTION)
    ("a functional PAI-1" . SPARSER::PROTEIN)
    ("T24 Scr ( p = 0.0007) and UM-UC-14-PAI-1 KD" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN)
    ("T24 Scr and UM-UC-14 Scr (  xref  )" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EDU" . SPARSER::DRUG)
    ("ethynyl" . SPARSER::MOLECULE) ("Cytometry" . SPARSER::PROTEIN)
    ("Fluor" . SPARSER::MOLECULE) ("EdU" . SPARSER::DRUG)
    ("controls T24 Scr and UM-UC-14 Scr" . SPARSER::COLLECTION)
    ("thymidine" . SPARSER::PROTEIN)
    ("cyclin D3, cdk4/6, cyclin E and cdk2" . SPARSER::COLLECTION)
    ("cdk4/6" . SPARSER::PROTEIN) ("plasminogen and uPA" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("KD" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("p21 Cip1/Waf1" . SPARSER::COLLECTION)
    ("cyclin E/cdk2" . SPARSER::COLLECTION)
    ("shRNA or tiplaxtinin" . SPARSER::COLLECTION) ("shRNA" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("tissue plasminogen activator (tPA) and inhibitors PAI-1 and PAI-2 ( xref - xref )"
     . SPARSER::COLLECTION)
    ("the serine protease urokinase-type plasminogen activator (uPA), its receptor uPA-R, tissue plasminogen activator (tPA) and inhibitors PAI-1 and PAI-2 ( xref - xref )"
     . SPARSER::COLLECTION)
    ("PAI-1 and PAI-2" . SPARSER::COLLECTION) ("tPA" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("p21Cip1/Waf1" . SPARSER::COLLECTION)
    ("Cyclin E/CDK2" . SPARSER::COLLECTION)
    ("Cyclin D3/CDK4/6" . SPARSER::COLLECTION) ("tiplaxtinin" . SPARSER::DRUG)
    ("a pleiotropic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAI-1/SERPINE1" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("TGF-beta" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tissue-type plasminogen activator" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("Plasminogen Activator Inhibitor 1" . SPARSER::PROTEIN)
    ("p27 kip1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cdk2" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("cdk4" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("PAI-039" . SPARSER::DRUG)
    ("PAI-2" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("Waf1" . SPARSER::PROTEIN)
    ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDK2" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("Given LRRK2" . SPARSER::PROTEIN) ("amphetamine" . SPARSER::DRUG)
    ("the striatal SPNs" . SPARSER::PROTEIN)
    ("the postsynaptic adaptor proteins PSD95" . SPARSER::PROTEIN)
    ("P21–P28" . SPARSER::COLLECTION) ("P10–P14" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("LTP" . SPARSER::PROTEIN)
    ("MAP2 and LRRK2" . SPARSER::COLLECTION)
    ("the synaptic protein GluR1" . SPARSER::PROTEIN)
    ("significantly more PKACα and PKARIIβ subunits" . SPARSER::FRAGMENT)
    ("receptors and adenylate" . SPARSER::COLLECTION)
    ("cyclase" . SPARSER::PROTEIN)
    ("an additional dendritic AKAP" . SPARSER::PROTEIN)
    ("a neuronal AKAP" . SPARSER::PROTEIN)
    ("dendritic MAP2" . SPARSER::PROTEIN) ("anchors" . SPARSER::ANCHOR)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S3A-cofilin" . SPARSER::COLLECTION) ("soma" . SPARSER::DRUG)
    ("key synaptic proteins" . SPARSER::PROTEIN)
    ("S845 GluR1 and other substrates" . SPARSER::COLLECTION)
    ("SKF81297-treated P21 LRRK2  +/+" . SPARSER::PROTEIN)
    ("P21 and 18-month-old" . SPARSER::COLLECTION)
    ("cofilin and pS845 GluR1" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("t" . SPARSER::PROTEIN)
    ("the postnatal developmental period" . SPARSER::PROTEIN)
    ("GluR1 and cofilin" . SPARSER::COLLECTION)
    ("P5 and P15" . SPARSER::COLLECTION)
    ("the potential impact" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("AMPA" . SPARSER::PROTEIN) ("microtubules" . SPARSER::PROTEIN)
    ("the postsynaptic density (PSD) fraction" . SPARSER::COMPONENT)
    ("base" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("LRRK2 and PKACα" . SPARSER::COLLECTION)
    ("LRRK2 and PKARIIβ" . SPARSER::COLLECTION) ("CREB" . SPARSER::PROTEIN)
    ("FSK" . SPARSER::PROTEIN) ("p-cofilin" . SPARSER::PROTEIN-PAIR)
    ("PKI" . SPARSER::PROTEIN-FAMILY) ("forskolin (FSK)" . SPARSER::PROTEIN)
    ("forskolin" . SPARSER::PROTEIN)
    ("LRRK2  +/+ and LRRK2  −/− neurons displayed similar changes of cofilin phosphorylation levels in response"
     . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR)
    ("kinase and Slingshot" . SPARSER::COLLECTION)
    ("active or inactive" . SPARSER::COLLECTION) ("DIV" . SPARSER::PROTEIN)
    ("cofilin and LRRK2" . SPARSER::COLLECTION)
    ("kinases or phosphatases" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("the striatal homogenate" . SPARSER::PROTEIN)
    ("homogenate" . SPARSER::PROTEIN) ("PPF" . SPARSER::MOLECULE)
    ("clamp" . SPARSER::PROTEIN) ("P15 and P21" . SPARSER::COLLECTION)
    ("PSD" . SPARSER::PROTEIN) ("the dorsal SPNs" . SPARSER::PROTEIN)
    ("COX" . SPARSER::PROTEIN) ("AKAP" . SPARSER::PROTEIN)
    ("Dopamine" . SPARSER::DRUG) ("holoenzyme" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID) ("Slingshot" . SPARSER::PROTEIN)
    ("LIM" . SPARSER::PROTEIN) ("thin" . SPARSER::PROTEIN)
    ("the striosomal SPNs" . SPARSER::PROTEIN) ("SPN" . SPARSER::PROTEIN)
    ("striatum" . SPARSER::PROTEIN)
    ("cofilin and glutamate receptor" . SPARSER::COLLECTION)
    ("dopamine" . SPARSER::PROTEIN) ("SPNs" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("cdc42" . SPARSER::PROTEIN)
    ("CAP1" . SPARSER::PROTEIN) ("Arp3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arp2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Diap2" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("14-3-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IP 1" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("PO 4" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("P28" . SPARSER::PROTEIN)
    ("P14" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("AC5" . SPARSER::PROTEIN) ("adenylate cyclase 5" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("AKAP79" . SPARSER::PROTEIN)
    ("SKF81297" . SPARSER::DRUG) ("P30" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDK1" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("AKT/protein" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("S3A" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("pS3" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21" . SPARSER::PROTEIN) ("PSD95" . SPARSER::PROTEIN)
    ("P15" . SPARSER::PROTEIN) ("GluR1" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN)
    ("PKA regulatory subunit" . SPARSER::PROTEIN) ("Drd1" . SPARSER::PROTEIN)
    ("protein kinase A" . SPARSER::PROTEIN)
    ("Leucine-rich repeat" . SPARSER::PROTEIN)
    ("heme oxygenase 1 (HMOX1) and thioredoxin reductase 1 (TXNRD1)"
     . SPARSER::COLLECTION)
    ("glutathione S-transferase A4 (GSTA4), glutathione peroxidase 1 (GPX1), glutamate-cysteine ligase, catalytic subunit (GCLC), heme oxygenase 1 (HMOX1) and thioredoxin reductase 1 (TXNRD1)"
     . SPARSER::COLLECTION)
    ("GSH" . SPARSER::DRUG)
    ("the prominent transcription factor" . SPARSER::PROTEIN)
    ("minor" . SPARSER::PROTEIN) ("AREs or a single ARE" . SPARSER::COLLECTION)
    ("Nrf1-" . SPARSER::PROTEIN) ("electrophiles" . SPARSER::MOLECULE)
    ("retinoid" . SPARSER::PROTEIN) ("cytoprotective genes" . SPARSER::GENE)
    ("25 Nrf1 target genes and 124 Nrf2 target genes" . SPARSER::COLLECTION)
    ("only 10 common target genes" . SPARSER::GENE)
    ("oxidative stress responsive genes" . SPARSER::GENE)
    ("stress-responsive genes" . SPARSER::GENE)
    ("factors, Nrf1 and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 −/− and wild type cells" . SPARSER::COLLECTION)
    ("MT-1 and MTF-1" . SPARSER::COLLECTION) ("MTF" . SPARSER::PROTEIN)
    ("pEF" . SPARSER::MOLECULE) ("MT" . SPARSER::PROTEIN)
    ("LC" . SPARSER::PROTEIN) ("translational elongation" . SPARSER::PROTEIN)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-E2/AP-1" . SPARSER::COLLECTION) ("CNC-bZIP" . SPARSER::COLLECTION)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("CNC" . SPARSER::PROTEIN) ("AP-1 or NF-E2" . SPARSER::COLLECTION)
    ("AP-1" . SPARSER::PROTEIN)
    ("transcription factor A, mitochondrial (TFAM)" . SPARSER::PROTEIN)
    ("glucosidase (MOGS)" . SPARSER::PROTEIN) ("TFAM" . SPARSER::PROTEIN)
    ("quinone" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("MOGS" . SPARSER::PROTEIN) ("glucosidase" . SPARSER::PROTEIN)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("catalytic subunit (GCLC)" . SPARSER::PROTEIN)
    ("subunit (GCLM)" . SPARSER::FRAGMENT) ("oxygenase" . SPARSER::PROTEIN)
    ("heme" . SPARSER::PROTEIN) ("GCLM" . SPARSER::PROTEIN)
    ("GCLC" . SPARSER::PROTEIN) ("IPA and Nrf1 or Nrf2" . SPARSER::COLLECTION)
    ("IPA" . SPARSER::MOLECULE) ("Differentially" . SPARSER::PROTEIN)
    ("copper-responsive genes" . SPARSER::GENE)
    ("Nrf1 or Nrf2-regulated genes" . SPARSER::COLLECTION)
    ("Nrf1, and Nrf1" . SPARSER::COLLECTION)
    ("The present functional network and Gene Ontology (GO) analyses using copper-responsive genes"
     . SPARSER::GENE)
    ("GO" . SPARSER::PROTEIN)
    ("metallothionein -1 (MT-1) and MT-2 genes" . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN) ("glutathione" . SPARSER::DRUG)
    ("ARE-driven reporter genes" . SPARSER::GENE)
    ("antioxidant and Phase II" . SPARSER::COLLECTION)
    ("xenobiotic" . SPARSER::MOLECULE)
    ("the Cap’n’Collar basic leucine zipper family" . SPARSER::PROTEIN-FAMILY)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("cofactor" . SPARSER::MOLECULE)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Nrf1 or Nrf2" . SPARSER::COLLECTION)
    ("Nrf1 and Nrf2" . SPARSER::COLLECTION) ("Nrf1" . SPARSER::PROTEIN)
    ("CYP2E1" . SPARSER::PROTEIN) ("TXNRD1" . SPARSER::PROTEIN)
    ("thioredoxin reductase 1" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("GPX1" . SPARSER::PROTEIN)
    ("glutathione peroxidase 1" . SPARSER::PROTEIN)
    ("GSTA4" . SPARSER::PROTEIN)
    ("glutathione S-transferase A4" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("transcription factor A, mitochondrial" . SPARSER::PROTEIN)
    ("PSMA5" . SPARSER::PROTEIN) ("alpha type" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("NAD(P)H" . SPARSER::MOLECULE)
    ("IL1RN" . SPARSER::PROTEIN)
    ("interleukin 1 receptor antagonist" . SPARSER::PROTEIN)
    ("MT1E" . SPARSER::PROTEIN) ("metallothionein 1E" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("βgal" . SPARSER::PROTEIN)
    ("p150" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("MT-2" . SPARSER::PROTEIN) ("metallothionein -1" . SPARSER::PROTEIN)
    ("Cap’n’Collar" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("MT-1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("ATPase activity and greater" . SPARSER::COLLECTION)
    ("ago" . SPARSER::PROTEIN)
    ("lid-closed conformation" . SPARSER::BIO-CONFORMATION)
    ("Drug" . SPARSER::DRUG)
    ("Aha1 and these inhibitors" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("ATPase activity and yAha1" . SPARSER::COLLECTION)
    ("coiled-coil" . SPARSER::PROTEIN) ("coil" . SPARSER::PROTEIN)
    ("ATPase activity and ATP-dependent" . SPARSER::COLLECTION)
    ("GR and v-Src" . SPARSER::COLLECTION)
    ("v-Src, GR, and CFTR" . SPARSER::COLLECTION)
    ("Aha1 and Hsp90" . SPARSER::COLLECTION)
    ("wild-type yHsp90 and yHsp90-K178R proteins" . SPARSER::COLLECTION)
    ("p23 and Cdc37" . SPARSER::COLLECTION)
    ("protein and Aha1" . SPARSER::COLLECTION)
    ("yHsp90 and yAha1" . SPARSER::COLLECTION) ("MET" . SPARSER::PROTEIN)
    ("SUMO-1, SUMO-2, or SUMO-3" . SPARSER::COLLECTION)
    ("PARP" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("GAL-SMT3" . SPARSER::COLLECTION) ("GAL" . SPARSER::PROTEIN)
    ("ganetespib and streptavidin" . SPARSER::COLLECTION)
    ("streptavidin" . SPARSER::PROTEIN) ("ganetespib" . SPARSER::DRUG)
    ("trap" . SPARSER::PROTEIN) ("GA or RD" . SPARSER::COLLECTION)
    ("the possible impact" . SPARSER::PROTEIN)
    ("GA and RD" . SPARSER::COLLECTION)
    ("the Hsp90 inhibitors geldanamycin (GA) and radicicol (RD)"
     . SPARSER::COLLECTION)
    ("geldanamycin (GA)" . SPARSER::DRUG) ("RD" . SPARSER::PROTEIN)
    ("radicicol" . SPARSER::DRUG) ("GA" . SPARSER::PROTEIN)
    ("geldanamycin" . SPARSER::DRUG)
    ("CFTR and FLAG-tagged hHsp90α proteins" . SPARSER::COLLECTION)
    ("Smt3 and SUMO-1" . SPARSER::COLLECTION)
    ("yHsp90 and hHsp90α" . SPARSER::COLLECTION)
    ("Hsp90/Aha1" . SPARSER::COLLECTION)
    ("HA-tagged CFTR (under the control of a constitutive promoter) and either wild-type yHsp90"
     . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN) ("CFTR" . SPARSER::PROTEIN)
    ("YPDA and YPEG" . SPARSER::COLLECTION)
    ("glucose (YPDA) and respiratory (YPEG) growth media"
     . SPARSER::COLLECTION)
    ("respiratory (YPEG) growth media" . SPARSER::PROTEIN)
    ("YPDA" . SPARSER::PROTEIN) ("yaha1" . SPARSER::PROTEIN)
    ("GR and Raf-1" . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("Aha1/Hsp90" . SPARSER::COLLECTION) ("GR" . SPARSER::PROTEIN)
    ("yHsp90" . SPARSER::PROTEIN) ("yHsp90-GFP" . SPARSER::PROTEIN-PAIR)
    ("Protein" . SPARSER::PROTEIN) ("a new chaperone" . SPARSER::PROTEIN)
    ("both hexahistidine-tagged mutants as well as wild-type yHsp90 in yeast cells"
     . SPARSER::COLLECTION)
    ("yAha1" . SPARSER::PROTEIN) ("FLAG-yAha1" . SPARSER::PROTEIN-PAIR)
    ("Smt3-Myc" . SPARSER::COLLECTION) ("anti-GLU/GLU" . SPARSER::COLLECTION)
    ("GLU/GLU" . SPARSER::COLLECTION) ("GLU" . SPARSER::PROTEIN)
    ("His" . SPARSER::AMINO-ACID) ("Aha1-FLAG" . SPARSER::COLLECTION)
    ("SUMO-1-HA" . SPARSER::COLLECTION) ("HOP and Sba1" . SPARSER::COLLECTION)
    ("SUMO-1, SUMO-2 and SUMO-3" . SPARSER::COLLECTION)
    ("SMT3-MYC" . SPARSER::COLLECTION)
    ("Myc-epitope-tagged Smt3" . SPARSER::PROTEIN)
    ("galactose" . SPARSER::MOLECULE) ("Myc" . SPARSER::PROTEIN)
    ("an essential protein" . SPARSER::PROTEIN)
    ("the only SUMO protein" . SPARSER::PROTEIN)
    ("agarose" . SPARSER::MOLECULE) ("NTA" . SPARSER::MOLECULE)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CG" . SPARSER::PROTEIN)
    ("leucine" . SPARSER::AMINO-ACID) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("isoleucine" . SPARSER::AMINO-ACID) ("amine" . SPARSER::MOLECULE)
    ("pdb" . SPARSER::MOLECULE) ("solvent" . SPARSER::MOLECULE)
    ("Lysine" . SPARSER::AMINO-ACID) ("amino acid and x" . SPARSER::COLLECTION)
    ("yeast Hsp82 (yHsp90) and human Hsp90α (hHsp90α)" . SPARSER::COLLECTION)
    ("Hsp82" . SPARSER::PROTEIN) ("hHsp" . SPARSER::PROTEIN)
    ("Eukaryotic Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the weak endogenous ATPase activity" . SPARSER::PROTEIN)
    ("HOP/Sti1" . SPARSER::COLLECTION) ("p50/Cdc37" . SPARSER::COLLECTION)
    ("HOP" . SPARSER::PROTEIN) ("conformations" . SPARSER::BIO-CONFORMATION)
    ("dimer" . SPARSER::DIMER) ("nutrient" . SPARSER::MOLECULE)
    ("an essential component" . SPARSER::COMPONENT)
    ("chaperones" . SPARSER::PROTEIN)
    ("the dimeric molecular chaperone Heat Shock Protein 90"
     . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("hsc82" . SPARSER::PROTEIN) ("ura3" . SPARSER::PROTEIN)
    ("leu2" . SPARSER::PROTEIN) ("trp1" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("AHA1" . SPARSER::PROTEIN)
    ("Hsf1" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("Ste11" . SPARSER::PROTEIN) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("COS7" . SPARSER::PROTEIN) ("Sba1" . SPARSER::PROTEIN)
    ("hAha1" . SPARSER::PROTEIN) ("SUMO-3" . SPARSER::PROTEIN)
    ("SUMO-2" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("SMT3" . SPARSER::PROTEIN) ("GAL1" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("Smt3" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID)
    ("ATPase activity" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("Sti1" . SPARSER::PROTEIN) ("Cdc37" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("Aha1" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Heat Shock Protein 90" . SPARSER::PROTEIN)
    ("FGFR-2 , and perhaps" . SPARSER::COLLECTION)
    ("perhaps transcriptional elongation" . SPARSER::PROTEIN)
    ("LAF and RLAF" . SPARSER::COLLECTION) ("LAF" . SPARSER::PROTEIN)
    ("deacetylase" . SPARSER::PROTEIN) ("acetyltransferase" . SPARSER::PROTEIN)
    ("H3K4 and H3K27" . SPARSER::COLLECTION)
    ("histone and DNA" . SPARSER::COLLECTION) ("nucleosome" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("cryptic" . SPARSER::PROTEIN)
    ("IIIb and IIIc ( xref ; xref )" . SPARSER::COLLECTION)
    ("intracting protein MRG15 and its binding partner PTB"
     . SPARSER::COLLECTION)
    ("insulin and IGF" . SPARSER::COLLECTION) ("IGF" . SPARSER::PROTEIN)
    ("insulin" . SPARSER::PROTEIN) ("MRG15 or PTB" . SPARSER::COLLECTION)
    ("the transcriptional elongation" . SPARSER::PROTEIN)
    ("media" . SPARSER::PROTEIN) ("matrigel" . SPARSER::PROTEIN)
    ("interacting protein MRG15 and its binding partner PTB"
     . SPARSER::COLLECTION)
    ("FGFR-2 and perhaps" . SPARSER::COLLECTION)
    ("SetD2, MRG15 and PTB" . SPARSER::COLLECTION)
    ("MRG15, PTB, or SetD2" . SPARSER::COLLECTION) ("IPs" . SPARSER::PROTEIN)
    ("protein (PTB)" . SPARSER::PROTEIN) ("DMSO" . SPARSER::MOLECULE)
    ("primarily FGFR-2 IIIb" . SPARSER::DRUG)
    ("SetD2 or IWS1" . SPARSER::COLLECTION) ("TSS" . SPARSER::PROTEIN)
    ("Chromatin" . SPARSER::PROTEIN) ("mark" . SPARSER::PROTEIN)
    ("HA-SetD2" . SPARSER::COLLECTION)
    ("neither IWS1 nor RNA Pol II" . SPARSER::COLLECTION)
    ("the phospho-IWS1 and total IWS1 antibodies ( xref , lower panel)"
     . SPARSER::COLLECTION)
    ("FLAG-IWS1" . SPARSER::COLLECTION)
    ("wild type IWS1 and its phosphorylation site mutants"
     . SPARSER::COLLECTION)
    ("Akt1, Akt2 or Akt3" . SPARSER::COLLECTION)
    ("Flag" . SPARSER::PROTEIN-FAMILY) ("Akt1 and Akt3" . SPARSER::COLLECTION)
    ("MAD" . SPARSER::PROTEIN) ("Akt1/2/3" . SPARSER::COLLECTION)
    ("phosphoproteomes" . SPARSER::PROTEIN) ("trypsin" . SPARSER::PROTEIN)
    ("LysC and the resulting peptides" . SPARSER::COLLECTION)
    ("LysC" . SPARSER::PROTEIN) ("Akt-phosphoproteome" . SPARSER::PROTEIN-PAIR)
    ("binding protein and its interacting partner PTB" . SPARSER::COLLECTION)
    ("Spt6-IWS1-Aly/REF" . SPARSER::COLLECTION)
    ("polypyrimidine tract binding protein (PTB)" . SPARSER::PROTEIN)
    ("basic FGF" . SPARSER::PROTEIN) ("bFGF or FGF-2" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("IIIb" . SPARSER::DRUG)
    ("Receptor" . SPARSER::PROTEIN) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("cis" . SPARSER::PROTEIN)
    ("significantly more complex" . SPARSER::BIO-COMPLEX)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("a complex and poorly understood process" . SPARSER::COLLECTION)
    ("Aly/REF" . SPARSER::COLLECTION) ("Spt6/IWS1" . SPARSER::COLLECTION)
    ("REF" . SPARSER::PROTEIN) ("Aly" . SPARSER::PROTEIN)
    ("CTD" . SPARSER::PROTEIN) ("chaperone" . SPARSER::PROTEIN)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION) ("PtdIns" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION) ("AGC" . SPARSER::PROTEIN)
    ("MRG15 and PTB" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("Akt3 and Akt1" . SPARSER::COLLECTION) ("Ser" . SPARSER::AMINO-ACID)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("GSK3α" . SPARSER::PROTEIN) ("VEZF1" . SPARSER::PROTEIN)
    ("Rpd3" . SPARSER::PROTEIN) ("Tip60" . SPARSER::PROTEIN)
    ("NuA4" . SPARSER::PROTEIN-FAMILY) ("KDM5B" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("ASH2" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("Histone H3K" . SPARSER::PROTEIN) ("SPT6" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("2/3" . SPARSER::PROTEIN)
    ("polypyrimidine tract binding protein" . SPARSER::PROTEIN)
    ("SetD2" . SPARSER::PROTEIN) ("Spt6" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein kinase" . SPARSER::PROTEIN) ("FGFR-2" . SPARSER::PROTEIN)
    ("MRG15" . SPARSER::PROTEIN) ("Pol II" . SPARSER::PROTEIN)
    ("SETD2" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("IWS1" . SPARSER::PROTEIN)
    ("an excellent therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the previously identified CD-associated SMAD3 risk variant"
     . SPARSER::VARIANT)
    ("neutrophils" . SPARSER::PROTEIN) ("KO" . SPARSER::PROTEIN)
    ("antibodies or antisense" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("antisense" . SPARSER::PROTEIN)
    ("modulators" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("IL-23/IL-17" . SPARSER::COLLECTION) ("LRRK2-MUC19" . SPARSER::COLLECTION)
    ("ileal" . SPARSER::PROTEIN) ("alleles" . SPARSER::ALLELE)
    ("azathioprine and infliximab" . SPARSER::COLLECTION)
    ("biologics" . SPARSER::DRUG) ("infliximab" . SPARSER::DRUG)
    ("SONIC" . SPARSER::PROTEIN) ("azathioprine" . SPARSER::DRUG)
    ("log-rank" . SPARSER::COLLECTION) ("rank" . SPARSER::PROTEIN)
    ("log" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("PRISM" . SPARSER::PROTEIN) ("IBD" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("Smad7" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("MUC19" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("IL23R" . SPARSER::PROTEIN) ("ATG16L1" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CARD15" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN) ("HR 4" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("TNF" . SPARSER::PROTEIN)
    ("RCC" . SPARSER::PROTEIN) ("Ubiquitin" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN) ("EGFR, KRAS and ALK" . SPARSER::COLLECTION)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("n " . SPARSER::PROTEIN)
    ("a mesenchymal transcription factor" . SPARSER::PROTEIN)
    ("twist" . SPARSER::PROTEIN) ("snail" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::PROTEIN)
    ("the commercial available phospho-ACK1 antibody" . SPARSER::ANTIBODY)
    ("EGFR and ALK" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN)
    ("molecularly-directed therapeutics" . SPARSER::THERAPEUTICS)
    ("Van" . SPARSER::PROTEIN) ("parts" . SPARSER::COMPONENT)
    ("sac" . SPARSER::PROTEIN) ("SK" . SPARSER::PROTEIN)
    ("ACK1/SRC" . SPARSER::COLLECTION) ("ACK1 or SRC" . SPARSER::COLLECTION)
    ("SRC and ACK1" . SPARSER::COLLECTION)
    ("ACK1 and SRC" . SPARSER::COLLECTION) ("Matrigel" . SPARSER::PROTEIN)
    ("FBS" . SPARSER::PROTEIN)
    ("a third generation dual SRC-ABL kinase inhibitor" . SPARSER::INHIBITOR)
    ("SRC-ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("SRC" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("melanoma" . SPARSER::PROTEIN)
    ("the ACK1 kinase and key signaling nodes e.g. androgen receptors"
     . SPARSER::COLLECTION)
    ("key signaling nodes e.g. androgen receptors" . SPARSER::RECEPTOR)
    ("androgen" . SPARSER::PROTEIN) ("ligase and Grb2" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN) ("CRIB" . SPARSER::DRUG)
    ("Activated Cdc42 associated kinase" . SPARSER::KINASE)
    ("States" . SPARSER::BIO-STATE) ("bosutinib" . SPARSER::DRUG)
    ("Bosutinib" . SPARSER::DRUG) ("precise biomarkers" . SPARSER::MOLECULE)
    ("Heat shock protein 60" . SPARSER::PROTEIN) ("HSP60" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("a 37" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("and 1 " . SPARSER::PROTEIN) ("ACK-1" . SPARSER::PROTEIN)
    ("SKI-606" . SPARSER::DRUG) ("Grb2" . SPARSER::PROTEIN)
    ("Nedd4" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("ACK1" . SPARSER::PROTEIN) ("ATGAATGT" . SPARSER::PROTEIN)
    ("the real OCT4 form and not its pseudogenes" . SPARSER::COLLECTION)
    ("gene or OCT4" . SPARSER::COLLECTION)
    ("gene and pseudogene 1" . SPARSER::COLLECTION)
    ("OCT4 and OCT4" . SPARSER::COLLECTION)
    ("p53, p63 or OCT4" . SPARSER::COLLECTION)
    ("p53-shRNA, p63-shRNA or OCT4-shRNA" . SPARSER::COLLECTION)
    ("OCT4-shRNA" . SPARSER::PROTEIN-PAIR)
    ("p63-shRNA" . SPARSER::PROTEIN-PAIR) ("p53-shRNA" . SPARSER::PROTEIN-PAIR)
    ("clear GFP" . SPARSER::PROTEIN) ("a viral oncogene" . SPARSER::ONCOGENE)
    ("Cdk4 and hTERT" . SPARSER::COLLECTION) ("reagent" . SPARSER::MOLECULE)
    ("oncogene" . SPARSER::ONCOGENE) ("hTERT" . SPARSER::PROTEIN)
    ("OCT4 or p63" . SPARSER::COLLECTION)
    ("site 1 (TGAGAAATCG)" . SPARSER::PROTEIN)
    ("biotin-p53" . SPARSER::COLLECTION)
    ("site 2 (ATGAATGT)" . SPARSER::PROTEIN) ("biotin" . SPARSER::PROTEIN)
    ("biotin-p63" . SPARSER::PROTEIN-PAIR) ("TAA" . SPARSER::PROTEIN)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("LE1 and LET1-1" . SPARSER::COLLECTION)
    ("p53 and p63" . SPARSER::COLLECTION) ("SSEA" . SPARSER::PROTEIN)
    ("miR-34a-3p directly targets OCT4" . SPARSER::PROTEIN)
    ("HA-OCT4" . SPARSER::COLLECTION) ("HA-OCT4-3" . SPARSER::COLLECTION)
    ("HA" . SPARSER::PROTEIN) ("miRNA" . SPARSER::MICRO-RNA)
    ("SOX2, MYC and NANOG" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("p53, p63, OCT4 and miR-34a" . SPARSER::COLLECTION)
    ("OCT4 (the major functional form, see the discussion section) and p63"
     . SPARSER::COLLECTION)
    ("MYC , KLF4 and miR-34b" . SPARSER::COLLECTION)
    ("factors and p63 or p53" . SPARSER::COLLECTION)
    ("OCT4 , SOX2 , MYC and KLF4" . SPARSER::COLLECTION)
    ("miR-34a, p53 or p63" . SPARSER::COLLECTION)
    ("OCT4 and p63" . SPARSER::COLLECTION) ("almost all types" . TYPE)
    ("the viral or chemical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a weaker carcinogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 or p63 and miR-34a" . SPARSER::COLLECTION)
    ("p63 and miR-34a" . SPARSER::COLLECTION)
    ("p53 or p63" . SPARSER::COLLECTION) ("ray" . SPARSER::PROTEIN)
    ("chemical" . SPARSER::MOLECULE)
    ("factors, OCT4, SOX2, MYC and KLF4" . SPARSER::COLLECTION)
    ("allele" . SPARSER::ALLELE)
    ("OCT4, SOX2, MYC and KLF4" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN) ("miR" . SPARSER::MICRO-RNA)
    ("MYC" . SPARSER::PROTEIN) ("p63 and p53" . SPARSER::COLLECTION)
    ("p63 or p53" . SPARSER::COLLECTION) ("p63 and OCT4" . SPARSER::COLLECTION)
    ("p53 and miR-34a" . SPARSER::COLLECTION) ("SSEA-1" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("Pseudogene 1" . SPARSER::PROTEIN) ("pseudogene 1" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("Tap63" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("LE1" . SPARSER::PROTEIN) ("MiR-34a" . SPARSER::MOLECULE)
    ("ΔNp63 α" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KLF4" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("OCT4" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Id1-bHLH" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER) ("bHLH" . SPARSER::PROTEIN)
    ("PEP-1 and PEP-2" . SPARSER::COLLECTION) ("PEP" . SPARSER::PROTEIN)
    ("Sox2 or Id1" . SPARSER::COLLECTION)
    ("Sox2 and Id1" . SPARSER::COLLECTION)
    ("PEP-1 (75 and 100  μ M) strongly decreased Y416 c-Src"
     . SPARSER::PROTEIN)
    ("TAT" . SPARSER::PROTEIN) ("tyrosines" . SPARSER::AMINO-ACID)
    ("SH3" . SPARSER::PROTEIN) ("Cx43–c-Src" . SPARSER::COLLECTION)
    ("saracatinib or PP2" . SPARSER::COLLECTION)
    ("saracatinib" . SPARSER::DRUG) ("dasatinib" . SPARSER::DRUG)
    ("Id1 and Sox2" . SPARSER::COLLECTION)
    ("Cx43 and Id1" . SPARSER::COLLECTION)
    ("Sox2, E-cadherin, N-cadherin and Id1" . SPARSER::COLLECTION)
    ("Ires-Cx43" . SPARSER::PROTEIN-PAIR)
    ("Cx43 (Cx43-siRNA) or a non-target siRNA (NT-siRNA)"
     . SPARSER::COLLECTION)
    ("Cx43-siRNA" . SPARSER::COLLECTION) ("NT" . SPARSER::PROTEIN)
    ("OB1 and TG" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("OB1 and TG10" . SPARSER::COLLECTION) ("TG" . SPARSER::PROTEIN)
    ("Cx43 and gap" . SPARSER::COLLECTION)
    ("connexin" . SPARSER::PROTEIN-FAMILY)
    ("Cx43 and c-Src" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carboxy" . SPARSER::MOLECULE) ("GSCs" . SPARSER::PROTEIN)
    ("α -actinin" . SPARSER::PROTEIN) ("Bis-Tris" . SPARSER::MOLECULE)
    ("or 2 " . SPARSER::MOLECULE) ("b-FGF" . SPARSER::DRUG)
    ("N2" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("gap junction protein" . SPARSER::PROTEIN) ("PEP-2" . SPARSER::PROTEIN)
    ("PEP-1" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("OB1" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sox2" . SPARSER::PROTEIN) ("Id1" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("antioxidant" . SPARSER::PROTEIN)
    ("IKK α or IKK β" . SPARSER::COLLECTION) ("cysteine" . SPARSER::AMINO-ACID)
    ("IKK γ and p65NF κ B" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("Cys" . SPARSER::AMINO-ACID)
    ("cysteines" . SPARSER::AMINO-ACID) ("STAT" . SPARSER::PROTEIN)
    ("severe DNA" . SPARSER::DNA) ("ligase" . SPARSER::LIGASE)
    ("SUMO" . SPARSER::PROTEIN) ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF κ B and JNK" . SPARSER::COLLECTION) ("genotoxic drug" . SPARSER::DRUG)
    ("genotoxic stress-induced ROS" . SPARSER::PROTEIN)
    ("genotoxic drug-induced ATM" . SPARSER::PROTEIN)
    ("CR-EAC-PIAS γ" . SPARSER::COLLECTION) ("p-JNK" . SPARSER::COLLECTION)
    ("CS-EACs" . SPARSER::COLLECTION) ("EACs" . SPARSER::PROTEIN)
    ("CR-EACs" . SPARSER::COLLECTION)
    ("doxorubicin and vinblastine" . SPARSER::COLLECTION)
    ("vinblastine" . SPARSER::DRUG) ("CR-EAC" . SPARSER::COLLECTION)
    ("CS-EAC" . SPARSER::COLLECTION) ("EAC" . SPARSER::PROTEIN)
    ("CS" . SPARSER::PROTEIN) ("ATM-NF κ B" . SPARSER::COLLECTION)
    ("ROS-inducer" . SPARSER::COLLECTION) ("ROS-PIAS γ" . SPARSER::COLLECTION)
    ("DS" . SPARSER::PROTEIN) ("transfectants" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("cisplatin (10–30  μ M) or H 2 O 2 (0.5–2 mM)" . SPARSER::COLLECTION)
    ("differentially" . SPARSER::PROTEIN) ("p-ATM-IKK γ" . SPARSER::COLLECTION)
    ("MKP1-siRNA" . SPARSER::COLLECTION)
    ("JNK-caspase-3" . SPARSER::COLLECTION)
    ("the genotoxic drug" . SPARSER::DRUG)
    ("JNK and caspase-3" . SPARSER::COLLECTION)
    ("MAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKK β and IKK γ" . SPARSER::COLLECTION)
    ("DN-IKK α" . SPARSER::COLLECTION) ("DN-IKK γ" . SPARSER::COLLECTION)
    ("DN-IKK β" . SPARSER::COLLECTION) ("DN" . SPARSER::PROTEIN)
    ("-SR" . SPARSER::COLLECTION) ("p-Chk2" . SPARSER::COLLECTION)
    ("ATM-siRNA" . SPARSER::COLLECTION)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("different genotoxic drugs" . SPARSER::DRUG)
    ("cisplatin, doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("cisplatin" . SPARSER::DRUG)
    ("ATM-JNK" . SPARSER::COLLECTION) ("-NF κ B" . SPARSER::COLLECTION)
    ("ATM-IKK γ" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IR" . SPARSER::PROTEIN)
    ("barrier" . SPARSER::PROTEIN) ("Atm" . SPARSER::PROTEIN)
    ("genotoxic drugs" . SPARSER::DRUG)
    ("cellular ROS and PIAS γ" . SPARSER::COLLECTION)
    ("ROS and PIAS γ" . SPARSER::COLLECTION) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("-IKK γ" . SPARSER::COLLECTION) ("cellular ROS" . SPARSER::PROTEIN)
    ("ATM/JNK" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("ROS" . SPARSER::PROTEIN) ("oxygen" . SPARSER::MOLECULE)
    ("redox" . SPARSER::PROTEIN) ("ATM" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("si-RNA" . SPARSER::RNA) ("AC-3" . SPARSER::PROTEIN)
    ("α -actin" . SPARSER::PROTEIN) ("DCFH-DA" . SPARSER::DRUG)
    ("Annexin-V" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("Transglutaminase 2" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("JNK-1" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("PIASγ" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("MKP1" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("I κ Bα" . SPARSER::PROTEIN)
    ("IKK α" . SPARSER::PROTEIN) ("IKK β" . SPARSER::PROTEIN)
    ("I κ B α" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("p-ATM" . SPARSER::PROTEIN)
    ("KU55933" . SPARSER::DRUG) ("γ H2AX" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-oxidant" . SPARSER::MOLECULE)
    ("ataxia telangiectasia" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("PIAS γ" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("IKK γ" . SPARSER::PROTEIN)
    ("the protein junctional complex" . SPARSER::BIO-COMPLEX)
    ("a transcriptionally active complex" . SPARSER::BIO-COMPLEX)
    ("LEF and TCF" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin, neuronal cell adhesion molecule, c-MYC and cyclin D1"
     . SPARSER::COLLECTION)
    ("Cx43 and β -catenin" . SPARSER::COLLECTION)
    ("proteins, cadherins and β -catenin" . SPARSER::COLLECTION)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cx43 and GJ" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("astrocytes" . SPARSER::PROTEIN) ("punctate" . SPARSER::PROTEIN)
    ("EGF and FGF-2" . SPARSER::COLLECTION) ("agonist" . SPARSER::AGONIST)
    ("ORF" . SPARSER::PROTEIN) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN) ("TCF" . SPARSER::PROTEIN)
    ("hNPCs neuronal fate" . SPARSER::PROTEIN)
    ("carbenoxolone (CBX)" . SPARSER::DRUG) ("dye" . SPARSER::MOLECULE)
    ("carbenoxolone" . SPARSER::DRUG) ("BrdU" . SPARSER::DRUG)
    ("bromo" . SPARSER::MOLECULE) ("GABA" . SPARSER::MOLECULE)
    ("SC" . SPARSER::PROTEIN) ("EGFP" . SPARSER::PROTEIN)
    ("TOPO" . SPARSER::PROTEIN) ("GFAP" . SPARSER::PROTEIN)
    ("an intense Cx43" . SPARSER::PROTEIN) ("nestin" . SPARSER::PROTEIN)
    ("MASH1" . SPARSER::PROTEIN) ("NPCs" . SPARSER::MOLECULE)
    ("GJs" . SPARSER::PROTEIN) ("Cx" . SPARSER::PROTEIN-FAMILY)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("glial" . SPARSER::PROTEIN)
    ("GJ" . SPARSER::PROTEIN) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("B27" . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("GSK-3b" . SPARSER::PROTEIN)
    ("3b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("cyclin D1" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("neuronal cell adhesion molecule" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("ZO1" . SPARSER::PROTEIN)
    ("Cx36" . SPARSER::PROTEIN) ("FGF-2" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("SC 1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("Pax6" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("Cx43" . SPARSER::PROTEIN) ("Connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hnRNP I-UCA1" . SPARSER::COLLECTION)
    ("hnRNP I–p27" . SPARSER::COLLECTION) ("p-hnRNP I" . SPARSER::COLLECTION)
    ("hnRNP I–GFP" . SPARSER::COLLECTION)
    ("hnRNP A1 and hnRNP A2" . SPARSER::COLLECTION) ("PKM" . SPARSER::PROTEIN)
    ("pyruvate" . SPARSER::PROTEIN) ("UCA1 or p27" . SPARSER::COLLECTION)
    ("the p27 mRNA and hnRNP I complex ( xref )" . SPARSER::COLLECTION)
    ("microRNA" . SPARSER::MICRO-RNA) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines" . SPARSER::PROTEIN) ("FoxO" . SPARSER::PROTEIN)
    ("UCA1–hnRNP I" . SPARSER::COLLECTION) ("weaker" . SPARSER::PROTEIN)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cip" . SPARSER::PROTEIN)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("oncogenes" . SPARSER::ONCOGENE) ("CISH" . SPARSER::PROTEIN)
    ("either control siRNA or UCA1-siRNA" . SPARSER::COLLECTION)
    ("UCA1 and hnRNP I" . SPARSER::COLLECTION)
    ("UCA1 and p27" . SPARSER::COLLECTION) ("luciferase" . SPARSER::PROTEIN)
    ("hnRNP I-siRNAs" . SPARSER::COLLECTION) ("siRNAs" . SPARSER::PROTEIN)
    ("UCA1" . SPARSER::PROTEIN) ("UCA1-siRNA" . SPARSER::COLLECTION)
    ("a potential target" . SPARSER::TARGET-PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::MOLECULE) ("siRNA" . SPARSER::PROTEIN)
    ("hnRNP I-siRNA" . SPARSER::COLLECTION)
    ("around nucleotide" . SPARSER::NUCLEOTIDE)
    ("-CTCTTCCTCCTGG-3" . SPARSER::COLLECTION)
    ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("hnRNP I and UCA1" . SPARSER::COLLECTION) ("subline" . SPARSER::PROTEIN)
    ("pro-apoptotic genes" . SPARSER::GENE) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("HOTAIR" . SPARSER::PROTEIN) ("LncRNAs" . SPARSER::RNA)
    ("microRNAs" . SPARSER::MICRO-RNA) ("p27 and UCA" . SPARSER::COLLECTION)
    ("-UTR" . SPARSER::COLLECTION) ("UTR" . SPARSER::PROTEIN)
    ("RoR" . SPARSER::PROTEIN-FAMILY) ("lincRNA" . SPARSER::RNA)
    ("ribonucleoprotein" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("Delta-" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("Not1" . SPARSER::PROTEIN)
    ("EF1" . SPARSER::PROTEIN) ("Protein kinase A" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("M2" . SPARSER::MOLECULE)
    ("M1" . SPARSER::MOLECULE) ("hnRNP A2" . SPARSER::PROTEIN)
    ("hnRNP A1" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("G-3" . SPARSER::PROTEIN)
    ("PTBP1" . SPARSER::PROTEIN)
    ("polypyrimidine tract-binding protein 1" . SPARSER::PROTEIN)
    ("RNA polymerase" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-YA" . SPARSER::PROTEIN) ("PCAT-1" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p27" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("hnRNP I" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein I" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("UK and Asian" . SPARSER::COLLECTION)
    ("these latter two GCs" . SPARSER::PROTEIN)
    ("FGFR2- and HER2-" . SPARSER::COLLECTION) ("HER2-" . SPARSER::PROTEIN)
    ("FGFR2-" . SPARSER::PROTEIN)
    ("UK (35.1%) and Chinese (44.2%) GC cohorts" . SPARSER::COLLECTION)
    ("resectable GC" . SPARSER::PROTEIN) ("gold" . SPARSER::MOLECULE)
    ("GCs, and HER2" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("CEP" . SPARSER::PROTEIN) ("FGFR2/HER2" . SPARSER::COLLECTION)
    ("TMA" . SPARSER::MOLECULE) ("TMAs" . SPARSER::MOLECULE)
    ("UK and Korean" . SPARSER::COLLECTION) ("Cox" . SPARSER::PROTEIN)
    ("UK ( P <0.0001) and Korean ( P =0.0073) cohorts" . SPARSER::COLLECTION)
    ("Type" . TYPE) ("intestinal type GC" . SPARSER::PROTEIN)
    ("Western GC cohorts" . SPARSER::MOLECULE) ("FGFR" . SPARSER::PROTEIN)
    ("the monomeric receptor" . SPARSER::PROTEIN) ("FGF" . SPARSER::PROTEIN)
    ("new potential targets" . SPARSER::TARGET-PROTEIN)
    ("panitumumab or cetuximab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("mTOR" . SPARSER::PROTEIN)
    ("everolimus" . SPARSER::DRUG) ("VEGF" . SPARSER::PROTEIN)
    ("bevacizumab" . SPARSER::DRUG) ("HER2 and FGFR2" . SPARSER::COLLECTION)
    ("FGFR2 and HER2" . SPARSER::COLLECTION)
    ("cohorts, and FGFR2" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("cohorts" . SPARSER::MOLECULE) ("GCs" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("L18" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("AZD4547" . SPARSER::DRUG)
    ("FGFR1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("FGFR2" . SPARSER::PROTEIN)
    ("concurrent (only with taxane) trastuzumab" . SPARSER::DRUG)
    ("anthracycline-" . SPARSER::MOLECULE) ("taxane" . SPARSER::DRUG)
    ("anthracycline" . SPARSER::MOLECULE)
    ("lapatinib or pertuzumab" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG)
    ("anthracyclines and trastuzumab" . SPARSER::COLLECTION)
    ("anthracyclines and taxanes" . SPARSER::COLLECTION)
    ("ER and HER2" . SPARSER::COLLECTION) ("CR" . SPARSER::PROTEIN)
    ("doxorubicin and cyclophosphamide" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("paclitaxel" . SPARSER::DRUG)
    ("NAC and trastuzumab" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("epirubicin, cyclophosphamide, and docetaxel" . SPARSER::COLLECTION)
    ("a poor pCR" . SPARSER::PROTEIN) ("AKT and ERK" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION) ("PTEN" . SPARSER::PROTEIN)
    ("ER−" . SPARSER::PROTEIN) ("transaminase" . SPARSER::PROTEIN)
    ("the experimental arm" . SPARSER::PROTEIN)
    ("ER and PR" . SPARSER::COLLECTION) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hormone" . SPARSER::PROTEIN) ("arms" . SPARSER::PROTEIN)
    ("arm" . SPARSER::PROTEIN)
    ("equivocal and further tested using FISH" . SPARSER::PROTEIN)
    ("hormonal receptors" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("epirubicine" . SPARSER::DRUG)
    ("taxanes and anthracyclines" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE) ("taxanes" . SPARSER::DRUG)
    ("a dual tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("HER1 and HER2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("luminal" . SPARSER::DRUG) ("the intrinsic subtypes" . SPARSER::PROTEIN)
    ("NAC" . SPARSER::PROTEIN)
    ("distinct biological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("receptor (ER)" . SPARSER::RECEPTOR)
    ("ER" . SPARSER::PROTEIN) ("EC-DT" . SPARSER::COLLECTION)
    ("DL" . SPARSER::MOLECULE) ("DT" . SPARSER::PROTEIN)
    ("docetaxel" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("epirubicin" . SPARSER::DRUG)
    ("trastuzumab (T) and lapatinib (L)" . SPARSER::COLLECTION)
    ("pCR" . SPARSER::PROTEIN) ("lapatinib" . SPARSER::DRUG)
    ("HER3" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("MIB1" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER1" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("consequent gene" . SPARSER::GENE) ("PRC1-RYBP" . SPARSER::COLLECTION)
    ("PRC1-CBXs" . SPARSER::PROTEIN-PAIR)
    ("RING1B and several CBXs" . SPARSER::COLLECTION)
    ("BMI1, RING1B and several CBXs" . SPARSER::COLLECTION)
    ("RYBP, KDM2B, PCGF1, PCGF5 and PCGF6" . SPARSER::COLLECTION)
    ("RING1B-MEL18" . SPARSER::COLLECTION) ("CBX-" . SPARSER::PROTEIN)
    ("KDM2B and RING1B" . SPARSER::COLLECTION)
    ("RYBP-PRC1" . SPARSER::COLLECTION) ("demethylase" . SPARSER::PROTEIN)
    ("either CBX components or RYBP protein xref" . SPARSER::COLLECTION)
    ("at least two forms" . SPARSER::FORM) ("RYBP" . SPARSER::PROTEIN)
    ("CBX" . SPARSER::PROTEIN) ("Antibodies" . SPARSER::ANTIBODY)
    ("BMI1, RING1A, RING1B, CBXs, and PHCs" . SPARSER::COLLECTION)
    ("PHCs" . SPARSER::PROTEIN) ("PRC" . SPARSER::PROTEIN)
    ("subunit" . SPARSER::FRAGMENT) ("PRCs" . SPARSER::PROTEIN)
    ("Examples" . SPARSER::EXAMPLE)
    ("The shared or unique PRC2 (EZH2 occupied genes) and PRC1 (uH2A occupied genes) target genes"
     . SPARSER::COLLECTION)
    ("BMI1, RING1A, RING1B and EED" . SPARSER::COLLECTION)
    ("H2A, BMI1, RING1A, RING1B and H3K27me3" . SPARSER::COLLECTION)
    ("WNT8B and the HOXA" . SPARSER::COLLECTION)
    ("WNT1 , WNT8B and the HOXA" . SPARSER::COLLECTION)
    ("examples" . SPARSER::EXAMPLE) ("HOXA" . SPARSER::PROTEIN)
    ("anti-RING1B and two different (one monoclonal and one polyclonal) anti-uH2A antibodies"
     . SPARSER::COLLECTION)
    ("MS (which only pulls down PRC1 and not PRC2), anti-EZH2, anti-H3K27me3, anti-BMI1, anti-RING1A, anti-RING1B and two different (one monoclonal and one polyclonal) anti-uH2A antibodies"
     . SPARSER::COLLECTION)
    ("the same mouse monoclonal anti-EED antibody" . SPARSER::ANTIBODY)
    ("EED, uH2A, EZH2, H3K27me3, BMI1, RING1A and RING1B"
     . SPARSER::COLLECTION)
    ("promoters" . SPARSER::PROMOTER)
    ("NUP214 or KIAA0066" . SPARSER::COLLECTION)
    ("ADRB2 , MYT , and CNR" . SPARSER::COLLECTION)
    ("p16INK4A , p19 , and HOXC13" . SPARSER::COLLECTION)
    ("CNR" . SPARSER::PROTEIN) ("the most efficient EED" . SPARSER::PROTEIN)
    ("classic PRC1 and PRC2 target genes" . SPARSER::GENE)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("DU145 and LNCaP" . SPARSER::COLLECTION)
    ("H2A and H3K27me3" . SPARSER::COLLECTION)
    ("RING1B:BMI1" . SPARSER::BIO-COMPLEX)
    ("RING1B-BMI1" . SPARSER::COLLECTION)
    ("anti-EED (aa186-304) antibody and control IgG" . SPARSER::COLLECTION)
    ("EED and EZH2" . SPARSER::COLLECTION)
    ("anti-EED (aa186-304) and control IgG antibodies" . SPARSER::COLLECTION)
    ("substrates" . SPARSER::SUBSTRATE) ("nucleosomes" . SPARSER::PROTEIN)
    ("an anti-EED (aa186-304) antibody or a control IgG ( xref )"
     . SPARSER::COLLECTION)
    ("EZH2 and EED" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("all human isoforms and aa186-304 sequence" . SPARSER::COLLECTION)
    ("Santa" . SPARSER::PROTEIN)
    ("the monoclonal anti-EED antibody (Millipore, cat# 05-1320) and polyclonal anti-EED antibody (Millipore Cat# 09-774)"
     . SPARSER::COLLECTION)
    ("the monoclonal anti-EED antibody" . SPARSER::ANTIBODY)
    ("cat" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("EED and RING1B" . SPARSER::COLLECTION)
    ("EED, BMI1, RING1B, EZH2 and SUZ12" . SPARSER::COLLECTION)
    ("IF" . SPARSER::PROTEIN) ("EED-PRC1" . SPARSER::COLLECTION)
    ("EED:EZH2 and EED:BMI1/RING1B" . SPARSER::COLLECTION)
    ("EED:BMI1/RING1B" . SPARSER::BIO-COMPLEX)
    ("EED:EZH2" . SPARSER::BIO-COMPLEX) ("EtBr" . SPARSER::PROTEIN)
    ("ethidium" . SPARSER::MOLECULE)
    ("down only PRC2 proteins" . SPARSER::PROTEIN)
    ("EED:PRC1" . SPARSER::BIO-COMPLEX) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("BMI1 or RING1B" . SPARSER::COLLECTION)
    ("anti-BMI1 or RING1A" . SPARSER::COLLECTION)
    ("BMI1, RING1A and RING1B" . SPARSER::COLLECTION)
    ("EED and BMI1" . SPARSER::COLLECTION)
    ("masks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("down both PRC2 components (i.e., EZH2 and SUZ12) and PRC1 components (BMI1 and RING1B)"
     . SPARSER::COLLECTION)
    ("down only PRC1 components" . SPARSER::COMPONENT)
    ("EZH2 and SUZ12" . SPARSER::COLLECTION) ("LNCaP" . SPARSER::PROTEIN)
    ("aa" . SPARSER::MOLECULE) ("IP" . SPARSER::PROTEIN)
    ("BMI1 or RING1A" . SPARSER::COLLECTION)
    ("importantly anti-EED antibodies" . SPARSER::ANTIBODY)
    ("EED and PRC1" . SPARSER::COLLECTION)
    ("PRC1 or PRC2" . SPARSER::COLLECTION) ("Eed" . SPARSER::PROTEIN)
    ("BMI1 and RING1B" . SPARSER::COLLECTION)
    ("anti-RING1B or anti-BMI1" . SPARSER::COLLECTION)
    ("Cat" . SPARSER::PROTEIN) ("EZH2 or SUZ12" . SPARSER::COLLECTION)
    ("EED, AEBP2, RBBP4 and RBBP7" . SPARSER::COLLECTION)
    ("interactors" . SPARSER::PROTEIN)
    ("components or regulators" . SPARSER::COLLECTION)
    ("EZH2, EED, and SUZ12" . SPARSER::COLLECTION) ("MS" . SPARSER::PROTEIN)
    ("jumonji" . SPARSER::PROTEIN) ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("tri" . SPARSER::PROTEIN) ("RING2 or RNF2" . SPARSER::COLLECTION)
    ("Embryonic Ectoderm Development (EED) and Suppressor"
     . SPARSER::COLLECTION)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("The two major Polycomb Repressive Complexes" . SPARSER::BIO-COMPLEX)
    ("PRC2 and PRC1" . SPARSER::COLLECTION) ("AK" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN)
    ("chromatin-associated protein complexes" . SPARSER::BIO-COMPLEX)
    ("PcG" . SPARSER::PROTEIN-FAMILY) ("ubiquitin" . SPARSER::PROTEIN)
    ("PRC1 and PRC2" . SPARSER::COLLECTION) ("Components" . SPARSER::COMPONENT)
    ("EED" . SPARSER::PROTEIN) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("Polycomb" . SPARSER::PROTEIN) ("DNA polymerase I" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("H2B" . SPARSER::PROTEIN)
    ("UBCH5C" . SPARSER::PROTEIN)
    ("ubiquitin activating enzyme E1" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("UbcH5c" . SPARSER::PROTEIN)
    ("UBE1" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN) ("19A" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("NP-40" . SPARSER::DRUG)
    ("Tween 20" . SPARSER::MOLECULE) ("AP-MS" . SPARSER::PROTEIN)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("β -Mercaptoethanol" . SPARSER::MOLECULE)
    ("L-Glutamine" . SPARSER::MOLECULE) ("PCGF6" . SPARSER::PROTEIN)
    ("PCGF5" . SPARSER::PROTEIN) ("PCGF2" . SPARSER::PROTEIN)
    ("MEL18" . SPARSER::PROTEIN) ("PCGF4" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("PCGF1" . SPARSER::PROTEIN)
    ("KDM2B" . SPARSER::PROTEIN) ("WNT8B" . SPARSER::PROTEIN)
    ("WNT1" . SPARSER::PROTEIN) ("KIAA0066" . SPARSER::PROTEIN)
    ("NUP214" . SPARSER::PROTEIN) ("HOXC13" . SPARSER::PROTEIN)
    ("p19" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p16INK4A" . SPARSER::PROTEIN)
    ("ADRB2" . SPARSER::PROTEIN) ("ubiquitin ligase" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN) ("aa1" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("IP-MS" . SPARSER::PROTEIN)
    ("RBBP7" . SPARSER::PROTEIN) ("RBBP4" . SPARSER::PROTEIN)
    ("AEBP2" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("JARID2" . SPARSER::PROTEIN) ("RNF2" . SPARSER::PROTEIN)
    ("RING2" . SPARSER::PROTEIN) ("RING1B" . SPARSER::PROTEIN)
    ("RING1" . SPARSER::PROTEIN) ("RING1A" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("Zeste 12" . SPARSER::PROTEIN)
    ("Embryonic Ectoderm Development" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN)
    ("Enhancer of Zeste Homolog 2" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("ligase activity" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("H2A" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::MOLECULE)
    ("PRC2" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("SW" . SPARSER::PROTEIN) ("JG" . SPARSER::PROTEIN)
    ("regarding potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("ACA, and EGFR" . SPARSER::COLLECTION) ("only 1 ACA" . SPARSER::PROTEIN)
    ("TK" . SPARSER::PROTEIN)
    ("Cetuximab, gefitinib, and erlotinib" . SPARSER::COLLECTION)
    ("gefitinib" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("the latter type" . TYPE) ("TNM" . SPARSER::MOLECULE)
    ("ACA and ACC" . SPARSER::COLLECTION) ("track" . SPARSER::PROTEIN)
    ("22 conventional ACC and 22 conventional ACA" . SPARSER::COLLECTION)
    ("the monoclonal anti-EGFR antibody cetuximab and the EGFR tyrosine kinase inhibitor erlotinib (in monotherapy or in combination with cytotoxic drugs)"
     . SPARSER::COLLECTION)
    ("the monoclonal anti-EGFR antibody cetuximab" . SPARSER::DRUG)
    ("erlotinib" . SPARSER::DRUG) ("ErbB" . SPARSER::PROTEIN)
    ("endocrine" . SPARSER::PROTEIN) ("ACC and ACA" . SPARSER::COLLECTION)
    ("ARMS" . SPARSER::PROTEIN) ("ACA" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("GC" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("CI " . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("Polymerase" . SPARSER::PROTEIN) ("SNP" . SPARSER::PROTEIN)
    ("CIs" . SPARSER::PROTEIN) ("Oct" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("RAD 51" . SPARSER::PROTEIN)
    ("a potential aid" . SPARSER::PROTEIN) ("aid" . SPARSER::PROTEIN)
    ("variants" . SPARSER::VARIANT) ("5-FU/RT" . SPARSER::COLLECTION)
    ("the indirect target" . SPARSER::TARGET-PROTEIN)
    ("capecitabine" . SPARSER::DRUG) ("uracil" . SPARSER::NUCLEOBASE)
    ("catabolism" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("FUR" . SPARSER::PROTEIN) ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("pyrimidine" . SPARSER::DRUG) ("purine" . SPARSER::DRUG)
    ("homocysteine" . SPARSER::MOLECULE) ("folate" . SPARSER::MOLECULE)
    ("part" . SPARSER::COMPONENT) ("fluorodeoxyuridine" . SPARSER::DRUG)
    ("metabolites" . SPARSER::MOLECULE) ("fluoropyrimidines" . SPARSER::DRUG)
    ("antimetabolite" . SPARSER::DRUG) ("Fluoropyrimidines" . SPARSER::DRUG)
    ("preoperative infusional 5-FU and RT" . SPARSER::COLLECTION)
    ("5-FU and RT" . SPARSER::COLLECTION)
    ("an independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Das" . SPARSER::DRUG)
    ("these predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytotoxic" . SPARSER::PROTEIN) ("postoperative 5-FU" . SPARSER::PROTEIN)
    ("Preoperative infusional 5-FU and concurrent RT" . SPARSER::COLLECTION)
    ("concurrent RT" . SPARSER::PROTEIN)
    ("Preoperative infusional 5-FU" . SPARSER::PROTEIN)
    ("CEA" . SPARSER::PROTEIN) ("genetic biomarkers" . SPARSER::MOLECULE)
    ("individual gene" . SPARSER::GENE)
    ("DPYD , TYMS , TYMP , ORPT , GLUT1 ,HIF-1 α ,HIF-2 α , TK1 , and TK2"
     . SPARSER::COLLECTION)
    ("DPYD , TYMS , TYMP , TK1 , TK2 , and ORPT" . SPARSER::COLLECTION)
    ("GLUT1 , HIF1 , and HIF2" . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("glucose" . SPARSER::PROTEIN) ("orotate" . SPARSER::MOLECULE)
    ("predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thymidylate synthetase ( TYMS ) and other fluorouracil-associated enzymes"
     . SPARSER::COLLECTION)
    ("thymidine phosphorylase ( TYMP ) and dihydropyrimidine dehydrogenase ( DPYD )"
     . SPARSER::COLLECTION)
    ("other fluorouracil-associated enzymes" . SPARSER::ENZYME)
    ("fluorouracil" . SPARSER::DRUG)
    ("different chemotherapeutic drugs" . SPARSER::DRUG)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("CRC" . SPARSER::PROTEIN)
    ("TRG" . SPARSER::PROTEIN)
    ("multiple genetic biomarkers" . SPARSER::MOLECULE)
    ("DPYD , TYMS , TYMP , TK1 , and TK2" . SPARSER::COLLECTION)
    ("chip" . SPARSER::PROTEIN)
    ("DPYD, ORPT, TYMS, TYMP, TK1 , and TK2" . SPARSER::COLLECTION)
    ("GLUT1 , HIF-1  α , and HIF-2  α" . SPARSER::COLLECTION)
    ("TYMP" . SPARSER::PROTEIN) ("TYMS" . SPARSER::PROTEIN)
    ("DPYD" . SPARSER::PROTEIN)
    ("radiation-related genetic biomarkers" . SPARSER::MOLECULE)
    ("fluoropyrimidine" . SPARSER::DRUG) ("LARC" . SPARSER::PROTEIN)
    ("or 2" . SPARSER::MOLECULE) ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("ribonucleotide reductase" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("HIF-2 α" . SPARSER::PROTEIN) ("HIF-1 α" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("housekeeping gene" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("ribonuclease inhibitor" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("TRG 1" . SPARSER::PROTEIN)
    ("TRG 3" . SPARSER::PROTEIN) ("of 45 " . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("carcinoembryonic antigen" . SPARSER::PROTEIN)
    ("HIF2" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("HIF1" . SPARSER::PROTEIN) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("member 1" . SPARSER::PROTEIN)
    ("thymidine kinase 2, mitochondrial" . SPARSER::PROTEIN)
    ("thymidine kinase 1, soluble" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN)
    ("thymidylate synthetase" . SPARSER::PROTEIN)
    ("HIF-2  α" . SPARSER::PROTEIN) ("HIF-1  α" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("TK2" . SPARSER::PROTEIN)
    ("TK1" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("AMP or Wnt/" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("testosterone" . SPARSER::MOLECULE) ("Luciferase" . SPARSER::PROTEIN)
    ("an online transcription factor" . SPARSER::PROTEIN)
    ("nuclear" . SPARSER::PROTEIN)
    ("Cyclin D1 and Cyclin E" . SPARSER::COLLECTION)
    ("Lgr4" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF α or IL-1 α" . SPARSER::COLLECTION)
    ("Cyclin D, Survivin, and Bcl-xL" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-6/Stat3" . SPARSER::COLLECTION) ("SOCS" . SPARSER::PROTEIN)
    ("Oncogenes and tumor suppressors play critical roles in the tumorigenesis [ xref ]"
     . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR) ("Oncogenes" . SPARSER::ONCOGENE)
    ("Stat3-LGR4" . SPARSER::COLLECTION) ("GPR48" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("IL-1 α" . SPARSER::PROTEIN) ("TNF α" . SPARSER::PROTEIN)
    ("R-spondins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein-coupled" . SPARSER::PROTEIN) ("S1PR1" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("β -Catenin" . SPARSER::PROTEIN)
    ("PGL3" . SPARSER::PROTEIN) ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-1" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("LGR4" . SPARSER::PROTEIN)
    ("G protein-coupled receptor 4" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("CD59 and the TCR/CD3 complex" . SPARSER::COLLECTION)
    ("Covalently binding Lck" . SPARSER::PROTEIN) ("his" . SPARSER::AMINO-ACID)
    ("anchor" . SPARSER::ANCHOR) ("MAL" . SPARSER::PROTEIN)
    ("the Src family tyrosine kinase Lck and the adaptor molecule LAT"
     . SPARSER::COLLECTION)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lck and Fyn" . SPARSER::COLLECTION)
    ("a very proximal step" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT) ("CD55 and CD73" . SPARSER::COLLECTION)
    ("CD3ζ-Lck" . SPARSER::COLLECTION) ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most upstream possible candidate molecule" . SPARSER::MOLECULE)
    ("Lck or LAT" . SPARSER::COLLECTION)
    ("kinases, Lck and Fyn" . SPARSER::COLLECTION)
    ("Molecules" . SPARSER::MOLECULE) ("Lck and LAT" . SPARSER::COLLECTION)
    ("CD59-" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("CD59 or CD71" . SPARSER::COLLECTION)
    ("both anti-CD59- and anti-CD71-coated surfaces mainly mobile CD3ζ-EYFP molecules"
     . SPARSER::COLLECTION)
    ("comparable low immobile fractions" . SPARSER::COMPONENT)
    ("anti-CD71-coated surfaces mainly mobile CD3ζ-EYFP molecules"
     . SPARSER::MOLECULE)
    ("anti-CD59-" . SPARSER::ANTIBODY)
    ("an expected large immobile fraction" . SPARSER::COMPONENT)
    ("fast" . SPARSER::PROTEIN)
    ("anti-CD3ε, anti-CD59 or anti-CD71" . SPARSER::COLLECTION)
    ("FRAP" . SPARSER::PROTEIN) ("CD3 and CD59" . SPARSER::COLLECTION)
    ("CD3ε and CD3ζ-EYFP" . SPARSER::COLLECTION)
    ("anti-CD3ε-grid" . SPARSER::COLLECTION) ("BSA" . SPARSER::PROTEIN)
    ("grid" . SPARSER::PROTEIN) ("EYFP" . SPARSER::PROTEIN)
    ("CD3ζ-EYFP" . SPARSER::COLLECTION)
    ("the fluorescent target molecule" . SPARSER::MOLECULE)
    ("a fluorescent target molecule" . SPARSER::MOLECULE)
    ("protein-protein" . SPARSER::COLLECTION) ("Abs" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("-ATPase" . SPARSER::COLLECTION) ("thapsigargin" . SPARSER::MOLECULE)
    ("ATPase" . SPARSER::PROTEIN) ("an alternative mAb" . SPARSER::DRUG)
    ("substrate" . SPARSER::SUBSTRATE) ("green" . SPARSER::PROTEIN)
    ("sharp" . SPARSER::PROTEIN) ("mAb" . SPARSER::DRUG)
    ("AM" . SPARSER::PROTEIN) ("anti-CD59 or anti-CD3ε" . SPARSER::COLLECTION)
    ("anti-CD59 or anti-CD3" . SPARSER::COLLECTION) ("mAbs" . SPARSER::DRUG)
    ("glass" . SPARSER::MOLECULE) ("type and extent" . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD59" . SPARSER::COLLECTION)
    ("mutants" . SPARSER::MUTANT) ("effector" . SPARSER::EFFECTOR)
    ("potential ligands" . SPARSER::LIGAND) ("PMA" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trigger" . SPARSER::PROTEIN) ("Antibody" . SPARSER::ANTIBODY)
    ("components" . SPARSER::COMPONENT)
    ("accessory molecules" . SPARSER::MOLECULE) ("calcium" . SPARSER::CALCIUM)
    ("ITAMs" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN) ("LAT" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("Src" . SPARSER::PROTEIN) ("CD59 and CD3" . SPARSER::COLLECTION)
    ("/CD3" . SPARSER::COLLECTION) ("anti-CD3ε-" . SPARSER::ANTIBODY)
    ("molecule" . SPARSER::MOLECULE) ("GPI" . SPARSER::PROTEIN)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("CD55" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("S3 B" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("CD71)" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("Indo-1" . SPARSER::MOLECULE) ("protein A" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N1" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::PROTEIN) ("CD8a" . SPARSER::PROTEIN)
    ("CD3-zeta" . SPARSER::PROTEIN) ("IgG2a" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("CD3 complex" . SPARSER::PROTEIN) ("CD3ζ" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("CD3ε" . SPARSER::PROTEIN) ("CD59" . SPARSER::PROTEIN)
    ("state" . SPARSER::BIO-STATE) ("side" . SPARSER::PROTEIN)
    ("the canine KRAS gene" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("nos" . SPARSER::PROTEIN)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("HER-2 and EGFR" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("glycine" . SPARSER::AMINO-ACID)
    ("CGT" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("foci" . SPARSER::PROTEIN)
    ("case" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("histological type" . TYPE) ("n " . SPARSER::PROTEIN)
    ("trastuzumab and cetuximab" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY)
    ("canine EGFR and HER-2 tumour-associated antigens"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antigens" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cetuximab" . SPARSER::DRUG)
    ("FISH" . SPARSER::PROTEIN) ("the primary HER-2" . SPARSER::PROTEIN)
    ("trastuzumab" . SPARSER::DRUG) ("Trastuzumab" . SPARSER::DRUG)
    ("HER-2 and their activating ligands" . SPARSER::COLLECTION)
    ("ligands" . SPARSER::LIGAND) ("EGF" . SPARSER::PROTEIN)
    ("HER-1, HER-2, HER-3 and HER-4" . SPARSER::COLLECTION)
    ("c-erbB-4" . SPARSER::COLLECTION) ("c-erbB-3" . SPARSER::COLLECTION)
    ("ligand" . SPARSER::LIGAND) ("extracellular" . SPARSER::PROTEIN)
    ("the most significant innovative targets" . SPARSER::TARGET-PROTEIN)
    ("HER" . SPARSER::PROTEIN) ("drug" . SPARSER::DRUG)
    ("prognostic and therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("EGFR and HER-2" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN) ("type" . TYPE)
    ("EGFR/HER-2" . SPARSER::COLLECTION)
    ("EGFR/HER-2/KRAS" . SPARSER::COLLECTION) ("drugs" . SPARSER::DRUG)
    ("KRAS" . SPARSER::PROTEIN) ("EGFR or HER-1" . SPARSER::COLLECTION)
    ("c-erbB-2" . SPARSER::COLLECTION) ("kinases" . SPARSER::KINASE)
    ("tyrosine" . SPARSER::AMINO-ACID) ("analog" . SPARSER::ANALOG)
    ("EGFR" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("erb-B2" . SPARSER::PROTEIN)
    ("citric acid" . SPARSER::MOLECULE)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("de-" . SPARSER::MOLECULE)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("HER-4" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("erbB-4" . SPARSER::PROTEIN) ("erbB-3" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("erbB-2" . SPARSER::PROTEIN) ("HER-1" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mediators" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECM" . SPARSER::PROTEIN)
    ("the myocardial matrix" . SPARSER::PROTEIN-FAMILY)
    ("Collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("form heterooligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("Cav-1 and Cav-3" . SPARSER::COLLECTION) ("rat" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("adrenergic" . SPARSER::PROTEIN)
    ("protein and mRNA" . SPARSER::COLLECTION) ("ischemia" . SPARSER::PROTEIN)
    ("the predominant caveolin isoform" . SPARSER::ISOFORM)
    ("caveolin" . SPARSER::PROTEIN) ("pro" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN)
    ("three principal matrix metalloproteinase collagenases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-1, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Scr" . SPARSER::PROTEIN)
    ("Western blot" . SPARSER::PROTEIN) ("MTT" . SPARSER::MOLECULE)
    ("exogenous TGF-β1" . SPARSER::PROTEIN)
    ("TGF-β1 and Cav-1" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN)
    ("Cav-2 and Cav-3" . SPARSER::COLLECTION)
    ("AF and SR" . SPARSER::COLLECTION)
    ("ejection fraction and degrees" . SPARSER::COLLECTION)
    ("SR and AF" . SPARSER::COLLECTION) ("SR" . SPARSER::PROTEIN)
    ("atrial Cav-1" . SPARSER::PROTEIN) ("CSD" . SPARSER::PROTEIN)
    ("MMP-8 and MMP-13" . SPARSER::COLLECTION) ("mRNAs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitor" . SPARSER::INHIBITOR)
    ("Cav-1 and Cav-2" . SPARSER::COLLECTION) ("variety" . SPARSER::VARIETY)
    ("macromolecules" . SPARSER::MOLECULE) ("past" . SPARSER::PROTEIN)
    ("omega" . SPARSER::PROTEIN) ("peptides" . SPARSER::PEPTIDE)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HAFs" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN) ("collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the principal structural component" . SPARSER::COMPONENT)
    ("component" . SPARSER::COMPONENT) ("AF" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("P2X7" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase " . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN)
    ("transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("CO2" . SPARSER::PROTEIN) ("amino acids" . SPARSER::AMINO-ACID)
    ("Smad 3" . SPARSER::PROTEIN) ("Smad 2" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-8" . SPARSER::PROTEIN)
    ("Cav-3" . SPARSER::PROTEIN) ("caveolin-3" . SPARSER::PROTEIN)
    ("Cav-2" . SPARSER::PROTEIN) ("caveolin-2" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN)
    ("transforming growth factor-β1" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("other clinically relevant factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("group" . SPARSER::MOLECULE) ("cut" . SPARSER::PROTEIN)
    ("qualitative gel-based MSP" . SPARSER::PROTEIN)
    ("nimotuzumab" . SPARSER::DRUG) ("cilengitide" . SPARSER::DRUG)
    ("antagonist" . SPARSER::MOLECULE) ("adjuvant" . SPARSER::DRUG)
    ("a strong clinically relevant factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RT and TMZ" . SPARSER::COLLECTION) ("Group" . SPARSER::MOLECULE)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("stars" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("the predictive impact" . SPARSER::PROTEIN) ("simple" . SPARSER::PROTEIN)
    ("PFS" . SPARSER::PROTEIN)
    ("a significant prognostic impact" . SPARSER::PROTEIN)
    ("HR " . SPARSER::PROTEIN) ("methylated MGMT promoter" . SPARSER::PROMOTER)
    ("formalin" . SPARSER::MOLECULE) ("MSP" . SPARSER::PROTEIN)
    ("Promoter" . SPARSER::PROMOTER)
    ("a methylated MGMT promoter" . SPARSER::PROMOTER)
    ("a predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biologic" . SPARSER::DRUG) ("NOS" . SPARSER::PROTEIN)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("seven" . SPARSER::PROTEIN)
    ("cohort" . SPARSER::MOLECULE) ("II" . SPARSER::PROTEIN)
    ("III" . SPARSER::PROTEIN) ("aim" . SPARSER::PROTEIN)
    ("TMZ and RT" . SPARSER::COLLECTION) ("DNA-repair" . SPARSER::DNA)
    ("guanine" . SPARSER::PROTEIN) ("biomarker" . SPARSER::MOLECULE)
    ("age" . SPARSER::PROTEIN) ("RT" . SPARSER::PROTEIN)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("HR" . SPARSER::PROTEIN)
    ("TMZ" . SPARSER::DRUG) ("temozolomide" . SPARSER::DRUG)
    ("CI" . SPARSER::PROTEIN) ("MGMT" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CI 1" . SPARSER::PROTEIN) ("Chi 2  " . SPARSER::PROTEIN)
    ("Chi 2" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN) ("DNA methyltransferase" . SPARSER::PROTEIN)
    ("IL-2 and Interferon-γ" . SPARSER::COLLECTION)
    ("inhibitors" . SPARSER::INHIBITOR) ("Interferon-γ" . SPARSER::PROTEIN)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("RAS-MEK" . SPARSER::COLLECTION) ("phosphatase" . SPARSER::PHOSPHATASE)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("Cofilin" . SPARSER::PROTEIN) ("WASP and WAVE2" . SPARSER::COLLECTION)
    ("cofilin and COTL1" . SPARSER::COLLECTION) ("red" . SPARSER::PROTEIN)
    ("LatB" . SPARSER::DRUG) ("pyrene" . SPARSER::PROTEIN)
    ("spikes" . SPARSER::PROTEIN) ("GST-RalGDS" . SPARSER::COLLECTION)
    ("GTP" . SPARSER::NUCLEOTIDE) ("RalGDS" . SPARSER::PROTEIN)
    ("GST" . SPARSER::PROTEIN) ("integrin" . SPARSER::PROTEIN)
    ("chemokine" . SPARSER::PROTEIN) ("period" . SPARSER::PROTEIN)
    ("GFP-actin" . SPARSER::COLLECTION) ("phalloidin" . SPARSER::MOLECULE)
    ("rhodamine" . SPARSER::PROTEIN) ("eGFP and mCherry" . SPARSER::COLLECTION)
    ("eGFP" . SPARSER::PROTEIN) ("H1p or pCMS3" . SPARSER::COLLECTION)
    ("mCherry" . SPARSER::PROTEIN) ("the pCMS3" . SPARSER::PROTEIN)
    ("pCMS" . SPARSER::PROTEIN) ("polymerized F-actin" . SPARSER::BIO-COMPLEX)
    ("min" . SPARSER::PROTEIN) ("fractions" . SPARSER::COMPONENT)
    ("SAC" . SPARSER::PROTEIN) ("superantigen" . SPARSER::MOLECULE)
    ("enterotoxin" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("COTL1 and F-actin" . SPARSER::COLLECTION) ("line" . SPARSER::PROTEIN)
    ("GFP" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("NKAP" . SPARSER::PROTEIN)
    ("activating protein (NKAP)" . SPARSER::PROTEIN)
    ("repressor" . SPARSER::REPRESSOR)
    ("a potential novel regulator" . SPARSER::REGULATOR)
    ("a potential regulator" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR) ("lysine" . SPARSER::AMINO-ACID)
    ("globular (G)-actin" . SPARSER::COLLECTION)
    ("cofilin, COTL1 and cofilin" . SPARSER::COLLECTION)
    ("Coactosin" . SPARSER::PROTEIN) ("Abp1/drebrins" . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION) ("drebrins" . SPARSER::PROTEIN)
    ("new actin" . SPARSER::PROTEIN) ("monomers" . SPARSER::MONOMER)
    ("actin depolymerizing factor-homology" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("ADP" . SPARSER::PROTEIN)
    ("ATP" . SPARSER::ATP) ("profilin" . SPARSER::PROTEIN)
    ("impact" . SPARSER::PROTEIN)
    ("HS1 and several other proteins" . SPARSER::COLLECTION)
    ("mDia" . SPARSER::PROTEIN) ("WASP" . SPARSER::PROTEIN)
    ("-actin" . SPARSER::COLLECTION) ("factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APC" . SPARSER::PROTEIN)
    ("peptide-major histocompatibility complexes" . SPARSER::BIO-COMPLEX)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("APCs" . SPARSER::PROTEIN)
    ("complexes" . SPARSER::BIO-COMPLEX) ("peptide" . SPARSER::PEPTIDE)
    ("antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COTL1 and cofilin" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mutant" . SPARSER::MUTANT)
    ("regulators" . SPARSER::REGULATOR) ("coactosin" . SPARSER::PROTEIN)
    ("Actin depolymerizing factor-homology" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("actin" . SPARSER::PROTEIN)
    ("family" . SPARSER::PROTEIN-FAMILY) ("ADF" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) (NIL . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K" . SPARSER::PROTEIN-FAMILY) ("SSH1L" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("activating protein" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("CO 2" . SPARSER::PROTEIN)
    ("Latrunculin B" . SPARSER::DRUG) ("Mg 2+" . SPARSER::MOLECULE)
    ("MgCl 2" . SPARSER::MOLECULE) ("SDF-1" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("for 3" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("T1B" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("H1p" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("Zap70" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Abp1" . SPARSER::PROTEIN)
    ("actin depolymerizing factor" . SPARSER::PROTEIN)
    ("HS1" . SPARSER::PROTEIN) ("IQGAP1" . SPARSER::PROTEIN)
    ("WAVE2" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("COTL1" . SPARSER::PROTEIN)
    ("Actin depolymerizing factor" . SPARSER::PROTEIN) ("class" . CLASS)
    ("molecules" . SPARSER::MOLECULE) ("n" . SPARSER::PROTEIN)
    ("LNA, AA, and DHA" . SPARSER::COLLECTION) ("IDAX" . SPARSER::PROTEIN)
    ("monocytes" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("enzymes" . SPARSER::ENZYME) ("RNA" . SPARSER::RNA)
    ("elongation" . SPARSER::PROTEIN)
    ("factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intronic chromatin conformation" . SPARSER::BIO-CONFORMATION)
    ("the proximal promoter region upstream exon" . SPARSER::PROTEIN)
    ("EPA and other PUFA" . SPARSER::COLLECTION)
    ("complex" . SPARSER::BIO-COMPLEX) ("Ras/MEK/ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an accessible chromatin" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION) ("antibody" . SPARSER::ANTIBODY)
    ("ChIP" . SPARSER::PROTEIN)
    ("RNA Polymerase II and p53" . SPARSER::COLLECTION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("Bisulfite" . SPARSER::MOLECULE)
    ("the methylated cytosines" . SPARSER::NUCLEOBASE)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bisulfite" . SPARSER::MOLECULE) ("Ras and H-Ras" . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE) ("aza" . SPARSER::DRUG) ("ATG" . SPARSER::DRUG)
    ("exon" . SPARSER::PROTEIN) ("EPA and OA" . SPARSER::COLLECTION)
    ("H-Ras and N-Ras" . SPARSER::COLLECTION)
    ("potential inactive and active inducers" . SPARSER::MOLECULE)
    ("inactive and active" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE) ("inactive" . SPARSER::INACTIVE)
    ("H-Ras, N-Ras and K-Ras" . SPARSER::COLLECTION) ("classes" . CLASS)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("Proteins" . SPARSER::PROTEIN)
    ("ERK/C/EBPβ" . SPARSER::COLLECTION)
    ("membrane-associated signaling proteins" . SPARSER::PROTEIN)
    ("isoforms" . SPARSER::ISOFORM) ("lipid" . SPARSER::LIPID)
    ("Ras/ERK" . SPARSER::COLLECTION) ("post" . SPARSER::PROTEIN)
    ("LNA, AA, EPA, and DHA" . SPARSER::COLLECTION) ("LA" . SPARSER::PROTEIN)
    ("DHA" . SPARSER::PROTEIN) ("AA" . SPARSER::MOLECULE)
    ("LNA" . SPARSER::PROTEIN) ("mRNA and protein" . SPARSER::COLLECTION)
    ("mRNA" . SPARSER::RNA) ("isoform" . SPARSER::ISOFORM)
    ("Ras/ERK/C/EBPβ" . SPARSER::COLLECTION) ("receptors" . SPARSER::RECEPTOR)
    ("cytokine" . SPARSER::PROTEIN) ("fate" . SPARSER::PROTEIN)
    ("an essential step" . SPARSER::PROTEIN) ("step" . SPARSER::PROTEIN)
    ("proteins" . SPARSER::PROTEIN) ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Thr" . SPARSER::AMINO-ACID) ("form" . SPARSER::FORM)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("dietary polyunsaturated fatty acid (PUFA)" . SPARSER::MOLECULE)
    ("the associated genes" . SPARSER::GENE)
    ("chromatin" . SPARSER::BIO-COMPLEX) ("types" . TYPE)
    ("cytosine" . SPARSER::NUCLEOBASE)
    ("polyunsaturated fatty acid (PUFA)" . SPARSER::MOLECULE)
    ("PUFA" . SPARSER::PROTEIN) ("RNAPII" . SPARSER::PROTEIN)
    ("CpG" . SPARSER::PROTEIN) ("fraction" . SPARSER::COMPONENT)
    ("gene" . SPARSER::PROTEIN) ("activator" . SPARSER::ACTIVATOR)
    ("C/EBPβ and ERK1/2" . SPARSER::COLLECTION)
    ("RAS/ERK/C/EBPβ" . SPARSER::COLLECTION) ("forms" . SPARSER::FORM)
    ("active" . SPARSER::ACTIVE) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/C/EBPβ" . SPARSER::COLLECTION)
    ("RAS/extracellular signal regulated kinases" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("aims" . SPARSER::PROTEIN)
    ("heterodimer" . SPARSER::HETERODIMER) ("EBP" . SPARSER::PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("CCAAT" . SPARSER::PROTEIN)
    ("EPA" . SPARSER::PROTEIN)
    ("potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("genes" . SPARSER::GENE) ("suppressor" . SPARSER::SUPPRESSOR)
    ("DNA" . SPARSER::DNA) ("TET2" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("Fatty acid" . SPARSER::MOLECULE) ("monoclonal antibody" . SPARSER::DRUG)
    ("Anti-β" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("pERK1/2" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("-3" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("N-Ras" . SPARSER::PROTEIN) ("and 1" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("fatty acid" . SPARSER::MOLECULE)
    ("serum albumin" . SPARSER::PROTEIN)
    ("docosahexaenoic acid" . SPARSER::MOLECULE) ("n-3" . SPARSER::PROTEIN)
    ("Oleic acid" . SPARSER::MOLECULE)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("p53" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C/EBPβ" . SPARSER::PROTEIN) ("tumor suppressor gene" . SPARSER::PROTEIN)))